RA12-015, Annual Radioactive Effluent Release Report

Annual Radioactive Effluent Release Report

ML12116A148
Person / Time
Site:	LaSalle
Issue date:	04/20/2012
From:	Rhoades D Exelon Nuclear, Exelon Generation Co
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
RA12-015
Download: ML12116A148 (512)

Text

{{#Wiki_filter:Exelkn. LaSalle Generating Station 26ol North 21st Road Marseilles, IL 61341-9757 www.exeloncorp.coM Nucear RA12-015 10 CFR 50.36a April 20, 2012 U. S. Nuclear Regulatory Commission Attention: Document Control Desk Washington, D.C. 20555 LaSalle County Station, Units I and 2 Facility Operating License Nos. NPF-1 1 and NPF-18 NRC Docket Nos. 50-373 and 50-374

Subject:

2011 Annual Radioactive Effluent Release Report Enclosed is the Exelon Generation Company, LLC, 2011 Annual Radioactive Effluent Release Report for LaSalle County Station, submitted in accordance with 10 CFR 50.36a, "Technical specifications on effluents from nuclear power reactors," paragraph (a)(2), and Technical Specification 5.6.3, "Radioactive Effluent Release Report." Should you have any questions concerning this letter, please contact Mr. Terrence Simpkin, Regulatory Assurance Manager, at (815) 415-2800. Respectfully, David P. Rhoades Site Vice President LaSalle County Station

Attachment:

2011 Effluent and Waste Disposal Annual Report cc: Regional Administrator - NRC Region III NRC Senior Resident Inspector - LaSalle County Station

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SUPPLEMENTAL INFORMATION

1. Regulatory Limits

a. Gaseous Effluents

1) The air dose due to noble gases released in gaseous effluents, from each reactor unit, from the site shall be limited to the following:

a) During any calendar quarter: Less than or equal to 5 mrad for gamma radiation and less than or equal to 10 mrad for beta radiation, and b) During any calendar year: Less than or equal to 10 mrad for gamma radiation and less than or equal to 20 mrad for beta radiation.

2) The dose to an individual from radioiodines and radioactive materials in particulate form, and radionuclides, other than noble gases, with half-lives greater than eight days in gaseous effluents released, from each reactor unit, from the site shall be limited to the following:

a) During any calendar quarter: Less than or equal to 7.5 mRem to any organ, and b) During any calendar year: Less than or equal to 15 mRem to any organ.

b. Liquid Effluents

1) The dose or dose commitment to an individual from radioactive materials in liquid effluents released, from each reactor unit, from the site shall be limited:

a) During any calendar quarter: Less than or equal to 1.5 mRem to the total body and to less than or equal to 5 nmRem to any organ, and b) During any calendar year: Less than or equal to 3 mRem to the total body and to less than or equal to 10 mRem to any organ.

c. Total Dose

1) The dose or dose commitment to any member of the public, due to releases or radioactivity and radiation. from uranium fuel cycle sources shall be limited to less than or equal to 25 mRem to the body or any organ (except the thyroid, which shall be limited to less than or equal to 75 mRem) over 12 consecutive months.

2. Allowable Concentrations

a. Gaseous Effluents

1) The dose rate due to radioactive materials released in gaseous effluents from the site shall be limited to the following:

a) For noble gases: Less than or equal to 500 mRem/year to the total body and less than or equal to 3000 mRem/year to the skin, and b) For all radioiodines and for all radioactive materials in particulate form, and radionuclides, other than noble gases, with half-lives greater than eight days: Less than or equal to 1500 mRem/year to any organ via the inhalation pathway.

b. Liquid Effluents Page 1 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SUPPLEMENTAL INFORMATION

1) The concentration of radioactive material released from the site shall be limited to ten (10) times the concentrations specified in 10 CFR Part 20, Appendix B, Table II, Column 2 for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to the following:

Nuclide DWC (pCi/mL) Kr-85m 2.00E-04 Kr-85 5.OOE-04 Kr-87 4.OOE-05 Kr-88 9.OOE-05 Xe-131m 7.OOE-04 Xe-133m 5.OOE-04 Xe-133 6.OOE-04 Xe-135m 2.OOE-04 Xe- 135 2.00E-04 Ar-41 7.OOE-05

3. Average Energy

1) Not applicable - average energy is no longer used to determine dose to the public.

4. Measurements and Approximations of Total Radioactivity

a. Gaseous Effluents I) Containment Vent and Purge System is sampled by grab sample, which is analyzed for principal gamma emitters and H-3.

2) Main Vent Stack is sampled by grab sample, which is analyzed for principal gamma emitters and H-3.

3) Standby Gas Treatment System is sampled by grab sample, which is analyzed for principal gamma emitters.

4) All release types as listed in 1 and 2 above are sampled at the vent stack, and those listed in 3 above are sampled at the Standby Gas Treatment System whenever there is flow. These effluents are continuously sampled by charcoal cartridge and particulate filter paper, which are analyzed for iodines and principal gamma emitters. Particulate filter papers are composited and analyzed for gross alpha, Sr-89 and Sr-90. Noble gases, gross beta and gamma are continuously monitored by noble gas monitors for the vent stack and the standby gas treatment system.

5) The LaSalle County Station estimate of 17.01Ci/Unit/year of C-14 (in the dioxide fraction) is based upon a normalized C- 14 production rate of 5.1 Ci/GWt-yr, a gaseous release fraction of 0.99, a C-14 dioxide fraction of 0.95, a reactor power rating of 3546 MWt (per Unit) and equivalent full power operation of 365 days.

b. Liquid Effluents

1) Batch waste release tanks are sampled each batch for principal gamma emitters, 1-131, dissolved and entrained noble gases, H-3, gross alpha, Sr-89, Sr-90 and Fe-55.

Page 2 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SUPPLEMENTAL INFORMATION

2) Continuous releases are sampled continuously in proportion to the rate of flow of the effluent stream and by grab sample. Samples are analyzed for principal gamma emitters, 1-13 1, dissolved and entrained noble gases, H-3, gross alpha, Sr-89, Sr-90 and Fe-55.

5. Batch Releases

a. Gaseous

1) Number of batch releases: None

2) Total time period for batch releases: N/A

3) Maximum time period for a batch release: N/A

4) Average time period for batch releases: N/A

5) Minimum time period for a batch release: N/A

b. Liquid

1) Number of batch releases: None

2) Total time period for batch releases: Min. N/A

3) Maximum time period for a batch release: Min. N/A

4) Average time period for batch releases: Min. N/A

5) Minimum time period for a batch release: Min. N/A

6) Average stream flow during periods of release of effluent into a flowing stream: gpin N/A

6. Abnormal Releases

a. Gaseous

1) Number of releases: None

2) Total activity released: N/A

b. Liquid

1) Number of releases: None

2) Total activity released: N/A

7. Process Control Program In the 2011 period, there were no changes to the Process Control Program (PCP) implementation, processing systems or components.

8. Effluent Monitoring Instrumentation timneclocks and sample anomalies.

a. Time clocks:

Page 3 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SUPPLEMENTAL INFORMATION There were no effluent monitoring time clocks exceeded in 2011.

b. Sample anomalies:

There were no sampling anomalies affecting the measurement of effluents experienced during 2011. On March 11. 2011, an earthquake off the east coast of Japan triggered a massive tsunami that ultimately caused nuclear accidents to four of the six Fukushima Daiichi reactors. The radioactive plume reached the United States, where low levels of radioactivity were measured at nearly all nuclear reactor sites. These low levels of radioactivity were not related to licensed operations at LaSalle County Station, and did not impact effluent data. During regular quarterly groundwater sampling in accordance with LaSalle's Radiological Groundwater Protection Program (RGPP), tritium was detected at concentrations above the LLD in the South Storm Water Pond during the 3rd and 4 1hquarters of 2011. The South Storm Water Pond interfaces with the Condenser Discharge, which flows to the Cooling Pond, and the Cooling Pond ultimately blows down to the Illinois River. This issue was captured in the Corrective Action Program (CAP). No other nuclides were detected, and no tritium has been found to have migrated off site. This tritium is attributed to the migration of the plume resultant from the U I CY tank leak in 2010., which was documented in the 2010 Annual Radioactive Effluent Release Report (ARERR) and the 2010 Annual Radiological Environmental Operating Report (AREOR). The plume is migrating in an expected manner based on observed hydrogeological conditions at LaSalle County Station. Though no measurable tritium has been detected offsite, a bounding study was performed using the amount of tritium released to groundwater during the 2010 event. This bounding study concluded that the tritium and dose to a member of the public from the migration of the existing plume was not a significant contribution to the total dose attributed to licensed operations at LaSalle County Station based on guidance put forth by the USNRC in Regulatory Guide 1.109. Because tritium was not detected in the Cooling Pond blow down to the Illinois River, LaSalle County Station's permitted liquid effluent pathway, no liquid release was reported for 2011. Tritium results were detected at concentrations above the LLD in the waste water treatment facility (WWTF) effluent during March of 2011, and this issue was captured in the CAP. The source was traced back to an input in the plant that flows to the WWTF, which presents a potential pathway for low level tritium in the WWTF. The effluent of the WWTF empties into the Cooling Pond, and the Cooling Pond ultimately blows down to the Illinois River. No other nuclides were detected, and no tritium has been found to have migrated off site. A bounding study was performed using conservative assumptions. This bounding study concluded that the tritium and dose to a member of the public from the potential pathway was not a significant contribution to the total dose attributed to licensed operations at LaSalle County Station based on guidance put forth by the USNRC in Regulatory Guide 1.109. Because tritium was not detected in the Cooling Pond blow down to the Illinois River, LaSalle County Station's permitted liquid effluent pathway, no liquid release was reported for 2011.

9. Offsite Dose Calculation Manual Revisions.

There was one revision made to the ODCM in 2011. Changes included editorial/grammatical corrections, changes related to implementation of new effluent calculation software, changes related to radwaste discharges, and changes related to source check definition. Formatting and other presentation differences in this report compared to past annual reports are a result of the transistion to the newly implemented effluent software utilized at LaSalle County Station. Page 4 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SUPPLEMENTAL INFORMATION Each change had a determination performed, in accordance with ODCM revision procedures, to ensure the change would not adversely impact accuracy or reliability of effluent, dose or set point calculations and will maintain the level of radiological effluent controls established by regulatory requirements. The determinations indicated no adverse impacts. A copy of the ODCM Change Summary Matrix for revision 3 has been included as Appendix A to this report. Also, a copy of revision 3 to the ODCM has been included as Appendix B to this report. All changes in revision 3 to the LaSalle Station ODCM became effective 05/12/2011. Page 5 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) UNITS ONE AND TWO DOCKET NUMBERS 50-373 AND 50-374 GASEOUS EFFLUENTS SUMMATION OF ALL RELEASES Es.Total A. Fission & Activation Gases Unit Quarter 1 Quarter 2 Quarter 3 Quarter4 Erroral Error %

1. Total Release Ci 3.45E+02 5.08E+02 7.69E+02 7.89E+02 2.50E+01

-2. Average release rate for the period          pCi/sec     4.43E+01     6.46E+01    9.68E+01    9.92E+01

3. Percent of ODCM limit  %....

B. Iodine

1. Total Iodine - 131. Ci 1.09E-02 2.72E-03 4.24E-03 8.22E-03 1.50E+01

2. Average release rate for the period pCi/sec 1.41 E-03 3.46E-04 5.33E-04 1.03E-03

3. Percent of ODCM limit  % ....

C. Particulates

1. Particulates with half-lives > 8 days Ci 4.44E-04 4.77E-04 4.77E-03 5.96E-03 3.50E+01

-2. Average release rate for the period          paCi/sec     5.70E-05     6.07E-05    6.OOE-04    7.50E-04

3. Percent of ODCM limit  % ....

D. Tritium

1. Total Release Ci 5.53E+00 9.66E+00 1.03E+01 1.54E+01 1.50E+01

2. Average release rate for the period l, Ci/sec 7.11 E-01 1.23E+00 1.30E+00 1.93E+00

3. Percent of ODCM limit  %*....

E. Gross Alpha I

1. Total Release Ci <1.00E-11 <1.00E-11 <1.OOE-11 <1.O0E-11 3.50E+01

12. Average release rate for the period RCi/sec I <LLD I <LLD I <LLD I <LLD

13. Percent of ODCM limit  % ....

F. Carbon-14

1. Total Release Ci 8.39E+00 8.47E+00 8.61 E+00 8.60E+00

2. Average release rate for the period pCi/sec 1.08E+00 1.08E+00 1.08E+00 1.08E+00

3. Percent of ODCM limit  % ....

This information is contained in the Radiological Impact on Man section of the report.

 "<"  Indicates activity of sample is less than LLD given in pCi/ml Page 6 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) GASEOUS EFFLUENTS ELEVATED RELEASE UNIT I AND UNIT 2 Nuclides Released I II Continuous Mode Batch Mode rt; f ] UnitL__uartjUi Quarter I Quarter j Quarter Quarter Quarter 1 Quarter Quarter -A. Fission gases - . . .;>...__. ._..._" , . . . . Kr-85m Ci 1.19E+02 1.31E+02 1.75E+02 1.81E+02 N/A N/A N/A N/A Kr-87 Ci 1.49E+01 1.38E+01 9.34E+00 1.12E+01 N/A N/A N/A N/A Kr-88 Ci 1.79E+02 2.14E+02 2.94E+02 2.98E+02 N/A N/A N/A N/A Xe-133m Ci <1.OOE-04 <1.OOE-04 <1.OOE-04 <1.OOE-04 N/A N/A N/A N/A Xe-133 Ci 3.20E+01 1.49E+02 2.92E+02 2.98E+02 N/A N/A N/A N/A Xe-135 Ci 4.40E-02 6.56E-03 1.48E-02 1.41 E-02 N/A N/A N/A N/A Xe-138 Ci <1.OOE-04 <1.OOE-04 <1.OOE-04 <1.OOE-04 N/A N/A N/A N/A Ar-41 Ci 8.14E-03 2.53E-02 1.18E-02 1.55E-02 N/A N/A N/A N/A Total for Period Ci 3.45E+02 5.08E+02 7.69E+02 7.89E+02 N/A N/A N/A N/A ..B. Iodines ok 1-131 Ci 1.09E-02 2.72E-03 4.24E-03 8.22E-03 N/A N/A N/A N/A 1-132 Ci 7.79E-03 8.27E-04 1.64E-03 1.28E-02 N/A N/A N/A N/A 1-133 Ci 1.63E-02 4.69E-03 1.09E-02 2.15E-02 N/A N/A N/A N/A 1-134 Ci 2.61E-04 <1.OOE-11 <1.O0E-11 1.23E-02 N/A N/A N/A N/A 1-135 Ci 1.16E-02 <1.O0E-1I <1.O0E-11 1.77E-02 N/A N/A N/A N/A Total for Period Ci 4.69E-02 8.24E-03 1.68E-02 7.25E-02 N/A N/A N/A N/A Tot.1-131,1-133,1-135 Ci 3.89E-02 7.42E-03 1.51E-02 4.75E-02 N/A N/A N/A N/A C. Particulates __ _ ___ _ _ '._ _ _ _ Mn-54 Ci <1.00E- 11 <1.00E-1I <1.OE- 1I <1.00E- II N/A N/A N/A N/A Co-58 Ci <1.OOE-11 <1.OE-11 2.96E-05 1.76E-04 N/A N/A N/A N/A Fe-59 Ci <1.O0E-11 <1.O0E-11 <1.O0E-11 <1.00E-il1 N/A N/A N/A N/A Co-60 Ci 1.62E-04 1.06E-04 4.15E-04 4.93E-04 N/A N/A N/A N/A Zn-65 Ci <1.O0E-11 <1.O0E-11 1.81 E-04 2.20E-04 N/A N/A N/A N/A Sr-89 Ci 1.82E-04 1.42E-04 3.99E-04 2.07E-04 N/A N/A N/A N/A Sr-90 Ci <1.O0E-11 <1.O0E-11 <1.O0E-11 <1.OOE-11 N/A N/A N/A N/A Mo-99 Ci <1.OOE-11 7.83E-05 7.57E-04 1.15E-03 N/A N/A N/A N/A Cs-134 Ci <1.O0E-11 <1.00E-11 <1.00E-11 <1.00E-11 N/A N/A N/A N/A Cs-137 Ci 7.57E-08 <1.OE-11 <1.00E-11 <1.OOE-11 N/A N/A N/A N/A Ba-140 Ci 9.93E-05 <l.00E-11 6.40E-04 5.66E-04 N/A N/A N/A N/A La-140 Ci <1.O0E-11 1.51E-04 2.35E-03 3.15E-03 N/A N/A N/A N/A Ce-141 Ci <1.00E-11 <1.OOE-11 <1.OOE-11 <1.OOE-11 N/A N/A N/A N/A Ce- 144 Ci <1.OE-11 <1.OE-11 <1.OOE-11 <1.OOE-11 N/A N/A N/A N/A Total for Period Ci 4.44E-04 4.77E-04 4.77E-03 5.96E-03 N/A N/A N/A N/A D. Tritium ___ _ _ `7__ , H-3 Total for Period Ci 5.53E+00 9.66E+00 1.03E+01 1.54E+01 N/A N/A N/A N/A E. Gross Alpha _____l ________ jJ MEN____ "____M_ ______________ 1W-0 ___ Gross Alpha Total for Ci Period <1.OE-11 <1.OE-11 <1.OE-11 <1 00E-11 N/A N/A N/A N/A F. Carbon-14 _C Jeio 84+ 8.61W+00 w N/A m6E0N/A N/A N/A C-14 Total for Pero Ci [8.39E+00 8.47E+00 1 8.61 E+00 8.60E,00 I[ N/A [ N/A ] N/A [ N/A Page 7 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) LIQUID RELEASES UNIT I AND UNIT 2 SUMMATION OF ALL LIQUID RELEASES A. Fission & Activation Products Unit Quarter 1 Quarter 2 Quarter 3 Quarter4 Est. Total Error %

1. Total Release (not including tritium, gases Ci <LLD <LLD <LLD <LLD N/A

& alpha)

2. Average diluted concentration during gCi/ml <LLD <LLD <LLD <LLD period _____/mL <LD <LLD <L

3. Percent of applicable limit  %....

B. Tritium

1. Total Release Ci <LLD <LLD <LLD <LLD N/A

2. Average diluted concentration during .iCifmL <LLD <LLD <LLD <LLD period _____/mL <LLD <LLD <LLD <LLD

3. Percent of applicable limit  %*.

C. Dissolved & Entrained Gases

1. Total Release Ci <LLD <LLD <LLD <LLD N/A

2. Average diluted concentration during period !tim <LLD LD <LLD

                                                                             <L           LD
                                                                                         <LLD        <L
                                                                                                     <LLD                1lCi/mL

3. Percent of applicable limit  % ....

D. Gross Alpha Activity

1. Total Release Ci <LLD Eý= 1

                                                                             <LLD        <LLD        <LLD        N/A     J

2. Average release rate for the period pCi/mL <LLD <LLD <LLD <LLD 3 Percent of ODCM limit  % [..*

E. Volume of Waste Released (prior to Liters O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 dilution) I I I F. Volume of Dilution Water Used During Liters O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Period I I. I I I I ... This information is contained in the Radiological Impact on Man section of the report. "<" Indicates activity of sample is less than LLD given in pCi/ml Page 8 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) LIQUID RELEASES UNIT 1 AND UNIT 2 Nuclides Released [ 11 Continuous Mode -___ Batch Mode A. Fission & Quarter Quarter I Quarter I Quarter 1 Quarter Quarter Quarter Quarter Activation Products Uni 1 2 J 3 1 4 1 2 3 4 Mn-54 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Fe-55 Ci <1.OOE-06 <1.OOE-06 <1.OOE-06 <1.OOE-06 N/A N/A N/A N/A Co-58 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Fe-59 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Co-60 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Zn-65 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Sr-89 Ci <5.OOE-08 <5.OOE-08 <5.OOE-08 <5.OOE-08 N/A N/A N/A N/A Sr-90 Ci <5.OOE-08 <5.OOE-08 <5.OOE-08 <5.OOE-08 N/A N/A N/A N/A Mo-99 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.0OE-07 N/A N/A N/A N/A 1-131 Ci <1.OOE-06 <1.OOE-06 <1.OOE-06 <1.OOE-06 N/A N/A N/A N/A Cs-134 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Cs-137 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Ce-141 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Ce-144 Ci <5.OOE-07 <5.OOE-07 <5.OOE-07 <5.OOE-07 N/A N/A N/A N/A Total for Period Ci <LLD <LLD <LLD <LLD N/A N/A N/A N/A H-3 Total for Period CiI <1.00E-05 . <1.OOE-05 <1.00E-05 <1 .OOE-05 N/A N/A N/A N/A C. Dissolved & 5U 1 1  ;,,<, 50 Entrained Gasses o_________ _ _ - . § j IN___ Min ' I Kr-85m Ci <1.OOE-05 <1.OOE-05 <1.OOE-05 <1.OOE-05 N/A N/A N/A N/A Kr-85 Ci <1.OOE-05 <1.OOE-05 <1.00E-05 <1.OOE-05 N/A N/A N/A N/A Kr-87 Ci <1.00E-05 <1.OOE-05 <1.OOE-05 <1.OOE-05 N/A N/A N/A N/A Kr-88 Ci <1.OOE-05 <1.OOE-05 <1.OOE-05 <1.00E-05 N/A N/A N/A N/A Xe-131m Ci <1.OOE-05 <1.OOE-05 <1.OOE-05 <1.OOE-05 N/A N/A N/A N/A Xe-133m Ci <1.OOE-05 <1.OOE-05 <1.00E-05 <1.OOE-05 N/A N/A N/A N/A Xe-133 Ci <1.OOE-05 <1.OQE-05 <1.00E-05 <1.OOE-05 N/A N/A N/A N/A Xe-135m Ci <1.OOE-05 <1.OOE-05 <1.OOE-05 <1.OOE-05 N/A N/A N/A N/A Xe-135 Ci <1.00E-05 <1.OOE-05 <1.00E-05 <1.00E-05 N/A N/A N/A N/A Ar-41 Ci <1.OOE-05 <1.OOE-05 <1.O0E-05 <1.00E-05 N/A N/A N/A N/A Total for Period Ci <LLD <LLD <LLD <LLD N/A N/A N/A N/A

0. Gross Alpha I ., ., .. _,. I ,. . 0 - .811, Gross Alpha Total for [Ci[ <1.O0E-07 <1.OGE-07 <1.00E-07 <1.00E-07 N/A N/A N/A N/A Period I II Page 9 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS FIRST QUARTER A. Solid Waste Shipped Offsite for Burial or Disposal (Not irradiated fuel)

1. Types of Waste Total Quantity Total Est. Total Types of Waste (M) Activity (Ci) Period Error (%)

a. Spent resins, filter sludges, evaporator bottoms, 7.62E+00 2.38E-01 1Q11 +/-25%

etc

b. Dry compressible waste, contaminated equip, etc 1.05E+03 1.42E+00 1Q11 +/-25%

c, Irradiated components, control rods, etc None None 1Q11 N/A

d. Other (water and oil, FW heater) 1.87E+02 1.46E-01 1Q11 +/-25%

2. Estimate of major nuclide composition (by waste type)

Percent Shipment Abundance Type(s) Major Nuclide Composition >1%)

a. Spent resins, filter sludges, evaporator bottoms, etc H-3 5.386% LSA C-14 19.806%

Mn-54 1.458% Fe-55 19.070% Co-60 47.236% Zn-65 6.230%

b. Dry compressible waste, contaminated equip, etc Cr-51 1.399% LSA Mn-54 6.847%

Fe-55 26.313% Co-60 57.826% Zn-65 3.792% 1-131 1.277%

c. Irradiated components, control rods, etc None N/A N/A

d. Other (water and oil, FW heater)

Cr-51 2.409% LSA Mn-54 6.855% Fe-55 25.149% Co-60 54.679% Zn-65 3.869% 1-131 3.372% La-140 1.366% Page 10 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS FIRST QUARTER

3. Solid Waste Disposition Number of Shipments Mode of Transportation Destination 4 Hittman Transport Clive Disposal Facility (Bulk) 20 Hittman Transport Energy Solutions - Bear Creek 4 Hittman Transport Energy Solutions - Gallaher B. Irradiated Fuel Shipments (disposition)

Number of Shipments Mode of Transportation Destination None N/A N/A C. Changes to the Process Control Program There were no changes to the Process Control Program during this period. Page 11 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS SECOND QUARTER A. Solid Waste Shipped Offsite for Burial or Disposal (Not irradiated fuel)

1. Types of Waste Total Quantity Total Est. Total Types of Waste (M) Activity (Ci) Period Error (%)

a. Spent resins, filter sludges, evaporator bottoms, 7.62E+00 9.48E-01 2Q11 +/-25%

etc

b. Dry compressible waste, contaminated equip, etc 1.96E+02 1.25E-01 2Q11 +/-25%

c. Irradiated components, control rods, etc None None 2Q11 N/A

d. Other (Water and Oil, filters & DAW HIC) 2.45E+01 2.11 E+00 2Q11 +/-25%

2. Estimate of major nuclide composition (by waste type)

Percent Shipment Abundance Type(s) Major Nuclide Composition (>1%)

a. Spent resins, filter sludges, evaporator bottoms, etc H-3 1.350% LSA C-14 21.301%

Mn-54 1.070% Fe-55 20.223% Co-60 50.437% Cs-137 3.687%

b. Dry compressible waste, contaminated equip, etc Cr-51 2.295% LSA Mn-54 6.940%

Fe-55 25.567% Co-60 55.640% Zn-65 3.910% 1-131 2.754%

c. Irradiated components, control rods, etc NoneJ N/A N/A

d. Other (Water and Oil, filters & DAW HIC)

Cr-51 1.887% LSA Mn-54 5.343% Fe-55 26.652% Co-60 58.375% Zn-65 2.681% 1-131 2.040% 1 Page 12 of 76

LASALLE COUNTY NUCLEAR POWER'STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS SECOND QUARTER

3. Solid Waste Disposition Number of Shipments Mode of Transportation Destination 1 Hittman Transport Clive Disposal Facility (Bulk) 5 Hittman Transport Energy Solutions - Bear Creek B. Irradiated Fuel Shipments (disposition)

Number of Shipments Mode of Transportation Destination None N/A N/A C. Changes to the Process Control Program There were no changes to the Process Control Program during this period. Page 13 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS THIRD QUARTER A. Solid Waste Shipped Offsite for Burial or Disposal (Not irradiated fuel)

1. Types of Waste Total Quantity Total Est. Total Types of Waste (M) Activity (Ci) Period Error (%)

a. Spent resins, filter sludges, evaporator bottoms, None None 3Q11 N/A etc

b. Dry compressible waste, contaminated equip, etc 7.25E+01 1.94E-02 3Q11 +/-25%

c. Irradiated components, control rods, etc None None 3Q11 N/A

d. Other (water and oil) 8.33E+00 3.34E-03 3Q11 N/A

2. Estimate of major nuclide composition (by waste type)

Percent Shipment Abundance Type(s) Major Nuclide Composition >1%)

a. Spent resins, filter sludges, evaporator bottoms, etc None[ N/A N/A

b. Dry compressible waste, contaminated equip, etc Cr-51 2.407% LSA Mn-54 6.839%

Fe-55 25.087% Co-60 54.545% Zn-65 3.860% 1-131 3.378% La-140 1.385%

c. Irradiated components, control rods, etc None[ N/A N/A

d. Other (water and oil)

Cr-51 2.411% LSA Mn-54 6.853% Fe-55 25.138% Co-60 54.656% Zn-65 3.867% 1-131 3.385% La-140 1.388% Page 14 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS THIRD QUARTER

3. Solid Waste Disposition Number of Shipments Mode of Transportation Destination 1 1 Hittman Transport Energy Solutions - Bear Creek L 1 Visionary Solutions Energy Solutions - Bear Creek B. Irradiated Fuel Shipments (disposition)

I Number of Shipments Mode of Transportation Destination I None N/A N/A C. Changes to the Process Control Program There were no changes to the Process Control Program during this period. Page 15 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS FOURTH QUARTER A. Solid Waste Shipped Offsite for Burial or Disposal (Not irradiated fuel)

1. Types of Waste Total Quantity Total Est. Total Types of Waste (M) Activity (Ci) Period Error %

a. Spent resins, filter sludges, evaporator bottoms, 7.62E+00 4.84E-01 4Q11 +/-25%

etc

b. Dry compressible waste, contaminated equip, etc 1.35E+02 1.64E+00 4Q11 +/-25%

c. Irradiated components, control rods, etc None None 4Q11 N/A

d. Other (Water and Oil) 1.60E+02 3.20E-02 4Q11 +/-25%

2. Estimate of major nuclide composition (by waste type)

Percent Shipment Abundance Type(s) Major Nuclide Composition >1%)

a. Spent resins, filter sludges, evaporator bottoms, etc H-3 2.641% LSA C-14 20.843%

Fe-55 19.928% Co-60 49.531% Cs-137 5.805%

b. Dry compressible waste, contaminated equip, etc Cr-51 2.198% LSA Mn-54 6.995%

Fe-55 25.855% Co-60 56.309% Zn-65 3.936% 1-131 2.278%

c. Irradiated components, control rods, etc None] N/A N/A

d. Other (Water and Oil)

Cr-51 2.430% LSA Mn-54 6.780% Fe-55 24.843% Co-60 53.999% Zn-65 3.828% 1-131 3.587% La-140 1.970% Page 16 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) SOLID WASTE AND IRRADIATED FUEL SHIPMENTS FOURTH QUARTER

3. Solid Waste Disposition Number of Shipments Mode of Transportation Destination 1 Hittman Transport Clive Disposal Facility (Bulk) 6 Hittman Transport Energy Solutions - Bear Creek 1 Tri State Motor Transit Energy Solutions - Bear Creek 3 Visionary Solutions Energy Solutions - Bear Creek B. Irradiated Fuel Shipments (disposition)

Number of Shipments Mode of Transportation NADestination None N/A N/A C. Changes to the Process Control Program There were no changes to the Process Control Program during this period. Page 17 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) RADIOLOGICAL IMPACT ON MAN MAXIMUM DOSES RESULTING FROM GASEOUS RELEASES AND COMPLIANCE STATUS Quarterly Units 1st %of 2nd  % of 3rd  % of 4th  % of Annual  % of Infant Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit Gamma Air 5.OOE+00 mRad 6.23E-03 0.13 7.40E-03 0.15 1.OOE-02 0.20 1.02E-02 0.21 1.OOE+01 0.34 Beta Air 1.00E+01 mRad 2.54E-04 0.00 3.18E-04 0.00 4.31E-04 0.00 4.45E-04 0.00 2.OOE+01 0.01 NG Total Body 2.50E+00 mRem 4.15E-03 0.17 4.93E-03 0.20 6.69E-03 0.27 6.82E-03 0.27 5.OOE+00 0.45 NG Skin 7.50E+00 mRem 7.OOE-03 0.09 8.31 E-03 0.11 1.13E-02 0.15 1.15E-02 0.15 1.50E+01 0.25 NNG Organ 7.50E+00 mRem 5.37E-02 0.72 1.45E-02 0.19 2.20E-02 0.29 4.12E-02 0.55 1.50E+01 0.88 Quarterly Units 1st %of 2nd  % of 3rd  % of 4th  % of Annual  % of Child Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit Gamma Air 5.OOE+00 mRad 6.23E-03 0.13 7.40E-03 0.15 1.OOE-02 0.20 1.02E-02 0.21 1.OOE+01 0.34 Beta Air 1.OOE+01 mRad 2.54E-04 0.00 3.18E-04 0.00 4.31E-04 0.00 4.45E-04 0.00 2.OOE+01 0.01 NG Total Body 2.50E+00 mRem 4.15E-03 0.17 4.93E-03 0.20 6.69E-03 0.27 6.82E-03 0.27 5.OOE+00 0.45 NG Skin 7.50E+00 mRem 7.OOE-03 0.09 8.31 E-03 0.11 1.13E-02 0.15 1.15E-02 0.15 1.50E+01 0.25 NNG Organ 7.50E+00 mRem 2.23E-02 0.30 6.10E-03 0.08 9.20E-03 0.12 1.71 E-02 0.23 1.50E+01 0.36 Teenager Quarterly Units 1st %of 2nd  % of 3rd  % of 4th  % of Annual  % of Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit Gamma Air 5.OOE+00 mRad 6.23E-03 0.13 7.40E-03 0.15 1.OOE-02 0.20 1.02E-02 0.21 1.OOE+01 0.34 Beta Air 1.OOE+01 mRad 2.54E-04 0.00 3.18E-04 0.00 4.31E-04 0.00 4.45E-04 0.00 2.OOE+01 0.01 NG Total Body 2.50E+00 mRem 4.15E-03 0.17 4.93E-03 0.20 6.69E-03 0.27 6.82E-03 0.27 5.OOE+00 0.45 NG Skin 7.50E+00 mRem 7.OOE-03 0.09 8.31 E-03 0.11 1.13E-02 0.15 1.15E-02 0.15 1.50E+01 0.25 NNG Organ 7.50E+00 mRem 1.12E-02 0.15 3.03E-03 0.04 4.61 E-03 0.06 8.63E-03 0.12 1.50E+01 0.18 Quarterly Units 1st  % of 2nd  % of 3rd  % of 4th  % of Annual  % of Adult Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit Gamma Air 5.OOE+00 m Rad 6.23E-03 0.13 7.40E-03 0.15 1.OOE-02 0.20 1.02E-02 0.21 1.OOE+01 0.34 Beta Air 1.OOE+01 mRad 2.54E-04 0.00 3.18E-04 0.00 4.31 E-04 0.00 4.45E-04 0.00 2.OOE+01 0.01 NG Total Body 2.50E+00 mRem 4.15E-03 0.17 4.93E-03 0.20 6.69E-03 0.27 6.82 E-03 0.27 5.OOE+00 0.45 NG Skin 7.50E+00 mRem 7.OOE-03 0.09 8.31 E-03 0.11 1.13E-02 0.15 1.15E-02 0.15 1.50E+01 0.25 NNG Organ 7.50E+00 mRem 7.08E-03 0.09 1.90E-03 0.03 2.90E-03 0.04 5.45E-03 0.07 1.50E+01 0.12 The LaSalle County Nuclear Power Station maximum expected annual dose from Carbon-14 has been calculated using the maximum gross thermal capacity at full power operation. The resultant bounding doses are based upon site specific assumptions of source term. Page 18 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) RADIOLOGICAL IMPACT ON MAN MAXIMUM DOSES RESULTING FROM LIQUID RELEASES AND COMPLIANCE STATUS Infant Quarterly Units 1st  % of 2nd  % of 3rd  % of 4th  % of Annual  % of Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit 10CFR50 Appendix I compliance Total Body 1.50E+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 3.OOE+00 0.00 Organ 5.OOE+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 1.OOE+01 0.00 40CFR141 compliance (nearest public drinking water) Total Body mRem O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+O0 4.OOE+00 0.00 Organ mRem O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 4.OOE+00 0.00 Child Quarterly Units 1st  % of 2nd  % of 3rd  % of 4th  % of Annual  % of Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit 10CFR50 Appendix I compliance Total Body 1.50E+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 3.OOE+00 0.00 Organ 5.OOE+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 1.OOE+01 0.00 40CFR141 compliance (nearest public drinking water) Total Body mRem O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 4.OOE+00 0.00 Organ mRem O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 4.OOE+00 0.00 Teenager Quarterly Units 1st  % of 2nd  % of 3rd  % of 4th  % of Annual  % of Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit 10CFR5O Appendix I compliance Total Body 1.50E+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 3.OOE+00 0.00 Organ 5.OOE+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 1.OOE+01 0.00 40CFR141 compliance (nearest public drinking water) Total Body mRem O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 4.OOE+00 0.00 Organ mRem O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 4.OOE+00 0.00 Adult Quarterly Units 1st  % of 2nd  % of 3rd  % of 4th  % of Annual  % of Receptor Limit Quarter Limit Quarter Limit Quarter Limit Quarter Limit Limit Limit 10CFR50 Appendix I compliance Total Body 1.50E+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 3.OOE+00 0.00 Organ 5.OOE+00 mRem O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 O.OOE+00 0.00 1.OOE+01 0.00 40CFR141 compliance (nearest public drinking water) Total Body mRem O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 4.OOE+O0. 0.00 Organ mRem O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 4.OOE+00 0.00 Page 19 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) RADIOLOGICAL IMPACT ON MAN MAXIMUM DOSES RESULTING FROM RELEASES AND COMPLIANCE STATUS 10CFR20 / 40CFR1 90 Compliance I st nd 3 rd 4 th 2 Quarter Quarter Quarter Quarter Annual Annual Annual Dose Dose Dose Dose Dose Limit Limit (mRem) (mRem) (mRem) (mRem) (mRem) (mRem/yr) Unit 1 40CFR 190 Compliance U1 DEx 9.14E-02 1.02E-01 1.03E-01 1.05E-01 4.01 E-01] 25 1 .60 10CFR20 Compliance u1 DTot 1.44E-01 1.16E-01 1.25E-01 1.46E-01 40CFR190 Compliance Bone 1.71 E-04 4.40E-03 7.05E-03 7.11 E-03 1.87E-02 25 0.07 Liver 1.96E-04 9.85E-04 1.61E-03 1.68E-03 4.47E-03 25 0.02 Thyroid 5.22E-02 1.40E-02 2.20E-02 4.12E-02 1.29E-01 75 0.17 Kidney 2.22E-04 9.91E-04 1.61 E-03 1.69E-03 4.52E-03 25 0.02 Lung 8.28E-05 9.44E-04 1.53E-03 1.54E-03 4.1OE-03 25 0.02 GI-LLI 8.24E-05 9.46E-04 1.55E-03 1.56E-03 4.13E-03 25 0.02 Unit 2 40CFR190 Compliance U2 Dx 7.23E-02 9.61E-02 9.61E-02 9.84E-02 [3.63E-01 25 1.45 10CFR20 Compliance U2DDTt 7.23E-02 9.61 E-02 9.61 E-02 9.84E-02] F3.63E-O11 100 I03I 40CFR 190 Compliance Bone 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 25 0.00 Liver 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 25 0.00 Thyroid 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 75 0.00 Kidney 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 25 0.00 Lung 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 25 0.00 GI-LLI 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 25 0.00 Page 20 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Extremely Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wincd Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 1 1 0 0 2 NNE 0 2 0 0 0 2 NE 0 5 0 0 0 5 ENE 0 0 0 0 0 0 E 0 4 3 0 0 7 ESE 0 3 0 0 0 3 SE 0 0 3 2 0 5 SSE 0 0 0 0 0 0 S 0 2 1 0 0 3 SSW 0 2 3 3 0 8 SW 0 2 4 1 0 7 WSW 0 1 0 0 0 1 W 0 0 0 0 0 0 WNW 1 1 0 0 0 2 NW 0 0 0 0 0 0 NNW 0 0 5 0 0 5 Variable 0 0 0 0 0 0 Total 0 1 23 20 6 0 50 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 21 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Moderately Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N NNE NE ENE E ESE SE SSE S SSW SW WSW W WNW NW NNW Variable Total 0 20 26 9 1 0 56 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 22 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Slightly Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 2 6 6 0 0 14 NNE 0 4 5 4 0 0 13 NE 0 2 3 11 0 16 ENE 0 0 5 0 6 E 0 0 1 0 0 2 ESE 0 1 0 3 SE 0 1 2 2 0 5 SSE 1 9 5 0 16 S 0 1 1 1 0 5 SSW 0 0 1 0 0 2 SW 0 0 0 0 2 WSW 0 0 4 2 0 7 W 0 2 1 0 0 3 WNW 0 2 3 2 0 8 NW 0 0 0 2 0 2 NNW 0 5 2 3 0 0 10 Variable 0 0 0 0 0 0 0 Total 1 22 39 45 7 0 114 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabil ity class: 0 Hours of missing stability measurements in all st ability classes: Page 23 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Neutral 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 3 25 34 28 0 90 NNE 3 15 16 7 3 44 NE 0 18 32 19 3 80 ENE 2 14 34 58 19 127 E 0 14 25 35 10 84 ESE 1 9 20 15 2 47 SE 0 1 10 8 5 24 SSE 0 1 7 5 6 19 S 0 6 18 2 1 27 SSW 1 20 12 7 1 41 SW 1 14 21 6 0 42 WSW 1 12 25 5 8 51 W 0 18 37 15 3 75 WNW 1 13 61 57 9 145 NW 0 4 31 42 1 78 NNW 1 7 49 35 10 107 Variable 0 0 0 0 0 0 Total 14 191 432 344 81 19 1081 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 3 Hours of missing stability measurements in all stability classes: 1 Page 24 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Slightly Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 20 2 "0 23 NNE 16 8 0 24 NE 3 4 4 12 ENE 0 4 8 12 E 5 25 12 42 ESE 3 3 8 16 SE 7 9 13 32 SSE 5 2 7 16 S 2 26 14 47 SSW 6 21 17 45 SW 12 21 25 65 WSW 6 20 8 37 W 9 16 17 47 WNW 13 42 29 90 NW 12 30 7 49 NNW 12 4 0 17 Variable 0 0 0 0 Total 18 131 237 169 18 1 574 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 25 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Moderately Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 1 NNE 0 0 0 NE 0 0 0 ENE 0 0 0 E 9 0 15 ESE 3 0 11 SE 7 0 10 SSE 2 0 8 S 3 8 13 SSW 15 10 33 SW 8 17 29 WSW 17 14 36 W 23 7 35 WNW 13 3 31 NW 0 0 2 NNW 0 0 0 Variable 0 0 1 Total 5 45 100 59 13 3 225 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 26 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Extremely Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 NNE 0 NE 0 ENE 0 E 0 ESE 1 SE SSE 2 S 3 SSW 9 SW 14 WSW 7 W 8 WNW 1 NW 0 NNW 0 Variable 0 Total 0 14 32 10 0 0 56 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabili ty class: 0 Hours of missing stability measurements in all stalbility classes: Page 27 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Extremely Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N NNE NE ENE E ESE SE SSE S SSW SW WSW W WNW NW NNW Variable Total 0 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: I Page 28 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Moderately Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 0 0 0 0 NNE 0 0 0 0 0 0 0 NE 0 0 0 0 0 0 0 ENE 0 0 0 0 0 0 0 E 0 0 0 0 0 0 0 ESE 0 0 0 0 0 0 0 SE 0 0 0 0 0 0 0 SSE 0 0 0 0 0 0 0 S 0 0 0 0 0 0 0 SSW 0 0 0 0 0 0 0 SW 0 0 0 0 0 0 0 WSW 0 0 0 0 0 0 0 W 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 0 0 0 0 0 0 NNW 0 0 0 0 0 0 0 Variable 0 0 0 0 0 0 0 Total 0 0 0 0 0 0 0 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 29 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Slightly Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Directic 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 0 NNE 0 0 0 0 NE 0 0 0 1 ENE 0 0 0 0 E 0 0 0 0 ESE 0 0 0 0 SE 0 0 0 0 SSE 0 0 0 0 S 0 0 0 0 SSW 0 0 1 0 SW 0 0 0 0 WSW 0 0 0 0 W 0 0 0 0 WNW 0 0 0 0 NW 0 0 0 0 NNW 0 0 0 1 Variable 0 0 0 0 Total 0 0 1 2 2 5 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 30 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Neutral - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 1 10 21 33 35 3 103 NNE 1 17 15 9 9 7 58 NE 1 11 27 43 27 14 123 ENE 2 16 16 47 64 14 159 E 0 5 15 27 27 10 84 ESE 2 2 16 17 4 3 44 SE 2 3 7 9 15 3 39 SSE 0 0 12 11 7 6 36 S 0 3 14 21 4 6 48 SSW 0 4 15 12 8 5 44 SW 1 8 15 26 5 3 58 WSW 1 0 11 19 2 9 42 W 0 6 13 17 17 9 62 WNW 2 10 19 22 32 13 98 NW 0 10 38 48 64 8 168 NNW 0 4 21 20 12 13 70 Variable 0 0 0 0 0 0 0 Total 13 109 275 381 332 126 1236 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 91 Hours of missing stability measurements in all stability classes: 1 Page 31 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Slightly Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 2 2 0 6 4 0 14 NNE 0 0 3 12 3 0 18 NE 0 2 7 10 2 0 21 ENE 0 1 2 9 4 0 16 F 1 3 8 11 10 1 34 ESE 0 2 5 8 13 6 34 SE 0 4 4 5 15 12 40 SSE 2 1 4 7 5 3 22 S 0 0 3 5 9 15 32 SSW 1 0 2 12 12 23 50 SW 0 0 11 19 25 27 82 WSW 0 4 1 13 5 17 40 W 2 1 3 9 6 16 37 WNW 0 3 7 20 39 28 97 NW 2 3 12 28 32 5 82 NNW 0 2 2 8 6 0 18 Variable 0 0 0 0 0 0 0 Total 10 28 74 182 190 153 637 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 18 Hours of missing stability measurements in all stability classes: Page 32 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Moderately Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 3 NNE 0 5 NE 0 5 ENE 0 0 E 0 2 ESE 0 4 SE 0 4 SSE 1 7 S 4 15 SSW 8 12 SW 18 34 WSW 15 28 W 6 18 WNW 2 13 NW 0 5 NNW 0 4 Variable 0 0 Total 0 3 17 46 39 54 159 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 33 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: January - March 2011 Stability Class - Extremely Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 0 0 NNE 0 0 0 0 NE 0 0 0 0 ENE 0 0 0 0 E 0 0 0 0 ESE 0 0 0 0 SE 0 0 0 0 SSE 1 0 2 S 0 0 3 SSW 0 0 0 SW 0 0 0 WSW 0 0 1 W 1 0 2 WNW 2 0 2 NW 2 0 3 NNW 0 0 0 Variable 0 0 0 Total 6 0 13 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 34 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Extremely Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 4 24 1 0 0 29 NNE 0 2 22 7 0 0 31 NE 0 0 3 4 0 0 7 ENE 0 4 2 S 0 0 11 E 1 2 4 1 0 0 8 ESE 0 1 3 1 4 0 9 SE 0 0 1 1 1 0 3 SSE 0 0 3 1 0 0 4 S 0 0 5 0 2 0 7 SSW 0 1 7 1 3 0 12 SW 0 0 3 2 3 0 8 WSW 0 0 4 0 0 5 W 0 0 3 4 0 0 7 WNW 0 1 2 0 0 0 3 NW 0 2 1 0 0 0 3 NNW 2 5 0 0 0 8 Variable 0 0 0 0 0 0 0 Total 2 20 88 32 13 0 155 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 35 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Moderately Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 1 2 0 0 3 NNE 0 0 6 5 0 0 11 NE 0 0 9 10 2 0 21 ENE 0 4 7 3 0 15 E 0 0 4 4 0 0 8 ESE 0 1 0 2 0 1 4 SE 0 0 3 2 3 9 SSE 0 4 4 0 1 1 10 S 1 0 1 2 1 6 SSW 0 2 1 5 3 0 11 SW 0 0 0 4 2 0 6 WSW 0 0 1 8 1 0 10 W 0 0 3 7 3 0 13 WNW 0 0 0 4 0 1 5 NW 0 0 3 3 0 0 6 NNW 0 1 4 4 0 0 9 Variable 0 0 0 0 0 0 0 Total 1 9 44 69 19 5 147 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 36 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Slightly Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 4 11 2 0 17 NNE 6 12 6 0 24 NE 2 10 7 5 24 ENE 5 6 12 11 38 E 6 7 4 2 19 ESE 1 1 5 0 7 SE 1 1 3 1 7 SSE 0 3 2 2 8 S 2 7 4 1 14 SSW 1 9 11 1 24 SW 1 3 7 2 13 WSW 1 7 3 1 13 W 2 10 14 1 27 WNW 3 8 18 1 30 NW 2 7 9 3 21 NNW 0 1 1 0 2 Variable 0 0 0 0 0 Total 1 37 103 108 31 8 288 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabili ty class: 0 Hours of missing stability measurements in all sta bility classes: 1 Page 37 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Neutral - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 8 16 1 0 25 NNE 10 30 1 0 42 NE 12 23 31 9 77 ENE 9 15 24 9 62 E 15 26 22 13 79 ESE 10 15 15 7 51 SE 6 14 12 7 45 SSE 8 19 5 1 35 S 9 18 13 3 47 SSW 9 23 16 4 57 SW 15 8 26 7 59 WSW 6 14 22 3 47 W 10 28 37 14 90 WNW 8 30 20 8 71 NW 6 11 11 1 31 NNW 11 12 8 1 36 Variable 0 0 0 0 0 Total 24 152 302 264 87 25 854 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabi lity class: 0 Hours of missing stability measurements in all s tability cl asses: I Page 38 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Slightly Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 12 11 0 0 0 23 NNE 1 11 2 2 0 0 16 NE 0 1 10 3 0 0 14 ENE 1 1 8 6 1 1 18 E 0 16 22 7 0 0 45 ESE 1 8 6 13 2 0 30 SE 1 10 16 10 3 0 40 SSE 1 6 6 5 1 0 19 S 0 3 6 11 4 0 24 SSW 0 6 4 17 5 1 33 SW 1 4 20 21 1 0 47 WSW 0 7 20 7 1 0 35 W 1 13 14 8 2 0 38 WNW 2 12 14 8 5 3 44 NW 1 3 6 0 0 0 10 NNW 0 3 2 0 0 0 5 Variable 0 0 0 0 0 0 0 Total 10 116 167 118 25 5 441 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabi lity class: 0 Hours of missing stability measurements in all s tability classes: 1 Page 39 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Moderately Stable 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 2 6 0 0 0 0 8 NNE 0 3 0 0 0 0 3 NE 0 0 1 0 0 0 ENE 0 3 0 0 0 4 E 1 14 6 0 0 0 21 ESE 11 0 0 0 17 SE 0 10 3 1 0 0 14 SSE 0 13 4 1 0 0 18 S 0 12 10 4 0 0 26 SSW 0 9 21 4 0 0 34 SW 0 5 6 0 0 12 WSW 0 6 5 0 0 0 11 W 0 12 14 2 0 0 28 WNW 2 6 7 0 0 0 15 NW 1 1 0 0 0 0 2 NNW 0 1 0 0 0 0 Variable 0 0 0 0 0 0 0 Total 7 106 89 12 0 215 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 40 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Extremely Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wincd Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total 0 0 N 2 2 0 0 4 0 0 NNE 1 0 0 0 1 0 0 NE 0 0 0 0 0 0 0 ENE 0 0 0 0 0 0 0 E 1 0 0 0 1 ESE 0 1 1 0 0 0 2 SE 0 7 4 0 0 0 ii SSE 1 10 0 0 0 0 S 0 13 5 0 0 0 18 SSW 1 5 1 0 0 0 7 SW 0 4 2 0 0 0 6 WSW 0 5 0 0 0 0 5 W 1 10 2 0 0 0 13 WNW 1 2 0 0 0 0 3 NW 1 0 0 0 0 0 1 NNW 0 0 0 0 0 0 0 Variable 0 0 0 0 0 0 0 Total 9 59 15 0 0 0 83 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability cl asses: Page 41 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Extremely Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 0 0 NNE 0 1 0 3 NE 0 0 0 0 ENE 0 0 0 0 E 0 0 0 0 ESE 0 0 0 0 SE 0 0 0 0 SSE 0 0 0 0 S 0 0 0 0 SSW 0 0 1 SW 0 0 0 0 WSW 0 0 0 0 W 0 0 0 0 WNW 0 0 0 0 NW 0 0 0 0 NNW 0 0 0 0 Variable 0 0 0 0 Total 0 2 0 4 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 42 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Moderately Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 1 1 0 2 NNE 3 10 1 14 NE 2 2 ENE 0 0 E 0 0 ESE 0 SE 0 0 SSE 0 1 S 2 2 SSW 2 4 SW 0 0 WSW 0 0 W 0 0 WNW 0 0 NW 0 0 NNW 0 0 Variable 0 0 Total 7 11 7 26 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 43 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Slightly Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 1 10 4 0 15 NNE 0 0 3 6 9 0 18 NE 0 0 1 0 4 1 6 ENE 0 0 0 3 4 0 7 E 0 0 2 6 0 1 9 ESE 0 0 1 2 0 0 3 SE 0 0 0 1 0 0 1 SSE 0 0 0 0 0 0 0 S 0 0 0 2 1 0 3 SSW 0 0 1 1 0 2 4 SW 0 0 2 2 3 2 9 WSW 0 0 0 0 0 1 1 W 0 0 0 1 1 0 2 WNW 0 0 0 0 0 0 0 NW 0 1 2 1 0 0 4 NNW 0 0 3 1 0 0 4 Variable 0 0 0 0 0 0 0 Total 0 1 16 36 26 7 86 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 44 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Neutral - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 4 19 8 3 0 34 NNE 10 17 21 23 7 79 NE 7 17 39 44 16 123 ENE 12 30 29 38 36 145 E 7 15 18 16 27 83 ESE 4 15 29 17 16 81 SE 8 9 9 12 23 62 SSE 8 25 12 9 6 61 S 8 12 26 14 14 75 SSW 6 12 25 26 23 93 SW 8 7 11 30 21 78 WSW 9 9 17 30 9 77 W 6 7 41 38 19 113 WNW 2 17 37 37 13 106 NW 7 14 24 23 8 77 NNW 5 11 15 7 0 38 Variable 0 0 0 0 0 0 Total 12 i11 236 361 367 238 1325 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 45 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Slightly Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 4 2 5 0 0 11 NNE 0 6 5 18 7 0 36 NE 0 1 4 6 2 0 13 ENE 0 5 4 8 4 0 21 E 0 3 5 9 6 4 27 ESE 0 2 6 13 10 7 38 SE 0 4 3 9 19 19 54 SSE 0 1 5 8 8 7 29 S 0 1 3 9 7 15 35 SSW 0 3 12 7 12 35 69 SW 0 1 4 10 21 13 49 WSW 0 1 1 14 20 2 38 W 0 3 6 9 17 5 40 WNW 0 1 9 15 31 9 65 NW 0 3 9 1 7 3 23 NNW 0 1 3 5 1 0 10 Variable 0 0 0 0 0 0 0 Total 0 40 81 146 172 119 558 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 46 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Moderately Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 1 3 1 0 0 0 5 NNE 1 2 2 2 0 0 7 NE 0 1 2 2 0 0 5 ENE 0 1 1 3 0 0 5 E 0 1 3 6 0 0 10 ESE 0 2 4 0 1 12 SE 0 1 3 6 1 13 SSE 0 0 7 8 0 18 S 0 0 1 6 4 13 SSW 0 1 4 12 0 25 SW 0 2 5 5 0 15 WSW 0 7 3 0 11 W 7 3 2 16 WNW 1 0 7 3 0 14 NW 0 0 5 1 0 7 NNW 0 0 0 2 Variable 0 0 0 0 0 0 Total 4 17 60 60 29 8 178 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 47 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: April - June 2011 Stability Class - Extremely Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 1 NNE 0 0 NE 0 0 ENE 0 0 E 0 0 ESE 0 0 SE 0 SSE 0 3 S 0 1 SSW 0 0 SW 0 0 WSW 0 0 W 0 0 WNW 0 0 NW 0 0 NNW 0 0 Variable 0 0 Total 0 0 6 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabi lity class: 0 Hours of missing stability measurements in all stability classes: 1 Page 48 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Extremely Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 1 0 0 1 NNE 0 0 1 1 0 0 2 NE 0 0 0 0 0 0 0 ENE 0 0 0 0 0 0 0 E 0 0 0 0 0 0 0 ESE 0 0 0 0 0 0 0 SE 0 0 0 0 0 0 0 SSE 0 0 0 0 0 0 0 S 0 0 0 0 1 0 1 SSW 0 1 3 1 0 0 5 SW 0 2 5 1 0 0 8 WSW 0 1 10 4 0 0 15 W 0 0 1 1 0 0 2 WNW 0 0 1 1 1 0 3 NW 0 0 0 0 0 0 0 NNW 0 0 0 2 0 0 2 Variable 0 0 0 0 0 0 0 Total 0 4 21 12 2 0 39 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 49 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Moderately Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 2 6 4 0 0 12 NNE 0 0 10 0 0 0 10 NE 0 0 4 1 0 0 5 ENE 0 0 1 0 0 0 1 E 0 1 0 0 0 0 1 ESE 0 0 2 0 0 0 2 SE 0 1 3 0 0 0 4 SSE 0 0 0 0 0 0 0 S 0 1 1 1 1 0 4 SSW 0 3 9 1 0 0 13 SW 0 6 1 0 0 0 7 WSW 0 5 12 12 0 0 29 W 0 2 9 3 0 0 14 WNW 0 2 3 2 1 0 8 NW 0 2 0 0 0 0 2 NNW 0 5 2 1 0 0 8 Variable 0 0 0 0 0 0 0 Total 0 30 63 25 2 0 120 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 50 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Slightly Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 6 12 4 0 0 22 NNE 0 4 12 0 0 0 16 NE 0 4 0 0 0 0 4 ENE 0 1 1 2 0 0 4 E 0 0 4 0 0 0 4 ESE 0 4 4 0 0 0 8 SE 0 2 0 1 0 0 3 SSE 0 8 2 0 1 0 11 S 0 6 12 0 0 0 18 SSW 0 5 4 1 0 0 10 SW 0 9 5 1 0 0 15 WSW 0 10 9 2 0 0 21 W 0 9 4 1 0 0 14 WNW 0 3 4 0 0 0 7 NW 0 3 4 3 0 0 10 NNW 0 2 14 2 0 0 18 Variable 0 0 0 0 0 0 0 Total 0 76 91 17 1 0 185 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 51 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July September 2011 Stability Class - Neutral - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 42 23 5 74 NNE 30 12 0 46 NE 21 17 1 40 ENE 18 15 5 39 E 22 12 0 38 ESE 24 21 1 51 SE 9 7 4 25 SSE 14 16 4 37 S 19 9 10 42 SSW 13 9 7 31 SW 17 14 6 38 WSW 10 13 6 31 W 18 17 7 43 WNW 16 23 6 50 NW 18 26 2 49 NNW 22 56 16 104 Variable 0 0 0 0 Total 41 313 290 80 13 1 738 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 52 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Slightly Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 57 22 84 NNE 30 9 44 NE 17 13 34 ENE 20 14 39 E 29 22 55 ESE 9 14 26 SE 5 4 11 SSE 4 3 10 S 3 13 23 SSW 14 14 33 SW 11 29 47 WSW 6 23 33 W 13 9 28 WNW 25 11 45 NW 8 10 29 NNW 13 14 32 Variable 0 0 0 Total 52 264 224 28 3 2 573 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability cl asses: 0 Page 53 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Moderately Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 22 0 23 NNE 2 0 4 NE 3 0 3 ENE 0 0 0 E 31 7 41 ESE 17 4 25 SE 18 0 19 SSE 15 0 17 S 22 1 25 SSW 24 10 37 SW 20 17 38 WSW 17 10 28 W 14 2 25 WNW 19 2 26 NW 2 0 6 NNW 14 2 16 Variable 0 0 0 Total 37 240 55 1 0 0 333 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 54 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Extremely Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 1 2 NNE 0 0 NE 0 0 ENE 0 0 E 3 4 ESE 13 14 SE 19 23 SSE 22 22 S 34 35 SSW 27 36 SW 14 23 WSW 28 32 W 16 19 WNW 9 9 NW 0 0 NNW 1 1 Variable 0 0 Total 14 187 19 0 0 0 220 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 55 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Extremely Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 NNE 0 0 NE 0 0 ENE 0 0 E 0 0 ESE 0 0 SE 0 0 SSE 0 0 S 0 0 SSW 0 0 SW 0 0 WSW 0 0 W 0 0 WNW 0 0 NW 0 0 NNW 0 0 Variable 0 0 Total 0 0 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 56 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Moderately Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N NNE NE ENE E ESE SE SSE S SSW SW WSW W WNW NW NNW Variable Total 0 0 10 2 0 13 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 57 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Slightly Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 2 2 2 0 6 NNE 0 1 3 7 1 0 12 NE 0 0 1 5 0 0 6 ENE 0 0 0 2 0 0 2 E 0 0 0 0 0 0 0 ESE 0 0 0 1 0 0 1 SE 0 0 0 2 0 0 2 SSE 0 0 0 0 0 0 0 S 0 1 0 1 0 1 3 SSW 0 1 3 3 1 0 8 SW 0 1 6 2 0 0 9 WSW 0 1 6 7 3 0 17 W 0 0 4 4 0 0 8 WNW 0 0 3 0 0 0 3 NW 0 0 0 1 0 0 1 NNW 0 0 5 0 0 0 5 Variable 0 0 0 0 0 0 0 Total 0 5 33 37 7 1 83 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 58 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Neutral - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 1 22 33 31 14 0 101 NNE 1 16 20 24 3 0 64 NE 2 20 21 21 3 1 68 ENE 2 20 11 18 5 0 56 E 1 19 16 6 0 0 42 ESE 0 12 19 3 1 0 35 SE 1 10 13 14 6 0 44 SSE 0 21 10 4 3 2 40 S 2 8 18 15 7 9 59 SSW 3 14 16 13 14 2 62 SW 2 17 18 20 6 0 63 WSW 1 16 21 13 10 0 61 W 1 11 22 15 7 1 57 WNW 1 11 18 11 9 3 53 NW 0 11 35 19 2 8 75 NNW 1 16 43 30 15 11 116 Variable 0 0 0 0 0 0 0 Total 19 244 334 257 105 37 996 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 59 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Slightly Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 6 11 15 13 1 47 NNE 13 16 30 12 0 71 NE 4 26 10 9 0 49 ENE 16 20 15 6 0 59 E 7 25 25 4 0 61 ESE 6 18 11 10 0 48 SE 3 8 6 7 0 24 SSE 2 3 3 3 1 12 S 7 7 9 9 7 40 SSW 6 5 13 11 10 47 SW 2 10 18 18 13 62 WSW 7 5 4 28 4 51 W 5 5 9 7 1 27 WNW 10 10 15 6 5 48 NW 6 7 18 5 4 40 NNW 3 7 10 13 0 34 Variable 0 0 0 0 0 0 Total 16 103 183 211 161 46 720 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 60 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Moderately Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 1 3 2 3 1 3 13 NNE 0 4 5 8 1 0 18 NE 0 2 6 4 0 0 12 ENE 0 5 3 1 0 0 9 E 0 3 3 6 5 0 17 ESE 0 1 6 15 6 0 28 SE 0 0 10 8 4 0 22 SSE 0 6 11 5 2 0 24 S 0 9 16 14 1 0 40 SSW 0 6 11 17 12 0 46 SW 1 2 12 9 11 7 42 WSW 0 6 11 7 4 1 29 W 1 3 11 4 6 0 25 0 2 5 6 1 0 14 NW 1 2 13 0 4 0 20 NNW 0 0 5 3 0 0 8 Variable 0 0 0 0 0 0 0 Total 4 54 130 110 58 11 367 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 0 Page 61 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (201 1) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: July - September 2011 Stability Class - Extremely Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 NNE 0 0 NE 0 1 ENE 0 0 E 0 0 ESE 0 1 SE 0 0 SSE 0 8 S 0 4 SSW 0 8 SW 0 0 WSW 0 2 W 0 0 3 WNW 0 1 0 1 NW 0 1 0 1 NNW 0 0 0 0 Variable 0 0 0 0 Total 0 1 8 13 7 0 29 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabi lity class: 0 Hours of missing stability measurements in all stability classes: 0 Page 62 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Extremely Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 1 3 0 10 NNE 0 0 0 0 NE 0 0 0 0 ENE 0 0 0 0 E 0 0 0 3 ESE 0 1 0 1 SE 0 0 1 SSE 0 5 S 0 2 SSW 0 4 SW 0 2 WSW 0 13 W 0 9 WNW 0 2 NW 0 2 NNW 0 8 Variable 0 0 Total 1 14 29 18 0 0 62 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabi lity class: 0 Hours of missing stability measurements in all stability classes: 1 Page 63 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Moderately Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 3 0 0 0 3 NNE 0 0 0 0 0 0 0 NE 0 0 0 0 0 0 0 ENE 0 0 0 0 0 1 E 0 1 0 0 0 0 ESE 0 0 0 0 0 1 SE 0 0 0 0 0 0 0 SSE 0 0 1 0 3 S 0 0 1 7. 0 0 8 SSW 0 1 5 7 0 0 13 SW 0 0 2 3 1 0 6 WSW 0 1 3 0 1 0 5 W 1 0 0 0 0 0 1 WNW 0 0 0 0 0 0 0 NW 0 0 1 1 0 0 2 NNW 1 0 0 0 0 2 Variable 0 0 0 0 0 0 0 Total 2 5 17 19 0 46 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 64 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Slightly Unstable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 3 1 0 0 4 NNE 0 0 0 0 0 0 0 NE 0 0 0 0 0 0 0 ENE 0 0 2 0 0 0 2 E 0 0 0 0 0 0 0 ESE 0 0 0 0 0 0 0 SE 0 1 2 0 2 0 5 SSE 0 4 5 1 0 11 S 0 0 3 6 0 0 9 SSW 0 1 6 11 2 1 21 SW 0 0 2 2 2 1 7 WSW 0 1 1 2 0 0 4 W 0 1 0 0 0 0 1 WNW 0 0 1 7 2 0 10 NW 1 0 0 3 0 0 4 NNW 0 0 0 2 0 0 2 Variable 0 0 0 0 0 0 0 Total 1 8 25 35 9 2 80 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 65 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October December201l Stability Class - Neutral - 20 OFt-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 26 65 29 6 0 126 NNE 3 30 8 0 0 43 NE 5 9 14 8 0 38 ENE 2 18 26 0 0 46 E 4 17 3 0 0 24 ESE 0 3 0 0 0 3 SE 4 9 0 0 0 17 SSE 9 15 6 4 0 34 S 6 19 13 6 0 44 SSW 15 19 21 16 5 77 SW 5 23 17 3 2 50 WSW 11 17 10 1 0 39 W 18 16 23 4 2 63 WNW 18 41 29 10 4 104 NW 9 26 24 0 0 60 NNW 11 64 39 16 5 136 Variable 0 0 0 0 0 0 Total 13 146 391 262 74 18 904 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 4 Hours of missing stability measurements in all stability classes: I Page 66 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station

                   .Period of Record: October           - December2011 Stability     Class - Slightly Stable                   - 200Ft-33Ft Delta-T       (F)

Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 4 8 8 0 0 0 20 NNE 0 4 7 0 0 0 11 NE 2 3 0 0 7 ENE 0 2 4 0 0 7 E 1 2 4 0 0 0 7 ESE 0 2 0 1 0 0 3 SE 3 2 0 0 0 6 SSE 6 7 9 0 0 23 S 1 3 16 29 6 1 56 SSW 2 10 24 57 17 0 110 SW 2 7 24 20 3 1 57 WSW 2 17 10 12 1 1 43 W 0 9 35 22 10 0 76 WNW 0 15 17 14 16 6 68 NW 1 7 9 1 0 0 18 NNW 4 7 7 0 0 19 Variable 0 0 0 0 0 0 0 Total 19 100 176 174 53 9 531 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabi lity class: 7 Hours of missing stability measurements in all s tability classes: Page 67 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Moderately Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 0 0 0 0 NNE 0 2 0 0 0 0 2 NE 1 0 0 0 0 0 1 ENE 1 0 0 0 0 0 1 E 0 3 5 0 0 0 8 ESE 0 5 0 0 0 0 5 SE 0 4 9 1 0 0 14 SSE 3 8 4 0 0 0 15 S 1 10 17 6 0 0 34 SSW 3 16 25 18 0 0 62 SW 0 13 7 0 0 21 WSW 2 7 16 2 1 0 28 W 1 9 44 5 0 0 59 WNW 0 17 5 0 0 0 22 NW 1 5 1 0 0 0 7 NNW 1 1 0 0 0 0 2 Variable 0 0 0 0 0 0 0 Total 14 100 133 33 1 0 281 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability cl,asses: 1 Page 68 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Extremely Stable - 200Ft-33Ft Delta-T (F) Winds Measured at 33 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 0 0 0 0 NNE 0 0 0 0 0 0 0 NE 0 0 0 0 0 0 0 ENE 0 0 0 0 0 0 0 E 0 5 5 0 10 ESE 0 13 1 0 14 SE 0 14 6 0 20 SSE 0 33 24 0 57 S 1 26 26 0 54 SSW 1 15 31 0 51 SW 3 11 8 0 25 WSW 1 10 7 0 20 W 0 9 4 0 13 WNW 0 14 8 0 22 NW 0 4 0 0 4 NNW 0 2 0 0 2 Variable 0 0 0 0 0 Total 6 156 120 10 0 0 292 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabi lity class: 0 Hours of missing stability measurements in all stability classes: 1 Page 69 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Extremely Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N NNE NE ENE E ESE SE SSE S SSW SW WSW W WNW NW NNW Variable Total 0 0 1 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 70 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011* Stability Class - Moderately Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 NNE 0 0 NE 0 0 ENE 0 0 E 0 0 ESE 0 0 SE 0 0 SSE 0 1 S 0 0 SSW 0 0 SW 0 0 WSW 0 2 W 0 2 WNW 0 0 NW 0 0 NNW 1 3 Variable 0 0 Total 1 8 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stabil ity class: 0 Hours of missing stability measurements in all st ability classes: 1 Page 71 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Slightly Unstable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 3 1 2 0 6 NNE 0 0 1 0 0 0 1 NE 0 0 0 0 0 0 0 ENE 0 0 0 0 0 0 0 E 0 0 0 0 0 0 0 ESE 0 0 0 0 0 0 0 SE 0 0 0 2 0 0 2 SSE 0 0 0 0 3 0 3 S 0 0 1 1 2 0 4 SSW 0 1 1 0 0 0 2 SW 0 0 0 1 0 0 1 WSW 0 0 0 4 1 0 5 W 0 0 0 2 1 0 3 WNW 0 0 0 0 1 0 1 NW 0 0 0 1 3 0 4 NNW 0 0 1 0 1 0 2 Variable 0 0 0 0 0 0 0 Total 0 1 7 12 14 0 34 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 72 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Neutral - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 24 63 17 22 132 NNE 19 22 6 7 57 NE 0 15 18 8 43 ENE 7 38 11 0 61 E 4 12 2 0 22 ESE 0 0 0 0 1 SE 5 7 1 2 19 SSE 15 12 5 7 43 S 18 20 18 24 85 SSW 20 32 22 45 123 SW 12 29 10 11 66 WSW 15 12 9 4 48 W 23 7 17 9 64 WNW 27 24 25 13 99 NW 26 26 28 21 106 NNW 22 41 20 20 110 Variable 0 0 0 0 0 Total 13 67 237 360 209 193 1079 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 73 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Slightly Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 2 3 1 4 0 10 NNE 0 1 5 1 8 0 15 NE 0 2 3 4 1 0 10 ENE 0 2 2 5 2 0 11 E 1 0 3 2 3 0 9 ESE 3 1 0 2 0 0 6 SE 1 2 0 2 5 0 10 SSE 1 0 3 5 3 6 18 S 1 3 7 8 13 38 70 SSW 0 2 6 8 30 85 131 SW 0 1 16 20 17 17 71 WSW 2 1 12 11 6 11 43 W 0 2 16 19 37 34 108 WNW 0 2 12 24 15 32 85 NW 1 1 5 17 7 3 34 NNW 0 2 6 6 6 0 20 Variable 0 0 0 0 0 0 0 Total 10 24 99 135 157 226 651 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 74 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Moderately Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 4 0 0 0 4 NNE 0 1 3 0 0 0 4 NE 1 0 0 1 0 0 2 ENE 0 0 1 4 0 0 5 E 0 3 2 1 1 2 9 ESE 0 1 4 5 0 1 11 SE 0 3 3 6 2 7 21 SSE 0 3 1 2 6 10 22 S 0 0 3 4 12 20 39 SSW 0 0 3 18 13 26 60 SW 0 0 2 23 4 6 35 WSW 0 3 3 3 8 2 19 W 0 2 3 1 11 11 28 WNW 0 1 3 12 2 4 22 NW 0 0 2 14 1 0 17 NNW 0 0 1 6 0 0 7 Variable 0 0 0 0 0 0 0 Total 1 17 38 100 60 89 305 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: 1 Page 75 of 76

LASALLE COUNTY NUCLEAR POWER STATION EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (2011) METEOROLOGICAL DATA LaSalle County Generating Station Period of Record: October - December2011 Stability Class - Extremely Stable - 375Ft-33Ft Delta-T (F) Winds Measured at 375 Feet Wind Speed (in mph) Wind Direction 1-3 4-7 8-12 13-18 19-24 > 24 Total N 0 0 0 2 0 0 2 NNE 0 0 0 0 0 0 0 NE 0 0 0 0 0 0 0 ENE 0 0 0 0 0 0 0 E 0 0 0 0 0 0 0 ESE 0 0 0 0 0 0 0 SE 0 2 4 2 0 0 8 SSE 0 1 8 6 4 19 S 0 1 9 7 6 23 SSW 7 14 11 10 42 SW 1 2 1 0 4 WSW 7 9 0 1 19 W 2 0 0 0 2 WNW 0 1 0 0 1 NW 0 0 0 0 0 NNW 0 3 5 0 9 Variable 0 0 0 0 0 Total 3 23 50 30 21 129 Hours of calm in this stability class: 0 Hours of missing wind measurements in this stability class: 0 Hours of missing stability measurements in all stability classes: Page 76 of 76

Appendix A Offsite Dose Calculation Manual Revision 3 ODCM Change Summary Matrix

ODCM change summary matrix I Page 1 of 3 Item # (Old) Rev. (New) Rev. Determination Description of change 2 page # 3 page # identifier Editorial and grammatical - EG OpenEMS implementation related changes - Determination OEMS Rad Waste Discharge related changes - Determination RWD Source check - SC

1. 1-1.1-4 1-1.1-4 SC Clarified definition of source check (Ref IR #1138604)

2. 1-12.2.1-1 1-12.2.1-1 RWD Removed Note 2

3. 1-12.2.1-2 1-12.2.1-2 RWD Changed completion time of C.3 to 30 days

4. 1-12.2.1-2 1-12.2.1-2 RWD Added "OR" statement and Required Action C.4 to place admin clearance order to remove ability to conduct a liquid Radwaste Discharge

5. 1-12.2.1-3 1-12.2.1-3 RWD Added Required Action F.2 to verify BDFCV indication locally when remote position indication not available prior to each releases

6. 1-12.2.1-3 1-12.2.1-3 RWD Added "OR C.4" to Condition G

7. 1-12-2.1-4 1-12-2.1-4 RWD Revised the description of RSR 12.2.1.6 to reflect 'N/A' status (instrument abandoned)

8. 1-12-2.1-4 1-12-2.1-4 RWD Added RSR 12.2.1.8 to perform position indication verification every 12 months

_______(BDFCV)

9. 1-12.2.1-6 1-12.2.1-6 RWD Removed references blowdown flow instrumentation (abandoned under EC# 360580) and clarification footnote (b)

10. 1-12.2.1-6 1-12.2.1-6 RWD Added instrument 3.b. (OWL005 BDFCV position indication) listing to Table R12.2.1-1

11. 11.1-17 11.1-17 OEMS Edited table 1-3 to incorporate new NUREG-0133/OpenEMS data

12. 11.2-1 11.2-1 RWD Revised the body of 2.1.2 reflect blowdown flow determination from blowdown flow control valve position vice the flow instrumentation abandoned under EC# 360580

13. 11.2-10 11.2-10 EG Equation corrected with correct values

14. N/A 11.3-5 OEMS Added dual methodology discussion in support of integrating new dose assessment software

15. N/A 11.3-7 OEMS Added 3.4.1.2 (NUREG-0133 general liquid effluent dose methodology) in support of integrating new dose assessment software

16. N/A 11.3-7 OEMS Added 3.4.2.2 (NUREG-0133 potable water pathway methodology) in support of integrating new dose assessment software

17. N/A 11.3-9 OEMS Added 3.4.3.2 (NUREG-0133 fish ingestion pathway methodology) in support of integrating new dose assessment software

18. N/A 11.4-1 OEMS Added dual methodology discussion in support of integrating new dose assessment software in section 4.1

19. N/A 11.4-3 OEMS Added dual methodology (NG Total Body dose rate) discussion in support of I I__ Iintegrating new dose assessment software in section 4.2.1.1

ODCM change summary matrix I Page 2 of 3 Item # ] (Old) Rev. * (New) Rev. Determination identifier Description of change 2 page # 3 page #

20. N/A 11.4-5 OEMS Added dual methodology (NG Skin dose rate) discussion in support of integrating new dose assessment software in section 4.2.1.2

21. N/A 11.4-7 OEMS Added dual methodology (NNG Organ dose rate) discussion in support of integrating new dose assessment software in section 4.2.1.3

22. N/A 11.4-9 OEMS Added dual methodology (Gamma Air dose) discussion in support of integrating new dose assessment software in section 4.2.2.1

23. N/A 11.4-11 OEMS Added dual methodology (Beta Air dose) discussion in support of integrating new dose assessment software in section 4.2.2.2

24. N/A 11.4-13 OEMS Added dual methodology (Whole Body dose) discussion in support of integrating new dose assessment software in section 4.2.2.3

25. N/A 11.4-15 OEMS Added dual methodology (Skin dose) discussion in support of integrating new dose assessment software in section 4.2.2.4

26. N/A 11.4-17 OEMS Added dual methodology (NNG Organ dose) discussion in support of integrating new dose assessment software in section 4.2.3

27. N/A 11.4-19 OEMS Added dual methodology (Ground Plane pathway) discussion in support of integrating new dose assessment software in section 4.2.3.1

28. N/A 11.4-21 OEMS Added dual methodology (Inhalation pathway) discussion in support of integrating new dose assessment software in section 4.2.3.2

29. N/A 11.4-25 OEMS Added dual methodology (Vegetation Ingestion pathway) discussion in support of integrating new dose assessment software in section 4.2.3.3

30. N/A 11.4-27 OEMS Added dual methodology (Milk Ingestion pathway) discussion in support of integrating new dose assessment software in section 4.2.3.4

31. N/A 11.4-30 OEMS Added dual methodology (Meat Ingestion pathway) discussion in support of integrating new dose assessment software in section 4.2.3.5

32. 11.4-20 11.4-32 OEMS Updated table 4-1 to reflect current data

33. 11.4-22 11.4-34 OEMS Updated table 4-3 to reflect current data

34. 11.4-23 11.4-35 OEMS Updated table 4-4 to reflect current data

35. 11.4-24 11.4-36 OEMS Updated table 4-5 to reflect current data

36. N/A 11.4-80 OEMS Added table 4-15 to incorporate BiNi dose factor data

37. N/A 11.4-95 OEMS Added table 4-16 through 4-19 to incorporate drinking water aquatic pathway factors

38. N/A 11.4-111 OEMS Added table 4-20 through 4-23 to incorporate fish aquatic pathway factors

39. N/A 11.4-127 OEMS Added table 4-24 through 4-27 to incorporate inhalation dose rate (Pi) pathway factors

40. N/A 11.4-143 OEMS Added table 4-28 to incorporate ground plane dose (Re) pathway factors

41. N/A 11.4-147 OEMS Added table 4-29 through 4-32 to incorporate inhalation dose (Ri) pathway factors

42. N/A 11.4-163 OEMS Added table 4-33 through 4-36 to incorporate vegetation dose (Ri) pathway factors

43. N/A 11.4-179 OEMS Added table 4-37 through 4-40 to incorporate milk dose (Ri) pathway factors

ODCM change summary matrix I Page 3 of 3 Item # (Old) Rev. (New) Rev. Determination Description of change 2 page # 3 page # identifier

44. N/A 11.4-195 OEMS Added table 4-41 through 4-44 to incorporate meat dose (Ri) pathway factors

45. 11.6-2 11.6-2 EG Corrected grammatical errors in Table 6-1.

46. 11.6-11 11.6-9 EG Figure 6-1 revised to enhance clarity.

47. 11.6-12 11.6-10 EG Figure 6-2 revised to enhance clarity.

48. 11.6-13 11.6-11 EG Figure 6-3 revised to enhance clarity

Appendix B Offsite Dose Calculation Manual Part I RECS Part II ODCM LaSalle Station Units 1 and 2 Revision 3

CY-LA-170-301 Revision 3 OFFSITE DOSE CALCULATION MANUAL PART I RECS PART II ODCM LaSalle Station Units 1 and 2

CY-LA-170-301 Revision 3 ODCM Parts I and II ODCM TABLE OF CONTENTS PART I - RADIOLOGICAL EFFLUENT CONTROLS (RECS) PAGE 1.0 US E A ND A P P LIC A T IO N ....................................................................................... 1-1.1-1 1.1 D E F INIT IO NS ......................................................................................................... 1-1 .1-1 1.2 LO G IC A L C O NNE C TO R S ...................................................................................... 1-1.2-1 1.3 C O MP LE T IO N T IME S ............................................................................................ 1-1.3-1 1.4 F R E Q UE NC Y ......................................................................................................... 1-1 .4-1 1.5 R EC & RSR IMPLEM ENTA TIO N............................................................................ 1-1.5-1 2.0-11.0 NOT USED 12.0 ODCM RADIOLOGICAL EFFLUENT CONTROL (REC) APPLICABILITY ........... 1-12.0-1 12.0 ODCM RADIOLOGICAL EFFLUENT SURVEILLANCE REQUIREM ENT (RSR) APPLICABILITY ............................................................. 1-12.0-3 12.1 NOT USED 12 .2 INS T R UME NTA T IO N ........................................................................................ 1-12.2.1-1 12.2.1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION ....... 1-12.2.1-1 12.2.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION. 1-12.2.2-1 12 .3 LIQ UID E F F LU E NT S ......................................................................................... 1-12 .3 .1-1 12.3.1 Liquid Effluent C oncentration .................................................................. 1-12.3.1-1 12.3.2 Dose from Liquid Effluents ...................................................................... 1-12.3.2-1 12.3.3 Liquid Radwaste Treatm ent System ....................................................... 1-12.3.3-1 Page 1 of 11 LaSalle ODCM Table of Contents

CY-LA-1 70-301 Revision 3 ODCM Parts I and II ODCM TABLE OF CONTENTS PART I - RADIOLOGICAL EFFLUENT CONTROLS (RECS) PAGE 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE ................................................... 1-12.4.1-1 12.4.1 G aseous Effluent Dose Rates ................................................................. 1-12.4.1-1 12.4.2 D ose from Noble G ases ......................................................................... 1-12.4.2-1 12.4.3 Dose from Iodine-131, Iodine-1 33, Tritium and Radioactive Materials in P a rtic u la te Fo rm ...................................................................................... 1-12 .4.3 -1 12.4.4 Gaseous Radwaste Treatment System ................................................... 1-12.4.4-1 12.4.5 Ventilation Exhaust Treatment System ................................................... 1-12.4.5-1 12 .4.6 Mark II C ontainm ent ................................................................................ 1-12 .4 .6-1 12 .4.7 T ota l Do se ............................................................................................... 1-12 .4.7 -1 12 .4.8 Main C o ndense r ...................................................................................... 1-12 .4.8-1 12.4.9 Dose Limits For Members Of The Public ................................................ 1-12.4.9-1 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM ..................... 1-12.5.1-1 12.5.1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (REMP) ..... 1-12.5.1-1 12 .5.2 LA ND US E C E NS US ......................................................................................... 1-12.5.2-1 12.5.3 INTERLABORATORY COMPARISON PROGRAM ........................................... 1-12.5.3-1 12.5.4 METEOROLOGICAL MONITORING PROGRAM .............................................. 1-12.5.4-1 12.6 REPO RTING REQ UIREM ENTS ........................................................................ 1-12.6.1-1 12.6.1 Annual Radiological Environmental Operating Report .......................... 1-12.6.1-1 12.6.2 Annual Radioactive Effluent Release Report ........................................ 1-12.6.2-1 12.6.3 Off-site Dose Calculation Manual (ODCM) ........................................... 1-12.6.3-1 12.6.4 Major Changes to Radioactive Waste Treatment Systems (Liquid a nd G a se o us) ....................................................................................... 1-12 .6 .4-1 Page 2 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II ODCM TABLE OF CONTENTS PART I - RADIOLOGICAL EFFLUENT CONTROLS (RECS) B BA S ES ....................................................................................................................... I-B -1 B.12.0 REC & RSR APPLICABILITY BASES .................................................. I-B.12.0-1 B.12.1 NOT USED B.12.2 INSTR UMEN TA TIO N ........................................................................ I-B .12.2.1-1 B. 12.2.1 Radioactive Liquid Effluent Monitoring Instrum e ntatio n ............................................................... I-B .12 .2 .1-1 B.12.2.2 Radioactive Gaseous Effluent Monitoring Instrumentation ............................................. I-B. 12.2.2-1 B 12.3 LIQ UID EFFLU ENTS ......................................................................... I-B .12.3.1-1 B.12.3.1 Liquid Effluent Concentration .......................................... I-B,12.3.1-1 B.12.3.2 Dose from Liquid Effluents .................... I-B.12.3.2-1 B.12.3.3 Liquid Radwaste Treatment Systems ............................. I-B.12.3.3-1 B.12.4 GASEOUS EFFLUENTS & TOTAL DOSE ........................................ I-B.12.4.1-1 B.12.4.1 Gaseous Effluent Dose Rates ......................................... I-B.12.4.1-1 B.12.4.2 Dose From Noble Gases ................................................ I-B.12.4.2-1 B.12.4.3 Dose From Iodine-1 31, Iodine-1 33Tritium And Radioactive Materials In Particulate Form ...................... I-B.12.4.3-1 B. 12.4.4 Gaseous Radwaste Treatment (O ffgas) S ystem .............................................................. I-B .12.4 .4-1 B.12.4.5 Ventilation Exhaust Treatment System ........................... I-B.12.4.5-1 B.12.4.6 Mark II C ontainm ent ....................................................... I-B.12.4.6-1 B .12 .4.7 T otal D ose ...................................................................... I-B .12.4.7-1 B .12.4.8 Main C ondenser ............................................................. I-B .12.4.8-1 B.12.4.9 Dose Limits for Members of the Public ........................... 1-B.12.4.9-1 B.12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM .... I-B.12.5.1-1 B .12 .5 .1 R E MP ............................................................................. I-B .12 .5 .1-1 B.12.5.2 Land Use Census ........................................................... I-B.12.5.2-1 B.12.5.3 Interlaboratory Comparison Program .............................. I-B.12.5.3-1 B.12.5.4 Meteorological Monitoring Program ................................ I-B.12.5.4-1 Page 3 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II TABLE OF CONTENTS PART II - ODCM PAGE

1.0 INTRODUCTION

- ODCM GENERAL INFORMATION ...........................................                                           11.1-1 1.1  STRUCTURE OF THE ODCM .......................................................................                            11.1-1 1 .2 R E G ULAT IO NS .............................................................................................            11.1-2 1.2.1 C ode of Federal R egulations ...............................................................                      11.1-2 1.2.2 Radiological Effluent Technical Specifications ....................................                                 11.1-4 1.2.3 Offsite Dose Calculation Manual .........................................................                           11.1-5 1.2.4 Overlapping R equirem ents ..................................................................                       11.1-5 1.2.5 Dose Receiver Methodology ...............................................................                          11.1-6 1.3  OFFSITE DOSE CALCULATION PARAMETERS .......................................                                             11.1-10 1.4  R E F E R E NC E S .............................................................................................        11.1-10 2.0     INSTRUMENTATION AND SYSTEMS .....................................................................                             11.2-1 2 .1 LIQ UID R E LEA S E S .......................................................................................            11.2 -1 2.1.1 Radwaste Discharge tanks ...........................................................                          11.2-1 2.1.2 C ooling Pond B low dow n ...............................................................                     11.2-1 2.2  RA D IAT IO N MO NIT O R S ...............................................................................               11.2-1 2.2.1 Liquid Radwaste Effluent Monitor .................................................                            11.2-1 2.2.2 Service Water Effluent Monitor .....................................................                          11.2-1 2.2.3 RHR Heat Exchange Cooling Water Effluent Monitors .................                                           11.2-2 2.3  LIQUID RADIATION EFFLUENT MONITORS ALARM AND T R IP S E T P O INT S ..........................................................................................        11.2 -2 2.3.1 Liquid Radwaste Effluent Monitor .................................................                            11.2-2 2.3.2 Service Water Effluent Monitor .....................................................                          11.2-3 2.3.3 RHR Heat Exchanger Cooling Water Effluent Monitors ................                                           11.2-3 2.3.4 D ischarge Flow R ates ...................................................................                    11.2-3 2.3.5 Allocation of Effluents from Common Release Points ...................                                        11.2-4 2.3.6 Projected Doses from Releases ....................................................                            11.2-5 2.3.7 Solidification of Waste/Process Control Program ..........................                                    11.2-5 2.4  A IR BO R NE R E LEA S E S .................................................................................             11.2-5 2.4.1 Condenser Offgas Treatment System ...........................................                                 11.2-6 2.4.2 Ventilation Exhaust Treatment System .........................................                                 11.2-7 2.5  GASEOUS EFFLUENT RADIATION MONITORS .........................................                                             11.2-7 2.5.1 Station Vent Stack Effluent Monitor ..............................................                            11.2-7 2.5.2 Standby Gas Treatment System Effluent Monitor .........................                                       11.2-7 2.5.3 Reactor Building Ventilation Monitors ...........................................                             11.2-8 2.5.4 Condensor Air Ejector Monitors ....................................................                           11.2-8 2.5.5 Turbine Building Trackway and North Service Building .................                                        11.2-9 Page 4 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II TABLE OF CONTENTS PART II - ODCM PAGE 2.6 GASEOUS RADIATION EFFLUENT ALARM AND TRIP SETPOINTS... 11.2-9 2.6.1 Reactor Building Vent Effluent Monitor ......................................... 11.2-9 2.6.2 Condenser Air Ejector Monitors .................................................... 11.2-9 2.6.3 Station Vent Stack Effluent Monitor ............................................ 11.2-10 2.6.4 Standby Gas Treatment Stack Monitor ....................................... 11.2-10 2 .6 .5 Re le ase Lim its ............................................................................ 11.2 -10 2 .6 .6 Re lease Mixture .......................................................................... 11.2 -11 2 .6 .7 C o nve rsio n Facto rs ..................................................................... 11.2-11 2 .6 .8 HV A C Flow R ates ....................................................................... 11.2-12 2.6.9 Allocation of Effluents from Common Release Points ................. 11.2-12 2 .6 .10 Dose P rojectio ns ......................................................................... 11.2-12 3 .0 LIQ UID E F F LU E NTS .......................................................................................... 11.3-1 3.1 LIQUID EFFLUENT RELEASES - GENERAL INFORMATION .............. 11.3-1 3.2 LIQUID EFFLUENT CONCENTRATIONS ............................................... 11.3-2 3.3 LIQUID EFFLUENT DOSE CALCULATION REQUIREMENTS .............. 11.3-4 3.4 D O SE METH O D O LO G Y ......................................................................... 11.3-5 3.4.1 Liquid Effluent Dose Method: General .......................................... 11.3-5 3.4.2 Potable W ater Pathw ay ................................................................. 11.3-8 3.4.3 Fish Ingestion Pathw ay ................................................................. 11.3-9 3 .4 .4 O ffsite D o se s ................................................................................ 11.3 -9 3 .4 .5 D rinking W ate r .............................................................................. 11.3-9 3.5 BIOACCUMULATION FACTORS .......................................................... 11.3-10 4.0 GA S EO US E FFLU E NTS .................................................................................... 11.4-1 4.1 GASEOUS EFFLUENTS - GENERAL INFORMATION .......................... 11.4-1 4.2 GASEOUS EFFLUENTS - DOSE AND DOSE RATE CALCULATION R E Q UIR E ME NT S .................................................................................... 11.4 -2 4.2.1 Instantaneous Dose Rates ............................................................ 11.4-2 4.2.2 Time Averaged Dose from Noble Gas .......................................... 11.4-8 4.2.3 Time Averaged Dose from Non-Noble Gas Radionuclides ......... 11.4-16 Page 5 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II TABLE OF CONTENTS PART II - ODCM PAGE 5 .0 T OT A L D O S E ..................................................................................................... 11.5 -1 5.1 TOTAL DOSE CALCULATION REQUIREMENTS .................................. 11.5-1 5.1.1 Total Effective Dose Equivalent Limits; 10CFR20 and 4 0 C F R 19 0 ..................................................................................... 11.5 -1 5.1.2 Total Dose Calculation Methodology ............................................ 11.5-2 5 .1.3 BWR S kyshine .............................................................................. 11.5-2 5.2 BWR SKYSHINE CALCULATION ............................................................ 11.5-3 5.3 ONSITE RADWASTE AND RAD MATERIAL STORAGE FACILITIES ..... 11.5-6 5.3.1 Process Waste Storage Facilities ................................................ 11.5-6 5.3.2 DA W Storage Facilities ................................................................ 11.5-6 5 .3 .3 IS F S I F a c ilitie s ............................................................................ 11.5 -6 5 .4 ME T HO D O LO G Y...................................................................................... 11.5-6 5 .5 TO T A L D O S E ........................................................................................... 11.5-7 5.6 COMPLIANCE TO TOTAL DOSE LIMITS ................................................ 11.5-8 5.6.1 Total Effective Dose Equivalent Limit- 10CFR20 Compliance ..... 11.5-8 5.6.2 Dose to a MEMBER OF THE PUBLIC in the Unrestricted A re a .............................................................................................. 11.5 -8 5.6.3 Dose to a MEMBER OF THE PUBLIC in the Restricted Area ....... 11.5-8 5.6.4 Total Dose Due to the Uranium Fuel Cycle (40CFR190) .............. 11.5-9 5.7 WHEN COMPLIANCE ASSESSMENT IS REQUIRED ........................... 11.5-10 6.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM ..................... 11.6-1 Page 6 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II ODCM TABLE OF CONTENTS LIST OF TABLES PART I - RADIOLOGICAL EFFLUENT CONTROLS (RECS) PAGE Table 1-1 Compliance Matrix.. 1-1.1-6 Table R12.2.1-1 Radioactive Liquid Effluent Monitoring Instrumentation ................ 1-12.2.1-5 Table R12.2.2-1 Radioactive Gaseous Effluent Monitoring Instrumentation ........... 1-12.2.2-5 Table R12.2.2-2 Radioactive Gaseous Effluent Monitoring Instrumentation A p p lica b ility .................................................................................. 1-12 .2 .2 -7 Table R12.3.1-1 Allowable Concentration of Dissolved or Entrained Noble Gases Released from the Site to Unrestricted Areas in Liq u id Wa ste ................................................................................. 1-12 .3 .1-3 Table R12.3.1-2 Radioactive Liquid Waste Sampling and Analysis Program ......... 1-12.3.1-4 Table R12.4.1-1 Radioactive Gaseous Waste Sampling and Analysis Program .... 1-12.4.1-2 Table R12.5.1-1 Radiological Environmental Monitoring Program .......................... 1-12.5.1-6 Table R12.5.1-2 Reporting Levels for Radioactivity Concentrations in Environm ental Sam ples .............................................................. 1-12.5.1-11 Table R12.5.1-3 Detection Capabilities for Environmental Sample Analysis Low er Lim it of D etection ............................................................. 1-12.5.1-12 PART II - ODCM Table 1-1 R egulatory D ose Lim it Matrix ......................................................................... 11.1-7 Table 1-2 Dose Assessm ent R eceivers ......................................................................... 11.1-8 Table 1-3 Miscellaneous Dose Assessment Factors: Environmental Parameters ....... 11.1-17 Table 1-4 S table E lem ent T ransfer D ata ...................................................................... 11.1-19 Table 2-1 Assumed Composition Of the LaSalle Station Noble Gas Effluent ............... 11.2-13 Page 7 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II ODCM TABLE OF CONTENTS LIST OF TABLES PART II - ODCM PAGE Table 3-1 Bioaccumulation Factors (Bfi) to be Used in the Absence of Site-S p e c ific D a ta ................................................................................................ 11.3 -1 1 T a b le 4 -1 C ritica l R a ng es ............................................................................................. 11.4 -32 Table 4-2 A verage W ind Speeds ................................................................................. 11.4-33 Table 4-3 X/Q and D/Q Maxima at or Beyond the Unrestricted Area Boundary ........... 11.4-34 Table 4-4 X/Q and D/Q Maxima at or Beyond the Restricted Area Boundary .............. 11.4-35 Table 4-5 D/Q at the Nearest Milk Cow and Meat Animal Locations within 5 miles ..... 11.4-36 Table 4-6 Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Various Nuclides ..................... 11.4.38 Table 4-7 Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Various Nuclides ....................... 11.4-53 Table 4-8 Parameters for Calculations of N-16 Skyshine Radiation From La Sa lle ......................................................................................................... 11.4 -6 8 Table 4-9 Elevated Level Joint Frequency Distribution Table Summary ...................... 11.4-69 Table 4-10 Mid Elevation Joint Frequency Distribution Table Summaries ...................... 11.4-71 Table 4-11 Ground Level Joint Frequency Distribution Table Summary ......................... 11.4-73 Table 4-12 Station C haracteristics ...................................................................................... 11.4-75 Table 4-13 Dose Factors for Noble G ases ..................................................................... 11.4-76 Table 4-14 External Dose Factors for Standing on Contaminated Ground DFGjj (m re m /hr pe r pC i/ m2) ................................................................................... 11.4 -77 Table 4-15 Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary ....... 11.4-80 Table 4-16 Infant Drinking Water A iT.............................................................................. 11.4-95 Table 4-17 C hild D rinking W ater A iT............................................................................... 11.4-99 Table 4-18 Teen Drinking Water A iT............................................................................. 11.4-103 Page 8 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II Table 4-19 Adult Drinking W ater AfT ............................................................................. 11.4-107 Table 4-20 Infa nt F is h A iT............................................................................................. 11.4 -1 11 Table 4-21 C hild Fis h A iT.............................................................................................. 11.4 -1 15 Table 4-22 T e e n F is h A iT.............................................................................................. 11.4 -1 19 Table 4-23 Ad ult Fis h A fT .............................................................................................. 11.4 -12 3 Table 4-24 Infant Inhalation Pi ...................................................................................... 11.4-127 Table 4-25 Child Inhalation Pi ..................................................................................... 11.4-131 Table 4-26 Teen Inhalation Pi ............................................... ... .... .... ..... .... .... ... .... ..... .. 11.4-135 Table 4-27 Adult Inhalation P1 ............................................... ... .... .... ..... .... .... .... ... ..... .. 11.4-139 Table 4-28 All Age Groups Ground Plane Ri ............................................................... 11.4-143 Table 4-29 Infant Inhalation Ri .................................................................................... 11.4-147 Table 4-30 Child Inhalation Ri ..................................................................................... 11.4-151 Table 4-31 Teen Inhalation Ri ..................................................................................... 11.4-155 Table 4-32 Adult Inhalation R1 ............................................... ... .... .... ..... .... ... .... .... .... ... 11.4-159 Table 4-33 Infant Vegetation R1 .............................................. .. .... .... ..... .... .... ... .... ..... .. 11.4-163 Table 4-34 Child Vegetation R ..................................................................................... 11.4-167 Table 4-35 Teen Vegetation R1 .............................................. ... ..... .... .... .... .... .... ... ..... . . 11.4-171 Table 4-36 Adult Vegetation Ri ...................................... 11.4-175 Table 4-37 Infa nt Milk R i.............................................................................................. 11.4 -17 9 Table 4-38 C h ild Milk R1 ..................................................... . ..... .... .... .... .... .... .... .... .... .... 11.4 -1 8 3 Table 4-39 T e e n Milk R i ............................................................................................... 11.4 -1 8 7 Table 4-40 A d u lt Milk R i ............................................................................................... 11.4 -1 9 1 Table 4-41 Infa nt Me a t R i ............................................................................................. 11.4 -1 9 5 Table 4-42 Child Meat R1... 11.4-199 Page 9 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II Table 4-43 Teen Meat Ri .............................................................................................. 11.4-203 Table 4-44 Adult Meat Rj .............................................................................................. 11.4-207 Table 6-1 Radiological Environmental Monitoring Program ........................................... 11.6-2 Page 10 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 ODCM Parts I and II ODCM TABLE OF CONTENTS LIST OF FIGURES PART I - RADIOLOGICAL EFFLUENT CONTROLS PAGE None PART 11- ODCM Figure 1-1 Radiation Exposure Pathways to Humans ....... ........................................ 11.1 -9 Figure 1-2 Unrestricted Area Boundary ............................. ...................................... 11.1 -2 1 Figure 1-3 Restricted Area Boundary ............................... ...................................... 11.1 -2 2 Figure 2-1 Simplified Gaseous Radwaste and Gaseous Effluent Flow Diagram ..... 11.2-14 Figure 2-2 Simplified Liquid Radwaste Processing Diagra rm ................................... 11.2 -16 Figure 2-3 Simplified Liquid Effluent Flow Diagram ......... ...................................... 11.2 -17 Figure 2-4 Simplified Solid Radwaste Processing Diagrar n .................................... 11.2 -1 8 Figure 6-1 Fixed Air Sampling Sites and Outer Ring TLD Locations ........................ 11.6-9 Figure 6-2 Inner Ring TLD Locations ............................... ...................................... 11.6 -1 0 Figure 6-3 Ingestion and Waterborne Exposure Pathway Sample Locations ......... 11.6-11 Page 11 of 11 LaSalle ODCM Table of Contents

CY-LA-170-301 Revision 3 OFFSITE DOSE CALCULATION MANUAL PART I RECS PART II ODCM LaSalle Station Units 1 and 2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls RADIOLOGICAL EFFLUENT CONTROLS LASALLE STATION Units 1 and 2

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.1 DEFINITIONS

                   -------------------- NOTE ------------------------------------

The defined terms of this section appear in capitalized type and are applicable throughout these Offsite Dose Calculation Manual (ODCM) Controls and Bases. Term Definition ACTION ACTION shall be that part of a control that prescribes remedial measures required under designated conditions. CHANNEL A CHANNEL CALIBRATION shall be the adjustment, as CALIBRATION necessary, of the channel output such that it responds within the necessary range and accuracy to known values of the parameter that the channel monitors. The CHANNEL CALIBRATION shall encompass the entire channel, including the required sensor, alarm, display, and trip functions, and shall include the CHANNEL FUNCTIONAL TEST. Calibration of instrument channels with resistance temperature detector (RTD) or thermocouple sensors may consist of an in-place qualitative assessment of sensor behavior and normal calibration of the remaining adjustable devices in the channel. The CHANNEL CALIBRATION may be performed by means of any series of sequential, overlapping, or total channel steps so that the entire channel is calibrated. For specific calibration requirements refer to surveillance requirements section for the applicable instrumentation. CHANNELCHECK A CHANNEL CHECK shall be a qualitative assessment, by observation, of channel behavior during operation. This determination shall include, where possible, comparison of the channel indication and status to other indications or status derived from independent instrument channels measuring the same parameter. CHANNEL A CHANNEL FUNCTIONAL TEST shall be the injection of a FUNCTIONAL TEST simulated or actual signal into the channel as close to the sensor as practicable to verify OPERABILITY, including required alarm, interlock, display, and trip functions, and channel failure trips. The CHANNEL FUNCTIONAL TEST may be performed by means of any series of sequential, overlapping, or total channel steps so that the entire channel is tested. (continued) Page 1-1.1-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.1 DEFINITIONS (continued) CONTINUOUS Uninterrupted sampling with the exception of sampling SAMPLING interruptions of short duration for required surveillances. DOSE EQUIVALENT That concentration of 1-131 (microcuries/gram) that alone would 1-131 produce the same thyroid dose as the quantity and isotopic mixture of 1-131, 1-132, 1-133, 1-134, and 1-135 actually present. The thyroid dose conversion factors used for this calculation shall be those listed in Table III of TID -14844, AEC, 1962, "Calculation of Distance Factors for Power and Test Reactor Sites"; Table E-7 of Regulatory Guide 1.109, Rev. 1, NRC, 1977; or ICRP 30, Supplement to Part 1, pages 192-212, Table titled, "Committed Dose Equivalent in Target Organs or Tissues per Intake of Unit Activity." GASEOUS Any system designed and installed to reduce radioactive RADWASTE gaseous effluents by collecting primary coolant system TREATMENT offgases from the primary system and providing for delay or SYSTEM holdup for the purpose of reducing the total radioactivity prior to release to the environment. MEMBERS OF THE Any individual, except when that individual is receiving an PUBLIC occupational dose. MODE A MODE shall correspond to any one inclusive combination of mode switch position, average reactor coolant temperature, and reactor vessel head closure bolt tensioning specified in Technical Specifications with fuel in the reactor vessel. OCCUPATIONAL The dose received by an individual in the course of DOSE employment in which the individual's assigned duties involve exposure to radiation and/or to radioactive material from licensed and unlicensed sources of radiation, whether in the possession of the licensee or other person. Occupational dose does not include dose from background radiation, as a patient from medical practices, from voluntary participation in medical research programs, or as a member of the public. (continued) Page 1-1.1-2

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.1 DEFINITIONS (continued) OFFSITE DOSE The ODCM shall contain the methodology and parameters used in CALCULATION the calculation of offsite doses resulting from radioactive gaseous MANUAL (ODCM) and liquid effluents, in the calculation of gaseous and liquid effluent monitoring Alarm/Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program. The ODCM shall also contain (1) the Radioactive Effluent Controls and Radiological Environmental Monitoring Program and (2) descriptions of the information that should be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports. OPERABLE - A system, subsystem, division, component, or device shall be OPERABILITY OPERABLE or have OPERABILITY when it is capable of performing its specified function(s) and when all necessary attendant instrumentation, controls, normal or emergency electrical power, cooling and seal water, lubrication, and other auxiliary equipment that are required for the system, subsystem, division, component, or device to perform its specified function(s) are also capable of performing their related support function(s). PROCESS CONTROL The PCP shall contain the current formulas, sampling, analyses, PROGRAM (PCP) test, and determinations to be made to ensure that processing and packaging of solid radioactive wastes based on demonstrated processing of actual or simulated wet solid wastes shall be accomplished in such a way as to assure compliance with 10 CFR Parts 20, 61, and 71, State regulations, burial ground requirements, and other requirements governing the disposal of solid radioactive waste. PURGE - PURGING PURGE or PURGING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is required to purify the confinement. RATED THERMAL The applicable unit's RTP shall be a total reactor core heat POWER (RTP) transfer rate to the reactor coolant as defined in Technical Specifications. (continued) Page 1-1.1-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.1 DEFINITIONS (continued) RADIOLOGICAL A compilation of the various regulatory requirements, EFFLUENT CONTROL surveillance and bases, commitments and/or components of STANDARDS (RECS) the radiological effluent and environmental monitoring programs for LaSalle Station. To assist in the understanding of the relationship between effluent regulations, ODCM equations, RECS and related Technical Specification requirements, Table 1-1 provides a matrix that relates these various components, as well as the Radiological Environmental Monitoring Program fundamental requirements. SITE BOUNDARY That line beyond which the land is not owned, leased, or otherwise controlled by licensee as defined in ODCM Part II Figure 1-3. SOLIDIFICATION SOLIDIFICATION shall be the conversion of radioactive wastes from liquid systems to a homogeneous (uniformly distributed), monolithic, immobilized solid with definite volume and shape, bounded by a stable surface of distinct outline on all sides (free-standing). SOURCE CHECK A SOURCE CHECK shall be the qualitative assessment of channel response when the channel sensor is exposed to a radioactive source (This could be an external source or known radioactive process stream). THERMAL POWER THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant. UNRESTRICTED AREA UNRESTRICTED AREA means an area, access to which is neither limited nor controlled by the licensee. VENTILATION A VENTILATION EXHAUST TREATMENT SYSTEM shall be EXHAUST TREAT- any system designed and installed to reduce gaseous MENT SYSTEM radioiodine or radioactive material in particulate form in effluents by passing ventilation or vent exhaust gases through charcoal adsorbers and/or HEPA filters for the purpose of removing iodines or particulates from the gaseous exhaust system prior to the release to the environment (such a system is not considered to have any effect on noble gas effluents). Engineered Safety Feature (ESF) atmospheric cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components. (continued) Page 1-1.1-4

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.1 DEFINITIONS (continued) VENTING VENTING shall be the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is not provided or required during VENTING. Vent, used in system names, does not imply a VENTING process. DEFINITIONS PECULIAR TO ESTIMATING DOSE TO MEMBERS OF THE PUBLIC USING THE ODCM COMPUTER PROGRAM:

a. ACTUAL Refers to using known release data to project the dose to the public for the previous time period. These data are stored in the database and used to demonstrate compliance with the reporting requirements of RECS.

b. PROJECTED Refers to using known release data from the previous time period or estimated release data to forecast a future dose to the public. This data is NOT incorporated into the database.

Page 1-1.1-5

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table 1-1 (Page 1 of 2) COMPLIANCE MATRIX ODCM Technical Regulation Dose Component Limit Equation RECS Specification 10 CFR 50 1. Gamma air dose and beta air dose due to airborne 4-4 12.4.2 5.5.4.h Appendix I radioactivity in effluent plume. 4-5

a. Whole body and skin dose due to airborne 4-2 N/A N/A radioactivity in effluent plume are reported only if 4-8 certain gamma and beta air dose criteria are exceeded.

b Projected doses due to gaseous release, when N/A 12.4.5 5.5.4.f averaged over 31 days, exceed 0.3 mrem to any organ. c Projected doses due to liquid release, when N/A 12.3.3 5.5.4.f averaged over 31 days, exceed 0.06 mrem to the total body or 0.2 mrem to any organ.

2. CDE for all organs and all four age groups due to 4-14 12.4.3 5.5.4.i iodines and particulates in effluent plume. All pathways are considered.

3. CDE for all organs and all four age groups due to 3-3 12.3.2 5.5.4.d radioactivity in liquid effluents.

10 CFR 20 1. TEDE, totaling all deep dose equivalent components 5-3 12.4.9 5.5.4.c (direct, ground and plume shine) and CDE (all pathways, both airborne and liquid-borne). CDE evaluation is made for adult only using FGR 11 database. 40 CFR 190 1. Whole body dose (DDE) due to direct dose, ground and 5-2 12.4.7 5.5.4.j (now by plume shine from all sources at a station. reference, also part of 2. Organ doses (CDE) to an adult due to all pathways. 3-3 10 CFR 20) 4-8 Technical 1. "Instantaneous" whole body (DDE), skin (SDE), and 4-9 12.4.1 5.5.4.g Specifications thyroid (CDE) dose rates due to radioactivity in airborne 4-10 effluents. For the thyroid dose, only inhalation is 4-6 considered.

2. "Instantaneous" concentration limits for liquid effluents. 3-5 12.3.1 5.5.4.b

3. Radioactive Effluent Release Report N/A 12.6.2 5.6.3 (continued)

Page 1-1.1-6

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table 1-1 (Page 2 of 2) COMPLIANCE MATRIX 0DCM Eqaion RECS Technical Secificat Regulation Dose Component Limit Equation Specification 10CFR50 Appendix I 1. Implement environmental monitoring program. N/A 12.5.1 N/A Section IV.B.2 10CFR50 Appendix I 1. Land Use Census N/A 12.5.2 N/A Section IV.B.3 10CFR50 Appendix I 1. Interlaboratory Comparison Program N/A 12.5.3 N/A Section IV.B.2 10CFR50 Appendix I Section IV.B.2 1. Annual Radiological Environmental Operating Report N/A 12.6.1 5.6.2 and Technical Specifications I Page 1-1.1-7

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.2 Logical Connectors PURPOSE The purpose of this section is to explain the meaning of logical connectors. Logical connectors are used in ODCM to discriminate between, and yet connect, discrete Conditions, Required Actions, Completion Times, Surveillances, and Frequencies. The only logical connectors that appear in ODCM are AND and OR. The physical arrangement of these connectors constitutes logical conventions with specific meanings. BACKGROUND Several levels of logic may be used to state Required Actions. These levels are identified by the placement (or nesting) of the logical connectors and by the number assigned to each Required Action. The first level of logic is identified by the first digit of the number assigned to a Required Action and the placement of the logical connector in the first level of nesting (i.e., left justified with the number of the Required Action). The successive levels of logic are identified by additional digits of the Required Action number and by successive indentations of the logical connectors. When logical connectors are used to state a Condition, Completion Time, Surveillance, or Frequency, only the first level of logic is used, and the logical connector is left justified with the statement of the Condition, Completion Time, Surveillance, or Frequency. EXAMPLES The following examples illustrate the use of logical connectors. (continued) Page 1-1.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.2 Logical Connectors EXAMPLES (continued) EXAMPLE 1.2-1 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. Control not met. A.1 Verify... AND A.2 Restore... In this example, the logical connector AND is used to indicate that, when in Condition A, both Required Actions A.1 and A.2 must be completed. (continued) Page I-1.2-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.2 Logical Connectors EXAMPLES (continued) EXAMPLE 1.2-2 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. Control not met. A.1 Trip... OR A.2.1 Verify... AND A.2.2.1 Reduce... OR A.2.2.2 Perform... OR A.3 Align This example represents a more complicated use of logical connectors. Required Actions A. 1, A.2 and A.3 are alternate choices, only one of which must be performed as indicated by the use of the logical connector OR and the left justified placement. Any one of these three Action may be chosen. If A.2 is chose, then both A.2.1 and A.2.2 must be performed as indicated by the logical connector AND. Required Action A.2.2 is met by performing A.2.2.1 or A.2.2.2. The indented position of the logical connector OR indicates that A.2.2.1 and A.2.2.2 are alternative choices, only one of which must be performed. Page I-1.2-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.3 Completion Times PURPOSE The purpose of this section is to establish the Completion Time convention and to provide guidance for its use. BACKGROUND ODCM Radiological Effluent Controls (RECs) specify minimum requirements for ensuring safe operation of the unit. The ACTIONS associated with a REC state Conditions that typically describe the ways in which the requirements of the REC can fail to be met. Specified with each stated Condition are Required Action(s) and Completion Times. DESCRIPTION The Completion Time is the amount of time allowed for completing a Required Action. It is referenced to the time of discovery of a situation (e.g., inoperable equipment or variable not within limits) that requires entering an ACTIONS Condition unless otherwise specified, providing the unit is in a MODE or specified condition stated in the Applicability of the REC. Required Actions must be completed prior to the expiration of the specified Completion Time. An ACTIONS Condition remains in effect and the Required Actions apply until the Condition no longer exists or the unit is not within the REC Applicability. If situations are discovered that require entry into more than one Condition at a time within a single REC (multiple Conditions), the Required Actions for each Condition must be performed within the associated Completion Time. When in multiple Conditions, separate Completion Times are tracked for each Condition starting from the time of discovery of the situation that required entry into the Condition. Once a Condition has been entered, subsequent divisions, subsystem, components or variables expressed in the Condition, discovered to be inoperable or not within limits, will not result in separate entry into the Condition unless specifically stated. The Required Actions of the Condition continue to apply to each additional failure, with Completion Times based on initial entry into the Condition. (continued) Page 1-1.3-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times DESCRIPTION However, when a subsequent division, subsystem, component, or variable (continued) expressed in the Condition is discovered to be inoperable or not within limits, the Completion Time(s) may be extended. To apply this Completion Time extension, two criteria must first be met. The subsequent inoperability:

a. Must exist concurrent with the first inoperability; and

b. Must remain inoperable or not within limits after the first inoperability is resolved.

The total Completion Time allowed for completing a Required Action to address the subsequent inoperability shall be limited to the more restrictive of either:

a. The stated Completion Time, as measured from the initial entry into the Condition, plus an additional 24 hours; or

b. The stated Completion Time as measured from discovery of the subsequent inoperability.

The above Completion Time extension does not apply to those RECs that have exceptions that allow completely separate re-entry into the Condition (for each division, subsystem, component, or variable expressed in the Condition) and separate tracking of Completion Times based on this re-entry. These exceptions are stated in individual RECs. The above Completion Time extension does not apply to a Completion Time with a modified "time zero." This modified "time zero" may be expressed as a repetitive time (i.e., "once per 8 hours," where the Completion Time is referenced from a previous completion of the Required Action versus the time of Condition entry) or as a time modified by the phrase "from discovery. . ." Example 1.3-3 illustrates one use of this type of Completion Time. The 10 day Completion Time specified for Condition A and B in Example 1.3-3 may not be extended. EXAMPLES The following examples illustrate the use of Completion Times with different types of Conditions and changing Conditions. (continued) Page 1-1.3-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES (continued) EXAMPLE 1.3-1 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME B. Required Action and B.1 Be in MODE 3. 12 hours associated Completion Time not met. AND 36 hours B.2 Be in MODE 4. Condition B has two Required Actions. Each Required Action has its own separate Completion Time. Each Completion Time is referenced to the time that Condition B is entered. The Required Actions of Condition B are in to be in MODE 3 within 12 hours AND in MODE 4 within 36 hours. A total of 12 hours is allowed for reaching MODE 3 and a total of 36 hours (not 48 hours) is allowed for reaching MODE 4 from the time that Condition B was entered. If MODE 3 is reached within 6 hours, the time allowed for reaching MODE 4 is the next 30 hours because the total time allowed for reaching Mode 4 is 36 hours. If Condition B is entered while in MODE 3, the time allowed for reaching MODE 4 is the next 36 hours. (continued) Page I-1.3-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES (continued) EXAMPLE 1.3-2 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. One monitor A.1 Restore monitor to 7 days inoperable. OPERABLE status. B. Required Action and B.1 Be in MODE 3. 12 hours associated Completion Time not met. AND B.2 Be in MODE 4. 36 hours When a monitor is declared inoperable, Condition A is entered. If the monitor is not restored to OPERABLE status within 7 days, Condition B is also entered and the Completion Time clocks for Required Action B.1 and B.2 start. Ifthe inoperable monitor is restored to OPERABLE status after Condition B is entered, Condition A and B are exited, and therefore, the Required Actions of Condition B may be terminated. When a monitor pump is declared inoperable while the first monitor is still inoperable, Condition A is not re-entered for the second monitor. REC 12.0.3 is entered, since the ACTIONS do not include a Condition from more than one inoperable monitor. The Completion Time clock for Condition A does not stop after REC 12.0.3 is entered, but continues to be tracked from the time Condition A was initially entered. While in REC 12.0.3, if one of the inoperable monitors is restored to OPERABLE status and the Completion Time for Condition A has not expired, REC 12.0.3 may be exited and operation continued in accordance with Condition A. (continued) Page I-1.3-4

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES EXAMPLE 1.3-2 (continued) While in REC 12.0.3, if one of the inoperable monitors is restored to OPERABLE status and the Completion Time for Condition A has expired, REC 12.0.3 may be exited and operation continued in accordance with Condition B. The Completion Time for Condition B is tracked from the time the Condition A Completion Time expired. On restoring one of the monitors to OPERABLE status, the Condition A Completion Time is not reset, but continues from the time the first monitor was declared inoperable. This Completion Time may be extended if the monitor restored to OPERABLE status was the first inoperable monitor. A 24 hour extension to the stated 7 days is allowed, provided this does not result in the second monitor being inoperable for > 7 days. (continued) Page I-1.3-5

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES (continued) EXAMPLE 1.3-3 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. One Function X A.1 Restore Function X 7 days subsystem inoperable, subsystem to OPERABLE status. AND 10 days from discovery of failure to meet the Control B. One Function Y B. 1 Restore Function Y 72 hours subsystem inoperable, subsystem to OPERABLE status. AND 10 days from discovery to meet Control C. One Function X C.1 Restore Function X 72 hours subsystem inoperable, subsystem to OPERABLE status. AND One Function Y OR subsystem inoperable. 72 hours C.2 Restore Function Y subsystem to OPERABLE status. (continued) Page I-1.3-6

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES EXAMPLE 1.3-3 (continued) When one Function X subsystem and one Function Y subsystem are inoperable, Condition A and Condition B are concurrently applicable. The Completion Times for Condition A and Condition B are tracked separately for each subsystem, starting from the time each subsystem was declared inoperable and the Condition was entered. A separate Completion Time is established for Condition C and tracked from the time the second subsystem was declared inoperable (i.e., the time the situation described in Condition C was discovered). If Required Action C.2 is completed within the specified Completion Time, Conditions B and C are exited. If the Completion Time for Required Action A.1 has not expired, operation may continue in accordance with Condition A. The remaining Completion Time in Condition A is measured from the time the affected subsystem was declared inoperable (i.e., initial entry into Condition A). The Completion Times of Conditions A and B are modified by a logical connector, with a separate 10 day Completion Time measured from the time it was discovered the REC was not met. In this example, without the separate Completion Time, it would be possible to alternate between Conditions A, B, and C in such a manner that operation could continue indefinitely without ever restoring systems to meet the REC. The separate Completion Time modified by the phrase "from discovery of failure to meet the Control" is designed to prevent indefinite continued operation while not meeting the REC. This Completion Time allows for an exception to the normal "time zero" for beginning the Completion Time "clock." In this instance, the Completion Time "time zero" is specified as commencing at the time the associated Condition was entered. (continued) Page I-1.3-7

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES (continued) EXAMPLE 1.3-4 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. One or more required A.1 Restore 4 hours instruments inoperable, instruments(s) to OPERABLE status. B. Required Action and B.1 Be in MODE 3. 12 hours associated Completion Time not met. AND 36 hours B.2 Be in MODE 4. A single Completion Time is used for any number of instruments inoperable at the same time. The Completion Time associated with Condition A is based on the initial entry into Condition A and is not tracked on a per instrument basis. Declaring subsequent instruments inoperable, while Condition A is still in effect, does not trigger the tracking of separate Completion Times. Once one of the instruments has been restored to OPERABLE status, the Condition A Completion Time is not reset, but continues from the time the first instrument was declared inoperable. The Completion Time may be extended if the instrument restored to OPERABLE status was the first inoperable instrument. The Condition A Completion Time may be extended for up to 4 hours provided this does not result in any subsequent instrument being inoperable for > 4 hours. If the Completion Time of 4 hours (plus the extension) expires while one or more instruments are still inoperable, Condition B is entered. (continued) Page I-1.3-8

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES EXAMPLE 1.3-5 (continued) ACTIONS

                                                       -NOTE-Separate Condition entry is allowed for each inoperable instrument.

CONDITION REQUIRED ACTION COMPLETION TIME A. One or more instruments A. 1 Restore 4 hours inoperable, instrument(s) to OPERABLE status. B. Required Action and B.1 Be in MODE 3. 12 hours associated Completion Time not met. AND 36 hours B.2 Be in MODE 4. The Note above the ACTIONS Table is a method of modifying how the Completion Time is tracked. If this method of modifying how the Completion Time is tracked was applicable only to a specific Condition, the Note would appear in that Condition rather than at the top of the ACTIONS Table. The Note allows Condition A to be entered separately for each inoperable instrument, and Completion Times tracked on a per instrument basis. When an instrument is declared inoperable, Condition A is entered and its Completion Time starts. If subsequent instruments are declared inoperable, Condition A is entered for each instrument and separate Completion Times start and are tracked for each instrument. If the Completion Time associated with an instrument in Condition A expires, Condition B is entered for that instrument. If the Completion Times associated with subsequent instruments in Condition A expire, Condition B is entered separately for each instrument and separate Completion Times start and are tracked for each instrument. If a instrument that caused entry into Condition B is restored to OPERABLE status, Condition B is exited for that instrument. Since the Note in this example allows multiple Condition entry and tracking of separate Completion Times, Completion Time extensions do not apply. (continued) Page I-1.3-9

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES (continued) EXAMPLE 1.3-6 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. One channel Perform RSR 12.x.x.x. Once per 8 hours inoperable. OR Reduce THERMAL POWER to 8 hours

• 50% RTP.

B. Required Action and B.1 Be in MODE 3. 12 hours associated Completion Time not met. Entry into Condition A offers a choice between Required Action A.1 or A.2. Required Action A. 1 has a "once per" Completion Time, which qualifies for the 25% extension, per RSR 12.0.2 to each performance after the initial performance. The initial 8 hour interval of Required Action A. 1 begins when Condition A is entered and the initial performance of Required Action A. 1 must be completed within the first 8 hour interval. If Required Action A.1 is followed and the Required Action is not met within the Completion Time (plus the extension allowed by RSR 12.0.2), Condition B is entered. If Required Action A.2 is followed and the Completion Time of 8 hours is not met, Condition B is entered. If after entry into Condition B, Required Action A. 1 or A.2 is met, Condition B is exited and operation may then continue in Condition A. (continued) Page I-1.3-10

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.3 Completion Times EXAMPLES (continued) EXAMPLE 1.3-7 ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. One subsystem A.1 Verify affected 1 hour inoperable, subsystem isolated. AND Once per 8 hours thereafter AND A.2 Restore subsystem to 72 hours OPERABLE status. B. Required Action and B.1 Be in MODE 3. 12 hours associated Completion Time not met. AND B.2 Be in MODE 4. 36 hours Required Action A.1 has two Completion Times. The 1 hour Completion Time begins at the time the Condition is entered and each "Once per 8 hours thereafter" interval begins upon performance of Required Action A. 1. If after Condition A is entered, Required Action A. 1 is not met within either the initial 1 hour or any subsequent 8 hour interval from the previous performance (plus the extension allowed by RSR 12.0.2), Condition B is entered. The Completion Time clock for Condition A does not stop after Condition B is entered, but continues from the time Condition A was initially entered. If Required Action A.1 is met after Condition B is entered, Condition B is exited and operation may continue in accordance with Condition A, provided the Completion Time for Required Action A.2 has not expired. IMMEDIATE When "Immediately" is used as a Completion Time, the Required Action should be COMPLETION pursued without delay and in a controlled manner. TIME Page 1-1.3-11

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.4 Frequency PURPOSE The purpose of this section is to define the proper use and application of Frequency requirements. DESCRIPTION Each ODCM Radiological Effluent Surveillance Requirement (RSR) has a specified Frequency in which the Surveillance must be met in order to meet the associated ODCM REC. An understanding of the correct application of the specified Frequency is necessary for compliance with the RSR. The "specified Frequency" is referred to throughout this section and each of the Requirements of Section 12.0, ODCM Surveillance Requirement (RSR) Applicability. The "specified Frequency" consists of the requirements of the Frequency column of each RSR, as well as certain Notes in the Surveillance column that modify performance requirements. Sometimes special situations dictate when the requirements of a Surveillance are to be met. They are "otherwise stated" conditions allowed by RSR 12.0.1. They may be stated as clarifying Notes in the Surveillance, as part of the Surveillance, or both. Example 1.4-4 discusses these special situations. Situations where a Surveillance could be required (i.e., its Frequency could expire), but where it is not possible or not desired that it be performed until sometime after the associated REC is within its Applicability, represent potential RSR 12.0.4 conflicts. To avoid these conflicts, the RSR (i.e., the Surveillance or the Frequency) is stated such that it is only "required" when it can be and should be performed. With a RSR satisfied, RSR 12.0.4 imposes no restriction. The use of "met" or "performed" in these instances conveys specified meanings. A Surveillance is "met" only when the acceptance criteria are satisfied. Known failure of the requirements of a Surveillance, even without a Surveillance specifically being "performed," constitutes a Surveillance not "met."

              "Performance" refers only to the requirement to (continued)

Page I-1.4-1

CY-LA- 170-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.4 Frequency DESCRIPTION specifically determine the ability to meet the acceptance criteria. (continued) RSR 12.0.4 restrictions would not apply if both the following conditions are satisfied:

a. The Surveillance is not required to be performed; and

b. The Surveillance is not required to be met or, even if required to be met, is not known to be failed.

EXAMPLES The following examples illustrate the various ways that Frequencies are specified. In these examples, the Applicability of the REC (REC not shown) is MODES 1, 2, and 3. EXAMPLE 1.4-1 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY Perform CHANNEL CHECK 12 hours Example 1.4-1 contains the type of RSR most often encountered in the ODCM. The Frequency specifies an interval (12 hours) during which the associated Surveillance must be performed at least one time. Performance of the Surveillance initiates the subsequent interval. Although the Frequency is stated as 12 hours, an extension of the time interval to 1.25 times the interval specified in the Frequency is allowed by RSR 12.0.2 for operational flexibility. The measurement of this interval continues at all times, event when the RSR is not required to be met per RSR 12.0.1 (such as when the equipment is inoperable, a variable is outside specified limits, or the unit is outside the Applicability of the REC). If the interval specified by RSR 12.0.2 is exceeded while the unit is in a MODE or other specified condition in the Applicability of the REC, (continued) Page I-1.4-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.4 Frequency EXAMPLES EXAMPLE 1.4-1 (continued) and the performance of the Surveillance is not otherwise modified (refer to Examples 1.4-3 and 1.4-4), then RSR 12.0.3 becomes applicable. If the interval as specified by RSR 12.0.2 is exceeded while the unit is not in a MODE or other specified condition in the Applicability of the REC for which performance of the RSR is required, the Surveillance must be performed within the Frequency requirements of RSR 12.0.2 prior to entry into the MODE or other specified condition. Failure to do so would result in a violation of RSR 12.0.4. EXAMPLE 1.4-2 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY Verify flow is within limits. Once within 12 hours after > 25% RTP AND 24 hours thereafter Example 1.4-2 has two Frequencies. The first is a one time performance Frequency, and the second is of the type shown in Example 1.4-1. The logical connector "AND" indicates that both Frequency requirements must be met. Each time reactor power is increased from a power level < 25% RTP to > 25% RTP, the Surveillance must be performed within 12 hours. (continued) Page I-1.4-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.4 Frequency EXAMPLES EXAMPLE 1.4-2 (continued) The use of "once" indicates a single performance will satisfy the specified Frequency (assuming no other Frequencies are connected by "AND"). This type of Frequency does not qualify for the extension allowed by RSR 12.0.2.

               "Thereafter" indicates future performances must be established per RSR 12.0.2, but only after a specified condition is first met (i.e., the "once" performance in this example). If reactor power decreases to < 25% RTP, the measurement of both intervals stops. New intervals start upon reactor power reaching 25% RTP.

EXAMPLE 1.4-2 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY NOTE ------------- Not required to be performed until 12 hours after > 25% RTP. Perform channel adjustment. 7 days The interval continues whether or not the unit operation is < 25% RTP between performances. As the Note modifies the required performance of the Surveillance, it is construed to be part of the "specified Frequency." Should the 7 day interval be exceeded while operation is < 25% RTP, this Note allows 12 hours after power reaches

               > 25% RTP to perform the Surveillance. The Surveillance is still considered to be within the "specified Frequency." Therefore, if the Surveillance were not performed within the 7 day interval (plus the extension allowed by RSR 12.0.2),

but operation was < 25% RTP, (continued) Page I-1.4-4

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.4 Frequency EXAMPLES EXAMPLE 1.4-3 (continued) it would not constitute a failure of the RSR or failure to meet the REC. Also, no violation of RSR 12.0.4 occurs when changing MODES, even with the 7 day Frequency not met, provided operation does not exceed 12 hours with power

               > 25% RTP.

Once the unit reaches 25% RTP, 12 hours would be allowed for completing the Surveillance. If the Surveillance were not performed within this 12 hour interval, there would then be a failure to perform a Surveillance within the specified Frequency, and the provisions of RSR 12.0.3 would apply. EXAMPLE 1.4-2 SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY

               -------------------NOTE ---------------------------

Only required to be met in MODE 1. Verify leakage rates are within limits. 24 hours Example 1.4-4 specifies that the requirements of this Surveillance do not have to be met until the unit is in MODE 1. The interval measurement for the Frequency of this Surveillance continues at all times, as described in Example 1.4-1. However, the Note constitutes an "otherwise stated" exception to the Applicability of this Surveillance. Therefore, if the Surveillance were not performed within the 24 hour interval (plus the extension allowed by RSR 12.0.2), but the unit was not in MODE 1, there would be no failure of the RSR nor failure to meet the REC. Therefore, no violation of RSR 12.0.4 occurs when changing MODES, even with the 24 hour Frequency exceeded, provided the MODE change was not made into MODE 1. Prior to entering MODE 1 (assuming again that the 24 hour Frequency were not met), RSR 12.0.4 would require satisfying the RSR. Page I-1.4-5

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 1.0 USE AND APPLICATION 1.5 REC and RSR Implementation The ODCM provides those limitations upon plant operations which are part of the licensing basis for the station but do not meet the criteria for continued inclusion in the Technical Specifications. It also provides information which supplements the Technical Specifications by implementing the requirements of Technical Specification Sections 5.5.1, 5.5.4, 5.6.2, and 5.6.3. RECs and RSRs are implemented the same as Technical Specifications (see 12.0 Applicability). However, RECs and RSRs are treated as plant procedures and are not part of the Technical Specifications. Therefore the following exceptions apply:

a. Violations of the Action or Surveillance requirements in a REC are not reportable as conditions prohibited by, or deviations from, the Technical Specifications per 10 CFR 50.72 or 10 CFR 50.73.

b. Power reduction or plant shutdowns required to comply with the Actions of a REC are not reportable per 10 CFR 50.72 or 10 CFR 50.73.

Page I-1.5-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 2.0 through 11.0 NOT USED INTENTIONALLY BLANK Sections 2.0 through 11.0 are not used in the ODCM in order to maintain the Original ODCM numbering convention Page 1-2.0-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.0 ODCM RADIOLOGICAL EFFLUENT CONTROL (REC) APPLICABILITY REC 12.0.1 RECs shall be met during the MODES or other specified conditions in the Applicability, except as provided in REC 12.0.2. REC 12.0.2 Upon discovery of a failure to meet a REC, the Required Actions of the associated Conditions shall be met, except as provided in REC 12.0.5. If the REC is met or is no longer applicable prior to expiration of the specified Completion Time(s), completion of the Required Action(s) is not required, unless otherwise stated. REC 12.0.3 When a REC is not met and the associated ACTIONS are not met, an associated ACTION is not provided, or if directed by the associated ACTIONS, action shall be initiated within 1 hour to:

a. Implement appropriate compensatory actions as needed;

b. Verify that the plant is not in an unanalyzed condition or that a required safety function is not compromised by the inoperabilities; and

c. Within 12 hours, obtain Shift Operations Superintendent or designee approval of the compensatory actions and the plan for exiting REC 12.0.3.

Exceptions to this REC are stated in the individual RECs. Where corrective measures are completed that permit operation in accordance with the REC or ACTIONS, completion of the actions required by REC 12.0.3 is not required. REC 12.0.3 is only applicable in MODES 1, 2, and 3. REC 12.0.4 When a REC is not met, entry into a MODE or other specified condition in the Applicability shall not be made except when the associated ACTIONS to be entered permit continued operation in the MODE or other specified (continued) Page 1-12.0-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.0 REC APPLICABILITY REC 12.0.4 condition in the Applicability for an unlimited period of time. This REC shall (continued) not prevent changes in MODES or other specified conditions in the Applicability that are required to comply with ACTIONS or that are part of a shutdown of the unit. Exceptions to this REC are stated in the individual RECs. REC 12.0.4 is only applicable for entry into a MODE or other specified condition in the Applicability in MODES 1, 2, and 3. REC 12.0.5 Equipment removed from service or declared inoperable to comply with ACTIONS may be returned to service under administrative control solely to perform testing required to demonstrate its OPERABILITY or the OPERABILITY of other equipment. This is an exception to REC 12.0.2 for the system returned to service under administrative control to perform the testing required to demonstrate OPERABILITY. REC 12.0.6 RECs, including associated ACTIONS, shall apply to each unit individually, unless otherwise indicated. Whenever the REC refers to a system or component that is shared by both units, the ACTIONS will apply to both units simultaneously. Page 1-12.0-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.0 ODCM RADIOLOGICAL EFFLUENT SURVEILLANCE REQUIREMENT (RSR) APPLICABILITY RSR 12.0.1 RSRs shall be met during the MODES or other specified conditions in the Applicability for individual RECs, unless otherwise stated in the RSR. Failure to meet a RSR, whether such failure is experienced during the performance of the RSR or between performances of the RSR, shall be failure to meet the REC. Failure to perform a RSR within the specified Frequency shall be failure to meet the REC except as provided in RSR 12.0.3. RSRs do not have to be performed on inoperable equipment or variables outside specified limits. RSR 12.0.2 The specified Frequency for each RSR is met if the RSR is performed within 1.25 times the interval specified in the Frequency, as measured from the previous performance or as measured from the time a specified condition of the Frequency is met. For Frequencies specified as "once," the above interval extension does not apply. If a Completion Time requires periodic performance on a "once per.. basis, the above Frequency extension applies to each performance after the initial performance. Exceptions to this RSR are stated in the individual RSRs. RSR 12.0.3 If it is discovered that a RSR was not performed within its specified Frequency, then compliance with the requirement to declare the REC not met may be delayed, from the time of discovery, up to 24 hours or up to the limit of the specified Frequency, whichever is greater. This delay period is permitted to allow performance of the RSR. A risk evaluation shall be performed for any Surveillance delayed greater than 24 hours and the risk impact shall be managed. If the RSR is not performed within the delay period, the REC must immediately be declared not met, and the applicable Condition(s) must be entered. When the RSR is performed within the delay period and the RSR is not met, the REC must immediately be declared not met, and the applicable Condition(s) must be entered. (continued) Page 1-12.0-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.0 RSR APPLICABILITY (continued) RSR 12.0.4 Entry into a MODE or other specified condition in the Applicability of a REC shall not be made unless the REC's RSRs have been met within their specified Frequency. This provision shall not prevent entry into MODES or other specified conditions in the Applicability that are required to comply with ACTIONS or that are part of a shutdown of the unit. RSR 12.0.4 is only applicable for entry into a MODE or other specified condition in the Applicability in MODES 1, 2, and 3. RSR 12.0.5 RSRs shall apply to each unit individually, unless otherwise indicated. Page 1-12.0-4

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.1 NOT USED INTENTIONALLY BLANK Page 1-12.1-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 12.2 INSTRUMENTATION 12.2.1 Radioactive Liquid Effluent Monitoring Instrumentation. REC 12.2.1 The Radioactive Liquid Effluent Instrumentation channels in Table R12.2.1-1 shall be OPERABLE with their alarm/trip setpoints to ensure that the limits of REC 12.3.1 are not exceeded. APPLICABILITY: When pump flow is present in the system. For Blowdown, when the Blowdown Flow Control Valve is >0% open and the Blowdown line is not otherwise isolated. ACTIONS

                    ------------------ NOTE -----------------------------------

1. Separate Condition entry is allowed for each instrument channel.

CONDITION REQUIRED ACTION COMPLETION TIME A. One or more required A.1 Suspend the release of Immediately instrument channels radioactive liquid effluents inoperable due to its monitored by the alarm/trip setpoint less instrument channel. conservative than required. OR A.2 Enter the Condition referenced Immediately in Table R12.2.1-1 for the instrument channel. B. One or more required B.1 Enter the Condition referenced Immediately instrument channels In Table R12.2.1-1 for the inoperable for reasons instrument channel. other than Condition A. (continued) Page 1-12.2.1-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME C. As required by Required C.1 Perform RSR 12.3.1.1 on at Prior to each release Action A.2 or B.1 and least two independent referenced in Table samples of the tanks R12.2.1-1. contents. AND C.2 Verify the release rate Prior to each release calculations and discharge valve line-up independently with at least two qualified members of the technical staff. AND C.3 Return instrument channel to 30 days OPERABLE status. OR C.4 Place Administrative Control Clearance order to Lock-Closed OWF201, RW DSCH Tank River DSCH Valve, to remove the ability to conduct a Liquid Radwaste Discharge. D. Required Action and D.1 Suspend release of radioactive Immediately associated Completion effluents via this pathway. Time of Condition C not met. E. As required by Required E.1 Analyze affected effluent grab Once per 8 hours Action A.2 or B.1 and samples for principal gamma referenced in Table emitters and 1-131 at an LLD as R12.2.1-1. specified in Table R12.3.1-2. AND E.2 Restore the instrument channel 30 days to OPERABLE status. (continued) Page 1-12.2.1-2

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME F. As required by Required F.1 --------- NOTE ------------------ Action A.2 or B.1 and Pump curves for instrument 3.a, referenced in or known valve positions for Table R12.2.1-1. instrument 3.b, may be used to estimate flow. Estimate the flow rate for the Once per 4 hours release in progress via the affected pathway. F.2 With remote position indication Prior to each release. for OWL005 (BDFCV) not available, verify valve position locally. G. ------- NOTE --------- G.1 Explain why the inoperability In accordance with Required Action G.1 was not corrected in a timely Technical shall be completed if this manner in the next Radioactive Specification 5.6.3. Condition is entered. Effluent Release Report. Required Action C.3 or C.4, or E.2 and associated Completion Time not met. Page 1-12.2.1-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.2.1.1 Perform SOURCE CHECK. Prior to each release RSR 12.2.1.2 Perform CHANNEL FUNCTIONAL TEST. Prior to each Release RSR 12.2.1.3 Perform CHANNEL CHECK. 24 hours RSR 12.2.1.4 Perform SOURCE CHECK. 31 days RSR 12.2.1.5 Perform CHANNEL FUNCTIONAL TEST. Except for 92 days Instrument 3.b, the test shall also demonstrate that the instrument indicates measured levels above the alarm/trip setpoint and that the control room alarm annunciates and the affected pathway automatically isolates, as applicable, under the following conditions:

a. Loss of power, b Downscale failure, or

c. Controls not set in Operate or High Voltage mode.

RSR 12.2.1.6 Perform CHANNEL CALIBRATION. N/A (No longer applicable per E.C. #360580) RSR 12.2.1.7 Perform CHANNEL CALIBRATION 24 months RSR 12.2.1.8 12 months Perform POSITION INDICATION VERIFICATION Page 1-12.2.1-4

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.2.1-1 (page 1 of 2) Radioactive Liquid Effluent Monitoring Instrumentation CONDITION REQUIRED REFERENCED CHANNELS PER FROM REQUIRED SURVEILLANCE INSTRUMENT IINSTRUMENT ACTION A.2 AND B.1 REQUIREMENTS

1. Gamma Scintillation Monitor providing Alarm and Automatic Termination of Release

a. Liquid Radwaste Effluents Line 1 C RSR 12.2.1.1 RSR 12.2.1.3 RSR 12.2.1.5 RSR 12.2.1.7(a)

2. Gamma Scintillation Monitors providing Alarm but not providing Automatic Termination of Release

a. Service Water Effluent Line (Unit 1) 1 E RSR 12.2.1.4 RSR 12.2.1.3 RSR 12.2.1.5 RSR 12.2.1.7(a)

b. Service Water Effluent Line (Unit 2) 1 E RSR 12.2.1.4 RSR 12.2.1.3 RSR 12.2.1.5 RSR 12.2.1.7(a)

c. RHR Service Water (Line A) Effluent Line 1 E RSR 12.2.1.4 (Unit 1) RSR 12.2.1.3 RSR 12.2.1.5 RSR 12.2.1.7(a)

d. RHR Service Water (Line B) Effluent Line 1 E RSR 12.2.1.4 (Unit 1) RSR 12.2.1.3 RSR 12.2.1.5 RSR 12.2.1.7(a)

e. RHR Service Water (Line A) Effluent Line 1 E RSR 12.2.1.4 (Unit 2) RSR 12.2.1.3 RSR 12.2.1.5 RSR 12.2.1.7(a)

f. RHR Service Water (Line B) Effluent Line 1 E RSR 12.2.1.4 (Unit 2) RSR 12.2.1.3 RSR 12.2.1.5 RSR 12.2.1.7(a)

(continued) (a)The initial CHANNEL CALIBRATION shall be performed using one or more of the reference radioactive standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, the initial reference radioactive standards or radioactive sources that have been related to the initial calibration shall be used, in order to demonstrate linearity of the original calibration. This transfer calibration, combined with signal inputs, satisfies channel calibration and functional test requirements as implemented by station procedures. Page 1-12.2.1-5

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R1 2.2.1-1 (page 2 of 2) Radioactive Liquid Effluent Monitoring Instrumentation CONDITION REQUIRED REFERENCED CHANNELS PER FROM REQUIRED SURVEILLANCE INSTRUMENT IINSTRUMENT ACTION A.2 AND B.1 REQUIREMENTS

3. Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line 1 F RSR 12.2.1.2 RSR 12.2.1.3 RSR 12.2.1.7

b. OWLO05 BDFCV Position Indication 1 F RSR 12.2.1.8 Page 1-12.2.1-6

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 12.2 INSTRUMENTATION 12.2.2 Radioactive Gaseous Effluent Monitoring Instrumentation REC 12.2.2 The Radioactive Gaseous Effluent Instrumentation channels in Table R12.2.2-1 shall be OPERABLE with their alarm/trip setpoints set to ensure that the limits of REC 12.4.1 are not exceeded. APPLICABILITY: According to Table R12.2.2-1 ACTIONS

                 ------------------      NOTE -------------------------

Separate condition entry is allowed for each instrument channel. CONDITION REQUIRED ACTION COMPLETION TIME A. One or more required A.1 Suspend the release of Immediately instrument channels radioactive gaseous inoperable due to its effluents monitored by alarm/trip setpoint less the instrument channel. conservative than required. OR A.2 Enter the Condition Immediately referenced in Table R12.2.2-1 for the instrument channel. B. One or more required B.1 Enter the Condition Immediately instrument channels referenced in Table R12.2.2-1 inoperable for reasons for the instrument channel. other than Condition A. (continued) Page 1-12.2.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME C. As required by Required C.1 Place instrument channel in 1 hour Action A.2 or B. 1 and trip. referenced in Table R12.2.2-1. D. As required by Required D.1 Obtain grab samples. Once per 8 hours Action A.2 or B.1 and referenced in Table R12.2.2-1. AND D.2 Analyze grab samples for Within 24 hours noble gas emitters. following each grab sample AND D.3 Restore instrument channel to OPERABLE status. 30 days E. As required by Required E.1 Obtain grab samples. Once per 8 hours Action A.2 or B.1 and referenced in Table AND R12.2.2-1. E.2 Analyze grab samples for Within 24 hours noble gas emitters at an LLD following each grab as specified in Table sample R12.4.1-1. AND E.3 Restore instrument channel 30 days to OPERABLE status. F. As required by Required F.1 Establish CONTINUOUS 4 hours Action A.2 or B.1 and SAMPLING with auxiliary referenced in Table sampling equipment as R12.2.2-1. required in Table R12.4.1-1. AND F.2 Restore instrument channel 30 days to OPERABLE status. (continued) Page 1-12.2.2-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME G. As required by Required G.1 Estimate flow rate. Once per 4 hours Action A.2 or B.1 and AND referenced in Table R12.2.2-1. G.2 Restore instrument channel 30 days to OPERABLE status. H. As required by Required H.1 Verify offgas treatment Immediately Action A.2 or B.1 and system not bypassed. referenced in Table AND R12.2.2-1. H.2.1 Verify at least one Immediately Instrument 1.a channel OPERABLE. OR H.2.2 Verify Required Actions for Immediately Condition D are met. AND H.3 Obtain and analyze grab Once per 24 hours. samples. AND H.4 Restore instrument channel 30 days to OPERABLE status.

   -       - NOTE -----------   1.1   Explain in the next                 In accordance with Required Action 1.1 shall be       Radioactive Effluent Release        Technical completed if this Condition        Report why the inoperability        Specification 5.6.3.

is entered. was not corrected within the time specified. Required Action and associated Completion Time of Required Action D.3, E.3, F.2, or G.2 or H.4 not met. Page 1-12.2.2-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.2.2.1 Perform CHANNEL CHECK. 24 hours RSR 12.2.2.2 Perform SOURCE CHECK. 24 hours RSR 12.2.2.3 ------------------ NOTE ------------------ For Instruments 4.b and 4.c, not required to be performed until 7 days after Standby Gas Treatment is placed in operation. Perform CHANNEL CHECK. 7 days RSR 12.2.2.4 Perform SOURCE CHECK. 31 days RSR 12.2.2.5 Perform CHANNEL FUNCTIONAL TEST. For 92 days Instruments 3.a (log monitor only) and 1 .a, the test shall also demonstrate that the control room alarm annunciates and the automatic isolation capability of the affected pathway, as applicable, under the following conditions:

a. Upscale,

b. Inoperative, or

c. Downscale RSR 12.2.2.6 Perform CHANNEL FUNCTIONAL TEST. The test shall 92 days also demonstrate that the instrument indicates measured levels above the alarm setpoint and that the control room alarm annunciates on a Loss of Counts condition.

RSR 12.2.2.7 Perform CHANNEL CALIBRATION 24 months Page 1-12.2.2-4

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.2.2-1 (page 1 of 2) Radioactive Gaseous Effluent Monitoring Instrumentation APPLICABLE MODES OR REQUIRED CONDITION OTHER CHANNELS REFERENCED SPECIFIED PER FROM REQUIRED SURVEILLANCE INSTRUMENT(a) CONDITIONS INSTRUMENT ACTIONA.2ANDB.1 REQUIREMENTS

1. Main Condenser Offgas Treatment System Effluent Monitoring System

a. Noble Gas Activity Monitor - (b) 2 C, if only one required RSR 12.2.2.1 Providing Alarm and Automatic channel inoperable RSR 12.2.2.2 Termination of Release RSR 12.2.2.5 (Post-Treat) D, if both required RSR 12.2.2.7(e) channels inoperable

2. Main Stack Monitoring System

a. Noble Gas Activity Monitor (Low (c) I E RSR 12.2.2.1 or Mid Range WRGM) RSR 12.2.2.4 RSR 12.2.2.6 RSR 12 .2.2. 7 (d)

b. Iodine Sampler (Grab Sampler) (c) 1 F RSR 12.2.2.3

c. Particulate Sampler (Grab (c) 1 F RSR 12.2.2.3 Sampler)

d. Effluent System Flow Rate (c) 1 G RSR 12.2.2.1 Monitor RSR 12.2.2.5 RSR 12.2.2.7

e. Sampler Flow Rate Monitor (c) 1 G RSR 12.2.2.1 (Low/Mid/Hi) RSR 12.2.2.5 RSR 12.2.2.7 (Continued)

(a) Equipment Part Numbers (EPN) are provided in Table R12.2.2-2. (b) During effluent releases via this pathway. (c) At all times. (d) The initial CHANNEL CALIBRATION shall be performed using one or more of the referenced radioactive standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATIONS, the initial reference radioactive standards or radioactive sources that have been related to the initial calibration shall be used. (e) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference radioactive standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, the initial calibration shall be used, in order to demonstrate linearity of the original calibration. This transfer calibration, combined with signal inputs, satisfies channel calibration and functional test requirements as implemented by station procedures. Page 1-12.2.2-5

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.2.2-1 (page 2 of 2) Radioactive Gaseous Effluent Monitoring Instrumentation APPLICABLE MODES OR REQUIRED CONDITION OTHER CHANNELS REFERENCED SPECIFIED PER FROM REQUIRED SURVEILLANCE INSTRUMENT(a) CONDITIONS INSTRUMENT ACTION A.2AND B.1 REQUIREMENTS

3. Condenser Air Ejector Radioactivity Monitor (Prior to Input to Holdup System)

a. Noble Gas Activity Monitor (f) H RSR 12.2.2.1 RSR 12.2.2.4 RSR 12.2.2.5 RSR 1 2 .2.2.7(d)

4. Standby Gas Treatment (SGT)

Monitoring System

a. Noble Gas Activity Monitor (Low (g) 1 E RSR 12.2.2.1 or Mid Range WRGM) RSR 12.2.2.4 RSR 12.2.2.6 RSR 1 2 .2.2.7(d)

b. Iodine Sampler (Grab Sampler) (g) 1 F RSR 12.2.2.3

c. Particulate Sampler (Grab (g) 1 F RSR 12.2.2.3 Sampler)

d. Effluent System Flow Rate (g) 1 G RSR 12.2.2.1 Monitor RSR 12.2.2.5 RSR 12.2.2.7

e. Sampler Flow Rate Monitor (g) 1 G RSR 12.2.2.1 (Low/Mid/Hi) RSR 12.2.2.5 RSR 12.2.2.7 (a) Equipment Part Numbers (EPN) are provided in Table R12.2.2-2.

(d) The initial CHANNEL CALIBRATION shall be performed using one or more of the referenced radioactive standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATIONS, the initial reference radioactive standards or radioactive sources that have been related to the initial calibration shall be used. (M During operation of the main condenser air ejector. (g) During operation of SGT. Page 1-12.2.2-6

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table R1 2.2.2-2 (page 1 of 2) Radioactive Gaseous Effluent Monitoring Instrumentation Applicability INSTRUMENT EPNS OF APPLICABLE EQUIPMENT A. Unit 1 Applicable Instruments

1. Main Condenser Offgas Treatment System Effluent Monitoring System

a. Noble Gas Activity Monitor- Providing Alarm 1D18-N903A, K901A, K601A, R601 and Automatic Termination of Release 1D18-N903B, K901B, K601B, R601

2. Main Stack Monitoring System

a. Noble Gas Activity Monitor (Low or Mid Range 0D18-N514, R517, R518 Low Range WRGM) 0D18-N515, R517, R518 Mid Range

b. Iodine Sampler (Grab Sampler)

c. Particulate Sampler (Grab Sampler)

d. Effluent System Flow Rate Monitor OFT-VRO19, OFY-VRO19 AND 019A, 0FR-VR019, OD18-K510, 0D18-R518

e. Sampler Flow Rate Monitor (Low/Mid/Hi) 0D18-N527, 0D18-N528, 0D18-R518 Low 0D18-N530, 0D18-N531, 0B18-R518 Mid/Hi

3. Condenser Air Ejector Radioactivity Monitor (Prior to Input to Holdup System)

a. Noble Gas Activity Monitor 1D18-N002, K613, R604, or 1D18-N012, K600, R605

4. Standby Gas Treatment (SGT) Monitoring System

a. Noble Gas Activity Monitor (Low/Mid Range 0D18-N511, R515, R516 Low Range WRGM) 0D18-N512, R515, R516 Mid Range

b. Iodine Sampler (Grab Sampler)

c. Particulate Sampler (Grab Sampler)

d. Effluent System Flow Rate Monitor 1FT-VG009, 1FY-VG009, 1FR-VG-009

e. Sampler Flow Rate Monitor (Low/Mid/Hi) 0D18-N521, 0D18-N522, 0D18-R516 Low OD18-N524, 0D18-N525, OB18-R516 Mid/Hi (Continued)

Page 1-12.2.2-7

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table R12.2.2-2 (page 2 of 2) Radioactive Gaseous Effluent Monitoring Instrumentation Applicability INSTRUMENT EPNS OF APPLICABLE EQUIPMENT B. Unit 2 Applicable Instruments

1. Main Condenser Offgas Treatment System Effluent Monitoring System

a. Noble Gas Activity Monitor - Providing Alarm 2D18-N903A, K901A, K601A, R601 and Automatic Termination of Release 2D18-N903B, K901B, K601B, R601

2. Main Stack Monitoring System

a. Noble Gas Activity Monitor (Low or Mid Range 0D18-N514, R517, R518 Low Range WRGM) 0D18-N515, R517, R518 Mid Range

b. Iodine Sampler (Grab Sampler)

c. Particulate Sampler (Grab Sampler)

d. Effluent System Flow Rate Monitor OFT-VRO19, OFY-VRO19 AND 019A, OFR-VRO19, 0D18-K510, 0D18-R518

e. Sampler Flow Rate Monitor (Low/Mid/Hi) 0D18-N527, 0D18-N528, 0D18-R518 Low 0D18-N530, 0D18-N531, 0B18-R518 Mid/Hi

3. Condenser Air Ejector Radioactivity Monitor (Prior to Input to Holdup System)

a. Noble Gas Activity Monitor 2D18-N002, K613, R604, or 2D18-N012, K600, R605

4. Standby Gas Treatment (SGT) Monitoring System

a. Noble Gas Activity Monitor (Low/Mid Range 0D18-N511, R515, R516 Low Range WRGM) 0D18-N512, R515, R516 Mid Range

b. Iodine Sampler (Grab Sampler)

c. Particulate Sampler (Grab Sampler)

d. Effluent System Flow Rate Monitor 2FT-VG009, 2FY-VG009, 2FR-VG-009

e. Sampler Flow Rate Monitor (Low/Mid/Hi) 0D18-N521, 0D18-N522, 0D18-R516 Low 0D18-N524, OD18-N525, OB18-R516 Mid/Hi Page 1-12.2.2-8

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.3 LIQUID EFFLUENTS 12.3.1 Liquid Effluent Concentration REC 12.3.1 The concentration of radioactive material released from the site to areas at or beyond the SITE BOUNDARY shall be limited to:

a. 10 times the concentration specified in 10 CFR 20.1001-20.2402 Appendix B, Table 2, Column 2 for radionuclides other than dissolved or entrained noble gases; and

b. the values listed in Table R12.3.1-1 for total activity concentration for all dissolved or entrained noble gases.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. Concentration of radioactive A.1 Initiate action to restore the Immediately material released to areas at concentration to within or beyond the SITE limits. BOUNDARY not within limits. B. Requirements of RSR B.1 Enter Condition A of Immediately 12.3.1.4 not met. Technical Requirements Manual Section 3.7.d. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.3.1.1 Determine radioactivity content of each In accordance with the radioactive liquid waste batch by sampling Radioactive Liquid and analysis in accordance with Table Waste Sampling and R12.3.1-2. Analysis Program. RSR 12.3.1.2 Perform post-release analysis of samples In accordance with the composited from batch releases in Radioactive Liquid accordance with Table R12.3.1-2. Waste Sampling and Analysis Program. RSR 12.3.1.3 Determine radioactivity concentration of In accordance with the liquids discharged from continuous release Radioactive Liquid points by sampling and analysis in Waste Sampling and accordance with Table R12.3.1-2. Analysis Program. (Continued) Page 1-12.3.1-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls SURVEILLANCE REQUIREMENTS RSR 12.3.1.4 -------------- NOTE----------- Not required to be performed until 7 days after the start of addition if tank(s) is empty at the beginning of the addition. Verify the quantity of radioactive material of each outside temporary tank is low enough to 7 days when radioactive ensure that in the event of an uncontrolled material is being added release of the tanks contents, the resulting to the tank(s). concentration would be less than the REC limits. AND Once within 7 days after each completion of addition of radioactive material to the tank(s). Page 1-12.3.1-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.3.1-1 ALLOWABLE CONCENTRATION (AC) OF DISSOLVED OR ENTRAINED NOBLE GASES RELEASED FROM THE SITE TO UNRESTRICTED AREAS IN LIQUID WASTE NUCLIDE ALLOWABLE CONCENTRATION (PCi/mI)* Kr-85m 2 x 10.4 Kr-85 5 x 10-Kr-87 4 x 10-' Kr-88 9 x 10s Ar-41 7 x 10' 4 Xe-131m 7 x 10-Xe-1 33m 5x 10-4 Xe-133 6 x 10-4 Xe-1 35m 2 x 10-4 Xe-135 2 x 10-' Computed from Equation 20 of ICRP Publication 2 (1959), adjusted for infinite cloud submersion in water, and R = 0.01 rem/week, density = 1.0 g/cc and Pw/Pt = 1.0. Page 1-12.3.1-3

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table R12.3.1-2 (Page 1 of 4) RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM LOWER LIMIT LIQUID RELEASE SAMPLING MINIMUM ANALYSIS TYPE OF ACTIVITY OF DETECTION TYPE FREQUENCY'g' FREQUENCY'g) ANALYSIS (LLD)(a) (ijCi/ml) Principal Gamma 5x10-7 A. Batch Waste Prior to each Tanks(d) Release Taksd)Each release, Each Batch Prior to each release, Batch Emitters(O Batch 1-131 1x10 6 Prior to each 31 days H-3 1x10 5 release, Each Composite (b) Batch Gross Alpha 1xl0- 7 Prior to each 92 days Sr-89, Sr-90 5x10.8 release, Each Composite (b) Batch Fe-55 1x 10. Prior to each release, One 31 days Dissolved & 5 Batch per 31 Entrained Gases lx10 days (Gamma Emitters) B. Plant Continuous 7 days I-131 lxl0 6 Releases(e) CONTINUOUS(C) Composite (C) Cooling Pond Principal Gamma 5x10-7 Blowdown Emitters(O 31 days Dissolved & 1x10-5 31 days Grab Sample Entrained Gases Grab__Sample_(Gamma Emitters) CONTINUOUS(C) 31 days H-3 1x10.5 Composite(c) Gross Alpha lx10-7 Sr-89, Sr-90 5x10-8 CONTINUOUS(C) 92 days Composite(c) Fe-55 lx 0-6 Page 1-12.3.1-4

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.3.1-2 (Page 2 of 4) RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATION

a. The LLD is the smallest concentration of radioactive material in a sample that will be detected with 95%

probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system, which may include radiochemical separation: LLD = E.-V .2.22x14.66Sb 06.-Y -e* Where: LLD = the a priori lower limit of detection (microcurie per unit mass or volume), sb= the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (counts per minute), t B = background sum (counts) t= count time (minutes) E the counting efficiency (counts per transformation), V = the sample size (units of mass or volume), 2.22 x 106 = the number of transformations per minute per microcurie, Y = the fractional radiochemical yield, when applicable,

           ?,= the radioactive decay constant for the particular radionuclide and for composite samples, and At = the elapsed time between the midpoint of sample collection and the time of counting (for plant effluents, not environmental samples). For batch samples taken and analyzed prior to release, At is taken to be zero.

The value of sb used in the calculation of the LLD for a detection system shall be based on the actual observed variance of the background counting rate or of the counting rate of the blank samples (as appropriate) rather than on an unverified theoretically predicted variance. Typical values of E, V, Y, and At shall be used in the calculation. Alternate LLD Methodology An alternate methodology for LLD determination follows and is similar to the above LLD equation: LLD = (2.71 + 4 .6 5 J-). Decay E.q.b.Y.t.(2.22x10 6 ) Page 1-12.3.1-5

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.3.1-2 (Page 3 of 4) RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATION Where: B = background sum (counts) E = counting efficiency q = sample quantity (mass or volume) b = abundance (if applicable) Y= fractional radiochemical yield or collection efficiency (if applicable) t= count time (minutes) 2.22 x 106 = number of disintegrations per minute per microcurie 2.71 + 4.6541B = k2 + (2k 42 41B), and k = 1.645 (k=value of the t statistic from the single-tailed t distribution at a significance level of 0.95 and infinite degrees of freedom. This means that the LLD result represents a 95% detection probability with a 5% probability of falsely concluding that the nuclide is present when it is not or that the nuclide is not present when it is.) Decay = e*At [XRT/(1 -e'-'aT)][XT, /(1 -e Td)] if applicable

                 = radioactive decay constant (units consistent with At, RT and       Td)

At = "delta t", or the elapsed time between sample collection or the midpoint of sample collection and the time the count is started, depending on the type of sample (units consistent with k) RT = elapsed real time, or the duration of the sample count (units consistent with ,) Td = sample deposition time, or the duration of analyte collection onto the sample media (units consistent with k) The LLD may alternately be determined using installed radioanalytical software, if available. In addition to determining the correct number of channels over which to total the background sum, utilizing the software's ability to perform decay corrections (i.e. during sample collection, from sample collection to start of analysis, and during counting), this alternate method will result in a more accurate determination of the LLD. It should be recognized that the LLD is defined as a before the fact limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Page 1-12.3.1-6

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table R12.3.1-2 (Page 4 of 4) RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATION

b. A composite sample is one in which the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sample employed results in a specimen which is representative of the liquids released.

c. To be representative of the quantities and concentrations of radioactive materials in liquid effluents, samples shall be collected in proportion to the rate of flow of the effluent stream. Prior to analyses, all samples taken for the composite shall be thoroughly mixed in order for the composite sample to be representative of the effluent release.

d. A batch release is the discharge of liquid waste of a discrete volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling.

e. A continuous release is the discharge of liquid wastes of a non-discrete volume; e.g., from a volume of system that has an input flow during the continuous release.

f. The principal gamma emitters for which the LLD specification applies exclusively are the following radionuclides: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141, and Ce-144. This list does not mean that only these nuclides are to be detected and reported. Other peaks that are measurable and identifiable, at the 95% confidence level, together with the above nuclides, shall also be identified and reported.

g. The provisions of RSR 12.0.2 and RSR 12.0.3 are applicable to the Radioactive Liquid Waste Sampling and Analysis Program.

Page 1-12.3.1-7

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.3 LIQUID EFFLUENTS 12.3.2 Dose from Liquid Effluents REC 12.3.2 The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released, from each reactor unit, from the site shall be limited to:

a. < 1.5 mrem to the total body and _<5.0 mrem to any organ during any calendar quarter; and

b. _<3.0 mrem to the total body and _<10.0 mrem to any organ during any calendar year.

APPLICABILITY: At all times. Page 1-12.3.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. ------- NOTE ------------ A.1 Submit a Report, pursuant to 30 days following the Required Action A.1 shall 10CFR50, Appendix I, Section end of the quarter in be completed if this IVA, to the NRC that identifies which the release Condition is entered. causes for exceeding limits, occurred radiological impact on finished drinking water supplies at the Calculated dose not nearest downstream drinking within limits, water source and defines actions to be taken to reduce releases of radioactive materials in liquid effluents during the remainder of the current calendar quarter and during the subsequent three calendar quarters so that the cumulative dose or dose commitment is within the limits of REC 12.3.2.b. B. Calculated dose B.1 Enter Condition A of REC 12.4.7. Immediately exceeds two times (2x) the limits. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.3.2.1 --------------------- NOTE ------------------ Only required to be performed if liquid releases have occurred since the last performance of this RSR. Calculate cumulative dose contributions from liquid effluents 31 days in accordance with the ODCM. Page 1-12.3.2-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.3 LIQUID EFFLUENTS 12.3.3 Liquid Radwaste Treatment Systems REC 12.3.3. The Liquid Radwaste Treatment System shall:

a. Be OPERABLE; and

b. Be used to reduce the radioactive materials in liquid wastes prior to their discharge when the projected doses due to the liquid effluent, from each reactor unit, from the site would exceed 0.06 mrem to the total body or 0.2 mrem to any organ when averaged over 31 days.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. Liquid Radwaste A.1 Restore Liquid Radwaste 31 days Treatment System Treatment System to inoperable. OPERABLE status. B. -------- NOTE -------- B. 1 Submit a report to the NRC 30 days Required Action B.1 that includes inoperable shall be completed if this equipment or subsystem Condition is entered. identification and reason, action taken to restore the Untreated liquid waste inoperable equipment to release in progress. OPERABLE status, and a summary description of the action(s) taken to prevent AND recurrence. Projected dose not within limits. C. -------- NOTE -------- C.1 Submit a report to the NRC 30 days Required Action C.1 that includes inoperable shall be completed if this equipment or subsystem Condition is entered. identification and reason, action taken to restore the Required Action and inoperable equipment to Associated Completion OPERABLE status, and a time of Condition A not summary description of the met. action(s) taken to prevent recurrence. Page 1-12.3.3-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.3.3.1 ------------------- NOTE ---------------- Only required to be performed if liquid releases are planned and RSR has not been performed in the last 38 days 18 hours. Determine projected doses due to liquid releases in 31 days accordance with the ODCM methods. RSR 12.3.3.2 ------------------ NOTE ---------------- Not required to be performed if Liquid Radwaste Treatment System has been used to process radioactive liquid effluents in the last 115 days. Operate the Liquid Radwaste Treatment System 92 days if a portable equipment for at least 30 minutes. (vendor supplied) waste treatment system is being used. AND 180 days if a portable (vendor-supplied) waste treatment system is not being used. Page 1-12.3.3-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.1 Gaseous Effluent Dose Rates REC 12.4.1 The dose rate at or beyond the SITE BOUNDARY due to radioactive materials in gaseous effluents released from the site shall be limited to the following:

a. For noble gases, < 500 mrem/year to the total body and < 3000 mrem/year to the skin; and

b. For iodine-131, iodine-1 33, tritium, and all radionuclides in particulate form with half-lives > 8 days, < 1500 mrem/year to any organ via the inhalation pathway.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. Dose rate not within limits. A.1 Initiate action to Immediately decrease release rates to maintain dose rates within limits. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.1.1 Verify the dose rates due to noble gases, iodine-1 31, In accordance with iodine-133, tritium, and all radionuclides in the Radioactive particulate form with half lives > 8 days in gaseous Gaseous Waste effluents is within limits utilizing the methodology and Sampling and parameters of the ODCM limits by obtaining and Analysis Program analyzing representative samples in accordance with Table R12.4.1-1. Page 1-12.4.1-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table R12.4.1-1 (Page 1 of 4) RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM MINIMUM TYPE OF LOWER LIMIT OF GASEOUS RELEASE SAMPLING ANALYSIS ACTIVITY DETECTION (LLD) TYPE FREQUENCY(" FREQUENCY() ANALYSIS (pCi/ml)a A. Containment Vent Prior to each releaseEmtes Prior to each Principal9 Gamma lx10.4 and Purge b release Emitters Systemn Each Sample Grab Purge Each Purge H H-3 lxl_0.6 4 31 daysb b Principal Gamma 1X10 Main Vent Stack Grab Sample Emitters3 B. 7 daysb'be 7dybe7 daysb'e H-3 lx1061 Grab Sample C. Standby Gas Treatment 24 hoursc 24 hoursc Principal Gamma lx10.4 System Grab Sample Emitters 9 12 D. Main Vent Stack 7daySd 1-131 1X10 And Standby Gas CONTINUOUS' Charcoal Treatment 1C Systemc Sample 1-133 1x101° 7 daysd Principal Gamma CONTINUOUS' Particulate Emitters 9 (1-131, lx10.11 Sample Others) 31 days CONTINUOUS' Composite Particulate Gross Alpha lx1011 Sample 92 days CONTINUOUS' Composite Particulate Sr-89,Sr-90 10-11 Sample Uf Noble Gas Noble Gases, CONTINUOUS Montobe Gross Beta or 1x10-6 Monitor Gamma Page 1-12.4.1-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.4.1-1 (Page 2 of 4) RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATION

a. The LLD is the smallest concentration of radioactive material in a sample that will be detected with 95%

probability with 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system (which may include radiochemical separation): LLD = 4.66Sb E- V. 2.22x1 06. Y-e(-AA') Where: LLD is the "a priori" lower limit of detection as defined above (as microcurie per unit mass or volume), sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (as counts per minute), t B = background sum (counds) t = count time (minutes) E is the counting efficiency (as counts per transformation), V is the sample size (in units of mass or volume), 2.22x106 is the number of transformations per minute per microcurie, Y is the fractional radiochemical yield (when applicable),

  ,k           is the radioactive decay constant for the particular radionuclide, and At           is the elapsed time between midpoint of sample collection and time of counting (for plant effluents, not environmental samples).

The value of sb used in the calculation of the LLD for a detection system shall be based on the actual observed variance of the background counting rate or of the counting rate of the blank samples (as appropriate) rather than on an unverified theoretically predicted variance. Typical values of E, V, Y, and At shall be used in the calculation. Alternate LLD Methodology An alternate methodology for LLD determination follows and is similar to the above LLD equation: LLD = (2.71+ 4.65- B)*Decay 6 E.q.-b.Y.t.(2.22x1 0 ) Page 1-12.4.1-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.4.1-1 (Page 3 of 4) RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATION Where: B = background sum (counts) E = counting efficiency q = sample quantity (mass or volume) b = abundance (if applicable) Y = fractional radiochemical yield or collection efficiency (if applicable) t = count time (minutes) 2.22 x 106 = number of disintegrations per minute per microcurie 2.71 + 4.654/B = k2 + (2k 42 41B), and k = 1.645 (k=value of the t statistic from the single-tailed t distribution at a significance level of 0.95 and infinite degrees of freedom. This means that the LLD result represents a 95% detection probability with a 5% probability of falsely concluding that the nuclide is present when it is not or that the nuclide is not present when it is.) Decay = e ;At [kRT/(1 -e 'Rr)][?,Td /(1 -e -ITd)] if applicable

                   = radioactive decay constant (units consistent with At, RT and       Td)

At = "delta t", or the elapsed time between sample collection or the midpoint of sample collection and the time the count is started, depending on the type of sample (units consistent with k) RT = elapsed real time, or the duration of the sample count (units consistent with X) Td = sample deposition time, or the duration of analyte collection onto the sample media (units consistent with k) The LLD may alternately be determined using installed radioanalytical software, if available. In addition to determining the correct number of channels over which to total the background sum, utilizing the software's ability to perform decay corrections (i.e. during sample collection, from sample collection to start of analysis, and during counting), this alternate method will result in a more accurate determination of the LLD. It should be recognized that the LLD is defined as a before the fact limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.

b. Sampling and analyses shall also be performed following shutdown, startup, or a thermal power change exceeding 20 percent of RATED THERMAL POWER in 1 hour unless (1) analysis shows that the dose equivalent 1-131 concentration in the primary coolant has not increased more than a factor of 5, and (2) the noble gas activity monitor shows that effluent activity has not increased by more than a factor of 3.

Page 1-12.4.1-4

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table R12.4.1-1 (Page 4 of 4) RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATION

c. Whenever there is flow through the SGT. If SGT is run more than 2 hrs in a 24-hour period, ensure a noble gas sample is obtained prior to securing SGT and particulate and iodine samples are taken within 24 hrs after securing SGT. A 2-hour run ensures required sample lower limits of detection are met for particulates and iodine. A SGT run of less than 2 hrs is not a significant contribution to offsite dose and requires no sampling.

d. Samples shall be changed at least once per 7 days and the analyses completed within 48 hours after removal from the sampler. Sampling shall also be performed within 24 hours following each shutdown, startup, or thermal power level change exceeding 20% of RATED THERMAL POWER in one hour. This requirement does not apply if 1) analysis shows that the dose equivalent 1-131 concentration in the primary coolant has not increased by more than a factor of 5, and 2) the noble gas activity monitor shows that effluent activity has not increased by more than a factor of 3. When samples collected for 24 hours are analyzed, the corresponding LLDs may be increased by a factor of 10.

e. Tritium grab samples shall be taken at least once per 7 days from the plant vent to determine tritium releases in the ventilation exhaust from the spent fuel pool area whenever spent fuel is in the spent fuel pool. If there is no spent fuel in the fuel pool, sampling and analysis of tritium grab samples shall be performed at least once per 31 days.

f. The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with RECs 12.4.1, 12.4.2.and 12.4.3.

g. The principal gamma emitters for which the LLD specification applies include the following radionuclides:

Kr-87, Kr-88, Xe-1 33, Xe-1 33m, Xe-1 35, and Xe-1 38 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-1 34, Cs-1 37, Ce-141 and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be detected and reported. Other peaks that are measurable and identifiable, at the 95% confidence level, together with the above nuclides, shall also be identified and reported.

h. The drywell tritium and noble gas samples and associated purge calculations are required when the Unit is at power (i.e. critical) and for the first 24 hours of purging activities following shutdown. The drywell tritium and noble gas sample results are valid for 30 hours from sample time if 1) the drywell radioactivity monitors have not indicated an increase in airborne or gaseous radioactivity, and 2) the drywell equipment and floor drain sump pumps run times have not indicated an increase in leakage in the drywell since the sample was taken, and 3) conditions are such that activity can be calculated for the radionuclide concentration at the time of the release.

If there is any reason to suspect that gaseous radioactivity levels have changed in the drywell that would compromise the calculated, or estimated, radionuclide concentrations at the time of the release, since the last sample (30 hours), a new sample and analyses should be requested prior to starting a drywell purge to meet the intent of providing current analyses to reflect actual activity released to the environment. If a known steady state leakage condition exists in the drywell it is possible to calculate a safe and accurate release package. Final release quantification will be based on calculated radionuclide concentrations at the time of the actual release. Page 1-12.4.1-5

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls If the drywell is PURGED in accordance with the ODCM definition, both noble gas and tritium analyses must be completed before the purge begins. If the drywell is simply VENTING in accordance with the ODCM definition, no sample is required before venting. The provisions of RSR 12.0.2 and RSR 12.0.3 are applicable to the Radioactive Gaseous Waste Sampling and Analysis Program. Page 1-12.4.1-6

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.2 Dose from Noble Gases REC 12.4.2 The air dose due to noble gases in gaseous effluents released from each reactor unit from the site shall be limited to the following:

a. For gamma radiation, *_ 5 mrad during any calendar quarter and

                              < 10 mrad during any calendar year; and

b. For beta radiation, < 10 mrad during any calendar quarter and _<20 mrad during any calendar year.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. --------- NOTE -------------- A.1 Submit a report to the NRC, 30 days following the Required Action A. 1 shall pursuant to 10CFR50 end of the quarter in be completed if this Appendix I Section IV.A, that which the release Condition is entered. identifies causes for occurred exceeding limits, defines corrective actions to be Calculated air dose not taken to reduce the releases, within limits, and proposed corrective actions to assure that subsequent releases are within limits. B. Calculated air dose B.1 Enter Condition A of REC Immediately exceeds two times (2x) the 12.4.7. limits. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.2.1 Determine cumulative dose contributions for the 31 days current calendar quarter and current calendar year in accordance with the ODCM. Page 1-12.4.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.3 Dose From Iodine -131, Iodine -133, Tritium, and Radioactive Materials in Particulate Form REC 12.4.3 The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium and all radionuclides in particulate form, with half-lives > 8 days, in gaseous effluents released from each reactor unit, to areas at and beyond the SITE BOUNDARY shall be limited to:

a. _ 7.5 mrem to any organ during any calendar quarter; and

b. _ 15 mrem to any organ during any calendar year.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. --------- NOTE --------------- A.1 Submit a report to the NRC, 30 days following the Required Action A. 1 shall be pursuant to 10CFR50 end of the quarter in completed if this Condition is Appendix I Section IV.A, which the release entered. that identifies causes for occurred exceeding limits, defines corrective actions to be Calculated dose not within taken to reduce the limits, releases, and proposed corrective actions to assure that subsequent releases are within limits. B. Calculated dose exceeds B.1 Enter Condition A of Immediately two times (2x) the limits. REC 12.4.7. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.3.1 Determine cumulative dose contributions for the current 31 days calendar quarter and calendar year for iodine-1 31, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days in accordance with the methodology and parameters in the ODCM. Page 1-12.4.3-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.4 GASEOUS RADWASTE TREATMENT SYSTEM REC 12.4.4 The GASEOUS RADWASTE (OFF-GAS) TREATMENT SYSTEM shall be OPERABLE and in operation. APPLICABILITY: During Main Condenser Air Ejector system operation. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. GASEOUS RADWASTE A.1 Restore system to 7 days TREATMENT SYSTEM OPERABLE status. inoperable. AND OR A.2 Place system in operation. GASEOUS RADWASTE TREATMENT SYSTEM not in operation. B. --------- NOTE --------- B.1 Submit a report to the NRC 30 days Required Action B.1 shall that includes defective be completed if this equipment or subsystem Condition is entered. identification and inoperability cause, actions taken to restore the Required action and inoperable equipment to Associated Completion OPERABLE status, and Time not met. summary description of actions taken to prevent a recurrence. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.4.1 Verify the GASEOUS RADWASTE TREATMENT 7 days SYSTEM is in operation. Page 1-12.4.4-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.5 VENTILATION EXHAUST TREATMENT SYSTEM REC 12.4.5 The appropriate portions of the VENTILATION EXHAUST TREATMENT SYSTEM shall;

a. BE OPERABLE; and

b. be used to reduce radioactive materials in gaseous waste prior to their discharge when the projected doses from each reactor unit from the site would exceed 0.3 mrem to any organ, when average over 31 days.

APPLICABILITY: At all times.

                  ---------------------        NOTE -----------------------------------------------------------

Separate Condition entry is allowed for each VENTILATION EXHAUST TREATMENT system pathway. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. One or more required A.1 Restore system to 31 days VENTILATION EXHAUST OPERABLE status. TREATMENT SYSTEMS inoperable. B. --------- NOTE --------- B.1 Submit a report to the NRC 30 days Required Action B.1 shall that includes inoperable be completed if this equipment or subsystem condition is entered. identification and reason for inoperability, actions taken to restore the Untreated gaseous waste inoperable equipment to release in progress. OPERABLE status, and summary description of AND actions taken to prevent a recurrence. Projected dose not within limits. (continued) Page 1-12.4.5-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME C. -------- NOTE --------------- C.1 Submit a report to the NRC 30 days Required Action C.1 shall that includes inoperable be completed if this equipment or subsystem Condition is entered. identification and reason for inoperability, actions taken to restore the Required Action and inoperable equipment to associated Completion OPERABLE status, and Time of Condition A not summary description of met. actions taken to prevent a recurrence. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.5.1 Project doses due to gaseous releases from the 31 days site in accordance with the ODCM. RSR 12.4.5.2 ------------------ NOTE--------------- Not required to be performed if the VENTILATION EXHAUST TREATMENT SYSTEM has been used to process gaseous effluents in the last 115 days. OPERATE each required VENTILATION 92 days EXHAUST TREATMENT SYSTEM equipment for at least 30 minutes. Page 1-12.4.5-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.6 MARK II Containment REC 12.4.6 VENTING or PURGING of the containment drywell shall be:

a. through the Primary Containment Vent and Purge System, or

b. through the Standby Gas Treatment (SGT) System.

APPLICABILITY: During drywell VENTING or PURGING. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. Above requirements not A.1 Suspend all drywell Immediately met. VENTING and PURGING. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.6.1 Verify containment drywell is aligned for VENTING or 12 hours PURGING through the Primary Containment Vent and Purge System or the SGT System. RSR 12.4.6.2 ------------------- NOTE ---------------- Only required to be met when in MODES 1, 2, or 3. Verify: Prior to PURGING

a. Both SGT trains are OPERABLE, and through the SGT System.

b. Only one of the SGT System trains to be used for PURGING.

Page 1-12.4.6-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.7 Total Dose REC 12.4.7 The dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity and radiation from all uranium fuel cycle sources over 12 consecutive months shall be limited to:

a. < 25 mrem to the total body; and

b. < 75 mrem to the thyroid; and

c. _ 25 mrem to any other organ.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. --------- NOTE ---------- A.1 Submit a report to the NRC 30 days Required Action A. 1 and A.2 (Director, Nuclear Reactor shall be completed if this Regulation) that defines the Condition is entered. corrective action to be taken to reduce subsequent releases to prevent As required by Required recurrence of exceeding the Action B.1 of REC 12.3.2, limits to include estimates of 12.4.2, or 12.4.3. radiation exposure to a MEMBER OF THE PUBLIC OR from uranium fuel cycle sources, including all effluent pathways and direct radiation, Calculated Total Dose not for a 12 consecutive month within limits, period that includes the release(s) covered by this report. AND (continued) Page 1-12.4.7-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. (continued) A.2 --------- NOTE --------------- Only applicable if the release condition resulting in violation of 40 CFR 190 has not been corrected. Submit a request for a 30 days variance in accordance with 40 CFR 190, including the specified information of 40 CFR 190.11. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.7.1Determine cumulative dose contributions from direct 31 days radiation and liquid and gaseous effluents in accordance with the ODCM. Page 1-12.4.7-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.8 Main Condenser REC 12.4.8 The release rate of the sum of the activities from the noble gases measured prior to the holdup line shall be limited to < 3.4 x 105 pCi/sec after 30 minutes decay. APPLICABILITY: MODE 1, MODES 2 and 3 with any steam line not isolated and steam jet air ejectors (SJAE) in operation. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. Release rate of the sum of A.1 Restore the release rate to 72 hours the activities from noble within limit. gases prior to the holdup line not within the limits. B. Required Action and B.1 Isolate all main steam 12 hours associated Completion lines. Time not met. OR B.2 Isolate the SJAE. 12 hours OR B.3.1 MODE 3 12 hours AND B.3.2 MODE 4 36 hour's Page 1-12.4.8-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.8.1 Monitor the noble gas radioactivity rate prior to the CONTINUOUSLY holdup line in accordance with the ODCM and Table R12.2.2-1 RSR 12.4.8.2 ----------------- NOTE ---------------- Not required to be performed until 31 days after any Main Steam line not isolated and SJAE in operation. Verify the release rate of the sum of the activities from Once within 4 noble gases prior to the holdup line is within limits by hours after a performing an isotopic analysis of a representative _Ž50% increase in sample of gases taken prior to the holdup line. the nominal steady state fission gas release from the primary coolant, as indicated by the off gas pre-treatment Noble Gas Activity Monitor, after factoring out increases due to changes in THERMAL POWER level AND 31 days Page 1-12.4.8-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE 12.4.9 Dose Limits for MEMBERS OF THE PUBLIC REC 12.4.9 Operations shall be conducted such that:

a. Total Effective Dose Equivalent (TEDE) to individual MEMBERS OF THE PUBLIC does not exceed 100 mrem/year; and

b. The dose in any unrestricted area from external sources does not exceed 2 mrem in any one hour.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. --------- NOTE ---------- A.1 Submit a report to the NRC 30 days Required Action A.1 shall be in accordance with completed if this Condition is 10 CFR 20.2203. entered. Dose limit of REC Item a. exceeded. B. --------- NOTE --------------- B.1 Submit a report to the NRC 30 days Required Action B.1 shall be in accordance with completed if this Condition is 10 CFR 20.2203. entered. Dose limit of REC Item b. exceeded. Page 1-12.4.9-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.4.9.1 Calculate the TEDE to individual MEMBERS OF 12 months THE PUBLIC in accordance with the ODCM. RSR 12.4.9.2 Determine and/or evaluate direct radiation 12 months exposures in unrestricted areas. Page 1-12.4.9-2

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 12.5.1 Radiological Environmental Monitoring Program (REMP) REC 12.5.1 The REMP shall be conducted as specified in Table R12.5.1-1. APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. --------- NOTE -------------- A.1 Initiate action to identify Immediately Required Action A.2 shall suitable, alternative be completed if this sampling media and/or Condition is entered. specific locations for obtaining replacement samples for the pathway of Sample type or location(s) interest and add them to the required by Table REMP. Delete locations R12.5.1-1 permanently from which samples are unavailable, unavailable. AND A.2 Prepare and submit a In accordance with controlled version of the Technical Specification ODCM, in the next Annual 5.6.2 Radiological Environmental Operating Report (REOR) including revised figures and tables reflecting the new location(s) with supporting information identifying the sample unavailability cause and justification of the new sampling location(s). (continued) Page 1-12.5.1-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME B. -------- NOTE -------------- B.1 Submit a report to the NRC 30 days Required Action B.1 shall that identifies the cause(s) for be completed if this exceeding the limits and Condition is entered. defines the corrective actions to be taken to reduce radioactive effluents so that Level of radioactivity as the the potential annual dose to a result of plant effluents in MEMBER OF THE PUBLIC an environmental sampling is less than the calendar year medium at a specified reporting level of REC 12.3.2, location exceeds the 12.4.2 or 12.4.3. The reporting levels of Table methodology and parameters R12.5.1-2 when averaged used to estimate the potential over any calendar quarter. annual dose to a MEMBER OF THE PUBLIC shall be indicated in this report. C. -------- NOTE --------- C.1 Submit a report to the NRC 30 days Required Action C.1 shall that identifies the cause(s) for be completed if this exceeding the limits and Condition is entered. defines the corrective actions to be taken to reduce radioactive effluents so that More than one the potential annual dose to a radionuclide in Table MEMBER OF THE PUBLIC is R12.5.1-2 detected in the less than the calendar year sampling medium, reporting level of REC 12.3.2, 12.4.2 or 12.4.3. The AND methodology and parameters used to estimate the potential C1 C2 annual dose to a MEMBER

         +       + ... > 1.0          OF THE PUBLIC shall be RL1     RL 2                      indicated in this report.

where; C = concentration RL = reporting level. (continued) Page 1-12.5.1-2

CY-LA- 170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION J REQUIRED ACTION I COMPLETION TIME D. - NOTE -------------- D.1 ---------- NOTE --------------- Required Action D.1 and Only required when the D.2 shall be completed if measured levels of this Condition is entered. radioactivity are the result of plant effluents. Radionuclides other than those in Table R12.5.1-2 are detected. Submit a report to the NRC 30 days AND that identifies the cause(s) for exceeding the limits and defines the corrective actions The potential annual dose to be taken to reduce to a MEMBER OF THE radioactive effluents so that PUBLIC from all the potential annual dose to a radionuclides is greater MEMBER OF THE PUBLIC is than or equal to the less than the calendar year calendar year limits of reporting level. The REC 12.3.2, 12.4.2, or methodology and parameters 12.4.3. used to estimate the potential annual dose to a MEMBER OF THE PUBLIC shall be indicated in this report. AND D.2 --------- NOTE------- Only required when the radionuclides detected are not the result of plant effluents. In accordance with Describe the condition in the next Annual REOR. Technical Specification 5.6.2. (continued) Page 1-12.5.1-3

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED COMPENSATORY COMPLETION TIME MEASURE E. ------- NOTE ---------- E.1 Prepare and submit to the NRC, In accordance with Required Action E.1 in the next Annual REOR, a Technical shall be completed if description of the reasons for not Specification 5.6.2. this Condition is conducting the program as entered, required and the plans for preventing a recurrence. RSR 12.5.1.1 not met. Page 1-12.5.1-4

CY-LA- 170-30 1 Revision 3 Part I, Radiological Effluent Controls SURVEILLANCE REQUIREMENTS _______ SURVEILLANCE FREQUENCY RSR 12.5.1.1 ------------------- NOTES ---------------

1. Deviations to the sampling schedule for the following reasons may occur and the RSR still be considered met provided the deviations are described in the next Annual REOR:

a. specimens are unobtainable due to hazardous conditions, seasonal unavailability, or malfunction of sampling equipment, or

b. a person or business who participates in the program goes out of business or can no longer provide samples, or

c. a contractor omission which is corrected as soon as discovered.

2. Malfunctioning equipment shall be corrected/replaced and replacement suppliers shall be found, as applicable, as soon as practicable.

Collect and analyze samples in accordance with Table In accordance with R12.5.1-1 and the ODCM to the detection capabilities the Radiological required by Table R12.5.1-3. Environmental Monitoring Program Page 1-12.5.1-5

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.5.1-1 (Page 1 of 5) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION TYPE AND FREQUENCY ANDI OR SAMPLE SAMPLE LOCATIONS(') FREQUENCY(1"l OF ANALYSIS(1 "1

1. Airborne Radioiodine Samples from a total of eight locations: CONTINUOUS sampler Radioiodine Canister:

and Particulates operation with particulate sample 1-131 analysis once per

a. Indicator- Near Field collection once per 7 days, or 14 days on near field 2 more frequently ifrequired due samples and control( 1 Four samples from locations within 4.0 km (2.5 mi) in to dust loading, and radioiodine samples.

different sectors. canister collection once per 14 days. Particulate Sampler:

b. Indicator- Far Field Gross beta analysis following once per 7 day Four additional locations within 4.0 to 10 km (2.5 to 6.2 filter change 3) and gamma mi) in different sectors. isotopic analysis( 4) once per 92 days on composite

c. Control filters by location on near field and control(21 samples.

One sample from a control location within 10 to 30 km (6.2 to 18.6 mi). (continued) Page 1-12.5.1-6

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.5.1-1 (Page 2 of 5) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION TYPE AND FREQUENCY 1 AND/ OR SAMPLE SAMPLE LOCATIONS(') FREQUENCY(11" OF ANALYSIS( ")

2. Direct Radiation(*) Forty routine monitoring stations, either with a 92 days Gamma dose on each TLD thermoluminescent dosimeter (TLD) or with one once per 92 days.

instrument for measuring dose rate continuously, placed as follows:

a. Indicator- Inner Ring (100 Series TLD)

One in each meteorological sector, in the general area of the SITE BOUNDARY (within 0.1 to 2.0 miles; 0.2 to 3.2 km);

b. Indicator- Outer Ring (200 Series TLD)

One in each meteorological sector, within 4.8 to 10 km (3 to 6.2 mi);

c. Other (300 Series TLD)

One at each Airbome location given in part l.a. and l.b. The balance of the TLDs to be placed at special interest locations beyond the Restricted Area where either a MEMBER OF THE PUBLIC or Exelon Nuclear employees have routine access.

d. Control One at each airborne control location given in part 1.c.

(continued) Page 1-12.5.1-7

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.5.1-1 (Page 3 of 5) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION TYPE AND FREQUENCY AND/ OR SAMPLE SAMPLE LOCATIONS(') FREQUENCY"" OF ANALYSIS"1 ')

3. Waterborne a. Indicator 92 days Gamma isotopic'4' and tritium analysis once per 92

a. Ground/ Well Samples 6from two sources only if likely to be days.

affected.( )

b. Drinking"' a. Indicator Grab samples once per 7 days. Gross beta and gamma isotopic analyses(4) on once One Sample from each community drinking water per 31 day composite; supply that could be affected by the station discharge tritium analysis on once per within 10 km (6.2 mi) downstream of discharge. 92 day composite.

1-131 on each composite when calculated dose for water consumption > 1 mrem/year.

c. Surface Water') If no community water supply (Drinking Water) exists Grab samples once per 7 days. Gross beta and gamma within 10 km downstream of discharge then surface isotopic analyses(4) on once water sampling shall be performed. per 31 day composite; tritium analysis on once per

a. Indicator 92 day composite.

One sample downstream

d. Control Sample"') a. Control Grab samples once per 7 days. Gross beta and gamma isotopic analyses' 4' on once One surface sample upstream of discharge. per 31 day composite; tritium analysis on once per 92 day composite.

e. Sediment a. Indicator 184 days Gamma isotopic analysis"

7 once per 184 days.

                                                                   ) area within 10 At least one sample from downstream(

km (6.2 mi). (continued) Page 1-12.5.1-8

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.5.1-1 (Page 4 of 5) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION TYPE AND FREQUENCY ANDI OR SAMPLE SAMPLE LOCATIONS(') FREQUENCY 1.) OF ANALYSIS(1"

4. Ingestion a. Indicator Once per 14 days when animals Gamma isotopic"' and are on pasture (May through I-131(9) analysis on each

a. Milk' 8' Samples from milking animals from a maximum of October), once per 31 days at sample.

three locations within 10 km (6.2 mi) distance. other times (November through April).

b. Control One sample from milking animals at a control location within 10 to 30 km (6.2 to 18.6 mi).

4

b. Fish a. Indicator Twice per 12 months. Gamma isotopic analysis" )

on edible portions Representative samples of commercially and recreationally important species in discharge area, and representative samples from the LaSalle Lake.

b. Control Representative samples of commercially and recreationally important species in control locations upstream of discharge.

c. Food Products a. Indicator 12 months Gamma isotopic'4) and 1-131 analysis on each Two representative samples from the principal food sample.

pathways grown in each of four major quadrants within 10 km (6.2 mi), if available: At least one root vegetable sample(1") At least one broad leaf vegetable (or vegetation)")

b. Control Two representative samples similar to indicator samples grown within 15 to 30 km (9.3 to 18.6 mi).

Page 1-12.5.1-9

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls Table R12.5.1-1 (Page 5 of 5) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM TABLE NOTATIONS (1) Specific parameters of distance and direction from the centerline of the midpoint of the two units and additional description where pertinent, shall be provided for each and every sample location in Table R12.5.1-1, except for vegetation. For vegetation, due to location variability year to year, the parameters of distance and direction shall be provided in the Annual Environmental Operating Report. (2) Far field samples are analyzed when the respective near field sample results are inconsistent with previous measurements and radioactivity is confirmed as having its origin in airborne effluents from the station, or at the discretion of the ODCM Specialist. (3) Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours or more after sampling to allow for radon and thoron daughter decay. If gross beta activity in air particulate samples is greater than 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples. (4) Gamma isotopic analysis means the identification and quantification of gamma emitting radionuclides that may be attributable to the effluents from the station. (5) One or more instruments, such as a pressurized ion chamber, for measuring and recording dose rate continuously may be used in place of, or in addition to, integrating dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation. The 40 locations is not an absolute number. The number of direct radiation monitoring stations may be reduced according to geographical limitations; e.g., if a station is adjacent to a lake, some sectors may be over water thereby reducing the number of dosimeters that could be placed at the indicated distances. The frequency of analysis or readout for TLD systems will depend upon the characteristics of the specific system used and should be selected to obtain optimum dose information with minimal fading. (6) Groundwater samples shall be taken when this source is tapped for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination. (7) The "downstream" sample shall be taken in an area beyond but near the mixing zone. The "upstream sample" shall be taken at a distance beyond significant influence of the discharge. Upstream samples in an estuary must be taken far enough upstream to be beyond the station influence. (8) If milking animals are not found in the designated indicator locations, or if the owners decline to participate in the REMP, all milk sampling may be discontinued. (9) 1-131 analysis means the analytical separation and counting procedure are specific for this radionuclide. (10) One sample shall consist of a volume/weight of sample large enough to fill contractor specified container. (11) The provisions of RSR 12.0.2 and RSR 12.0.3 are not applicable to the REMP. Page 1-12.5.1-10

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.5.1-2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES REPORTING LEVELS AIRBORNE PARTICULATE FOOD PRODUCTS ANALYSIS WATER (pCi/I) OR GASES (pCi/m) FISH (pCi/kg, wet) MILK (pCi/i) (pCi/kg, wet) H-3 20,000(1) Mn-54 1,000 30,000 Fe-59 400 10,000 Co-58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 Zr-Nb-95 400 1-131 2(2) 0.9 3 100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000 Ba-La-140 200 300 (1) For drinking water samples. This is 40 CFR Part 141 value. If no drinking water pathway exists, a value of 30,000 pCi/I may be used. (2) If no drinking water pathway exists, a value of 20 pCi/I may be used. Page 1-12.5.1-11

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls Table R12.5.1-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS(a) LOWER LIMIT OF DETECTION (LLD)(b) AIRBORNE PARTICULATE FISH FOOD PRODUCTS SEDIMENT/SOIL ANALYSIS WATER (pCi/I) OR GASES (pCi/m 3) (pCi/kg, wet) MILK (pCi/I) (pCi/kg, wet) (pCi/kg, dry) Gross Beta 4 0.01 H-3 2,000 Mn-54 15 130 Fe-59 30 260 Co-58,60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 15 1-131 1(c) 0.07 1 60 Cs-134 15 0.05 130 15 60 150 Cs-137 18 0.06 150 18 80 180 Ba-140 60 60 La-140 15 15 (a) All peaks identified at the 95% confidence level, shall also be analyzed and reported. (b) Most restrictive ODCM LLD requirement or technical requirement. The reported minimum detectable concentration (MDC) shall be < these values. (c) If no drinking water pathway exists, a value of 15 pCi/I may be used (NUREG 1301/1302) Page 1-12.5.1-12

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 12.5.2 Land Use Census REC 12.5.2 A Land Use Census shall be conducted and shall identify within a distance of 10 km (6.2 miles) the location in each of the 16 meteorological sectors of the nearest milk animal, the nearest residence, and an enumeration of livestock. For dose calculation, a garden will be assumed at the nearest residence.

  --------------------------------              NOTES          ----------------------------

1. The 16 meteorological sectors requirement may be reduced according to geographical limitations; e.g. at a lake site where some sectors will be over water.

2. The nearest industrial facility shall also be documented if closer than the nearest residence.

APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. -------- NOTE -------------- A.1 Add the new location to the 30 days Required Action A. 1 and Radiological Environmental A.2 shall be completed if Monitoring Program this Condition is entered. (REMP). Land use census identifies AND a location which yields a calculated dose or dose commitment, via the same exposure pathway, that is at least 20% greater than at a location from which samples are currently being obtained in accordance with REC 12.5.1. (continued) Page I-12.5.2-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. (continued) A.2 -------- NOTE ------------------ The sampling location(s), excluding the control location, having the lowest calculated dose or dose commitment(s), via the same exposure pathway, may be deleted from the REMP after October 31 of the year in which Land Use Census was conducted. Submit the documentation for In accordance with a change in the ODCM in the Technical next Annual Radiological Specification 5.6.2. Environmental Operating Report and include the revised figures and tables for the ODCM reflecting the new location(s) with information supporting the change in sampling locations. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.5.2.1 Conduct a land use census during the growing -------- NOTE -------- season, between June 1 and October 1, using RSR 12.0.2 and 12.0.3 information that will provide the best results, such as are not applicable. by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results 12 months of the census shall be included in the Annual Radiological Environmental Operating Report. Page 1-12.5.2-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 12.5.3 Interlaboratory Comparison Program REC 12.5.3 Analyses shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program that is traceable to NIST. APPLICABILITY: At all times. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. -------- NOTE ------------- A.1 Report corrective actions to In accordance with Required Action A.1 shall prevent recurrence to the NRC Technical be completed if this in the next Annual Radiological Specification 5.6.2 Condition is entered. Environmental Operating Report. Requirements of the REC not met. SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY RSR 12.5.3 Include a summary of the results of the Interlaboratory In accordance with Comparison Program in the Annual Radiological Technical Environmental Operating Report. Specification 5.6.2 Page 1-12.5.3-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 12.5.4 Meteorological Monitoring Program (NOT APPLICABLE) Page 1-12.5.4-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.6 REPORTING REQUIREMENTS 12.6.1 Annual Radiological Environmental Operating Report 12.6.1.1 Routine Annual Radiological Environmental Operating Report covering the operation of the Units during the previous calendar year shall be submitted by May 15 of each year. The report shall include summaries, interpretations, and an analysis of trends of the results of the radiological environmental monitoring program for the report period. The material provided shall be consistent with the objectives outlined in the Offsite Dose Calculation Manual, and in 10 CFR 50, Appendix I, Sections IV.B.2, IV.B.3, and IV.c. It should include, as found appropriate, a comparison of preoperational studies with operational controls or with previous environmental surveillance reports, and an assessment of the observed impacts of the plant operation on the environment. A single submittal may be made for a multiple unit station. The submittal should combine sections common to all units at the station. 12.6.1.2 The Annual Radiological Environmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the period pursuant to the locations specified in the tables and figures in Part II, Section 6 of the ODCM, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Assessment Branch Technical Position, Revision 1, November 1979. In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. The missing data shall be submitted as soon as possible in a supplementary report. 12.6.1.3 The reports shall also include the following: a summary description of the Radiological Environmental Monitoring Program; legible maps covering all sampling locations keyed to a table giving distances and directions from the midpoint between the two units; reasons for not conducting the Radiological Environmental Monitoring Program as required by REC 12.5.1, and discussion of all deviations from the sampling schedule of Table R12.5.1-1; a Table of Missed Samples and a Table of Sample Anomalies for all deviations from the sampling schedule of ODCM Part II, Table 6.1-1; discussion of environmental sample measurements that exceed the reporting levels of Table R12.5.1-2 but are not the result of plant effluents; discussion of all analyses in which the LLD required by Table R12.5.1-3 was not achievable; results of the Land Use Census required by REC 12.5.2; and the results of licensee participation in an Interlaboratory Comparison Program and the corrective actions being taken if the specified program is not being performed as required by REC 12.5.3. (continued) Page 1-12.6.1-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.6 REPORTING REQUIREMENTS 12.6.1 Annual Radiological Environmental Operating Report (continued) 12.6.1.4 The Annual Radiological Environmental Operating Report shall also include an annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction, atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, and atmospheric stability. In lieu of submission with the Annual Radiological Environmental Operating Report, the licensee has the option of retaining the summary of required meteorological data on site in a file that shall be provided to the NRC upon request. 12.6.1.5 The Annual Radiological Environmental Operating Report shall also include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from the unit or station during the previous calendar year. This report shall also include an assessment of radiation doses to the most likely exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources, including doses from primary effluent pathways and direct radiation, for the previous calendar year. The assessment of radiation doses shall be performed in accordance with the methodology and parameters in the ODCM and in compliance with 10 CFR 20 and 40 CFR 190, "Environmental Radiation Protection Standards for Nuclear Power Operation." Page 1-12.6.1-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.6 REPORTING REQUIREMENTS 12.6.2 Annual Radioactive Effluent Release Report 12.6.2.1 The radioactive effluent release reports covering the operation of the unit during the previous calendar year of operation shall be submitted in accordance with 10 CFR 50.36a prior to May 1 of each year. The report shall include a summary of the quantities of radioactive liquid and gaseous effluent and solid waste released from the unit. The material provided shall be consistent with the objectives outlined in the ODCM and the PROCESS CONTROL PROGRAM and in conformance with 10 CFR 50.36a and 10 CFR 50, Appendix I, Section IV.B.1. A single submittal may be made for a multiple unit station. The submittal should combine those sections that are common to all units at the station; however, for units with separate radwaste systems, the submittal shall specify the releases of radioactive material from each unit. 12.6.2.2 The radioactive effluent release reports shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the unit as outlined in Regulatory Guide 1.21, "Measuring, Evaluating and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof. 12.6.2.3 The radioactive effluent release report shall include the following information for each type of solid waste shipped offsite during the report period:

1. Container volume,

2. Total curie quantity (specify whether determined by measurement or estimate),

3. Principal radionuclides (specify whether determined by measurement or estimate),

4. Type of waste (e.g., spent resin, compacted dry waste, evaporator bottoms),

5. Type of container (e.g., LSA, Type A, Type B, Large Quantity), and

6. Solidification agent (e.g., cement, urea formaldehyde).

(continued) Page 1-12.6.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.6 REPORTING REQUIREMENTS 12.6.2 Radioactive Effluent Release Report (continued) 12.6.2.4 The radioactive effluent release reports shall include unplanned releases from the site to unrestricted areas of radioactive materials in gaseous and liquid effluents on a quarterly basis. 12.6.2.5 The radioactive effluent release reports shall include any changes to the PROCESS CONTROL PROGRAM (PCP) made during the reporting period. 12.6.2.6 The radioactive effluent release reports shall include a description of licensee initiated major changes to the radioactive waste treatment systems (liquid, gaseous and solid), as described in Section 12.6.3.) Page 1-12.6.2-2

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.6 REPORTING REQUIREMENTS 12.6.3 Offsite Dose Calculation Manual (ODCM) 12.6.3.1 The ODCM is common to LaSalle Unit 1 and LaSalle Unit 2. The ODCM shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents, in the calculation of gaseous and liquid effluent monitoring alarm and trip setpoints, and in the conduct of the radiological environmental monitoring program; and 12.6.3.2 The ODCM shall also contain the radioactive effluent controls and radiological environmental monitoring activities, and descriptions of the information that should be included in the Annual Radiological Environmental Operating, and Radioactive Effluent Release Reports required by Technical Specifications 5.6.2 and 5.6.3. 12.6.3.3 Licensee-initiated changes to the ODCM:

a. Shall be documented and records of reviews performed shall be retained as required by the Quality Assurance (QA) Manual. This documentation:

1. Shall contain sufficient information to support the change(s) together with the appropriate analyses or evaluations justifying the change(s); and

2. Shall contain a determination that the change(s) maintain the level of radioactive effluent control required by 10 CFR 20.1302, 40 CFR Part 190, 10 CFR 50.36a, and 10 CFR Part 50, Appendix I, and not adversely impact the accuracy or reliability of effluent, dose, or setpoint calculations.

3. Shall become effective after approval of the Plant Manager.

4. Shall be submitted to the NRC in the form of a complete, legible copy of the entire ODCM as a part of or concurrent with the Radioactive Effluent Release Report for the period of the report in which any change to the ODCM was made. Each change shall be identified by markings in the margin of the affected pages, clearly indicating the area of the page that was changed, and shall indicate the date (i.e., month and year) the change was implemented.

Page 1-12.6.3-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls 12.6 REPORTING REQUIREMENTS 12.6.4 Major Changes to Radioactive Waste Treatment Systems (Liquid and Gaseous) 12.6.4.1 Licensee initiated major changes to the radioactive waste treatment systems (liquid and gaseous):

a. Shall be reported to the Commission in the Radioactive Effluent Release Report for the period in which the evaluation was reviewed by the Plant Operations Review Committee (PORC). The discussion of each change shall contain:

1. A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59;

2. Sufficient detailed information to totally support the reason for the change without benefit or additional or supplemental information;

3. A detailed description of the equipment, components and processes involved and the interfaces with other plant systems;

4. An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents waste that differ from those previously predicted in the license application and amendments thereto;

5. An evaluation of the change which shows the expected maximum exposures to individual in the unrestricted area and to the general population that differ from those previously estimated in the license application and amendments thereto;

6. A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents, to the actual releases for the period to when the changes are to be made;

7. An estimate of the exposure to plant operating personnel as a result of the change; and

8. Documentation of the fact that the change was reviewed and found acceptable by the PORC.

b. Shall become effective upon review and acceptance by the PORC.

Page 1-12.6.4-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls BASES General It is expected that releases of radioactive material in effluents will be kept at small fractions of the limits specified in Section 20.1302 of 10 CFR, Part 20. At the same time, the licensee is permitted the flexibility of operation, compatible with consideration of health and safety, to assure that the public is provided a dependable source of power even under unusual operating conditions which may temporarily result in releases higher than such small fractions, but still within the limits specified in Section 20.1302 of 10 CFR, Part 20. It is expected that in using this operational flexibility under unusual operating conditions the licensee will exert his best efforts to keep levels of radioactive material in effluents as low as practicable. I-B-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.0 OFFSITE DOSE CALCULATION MANUAL (ODCM) RADIOLOGICAL EFFLUENT CONTROL (REC) APPLICABILITY BASES RECs REC 12.0.1 through REC 12.0.6 establish the general requirements applicable to all RECs in Sections 12.1 through 12.5 and apply at all times, unless otherwise stated. REC 12.0.1 REC 12.0.1 establishes the Applicability statement within each individual REC as the requirement for when the REC is required to be met (i.e., when the unit is in the MODES or other specified conditions of the Applicability statement of each Requirement). REC 12.0.2 REC 12.0.2 establishes that upon discovery of a failure to meet a REC, the associated ACTIONS shall be met. The Completion Time of each Required Action for an ACTIONS Condition is applicable from the point in time that an ACTIONS Condition is entered. The Required Actions establish those remedial measures that must be taken within specified Completion Times when the requirements of a REC are not met. This Requirement establishes that:

a. Completion of the Required Actions within the specified Completion Times constitutes compliance with a REC; and

b. Completion of the Required Actions is not required when a REC is met within the specified Completion Time, unless otherwise specified.

There are two basic types of Required Actions. The first type of Required Action specifies a time limit in which the REC must be met. This time limit is the Completion Time to restore an inoperable system or component to OPERABLE status or to restore variables to within specified limits. If this type of Required Action is not completed within the specified Completion Time, a shutdown may be required to place the unit in a MODE or condition in which the REC is not applicable. (Whether stated as a Required Action or not, correction of the entered Condition is an action that may always be considered upon entering ACTIONS.) The second type of Required (continued) 1-B132.0-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls BASES REC 12.0.2 Action specifies the remedial measures that permit continued operation of (continued) the unit that is not further restricted by the Completion Time. In this case, compliance with the Required Actions provides an acceptable level of safety for continued operation. Completing the Required Actions is not required when a REC is met or is no longer applicable, unless otherwise stated in the individual RECs. The nature of some Required Actions of some Conditions necessitates that, once the Condition is entered, the Required Actions must be completed even though the associated Condition no longer exists. The individual REC's ACTIONS specify the Required Actions where this is the case. An example of this is in REC 12.4.2, "Dose from Noble Gases." The Completion Times of the Required Actions are also applicable when a system or component is removed from service intentionally. The reasons for intentionally relying on the ACTIONS include, but are not limited to, performance of Surveillances, preventive maintenance, corrective maintenance, or investigation of operational problems. Entering ACTIONS for these reasons must be done in a manner that does not compromise safety. Intentional entry into ACTIONS should not be made for operational convenience. Additionally, if intentional entry into ACTIONS would result in redundant equipment being inoperable, alternatives should be used instead. Doing so limits the time both subsystems/divisions of a function are inoperable and limits the time conditions exist which may result in REC 12.0.3 being entered. Individual RECs may specify a time limit for performing a RSR when equipment is removed from service or bypassed for testing. In this case, the Completion Times of the Required Actions are applicable when this time limit expires, if the equipment remains removed from service or bypassed. When a change in MODE or other specified condition is required to comply with Required Actions, the unit may enter a MODE or other specified condition in which another REC becomes applicable. In this case, the Completion Times of the associated Required Actions would apply from the point in time that the new REC becomes applicable and the ACTIONS Condition(s) are entered. (continued) 1-B132.0-2

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls BASES (continued) REC 12.0.3 REC 12.0.3 establishes the actions that must be implemented when a REC is not met and:

a. An associated Required Action and Completion Time is not met and no other Condition applies; or

b. The condition of the unit is not specifically addressed by the associated ACTIONS. This means that no combination of Conditions stated in the ACTIONS can be made that exactly corresponds to the actual condition of the unit. Sometimes, possible combinations of Conditions are such that entering REC 12.0.3 is warranted; in such cases, the ACTIONS specifically state a Condition corresponding to such combinations and also that REC 12.0.3 be entered immediately.

Upon entering REC 12.0.3, 1 hour is allowed to implement appropriate compensatory actions and verify the plant is not in an unanalyzed condition or that a required safety function is not compromised. Within 12 hours, Shift Operations Superintendent or designee approval of the compensatory actions and the plan for exiting REC 12.0.3 must be obtained. The use and interpretation of specified times to complete the actions of REC 12.0.3 are consistent with the discussion of Section 1.3, Completion Times. The actions required in accordance with REC 12.0.3 may be terminated and REC 12.0.3 exited if any of the following occurs:

a. The REC is now met.

b. A Condition exists for which the Required Actions have now been performed.

c. ACTIONS exist that do not have expired Completion Times. These Completion Times are applicable from the point in time that the Condition is initially entered and not from the time REC 12.0.3 is exited.

(continued) 1-B132.0-3

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls BASES REC 12.0.3 In MODES 1, 2, and 3, REC 12.0.3 provides actions for Conditions not (continued) covered in other Requirements. The requirements of REC 12.0.3 do not apply in MODES 4 and 5 because the unit is already in the most restrictive Condition. The requirements of REC 12.0.3 do not apply in other specified conditions of the Applicability (unless in MODE 1, 2, or 3) because the ACTIONS of individual RECs sufficiently define the remedial measures to be taken. REC 12.0.4 REC 12.0.4 establishes limitations on changes in MODES or other specified conditions in the Applicability when an REC is not met. It precludes placing the unit in a MODE or other specified condition stated in that Applicability (e.g., Applicability desired to be entered) when the following exist:

a. Unit conditions are such that the requirements of the REC would not be met in the Applicability desired to be entered; and

b. Continued noncompliance with the REC requirements, if the Applicability were entered, would result in the unit being required to exit the Applicability desired to be entered to comply with the Required Actions.

Compliance with Required Actions that permit continued operation of the unit for an unlimited period of time in a MODE or other specified condition provides an acceptable level of safety for continued operation. This is without regard to the status of the unit before or after the MODE change. Therefore, in such cases, entry into a MODE or other specified condition in the Applicability may be made in accordance with the provisions of the Required Actions. The provisions of this REC should not be interpreted as endorsing the failure to exercise the good practice of restoring systems or components to OPERABLE status before entering an associated MODE or other specified condition in the Applicability. The provisions of REC 12.0.4 shall not prevent changes in MODES or other specified conditions in the Applicability that are required to comply with ACTIONS. In addition, the provisions of REC 12.0.4 shall not prevent (continued) 1-B132.0-4

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls BASES REC 12.0.4 changes in MODES or other specified conditions in the Applicability that (continued) result from any unit shutdown. Exceptions to REC 12.0.4 are stated in the individual RECs. The exceptions allow entry into MODES or other specified conditions in the Applicability when the associated ACTIONS to be entered do not provide for continued operation for an unlimited period of time. Exceptions may apply to all the ACTIONS or to a specific Required Action of a REC. Surveillances do not have to be performed on the associated inoperable equipment (or on variables outside the specified limits), as permitted by RSR 12.0.1. Therefore, changing MODES or other specified conditions while in an ACTIONS Condition, either in compliance with REC 12.0.4, or where an exception to REC 12.0.4 is stated, is not a violation of RSR 12.0.1 or RSR 12.0.4 for those Surveillances that do not have to be performed due to the associated inoperable equipment. However, RSRs must be met to ensure OPERABILITY prior to declaring the associated equipment OPERABLE (or variable within limits) and restoring compliance with the affected REC. REC 12.0.4 is only applicable when entering MODE 3 from MODE 4, MODE 2 from MODE 3 or 4, or MODE 1 from MODE 2. Furthermore, REC 12.0.4 is applicable when entering any other specified condition in the Applicability only while operating in MODE 1, 2, or 3. The requirements of REC 12.0.4 do not apply in MODES 4 and 5, or in other specified conditions of the Applicability (unless in MODE 1, 2, or 3) because the ACTIONS of individual Requirements sufficiently define the remedial measures to be taken. REC 12.0.5 REC 12.0.5 establishes the allowance for restoring equipment to service under administrative controls when it has been removed from service or declared inoperable to comply with ACTIONS. The sole purpose of this Requirement is to provide an exception to REC 12.0.2 (e.g., to not comply with the applicable Required Action(s)) to allow the performance of required testing to demonstrate:

a. The OPERABILITY of the equipment being returned to service; or (continued)

I-Ri 20-5

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls BASES REC 12.0.5 b. The OPERABILITY of other equipment. (continued) The administrative controls ensure the time the equipment is returned to service in conflict with the requirements of the ACTIONS~is limited to the time absolutely necessary to perform the required testing to demonstrate OPERABILITY. This Requirement does not provide time to perform any other preventive or corrective maintenance. An example of demonstrating the OPERABILITY of other equipment is taking an inoperable channel or trip system out of the tripped condition to prevent the trip function from occurring during the performance of required testing on another channel in the other trip system. A similar example of demonstrating the OPERABILITY of other equipment is taking an inoperable channel or trip system out of the tripped condition to permit the logic to function and indicate the appropriate response during the performance of required testing on another channel in the same trip system. REC 12.0.6 REC 12.0.6 establishes the applicability of each REC to both Unit 1 and Unit 2 operation. Whenever a requirement applies to only one unit, or is different for each unit, this will be identified in the appropriate section of the REC (e.g., Applicability, RSR, etc.) with parenthetical reference, Notes, or other appropriate presentation within the body of the requirement. 1-B132.0-6

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.0 ODCM RADIOLOGICAL SURVEILLANCE REQUIREMENT (RSR) APPLICABILITY BASES RSRs RSR 12.0.1 through RSR 12.0.5 establish the general requirements applicable to all Requirements in 12.1 through 12.5 and apply at all times, unless otherwise stated. RSR 12.0.1 RSR 12.0.1 establishes the requirement that RSRs must be met during the MODES or other specified conditions in the Applicability for which the requirements of the REC apply, unless otherwise specified in the individual RSRs. This REC is to ensure that RSRs are performed to verify the OPERABILITY of systems and components, and that variables are within specified limits. Failure to meet a RSR within the specified Frequency, in accordance with RSR 12.0.2, constitutes a failure to meet a REC. Systems and components are assumed to be OPERABLE when the associated RSRs have been met. Nothing in this RSR, however, is to be construed as implying that systems or components are OPERABLE when:

a. The systems or components are known to be inoperable, although still meeting the RSRs; or

b. The requirements of the RSR(s) are known to be not met between required RSR performances.

RSR do not have to be performed when the unit is in a MODE or other specified condition for which the requirements of the associated REC are not applicable, unless otherwise specified. Unplanned events may satisfy the requirements (including applicable acceptance criteria) for a given RSR. In this case, the unplanned event may be credited as fulfilling the performance of the RSR. (continued) 1-B132.0-7

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls BASES RSR 12.0.1 RSRs, including RSRs invoked by Required Actions, do not have to be (continued) performed on inoperable equipment because the ACTIONS define the remedial measures that apply. RSRs have to be met and performed in accordance with RSR 12.0.2, prior to returning equipment to OPERABLE status. Upon completion of maintenance, appropriate post maintenance testing is required to declare equipment OPERABLE. This includes ensuring applicable RSRs are not failed and their most recent performance is in accordance with RSR 12.0.2. Post maintenance testing may not be possible in the current MODE or other specified conditions in the Applicability due to the necessary unit parameters not having been established. In these situations, the equipment may be considered OPERABLE provided testing has been satisfactorily completed to the extent possible and the equipment is not otherwise believed to be incapable of performing its function. This will allow operation to proceed to a MODE or other specified condition where other necessary post maintenance tests can be completed. RSR 12.0.2 RSR 12.0.2 establishes the requirements for meeting the specified Frequency for RSRs and any Required Action with a Completion Time that requires the periodic performance of the Required Action on a "once per..." interval. RSR 12.0.2 permits a 25% extension of the interval specified in the Frequency. This extension facilitates RSR scheduling and considers plant operating conditions that may not be suitable for conducting the RSR (e.g., transient conditions or other ongoing RSR or maintenance activities). The 25% extension does not significantly degrade the reliability that results from performing the RSR at its specified Frequency. This is based on the recognition that the most probable result of any particular RSR being performed is the verification of conformance with the RSRs. As stated in RSR 12.0.2, the 25% extension also does not apply to the initial portion of a periodic Completion Time that requires performance on a "once per..." basis. The 25% extension applies to each performance after the initial performance. The initial performance of the Required Action, (continued) 1-B132.0-8

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls BASES RSR 12.0.2 whether it is a particular RSR or some other remedial action, is considered a (continued) single action with a single Completion Time. One reason for not allowing the 25% extension to this Completion Time is that such an action usually verifies that no loss of function has occurred by checking the status of redundant or diverse components or accomplishes the function of the inoperable equipment in an alternative manner. The provisions of RSR 12.0.2 are not intended to be used repeatedly merely as an operational convenience to extend RSR intervals (other than those consistent with refueling intervals) or periodic Completion Time intervals beyond those specified. RSR 12.0.3 RSR 12.0.3 establishes the flexibility to defer declaring affected equipment inoperable or an affected variable outside the specified limits when a RSR has not been completed within the specified Frequency. A delay period of up to 24 hours or up to the limit of the specified Frequency, whichever is greater, applies from the point in time it is discovered that the RSR has not been performed in accordance with RSR 12.0.2, and not at the time that the specified Frequency was not met. This delay period provides adequate time to complete RSRs that have been missed. This delay period permits the completion of a RSR before complying with Required Actions or other remedial measures that might preclude completion of the RSR. The basis for this delay period includes consideration of unit conditions, adequate planning, availability of personnel, the time required to perform the RSR, the safety significance of the delay in completing the required RSR, and the recognition that the most probable result of any particular RSR being performed is the verification of conformance with the requirements. When a RSR with a Frequency based not on time intervals, but upon specified unit conditions, operating situations, or requirements of regulations (e.g., prior to each release, or in accordance with the Radioactive Liquid Waste Sampling and Analysis Program, etc.) is discovered to not have been (continued) I-B12 0-9

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls BASES RSR 12.0.3 performed when specified, RSR 12.0.3 allows for the full delay period of up (continued) to the specified Frequency to perform the RSR. However, since there is not a time interval specified, the missed RSR should be performed at the first reasonable opportunity. RSR 12.0.3 provides a time limit for, and allowances for the performance of, RSRs that become applicable as a consequence of MODE changes imposed by Required Actions. Failure to comply with specified Frequencies for RSRs is expected to be an infrequent occurrence. Use of the delay period established by RSR 12.0.3 is a flexibility which is not intended to be used as an operational convenience to extend RSR intervals. While up to 24 hours or the limit of the specified Frequency is provided to perform the missed RSR, it is expected that the missed RSR will be performed at the first reasonable opportunity. The determination of the first reasonable opportunity should include consideration of the impact on plant risk (from delaying the RSR as well as any plant configuration changes required or shutting the plant down to perform the RSR) and impact on any analysis assumptions, in addition to unit conditions, planning, availability of personnel, and the time required to perform the RSR. This risk impact should be managed through the program in place to implement 10 CFR 50.65(a)(4) and its implementation guidance, NRC Regulatory Guide 1.182, "Assessing and Managing Risk Before Maintenance Activities at Nuclear Power Plants." This Regulatory Guide addresses consideration of temporary and aggregate risk impacts, determination of risk management action thresholds, and risk management action up to and including plant shutdown. The missed RSR should be treated as an emergent condition as discussed in the Regulatory Guide. The risk evaluation may use quantitative, qualitative, or blended methods. The degree of depth and rigor of the evaluation should be commensurate with the importance of the component. Missed RSRs for important components should be analyzed quantitatively. Ifthe results of the risk evaluation determine the risk increase is significant, this evaluation should be used to determine the safest course of action. All missed RSRs will be placed in the station's Corrective Action Program. (continued) 1-B12.0-10

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls -BASES RSR 12.0.3 If a RSR is not completed within the allowed delay period, then the (continued) equipment is considered inoperable or the variable then is considered outside the specified limits and the Completion Times of the Required Actions for the applicable REC Conditions begin immediately upon expiration of the delay period. If a RSR is failed within the delay period, then the equipment is inoperable, or the variable is outside the specified limits and the Completion Times of the Required Actions for the applicable REC Conditions begin immediately upon the failure of the RSR. Completion of the RSR within the delay period allowed by this RSR, or within the Completion Time of the ACTIONS, restores compliance with RSR 12.0.1. RSR 12.0.4 RSR 12.0.4 establishes the requirement that all applicable RSRs must be met before entry into a MODE or other specified condition in the Applicability. This RSR ensures that system and component OPERABILITY requirements and variable limits are met before entry into MODES or other specified conditions in the Applicability for which these systems and components ensure safe operation of the unit. The provisions of this RSR should not be interpreted as endorsing the failure to exercise the good practice of restoring systems or components to OPERABLE status before entering an associated MODE or other specified condition in the Applicability. However, in certain circumstances, failing to meet a RSR will not result in RSR 12.0.4 restricting a MODE change or other specified condition change. When a system, subsystem, division, component, device, or variable is inoperable or outside its specified limits, the associated RSR(s) are not required to be performed per RSR 12.0.1 which states that RSRs do not have to be performed on inoperable equipment. When equipment is inoperable, RSR 12.0.4 does not apply to the associated RSR(s) since the requirement for the RSR(s) to be performed is removed. Therefore, failing to perform the RSRs within the specified Frequency, on equipment that is inoperable, does not result in a RSR 12.0.4 restriction to changing MODES or other specified conditions of the Applicability. However, since the REC is not met in this instance, REC 12.0.4 will govern any restrictions that may (or may not) apply to MODE or other specified condition changes. (continued) 1-B132.0-11

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls BASES RSR 12.0.4 The provisions of RSR 12.0.4 shall not prevent changes in MODES or (continued) other specified conditions in the Applicability that are required to comply with ACTIONS. In addition, the provisions of RSR 12.0.4 shall not prevent changes in MODES or other specified conditions in the Applicability that result from any unit shutdown. The precise requirements for performance of RSRs are specified such that exceptions to RSR 12.0.4 are not necessary. The specific time frames and conditions necessary for meeting the RSRs are specified in the Frequency, in the RSR, or both. This allows performance of RSRs when the prerequisite condition(s) specified in a RSR procedure require entry into the MODE or other specified condition in the Applicability of the associated REC prior to the performance or completion of a RSR. A RSR that could not be performed until after entering the REC Applicability would have its Frequency specified such that it is not "due" until the specific conditions needed are met. Alternately, the RSR may be stated in the form of a Note as not required (to be met or performed) until a particular event, condition, or time has been reached. Further discussion of the specific formats of RSRs' annotation is found in Section 1.4, Frequency. RSR 12.0.4 is only applicable when entering MODE 3 from MODE 4, MODE 2 from MODE 3 or 4, or MODE 1 from MODE 2. Furthermore, RSR 12.0.4 is applicable when entering any other specified condition in the Applicability only while operating in MODE 1, 2, or 3. The requirements of RSR 12.0.4 do not apply in MODES 4 and 5, or in other specified conditions of the Applicability (unless in MODE 1, 2, or 3) because the ACTIONS of individual Controls sufficiently define the remedial measures to be taken. RSR 12.0.5 RSR 12.0.5 establishes the applicability of each RSR to both Unit 1 and Unit 2 operation. Whenever a requirement applies to only one unit, or is different for each unit, this will be identified with parenthetical reference, Notes, or other appropriate presentation within the RSR. 1-B132.0-12

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.1 NOT USED INTENTIONALLY BLANK I-B112.1-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.2 INSTRUMENTATION B 12.2.1 Radioactive Liquid Effluent Monitoring Instrumentation BASES The radioactive liquid effluent monitoring instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM to ensure that the alarm/trip will occur prior to exceeding the limits of RECS. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. 1-B12.2.1-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.2 INSTRUMENTATION B 12.2.2 Radioactive Gaseous Effluent Monitoring Instrumentation BASES The radioactive gaseous effluent monitoring instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm/trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM to ensure that the alarm/trip will occur prior to exceeding the limits of RECS. 1-B132.2.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.3LIQUID EFFLUENTS B 12.3.1 Liquid Effluent Concentration BASES This control is provided to ensure that the concentration of radioactive materials released in liquid waste effluents from the site will be less than ten (10) times the concentration levels specified in Appendix B, Table 2, Column 2 to 10 CFR 20.1001-2402. This limitation provides additional assurance that the levels of radioactive materials in bodies of water outside the site will result in exposure within (1) the Section II.A design objectives of Appendix 1,10 CFR 50, to an individual, and (2) the limits of 10 CFR 20.1301 to the population. In addition, this limit is associated with 40 CFR 141 which states concentration limits at the nearest downstream potable water supply. The results of the analyses of RSR 12.3.1.1, 12.3.1.2, and 12.3.1.3 shall be used with the calculational methods in the ODCM to assure that the concentrations at the point of release are maintained within the limits of this REC. Refer to Technical Specification 5.5.9.b for the definition of an outside temporary tank. 1-B132.3.1-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B.12.3LIQUID EFFLUENTS B 12.3.2 Dose From Liquid Effluents BASES This control is provided to implement the requirements of Sections II.A, III.A and IV.A of Appendix 1,10 CFR Part 50. The REC implements the guides set forth in Section II.A of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as is reasonably achievable." Also, for fresh water sites with drinking water supplies which can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR 141. The dose calculations in the ODCM implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of an individual through appropriate pathways is unlikely to be substantially underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April 1977. This control applies to the release of radioactive materials in liquid effluents from each reactor at the site. For units with shared radwaste treatment systems, the liquid effluents from the shared systems are proportioned among the units sharing that system. 1-B132.3.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.3 LIQUID EFFLUENTS B 12.3.3 Liquid Radwaste Treatment Systems BASES The OPERABILITY of the liquid radwaste treatment system ensures that this system will be available for use whenever liquid effluents require treatment prior to release to the environment. The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as is reasonably achievable." A system bypass allows connection to portable waste treatment equipment. This enables the efficient processing of liquid radwaste through the use of state-of-the-art radwaste processing technology. The portable radwaste treatment system may be used in lieu of various portions of the liquid radwaste treatment system. When a portable waste treatment is not used, RSR 12.3.3.2 may be extended to 180 days. This control implements the requirements of 10 CFR Part 50.36a. General Design Criterion 50 of Appendix A to 10 CFR Part 50 and the design objective given in Section 11.0 of Appendix I to 10 CFR Part

50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix 1,10 CFR Part 50, for liquid effluents. This specification implements Technical Specification Section 5.5.4.f for liquid effluents.

Page I-B12.3.3-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.1 Gaseous Effluent Dose Rates BASES This control is provided to ensure that the dose at any time at the site boundary from gaseous effluents from all units on the site will be within the annual dose limits of RECS for unrestricted areas. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of an individual in an unrestricted area, either within or outside the site boundary exceeding the limits specified in 10 CFR 20.1301. For individuals who may at times be within the site boundary, the occupancy of the individual will be sufficiently low to compensate for any increase in the atmospheric diffusion factor above that for the site boundary. The specified release rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to an individual at or beyond the site boundary to less than or equal to a dose rate of 500 mrem/year to the total body or to less than or equal to a dose rate of 3000 mrem/year to the skin. These release rate limits also restrict, at all times, the corresponding thyroid dose rate above background via the inhalation pathway to less than or equal to a dose rate of 1500 mrem/year. This control applies to the release of radioactive effluents in gaseous effluents from all reactors at the site. For units within shared radwaste treatment systems, the gaseous effluents from the shared system are proportioned among the units sharing that system. Page 1-B12.4.1-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.2 Dose from Noble Gases BASES This control is provided to implement the requirements of Sections II.B, III.A and IV.A of Appendix 1,10 CFR Part 50. The Operability Requirements are the guides set forth in Section IL.B of Appendix I. The ACTION statements provide the required operating flexibilit' and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents will be kept "as low as is reasonably achievable." The Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of an individual through appropriate pathways is unlikely to be substantially underestimated. The dose calculations established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man fror Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I, "Revision 1, October 1977 and Regulatory Guide 1.111, "MethodE for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors," Revision 1, July 1977. The ODCM equatiom provided for determining the air doses at the site boundary are based upon the historical average atmospheric conditions. Page I-B12.4.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.3 Dose from Iodine-131, Iodine-1 33, Tritium and Radioactive Materials in Particulate Form BASES The control is provided to implement the requirements of Sections II.C, III.A and IV.A of Appendix 1,10 CFR Part 50. The operability requirements are the guides set forth in Section II.C of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." The ODCM calculational methods specified in the Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of an individual through appropriate pathways is unlikely to be substantially underestimated. The ODCM calculational methods for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I, "Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977. These equations also provide for determining the actual doses based upon the historical average atmospheric conditions. The release rate specifications for radioiodines, radioactive materials in particulate form and radionuclides other than noble gases are dependent on the existing radionuclide pathways to man, in the unrestricted area. The pathways which were examined in the development of these calculations were:

1) individual inhalation of airborne radionuclides, 2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, 3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.

Page I-B12.4.3-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.4GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.4 GASEOUS RADWASTE TREATMENT (OFF-GAS) SYSTEM BASES The OPERABILITY of the GASEOUS RADWASTE TREATMENT SYSTEM ensures that the system will be available for use whenever gaseous effluents require treatment prior to release to the environment. The requirement that the appropriate portions of these systems be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable". This specification implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section 11.0 of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in Sections 1I.B and II.C of Appendix 1,10 CFR Part 50, for gaseous effluents. Page 1-B12.4.4-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES The OPERABILITY of the VENTILATION EXHAUST TREATMENT SYSTEM ensures that the system will be available for use whenever gaseous effluents require treatment prior to release to the environment. The requirement that the appropriate portions of these systems be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable". This specification implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section 11.0 of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in Sections II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents. This control implements Technical Specification 5.5.4.f for gaseous effluents. Page I-B12.4.5-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.4GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.6 MARK II CONTAINMENT BASES This control provides reasonable assurance that releases from drywell purging operations will not exceed the annual dose limits of 10 CFR 20 for unrestricted areas. Based on definition, VENTING would not release a volume resulting in significant contribution to gaseous plant effluents, nor resultant offsite dose. As such, there is no ODCM requirement for sampling. Sampling is required for PURGING, however, since the entire drywell volume is potentially released. Sampling prior to conducting a drywell PURGE provides a pre-release check to ensure release limits will not be exceeded, and allows for the subsequent calculation of offsite dose as a result of the drywell purge. Once the Unit is sub-critical following shutdown, the initial 24 hour purge will exchange multiple volumes of the drywell removing the pre-existing noble gas concentration, and the lack of any source term will yield no new concentration. Likewise, there will be no source term until criticality has been achieved following startup. Page 1-B12.4.6-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.4GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.7 Total Dose BASES This control is provided to meet the dose limitations of 40 CFR 190. The specification requires the preparation and submittal of a report whenever the calculated doses from plant radioactive effluents exceed twice the design objective doses of Appendix I. For sites containing up to 4 reactors, it is highly unlikely that the resultant dose to a member of the public will exceed the dose limits of 40 CFR 190 if the individual reactors remain within the reporting requirement level. The report will describe a course of action that should result in the limitation of dose to a member of the public for 12 consecutive months to within the 40 CFR 190 limits. For the purpose of the report, it may be assumed that the dose commitment to the member of the public from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the same site or within a radius of 5 miles must be considered. If the dose to any member of the public is estimated to exceed the requirements of 40 CFR 190, the report with a request for a variance (provided the release conditions resulting in violation of 40 CFR 190 have not already been corrected), in accordance with the provisions of 40 CFR 190.11, is considered to be a timely request and fulfills the requirements of 40 CFR 190 until NRC staff action is completed. The variance only relates to the limits of 40 CFR 190, and does not apply in any way to the requirements for dose limitation of 10 CFR Part 20, as addressed in other sections of the RECS. An individual is not considered a member of the public during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel cycle. Page I-B12.4.7-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.4GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.8 Main Condenser BASES This control provides reasonable assurance that the releases from the main condenser will not exceed the requirements of the LaSalle Technical Specifications 3.7.6. In addition, a sample is required within 4 hours if the increase is not due to thermal power changes. Ifthe cause is known and not fuel related and less than 1 hour in duration, then no sample is required. [This is based on a letter from W. R. Huntington to Operating Engineers, Shift Engineers and F.R. Lawless, dated May 24, 1984.] Page I-B12.4.8-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.4 GASEOUS EFFLUENTS AND TOTAL DOSE B 12.4.9 Dose Limits for MEMBERS OF THE PUBLIC BASES This control applies to direct exposure of radioactive materials as well as radioactive materials released in gaseous and liquid effluents. 10 CFR 20.1301 sets forth the 100 mrem/year dose limit to members of the public; 2 mrem in any one-hour limit in the unrestricted area; and reiterates that the licensee is also required to meet the 40 CFR 190 standards. 10 CFR 20.1302 provides options to determine compliance to 10 CFR 20.1301. Compliance to the above operability requirement is based on 10 CFR 20, 40 CFR 190 and LaSalle Station Technical Specification 5.5.4.g. The Effluents Program shall implement monitoring, sampling, and analysis of radioactive liquid and gaseous effluents in accordance with 10 CFR 20.1302 and with the methodology and parameters of the ODCM. Page I-B12.4.9-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM B 12.5.1 Radiological Environmental Monitoring Program BASES The Radiological Environmental Monitoring Program required by this section provides representative measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the station operation. This monitoring program implements Section IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and the modeling of the environmental exposure pathways. Guidance for this monitoring program is provided by the Radiological Assessment Branch Technical Position on Environmental Monitoring. The initially specified monitoring program will be effective for at least the first 3 years of commercial operation. Following this period, program changes may be initiated based on operational experience. The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by Table R 12.5.1-3 are considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as a before the fact limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised annually), Currie, LA., "Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968), and Hartwell, J.K., "Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARH-SA-215 (June 1975). Table R12.5.1-1 requires "one sample of each community drinking water supply downstream of the plant within 10 kilometers." Drinking water supply is defined as water taken from rivers, lakes, or reservoirs (not well water) that is used for drinking. Page I-B12.5.1-1

CY-LA-1 70-301 Revision 3 Part I, Radiological Effluent Controls B 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM B 12.5.2 Land Use Census BASES This control is provided to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identified and that modifications to the Radiological Environmental Monitoring Program given in the ODCM are made if required by the results of this census. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. An annual garden census will not be required since the licensee will assume that there is a garden at the nearest residence in each sector for dose calculations. Page I-B12.5.2-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM B 12.5.3 Interlaboratory Comparison Program BASES The requirement for participation in an Interlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental samples matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are valid for the purposes of Section IV.B.2 of Appendix I to 10 CFR Part 50. Page 1-B12.5.3-1

CY-LA-170-301 Revision 3 Part I, Radiological Effluent Controls B 12.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM B 12.5.4 Meteorological Monitoring Program (NOT APPLICABLE) Page I-B12.5.4-1

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual OFFSITE DOSE CALCULATION MANUAL LASALLE STATION Units 1 and 2

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual

1.0 INTRODUCTION

- ODCM GENERAL INFORMATION The Offsite Dose Calculation Manual (ODCM) presents a discussion of the following:

• The basic concepts applied in calculating offsite doses from plant effluents.

       "     The regulations and requirements for the ODCM and related programs.
       "     The methodology and parameters for the offsite dose calculations to assess impact on the environment and compliance with regulations.

The methodology detailed in this manual is intended for the calculation of radiation doses during routine (i.e., non-accident) conditions. The calculations are normally performed using a computer program. Manual calculations may be performed in lieu of the computer program. The dose effects of airborne radioactivity releases predominately depend on meteorological conditions (wind speed, wind direction, and atmospheric stability). For airborne effluents, the dose calculations prescribed in this manual are based on historical average atmospheric conditions. This methodology is appropriate for estimating annual average dose effects and is stipulated in the Bases Section of the Radiological Effluents Controls (RECS). 1.1 Structure of the ODCM Part I of the ODCM is considered to be the Radiological Effluents Controls (RECS), and contains the former Radiological Effluent Technical Specifications that have been removed from the Technical Specifications. Part I is organized as follows: 1- Definitions 2- Not Used 3- Controls 4- Surveillance Requirements (Note: Sections 3 and 4 are presented together as 3/4)

0. Control and Surveillance Requirements

1. Radioactive Liquid Effluent Monitoring Instrumentation

2. Radioactive Gaseous Effluent Monitoring Instrumentation

3. Radioactive Liquid Effluents

4. Radioactive Gaseous Effluents

5. Total Dose

6. Radiological Environmental Monitoring Program

7. Land Use Census

8. Inter-Laboratory Comparison Program

9. Meteorological Monitoring Program 5- Bases 6- Administrative Requirements Page 11.1-1 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Part II of the ODCM is considered to be the Offsite Dose Calculation Manual (ODCM), and contains methods, equations, assumptions, and parameters for calculation of radiation doses from plant effluents. Part II is organized as follows: 1- Introduction 2- Instrumentation and Systems 3- Liquid Effluents 4- Gaseous Effluents 5- Total Dose 6- Radiological and Environmental Monitoring Program 1.2 Regulations This section serves to illustrate the regulations and requirements that define and are applicable to the ODCM. Any information provided in the ODCM concerning specific regulations are not a substitute for the regulations as found in the Code of Federal Regulations (CFR) or Technical Specifications. 1.2.1 Code of Federal Regulations Various sections of the Code of Federal Regulations (CFR) require nuclear power stations to be designed and operated in a manner that limits the radiation exposure to members of the public. These sections specify limits on offsite radiation doses and on effluent radioactivity concentrations and they also require releases of radioactivity to be "As Low As Reasonably Achievable". These requirements are contained in 10CFR20, 10CFR50 and 40CFR190. In addition, 40CFR141 imposes limits on the concentration of radioactivity in drinking water provided by the operators of public water systems.

• 10CFR20, Standards for Protection Against Radiation This revision of the ODCM addresses the requirements of 10CFR20. The 10CFR20 dose limits are summarized in Table 1 - 1.
• Design Criteria (Appendix A of 10CFR50)

Section 50.36 of 10CFR50 requires that an application for an operating license include proposed Technical Specifications. Final Technical Specifications for each station are developed through negotiation between the applicant and the NRC. The Technical Specifications are then issued as a part of the operating license, and the licensee is required to operate the facility in accordance with them. Section 50.34 of 10CFR50 states that an application for a license must state the principal design criteria of the facility. Minimum requirements are contained in Appendix A of 10CFR50. Page 11.1-2 LaSalle Part II Section 1

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual

                " ALARA Provisions (Appendix I of 10CFR50)

Sections 50.34a and 50.36a of 10CFR50 require that the nuclear plant design and the station RECS have provisions to keep levels of radioactive materials in effluents to unrestricted areas "As Low As Reasonably Achievable" (ALARA). Although 10CFR50 does not impose specific limits on releases, Appendix I of 10CFR50 does provide numerical design objectives and suggested limiting conditions for operation. According to Section I of Appendix I of 10CFR50, design objectives and limiting conditions for operation, conforming to the guidelines of Appendix I "shall be deemed a conclusive showing of compliance with the "As Low As Reasonably Achievable" requirements of 10CFR50.34a and 50.36a." An applicant must use calculations to demonstrate conformance with the design objective dose limits of Appendix I. The calculations are to be based on models and data such that the actual radiation exposure of an individual is "unlikely to be substantially underestimated" (see 10CFR50 Appendix I, Section III.A.1). The guidelines in Appendix I call for an investigation, corrective action and a report to the NRC whenever the calculated dose due to the radioactivity released in a calendar quarter exceeds one-half of an annual design objective. The guidelines also require a surveillance program to monitor releases, monitor the environment and identify changes in land use.

                " 40CFR190, Environmental Radiation Protection Standards for Nuclear Power Operations Under an agreement between the NRC and the EPA, the NRC stipulated to its licensees in Generic Letter 79-041 that "Compliance with Radiological Effluent Technical Specifications (RETS), NUREG-0473 (Rev.2) for BWR's, implements the LWR provisions to meet 40CFR1 90". (See Reference 103 and 49.)

The regulations of 40CFR190 limit radiation doses received by members of the public as a result of operations that are part of the uranium fuel cycle. Operations must be conducted in such a manner as to provide reasonable assurance that the annual dose equivalent to any member of the public due to radiation and to planned discharges of radioactive materials does not exceed the following limits: o 25 mrem to the total body o 75 mrem to the thyroid o 25 mrem to any other organ Page 11.1-3 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual An important difference between the design objectives of 10CFR50 and the limits of 40CFR1 90 is that 10CFR50 addresses only doses due to radioactive effluents. 40CFR190 limits doses due to effluents and to radiation sources maintained on site. See Section 1.2.4 for further discussion of the differences between the requirements of 10CFR50 Appendix I and 40CFR190. 40CFR141, National Primary Drinking Water Regulations The following radioactivity limits for community water systems were established in the July, 1976 Edition of 40CFR141: o Combined Ra-226 and Ra-228: < 5 pCi/L. o Gross alpha (particle activity including Ra-226 but excluding radon and uranium): < 15 pCi/L. o The average annual concentration of beta particle and photon radioactivity from man-made radionuclides in drinking water shall not produce an annual dose equivalent to the total body or any internal organ greater than 4 mrem/yr. The regulations specify procedures for determining the values of annual average radionuclide concentration that produce an annual dose equivalent of 4 mrem. Radiochemical analysis methods are also specified. The responsibility for monitoring radioactivity in a community water system falls on the supplier of the water. The LaSalle Station has requirements related to 40CFR141 in the RECS. 1.2.2 Radiological Effluent Technical Standards The Radiological Effluent Technical Standards (RETS) were formerly a subset of the Technical Specifications. They implement provisions of the Code of Federal Regulations aimed at limiting offsite radiation dose. The NRC published Standard RETS for BWRs (Reference 3) as guidance to assist in the development of technical specifications. These documents have undergone frequent minor revisions to reflect changes in plant design and evolving regulatory concerns. The RETS have been removed from the Technical Specifications and placed in the ODCM as the RECS (see Reference 90). The RECS are similar but not identical to the guidance of the Standard Radiological Effluent Technical Specifications. Page 11.1-4 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 1.2.3 Offsite Dose Calculation Manual The NRC in Generic Letter 89-01 defines the ODCM as follows (not verbatim) (see Reference 90): The Offsite Dose Calculation Manual (ODCM) shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents, in the calculation of gaseous and liquid effluent monitoring Alarm/Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program. The ODCM shall also contain (1) the Radioactive Effluent Controls and Radiological Environmental Monitoring Programs and (2) descriptions of the Information that should be included in the Annual Radiological Environmental Operating and Annual Radioactive Effluent Release Reports. Additional requirements for the content of the ODCM are contained throughout the text of the RECS. 1.2.4 Overlapping Requirements In 10CFR20, 10CFR50 and 40CFR190, there are overlapping requirements regarding offsite radiation dose and dose commitment to the total body. In 10CFR20.1301, the total effective dose equivalent (TEDE) to a member of the public is limited to 100 mrem per calendar year. In addition, Appendix Ito 10CFR50 establishes design objectives on annual total body dose or dose commitment of 3 mrem per reactor for liquid effluents and 5 mrem per reactor for gaseous effluents (see 10CFR50 Appendix I, Sections II.A and II.B.2(a)). Finally, 40CFR190 limits annual total body dose or dose commitment to a member of the public to 25 mrem due to all uranium fuel cycle operations. While these dose limits/design objectives appear to overlap, they are different and each is addressed separately by the RETS. Calculations are made and reports are generated to demonstrate compliance to all regulations. Refer to Table 1 - 1 and Table 1 - 2 for additional information regarding instantaneous effluent limits, design objectives and regulatory compliance. Page 11.1-5 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 1.2.5 Dose Receiver Methodology Table 1 - 2 lists the location of the dose recipient and occupancy factors, if applicable. Dose is assessed at the location in the unrestricted area where the combination of existing pathways and receptor age groups indicates the maximum potential exposures. The dose calculation methodology is consistent with the methodology of Regulatory Guide 1.109 (Reference 6) and NUREG 0133 (Reference 14). Dose is therefore calculated to a maximum individual. The maximum individual is characterized as "maximum" with regard to food consumption, occupancy and other usage of the area in the vicinity of the plant site. Such a "maximum individual" represents reasonable deviation from the average for the population in general. In all physiological and metabolic respects, the maximum individual is assumed to have those characteristics that represent averages for their corresponding age group. Thus, the dose calculated is very conservative compared to the "average" (or typical) dose recipient who does not go out of the way to maximize radioactivity uptakes and exposure. Page 11.1-6 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table I - 1 Regulatory Dose Limit Matrix ODCM Section REGULATION DOSE TYPE DOSE LIMIT(s) Airborne Releases: (quarterly) (annual) 10CFR50 App. I1 Gamma Dose to Air due to Noble Gas 5 mrad 10 mrad 4.2.2.1 Radionuclides (per reactor unit) Beta Dose to Air Due to Noble Gas 10 mrad 20 mrad 4.2.2.2 Radionuclides (per reactor unit) Organ Dose Due to Specified Non-Noble 7.5 mrem 15 mrem 4.2.3 Gas Radionuclides (per reactor unit) Total Body and Skin Total Body 2.5 mrem 5 mrem 4.2.2.3 Dose (if air dose is exceeded) Skin 7.5 mrem 15 mrem 4.2.2.4 Technical Specifications Total Body Dose Rate Due to Noble Gas 500 mrem/yr 4.2.1.1 Radionuclides (instantaneous limit, per site) Skin Dose Rate Due to Noble Gas 3,000 mrem/yr 4.2.1.2 Radionuclides (instantaneous limit, per site) Organ Dose Rate Due to Specified Non- 1,500 mrem/yr 4.2.1.3 Noble Gas Radionuclides (instantaneous limit, per site) Liquid Releases: (quarterly) (annual) 10CFR50 App. 14 Whole (Total) Body Dose 1.5 mrem 3 mrem 3.4 (per reactor unit) Organ Dose (per reactor unit) 5 mrem 10 mrem 3.4 Technical Specifications The concentration of radioactivity in liquid Ten times the values effluents released to unrestricted areas listed in 10CFR20 3.2 Appendix B; Table 2, Column 2, and in note 5 below for Noble Gases Total Doses 1. 10 CFR 20.1301 (a)(1) Total Effective Dose Equivalent 4 100 mrem/yr 5.2 10CFR20.1301 (d) Total Body Dose 25 mrem/yr 5.2 And 40CFR190 Thyroid Dose 75 mrem/yr 5.2 Other Organ Dose 25 mrem/yr 5.2 Other Limits 2: 40CFR141 Total Body Dose Due to Drinking Water 4 mrem/yr 3.4 From Public Water Systems Organ Dose Due to Drinking Water From 4 mrem/yr 3.4 Public Water Systems 1 These doses are calculated considering all sources of radiation and radioactivity in effluents. 2 These limits are not directly applicable to nuclear power stations. They are applicable to the owners or operators of public water systems. However, the LaSalle RECS requires assessment of compliance with these limits. 3 Note that 10CFR50 provides design objectives, not limits. 4 Compliance with 10CFR20.1301(a)(1) is demonstrated by compliance with 40CFR190. Note that it may be necessary to address dose from on-site activity by members of the public as well. Kr-85m, Kr-85, Kr-87, Kr-88, Ar-41, Xe-131m, Xe-133m, Xe-133, Xe-135m and Xe-135 allowable concentration is 2E-4, 5E-4, 4E-5, 9E-5, 7E-5, 7E-4, 5E-4, 6E-4, 2E-4 and 2E-4 pCi/ml, respectively, computed from Equation 17 of ICRP Publication 2 adjusted for infinite cloud submersion in water, and R = 0.01 rem/wk, Pw = 1.0 g/cm3, and Pw/Pt = 1.0. Page 11.1-7 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 1 - 2 Dose Assessment Receivers Location; Occupancy if Dose Component or Pathway Different than 100%

"Instantaneous" dose rates from            Unrestricted area boundary location that airborne radioactivity                     results in the maximum dose rate "Instantaneous" concentration limits in    Point where liquid effluents enter the liquid effluents                           unrestricted area Annual average concentration limits for    Point where liquid effluents enter the liquid effluents                           unrestricted area Direct dose from contained sources         Receiver spends part of this time in the controlled area and the remainder at his residence or fishing nearby; occupancy factor is considered and is site-specific.

Direct dose from airborne plume Receiver is at the unrestricted area boundary location that results in the maximum dose. Dose due to radioiodines, tritium and Receiver is at the location in the particulates with half-lives greater than unrestricted area where the combination of 8 days for inhalation, ingestion of existing pathways and receptor age groups vegetation, milk and meat, and ground indicates the highest potential exposures. plane exposure pathways. Ingestion dose from drinking water The drinking water pathway is considered as an additive dose component in this assessment only if the public water supply serves the community immediately adjacent to the plant. Ingestion dose from eating fish The receiver eats fish from the receiving body of water Total Organ Doses Summation of ingestion/inhalation doses Total Dose Summation of above data (Note it may also be necessary to address dose from on-site activity by members of the public.) Page 11.1-8 LaSalle Part II Section 1

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Figure 1 - 1 illustrates some of the potential radiation exposure pathways to humans due to routine operation of a nuclear power station. Figure 1 - 1 Radiation Exposure Pathways to Humans Page 11.1-9 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 1.3 Offsite Dose Calculation Parameters This section contains offsite dose calculation parameter factors, or values not specific only to one of the gas, liquid, or total dose chapters. Additional parameters are provided in the Sections 2, 4 and 5 of the ODCM. 10CFR50 Dose Commitment Factors With the exception of H-3, the dose commitment factors for 10CFR50 related calculations are exactly those provided in Regulatory Guide 1.109 (Reference 6). The following table lists the parameters and the corresponding data tables in the RG 1.109: PATHWAY ADULT TEENAGER CHILD INFANT Inhalation RG 1.109: RG 1.109: RG 1.109: RG 1.109: Table E-7 Table E-8 Table E-9 Table E-10 Ingestion RG 1.109: RG 1.109: RG 1.109: RG 1.109: Table E-11 Table E-12 Table E-13 Table E-14 These tables are contained in Regulatory Guide 1.109 (Reference 6). Each table (E-7 through E-14) provides dose factors for seven organs for each of 73 radionuclides, and Table E-5 lists Miscellaneous Dose Assessment Factors - Consumption Parameters. For radionuclides not found in these tables, dose factors will be derived from ICRP 2 (Reference 50) or NUREG-0172 (Reference 51). The values for H-3 are taken from NUREG-4013 (Reference 107). 1.4 References The references listed below were transferred from the previous ODCM revision that was common to all former Commonwealth Edison nuclear stations. The references not applicable to LaSalle Station have been deleted, however the numbering has been preserved for ease of reference management throughout the ODCM document; therefore, reference numbering is not sequential.

3. U.S. Nuclear Regulatory Commission, Standard Radiological Effluent Technical Specifications for Boiling Water Reactors, NUREG-0473, Rev. 3, Draft, September 1982 (frequently revised).

4. U.S. Nuclear Regulatory Commission, Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants, Regulatory Guide 1.21. Revision 1, June 1974.

Page 11.1-10 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual

5. U.S. Nuclear Regulatory Commission, Onsite Meteorological Programs, Regulatory Guide 1.23, Safety Guide 23, February 17, 1972.

6. U.S. Nuclear Regulatory Commission, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50 Appendix I, Regulatory Guide 1.109, Rev. 1, October 1977.

7. U.S. Nuclear Regulatory Commission, Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors, Regulatory Guide 1.111, Rev. 1, July 1977.

8. U.S. Nuclear Regulatory Commission, Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Light-Water-Cooled Power Reactors, Regulatory Guide 1.112, Rev. 0-R, April 1976; reissued May 1977.

9. U.S. Nuclear Regulatory Commission, Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I, Regulatory Guide 1.113, Rev. 1, April 1977.

10. U.S. Nuclear Regulatory Commission, Programs for Monitoring Radioactivity in the Environs of Nuclear Power Plants, Regulatory Guide 4.1, Rev. 1, April 1975.

11. U.S. Nuclear Regulatory Commission, Preparation of Environmental Reports for Nuclear Power Stations, Regulatory Guide 4.2, Rev. 2, July 1976.

12. U.S. Nuclear Regulatory Commission, Environmental Technical Specifications for Nuclear Power Plants, Regulatory Guide 4.8, Rev. 1, December 1975. (See also the related Radiological Assessment Branch Technical Position, Rev. 1, November 1979.)

13. U.S. Nuclear Regulatory Commission, Quality Assurance for Radiological Monitorinq Programs (Normal Operations)--Effluent Streams and the Environment, Regulatory Guide 4.15, Rev. 1, February 1979.

14. U.S. Nuclear Regulatory Commission, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, edited by J. S. Boegli et al. NUREG-0133, October 1978.

15. U.S. Nuclear Regulatory Commission, XOQDOQ: Computer Program for the Meteorological Evaluation of Routine Effluent Releases at Nuclear Power Stations, J. F.

Sagendorf et al. NUREG/CR-2919, PNL-4380, September 1982.

16. U.S. Nuclear Regulatory Commission, Radiological Assessment, edited by J. E. Till and H. R. Meyer, NUREG/CR-3332, ORNL-5968, September 1983.

17. U.S. Nuclear Regulatory Commission, Standard Review Plan, NUREG-0800, July 1981.

Page 11.1-11 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual

18. U.S. Atomic Energy Commission, Meteorology and Atomic Ener-gy 1968, edited by D. H.

Slade, TID-21940, July 1968.

19. U.S. Atomic Energy Commission, Plume Rise, G. A. Briggs, TID-25075, 1969.

20. U.S. Atomic Energy Commission, The Potential Radiological Implications of Nuclear Facilities in the Upper Mississippi River Basin in the Year 2000, WASH 1209, January 1973.

21. U.S. Atomic Energy Commission, HASL Procedures Manual, Health and Safety Laboratory, HASL-300 (revised annually).

22. U.S. Department of Energy, Models and Parameters for Environmental Radiological Assessments, edited by C. W. Miller, DOE/TIC-11468, 1984.

23. U.S. Department of Energy, Atmospheric Science and Power Production, edited by D.

Randerson, DOE/TIC-27601, 1984.

24. U.S. Environmental Protection Agency, Workbook of Atmospheric Dispersion Estimates, D. B. Turner, Office of Air Programs Publication No. AP-26, 1970.

25. U.S. Environmental Protection Agency, 40CFR190 Environmental Radiation Protection Requirements for Normal Operations of Activities in the Uranium Fuel Cycle, Final Environmental Statement, EPA 520/4-76-016, November 1, 1976.

26. U.S. Environmental Protection Agency, Environmental Analysis of the Uranium Fuel Cycle, EPA-520/9-73-003-C, November 1973.

27. American Society of Mechanical Engineers, Recommended Guide for the Prediction of the Dispersion of Airborne Effluents, 1973.

28. Eisenbud, M., Environmental Radioactivity, 3rd Edition, (Academic Press, Orlando, FL, 1987).

29. Glasstone, S., and Jordan, W. H., Nuclear Power and Its Environmental Effects (American Nuclear Society, LaGrange Park, IL, 1980).

30. International Atomic Energy Agency, Generic Models and Parameters for Assessing the Environmental Transfer of Radionuclides from Routine Releases, Safety Series, No. 57, 1982.

31. National Council on Radiation Protection and Measurements, Radiological Assessment:

Predictinq the Transport, Bioaccumulation, and Uptake by Man of Radionuclides Released to the Environment, NCRP Report No. 76, March 15, 1984.

32. American National Standards Institute, Guide to Sampling Airborne Radioactive Materials in Nuclear Facilities, ANSI N13.1-1969, February 19, 1969.

Page 11.1-12 LaSalle Part II Section 1

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual

33. Institute of Electrical and Electronics Engineers, Specification and Performance of On-Site Instrumentation for Continuously Monitoring Radioactivity in Effluents, ANSI N13.10-1974, September 19, 1974.

34. American National Standards Institute, Testing and Procedural Specifications for Thermoluminescence Dosimetry (Environmental Applications), ANSI N545-1975, August 20, 1975.

35. American Nuclear Insurers, Effluent Monitoring, ANI/MAELU Engineering Inspection Criteria for Nuclear Liability Insurance, Section 5.1, Rev. 2, October 24, 1986.

36. American Nuclear Insurers, Environmental Monitoring, ANI/MAELU Engineering Inspection Criteria for Nuclear Liability Insurance, Section 5.2, Rev. 1, March 23, 1987.

37. American Nuclear Insurers, Environmental Monitoring Programs, ANI/MAELU Information Bulletin 86-1, June 9, 1986.

38. Cember, H., Introduction to Health Physics, 2nd Edition (Pergamon Press, Elmsford, NY 1983).

39. Electric Power Research Institute, Guidelines for Permanent BWR Hydrogen Water Chemistry Installations--1987 Revision, EPRI NP-5283-SR-A, Special Report, September 1987.

40. Commonwealth Edison Company, Information Relevant to Keeping Levels of Radioactivity in Effluents to Unrestricted Areas As Low As Reasonably Achievable, LaSalle County Station, Units 1 and 2, June 4, 1976.

41. U.S. Nuclear Regulatory Commission, Branch Technical Position, Radiological Assessment Branch, Revision 1, November 1979. (This is a branch position on Regulatory Guide 4.8.)

44. U.S. Nuclear Regulatory Commission, Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Boiling Water Reactors (BWR-GALE Code),

NUREG-0016, April 1976.

45. Sargent & Lundy, N-16 Skyshine from BWR Turbine Systems and Piping, NSLD Calculation No. D2-2-85, Rev. 0, 2/1/85.

47. Sargent & Lundy Calculation ATD-0139, Rev. 0, N-16 Skyshine Ground Level Dose from LaSalle Turbine Systems and Piping, July 28, 1992.

49. U.S. Nuclear Regulatory Commission, Methods for Demonstrating LWR Compliance with the EPA Uranium Fuel Cycle Standard (40 CFR Part 190), NUREG-0543, February 1980.

Page 11.1-13 LaSalle Part II Section 1

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual

50. International Commission on Radiological Protection, Report of Committee Two on Permissible Dose for Internal Radiation, Recommendations of the International Commission on Radiological Protection, ICRP Publication 2, 1959.

51. U.S. Nuclear Regulatory Commission, Age-Specific Radiation Dose Commitment Factors for a One-Year Chronic Intake, Battelle Pacific Northwest Laboratories, NUREG-0172, 1977.

52. W. C. Ng, Transfer Coefficients for Prediction of the Dose to Man via the Forage-Cow-Milk Pathway from Radionuclides Released to the Biosphere, UCRL-51939.

53. E. C. Eimutis and M. G. Konicek, Derivations of Continuous Functions for the Lateral and Vertical Atmospheric Dispersion Coefficients, Atmospheric Environment 6, 859 (1972).

54. D. C. Kocher, Editor, Nuclear Decay Data for Radionuclides Occurring in Routine Releases from Nuclear Fuel Cycle Facilities, ORNL/NUREG/TM-102, August 1977.

55. R. L. Heath, Gamma-Ray Spectrum Catalog, Aerojet Nuclear Co., ANCR-1000-2, third or subsequent edition.

56. S. E. Thompson, Concentration Factors of Chemical Elements in Edible Aquatic Organisms, UCRL-50564, Rev. 1, 1972.

57. U.S. Nuclear Regulatory Commission, Instruction Concerning Risks from Occupational Radiation Exposure, Regulatory Guide 8.29, July 1981.

60. Sargent & Lundy Calculation ATD-0173, Rev. 0, 9/21/92, Annual Dose to Members of the Public Due to the LaSalle IRSF.

68. Sargent & Lundy Calculation ATD-01 83, Rev. 0, 9/25/92, Dose Information Around LaSalle DAW Sea/Land Van Storage Area.

70. D. C. Kocher, Radioactivity Decay Data Tables, DOE/TIC-1 1026, 1981.

71. J. C. Courtney, A Handbook of Radiation Shielding Data, ANS/SD-76/14, July 1976.

75. Sargent & Lundy, METWRSUM, S&L Program Number 09.5.187-1.0.

76. Sargent & Lundy, Comments on CECo ODCM and List of S&L Calculations, Internal Office Memorandum, P. N. Derezotes to G. R. Davidson, November 23, 1988.

77. Sargent & Lundy, AZAP, A Computer Program to Calculate Annual Average Offsite Doses from Routine Releases of Radionuclides in Gaseous Effluents and Postaccident X/Q Values, S&L Program Number 09.8.054-1.7.

Page 11.1-14 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual

78. National Oceanic and Atmospheric Administration, A Program for Evaluating Atmospheric Dispersion from a Nuclear Power Station, J. F. Sagendorf, NOAA Technical Memorandum ERL ARL-42, Air Resources Laboratory, Idaho Falls, Idaho, May 1974.

79. G. P. Lahti, R. S. Hubner, and J. C. Golden, Assessment of Gamma-Ray Exposures Due to Finite Plumes, Health Physics 41,319 (1981).

80. National Council of Radiation Protection and Measurements, Ionizing Radiation Exposure of the Population of the United States, NCRP Report No. 93, September 1, 1987.

82. W. R. Van Pelt (Environmental Analysts, Inc.), Letter to J. Golden (Exelon Nuclear) dated January 3, 1972.

83. Electric Power Research Institute, Radiological Effects of Hydrogen Water Chemistry, EPRI NP-4011, May 1985.

84. U.S. Nuclear Regulatory Commission, Draft Generic Environmental Impact Statement on Uranium Milling, NUREG-0511, April 1979.

85. U.S. Environmental Protection Agency, Environmental Analysis of the Uranium Fuel Cycle, Part I - Fuel Supply, EPA-520/9-73-003-B, October 1973.

86. U.S. Nuclear Regulatory Commission, Final Generic Environmental Statement on the Use of Recycle Plutonium in Mixed Oxide Fuel in Light Water Cooled Reactors, NUREG-0002, August 1976.

87. U.S. Nuclear Regulatory Commission, Demographic Statistics Pertaining to Nuclear Power Reactor Sites, NUREG-0348, Draft, December 1977.

88. Nuclear News 31, Number 10, Page 69 (August 1988).

89. General Electric Company, Irradiated Fuel Storage at Morris Operation, Operating Experience Report, January 1972 through December 1982, K. J. Eger, NEDO-20969B.

90. U.S. Nuclear Regulatory Commission, Generic Letter 89-01, "Guidance For The Implementation of Programmatic Controls For RETS In The Administrative Controls Section of Technical Specifications and the Relocation of Procedural Details of Current RETS to the Offsite Dose Calculation Manual or Process Control Program", January 1989.

92. NRC Safety Evaluation Report (SER)/Idaho Notional Engineering Laboratory Technical Evaluation Report (TER) of the Commonwealth Edison Offsite Dose Calculation Manual (ODCM), Revision O.A, December 2,1991.

93. Federal Guidance Report 11 Page 11.1-15 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual

95. U.S. Nuclear Regulatory Commission, Standards for Protection Against Radiation (10CFR20).

96. U.S. Nuclear Regulatory Commission, Licensing of Production and Utilization Facilities (1 OCFR50).

97. Federal Register, Vol. 57, No. 169, Monday, August 31, 1992, page 39358.

98. Miller, Charles W., Models and Parameters for Environmental Radiological Assessments, U.S. Dept. of Energy, DE8102754, 1984, pages 32, 33, 48, and 49.

99. Kocher, D. C., "Dose-Rate Conversion Factors For External Exposure To Photons and Electrons", Health Physics Vol. 45, No. 3 (September), pp. 665-686, 1983.

100. U.S. Department of Health, Education and Welfare Public Health Service, Radiological Health Handbook, January 1970. 101. ODCM Bases and Reference Document, rev.0, November 1998. 103. U.S. Nuclear Regulatory Commission, Generic Letter 79-041, September 17, 1979. 104. Federal Register, Vol. 56, No. 98, Tuesday, May 21, 1991, page 23374, column 3. 106. U.S. Nuclear Regulatory Commission, Offsite Dose Calculation Manual Guidance: Standard Radiological Effluent Controls for Boiling Water Reactors, NUREG-1 302, April 1991. 107. U.S. Nuclear Regulatory Commission, LADTAP II - Technical Reference and Users Guide, NUREG-4013, April 1986. Page 11.1-16 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 1 - 3 Miscellaneous Dose Assessment Factors: Environmental Parameters Parameter Value Comment Equation Basisa fa 0.76 4-11,4-12 A fL 1.0 Fraction of annual intake of fresh, leafy 4-11, 4-12 A vegetation grown locally fp 1.0 Fraction of year animals on pasture 4-13, 4-15 A

f. 1.0 Fraction of feed from pasture when on 4-13, 4-15 A pasture tb 262,800 30 years. Period of buildup of activity in 4-9 C hrs or soil 9.46E8 sec tf 48 hrs or Cow Milk Pathway 4-13 A 1.73E5 sec 480 hrs Cow Meat Pathway 4-15 A or 1.73E6 th 1440 hrs Delay time for ingestion of vegetation by 4-11 A or man 60 days for produce 5.18E6 sec 2160 hrs Delay time for ingestion of stored feed 4-13, 4-15 A or by animals 7.78E6 sec tL 24 hrs or Delay time for ingestion of leafy 4-11 A 8.64E4 vegetable by man sec QF 50 Cow Feed Consumption Rate 4-13, 4-14, 4-15, B Kg/day 4-16 r 1.0 For lodines Fraction of deposited 4-11, 4-13, 4-15 A particulates retained on vegetation 0.2 For Particulates 4-11,4-13, 4-15 A Yp 0.7 2 Grass Yield 4-13,4-15 A Kg/m Ys 2.0 2 Stored Feed Yield 4-13, 4-15 A Kg/m Yv 2.0 2 Vegetarian Area Density 4-11 A Kg/m 0.0021 Weathering decay constant 4-11, 4-13, 4-15 A hr1 or 5.73 E-7 sec H 8 gm/m3 Absolute Atmospheric Humidity 4-12, 4-14, 4-16 D Dw 1.0 Dilution Factor at point of withdrawal of 3-3 drinking water Page 11'.1-17 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 1 - 3 Miscellaneous Dose Assessment Factors: Environmental Parameters Parameter Value Comment Equation Basisa BR Breathing Rate (M3 / yr) E 1400 m 3/yr Infant 3700 m3/yr Child 8000 m3/yr Teen 8000 m3 /yr Adult E UL Leafy Vegetation Consumption Rate (kg/yr) 0 kg/yr Infant 26 Kg/yr Child 42 kg/yr Teen 64 kg/yr Adult UV Stored Vegetation Consumption (kg/yr) E 0 kg/yr Infant 520 kg/yr Child 630 kg/yr Teen 520 kg/yr Adult UG Cow Milk Consumption Rate (L/yr) E 330 L/yr Infant 330 L/yr Child 400 L/yr Teen 310 L/yr Adult UM Meat Consumption Rate (kg/yr) E 0 kg/yr Infant 41 kg/yr Child 65 kg/yr Teen 110 kg/yr Adult W. Fish Consumption Rate (kg/yr) E 0 kg/yr Infant 6.9 kg/yr Child 16 kg/yr Teen 21 kg/yr Adult UU Drinking Water Consumption Rate (L/yr) E 330 L/yr Infant 510 L/yr Child 510 L/yr Teen 730 L/yr Adult aBasis key: A: Reference 6, Table E-15. B: Reference 6, Table E-3. C: The parameter tb is taken as the midpoint of plant operating life (based upon an assumed 60 year plant operating lifetime). D: Reference 14, Section 5.3.1.3. E: Reference 6, Table E-5 Page 11.1-18 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 1 - 4 Stable Element Transfer Data Ff FM(Cow) Element Meat (d/kq) Milk (d/L) Reference H 1.2E-02 1.OE-02 6 Be 1.5E-03 3.2E-03 Footnote 1 C 3.1 E-02 1.2E-02 6 F 2.9E-03 1.4E-02 Footnote 2 Na 3.OE-02 4.OE-02 6 Mg 1.5E-03 3.2E-03 Footnote 1 Al 1.5E-02 1.3E-03 Footnote 3 P 4.6E-02 2.5E-02 6 Cl 2.9E-03 1.4E-02 Footnote 2 Ar NA NA NA K 1.8E-02 7.2E-03 16 Ca 1.6E-03 1.1E-02 16 Sc 2.4E-03 7.5E-06 Footnote 4 Ti 3.4E-02 5.OE-06 Footnote 5 V 2.8E-01 1.3E-03 Footnote 6 Cr 2.4E-03 2.2E-03 6 Mn 8.OE-04 2.5E-04 6 Fe 4.OE-02 1.2E-03 6 Co 1.3E-02 1.OE-03 6 Ni 5.3E-02 6.7E-03 6 Cu 8.OE-03 1.4E-02 6 Zn 3.OE-02 3.9E-02 6 Ga 1.5E-02 1.3E-03 Footnote 3 Ge 9.1 E-04 9.9E-05 Footnote 7 As 1.7E-02 5.OE-04 Footnote 8 Se 7.7E-02 1.OE-03 Footnote 9 Br 2.9E-03 2.2E-02 Ff Footnote 2 ;FM from Ref. 16 Kr NA NA NA Rb 3.1 E-02 3.OE-02 6 Sr 6.OE-04 8.OE-04 6 Y 4.6E-03 1.OE-05 6 Zr 3.4E-02 5.OE-06 6 Nb 2.8E-01 2.5E-03 6 Mo 8.OE-03 7.5E-03 6 Tc 4.OE-01 2.5E-02 6 Ru 4.OE-01 1.OE-06 6 Rh 1.5E-03 1.OE-02 6 Pd 5.3E-02 6.7E-03 Footnote 10 Cd 3.OE-02 2.OE-02 Footnote 11 In 1.5E-02 1.3E-03 Footnote 3 Sn 9.1 E-04 9.9E-05 Footnote 7 Sb 5.0E-03 2.OE-05 98 Ag 1.7E-02 5.0E-02 6 Te 7.7E-02 1.OE-03 6 I 2.9E-03 6.0E-03 6 Xe NA NA NA Cs 4.0E-03 1.2E-02 6 Ba 3.2E-03 4.OE-04 6 La 2.OE-04 5.OE-06 6 Ce 1.2E-03 1.OE-04 6 Pr 4.7E-03 5.OE-06 6 Nd 3.3E-03 5.OE-06 6 Page 11.1-19 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 1 - Cont'd) Stable Element Transfer Data Ff FM (Cow) Element Meat (d/kQ) Milk (d/L) Reference Pm 2.9E-04 2.OE-05 16 Sm 2.9E-04 2.OE-05 16 Eu 2.9E-04 2.OE-05 16 Gd 2.9E-04 2.0E-05 16 Dy 2.9E-04 2.OE-05 16 Er 2.9E-04 2.OE-05 16 Tm 2.9E-04 2.OE-05 16 Yb 2.9E-04 2.OE-05 16 Lu 2.9E-04 2.OE-05 16 Hf 3.4E-02 5.OE-06 Footnote 5 Ta 2.8E-01 1.3E-03 FM - Ref. 16; Ff -Footnote 6 W 1.3E-03 5.OE-04 6 Re 1.OE-01 1.3E-03 FM - Ref.16; Ff -Footnote 12 Os 2.2E-01 6.OE-04 Footnote 13 Ir 7.3E-03 5.5E-03 Footnote 14 Pt 5.3E-02 6.7E-03 Footnote 10 Au 1.3E-02 3.2E-02 Footnote 15 Hg 3.OE-02 9.7E-06 FM - Ref.16; Ff -Footnote 11 TI 1.5E-02 1.3E-03 FM - Ref.16; Ff-Footnote 3 Pb 9.1 E-04 9.9E-05 98 Bi 1.7E-02 5.OE-04 98 Ra 5.5E-04 5.9E-04 98 Th 1.6E-06 5.OE-06 98 U 1.6E-06 1.2E-04 98 Np 2.OE-04 5.OE-06 6 Am 1.6E-06 2.OE-05 98 Notes:

1. NA = It is assumed that noble gases are not deposited on the ground.

2. Elements listed are those considered for IOCFR20 assessment and compliance.

Footnotes: There are numerous F1 and FM values that were not found in published literature. In these cases, the periodic table was used in conjunction with published values. The periodic table was used based on a general assumption that elements have similar characteristics when in the same column of the periodic table. The values of elements in the same column of the periodic table, excluding atomic numbers 58-71 and 90-103, were averaged then assigned to elements missing values located in the same column of the periodic table. This method was used for all columns where there were missing values except column 3A, where there was no data, hence, the average of column 2B and 4A were used.

1. Values obtained by averaging Reference 6 values of Ca, Sr, Ba and Ra.

2. Ff value obtained by assigning the Reference 6 value for I. FM value obtained by averaging I (Ref. 6) and Br (Ref.16).

3. Ff values obtained by averaging Zn (Ref.6) and Pb (Ref. 98); there were no values for elements in the same column; an average is taken between values of columns 2B and 4A on the periodic table. FM values obtained by using the value for TI from Reference 16.

4. Values obtained by averaging Reference 6 values of Y and La.

5. Values obtained by assigning the Reference 6 value for Zr.

6. Ff values obtained from Ref. 6 value for Nb. FM values obtained by averaging values for Nb (Ref.6) and Ta (Ref. 16).

7. Values obtained from the Reference 6 values for Pb.

8. Values obtained from the Reference 6 values for Bi.

9. Values obtained from the Reference 6 values for Te.

10. Values obtained from the Reference 6 values for Ni.

11. Ff values obtained from Ref. 6 values for Zn. FM values obtained by averaging the Reference 6 values for Zn and Hg.

12. Values obtained by averaging Reference 6 values for Mn, Tc, Nd and Reference 98 value for U.

13. Values obtained by averaging Reference 6 values from Fe and Ru.

14. Values obtained by averaging Reference 6 values from Co and Rh.

15. Values obtained by averaging Reference 6 values from Cu and Ag.

Page 11.1-20 LaSalle Part II Section 1

CY-LA-1 70-301 Revision 3 Part It,Offsite Dose Calculation Manual Figure 1 - 2 Unrestricted Area Boundary OPPM 1 " CMULOKA1' I MANUALI LAAWLE Gm06PTY S?41u I mU - 4 M&-% LII b 1~ mU-mme

                           "-I.

Nsg LAhimt LA*

-l   ~lII~l i

6 A - .m Amw. 9l Page 11.1-21 LaSalle Part II Section 1

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Figure 1 - 3 Restricted Area Boundary

                                                                 .mwmwý.

wan

             -tw          Ma  ORMW
            %wn"      a Ns m-U1 U& Vr #NU94m=      000. -    -M
                                                     &WSJTI MR CODLAI gPOXw "Now Im L-
           *m 8

I0 lo m LA SmL CU 3I STATIO mmfut it" Page 11.1-22 LaSalle Part II Section 1

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 2.0 INSTRUMENATATION AND SYSTEMS 2.1 Liquid Releases A simplified liquid radwaste and liquid effluent flow diagram are provided in Figures 2-2 and 2-3. The liquid radwaste treatment system is designed and installed to reduce radioactive liquid effluents by collecting the liquids, providing for retention or holdup, and providing for treatment by filter or demineralizer for the purpose of reducing the total radioactivity prior to release to the environment. The system is described in Section 11.2.2 of the LaSalle UFSAR. 2.1.1 Radwaste Discharge Tanks There are two discharge tanks (1(2)WF05T, 25,000 gallons each) which receive water for discharge to the Illinois River via the cooling lake blowdown. 2.1.2 Cooling Pond Blowdown Cooling Pond Blowdown is the liquid discharge line to the Illinois River. The Cooling Pond Blowdown has a compositor to meet the sampling requirements of Part I RECS Table R12.3.1-2. Blowdown flow is determined by Blowdown Flow Control Valve position, in accordance with site implementing procedures. 2.2 Radiation Monitors 2.2.1 Liquid Radwaste Effluent Monitor Monitor 0D18-K907 monitors all releases from the release tanks. On hi-hi alarm the monitor automatically initiates closure of valve 0WL067 and trips the radwaste discharge pump to terminate the release. Pertinent information on the monitor and associated control devices is provided in LaSalle UFSAR Section 11.5.2.3.3. 2.2.2 Service Water Effluent Monitors Monitors 1/(2)D18-K912 continuously monitor the service water effluent. On high alarm service water discharge may be terminated manually. No control device is initiated by these monitors. Pertinent information on these monitors is provided in LaSalle UFSAR 11.2-1 LaSalle ODCM Part II Section 2

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 2.2.3 RHR Heat Exchanger Cooling Water Effluent Monitors Instrument channels 1/(2)D18-N906/8 continuously monitor the RHR heat exchanger cooling water effluent. On high alarm the operating loop may be terminated manually and the redundant loop brought on line. No control device is initiated by these monitors. Pertinent information on these monitors is provided in LaSalle UFSAR Section 11.5.2.3.4. 2.3 Liquid Radiation Effluent Monitors Alarm and Trip Setpoints Alarm and trip setpoints of liquid effluent monitors at the principal release points are established to ensure that the limits of RECS are not exceeded in the unrestricted area. 2.3.1 Liquid Radwaste Effluent Monitor The monitor setpoint is found by solving equation (2-1) for the total isotopic activity. P < Kx[XCi T /X(CiT 1/OxDWCi)] x[(Fd+ Fr max)/Fr max] (2-1) P Release Setpoint .[cpm] K [Y- (Ki x Ci x Wi) / 7 CiTi [cpm/pCi/ml] Ki Counting efficiency for radionuclide I [cpm/pCi/ml] W Weighting Factor CiT Concentration of radionuclide i in the release tank. [pCi/ml] Frmax Maximum Release Tank Discharge Flow Rate [gpm] The maximum flow rate is 45 gpm. DWC Derived Water Concentration [pCi/ml] of radionuclide i The concentration of radionuclide i given in Appendix B, Table 2, Column 2 to 10CFR20.1001-2402. 10 Multiplier associated with the limits specified in Part I RECS 12.3.1. Fd Dilution Flow [gpm] 11.2-2 LaSalle ODCM Part II Section 2

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 2.3.2 Service Water Effluent Monitors The monitor setpoint is established at two times the background count rate (not to exceed 10000 cpm). 2.3.3 RHR Heat Exchanger Cooling Water Effluent Monitors The monitor setpoint is established at two times the background count rate (not to exceed 10000 cpm). 2.3.4 Discharge Flow Rates 2.3.4.1 Release Tank Discharge Flow Rate Prior to each batch release, a grab sample is obtained. The results of the analysis of the sample determine the discharge rate of each batch as follows: Fr max= 0.1 x [Fd / I (C,/10xDWC,)] (2-2) The summation is over radionuclides i. 0.1 Reduction factor for conservatism. Frmax Maximum Permitted Discharge Flow Rate [gpm] The maxiumum permited flow rate from the radwaste discharge tank. Fd Dilution Flow [gpm] Ci Concentration of Radionuclide i in the Release Tank [pCi/mL] The concentration of radioactivity in the radwaste discharge tank based on measurements of a sample drawn from the tank. DWCG Maximum Permissible Concentration of Radionuclide i[pCi/ml] The concentration of radionuclide i given in Appendix B, Table 2, Column 2 to 10CFR20.1001-2402. 10 Multiplier associated with the limits specified in Part I RECS 12.3.1. MF Multiplication Factor 11.2-3 LaSalle ODCM Part II Section 2

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Frmax < 0.5; MF = 3 0.5 < Frmax< 5; < MF = 5 5 < Frmax ; MF = 7.5 Recommended Release Tank Flow Rate. Frrec = Fr max X MF (2-3) Frrec recommended discharge flow rate (gpm) Fr max maximum permitted discharge flow rate (gpm) MF multiplication factor. 2.3.4.2 Release Limits Release limits are determined from RECS. Calculated maximum permissible discharge rates are divided by 10 for conservatism and to ensure that release concentrations are well below applicable derived water concentrations (DWC). 2.3.4.3 Release Mixture For the liquid radwaste effluent monitor the release mixture used for the setpoint determination is the radionuclide mix identified in the grab sample isotopic analysis plus four additional radionuclides. The additional radionuclides are H-3, Fe-59, Sr-89, and Sr-90. The quantities to be added are obtained from the most current analysis for these four radionuclides. For all other liquid effluent monitors no release mixture is used because the setpoint is established at "two times background." 2.3.4.4 Liquid Dilution Flow Rates A conservative maximum blowdown flowrate of 20,000 gpm is used for all radwaste discharge calculations unless actual blowdown flow is determined to be less. 2.3.4.5 Conversion Factors The readout for the liquid radwaste effluent monitor is in CPM. The calibration constant is based on the detector sensitivity to Cs-1 37/Ba-1 37 and an energy response curve. 2.3.5 Allocation of Effluents from Common Release Points Based on common release point, liquid releases from the Station will be allocated to Unit 1. Other potential pathways (i.e., RHR) are allocated to their respective unit. 11.2-4 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II,Offsite Dose Calculation Manual 2.3.6 Projected Doses for Releases Doses are not calculated prior to release. Dose contributions from liquid effluents are determined in accordance with the RECS and station procedures. 2.3.7 Solidification of Waste/Process Control Program The process control program (PCP) contains the sampling, analysis, and formulation determination by which solidification of radioactive wastes from liquid systems is ensured. Figure 2-4 is a simplified diagram of solid radwaste processing. 2.4 Airborne Release A simplified gaseous radwaste and gaseous effluent flow diagram are provided in Figure 2-1. The airborne release point for radioactive effluents is the ventilation stack, which is classified as a stack in accordance with the definitions in Section 4.1.4. In addition, the standby gas treatment system effluent is released through a separate stack inside the ventilation stack. This release point has the same location and classification as the ventilation stack. Exfiltration to the environment from the Turbine Building has been identified at times of positive pressure in the Turbine Building. Within 20 hours of the turbine building being at positive pressure continuous air sampling shall be in place in the south Turbine Building trackway to monitor releases through this pathway. The releases through the trackway door and other potential release paths contain insignificant levels of contamination when compared to the Station Vent Stack which has a 1,000,000 cfm typical stack flow compared to the Trackway flow rate of 40,000 scfm and conservatively estimated as a total of 80,000 scfm to account for pathways other than the trackway. In addition, typical releases from LaSalle Station have not exceeded 0.02% of the 10CFR50 Appendix I dose limits. Any identified release via this pathway is a ground level release and should be considered in dose calculations. See Figure 2-1 for further information. Exfiltration to the environment from the North Service Building may occur due to changes in the ventilation system. Within 20 hrs of the turbine building being at positive pressure, air sampling shall be performed at times when the ventilation systems are aligned to support unit 2 egress. This air sampling is designed to ensure evaluation of releases emanating from the Turbine Building in accordance with Section 2.5.5. 11.2-5 LaSalle ODCM Part IISection 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual The station vent stack is equipped with three access hatches at elevations 853', 888' and 1055'. Nominal leakage from these access hatches is expected at an approximated value of up to 1000 SCFM. Resultant doses due to this nominal leakage are negligible when compared to the SVS flow of 1.00 E6 SCFM and have been calculated as such. Doses due to this nominal leakage are therefore accounted for in the gaseous effluent stream and do not require further calculation. During maintenance activities in which the hatch(es) would be opened, however, the lower elevation hatches (elevations 853' and 888') are classified as vent or "mixed mode" release pathways. These release pathways should be monitored during the maintenance activity period, with resultant releases calculated as mixed mode. Monitoring may be accomplished by determining flow at the point of release and conservatively utilizing the normal effluent release activity levels (at the SVS WRGM sample location). Flow via this pathway should be determined by measurement or engineering calculation. Release activities can be determined from the normal effluent sample point, assuming isokinetic flow at the release pathway. Alternately, grab sampling may be used to ensure representative sampling at the point of release. The higher elevation hatch at 1050' remains as a stack (elevated) release pathway and can be monitored via the SVS instrumentation and methodology. Airborne releases to the environment may result if a fire occurs in a contaminated material warehouse. In the event of a fire in a contaminated material warehouse this pathway would be considered a ground level release and should be quantified and considered in dose calculations. 2.4.1 Condenser Offgas Treatment System The condenser offgas treatment system is designed and installed to reduce radioactive gaseous effluents by collecting non- condensable off-gases from the condenser and providing for holdup to reduce the total radioactivity by radiodecay prior to release to the environment. The daughter products are retained by charcoal and HEPA filters. The system is described in Section 11.3.2.1 of the LaSalle UFSAR. 11.2-6 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 2.4.2 Ventilation Exhaust Treatment System Ventilation exhaust treatment systems are designed and installed to reduce gaseous radioiodine or radioactive material in particulate form in selected effluent streams by passing ventilation or vent exhaust gases through charcoal adsorbers and/or HEPA filters prior to release to the environment. Such a system is not considered to have any effect on noble gas effluents. The ventilation exhaust treatment systems are shown in Figure 2-1. Engineered safety features atmospheric cleanup systems are not considered to be ventilation exhaust treatment system components. 2.5 Gaseous Effluent Radiation Monitors 2.5.1 Station Vent Stack Effluent Monitor Monitor OPLD5J (Wide Range Noble Gas Monitor) continuously monitors the final effluent from the station vent stack. The monitor system has isokinetic sampling, gaseous grab sampling, iodine and particulate sampling, tritium sampling, and post-accident sampling capability. In normal operation the low-range noble gas channel is on line and active. The midrange channel replaces the low-range channel at a concentration of 0.01 pCi/cc png* and the high-range channel replaces the mid-range channel at a concentration of 10 uCi/cc png. The low-range and mid/high-range iodine and particulate samplers operate in a similar manner. In normal operation the low-range samplers are on line. At a concentration of 0.001 pCi/cc png the mid/high-range samplers are brought on line, and at a concentration of 0.1 pCi/cc png the low-range sample pump is turned off.

• To facilitate use of the wide range gas monitors on the Station Vent Stack and Standby Gas Treatment System Stack in post-accident dose assessment, the output of each is expressed in units of pseudo noble gas (png) activity. Pseudo noble gas is a fictitious radionuclide defined to have emission characteristics representative of a post-accident noble gas mix. Upon decay, a pseudo noble gas nuclide emits one gamma ray with energy 0.8 MeV and one beta particle with endpoint energy 1.68 MeV and average energy 0.56 MeV.

No automatic isolation or control functions are performed by this monitor. Pertinent information on this monitor is provided in the LaSalle UFSAR Section 11.5.2.2.1. 2.5.2 Standby Gas Treatment System Effluent Monitor Monitor OPLD2J (Wide Range Noble Gas Monitor) continuously monitors the final effluent from the standby gas treatment system (SGTS) stack. The SGTS stack monitor has isokinetic sampling, gaseous grab sampling, particulate and iodine sampling, and post accident sampling capability. 11.2-7 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual In normal operation the low range noble gas channel is on line and active. The midrange channel replaces the low-range channel at a concentration of 0.01 pCi/cc png and the high-range channel replaces the mid-range channel at a concentration of 10 pCi/cc png. The low-range and mid/high-range iodine and particulate samples operate in a similar manner. In normal operation, the low-range samples are on-line. At a concentration of 0.001 pCi/cc png the mid/high-range samplers are brought on-line, and at a concentration of 0.1 pCi/cc png the low-range sample pump is turned off. No automatic isolation or control functions are performed by this monitor. Pertinent information on this monitor is provided in the LaSalle UFSAR Section 11.5.2.2.2. 2.5.3 Reactor Building Ventilation Monitors Monitors 1(2)D1 8-NO09 continuously monitor the effluent from the Unit 1(2) reactor building. On high alarm, the monitors automatically initiate the following actions: A. Shutdown and isolation of the reactor building vent system B. Startup of the standby gas treatment system C. Isolation of primary containment purge and vent lines Pertinent information on these monitors is provided in LaSalle UFSAR Section 11.5.2.1.1. 2.5.4 Condenser Air Ejector Monitors Monitors 1(2)D18-N002/N012 (pre-treatment) and 1(2)D18-N903A/B (post-treatment) continuously monitor gross gamma activity downstream of the steam jet air ejector and prior to release to the main stack. On "high-high-high" alarm monitor 1(2)D18-N903A/B automatically initiates closure of valve 1(2)N62-F057 thus terminating the release. Pertinent information on these monitors is found in LaSalle UFSAR Sections 11.5.2.1.2 and 11.5.2.1.3. 11.2-8 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II,Offsite Dose Calculation Manual 2.5.5 Turbine Building Trackway and North Service building In order to quantify releases via either the (1) Turbine Building Trackway or (2) North Service Building (when the ventilation systems are aligned to support the unit 2 egress) at times of positive pressure in the Turbine Building, airborne sampling shall be continuously collected using an air sampler appropriately located. The air sampler collecting shall begin within 20 hours of the turbine building being at positive pressure, and then continuously for as long as the turbine building remains at positive pressure. The samples collected should be counted on a weekly basis. Air sampling to identify noble gas, iodine and particulate monitoring (either as a grab sampler or continuous sampling) is designed to ensure evaluation of releases emanating from the Turbine Building. The curie content of any contaminated material warehouse is maintained current by site administrative procedures. If a fire were to occur, the actual curie content of the warehouse would be used in determining the ground level release. 2.6 Gaseous Radiation Effluent Alarm and Trip Setpoints 2.6.1 Reactor Building Vent Effluent Monitor The setpoint for the reactor building vent effluent monitor is established at 10 mR/hr. 2.6.2 Condenser Air Ejector Monitors Pre-Treatment Monitor The high trip setpoint is established at 1.5 times the normal full power background rate, including nitrogen-16 (N-16) to help ensure that effluents are maintained ALARA. The high-high trip setpoint is established at < 100 pCi/sec per MW-th 3.4E+05 pCi/sec per Technical Specification 3.7.6. Post-Treatment Monitor The off-gas isolation setpoint is conservatively set at or below one-half the release limit calculated using the more conservative value obtained from equations (2-5) and (2-6) below. The off gas isolation setpoint is converted into the monitor units of counts per second (cps) as follows: P < Qsvs x E x [Rpng / ROG] + FOG (2-4) P Off-gas Post-treatment Monitor Isolation Setpoint. [cps] The off-gas post-treatment monitor setpoint which initiates isolation of flow of offgas to the station vent stack. 11.2-9 LaSalle ODCM Part IISection 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Qsvs Actual Station Vent Stack High Alarm Setpoint [pCi/sec of png] The actual high alarm setpoint of the Station Vent Stack wide range gas monitor in units of pCi/sec of png (pseudo noble gas). This is determined by using Equations (2-5) and (2-6) and then converting the result to units of pCi/sec of png. E Efficiency of the Off-Gas Post Treatment Monitor [cps/(pCi/sec of off gas mix)] Rpng Response of the Station Vent Stack WRGM to Pseudo Noble Gas [cpm per pCi/cc of pseudo noble gas] ROG Response of the Station Vent Stack WRGM to Off Gas [cpm per p0Ci/cc of off gas] FOG Maximum Off-Gas Flow Rate [cc/sec] 2.6.3 Station Vent Stack Effluent Monitor The high alarm setpoint for the station vent stack effluent monitor is conservatively set at or below one-half the calculated release limit calculated using the more conservative value obtained from equations (2-5) and (2-6) below. These equations yield the release limit in units of pCi/sec of the mix specified in Table 2-1. For consistency with the monitor readout, this calculated release limit is converted to units of pCi/sec of pseudo noble gas before being entered into the monitor data base. 2.6.4 Standby Gas Treatment Stack Monitor The high alarm setpoint for the standby gas treatment system effluent monitor is conservatively set at or below one-half the release limit calculated using the more conservative value obtained from equations (2-5) and (2-6) below. These equations yield the release limit in units of pCi/sec of the mix specified in Table 2-1. For consistency with the monitor readout, this calculated release limit is converted to units of pCi/sec of pseudo noble gas before being entered into the monitor data base. 2.6.5 Release Limits Alarm and trip setpoints of gaseous effluent monitors are established to ensure that the release rate limits of RECS are not exceeded. The release limit Qts is found by solving Equations (2-5) and (2-6). (1.11 ) Qt {Fi S} < 500 mremn/yr Q, {Li fi (X I Q), exp(-A2 R / 3600 U ) t + (1.11)(f, )S)} <3000 mrem / yr 11.2-10 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual The summations are over noble gas radionuclides i. Fractional Radionuclide Composition: The release rate of noble gas radionuclide i divided by the total release rate of all noble gas radionuclides. Qts Total Allowed Release Rate, Stack Release [pCi/sec of ODCM mix] The total allowed release rate of all noble gas radionuclides released as stack releases in units of pCi/sec of the mix specified in section 2.6.6. t exp (-X1R/3600 Us) is conservatively set equal to 1.0 for purposes of determining setpoints. The remaining parameters in Equation (2-5) have the same definitions as in Equation 4- 9 of Section 4.2.3.1. The remaining parameters in Equation (2-6) have the same definition as in Equation 4-10 of Section 4.2.3.2. Equation (2-5) is based on Equation 4-9 of Section 4.2.3.1 and the RECS restriction on whole body dose rate (500 mrem/yr) due to noble gases released in gaseous effluents (see Section 4.2.1.1). Equation (2-6) is based on Equation 4-10 of Section 4.2.3.2 and the RECS restriction on skin dose rate (3000 mrem/yr) due to noble gases released in gaseous effluents (see Section 4.2.1.2). The more conservative solution from Equations (2-5) and (2-6) is used as the limiting noble gas release rate. Calibration methods and surveillance frequency for the monitors will be conducted as specified in the RECS. 2.6.6 Release Mixture In the determination of alarm and trip set points, the radioactivity mixture in the exhaust air is assumed to have the radionuclide composition in Table 2-1, taken from Table 3-3 of GE NEDO-1 0871, March 1973. 2.6.7 Conversion Factors The conversion factors used to establish gaseous effluent monitor setpoints are obtained as follows. Station vent stack effluent monitor. 11.2-11 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Calibrations compare the response of station detectors to that of a reference detector using NIST traceable sources. Conversion factors for the station detectors are obtained from the response to noble gas or solid sources. Condenser air ejector monitor. Pretreatment Monitor The value is determined using noble gas radionuclides identified in a representative sample, and the offgas release rate and monitor response at the time the sample is taken. Post-treatment Monitor The value is determined using noble gas radionuclides identified in a representative sample, and the offgas concentration and monitor response at the time the sample is taken. Standby gas treatment system monitor. Calibrations compare the response of station detectors to that of a reference detector using NIST traceable sources. Conversion factors for the station detectors are obtained from the response to noble gas or solid sources. 2.6.8 HVAC Flow Rates The main stack flow rate is obtained from either the process computer or Monitor RM- 23. The SGTS flow rate is obtained from either the process computer or chart recorders in the main control room. 2.6.9 Allocation of Effluents from Common Release Points Radioactive gaseous effluents released from the main chimney are comprised of contributions from both units. Under normal operating conditions, it is difficult to allocate the radioactivity between units due to fuel performance, in-plant leakage, power history, and other variables. Consequently, no allocation is normally made between the units. Instead, the entire release is treated as a single source. 2.6.10 Dose Projections Because the gaseous releases are continuous, the doses are routinely calculated in accordance with the RECS. 11.2-12 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 2-1 Assumed Composition of the LaSalle Station Noble Gas Effluent (From GE NEDO - 10871 Table 3.3) Nuclide T1/2 uCi/s @ T=0 Contribution  % Contribution Kr83m 1.86h 3.40E+03 4.50E-03 0.45% Kr85m 4.4h 6.1OE+03 8.08E-03 0.81% Kr85 10.74h 2.OOE+01 2.65E-05 0.00% Kr87 76m 2.OOE+04 2.65E-02 2.65% Kr88 2.79h 2.OOE+04 2.65E-02 2.65% Kr89 3.18m 1.30E+05 1.72E-01 17.22% Kr9O 32.3s 2.80E+05 3.71 E-01 37.08% Xel31 m 11.96d 1.50E+01 1.99E-05 0.00% Xel33m 2.26d 2.90E+02 3.84E-04 0.04% Xe133 5.27d 8.20E+03 1.09E-02 1.09% Xe135m 15.7m 2.60E+04 3.44E-02 3.44% Xe135 9.16h 2.20E+04 2.91E-02 2.91% Xe137 3.82m 1.50E+05 1.99E-01 19.87% Xel 38 14.2m 8.90E+'04 1.18E-01 11.79% Total 7.55E+05 1 1.OOE+00J 100.00%] 11.2-13 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II.Offsite Dose Calculation Manual rl~' Iommm I.O J

                                                        =y-VA"        OLOIWL "IrWAIl
                                                       *7*IgwlllLII.

p r Dm

                                                         . IImv
                                                'OPLD4J 0PLD5J                                    A 0PLD1J DOD-".-

J*PLD2J I smw I L w! *:-J OFFSITE DOSE CALCULATION MANUJA

                      ----      -LASALLE                                                 COUNTY STATION FIGURE 2-1 I

SIMPLFIED GASEOUS RADWASTE AND GASEOUS EFFLUENT FLOW DIAGRAM (SHEET I OF 2) 11.2-14 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual mmurm

                  --       L-------------------

UNIT- a m - V-iFAN IA U 3Am a*IsllMII CmmIw

                           --   -i-i - - --     -O - -  -                                                                      -
                       -                                                        I45,000                                    CFM "Q-          b                                        II.II         mJI             I     &

ga* l~~a.wii j* GOA=ma fl.*.~. aw I 58,600oCFM

                                                                                                                     ,80 F I
             *-.T..

OCAIOAMliii C FLO PON 20,000 CFM 2 Tu"- BEim 9E---*- m . - I,-~ýA ~AU lWRIU 42 NOTES I 45,000 CFM I "A"ULOWR&A. CAM AM= BMW 7,800sINM 13 820 CFM fUhlLYum W1dR. loo mmjmsyAir.. nsuT, I U _ MMANly MG- - 10 CFM18I I5,870 1anCFM t -" O E DOSE CALCULATION MANUAL LASLLE COUNTY STATION. FIGURE 2-1 SIMPLWED GASEOUS RADWASTE AND GASEOUS EFFLUENT FLOW DIAGRAM (SHEET 2 OF 2) 11.2-15 LaSalle ODCM Part II Section 2

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual OPFSiTE DOSE MCUiLA-FION MANUAL PR-amF."IPAmI LASALLECOUNTY STATION

                             --- -.-.--- -- - -- ------- U.LRNAlI1FL0WP.A1H SKPIJ LIOJ RAINw45TE PRQCRA-n%0 D4,GRRJ 11.2-16 LaSalle ODCM Part IISection 2

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual It OFFSITE DOSE CALCULATION MANUAL LASALLE COUNTY STATION. I DmoNomm UWX= PMT=A WOT I FIGURE 2-3 SIMPUFiED LIQUID EFFLUENT FLOW DIAGRAM 11.2-17 LaSalle ODCM Part II Section 2

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual COWzEWrArA & RDvREEQwowo REMZ-ToR w4TaR C-FA-4.ud- Fj-u~ T4Mi .Bx.evo~wm B-s aFILTER DEMNERXA-UiAER I~~.T (URC Swum WASTE MIXED BED DEVAX-F, OFFSiTE DOSE CALCULATION MANUAL LEGEND AND NOTES LASALLE COUNTY STATION 4V% R-EK-E HOSE FIGURE 2-4 LIRC ý ULTR~siu4. Rasm CLF-4E-SIMPLIFIED SOLID RADWASTE PROCESSING DIAGRAMl

                          .nq;at4PLAZE 11.2-18 LaSalle ODCM Part II Section 2

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 3.0 LIQUID EFFLUENTS 3.1 Liquid Effluent Releases - General Information 3.1.1 The design objectives of 10CFR50, Appendix I and RECS provide the following limits on the dose to a member of the public from radioactive materials in liquid effluents released from each reactor unit to restricted area boundaries:

• During any calendar quarter, less than or equal to 1.5 mrem to the total body and less than or equal to 5 mrem to any organ.
• During any calendar year, less than or equal to 3 mrem to the total body and less than or equal to 10 mrem to any organ.

3.1.2 The organ doses due to radioactivity in liquid effluents are also used as part of the 40CFR1 90 compliance and are included in the combination of doses to determine the total dose used to demonstrate 10CFR20 compliance. (See Section 5.0, Total Dose) 3.1.3 Dose assessments for 10CFR20 and 40CFR190 compliance are made for an adult using Federal Guidance Report No. 11 (Reference 93) dose conversion factors. Dose assessments for 10CFR50 Appendix I compliance are made for four age groups (adult/teenager/child/infant) using Regulatory Guide 1.109 (Reference 6) dose conversion factors. 3.1.4 To limit the consequences of tank overflow, the RECS/Technical Specifications may limit the quantity of radioactivity that may be stored in unprotected outdoor tanks. Unprotected tanks are tanks that are not surrounded by liners, dikes, or walls capable of holding the tank contents and that do not have tank overflows and surrounding area drains connected to the liquid radwaste treatment system. The specific objective is to provide assurance that in the event of an uncontrolled release of a tank's contents, the resulting radioactivity concentrations beyond the unrestricted area boundary, at the nearest potable water supply and at the nearest surface water supply, will be less than the limits of 10CFR20 Appendix B, Table 2; Column 2. The Technical Specifications and RECS may contain a somewhat similar provision. For most nuclear power stations, specific numerical limits are specified on the number of curies allowed in affected tanks. Page 11.3-1 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 3.1.5 Cases in which normally non-radioactive liquid streams (such as the Service Water) are found to contain radioactive material are non-routine will be treated on a case specific basis if and when this occurs. Since the station has sufficient capacity to delay a liquid release for reasonable periods of time, it is expected that planned releases will not take place under these circumstances. Therefore, the liquid release setpoint calculations need not and do not contain provisions for treating multiple simultaneous release pathways. 3.2 Liquid Effluent Concentrations 3.2.1 One method of demonstrating compliance to the requirements of 10CFR20.1301 is to demonstrate that the annual average concentrations of radioactive material released in gaseous and liquid effluents do not exceed the values specified in 10CFR20 Appendix B, Table 2, Column 2. (See 10CFR 20.1302(b)(2).) However, as noted in Section 5.5, this mode of 10CFR20.1301 compliance has not been elected. As a means of assuring that annual concentration limits will not be exceeded, and as a matter of policy assuring that doses by the liquid pathway will be ALARA; RECS provides the following restriction:

                              "The concentration of radioactive material released in liquid effluents to unrestricted areas shall be limited to ten times the concentration values in Appendix B, Table 2, Column 2 to 10CFR20.1001-20.2402."

This also meets the requirement of Station Technical Specifications and RECS. 3.2.2 According to the footnotes to 10CFR20 Appendix B, Table 2, Column 2, if a radionuclide mix of known composition is released, the concentrations must be such that

                                        ~   CL1 1*                                    (3-1) where the summation is over radionuclide i.

C! Radioactivity Concentration in Liquid Effluents to the Unrestricted Area [pCi/ml] Page 11.3-2 LaSalle ODCM Part IISection 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Concentration of radionuclide i in liquid released to the unrestricted area. ECL1 Effluent Concentration Limit in Liquid Effluents Released to the Unrestricted Area [p.Ci/ml] The allowable annual average concentration of radionuclide i in liquid effluents released to the unrestricted area. This concentration is specified in 10CFR20 Appendix B, Table 2, Column 2. Concentrations for noble gases are different and are specified in the stations' Technical Specifications/RECS. 10 Multiplier to meet the requirements of Technical Specifications. If either the identity or concentration of any radionuclide in the mixture is not known, special rules apply. These are given in the footnotes in 10CFR20 Appendix B, Table 2, Column 2. 3.2.3 When radioactivity is released to the unrestricted area with liquid discharge from a tank (e.g., a radwaste discharge tank), the concentration of a radionuclide in the effluent is calculated as follows: C= (Ci) (Fr )/(F' + Fr) (3-2) C Concentration in Liquid effluent to the unrestricted area. [PCi/ml] Concentration of radionuclide 'i' in liquid released to the unrestricted area. Cit Concentration in the Discharge Tank [laCi/ml] Measured concentration of radionuclide i in the discharge tank. Fr Flow Rate, Tank Discharge [cfs] Measured flow rate of liquid from the discharge tank to the initial dilution stream. Fd Flow Rate, Initial Dilution Stream [cfs] Page 11.3-3 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Measured flow rate of the initial dilution stream that carries the radionuclides to the unrestricted area boundary (e.g. circulating cooling water or blowdown from a cooling tower or lake). The RECS and Technical Specifications require a specified sampling and analysis program to assure that liquid radioactivity concentrations at the point of release are maintained within the required limits. To comply with this provision, samples are analyzed in accordance with the radioactive liquid waste (or effluent) sampling and analysis program in Section 12.3 of Part I, RECS. Radioactivity concentrations in tank effluents are determined in accordance with Equation 3-2. Comparison with the Effluent Concentration Limit is made using Equation 3-1. 3.3 Liquid Effluent Dose Calculation Requirements 3.3.1 RECS require determination of cumulative and projected dose contributions from liquid effluents for the current calendar quarter and the current calendar year at least once per 31 days. For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system. 3.3.2 Operability and Use of the Liquid Radwaste Treatment System The design objectives of 10CFR50, Appendix I and RECS/Technical Specifications require that the liquid radwaste treatment system be operable and that appropriate portions be used to reduce releases of radioactivity when projected doses due to the liquid effluent from each reactor unit to restricted area boundaries exceed either of the following (see Section 12.3.3 of Part I, RECS);

• 0.06 mrem to the total body in a 31-day period.
• 0.2 mrem to any organ in a 31-day period.

Page 11.3-4 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 3.4 Dose Methodology 3.4.1 Liquid Effluent Dose Method: General The dose from radioactive materials in liquid effluents considers the contributions for consumption of fish and potable water. All of these pathways are considered in the dose assessment unless demonstrated not to be present. While the adult is normally considered the maximum individual, the methodology provides for dose to be calculated for all four age groups. Software currently used at the LaSalle Station calculates doses from liquid releases based upon Regulatory Guide 1.109 methodology. LaSalle will be switching to effluent software that calculates doses via the liquid pathway based upon the methodology presented in NUREG-0133. The NUREG-0133 methodology is based upon that presented in Reg. Guide 1.109, but has been simplified. For each liquid pathway considered both the Reg. Guide 1.109 and NUREG-0133 methodologies are presented. The dose to each organ (and to the total body) is calculated by the following expressions: 3.4.1.1 Reg. Guide 1.109 Methodology DjaLiq water ja + D fslj. (3-3) Where: Dw"atrja = (I.IE - 3)(8760)(U',a MW/F') x J,{Ai DFIija exp(-Xi t"' )} And: D'shja. = (I.lE-3)(8760)(U'ra Mr/Fr) x Z{Ai DF~ija Biexp(-Xi t' )} These summations are over I radionuclides. D ja Total organ, and total body, dose commitment [mrem] (CDE) Due to Radioactivity in Liquid Effluents. Dose commitment to organ j (and total body) of age group a consuming water and fish containing radioactivity released in liquid effluents. Djae, Committed Dose Equivalent (CDE) Due [mrem] to Consumption of Drinking Water Dose commitment to organ j of age group a consuming water containing radioactivity released in liquid effluents. Page 11.3-5 LaSalle ODCM Part II Section 3

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual D.ja Committed Dose Equivalent (CDE) Due to [mrem] Consumption of Fish Dose commitment to organ j of age group a consuming fish containing radioactivity released in liquid effluents. Usage Factor [L/hr, kg/hr] Consumption rate of water (UWa) or fish (Ufa). See Table C-2 of Appendix C. 1/MW ,1/M Dilution Factor Measure of dilution prior to withdrawal of potable water or fish. FW Average Flow Rate [cfs] Average flow rate of receiving body of water at point where Potable water is taken. Near-Field Flow Rate [cfs] Near field flow rate of receiving body of water (in region where fish are taken). Ai Radionuclide Release [jiCi] Measured amount of radionuclide 'i' released in liquid effluents during the time period under consideration. DFI ija Ingestion Dose Factor [mrem/pCi] Dose commitment to organ j (and total body) of an individual in age group 'a' per unit of activity of radionuclide T ingested. Assessment Dose Factor Age Group 10CFR50 App. I Reg. Guide 1.109 All (four) Tables E=1 1 through E-14. 10CFR20/40CFR1 90 Federal Guidance Adult Report-1 1; Table 2.2 (average) Page 11.3-6 LaSalle ODCM Part II Section 3

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Aj Decay Constant [hr-1] Radiological decay constant of radionuclide T. tw,tf Elapsed time Average elapsed time between release and consumption of potable water or fish. Bi Bioaccumulation Factor [L/kg] Equilibrium ratio of the concentration of radionuclide "i" in fish (pCi/kg) to its concentration in water (pCi/L). 1.1 E-3 Conversion Constant [(pCi/liter) per (pCi/yr)/(cfs)] Factor to convert to pCi/liter from (pCi/yr)/(cfs). 8760 Conversion Constant (hours per year) [hr/yr] 3.4.1.2 NUREG - 0133 Methodology 2ZA At C1 ,Ff] Dr= 1 Div where:

                        =   The cumulative dose commitment to the total body or any organ, -, from liquid effluents for the total time period mAt   ,(mrem).

f=l At, The length of the c th time period over which C,, and F, are averaged for the liquid release, (hours). Cie = The average concentration of radionuclide, i, in undiluted liquid effluent during time period At,, from any liquid release, (uCi/ml). Page 11.3-7 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II,Offsite Dose Calculation Manual F, = The near field average dilution factor for C,, during any liquid effluent release. Defined as the ratio of the maximum undiluted liquid waste flow during the release to the average flow through the discharge pathway Ft - (tank volume(gallons)) (tank volume(gallons)) + (Blowdown Dilution (gallons)) D, = The dilution factor at point of exposure or at point of withdrawal of drinking water (dimensionless). Al 7' = The site specific ingestion dose commitment factor to the total body or organ, z-, for each radionuclide and pathway 3.4.2 Potable Water Pathway 3.4.2.1 Reg. Guide 1.109 Methodology D wat erja = (1.1E - 3)(8760)(U ', MW"/F') x Yf{A, DFIija exp(-X, tw )} Terms defined under Equation 3-3 3.4.2.2 NUREG - 0133 Methodology Ai= ko

• UbV* D,* *e(-I'll) k0 = 114155, units conversion factor (1.0 E6 pCi/uCi
• 1000 mil/L/

8760 hr/yr). Note for fish units are g/kg. U = usage factor per pathway. Daipj = dose conversion factor for nuclide, i, for total body or any organ, *T, (mrem/pCi). Xi = radioactive decay constant of nuclide 'i' (hr-1). V = delay time for water pathway in hours to allow for nuclide decay during transport through the water purification plant and the water distribution system. Page 11.3-8 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 3.4.3 Fish Ingestion Pathway 3.4.3.1 Reg. Guide 1.109 Methodology DfiShja = (1. IE - 3)(8760)(Ufa Mr/Fr) x {Ai DFIik, Bi exp(-Xi t) Terms defined under Equation 3-3 3.4.3.2 NUREG -0133 Methodology Freshwater Fish A, = k0 *U *BF *D.,,j *e(-'11) k0 = 114155, units conversion factor (1.0 E6 pCi/uCi

• 1000 mil/L/

8760 hr/yr). Note for fish units are g/kg. U = usage factor per pathway. Daipj = dose conversion factor for nuclide, i, for total body or any organ, T, (mrem/pCi). BFi = bioaccumulation factor for nuclide, i, in fresh water fish (pCi/kg per pCi/L). xi = radioactive decay constant of nuclide T (hr-1). tpF = delay time for fish pathway to allow for nuclide decay during transport through the food chain, as well as during food preparation. 3.4.3 Offsite Doses Offsite doses due to projected releases of radioactive materials in liquid effluents are calculated using Equation 3-3. Projected radionuclide release concentrations are used in place of measured concentrations, CQ. 3.4.4 Drinking Water LaSalle Station has requirements for calculation of drinking water dose that are related to 40CFR141, the Environmental Protection Agency National Primary Drinking Water Regulations. These are discussed in Section 1.2.1. Page 11.3-9 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual 3.5 Bioaccumulation Factors 3.5.1 There are no public potable water intakes on the Illinois River for 97 miles downstream of the station at Peoria, IL. 3.5.2 There is no irrigation occurring on the Illinois River downstream of the station. 3.5.3 Recreation includes one or more of the following: boating, water-skiing, swimming, and sport fishing. Page 11.3-10 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 3-1 Bioaccumulation Factors (BF1 ) to be Used in the Absence of Site-Specific Data Element BFi for Freshwater Fish Reference (pCi/kg per pCi/L) H 9.OE-01 6 Be 2.8E+01 Footnote 2 C 4.6E+03 6 F 2.2E+02 Footnote 16 Na 1.OE+02 6 Mg 2.8E+01 Footnote 2 Al 2.2E+03 Footnote 13 P 1.OE+05 6 CI 2.2E+02 Footnote 16 Ar NA NA K 1.OE+03 Footnote 1 Ca 2.8E+01 Footnote 2 Sc 2.5E+01 Footnote 3 Ti 3.3E+00 Footnote 4 V 3.OE+04 Footnote 5 Cr 2.OE+02 6 Mn 4.OE+02 6 Fe 1.OE+02 6 Co 5.OE+01 6 Ni 1.OE+02 6 Cu 5.OE+01 6 Zn 2.OE+03 6 Ga 2.2E+03 Footnote 13 Ge 2.4E+03 Footnote 12 As 3.3E+04 Footnote 14 Se 4.OE+02 Footnote 15 Br 4.2E+02 6 Kr NA NA Rb 2.OE+03 6 Sr 3.OE+01 6 Y 2.5E+01 6 Zr 3.3E+00 6 Nb 3.OE+04 6 Mo 1.OE+01 6 Tc 1.5E+01 6 Ru 1.OE+01 6 Rh 1.OE+01 6 Pd 1.OE+02 Footnote 9 Page 11.3-11 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 3-1 (cont.) Bioaccumulation Factors (BF1 ) to be Used in the Absence of Site-Specific Data Cd 2.OE+03 Footnote 11 In 2.2E+03 Footnote 13 Sn 2.4E+03 Footnote 12 Sb 1.OE+00 98 Ag 2.3E+00 56 Te 4.OE+02 6 I 1.5E+01 6 Xe NA NA Cs 2.OE+03 6 Ba 4.OE+00 6 La 2.5E+01 6 Ce 1.OE+00 6 Pr 2.5E+01 6 Nd 2.5E+01 6 Pm 3.OE+01 98 Sm 3.OE+01 Footnote 3 Eu 1.OE+02 Footnote 3 Gd 2.6E+01 Footnote 3 Dy 2.2E+03 Footnote 3 Er 3.3E+04 Footnote 3 Tm 4.OE+02 Footnote 3 Yb 2.2E+02 Footnote 3 Lu 2.5E+01 Footnote 3 Hf 3.3E+00 Footnote 4 Ta 3.OE+04 Footnote 5 W 1.2E+03 6 Re 2.1 E+02 Footnote 6 Os 5.5E+01 Footnote 7 Ir 3.OE+01 Footnote 8 Pt 1.OE+02 Footnote 9 Au 2.6E+01 Footnote 10 Hg 2.OE+03 Footnote 11 TI 2.2E+03 Footnote 13 Pb 3.OE+02 98 Bi 2.OE+01 98 Ra 5.OE+01 98 Th 3.OE+01 98 U 1.OE+01 98 Np 1.OE+01 6 Am 3.OE+01 98 Page 11.3-12 LaSalle ODCM Part II Section 3

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Footnotes: NA = It is assumed that noble gases are not accumulated. In Reference 6, see Table A-I. A number of bioaccumulation factors could not be found in literature. In this case, the periodic table was used in conjunction with published element values. This method was used for periodic table columns except where there were no values for column 3A so the average of columns 2B and 4A was assigned.

1. Value is the average of Reference 6 values in literature for H, Na, Rb and Cs.

2. Value is the average of Ref. 6 values in literature for Sr, Ba and Ref. 98 values for Ra.

3. Value is the same as the Reference 6 value used for Y.

4. Value is the same as the Reference 6 value used for Zr.

5. Value is the same as the Reference 6 value used for Nb.

6. Value is the average of Reference 6 values in literature for Mn and Tc.

7. Value is the average of Reference 6 values in literature for Fe and Ru.

8. Value is the average of Reference 6 values in literature for Co and Rh.

9. Value is the same as the Reference 6 value used for Ni.

10. Value is the average of Reference 6 values in literature for Cu and Reference 56 value for Ag.

11. Value used is the same as the Reference 6 value used for Zn.

12. Value is the average of Reference 6 value in literature for C and Reference 98 value for Pb.

13. Value is the average of columns 2B and 4A, where column 2B is the "Reference 6 value for Zn" and column 4A is the average of "Reference 6 value for C and Reference 98 value for Pb".

14. Value is the average of Ref. 6 value found in literature for P and the Ref. 98 values for Bi and Sb.

15. Value is the same as the Reference 6 value used for Te.

16. Value is the average of Reference 6 values found in literature for Br and I.

Page 11.3-13 LaSalle ODCM Part II Section 3

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 4.0 Gaseous Effluents 4.1 Gaseous Effluents - General Information This section reviews the offsite radiological limits applicable to the LaSalle Station and presents in detail the equations and procedures used to assess compliance with these limits. This calculational approach uses the methodology of NUREG-0133 (Reference 14), and incorporates certain simplifications such as the use of average meteorology. Software currently used at LaSalle Generating Station calculates doses and dose rates from gaseous effluents based upon NUREG-0133 methodology with some simplifications and/or alternately expressed equations. LaSalle will be switching to effluent software that that will continue to calculate doses and dose rates based on NUREG-0133 methodology. The new software utilizes and expresses equations in a manor that more resembles the equations as they are described in NUREG-0133. As such, the current equations/methodology and the more traditional equations/methodology are both presented. 4.1.1 Pre-calculated atmospheric transport parameters are based on historical average atmospheric conditions. These historical meteorological conditions have resulted in the dispersion parameters shown in Table 4-2 through Table 4-5, and Table 4-9 through Table 4-11. 4.1.2 The equations and parameters of this section are for use in calculating offsite radiation doses during routine operating conditions. They are not for use in calculating doses due to non-routine releases (e.g., accident releases). 4.1.3 An overview of the required compliance is given in Table 1-1. The dose components are itemized and referenced, and an indication of their regulatory application is noted. Additionally, the locations of dose receivers for each dose component are given in Table 1-2. 4.1.4 Airborne Release Point Classifications The pattern of dispersion of airborne releases is dependent on the height of the release point relative to adjacent structures. Each release point is classified as one of the following three height-dependent types:

• Stack (or Elevated) Release Point (denoted by the letter S or subscript s)
• Ground Level Release Point (denoted by the letter G or subscript g)
• Vent (or Mixed Mode) Release Point (denoted by the letter V or subscript v) 11.4-1 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 4.1.5 Operability and Use of Gaseous Effluent Treatment Systems 10CFR50 Appendix I and ODCM Part I (RECS) require that the ventilation exhaust treatment system and the waste gas holdup system be used when projected offsite doses in 31 days, due to gaseous effluent releases, from each reactor unit, exceed any of the following limits:

• 0.2 mrad to air from gamma radiation.
• 0.4 mrad to air from beta radiation.

0 0.3 mrem to any organ of a member of the public. The station must project doses due to gaseous releases from the site at least once per 31 days. The calculational methods shown in sections 4.2.2.1 and 4.2.2.2 are used for this dose projection. 4.1.6 For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system. 4.2 Gaseous Effluents - Dose and Dose Rate Calculation Requirements 4.2.1 Instantaneous Dose Rates 4.2.1.1 Noble Gas: Total Body Dose Rate RECS limits the total body dose rate due to noble gases in gaseous effluents released from a site to areas at and beyond the site boundary to less than or equal to 500 mrem/yr at all times. The total body dose rate due to noble gases released in gaseous effluents is calculated by the following expression: DTb =(l.l ) + ViQi,

                                            ,{SiQi       + GiQjg}                            (4-1)

The summation is over noble gas radionucides 'i'. DTb Whole Body Dose Rate [mrem/yr] Dose rate to the whole body due to gamma radiation from noble gas radionuclides released in gaseous effluents. Qis, Qiv, Qig Release Rate [pCi/sec] Measured release rate of radionuclide 'i' from a stack, vent, or ground level release point. 11.4-2 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 1.11 Conversion Constant (rads in air to rem in tissue) [mrem/mrad] Si , Vi , G Gamma Whole Body Dose Factor [(mrad/yr)/ (GpCi/sec)] Gamma whole body dose rate at a specified location per unit of radioactivity release rate for radionuclide T released from a stack, vent or ground level release point. The attenuation of gamma 3 radiation due to passage through 1 cm of body tissue of 1 g/cm density is taken into account in calculating this quantity. In accordance with NUREG-0133 methodology, equation 4-1 can be alternatively calculated: 6 TB = 7 ![Vi*Q is + Ki*((X/Q)v*6 iv)] where: D TB is the instantaneous dose rate to the total body due to radioactive materials (noble gasses) released in gaseous effluents from the site (mrem/yr) Vi is the constant for each identified noble gas radionuclide accounting for the gamma radiation from the elevated finite plume (mrem*sec/yr*pCi) 6 is is the release rate of radionuclides, i, in gaseous effluents from a free standing (elevated) stack (pCi/sec) Ki is the total body dose factor due to gamma emissions for each identified noble gas radionuclide (mrem*m3/yr*pCi). Reference table 4-13. (x/Q)v is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for vent releases (sec/m3). 5 1v is the release rate of radionuclides, i, in gaseous effluents from all vent releases (pCi/sec) To comply with this specification, the effluent radiation monitor has a setpoint corresponding to an offsite total body dose rate at or below the limit (see Part II Section 2.6). In addition, compliance is assessed by calculating offsite total body dose rate based on periodic samples obtained per station procedures. 4.2.1.2 Noble Gas: Skin Dose Rate RECS limits the skin dose rate due to noble gases in gaseous effluents released from a site to areas at and beyond the site boundary to less than or equal to a dose rate of 3000 mrem/yr at all times. (See Part I Section 12.4.1) 11.4-3 LASALLE ODCM PART IISECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual The skin dose rate due to noble gases released in gaseous effluents is calculated by the following expression: Ds = Z{ Li[(X/Q)sQ'1s + (X/Q), Q'iv + (X/Q)gQ'ig]

                          + (1.11)[SiQ1s + V1Q1v + GiQig]}                                      (4-2)

The summation is over noble gas radionuclides i. Ds Skin Dose Rate [mrem/yr] Dose rate to skin due to beta and gamma radiation from noble gas radionuclides released in gaseous effluents. Q'is Release Rate, Adjusted for Radiodecay [pCi/sec] Q'iv Q'ig Measured release rate of radionuclide 'i' from a stack, vent, or ground level release point, reduced to account for radiodecay in transit from the release point to the dose point. a'is = Qis exp(-%1R/3600us) Q'iv = Q1, exp(-,iR/3600u,) Q'ig = Qig exp(-XIR/3600ug) Qis, Qiv, Qig Release Rate [g.Ci/sec] Measured release rate of radionuclide 'i' from a stack, vent, or ground level release point. Si, Vi, G1 Gamma Air Dose Factor [(mrad/yr)/(piCi/sec)] Gamma air dose rate at a specified location per unit of radioactivity release rate for radionuclide T released from a stack, vent, or ground level release point, respectively. (X/Q)s Relative Concentration Factor [sec/m 3 ] (X/Q)v (X/Q)g Radioactivity concentration at a specified location per unit of radioactivity release rate for a stack, vent, or ground level release. k Radiological Decay Constant [hr'] Radiological decay constant for radionuclide T. R Downwind Range [m] Distance from the release point to the dose point. 11.4-4 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 3600 Conversion Constant [sec/hr] Converts hours to seconds. us Average Wind Speed [m/sec] uv Ug Average wind speed for a stack, vent, or ground level release. 1.11 Conversion Constant (rads in air to rem in tissue) [mrem/mrad] Li Beta Skin Dose Factor [(mrem/yr)/ j.Ci/m 3 )] Beta skin dose rate per unit of radioactivity concentration for radionuclide T. Attenuation of beta radiation passing through 7 mg/cm 2 of dead skin is accounted for. In accordance with NUREG-0133 methodology, equation 4-2 can be alternatively calculated: D Skin = Y2i[(Li*(X/Q)s + 1 *Bi)* (5 is + (L1 + 1 .1*Mi)*(( X/Q)v*Q j,)] where: D Skin is the instantaneous dose rate to the skin due to radioactive materials (noble gasses) released in gaseous effluents from the site (mrem/yr) Li is the skin dose factor due to beta emissions for each identified noble gas radionuclide (mrem*m 3/yr*pCi). Reference table 4-13. (x/Q)s is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for elevated stack releases (sec/m3). 1.1 is the unit conversion constant to convert air dose to skin dose (mrem/mrad). ai is the constant for long term releases (greater than 500 hr/yr) for each identified noble gas radionuclide accounting for the gamma radiation from the elevated finite plume (mrad*sec/yr*pCi). is is the release rate of radionuclides, i, in gaseous effluents from a free standing (elevated) stack (pCi/sec). Mi is the air dose factor due to gamma emissions for each identified noble gas radionuclide (mrad*m 3/yr*pCi). Reference table 4-13. 11.4-5 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual (X/Q)v is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for vent releases (sec/m3). Qý 1v is the release rate of radionuclides, i, in gaseous effluents from all vent releases (pCi/sec). To comply with this specification, gaseous effluent radiation monitors have setpoints corresponding to an offsite skin dose rate at or below the limit (see Part II Section 2.6). In addition, compliance is assessed by calculating offsite skin dose rate based on periodic samples obtained per station procedures. 4.2.1.3 Non-Noble Gas Radionuclides: Organ Dose Rate RECS limits the dose rate to any organ, due to radioactive materials in gaseous effluents released from a site to areas at and beyond the site boundary, to less than or equal to a dose rate of 1500 mrem/yr (See Part I Section 12.4.1) Typically the adult is considered to be the limiting receptor in calculating dose rate to organs due to inhalation of non-noble gas radionuclides in gaseous effluents. The dose rate to any adult organ due to inhalation is calculated by the following expression: Dinhalj. = (1 E6)(Ra)TX{DFAija[(X/Q)sQ'is + (X/Q)vQ'1v + (X/Q)gQ'ig]} (4-3) The summation is over non-noble gas radionuclides 'i'. Dinhalja Inhalation Dose Rate [mrem/yr] Rate of dose commitment to organ j of an individual in age group a due to inhalation of non-noble gas radionuclides released in gaseous effluents; j and a are chosen to correspond to an adult thyroid. Q'is Radionuclide Release Rate, Adjusted for Radiodecay [p*Ci/sec] Q'iv Q'ig Measured release rate of radionuclide 'i' from a stack, vent, or ground level release point, reduced to account for radiodecay in transit from the release point to the dose point. 1E6 Conversion Constant (pCi to pCi) [pCi/(ltCi] Ra Individual Air Inhalation Rate [m3/yr] DFAija Inhalation Dose Commitment Factor [mrem/pCi] 11.4-6 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Dose commitment to organ 'j' of an individual in age group 'a' per unit of activity of radionuclide 'i inhaled. (X/Q)s Relative Effluent Concentration [sec/m 3] (X/Q)v (X/Q)g Radioactivity concentration at a specified location per unit of radioactivity release rate. In accordance with NUREG-0133 methodology, equation 4-3 can be alternatively calculated: D inhalja = zIPpI*[(x/Q)s*Q is + (X/Q)v*Q iv] inhaljais the instantaneous dose rate to organ (j) of an individual in ager group (a) due to inhalation of non noble gas radioactive materials released in gaseous effluents from the site (mrem/yr) P'1 is the inhalation dose rate factor for each identified non noble gas radionuclide, i, (mrem*m3 /yr*pCi). Pi inhalation dose rate factors are calculated in accordance with the following: P'i = K'(BR)DFAi where: P', is the inhalation dose rate factor (mrem*m3 /yr*pCi). K' is a constant of unit conversion = 1 E+06 (pCi/pCi). BR is the breathing rate of the age group of interest (m3/yr). DFA, is the inhalation dose factor (mrem/pCi) (x/Q)s is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for elevated stack releases (sec/m3 ). 1is is the release rate of radionuclides, i, in gaseous effluents from a free standing (elevated) stack (pCi/sec). (x/Q)v is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for vent releases (sec/m3). Q IV is the release rate of radionuclides, i, in gaseous effluents from all vent releases (pCi/sec). 11.4-7 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II,Offsite Dose Calculation Manual RECS requires the dose rate due to non-noble gas radioactive materials in airborne effluents be determined to be within the above limit in accordance with a sampling and analysis program specified in Part I Table R12.4.1-1. The adult organ dose rate due to inhalation is calculated in each sector at the location of the highest offsite X/Q (see Table 4-3). The result for the sector with the highest organ inhalation dose rate is compared to the limit. 4.2.2 Time Averaged Dose from Noble Gas 4.2.2.1 Gamma Air Dose RECS limits the gamma air dose due to noble gas effluents released from each reactor unit to areas at and beyond the unrestricted area boundary to the following:

• Less than or equal to 5 mrad per calendar quarter.

               " Less than or equal to 10 mrad per calendar year.

The gamma air dose due to noble gases released in gaseous effluents is calculated by the following expression: Dt = (3.17E - 8)y-{SjA,, + ViAi, + GjAig} (4-4) The summation is over noble gas radionuclides i. Dy Gamma Air Dose [mrad] Dose to air due to gamma radiation from noble gas radionuclides Released in gaseous effluents. 3.17E-8 Conversion Constant (seconds to years) [yr/sec] Si, Vi, G1 Gamma Air Dose Factor [(mrad/yr)/(gCi/sec)] Gamma air dose rate at a specified location per unit of Radioactivity release rate for radionuclide T released from a stack, vent, or ground level release point, respectively. See Section 4.2.1, Section B.5 of Appendix B, and Table F-7 of Appendix F. A1s, A1v, Aig Cumulative Radionuclide Release [IICi] Measured cumulative release of radionuclide T' over the time period of interest from a stack, vent, or ground level release point. 11.4-8 LASALLE ODCM PART IISECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual In accordance with NUREG-0133 methodology, equation 4-4 can be alternatively be calculated: DY= 3.17E-08*7,{Mi[(X/Q)v* Qiv+(X/q)v* qiv]+[Bi* Qis+bi* -qis]) where: DY is the dose to air due to gamma radiation from noble gas radiation released in gaseous effluents (mrad) 3.17E-08 is a conversion constant (yr/sec). Mi is the air dose factor due to gamma emissions for each identified noble gas radionuclide (mrad*m3/yr*pCi). Reference table 4-13. (x/Q)v is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for long term (greater than 500 hr/yr) vent releases (sec/m3). Qiv is the average release of noble gas radionuclides in gaseous effluents, i, for long term (greater than 500 hr/yr) vent releases (pCi). (x/q), is the relative concentration for areas at or beyond the unrestricted area boundary for short term (equal to or less than 500 hr/yr) vent releases (sec/m3). q~v is the average release of noble gas radionuclides, i, in gaseous releases, i, for short term (equal to or less than 500 hr/yr) vent releases (pCi). B1 is the constant for long term releases (greater than 500 hr/yr) for each identified noble gas radionuclide accounting for the gamma radiation from the elevated finite plume (mrad*sec/yr*pCi). Qis is the average release of noble gas radionuclides in gaseous effluents, i, for long term (greater than 500 hr/yr) releases from a free standing (elevated) stack (pCi). bi is the constant for short term releases (equal to or less than 500 hr/yr) for each identified noble gas radionuclide accounting for the gamma radiation from the elevated finite plume (mrad*sec/yr*pCi). qjs is the average release of noble gas radionuclides in gaseous effluents, i, for short term (equal to or less than 500 hr/yr) releases from a free standing (elevated) stack (pCi). 11.4-9 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual RECS Section 12.4.2, RSR 12.4.2.1, and Section 12.4.5, RSR 12.4.5.1 require determination of cumulative and projected gamma air dose contributions due to noble gases for the current calendar quarter and the current calendar year at least once per 31 days. Gamma air dose is calculated for the sector with the highest offsite (x/Q) and is compared with the RECS limits on gamma air dose. For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system. 4.2.2.2 Beta Air Dose RECS limits beta air dose due to noble gases in gaseous effluents released from each reactor unit to areas at and beyond the unrestricted area boundary to the following:

• Less than or equal to 10 mrad per calendar quarter.
• Less than or equal to 20 mrad per calendar year.

The beta air dose due to noble gases released in gaseous effluents is calculated by the following expression: Dp = (3.17E - 8)'{ N, [(XIQ)r A',5 + (X/Q)v A',, + (X/Q)g A'ig } (4-5) The summation is over noble gas radionuclides i. Dp Beta Dose [mrad] Dose to air due to beta radiation from noble gas radionuclides released in gaseous effluents. 3.17E-8 Conversion Constant (seconds to years) [yr/sec] Ni Beta Air Dose Factor [(mrad/yr)I(VC i/im3 )] Beta air dose rate per unit of radioactivity concentration for radionuclide i. (X/Q)s Relative Concentration Factor [sec/m 3] (X/Q)v (X/Q)g Radioactivity concentration at a specified location per unit of radioactivity release rate for a stack, vent, or ground level release. Nis Cumulative Radionuclide Release, [1 iCi] A'iv Adjusted for Radiodecay A'ig 11.4-10 LASALLE ODCM PART IISECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Measured cumulative release of radionuclide 'i' over the time period of interest from a stack, vent, or ground level release point, reduced to account for radiodecay in transit from the release point to the dose point. A'j, = A1s exp(-X1R/3600uj) A'iv= Aiv exp(-A4R/3600uv) A'ig = Aig exp(-%3R/3600ug)

                           *I      Radiological Decay Constant                                      [hr 1 ]

R Downwind Range [m] Distance from the release point to the dose point. 3600 Conversion Constant [sec/hr] Converts hours to seconds. Us Average Wind Speed [m/sec] Uv Ug Average wind speed for a stack, vent, or ground level release. A1s, A1v,AigCumulative Radionuclide Release [pCi] Measured cumulative release of radionuclide i over the time period of interest from a stack, vent, or ground level release point, respectively. In accordance with NUREG-01 33 methodology, equation 4-5 can be alternatively be calculated: DP = 3.17E-08*j{Ni[(X/Q)v* aiv + (X/q)v* qiv + (X/Q)s* ais + (X/q)s* qis]} where: Dp is the dose to air due to beta radiation from noble gas radiation released in gaseous effluents (mrad) 3.17E-08 is a conversion constant (yr/sec). Ni is the air dose factor due to beta emissions for each identified noble gas radionuclide (mrad*m3/yr*pCi). Reference table 4-13. (X/Q)v is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for long term (greater than 500 hr/yr) vent releases (sec/m3 ). 11.4-11 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Qi'v is the average release of noble gas radionuclides in gaseous effluents, i, for long term (greater than 500 hr/yr) vent releases (pCi). (xIq)v is the relative concentration for areas at or beyond the unrestricted area boundary for short term (equal to or less than 500 hr/yr) vent releases (sec/m3). q is 1vthe average release of noble gas radionuclides, i, in gaseous releases, i, for short term (equal to or less than 500 hr/yr) vent releases (pCi). (xIQ)s is the highest calculated annual average relative concentration for areas at or beyond the unrestricted area boundary for long term (greater than 500 hr/yr) releases from a free standing (elevated) stack (sec/m3). Qis is the average release of noble gas radionuclides in gaseous effluents, i, for long term (greater than 500 hr/yr) releases from a free standing (elevated) stack (pCi). (X/q)s is the relative concentration for areas at or beyond the unrestricted area boundary for short term (equal to or less than 500 hr/yr) releases from a free standing (elevated) stack (sec/m3). qjs is the average release of noble gas radionuclides in gaseous effluents, i, for short term (equal to or less than 500 hr/yr) releases from a free standing (elevated) stack (pCi). RECS Section 12.4.2, RSR 12.4.2.1, and Section 12.4.5, RSR 12.4.5.1 require determination of cumulative and projected beta air dose contributions due to noble gases for the current calendar quarter and the current calendar year at least once per 31 days. Beta air dose is calculated for the sector with the highest offsite (xIQ) and is compared with the RECS limit on beta air dose. For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system. 4.2.2.3 Whole Body Dose The total (or whole) body dose, to any receiver is due, in part, to gamma radiation emitted from radioactivity in airborne effluents. This component is added to others to demonstrate compliance to the requirements of 40CFR1 90 and 1 OCFR20. 11.4-12 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II,Offsite Dose Calculation Manual The total body dose component due to gamma radiation from noble gases released in gaseous effluents is calculated by the following expression: DTB =(0.7(1.1 1)(3.17E - 8) x Y{S , + VAN, + GiAig } (4-6) The summation is over noble gas radionuclides i. DTB Total Body Dose [mrem] Dose to the total body due to gamma radiation from noble gas radionuclides released in gaseous effluents. 0.7 Shielding Factor; a dimensionless factor that accounts for shielding due to the occupancy of structures. 1.11 Conversion Constant (rads in air to rem in tissue) [mrem/mrad] 3.17E-8 Conversion Constant (seconds to years) [yr/sec] Si ,Vqi9, Gamma Total Body Dose Factor [(mrad/yr ([tCi/sec)] Gamma total body dose rate at a specified location per unit of radioactivity release rate for radionuclide"i" released from a stack, vent, or ground level release point. The attenuation of gamma 3 radiation due to passage through 1 cm of body tissue of 1 g/cm density is taken into account in calculating this quantity. Ais, Ai,, Aig Cumulative Radionuclide Release [pCi] Measured cumulative release of radionuclide i over the time period of interest from a stack, vent, or ground level release point, respectively. Alternatively, the total (or whole) body dose for the period of interest can be calculated from the total body dose rate: DTB = 3.17E-08

• t
• D TB where:

DTB is the total (or whole) body dose due to gamma radiation from noble gas radionuclides released in gaseous effluents (mrem) 3.17E-08 is a conversion constant (yr/sec). t is the number of seconds in the period of interest (sec) 11.4-13 LASALLE ODCM PART IISECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II,Offsite Dose Calculation Manual D TB is the instantaneous dose rate to the total body due to radioactive materials (noble gasses) released in gaseous effluents from the site (mrem/yr) The total body dose is also calculated for the 40CFR190 and 10CFR20 compliance assessments. In some cases, the total body dose may be required in 10CFR50 Appendix I assessments (See Part II Table 1-1). 4.2.2.4 Skin Dose There is no regulatory requirement to evaluate skin dose. However, this component is evaluated for reference as there is skin dose design objective contained in 10CFR50 Appendix I. Note that in the unlikely event that if beta air dose guideline is exceeded, then the skin dose will require evaluation. The part of skin dose due to noble gases released in gaseous effluents is calculated by the following expression: I=(3.17 E - 8)E{ Li [(X/Q)srA',. + (X/Q)v A'iv, + (X/Q),gA',, ] (4-7)

                       + (0.7)(1.11)[SAIS + VA, + GAg])

The summation is over noble gas radionuclides i. Ds Skin Dose [mrem] Dose to skin due to beta and gamma radiation from noble gas radionuclides release in gaseous effluents. Ais, A1 v, Aig Cumulative Radionuclide Release [p.Ci] Measured cumulative release of radionuclide i over the time period of interest from a stack, vent, or ground level release point, respectively. Li Beta Skin Dose Factor [(mrem/yr)/(p.Ci/m 3 )] (X/Q)s Relative Concentration Factor [sec/m 3] (X/Q). (X/Q)g Radioactivity concentration at a specified location per unit of radioactivity release rate for a stack, vent, or ground level release. Xis Cumulative Radionuclide Release, [WCi] A'iv A'ig 11.4-14 LASALLE ODCM PART IISECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Measured cumulative release of radionuclide 1' over the time period of interest from a stack, vent, or ground level release point, reduced to account for radiodecay in transit from the release point to the dose point. A'is = Ais exp(-XIR/3600us) A',v= Ai, exp(-%1R/3600uv) A'ig = Aig exp(-XiR/3600ug) Xi Radiological Decay Constant [hr-W] R Downwind Range [m] Distance from the release point to the dose point. 3600 Conversion Constant [sec/hr] us Average Wind Speed [m/sec] Uv Ug Average wind speed for a stack, vent, or ground level release. 0.7 Shielding Factor; a dimensionless factor that accounts for shielding due to the occupancy of structure. 1.11 Conversion Constant (rads in air to rem in tissue) [mrem/mrad] 3.17E-3 Conversion Constant (seconds to years) [yr/sec] Si, Vi, Gi, Gamma Air Dose Factor [(mrad/yr)/(p.Ci/sec)] Gamma air dose rate at a specified location per unit of Radioactivity release rate for radionuclide T released from a stack, vent, or ground level rease point, respectively. Alternatively, the skin dose for the period of interest can be calculated from the skin dose rate: DSki, = 3.17E-08

• t
• D Skin where:

DSkin is the skin dose due to beta and gamma radiation from noble gas radionuclides released in gaseous effluents (mrem)

              .3.17E-08 is a conversion constant (yr/sec).

11.4-15 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual t is the number of seconds in the period of interest (sec) Skin is the instantaneous dose rate to the total body due to radioactive materials (noble gasses) released in gaseous effluents from the site (mrem/yr) 4.2.3 Time Averaged Dose from Non-Noble Gas Radionuclides RECS provides the following limits, based on 10CFR50 Appendix I, on the dose to a member of the public from specified non-noble gas radionuclides in gaseous effluents released from each reactor unit to areas at and beyond the unrestricted area boundary:

           " Less than or equal to 7.5 mrem to any organ during any calendar quarter
           " Less than or equal to 15 mrem to any organ during any calendar year The individual dose components are also required as part of the 40CFR190 assessments and combined as part of the 10CFR20 assessment (Part II Table 1-1).

The dose due to radionuclides deposited on the ground is considered to be a component of the deep dose equivalent for 10CFR20 and 40CFR1 90 compliance and an organ (and total body) dose component for 10CFR50 Appendix I compliance. The dose is calculated for releases in the time period under consideration. Specifically, the dose is calculated as follows: DNNG. = Dinhal ja + Df°dja (4-8) DNNGja Committed Dose Equivalent (CDE) Due to Non-Noble Gas [mrem] Radionuclides Sum of the committed dose equivalents to organ j of an individual of age group a due to non-noble gas radionuclides released in gaseous effluents during a specified time period. D nhalj. Inhalation Committed Dose Equivalent (CDE) [mrem] CDE to organ j of an individual of age group a due to inhalation of non-noble gas radionuclides released in gaseous effluents Dfoodja Food Pathways Committed Dose Equivalent (CDE) [mrem] CDE due to ingestion via food pathways (leafy vegetables, produce, milk, and meat) of non-noble gas radionuclides released in gaseous effluents. 11.4-16 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual In accordance with NUREG-0133 methodology, equation 4-8 can be alternatively be calculated using the following equation and the pathway specific "R" dose factor defined in the subsections below: DNaG = 3.17E-08*7,1{Ri[Ws* Qis + Ws* q~s + Wv* hv + wv* qiv]} Where: DNNG is the committed dose equivalent (CDE) due to non noble gas radionuclides in gaseous effluents (mrem) 3.17E-08 is a conversion constant (yr/sec). Ri is the dose factor for each identified radionuclide, i (m2*mrem*sec/yr*pCi for (D/Q) calculations, or mrem*m 3/yr*pCi for (X/Q) calculations) W is the dispersion parameter for estimating the dose to an individual at the controlling location for long term (greater than 500 hr/yr) releases: W = (X/Q) for the inhalation pathway (sec/mi3 ) W = (D/Q) for the food and ground pathways (m 2 ) Qi is the release of radionuclides, radioactive materials in particulate form, and radionuclides other than noble gasses in gaseous effluents, i, for long term (greater than 500 hr/yr) releases (pCi). w is the dispersion parameter for estimating the dose to an individual at the controlling location for long term (equal to or less than 500 hr/yr) releases: w = (x/q) for the inhalation pathway (sec/m 3) w = (D/q) for the food and ground pathways (m-2 ) q1 is the release of radionuclides, radioactive materials in particulate form, and radionuclides other than noble gasses in gaseous effluents, i, for short term (equal to or less than 500 hr/yr) releases (pCi). RECS Section 12.4.3, RSR 12.4.3.1, and Section 12.4.5, RSR 12.4.5.1 require cumulative and projected dose contributions for the current calendar quarter and the current calendar year for the specified non-noble gas radionuclides in airborne effluents to be determined at least once per 31 days. 11.4-17 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual To comply with this specification, each nuclear power station obtains and analyzes samples in accordance with the radioactive gaseous waste or gaseous effluent sampling and analysis program in its RETS. For each organ of each age group considered (adult/teenager/child/infant), the dose for each pathway is calculated in every sector (except for sectors over water bodies). The calculation is based on the location assumptions discussed below in conjunction with the pathway equations. For each organ of each age group, the doses are summed in each sector over all pathways. The result for the sector with the highest total dose is compared to the limit. The values used for (X/Q) and (D/Q) are shown in Table 4-3 through Table 4-5 and correspond to the applicable pathway location. For a release attributable to a processing or effluent system shared by more than one reactor, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system. The dose evaluated is also included as part of the 10CFR20 and 40CFR1 90 assessment (See Part II Section 5). 4.2.3.1 Ground Plane The dose due to ground deposition of radioactivity is considered to be a total body dose component and is calculated by the following expressions: Dond = (24)(0.7)tr7,{ DFGiCGi} (4-9) Where: cG, = (dili)[1 - exp(-,itb)] And: d, = [(1 E6)/(24tr)] X [A'is(DIQ)s + A'iv(DIQ)v + A'ig(D/Q)g] The summation is over non-noble gas radionuclides'i'. Dgnd Ground Deposition Deep Dose Equivalent (DDE) [mrem] DDE due to ground deposition of non-noble gas radionuclides released in gaseous effluents. 24 Conversion Constant (days to hours) [hr/day] 0.7 Shielding Factor; a dimensionless factor which accounts for shielding due to occupancy of structures. tr Release or Exposure Period [days] Time period of the calculation (e.g., number of days in the quarter for a calendar quarter calculation). 11.4-18 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual DFGi Ground Plane Dose Conversion Factor [(mrem/hr)/(pCi/m 2)] Dose rate to the whole body per unit of ground radioactivity concentration due to standing on ground uniformly contaminated with radionuclide 'i'. See Part II Table 4-14. cG1 Ground Plane Concentration [pCi/m 2] Concentration of radionuclide 'i' on the ground. di Deposition Rate [(pCi/hr)/m 2] Rate at which radionuclide 'i' is deposited onto the ground. Xi Radiological Decay Constant [hr-'] Radiological decay constant for radionuclide 'i'. tb Time Period of Ground Deposition [hr] Time period during which the radioactivity on the ground is assumed to have been deposition (See Part II Table 1-3) 1E6 Conversion Constant ([tCi to pCi) [pCi/PjCi] A'is Cumulative Radionuclide [jICi] A'i,, Release, Adjusted for Radiodecay A'ig Measured cumulative release of radionuclide 'i' from a stack, vent, or ground level release point, reduced to account for radiodecay in transit from the release point to the dose point. (DIQ)s Relative Deposition Factor [m-2] (D/Q)v (DIQ)g Rate of deposition of radioactivity at a specified location per unit of radioactivity release rate for a stack, vent, or ground level release. Alternatively, dose due to the ground plane pathway can be calculated using the methodology described in 4.2.3 and the ground plane dose factor (RGi) defined below: RG = K'*K"*SF*DFGI*(1-exp(-Xl*t))/,i where: 11.4-19 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual RRG is the ground plane dose factor for each identified radionuclide, i (m2 *mrem*sec/yr*pCi) K' is a constant of unit conversion = 1E+06 (pCi/pCi) K" is a constant of unit conversion = 8760 (hr/yr) SF is the shielding factor (dimensionless) DFGi is the ground plane dose conversion factor for the ith radionuclide (mrem *m3/hr*pCi) ki is the decay constant for the ith radionuclide (sec-1) t is the exposure time (sec) Note that ground plane dose factors are only given for the total body and no age group. Doses to other organs are assumed to be equal to the total body dose. All age groups are assumed to receive the same dose. The deep dose equivalent (DDE) due to ground deposition is determined for each sector using the highest calculated offsite value of DIQ for that sector. The ground plane exposure pathway is considered to exist at all locations. 4.2.3.2 Inhalation The committed dose equivalent (CDE) due to inhalation is calculated by the following expression: Dinhal ja = (3.1 7E-8)(1 E6)(Ra) x Y{DFAija[(X/Q)sA'js + (X/Q)v A'iv + (X/Q)gA'ig]} (4-10) The summation is over non-noble gas radionuclides 'i'. Dinhalja Inhalation Committed Dose Equivalent (CDE) [mrem] CDE to organ j of an individual in age group a due to inhalation of non-noble gas radionuclides released in gaseous effluents. 3.17E-8 Conversion Constant (seconds to years) [yrs/sec] 1E6 Conversion Constant (pCi to pCi) [pCi/pCi] Ra Individual Air Inhalation Rate [m3/yr] 11.4-20 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual The air intake rate for individuals in age group 'a'. DFAija Inhalation Dose Commitment Factor [mrem/pCi] Dose commitment to organ 'j' of an individual in age group 'a' per unit of activity of radionuclide 'i' inhaled. Assessment Dose Factor Age Group 10CFR50 App. I Reg. Guide 1.109 All (four) Tables E-7 through E-10. 10CFR20/40CFR190 Federal Guidance Adult only Report-1 1; Table 2.2 (average individual) (X/Q)s Relative Effluent Concentration [sec/M 3] (X/Q)v (X/Q)g Radioactivity concentration at a specified location per unit of radioactivity release rate. A'is,A'iv,A'ig Cumulative Radionuclide Release, Adjusted for Radiodecay [WCi] Measured cumulative release of radionuclide "i" from a stack, vent or ground level release point, reduced to account for radiodecay in transit from the release point to the dose point. Alternatively, dose due to the inhalation pathway can be calculated using the methodology described in 4.2.3 and the inhalation dose factor (R'i) defined below: Rli = K'*(BR).*(DFA1). where: R'1 is the inhalation dose factor for each identified radionuclide, i (mrem*m 3/yr*pCi) K' is a constant of unit conversion = 1E+06 (pCi/pCi) (BR)a is the breathing rate of the receptor age group (a) (m3/yr) (DFAI)a is the organ inhalation dose factor for the receptor of age group (a) for the ith radionuclide (mrem/pCi) The inhalation exposure pathway is considered to exist at all locations. The CDE due to inhalation is determined for each sector using the highest calculated offsite value of X/Q for that sector. 11.4-21 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 4.2.3.3 Ingestion: Vegetation Food ingestion pathway doses are calculated at locations indicated by the land use census survey. If no real pathway exists within 5 miles of the station, the cow-milk pathway is assumed to be located at 5 miles. Food pathway calculations are not made for sectors in which the offsite regions near the station are over bodies of water. Dfoodja=(tr/365) X Z{DFlIja[iVia + iPia + iMia + iFia]} (4-11) The summation is over non-noble gas radionuclides 'i'. Dfo°dja Food Pathways Committed Dose Equivalent [mrem] (CDE) commitment to organ j of an individual in age group a due to ingestion via food pathways (leafy vegetables, produce, milk, and meat) of non-noble gas radionuclides relased in gaseous effluents. tr Time Period of Release or Exposure [days] (e.g., number of days in a quarter for a calendar quarter calculation). 1/365 Conversion Constant (days to years) [yr/day] DFlija Ingestion Dose Commitment Factor [mrem/pCi] Dose commitment to organ 'j' of an individual in age group 'a' per unit of activity of radionuclilde 'i' ingested. Assessment Dose Factor Age Group 10CFR50 App. I Reg. Guide 1.109 All (four) Tables E-11 through E-14. 10CFR20/40CFR190 Federal Guidance Adult only Report-1 1; Table 2.2 (average individual) 11.4-22 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual iV.a PIia Rate of Ingestion of Activity [pCi/yr] iiajFja Activity of radionuclide 'i' ingested annually by an individual in age group a from, respectively, the following:

• Leafy vegetables
• Produce (nonleafy vegetables, fruits, and grain).
• Milk
• Meat (flesh)

Calculated as follows: iVia - UVafvCv iPia =UPa fp CPi iMia = UMa cMi i*Fia

                                    !a==UFaci F CF!

UVa Food Product Consumption Rate [kg/yr] upa [kg/yr] UMa [L/yr] UFa [kg/yr] Annual consumption (usage) rate of leafy vegetables, produce, milk, or meat, respectively, for individuals in age group 'a'. fv Food Product Affected Fraction fp Fraction of ingested leafy vegetables (V) or produce (P) grown in the garden of interest. Cv1 Food Product Radioactivity Concentration [pCi/kg] cP i [pCi/kg] CMi [pCi/L] cFi [pCi/kg] CVi and Cpi represent, respectively, the average concentration of radionuclide I in leafy vegetables and produce grown in the garden of interest. Calculated from the amount of radioactivity released and the relative deposition factor D/Q at the garden of interest. Cm and CFi represent, respectively, the average concentration of radionuclide I in milk and meat from the producer of interest. Calculated from the amount of radioactivity released and the relative deposition factor D/Q at the locations of the producers of interest. 11.4-23 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II,Offsite Dose Calculation Manual Where: The radioactivity concentration in leafy vegetables (Cvi), produce CP1), or other vegetation is calculated b y the following expression: C = [(di)(r)/(Yv)(XEi)] x [1 - exp(-XEit.,)] [exp(-X*ith)](ff) C1 Food Product Radioactivity Concentration [pCi/kg] Average concentration of radionuclide T' in leafy vegetables, produce, or other vegetation. di Deposition Rate [(pCi/hr)/m 2] Rate at which 'i' is deposited on the ground. Calculated from the amount of radioactivity released and the relative deposition factor D/Q at the location of interest r Vegetation Retention Factor Fraction of deposited activity retained on vegetation. Yv Agricultural Productivity [kg/m 2] The quantity of vegetation produced per unit area of the land on which the vegetation is grown. XEi Effective Decay Constant [hr'1 ] Effective removal rate constant for radionuclide 'i' from vegetation: XEi "=Xi+ XW Xi Radiological Decay Constant [hr 1 ] Radiological decay constant for radionuclide 'i'. Weathering Decay Constant [hr'] Removal constant for physical loss by weathering. te Effective Vegetation Exposure Time [hr] Time that vegetation is exposed to contamination during the growing season. 11.4-24 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual th Harvest to Consumption Time [hr] Time between harvest and consumption. ff Seasonal Growing Factor Factor which accounts for the seasonal growth of vegetation. It has the value '1' during the growing season, '0' otherwise. Alternatively, dose due to the vegetation ingestion pathway can be calculated using the methodology described in 4.2.3 and the vegetation dose factor (RVi) defined below: Rvi = K'*[r/(Yv*(Xi+Xw))]*DFLia*[(ULa*fL*exp(-Xi*tL)) + (USa*fg*exp(-Xi*th))] or in the case of tritium: Rvi = K'

• K"' * [(ULa
• fL) + (Usa
• fg)] *(DFLI)a * [0.75(0.5/H)]

or in the case of C-14: RVi = K'

• K"' * [(ULa
• fL) + (Usa
• fg)] *(DFLi)a
• p * [0.11 1 0.16]

where: Rv, is the vegetation dose factor for each identified radionuclide, i (m 2*mrem*sec/yr*pCi) K' is a constant of unit conversion = 1E+06 (pCi/pCi) r is the fraction of deposited activity retained on vegetation/grass (dimensionless) Y, is, the vegetation areal density (kg/M 2) Xi is the decay constant for the ith radionuclide (sec-1) X is the decay constant for removal of activity on leaf and plant surfaces by weathering = 5.73E-07 (sec-1) (DFLI)a is the organ ingestion dose factor for the ith radionuclide for the receptor in age group (a) (mrem/pCi) UL, is the consumption rate of fresh leafy vegetation by the receptor in age group (a) (kg/yr) fL is the fraction of the annual intake of fresh leafy vegetation grown locally (dimensionless) 11.4-25 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual tL is the average time between harvest of leafy vegetation and its consumption (sec) uSa is the consumption rate of stored vegetation by the receptor in age group (a) (kg/yr) fg is the fraction of the annual intake of stored vegetation grown locally (dimensionless) th is the average time between harvest of stored vegetation and its consumption (sec) K"' is a constant of unit conversion = I E+03 (g/kg) H is the absolute humidity of the atmosphere (g/m 3) 0.75 is the fraction of total feed that is water (dimensionless) 0.5 is the ratio of the specific activity of the feed water to atmospheric water (dimensionless) p is the fractional equilibrium ratio (4400 hrs/8760 hrs). The ratio of total annual release time (for C-14 atmospheric releases) to the total annual time during which photosynthesis occurs (taken to be 4400 hrs), under the condition that the value of p should never exceed unity. For continuous C-14 releases, p is taken to be unity. 0.11 is the fraction of total plant mass that is natural carbon (dimensionless) 0.16 is the concentration of natural carbon in the atmosphere (g/m 3 ) 4.2.3.4 Ingestion: Milk The radioactivity concentration in milk is calculated by the following expressions: cMi-- FM CfiWfexp(-XtM) C= Fa fg Cgj + (1 - fa)CSi + Fa(1 - fg)CSI (4-12) CMa Milk Radioactivity Concentration [pCi/L] Average concentration of Radionuclide T' in milk from the producer of interest. 11.4-26 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual FM Milk Fraction [day s/L] Fraction of an animal's daily intake of radionuclide i which appears in each liter of milk (pCi/L in milk per day pCi/day ingested by the animal). Cf Feed Concentration [pCi /kg] Average concentration of radionuclide 'i' in animal feed. Wf Feed Consumption [kg/cJay] Amount of feed consumed by the animal each day.

              %I           Radiological Decay Constant                                                        hr']

Radiological Decay constant for radionuclide 'i'. tm Milk Transport Time [hr] Average time from the production of milk to its consumption. fa Pasture Time Fraction Fraction of time that animals graze on pasture. fg Pasture Grass Fraction Fraction of daily feed that is pasture grass when animals graze on pasture. C~i Pasture Grass Concentration [pCi/kg] Concentration of radionuclide 'i' in pasture grass. CS1 Stored Feed Concentration [pCi /kg] Concentration of radionuclide 'i' in stored feed. Alternatively, dose due to the milk ingestion pathway can be calculated using the methodology described in 4.2.3 and the milk dose factor (RCi) defined below: Rci = K*((QF*Uap)/l*i+Xw))*Fm*r*(DFLi)a*[((fp*fs)/Yp) + (((1 -fp*fs)*exp(-Xi*th))Ns)]*exp(-Xi*tf) 11.4-27 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual or in the case of tritium: RCi = K'*K"..*Fm*QF*Uap*(DFLi)a*[0.75(0.5/H)] or in the case of C-14: Rci = K'

• K"'
• Fm
• QF
• Uap * (DFLi)a
• p * [0.11 / 0.16]

where: Rci is the milk dose factor for each identified radionuclide, i (m2*mrem*sec/yr*pCi or mrem*m3/yr*pCi) K' is a constant of unit conversion = 1EE+06 (pCi/pCi) QF is the animal's consumption rate (kg/day, wet weight) Uap is the receptor's milk consumption rate for age group (a) (L/yr) xi is the decay constant for the ith radionuclide (sec-1) xW* is the decay constant for removal of activity on leaf and plant surfaces by weathering = 5.73E-07 (sec-1) Fm is the stable element transfer coefficient (day/L) r is the fraction of deposited activity retained on vegetation/grass (dimensionless) (DFLn). is the organ ingestion dose factor for the ith radionuclide for the receptor in age group (a) (mrem/pCi) fp is the fraction of the year that the animal is on pasture (dimensionless) fs is the fraction of the feed that is pasture grass while the animal is on pasture (dimensionless) Yp is the agricultural productivity by unit area of pasture feed grass (kg/m2) th is the transport time from pasture, to harvest, to animal, to milk, to receptor (sec) Ys is the agricultural productivity by unit area of stored feed (kg/m 2 ) tf is the transport time from pasture, to animal, to milk, to receptor (sec) 11.4-28 LASALLE ODCM PART IISECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual K'" is a constant of unit conversion = 1E+03 (g/kg) H is the absolute humidity of the atmosphere (g/m 3) 0.75 is the fraction of total feed that is water (dimensionless) 0.5 is the ratio of the specific activity of the feed water to atmospheric water (dimensionless) p is the fractional equilibrium ratio (4400 hrs/8760 hrs). The ratio of total annual release time (for C-14 atmospheric releases) to the total annual time during which photosynthesis occurs (taken to be 4400 hrs), under the condition that the value of p should never exceed unity. For continuous C-14 releases, p is taken to be unity. 0.11 is the fraction of total plant mass that is natural carbon (dimensionless) 0.16 is the concentration of natural carbon in the atmosphere (g/m 3) 4.2.3.5 Ingestion: Meat The radioactivity concentration in meat is calculated by the following expression: cFi " FFCfiWf exp(-Xits) (4-13) cF Meat Radioactivity Rate [pCi/kg] Average concentration of radionuclide 'i' in meat from the producer of interest. FF Meat Fraction [days/kg] Fraction of an animal's daily intake of radionuclide 'i' which appears in each kilogram of flesh (pCi/kg in meat per pCi/day ingested by the animal). cf Feed Concentration [pCi/kg] Average concentration of radionuclide 'i' in animal feed. Wf Feed Consumption [kg/day] Amount of feed consumed by the animal each day. X, Radiological Decay Constant [hr1] Radiological decay constant for radionuclide 'i'. 11.4-29 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual ts Time From Slaughter to Consumption [hr] All other terms have been previously defined. Alternatively, dose due to the meat ingestion pathway can be calculated using the methodology described in 4.2.3 and the meat dose factor (RMi) defined below: RMi = K'*((QF*Uap)/(Xi+Xw))*Ff*r*DFLia*[((fp*fs)/Yp) + (((1 -fp*fs)*exp(-Xi*th))I~s)]*exp(-X,i*tf) or in the case of tritium: RMi = K'

• K"'
• Ff
• QF
• Uap * (DFLI)a * [0.75(0.5/H)]

or in the case of C-14: RMi = K'

• K"'
• Ff
• QF
• Uap * (DFLi)a
• p *[0.11 / 0.16]

where: RMi is the meat dose factor for each identified radionuclide, i (m 2*mrem*sec/yr*pCi) K' is the animal's consumption rate (kg/day, wet weight) QF is the animal's consumption rate (kg/day, wet weight) Uap is the receptor's meat consumption rate for age group (a) (kg/yr)

                ,i is the decay constant for the ith radionuclide (sec-1)

Xw is the decay constant for removal of activity on leaf and plant surfaces by weathering = 5.73E-07 (sec-1) Ff is the stable element transfer coefficient (day/kg) r is the fraction of deposited activity retained on vegetation/grass (dimensionless) (DFL*)a is the organ ingestion dose factor for the ith radionuclide for the receptor in age group (a) (mrem/pCi) fp is the fraction of the year that the animal is on pasture (dimensionless)

f. is the fraction of the feed that is pasture grass while the animal is on pasture (dimensionless)

Yp is the agricultural productivity by unit area of pasture feed grass (kg/m 2) 11.4-30 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual th is the transport time from crop field to receptor (sec) Ys is the agricultural productivity by unit area of stored feed (kg/m2) tf is the transport time from pasture to receptor (sec) K"' is a constant of unit conversion = 1E+03 (g/kg) H is the absolute humidity of the atmosphere (g/m 3 ) 0.75 is the fraction of total feed that is water (dimensionless) 0.5 is the ratio of the specific activity of the feed water to atmospheric water (dimensionless) p is the fractional equilibrium ratio (4400 hrs/8760 hrs). The ratio of total annual release time (for C-14 atmospheric releases) to the total annual time during which photosynthesis occurs (taken to be 4400 hrs), under the condition that the value of p should never exceed unity. For continuous C-14 releases, p is taken to be unity. 0.11 is the fraction of total plant mass that is natural carbon (dimensionless) 0.16 is the concentration of natural carbon in the atmosphere (g/m 3) 11.4-31 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-1 Critical Ranges DirectionFarm Unrestricted Area Restricted Area Nearest Residentb Nearest Dairy within Direction Boundarya (m) Boundary (m) (m) miFesc (in) N 1036 1036 6300 None NNE 1378 1378 2575 None NE 2408 1609 3400 None ENE 4450 1079 5300 None E 1996 833 5200 None ESE 1465 845 2300 None SE 969 969 2700 None SSE 838 698 2900 None S 829 620 2400 None SSW 835 835 1100 None SW 628 628 1600 None WSW 533 533 2400 None W 524 524 2400 None WNW 643 643 1400 None NW 762 762 2900 None NNW 890 890 2700 None Used in calculating the meteorological dose factors in Tables 4-3, 4-4, 4-6, and 4-7. b The distances are rounded to the nearest conservative 100 meters. Used in calculating the D/Q values in Table 4-5. The distances are rounded to the nearest conservative 100 meters. A default value of 8000 meters is used when there are no dairies within 5 miles. 11.4-32 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-2 Average Wind Speeds Downwind Average Wind Speed (m/sec)a Direction Elevated Vent Ground Level N 9.7 7.7 4.9 NNE 10.1 8.0 5.1 NE 9.2 7.4 4.9 ENE 9.0 7.2 4.8 E 9.5 7.8 5.2 ESE 9.7 8.4 5.9 SE 8.1 7.4 5.9 SSE 7.4 8.7 5.0 S 6.7 5.9 4.3 SSW 5.6 3.7 2.9 SW 5.5 4.1 3.1 WSW 6.9 5.4 3.9 W 7.6 6.5 4.5 WNW 7.5 6.3 4.3 NW 7.5 6.2 3.9 NNW 8.3 6.7 4.3 Based on LaSalle site meteorological data, January 1978 through December 1987. See Sargent & Lundy, Analysis and Technology Division, LaSalle calculation no. ATD-0164, revisions 0, 1, 2, and 3. 11.4-33 LASALLE ODCM PART IISECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-3 X/Q and D/Q Maxima at or Beyond the Unrestricted Area Boundary Ground Level Release Mixed Mode (Vent) Elevated (Stack) Direction Distance X/Q D/Q Distance X/Q D/Q Distance X/Q Distance D/Q (meters) (sec/m3) (m-2) (meters) (sec/m3) (m-2) (meters) (seclm3) (meters) (m-2) N 1036 1.43E-06 9.09E-09 1036 4.73E-07 5.23E-09 6437 5.15E-09 1609 3.97E-10 NNE 1378 9.84E-07 6.85E-09 1378 4.01E-07 4.38E-09 5633 6.21E-09 1609 5.08E-1 0 NE 2408 4.43E-07 2.72E-09 2408 2.13E-07 1.81E-09 5633 6.42E-09 2408 1.74E-10 ENE 4450 1.70E-07 7.55E-10 4450 8.62E-08 4.89E-10 5633 5.38E-09 4450 1.53E-10 E 1996 5.52E-07 3.45E-09 1996 2.29E-07 2.24E-09 5633 6.60E-09 1996 1.84E-10 ESE 1465 9.07E-07 7.12E-09 1465 3.78E-07 4.92E-09 5633 8.46E-09 1609 6.75E-10 SE 969 1.05E-06 8.48E-09 969 3.80E-07 5.16E-09 5633 8.16E-09 1609 6.70E-10 SSE 838 1.16E-06 1.09E-08 838 4.68E-07 7.21E-09 6437 5.76E-09 1609 4.57E-10 S 829 1.40E-06 9.82E-09 829 3.76E-07 4.69E-09 6437 5.71E-09 1609 4.51 E-10 SSW 835 1.21 E-06 8.31E-09 835 3.OOE-07 3.58E-09 6437 5.50E-09 1609 4.13E-10 SW 628 1.32E-06 1.32E-08 628 5.01E-07 8.29E-09 5633 6.52E-09 1609 5.47E-10 WSW 533 1.59E-06 1.70E-08 533 6.77E-07 1.13E-08 6437 6.13E-09 1609 4.80E-1 0 W 524 3.29E-06 2.33E-08 524 9.40E-07 1.13E-08 6437 4.32E-09 1609 2.99E-1 0 WNW 643 2.22E-06 1.26E-08 643 5.31E-07 5.80E-09 6437 3.41E-09 1609 2.53E-10 NW 762 1.88E-06 9.48E-09 762 4.33E-07 4.12E-09 7242 3.03E-09 1609 2.07E-10 NNW 890 1.63E-06 8.40E-09 890 4.18E-07 3.90E-09 7242 3.38E-09 1609 2.30E-10 LaSalle Site Meteorological Data 2000-2009 11.4-34 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-4 X/Q and D/Q Maxima at or Beyond the Restricted Area Boundary Ground Level Release Mixed Mode (Vent) Elevated (Stack) Direction Distance X/Q D/Q Distance X/Q D/Q Distance X/Q Distance D/Q (meters) (sec/m3) (m-2) (meters) (sec/m3) (m-2) (meters) (sec/m3) (meters) (m-2) N 1036 1.43E-06 9.09E-09 1036 4.73E-07 5.23E-09 6437 5.15E-09 1609 3.97E-10 NNE 1378 9.84E-07 6.85E-09 1378 4.01E-07 4.38E-09 5633 6.21E-09 1609 5.08E-10 NE 1609 7.99E-07 5.44E-09 1609 3.48E-07 3.53E-09 5633 6.42E-09 1609 5.43E-10 ENE 1079 1.28E-06 8.67E-09 1079 4.49E-07 5.11E-09 5633 5.38E-09 1609 4.62E-10 E 833 2.13E-06 1.50E-08 833 6.95E-07 9.04E-09 5633 6.60E-09 1609 5.23E-10 ESE 845 2.14E-06 1.78E-08 845 7.66E-07 1.18E-08 5633 8.46E-09 1609 6.75E-10 SE 969 1.05E-06 8.48E-09 969 3.80E-07 5.16E-09 5633 8.16E-09 1609 6.70E-10 SSE 698 1.52E-06 1.46E-08 698 5.88E-07 9.45E-09 6437 5.76E-09 1609 4.57E-10 S 620 2.16E-06 1.56E-08 620 5.25E-07 6.94E-09 6437 5.71E-09 1609 4.51E-10 SSW 835 1.21E-06 8.31E-09 835 3.OOE-07 3.58E-09 6437 5.50E-09 1609 4.13E-10 SW 628 1.32E-06 1.32E-08 628 5.01E-07 8.29E-09 5633 6.52E-09 1609 5.47E-10 WSW 533 1.59E-06 1.70E-08 533 6.77E-07 1.13E-08 6437 6.13E-09 1609 4.80E-10 W 524 3.29E-06 2.33E-08 524 9.40E-07 1.13E-08 6437 4.32E-09 1609 2.99E-10 WNW 643 2.22E-06 1.26E-08 643 5.31E-07 5.80E-09 6437 3.41E-09 1609 2.53E-10 NW 762 1.88E-06 9.48E-09 762 4.33E-07 4.12E-09 7242 3.03E-09 1609 2.07E-10 NNW 890 1.63E-06 8.40E-09 890 4.18E-07 3.90E-09 7242 3.38E-09 1609 2.30E-10 LaSalle Site Meteorological Data 2000-2009 11.4-35 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-5 (Page 1 of 2) D/Q at the Nearest Milk Cow and Meat Animal Locations Within 5 Miles Direction Distance Ground Level Release Mixed Mode (Vent) Elevated (Stack) X/Q D/Q X/Q D/Q X/Q D/Q miles meters (sec/m3) (m-2) (sec/m3) (m-2) (sec/m3) (m-2) N 4.0 6400 1.11E-07 3.87E-10 5.69E-08 2.45E-10 5.15E-09 1.12E-10 NNE 1.7 2800 3.54E-07 2.03E-09 1.70E-07 1.35E-09 4.33E-09 3.44E-10 NE 3.5 5600 1.43E-07 6.19E-10 8.01E-08 4.21E-10 6.42E-09 1.75E-10 ENE 3.8 6116 1.11E-07 4.29E-10 6.01E-08 2.81E-10 5.39E-09 1.37E-10 E 5.0 8000 8.34E-08 2.99E-10 4.69E-08 2.05E-10 6.25E-09 1.07E-10 ESE 5.0 8000 8.37E-08 3.64E-10 5.1OE-08 2.71E-10 7.82E-09 1.41E-10 SE 4.7 7600 5.41E-08 2.39E-10 3.66E-08 1.67E-10 7.71E-09 1.54E-10 SSE 4.7 7600 4.46E-08 2.41E-10 3.32E-08 1.93E-10 5.58E-09 1.06E-10 S 4.7 7600 5.45E-08 2.14E-10 3.86E-08 1.45E-10 5.60E-09 1.01E-10 SSW 5.0 8000 4.39E-08 1.67E-10 3.27E-08 1.10E-10 5.38E-09 8.37E-1 1 SW 5.0 8000 3.02E-08 1.69E-10 2.44E-08 1.37E-10 6.20E-09 1.11E-10 WSW 1.5 2400 1.69E-07 1.40E-09 1.10E-07 1.10E-09 2.75E-09 4.02E-10 W 3.0 4800 1.25E-07 5.58E-10 7.21E-08 3.33E-10 3.97E-09 1.34E-10 WNW 3.0 4800 1.15E-07 4.14E-10 5.35E-08 2.33E-10 3.17E-09 1.09E-10 NW 4.0 6400 8.73E-08 2.46E-10 4.06E-08 1.30E-10 3.02E-09 6.37E-11 NNW 4.6 7403 8.11E-08 2.15E-10 3.83E-08 1.16E-10 3.38E-09 5.50E-11 LaSalle Site Meteorological Data 2000-2009 11.4-36 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-5 (Page 2 of 2) D/Q at the Nearest Milk Cow and Meat Animal Locations Within 5 Miles Direction Distance Ground Level Release Mixed Mode (Vent) Elevated (Stack) X/Q D/Q X/Q D/Q X/Q D/Q miles meters (sec/m3) (m-2) (sec/m3) (m-2) (sec/m3) (m-2) N 5.0 8000 8.26E-08 2.59E-10 4.43E-08 1.65E-10 4.96E-09 7.82E-11 NNE 5.0 8000 8.80E-08 3.16E-10 5.06E-08 2.15E-10 5.82E-09 9.32E-11 NE 5.0 8000 8.95E-08 3.27E-10 5.28E-08 2.24E-10 6.05E-09 1.01E-10 ENE 5.0 8000 7.76E-08 2.65E-10 4.42E-08 1.75E-10 5.12E-09 8.92E-11 E 5.0 8000 8.34E-08 2.99E-10 4.69E-08 2.05E-10 6.25E-09 1.07E-10 ESE 5.0 8000 8.37E-08 3.64E-10 5.1OE-08 2.71E-10 7.82E-09 1.41E-10 SE 5.0 8000 5.03E-08 2.17E-10 3.44E-08 1.53E-10 7.56E-09 1.41E-10 SSE 5.0 8000 4.14E-08 2.20E-10 3.11E-08 1.76E-10 5.49E-09 9.73E-11 S 5.0 8000 5.06E-08 1.95E-10 3.62E-08 1.33E-10 5.52E-09 9.30E-11 SSW 5.0 8000 4.39E-08 1.67E-10 3.27E-08 1.10E-10 5.38E-09 8.37E-11 SW 5.0 8000 3.02E-08 1.69E-10 2.44E-08 1.37E-10 6.20E-09 1.11E-10 WSW 5.0 8000 2.86E-08 1.67E-10 2.33E-08 1.38E-10 5.89E-09 1.01E-10 W 5.0 8000 6.20E-08 2.24E-10 4.01E-08 1.36E-10 4.25E-09 6.30E-11 WNW 5.0 8000 5.82E-08 1.66E-10 3.07E-08 9.52E-11 3.35E-09 5.15E-11 NW 5.0 8000 6.52E-08 1.64E-10 3.20E-08 8.77E-11 2.99E-09 4.45E-11 NNW 5.0 8000 7.34E-08 1.87E-10 3.53E-08 1.01E-10 3.34E-09 4.83E-11 LaSalle Site Meteorological Data 2000-2009 11.4-37 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 1 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Kr-83m Sin ow" "vows). w0V~IU j)Mom ohm Nod~) WOWn *m~ L~ M~ boom. V I him. 4111m11WO) bIwwdwvrL ftog~w ~hsru) ~wr)IPSAIes~ us. 3M1. U6.=I4? IS.-W 641311111117 3131-V NbL 1.M1.11.34. M onM. 6u.01tv 1.11" ate. L131111 -411 a SUlL Ago. L.471-V 4.100-10 13W. &."417VAINI-V SM6 4JBR-U J 1"%. IJIW-V 4.211311-If S5.53-P11 4MM-V1 4451L 1AW-0 1111110 4.410-If 3.534-I ?35g1e 3.W131-P 191111. 34WU414-to. 148. SJAW-S L3UM4 am, LOU-*5 1.0111- 1w43 £3343. 6.84-w UN on. 3.MX1-859.35434 90. 131014% 1.4354 Vu M. 5.1511-W 1.31611? 1111111-a 1.110-11 M. s03I-111 10.111114 sI on. UP5. LIM131-V 1.1411-111 "I. 1.66f-fl 1.0211-11 W. 1.M131-U LOU-" a'H. ins. 3.11141f-P 41.3111-P 191111.LOPU- I.V1-V M33. 9JIl.16 MMl-1111

                  '35.                                                            S.8254 1.13111-If              SU.       L~fm.K 1.73K-S LIM111-S     1.934?

83113-P 3.154-P 84741-0 L8OIN-U SM. LS 1.113161-0 324. 1.71464 1.63-ft 1.&M-1111 MN LU33-ft L.32-84 Us3. 1.So464 1.835-P 3.44-V 1.1444?1J164 J4AL L7IU-8 2.511-0

                                                                                  &..an-W u.3111We               742. 2411114111.64111n-0i 1.M4-P asil"~ M.                         11m-42111     IS1111-111 tomm$11111SIN                Amm *1?          Im - w Based on Sargent & Lundy, Analysis and Technology Division, LaSalle calculation no. ATD-0164, revisions 0, 1, 2, and 3.

11.4-38 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 2 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Kr-85m bamlat ku6040" 361owne8111US111 Noe0i lýI MOM' OWN";;=im U 5.711-S W1116IU. A..316.1-U 9.631146 9511 U. We". 9.0=45 4."46UM S315. 5r- .341- ~5 U SM. 2.911111101.511110415 ales aMu.11 sEAM-1 MU. 3.131SX 1411 m.5 Eu Il. 4511I 1.11111-1111 M. 1.35111111-a 1.M11- 441.. U 2J7w-0 &AW115.S 106. LUXl-11S1 1.11111-6 19*. Sim-*41.11111111-ft

   .3                             4.3SU-16 U11111111411 SM.           4.U*4-15 4AM-61 We.

S on. go*. S.ui-W 5453-111 U. U.1.1111 A*30" 10.

   .3                             5.51111141  5.3.1-U         US.       .316641.                     833.

S sm. 6". 4.7111 431 WIWI u p3. L~lS ."1511-U1 a,'. 13 an. 133. .&mu4.31.-U6 me. 5.U.

                                                                                    .17411-U11       m.

U U.

                                                                                                    'as.

533. LOW"4- 7.371-r Sm5. 9.1111114111119.=.u1 133. U '34-U. 33-l5.11345 AL 643 1- 6.3.1-U1I MS. 44144.511IU-U 7111.aS.6148-0 4."a-45 m. U. US. LM.M son Usa OWmu I - Wff 11.4-39 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 3 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Kr-85

• usmegd 0--m wa 1- 5w69Su* . -d s6well) iw hs S IP&. ~. 6511147 L"" Viw&m-w m-ur miw. I."u-% r

           *1W-                    I          I tNii            am.                              1NO.      LIM"1- LI..U

• 19. 19 . 3.91*0 3.1111NU4 IWIL L4=-* 6.110-U mu I4~S 1141.*.28W4 6.14W-0 "ow. NO. 74.66-6 5*69A-116 1=06 LIM3-06 5.513-$

90S. Us. 1.401-8 sum-111s1 Inm. as. 7.im-M6? .UUT-0 LUS=f 4301111-W in. s1u.s eis-111 us 43. Sm1. M.1411-616 1.1341-0 03. 1.4-113-3 1.u.-u

        -      135.        5S. 11.114611"M        1-                     1.M- .1446*t         533.      $."1-11U4 1AW411

w. mt. Timn-If &.ws1-I WS. 1.0U4115 0.7533 7a1.

        -      I           on. 1. RK-W GAW-9                no.

UNMU111 11 111111111 515 "TU I- 1W 11.4-40 LASALLE ODCM PART 11SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 4 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Kr-87 Imn iNa im'eowloo Imo ý towaam ntouo sulow 10d11ba ) g1o16o grow0 goolo l. CII~ m'gg'ig Oft~ S Uteta'= 8"adm ¢UJfv)O 3km~ Imnlad )dr ,3km t inS 3kmr.

*1rlulu m                                       33        so emil.                                      he           #S bowelmm £mllvs fual'W)Ai12alo vosm)                       tlww~p1wilwIols          Now"s twomwor)                     flim)

I V"'. INS. SMUII4 LINK-A 5.7=-%4 L".641 VOL SW ISY. 10u. 5.40"- 1.3341 line"6 1.16164 U 2"L no. lin*3I-K13w-"

                         "Sm.      1.U=-" lift4-"                     5.85166 5.33.6
    £                      143.                               am. 1.451-f 1.4171-4 Lu                     SM1.                               "S.. 1.4310-a 2.351144-U         up.          no9.                              SM.      3.613-K     3.5110-0        "U.        1.UU-I 9.31011-SW         03L          110.                               ON. 3.560-P     3.5511-          '49.      I.PW-U IANS4-S         SM.          on'.         .43-P131141R                  3.31-K4     LOW946           on.         .33-U*4 S.311t43 SW         so5.         ons.                                       J433-p      L3U641           me.

U 6U- an. 536-PM8 1.7416 145114614.90-0

   -I         in3.         $33.                                       I."*-       Sim"-            in.

U Sm4. $34. L11IM-1K 5.543a-P 9.13ft-0 4.11w-U

   -e         Us.          "3.                                MI3. 3.1111-A1   SAW114           so4.      416"-a        3.31-U U         Us'.         Il.                               "3.      Sim59-"      .1-                       3.1116        S.M--U U.         o..          41".                                       s.ide-"     S.9911-P                   3.781-0       LAX1-U 01~1a   On1                     OIUA IM il-      1W 11.4-41 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 5 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Kr-88 owwwwoSuetqiewg f4it~ s) I. Now a*ut - - &" firmtikaftwaft selow.. Ohms Nmews) li~w)ter6n~~wj I r on". V ur ladle 0 mm! U 'U'.l I.65-04 U.3146O 10'6. 1.48"3- 9.16".0 'U6. Mo. LS.N-191- LI913-O 1111. MOWN1-0 7.717304 2.11IN-U L.18-43 U 144S0. 3.041-OS 1.591110 MsK. 1U S..4U*0 1.43114-04 8.913-U Law1111 1 m)9. 1904. 3.81A-O 4 m-0 "9. 1.6w-84 1.611111-011 amS. L31111111.1-4211-14 EM 1415. SA.443- 631A-ft "9. 14635.

                         "53.                              On.                                             3.811111-4 3JLM0111 U                                                                     9.7619.3111-M4 5M         835.         ON.

I 829. 83. S511411413 5.41131-0 "I.. 4"9. SIN. 91.0418-011 5.61110-0 urn. "924 7U. 9.1313- 19.411111-04 on9. 4.1611S-U4308-U' W'. 615. M.3 WE 533. 11.0111,3-03 1.519241-V S534. 9.3712W34 9.12-011 So3. 1.011-a 9.01114111 S".

                          $43.

em. I.43 71". us4. I.2881- 1.1109-01 9.51.U 9.3171-U El 891t. 742. mu' We. .3.1  ?.On-=3 7.44-A 8.1611-04 7.9491-04 &A93-I US.51-" Wlmla SITE OTA InvI DASl - 9w/8 114-42 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 6 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Kr-89 00"M worgiSIvwgmapie hmsuwft aind 600w Idui wu Im NM Pkfths *a"" go" S

                                       $~bm                 sho"        V        1w omwin)       lWINriIav~Mhs 0                      UsN. L-W6S. L1#4144                4.UU-5    A.13K44           am'. LOSIE45 1.W146 "W3.                 LAW"       L.VIWW                 L44       LUEISS i..uin-u  i.iu.-u          am.        I."w"O 1.611W4l Me.                                                                                         LO1W-* 1.05-f MW. 1.153-U   1.1211-US am     I.ssa-s4 368344                   SUR-U     9.611-U uS                             2.31MW4    sam-%            ifS. 1.246-54 1.11W-SI            03LU ?1.110-1141 7."011-411 w         am.                                             140. 4.1aK..4 4.WU44 us                             4.0la4     3.95U"s                4JIU-54   4.31544                     I.1j"8I-U 1J54 V                                                               5.53-04   3.141144           NMI.

LON46U4 1J1.4w8 in0.

                            $33. 6.9*13440  1.UNM-                 1.71W-el  LIWI4S                      5.1741- L1UU-S
                                                               'Ul. 6.46K-el  5.11W-OS                    1.0"8399111-U .44-
                                                               .15. 14111-OS  7.5141-54          643.

6.5W-Ol SIlK -OS 1111-

                            "31.                                    5.1411.54 5.053-SI           me.

762. a.uss-rn 5.ua.e 5.5413U 11.110-43 1". 2.3"11-44 3.30I-0K 34151-SI 5.31W-K 1361 "To U101Wm1119f ORA Va7- 1Vw 11.4-43 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 7 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Kr-90 smu-Umtm". ON 11104"M ) u pond Ni- 19 i)t gliwll kad LadS ftk Nrew"l *a D.A ma,. I r bib" V -111Mboom 19

            -g          Noocl/wflgwilm) lntss)                           "Wutes) wob            Wwv14~s)                                  am I U                                                               5.19W-U  5.6111-U we                            3 IN-U1 LIM"                Me'. LUUU     8MW-U U        "ILS                L.W-06 LIll-f              anK. S.1361-U    6.86K-U                     SA5W-Ut 7956-U we                            11.11U1MV 11*30-V                  3.WlE-U  3.193-S I        "06.          MU    &M31W-86 UM52UM                    1.53-    a.uug-u            WU.

we L1IME-6 LI3-U W41. 1MW-U IJUE-U 140. U to. W14. 1.8w-9 5aIR-n 5.5361-U LSK-U "I. we an. 145. 6.1141-S 1.99K-U U M". &A.u116 LUll-U Ge. 3.1456-U 1.4536-S

   'a,        Will                                                  1.1746-U 1.511-U                    3.11111-8 L"W"1-U                      6n.                                      6.53U-U 4.3411-U           7".       I.mW-f I.SU-ft EM.                               611. 1.5256-K 1.51W-US U                      11a. 11.8110011 9.11ft-111              LiUW-Ol 11816-K            NO9. 1*51-U1115 A"U Is,                     "43.                                     i.u.-a P.?WU-U U                            L64W-4 6.4W-U1                     5.313-U S.MU-U we                            5.725-ff 5.95111-11                4.33K-U 4.156-U 1*615161S13USM *"A6 SIX - "M 11.4-44 LASALLE ODCM PART IISECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 8 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Xe-1 31 m bo*Illem tll. 96ed luibe

                                                                                                  ý-ww Lit            et I      oft        am".           V         "a5        ON".               I           an (inter.        eeaiwud.ieiu.461 U                    'UK. 1.6511-S 5.41345
                                                                                              'SM. thUS-9 mof                                                                                          limS-f "It.                 1.71.U UU45                     1.71111-116U 1.831*0                    I Jr-* LWll-0 U                    MM.      1.0K-U   1J2U4?        443l                                  4twl         "1.11-6 11412145 Eu                             1.9316-U 6.611141               711.1111-11  6.555-V        "S.         1.61-05      1213-Ui I                    1996. 9.5725-U 5A5114?       I196. 1.211111-S010-                  191111.LAS1ue-u 4.2531-O
   'U        11465.      145. 1.3411-u mm-s           140. SAWNU                           1445. 7.9361N           6.1-01 U         to.         on. 5.4725-S 5.36346                             1.8601-0         No.
   'U         on9.        ow. 1.4151-S ISlE-S         535. Low6-S 8.M-1154                  83L       14=*S-       9.391145 a                     no. 1.23W-U  1.1141-U                                             in.       1.23284      9.0101-05 SW                     5135. 5.2965., 1.113-S               1..01-4 1.M1171-S1                       111.111111-6 Lall-11 U         S.33        62A. 1.855-56 1.6911-N       Em.                                             LIO-04 1444-0 we                     533.

521. 1.uM-N ~53.S Sm3. 4.11611-01 3.371-811 2.384-S 1.8131-0 V $24. l.asus.u IJUMS 3.31511 211-011 W24. 762 L0111111-911 2.3-04 we 645. 1JUN46 1.155-S .9L.. iN. 64o. B."1110114 1.1121-011-U "S. a'.. s.usu-. :.sm-s 762. 1.5611-St 1.9331-S6 2.509144 1.5654 U. 1.1911-S 1.1121-U me. 11.3"931-U11 5.2 1.045-S4 1.M61-44 06111 INU ,437 IIAI UPSum - WW* 11.4-45 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 9 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Xe-1 33m some"d EasgSuw 91o9wrn ft"1I" u. Sum 41111111111) vowsu) £a~ )t tl com) (aW" ths -I 4 9..,u-. 9.4111-u LINE-* L49W-U U"I. U". 7.9111-1111 Lno-11-u11 amg 8.40U-S .e-u "So 4.2w-111111 3.111111111-u 4.415-M 4.3175-IS 2.440-U 8.1111111- VAL

                                                                     *A56.u i.am-m                      9.94201115    34"      -15.

1964. 4.519144 4AW-111 4.77W-U 4.UW-W UP. 6.6141-U &.3111IN0 7.3911-S 6.WE.M ow me. as4. l.O3U..0 9.654GM GEL LM-"5. LOUl-U V1 US. 6wU. ISAMU14 7.911IN-1 tHU-U 9.951-H No. wu o.33 533. 8.431-U 1.951-H

   'U         'as.                                           "64     suns-s ansi-s            uSI.      1.11741-8I 1.51.31I      401 M                             1.533t6- 16111M-115                14311-IS u.sauu-s                  1.6111f-11111 3.11411111-04 533.                                                    1335-55 3.49545                    4.411-8 31.421111-66
              $24.        SIR.                                       u.so.u-s i.~m-us                   LIM1-04 44M1-464
                          $43.                                       9.95115 9535.5                     4.11111111-ftS."111-11111 MS.                                                    s.41U-u 8.5K-u                     3.3341-54 3.Sm-I 75K-S 7.351-U SASWU $11116    SIISSSM 1UIAM         t-   13/5 11.4-46 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II,Offsite Dose Calculation Manual Table 4-6 (Page 10 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Xe-1 33 bwiwU ý06-ai 1msSaub mod -0003ta wow tld bkm Ishius11 &ar IV um IN" V an hums a U tenonr) oftos3 I4WOU1414*M) ~twu3 "N)/Mtwus"Ieali I0M3 a£fY)#SIdAM 1UK. IAIU44 LSU-M 134  ?.=1-* 741-Ut "1164. L.3MHK 3.g

                                  ~         sum-u           Win     7.1f40464w6-U 1313                     L="23- I.

U 1ia4. "EL 3.093-0 LWUU an. A.131-a SAM2-* am. 9.0461 LIN4 MAL 3443-U 3.165-U 44N3. J-ft U.31- "U. L5IUU 5.39-0 I 4w.

90. 1.511-U S.6?U-U "0134 .1 4.5134 "". 1.365-0 to.065-5.1611-US 5.55410 16. .534 4117344 1411111.11.615-ft 1.443-41 m6. *MIl-U 4.11644 90.3975-01.30- to. 3.455-ft I.M-0 Sao. 6.1341-U 6.1553-U m.9.33W-N 4. 166- Us.sit-u A.u.-f 140. 1.353-U 5.151144 4.3-#A.M7-*S 339 329.31-84 L3,1-.0 4.901-U 4.1913-US M3. L6a1195- L.3011441 M3. 1.734 1SU-MIN 90. i.iu-u isis-rn M13. 1.36U18-U 1.21111f-111111 63. 4.061-ft 31.641111-f so. a". 3.245344 7.9913-U W5. 1.311 46 M.534

3. 4.475184 5.3513-0 62L 3.1411-S 7.9391-U W3. 1AW465- 1.16"4 US4. 5.15U1104.1116 .U0 5.7151-S 5.5415-0 41L 7.35146 1570-U 643. 4.441141110 LM32-84 5.lflI-u 4.9593.0 74. .5ft144 &53=441637. 34411.06 3.3344 5.54K-U 5.1351-16 39."W $.1- ."a3-0111 M. 3.0501.E-04

                                    ".MJASU8MUNU8UOL mI fire                   13/m 11.4-47 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part I1,Offsite Dose Calculation Manual Table 4-6 (Page 11 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Xe-1 35m Swmw'I.ad EtewWitU.*) Moms lob" ~ 1hi &=d 4llMlet Wreindus bern mud ~1w S sm" I g.swsI tm.n~ (uw#prV4.~II3w) -Wre IuwI~4 I "Is. 1.30W-P 1.34W-OS "I-0W 'IM. 1.UI-OS 3.3364 S S.~lmU OWNm- smW. 5.33W-U 4.9363'S 0W 1.65-P, 9.WIN 1.17K-U 1.71U.U WI-

    *1                                                          19011. 5*3315 5.4651-U             "96.       4.32W-OS      4.1111-0
  -  131                   69. I.11.14165-O 1.611-1 1W0.             1.5111-OS 9.35-U                            7.0WK     10-4 11                                                          No. i .57K-P I .528-P          1w.

1.636 Jm-f 46 tin. 08. 1.5911-P 1.57K-P INi. 1.549 U USE-03 5 t.aus-P 1.1941-OS U1.41-U 1.M9-Ufi 3m a.3111-0S 1.9141-P4 1.3.-K 1.1W-OS LOW1-66 L.45-11-11 me *SN. 11.111-O IlU.P41110 3.4441-P 2.343-P 054. LIM-.s SIMU-111 3m me. 5Us. 11.31M-ft 1.311111-611 933. 3.4211-OS 13451-P 1.4W-0 1.E-U U 1.1111-OS 3.4211-P INS. LOW$$ Lam-121-U

    ~9                                                            'a'. 1.WU-P 1.4311-OS                      1.3.-S li.311-U1 U                           1.11132-111 1.14ft-ft           no2. 1.4131-94 13711-OS                    1.0K-U 1fUM-1 3m                           3.35 1111K   1.18111-u                3.3W-OS 12111-U                         .41.4.4311-04 LM.,I All E1mmWS                   MR& IR    -  13157 11.4-48 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 12 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Xe-1 35 WaW LwM blSs Doi" V w bile owlS somws cmaeVU)/4dlI... 111111%."Is3. .145CIF O."*6 SAMRU sm MIL 1*66-U Mill" %ft3 E am.5 am6 L"4156- jigSIS 3.8166 5.731145 VAL. 4.U!y" LUTE-"4 m w. 4wU. MsIMI$ 1.um11041 1.UU1.M515US456 a 196. "NW. sSAIM4-u 3.LYV6 34w. 4j51- 3* 0 3959 7411VUn9 &"15-04 6.%396* CR.6 1W6. 1w. 9.3W-_U 1.60464 9". SK 836. go.  ?.SSS-111 Y.593- 9.3111I-111 9.64-636 2 Up. as,. 6.vm-U CM45-. 1.65.J.3145 8a9. Ws. ans. &Jam-1111 .sM4 No. - T.1 ."66 111 ill. 2.35"- 1*17-6 61Ms. as. 11.01111-0i 1AW-M WIS. Il.AW11-K1.111 .4 43t0 2 1.63-U 1.01-6 so53. 533. 11Ii-41.110 1.3713-1111 141111-8 535L 1.116048 11.113-01 V 531. 526. 1.834 1.111101-1111 m. 1.314-ft 1.2ft.31 Sm. 1.0126-a I.1*75-WI 731. "1.2 ?J=48. 6.4434 a"3. 91.351-U LOWS. 443. S.MW-IS .M3-0 XL1 in.e We. 1111.73-111 A.u.- 7.32710 LOW"34 so. LIKIUE UU11M7 anE - wi? 11.4-49 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 13 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Xe-1 37 SIM MAN")M Ideas Lad Ideas

• iresti. a" Da so"u I am sim" V anme h,.4 m allowfsm) a1w"W")A al W-io) tmwwwwIftml 1- & I (a uwf;;fti1Uf
• u.

M6 4.11111111- C.1115U 5.53-U 1.1646-U 10K. LUE-4 Si-"u-5K tPS. 0WI. 5.911111041W- LIU-U 3.05-S MU-M6. I .63-U 1.63-U 1-9111-01 1.933-U 1.3111-U 21405. 1.311-U 18141-U S.59111-1111 1.4W-Ut U 5. M1. COWS3- CIO"s 1.916-U 8.651-Il "06. M.Up 4W3. 4.011U01 L.43-f "So. L98"34 1.3 111164 5)~5 1.6K-U MY"f-1. M W99. LS1.1:1-U1 11.41118-U 5.UPS-U 5.161-U Uj 6. 619. 4.73-0 .11113-411 S.~-6 LUff-U Site-" W*K1 &AMa-" m3. inm.

m.  ?."11111111-4 Sm. 1.911101-6 .11I us. 3.1241-6 PAUl-U 3.316-U V.4151-U aim90114 SA. LRU LSIU-U 'A-UK-.

              "31U. US3. 5.02111-111             4AMl-U           443. 9.61K-U 9.3W-U           'SI-im        4M.         la. 5.63-15 4.111-U                          6.1991-U 5-35K-U M6. S.910 J1111-       .f- 0                4.4111-U SAPS-U          MI.
         -      4.                                                      4.1511-U 4.56K-U umiSK      $111 UUIK              SUU smu -

11.4-50 LASALLE ODCM PART IISECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 14 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Xe-1 38 soon

• 3 sua.3 Aiim 11usiNd N-Vmu9--111 beIsous skl
• ig mOn Owd 8 o om" 9 111111 hu A 1 waws)w c1use) (waftrVI.HItin eMtwo) Wetwpr)Ig.1hu to""s) fwsewkfiIA"Il I SU. t1o. L3.31I- SAW-I WINi. 4J41 6.514 1 L LIM4S3AIP N 1.M L141 3.M-NI13. 3.103 1,13, &LI A S. HM. I.M111.411.301111- am. I.3P-0 U Il 1-1 I VALJ114".U l4D.

64W.

               ,E        44w. 4.3-e,,  4.9111-11 51.            4.5111-lu 4.446-              445.         1.?W13K 4             4%11-40 I           1911. 19S. 1.S4*11 1.401-aN        199.      I.S35-*4 1.4N9-I              1IL. a. **-a a.13-U Ut an NO. 119. 1415.

93. $.11IW-U IAM-41-A 8.7WN4 3.W- 141.

919. .151141 8544 1.WUlI- 4J,1-l 1145. 969. 1.UM-01.AW3431 3.41I1-U 3.1514-U1 1111 No. Ws. 4.U3119f Sim9-" on. 4.15114 4.1111410 111111.8.3111- S.51-63 8S. U on. 3.15- 1.011.1* I. =.31W-IS.1111 . 1.131114 li9 053. US. SASM-84 3JU9-1 33. .635-11 S.1141 6- UP. R.AM-iS I.7141-U

           *    .,.        M1. LIM-411                   W."D0I. SAW"-5     S.111141               M3.      ti.5416- 4.11-U WI           531.       333. 6.C111-N 5.93f0           53n.    ?.1314     6.3114               135.       5.3u-0       l.33413 S254. 51". COM1-" SAMl-*             M.      r.31ft41                          1.

In131 4JMUN4 4.15-U S INS. 6. S.614-16 SAM-% 13. 4.11141 43I514 643. .31- 4.A41'3

7. 7.

M 31.45,-0 I7?M . 4.*o 3-54111,411 76. 3.71- 3.=-0

                                  -.. 11WA XJ3116l           M3. 3.IW13111 3.S*          46           W.        .0f-US *M-U ILau14n WI fham.                "I& 111-      1am5 11.4-51 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-6 (Page 15 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Unrestricted Area Boundary for Ar-41 9=~i mm18-818 N6ft* £v Rsea" 5Allm. on"i W . 64409a~ it a"~1 Now I~Uiu i on"t I 3sml IKkl. m"")twWft~1 amu wme) iwy)lthm ow)(w"SAWInuss

• 1931.1101.1111111U 4.5341-U 1116. S.111K-04 S.SA 5411519-111 O*S.16W* 4.IA- 441114 M. 136 13SM. L011111-11111 LUK611 Mo". 4.114111 4.=*-K MS3.

W- am also. 111.111I-411 LOW3-U 9.5343a t5.773-6. IN 4490. 44N. 9.1414-GS 6.3II4K- IJSK-U 53K a 11111. 11No LSll-U Lft%1111-U1 3.1953- 5.4)53.34 M 14W. "4. 3.41111-0 S331-U 5.3W-Ut $.14-U "a6. a 111. 969. 4.11111-41111145in-6 4."111K- 1414.KU 1.611111-811 L3.55-U8 MR6. W.9 3.3K-G LOWS4 W4 43. IN,. 4.16341 4AM-0 NO53. 2119. 4.1111 4.401-0 4.1331-U 441K-S 43L 3.3K-0 IJIIE-4 on

u. MSs. LS.u4-f SAW-.K in. ,*L*M- 8.311111K-L.7-U4 4.901-8 4.=1-n IAJM-0i Mo3 61.

SMN. 6."114111111 .40111111Uin. 8.5911-U 3.316-K 41M-3 6.651.4156 EU S. In. 7.3K-U6 #A1101-011 m0. V M 534. L.33411 6JOW-U 6.11MR-111.31. asJ84. 643. 4.1111111-0. 436K-0 4.931-UM 4.513*1 Sim-on.01-Ta76. 7U. C6.134111 3.0W111-U11 761. 4,/441-U 4.,01-S S.17345 5Kf m. Mo os 4.M3-0U 3UE-0 WIS. 4.741-0 4X111111-0 LAWN SIN U1selo 1u~ O3111411111 - 1W18 11.4-52 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-30 1 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 1 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Kr-83m d 1.sWO .oh. -wdhu s" s.aw* wa.d Iskl.. asam I" iw.ow- ds -e" ot llke6sII'm$110111111 11111" isd. of me" V me" a~ 411111"1111 111- 1~~~Im111 " s)l IWWrI/thiI *u Ingliahs)65 S 3.11113 *& . -l.421141 535. lII*W5.13-P IU. 1.S.- 1J s 4# 1516 OI 136.3.11-4 SULW- .953 J4 13 SUL 1.13"46 111-a W,3,. V,. ,.,,,-,,.,aLN" 16P. 1.,,,-,.,,,,1-, ,WI. L,,,-6" 6.1=-I, MO1. Wt'. 4.16146 5.17-P 9 . LASS-P 6.66114 MO. 1.461.33

           ,=           U .           ",.      ,.6,1,7           4,-P       1 .       ,.,, 1               .,   ,N.         I,11L .A=--"

In MR.

                         ,,.                   4."          ,- ,.,1,         ,,,. 1.17,-U ,,,-,,            UN.            .3M -, ,.66-8, a             ,,.           ,,. L.SI,-W           .nX-o       9W.        .,,,,-M,,US4,             W,.          .34.3 1A.uw as             3i5.          335      2.4161419311W   AM           O55      0.11645 3.811146           35       .79J*41       I.=62-*

I sm. Ul &M. .1711*1T LINPS-P 1M. 2.13-U 3L U.3-N l.im-ft I.U-114-o n). on. L3. 4 1.90-9* 555. 1.1174*1-1,.t 2411-N an. C.M-0 741 111-3 NoM.. 6.. L.5M-111-P I,74-0r 524. 1.351-Si il4. UJ5U- 33 1XI* 3.53-. W4 53. &U. 2.4111413-I 114. - 1 W0 . 71.-mIt 51.013-Pt AS. 2.11111-A .9=4-6 t 752. Sm. I.1544-P 1.516-V in. 4.591-Pf I313-86 SI. L214-0 14751-SI "S. "L, I I1. -W* IJMl-* UL, IIl*-W 1,1A4-W* 6U. IMII-0! ISMl-011

                 -S                    P.

in6 11.111147W 1.6630-3 Ia. 4."--P 3.1143-P 31M. 15241111f 1.314-9 no. ~li lef-W1.11011111' NB . 1Ilia-Wimit on IA - 11351 an "IAIW 1 - a53 In5 The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F. is the resulting dose factor at the new range (i.e. 833). FRo is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R0 is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) FR)=/"-R. expl.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. Based on Sargent & Lundy, Analysis and Technology Division, LaSalle calculation no. ATD-01 64, revisions 0, 1, 2, and 3. 11.4-53 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 2 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Kr-85m

 $VAR"           besufrl d *4.imilwan dms *                               *u!N                   fEl)               N Woes        . i iom b"* so         ft                s 5ai       u01111                         v                     a1 M              a           M 41111111111111111 41111111"W1111 W ~V1111118                                  .W~ ~a~11es"                  I1e)g w Mhs
                     " ft.         m.WI.S.f          -   5.5i4"           UM.        S.0A    -    SJW-U          3W.        V W-ft 9J.            4t a             136".        1O.        SM.
                                             ?.IS        4.3-6            1*11.

WW .A - 5 U 5 41-5 31W. 1,.11-31 4.W5-U3 M MO. U". 4.4111 4. IN"4 1W. .9 -S 4.4111194 "Re. i -* I.=1K I 13s. gas. 35. to1 am Me. 4.5ta1.

                                  "I.s65. 9.66".. 4.u-t'U 5.7365- 4.11111110411         Wk        S.AW-@

15%. IS.BMw 11116-U Lam-111115 4.m-o 9.$M-0 M

• s.

4.135I-S 161 1W. 5.13-4 ril.n-U M.5 6.7m-06M ILMU1441437-S

6. f9.

U 5.516-S141 3-6 949. 6.610-S CU.91.1 fft. 7.1IN-A ,.A? -8i me3.

9. #.47114 A.Un-05 61. 7."u-11115 7.03.45 411111. 935-K 94014 *m. me. CMUs-111111 e.mm1I-11 11112.$."111-111 sLau-us Mm. Cl.w11m.U L7.11116 35 3. 4.4254 4MUf-fl1 M5 535. 5.11U-0S5.17141-45 335. 5.46-3111 5.450-04

                *                  &.U2. 116I114670 166                     &U. VAX-53            #.619953-65 W. 1.25-85 UM3-1111 II     533.         513. 7.1511-U 1.5011f-U111               535. 9.7R141.1 93335                   3        I.NU-1 U311-0

• 24. S24. 1801146 7.NW464 524. 9A7356-US 9.309-85 514. 141.611145t- 1.141.31

               -643.               645. 5,5145                  11140 1.1         64.      6.61151-111 6.3W1-1111      643        1.37-U  0        U*

• Tn5. 751. 4. 5.5 S1.35-11111 Va . .63-Va4154.3- *

              -                     M.       4.411111-6 4.53-S              -".      5.14U-0 4.11111I-0          8". 9.35-U C1111111I-Ut SilJUl 363l UIM                      Ilia Ins -

The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F, is the resulting dose factor at the new range (i.e. 833). FR. is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). Ro is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) FR? = FXR.L ~expl.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-54 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part I1,Offsite Dose Calculation Manual Table 4-7 (Page 3 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Kr-85 I1s6i gSmsveeN Iftummaku&)l k~isem lnu li= 3nila0e &* Misnd~s nMvmk Ios S i~M am V aom ,aS UI (u,$s ls~1,W C',fo*./.i,.0) W, lIj IW~WgWt &on, we k ,o)

       ,            335.           3511.     ,.4-P        S.N.ULa.        331
                                                                           ,           .111~-.a
                                                                                             -P9.s-.           3n.          ,.       -,.-61.51-3        I a3m1.         am         7.31-P,.12r                  PU.          .oWN-P ,.11-P           1.          ,.41.41ft      ,.5 of.                         -.        ,.3-        E,.

• m.

n 3.,11-1 S.sm-.

                                                                                                    . .,       "W.             .nm        som=-
                     -.           319.       ,.11A-W L.AW-N               3Al.       ,.13-P .4=-Pw             3oo. O.6511111 ,.MU-0 m,            MS.

les. ISS. lus. 15-W o~su.w

                                             *.isu-o        .s*1-P        MS.

ius. ,.5-P

                                                                                     ,.I.Os.Uum- 7.,. -P        ISr. L.M "U.         s.m- -. .is.,...

LSIX-U. a 39. 30. ,.4?-o L.,116* W. 9.=I-P ,.)LU - 9i. 1.55-U 3145 W 561. ,OI. ,.a14, 9."W SO. ,.1,-o4 1.1=111-f OIL I -M46 .I3-9 UP. UL5 13364? 1.691-P on. L.41-P ?AWiV UL. 6.61-3 UM73-U a. M m. ,.S1M-P 5.63 ? W. 0.4111W LIXI-P 53.L 5,o ,,n45.6-U, s.M #U. 1.%N-6 1.11-4 6. ,.44u1.4o 4

                                                                                                    .,6-.,62     5.         1.4         I,.i5-U So.            53.       1.11,,-U              4       53,.
                                                                            ,1.      1M3-34,      1.310-8        No.        1.31111-0 16.W"-

V 534. 3,.. t.,.,I.. 1.1346n-f $.4. L.391U a.44345,.6140 1,.11-I IS.

                      "L 013.          ,,         .U1a4      ,.9W15-I?         543.     ,.a,        9.5..-7         63.        1.3-64         1,11110-1 I             153.           YI. 7.l9-il ,.4I-Sir                M.      lSAN-P L4011-P              16L        I.135S3 1.111-0
       ,.                            W8. I. ,            .a3-4          MO.      ,A      -P 7.5.M-P          I          LO.           ,.1m114 0.1111U LiO"u all                             IS 10 111KiUL     - WiWO The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, Fn is the resulting dose factor at the new range (i.e. 833).

FROis the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R, is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-55 LASALLE ODCM PART IISECTION 4.doc

CY-LA-170-301 Revision 3 Part I1,Offsite Dose Calculation Manual Table 4-7 (Page 4 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Kr-87 S~I ft"

                &amI              ~       ~      S~      6011111        ownA                    Ug oeuý      me              L       S s...          .,g-w      .       .wM1,..,-,Iwo.                    a,,W,,,,            ) 11,,.W-S         16.             I.       LI.S   -1    .111144        01111a.OS I".                   IJIISA-O      MG.       i     .- U     10=411 19.

o n4. usM-S IUK- e. - IUI-OS 146. LINL-U I.I4-U I16M. - .3-S 1. Li-lI-U 3.S11I4- 169.

                                                                                                                "         L .W- 3U         lSU4U I           1115.         lay.            w g 3.         5         6,       I.3-M 1.6N1"              1g0.       L"       "   LUIK-

• 6211. MS 4.lIIUI3443.1I-P WI. 2.111-O11 .113-44 "". SI-I."111-U11 i.

a Is. L7 -4 LUM-O U5. S.41I3-44 3.31511 1 to U. . I-0 LJMU N oS. "P. UIN-S 3.111-1 up. 5.II-P 3.5in-f. No. I45-I I3. 43 so M. U. I.XU-% LUM1-SI M. 3.404 3.119-04 05-. I. 1U 1 -

                      &a62. AIL               441464 4.4M4-86              6U. SAW011O              I. 6U.            LIeU-U 3.115K-US Mo653. SM.               .1KO 4.71153-OS             use. La-.6 -S     1      ."W54        In.       4,2111111-U LO.13K-V            in4.           so4. 4AM1-SI 4.5435-f              522.               11, .415-M5.155-                5M.       5.1315- 4.qW143 SUM 64.               643. 3.U14-SI 2.11SX-M                 64.       S."142-0 3.6546            643.      4.61K-U SAW54-U M41.           M6. 3.153-OS 374341                   VU.       L.51-ft 3.3W-OS            703.      3.316-       3.611
               -      I.             NO.LN3115-M 3.1'-N                     1.        3.6311-K I.i-84            M .       i.'4S-       3413-UWAML                         mwu   osi   Uft    -   MIR1 The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, Fn is the resulting dose factor at the new range (ie. 833).

FR. is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R. is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) ER = FR.R.[ ~exp 1.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-56 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 5 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Kr-88 SNlm"tla m 0nml buam

                      .ki                        1                                                             b 61141111.--

1111 I10 qmmuu t~W8 $WW~ywwmmd ("tw 6WaVr inus IcStl. 4Uwuru &4W*14W1hs.5 Nr.

                                  "36           111        A.."."                   1.U3 1        9.115 La  rMW                   4.11111          I,13h1 Wkn 14W.

am. s. SU.

                                  "W Vnnu-"

S.A1- 4.15-SI-9"- Mow". ri80o smP. LOUW"*3.3" T~.u W .C.smU4 aus iN. ;5me-U Sli wo-. lliqf 5.

                                  " T. 685=-* L2                       "It. 9.51          LM.-M         11.         5.31-01 S."W--A ON         Ul iN6-V11159ii-0M.S. 6.911-6N1-31      #*1I.=-*         UN

90. 701.112111-.t 9.41 L710-0 F-M-0IM MS. .lfle

                                                                                                                          " L 4,1- M 65.,5-1 LNIMB$

a 31. Ion. Usm-o.1- I.3-5 to. 9.113II-M 9.,511- W5. o .7156 $.343-m urM irN. MS. Sm. 5.55"1415.315-5

                                  -1.      I.01a-11            .11 AX.8         155.. L.Sflh-0 9.U41    -M   lSO-Wl 1.1*-46        A . -5.:I1P.4
                                                                                                                 ,fl. f.S91-56 5.815=-e 1.64 -u 0              M.         &U. f.mN-U P.i-s0ru.                             ai.lIl-ft     L.gsI-f        08. - S.0                  sN41-WW5. on.          Lanu-" ?asu-oi                   Mo. OX.sn-Itsuiu-11                  on.        *.rnu4.161446 re3ic1e bas          &U. r          d Ued  sec-tor            011111110 11.11111114 fm 10. ad 0                      9.mcIv-y Aasum-ls F3 vi         r        i      3n.OM1.3o14e tables. (.51U                                R       .5istme1-3                1.05511)-

(3M. #.W-1111s U34 54. Sm 1."1415.1 5.3113 sm..1115

1. .3-U M -83 2". 1.M1211-W 1.59U-S111 "La 445 . 8.445-K SA.4451 643. 5.051651071S 443. 9.195-6 1.3171-0 W 1". 768. in51U13164

1. 0.iase-0951164 745 LON-"64 rim-11-61 Sm. NO. 7.3116 .1111411 an. 8.5161-96 7X111-P 511. 6."1-" 6.3 13U tUNS 33U.U 446 Im - Um16 The restricted area boundary (RAB) was redefined in sectors Eand ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F.is the resulting dose factor at the new range (i.e. 833).

FR., is the value provided inthe above 00CM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R., is the former RAB distance (i~e. 1055), and R is the RAB distance (i.e. 833) FR=/'*o{-R.exp I. 5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-57 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 6 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Kr-89 SinWW blteftld Nlevueiglt ) ldv& Ila1" "N )J kIm. lUll It I Is8 imt. K..eImN Ur &(mBIwm) 4mwa t~inuus We~mT3ltia¢isIU 6 I tlmwrTs beldl so" 9 l6@0 4£TewrnhI/l*a)! me (maTelvyrlI4.g*.) *m)w l 1116. 156. 1.tlO1-K LPISI- 1136. 4.am-" 4.UUl1S 1136 LSM-04 Un.tn-13 WO. La. .IM-s LAN-ft 1IL. L.5K-U1 R.wu- s 1.15s146 1.1s"

• 1I" . Mo. 1.11.-K 1.N15-0 1ue. 1.6541-U 1.51M-U Mo. 6Sim-" 6#15-0K M1g7. "It. lLIM-94 1.120-0 1Wt. 2.SW4--

2.6111-1 Wt. t.4S-U 1M-43 13. n o. 34-I 2 -" Ms. L"a, -* 1AE-U "15. 1.56-61 I.S-M4-

                                  "I S05.

t05. 3MW-U6 3..9uI- 1s. S.09-0 Io1IN-M 165s. 1.0130- 1.1I33-43 l* 09. 09. 3. 1.WN.U 3.11-I 09. 4A.I1-K 4.4IU-K 09. 1.KM-09 I.lX-0e SM m. aM. S.nS-M utm-K 6". S."in-, $.0U4-S1K i . I.7In-es L341-" I SN. III. 1,4641-U 1.1511-U le0. 3.312104- S.M-111- . 3.1IM41 3.5M-4 SWl 135. 135. 2.1111-4 LIE-K 35s. 2.71m" * .7m5.8-4 133. 1.82-U. 9.9m-8

1. . L M,.- 6A-.11-K 01.14 6.4=-U 6S. 3.V41-0 3.UM--1

53. 533. 6.9131-K 6.115- n 533. .I-U 1.3111114-K4 M. 4JUN4344.461* 111111-0 53S.*. U4.

14.&.%

34. COWIN -U 67W-4 4.17-8 3S.

43S. 1.250-0 5.110-U LJ2K-K 5.9W-K 524. Us. 5.71946

                                                                                                                                 .7M - S.296-SI 3.6=KU W             76, ..       76.

TOK-U 3,33-K "lWN .C4M - SWIN a-U 753. 3.54R1- l.4R 1-U ow M. MS. 3.31M1-K 3.UK-0U M6. 5.41m-K 1.31U-0 M6. I.56-05 1.IN-0S UIiSK UN I OAUL 11111 - 1WMl The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F, is the resulting dose factor at the new range (i.e. 833). FRO is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R. is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) FR = FRR.[- exp 1.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-58 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 7 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Kr-90 tm idaW ohIleeir fIevutedillwaI) Iteins. oIbM nim(S ) 0"M... i I WM W6 Ii 0,1fe f gum on" AmU "r) mnd- 4W*'W3l60Al"l 111111111111" .I ShS1111101111 11111110111011%) tI'ii!)dw V l Imatbl Waw ON" ('lWl** an~e~ 111o11 am1 0 on3. W&1. d.*9415 6.5f-W W . 5.1110-14 5.1114it11-US 3M W .SUX4 .01# onS on7. UM70."1111114 I.111103- O3M5 13SX1163 1.5W-0 OIL5 LUM40- 1.111-a Uf. MOP. 11.8411 1.3111111-liP. 6.ftt-61 &.M-034 U0. 1.3,1S-4 7.134-61 MI MO. IWI". 3.71145U 3.6]l-.*" 179. 2.01111415 .41114-15 t. 4.53-46 LIUMIIS MSI. 1111. 4.5=135 ~4.6W- 1MS. 3.31148 L.1M48 151. &1.119451.11GA -5 S U. I155. 6.311415 LON-* 15. S*1345 4.5-36 1S1. I1Nh4- 1.#61-% Vas. us. S w140 LOem-0 M. .gLUNAG .mU-s s. I..41r .UIN-46 6".. 6M1. IN41111 1.1, -ft AIL  !.13-1 1.01-61 011. SAW A 2-1 1.1111-0 s o. W. $.=5"-5 N.011- Um. 3.1 LS I1SI-IS on. 1.1111-91 1.17-11K n 55. 0. 3.1 I 3.WI-ft 55. 1.74I-5 1.I31-U 855. l.85I1-5 !.79-S

• WU. 6111 9.1-U 5.41111 68-. 6.3I-U 4.3*11-S UL. 141-I 1.39-us in. 133. I.AM-1 .I55114- i33. l.5833-61 S3.

USl-U 4.101U- 4.?71-SI V 534. W4. A.13-* 1.1011-0 514. 1.11N-0 LIMl-A 524. LUM21-04 S.1701-01 U s3. 44. 1.1 11- 90L -S S, I,-1.111-11 9.18n-U 643. 3.1411- 3.0114-ft S 761. "I. 6.63184- 6.44t-t11U 76. 5L.5 1-,1*U 3.I41S in. 1.34-SI t.I614-04 UIn m. 3.. .11-1 4..111 1*. 4.21-0 4,111-0 85. 5SN-I LO.43 IU1111iU Sfloluk MIA Ii 15- am The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F. is the resulting dose factor at the new range (i.e. 833). FR. is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R, is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) F?= FR{.R]exp1.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-59 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part 11,Offsite Dose Calculation Manual Table 4-7 (Page 8 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Xe-131m tmm"3 Now*) tWetfW110911m)oo pWo1 Im,1 40tl4ub

• 1036. 1636. 1..603* 1.413-OS 3M.t./JU

                                                                          *1.t.             -346               !16.               -111111 1.*.111. .. 1, ,.-              no. uJ.*          1.u4         sm.        ?.14146 &1 I           lo.n.                    t.a-ft        I16-             M.         1.4669-U   t..oU4                      4    .0u- M g           "s.             ",.       ,.aft-  11-6                   nd. S.AW-A       l,.m     t-    W.        tM      -6   Jm-"

i 1M. 165. 1.3466-SI.*46l. S "is. 1.0I6- I.3N-N s. 1.2-m. 1.914*4* a3 65. 6 195.Ii I.4-- i -1116 OW. 1.U1-J.1 RIK so. M.195-41 1.1*1W-ns m, t.ms-ft i.41M." m-e. .6-W 39-u e. I2.9-.8 l.M

m. a ~Is. -tur11.111W us. i.uu- 1W- as. .3- 9* 6 I Na. os. I.uul-s us, M..i-u I,3 - . IlL 5 . 1 -04.U3M-6 6; . "s. 111 m.

M.tc 4.11- L.t-N 6n. 2.1 1.6111-" 3. ma 531. 1.115"46 1.M-461SU53. 4.1611-K1116 SN1- 1111. A.M .%-S 1.013-Kt Va31. 524. 1II-sm- sm61N

1. 3.3ff-U I.Wx1-ft sm. 3.1m340 8.0m.06

                    &at64. 643.             1AM1-03 1.11141-               Ga3. IV 1.9110          U.19-    643.      11.4w.0 1.0m."O 1i,112 in.              tim-u6        IA            Mi. 1.96U- .96               -      via,      2A.u - *.SM."
               -1s                  s.      ie-19    11146II      -U6       M-. S1-11111tf 1.53-1111            IN.       14946411.83-O uIm" an1                 3MRSU1K WMU             - 1M The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F. is the resulting dose factor at the new range (i.e. 833).

FR. is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R, is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) FR= FR.[-&] expl.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-60 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part I, Offsite Dose Calculation Manual Table 4-7 (Page 9 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Xe-1 33m kmiUN ftrleui lOWftedwkek) Wom e e011 Od1411" Mlese *1 S."S sl41.N hWrasM aM bud b" I ON on V- No sm II isten) WWIrhI 4Wmil WI1)4Ul "Wer) WemflWlOll5hS "IWI* oin lry"fth") 1M. S SOL. u X- LIW I- uN. 9.4%9-U 9.415-t OIn #AM-* aL* 1-0

       -                         133 W5           .9131 7JWU 1O15.                      LM.411S     LUM-0         W1           1.3N     S 1.453fS 11me.

U MO. S SA.N-S 111, 160. 6.10111-0 L U- 101.111-I S I.16-S MeNi. Wt* .45- 641-S 1 1'.1111111111-0, 163 .1211-S IASW-ft 1* IIUS.011. 11. 6,1 -S16.4=5-U 145. 71.911111111- 1111 U . .UJ1141E 3611-S E1 115. UN. 611-* l.4516-U l15. 9.33-S 165. 1Jil-U4 L8u110 .K1l-S I 110. - W. I41-111,71111111-81, 9. 1.1111-1111 9.411-5 11W. 1.115-411, I.63-o 31". II. 91.1-U 6, - I 1.81111-1 5,1111-1111101111411 IL, 41.18-4 1, - sm sm. Un. £.41- 6I-U 6. .6.t 41 LIMIUI E15. I.5M4- I1.341-N W SM. 4116. I.II-1 SAM3-OF 413. 1,4311-U 1, 1-IU 4..L ,4111 ,11111-ft WV 533. 513. 1.12111-11 .111 .- 53 SU. 1113U l A..IN-0 NO. 4.0111 31.41-ft V 53K. 524. 1.011-11 I*1- 531. S .11II*UI 1.4171-1 MIR. S.AM-" 4.W11-S4

      ,"             $4..         643.. ?."a-*           1*46-1              641     9.        1 9.111-U4        64L       4.5,1,- 3.4416*-S WI            11.           41. L.41-.,          6.S14-O              M. 6.43%-86    L.N-U           1U1.      3.3311-0S 3.3I-S

_" 66, MS, 6.8011-46 6.53-S M. - 7.SNW-S  ?.t-U mt. 13. -0 2.1111111111416S lamuasn au U3um6 1, SM- IlW The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F, is the resulting dose factor at the new range (i.e. 833). FR, is the value provided inthe above ODCM tables (i.e. S, SBAR, V,VBAR, G, GBAR). R, is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) It R.

                                                                          'expl.5 R.-

This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-61 LASALLE ODCM PART IISECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 10 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Xe-1 33 SWAN bS=Wk* 61-w-WROMW 11h1k Read Eibrn am WM 61.11131111-1111111161 W31  ?.""- LAzm.- M .O W1 W. SA W "-4.15* 0U pt . Si m4-" SA Mii 11i 153. LON-* 1.90"- U Wt6. 15". S.UK-11U1 4.53111-U Wt. 5.411-0 9.193- SM. 1.5110-K 1*1-N" No67. 1"MS. 5.m-M.1- . 4.169-U 5.91-U Wt5. Lis"U 34W-K 1111155. 3. MS.SEUS.6~ 894- .5- MS. SAW 1.3111111-11111 "a. L.541136 LIS-M so AI on. R.49-K LU-ft d".U 08 6.6W311-6.U63 LIES" LN-ft no6. No6. 5.332-U5113S"-U me3. Y."1114A £ JAR-U 61116 1111W3.~t1111-K UW.811-ono61. on1. 4.0ft-f 4.111311-111 US. 6.9111111-411 u 6.44-U as*5111- 1.36-134 II 813. G16. 4 .1409-U6 Y.3 862. 1.314111111- 1.2111f-11111 me3. 4.6 &-33.464 WW Us5. 53. 111.341111-011 1.10396 In. LIsM-* 1.2=-" 935. 4.4411-04 3AU-03 V 531. 5sm. IliuM KiwiU 521. 1.Z6-U ,5m6-U 534. 5.L01 4.909141 UmM ..

8. 43. lt 9.5419-06 643. Laft-011 T.I5"116- "I. 4."W"-3.9m41 N2.i. 4is.111111111-M MR. 6.00-06 6.ui=-U M6. S.53-1111 3.33-K111

             -       56.          UM.                                            U.

M.WU1126 5.91WU1 111- 56. LOW3-" .19 UAKM 311Uil NAIA IUN - 1 The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F. is the resulting dose factor at the new range (i.e. 833). FRo is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). RPis the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) l;*?= lR.,[--. expl1. 5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-62 LASALLE ODCM PART II SECTION 4,doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 11 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Xe-1 35m OWi law111s ntN" NI t l 10d tweap t.ftItuut) 1t t WowsIrIIt ust Hv=i lirn . tHIN. I U1g!,, tra . ,.i. UNI ~IU. U,~l,~lN, a m. a . 1.35" N1W 1131. 1.3 K tWS-K .- .l 48 1.M IN W-O. 16. NM. 0" LOU-" 1.44- 03. 1. WO. Wt.3 L1. tIN 4- V.0,-ULima. MM. Wt. J."-4 1*165-0 &.IM-A I.""3 am s ties. so. tsi. t.ts-i 1.t11-A t. s u~lI.In. t.wS-3 .a-K 1U541-1 -i03 as. t.1-0 141111 t.tinI-0

11. 1.1-m

     $ 1.

oi. AILU W. 61. ft1-K t.iSli-1 10. t.,. 2 1.,135 l.03-K 11.443-Si tlo. I.t1-1 111U -i 11>9. OILdS" . OI. 1.10 11.1 ,.U 2 M. .W.I.m-.1 ,.u4.- Us. 1.115.11-1 La- as,. *.,s,,-u ,t -., E D5. 1.1111S -1. 1.64- 55. 1111111 1-0. 2t. -IK I.444'-K

      "               m.          01a.       1.615-8I I.           -Ut     4m.       RAW
                                                                                       .2L        1.l-           614 5        Lt,1- -. tL1I6-1 1 No33U.      V0.         L.615-K $.*XI                13A. t         -A IIM-K4          53L        L43-U L3W-U V               511.        5U.        3.3.           111-MU         526.      1.5116-M     11UN-U         1111. 5.161-11111 2393751-U10 "L3 76.

11143. 1.311-K 1.1K 711. 1.31-" .11-43. 741. 1."N1-96 1.U1131-K Lan-* I.W`111-K go.L 7in. 36-UI-

                                                                                                                                          .5-1.5-1Wsm.                u.        1.16:1111Kf t.11I-11111        u.       1.3m.K       w.2171-0       us.               1.42U11141111
                                               .rU11111111113sn U     Imm CAU      51*11"      3I- S3W The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F. is the resulting dose factor at the new range (i.e. 833).

FRQis the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). R, is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) FiR= FR.[--Rexp1.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-63 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 12 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Xe-1 35 bon"k mbi" ak -1 llllsll) llee Nowu embw WOO@ w ft"1 owS m.m an8 me" 9 1111111110 CROWD') iwftb invwrvWCL4"4ms C~ROW) swowwwalletIIS) ""aw V* Il U 111111011.

                            -1111.         614           .5118W1l-0 1111136.          9JSIU-111      .62-6     313L 65            1am1          1ISM. I-1115- 16.04                         Me1. Y7.8 11-U1; 5            1376 U           MOl.          IMO.      I. UU461- 4.741-S "N. S.4U1311-U SJE-S                              WO, 65            379.          11N.      I.1346 S .61-0                   "M1 6.4111"             SJPI6       MO1.

I us6. 35. .4X45 &611111"4 155I. 7."s15K-U6.1 4 1M5. smg. 11111111. s. 11111- 11.111111111114 "Is5. 1.8WR-S11 "111111-11115 No5. 6 Us. 9V9. ."9511115 ?Am-*5 no. 9.5161. UNWO- 911111. .1.UU-6 1.3162-6 SE eo. Mo. V.353U S.119W-111 69. 1.11- 1.NP S IM. 1111111*111-5 S NO. VS. G."aU41 M~us. 1.41"-o u. met6-s a3n. M15. 6.3111456.1- 1 . SE. 1.6311.-1111 ,imes 1113. I.69f-K 1.43ft-K U 531. 53o . 63 1.11 .5734 SE on5. 1.411111111-4 1.3K-K 53s. U Sm4. $34. .614 3 in.14 1.3741-a 1J19. 5$4. 1.15.6 "u-0

      .me           "I.           6U.       I.5361451 1.211111116            UL.      93555'.NX09U11            6U.               1. LI-M16-Is U             "a1.         761. 6.841- &.44-111                       7In.                    U111111111111-0 No.

m. IN. 6.6-11-S11 L"459- m. 1.3X11111 P11.MU111-1PS MUs madA. arn .11.RU" #"A Un- am3 The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, Fn is the resulting dose factor at the new range (i.e. 833).

FRo is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). Ro is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) 1R = I.Ro[-.jexp1.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-64 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 13 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Xe-1 37 ge*bi. I - ,S " a t"edim) Io#" e I SmiihaNd 0 0V-IIm aei" S" ai WNiWe came) rmemlyr)I(.tIueelI C ir*s IMIIges JImbr, IwWpW4aIg,.e)

                    " U..         IM.       4.7111111-5 4.4o               $161.            S.        t.41       1 . 3.M4M                S.M."-

VOL. UN. 3J=48 S*qI- mu. 5.841 I.eM-u an. 011-0 1914-a I. O W . LM -411 815W-U 11W. 21M-I 2.111-5 1 51W. 1*.111144 1IdI-S N ". MO. 3.5 41- 3*0.51- SM. 3.111 11I2l115 SM. L4111-f LI51-11.

46. "111S. 3.7411-11111 3AM-05 1111151. L"11114 11.59011-110 651. LSe-0 *3111111-11 95.

11110. 4.111I1-4 4.411-S WIS. 4.8716- 4.721K-11111 . LIMl-0 24AW-1

• 90. 4.^X3-0 4.5"11-S6 %9. 15- 5.1101116 .S 5 NO9. LUM-0 28491N11-S

55. Me. 64 56- 6.SLAW 6.111411 6. 4,UE 4.01-1 I m es. 4..im 4.90-t6 m. GAW-.II- S."l1-1 1 11 . 3JIM373 351J"0 IN M. a3. 3.2 31.45K-S as. 3]M-S11 -Sim-I a. 1.111-0 1lowa-*

a in. an3. 41W 6.563-15 63. 7AWI-U111 7A4MB M3. 5131311111 2.146111-ft W, 533. SX. 7.9"1-I5 ?.R W1. 1.0111- 1115 S.M . 5. 7.141146 64.1 -1 V 524. 524. 1.11-4 7.110-5 SM. 9.1f145 9.3111-1 SM. 9. -66 8.1134-do. 8]o 543. 11-11.1-4.13-. 843. L.-S1 .11K-61 U1111 5m11 11 "a21. 7. 4..i11111111U-1111. 4.41-110111-111 7we. 4.2=464 4AM95-51 M. 00. LW.U 3.l53 U 4.111-U-11 -U M. .11-K 1.173-0 The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, F. is the resulting dose factor at the new range (i.e. 833). FR. is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). Ro is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) 1'l?= l'.,R-- exp 1.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-65 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 14 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Xe-1 38 1 WUdau les setk"" Ili Nod ) MUM Ubld s L Ide

               &"~lm  ft bud                                             so"l.             V        w          6"                 a          M ftwa          *new" 561.         .36-33.51161t              1636      4.511-1      4.161-1       35.M        3.51-        3.WAM S             W.         U6.      3.N36-3 SAM 1-04 469, 8.111311f 4.3%6-84                           1N.         1.4l1-U &.4146-
                   .NO.          1M9.                    3.

L.OIN- -4 1679. ,.86-f ,.9i4 NO9. I - 1,1U

      ,                          165.

wt. ,.S-i-,LawN-* 1WIC. L.OW1 SEf.U.Ulm ! . U 1.511411

                                                                                                                                       &.1 1 5.         1W          1...3341.1141-f             IMl.       4.14"K- .6            3   011.         U14111 2 1-4X4 MR.          "0.           9361-1 I.W34              IN.       4.4 -ft CM  4.I-311         39.       LAWN-6 &               -4 1111.        A".       4.93, 1 4."U-%                39.       5.IM-9      5.3111-.        SOL          16 W      3.W9-U 31.

M 11S. 3.49641 3.411141 N. 5.111111-13.561-119-0 33. . 3.,1*83 -1 UiS. as5. 3.3**-1 3.11641-K on. 3.63-111 3.11111- In. 1.316*U 1.34S3-U 6116 13.UL MUI 1.51-K Mt. 721111-3116141 mL 4JW49-4.4111-0 VW Sm. 5i3. 6.54434 im91-11 BE3 m.71-11 3-11 533. 5.3U43 5.621 W ua. Sm. S.976-ft SA.M.1-*4 is. 7.M11-84 .1.109-6 s4. &.J3 .-U 6.L36160 1145. "S. 3.6-4 3.$,41 . - "I. .6 -11 4.I16-01 "I. 4.1U-46 4.61,-0-5

• 71". 748. 3.45-11-4 .3116-K 74L. 4.1534 4.611-4 V1. SAM1-U 3.U155-3

              -S.,                06.                    3.21-536-110 1                US. 3.68111114111 3-MN-0             39.       31       1 .041 11111111
                                                    ,1 "1111111111     INSUI              U.

M - Um The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, Fn is the resulting dose factor at the new range (i.e. 833). FRois the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). RFis the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) FR= FR,,[-. exp1.5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-66 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-7 (Page 15 of 15) Maximum Offsite Finite Plume Gamma Dose Factors Based on 1 cm Depth at the Restricted Area Boundary for Ar-41 u 1bu6rh1elew ua.~UaSkJ)Wlewme auMW hifgeVef) llllR.. &rul £oo. ftlmm

                 &W u             1.11V .,I 0.

Ift" 4.SH-4 sINam-s £.ufu 1.1on *.on-As"411 so ISIs. ISM. 3.11414 SAN" MS.  ;.eiN-u .wu-mK UN, -SM-U LUff-U a 111. MO. RAN LIM-IN

                                                           ,"            0      . SAM-* LIM-                     ,SIM U          6 L=44 MO-19 16*9             513-N8        1-"*-*4         MO. 31-7811-0 U11111                 MO.        1.413-U 5811111011 No.           1 "SI         .1W,-ft 1.DM-Nt            11111. 4.11111111-0 .111-            11115.      S            Ln U M           "     .       1111. Inl       -N 4AI      -ft      Mr*.      5.1N        4.416N        M.         SAM4- samB-u
        $            11.           i9.      4.nl3-es 4.wa6-N              so.         i.3im-     Il.14tN       up.        I.7"1-o L.ShU-u on            em            So.      5.415-N                       Ms.        6.411-N 6311-1            491        4M4516- 4.5 -0U Ua.

m 0. 4.111-N 4.MU-N m. *..ma-4.430-N S. 5L.A U SUN1-IN us. I. 34,94- 3AM-8 M. 4.W-SI 4.117" m. S.1110-0 J.A44-W 431. 6111. 6.?53 LOU-1-N 430. £33-U 1.1SIU-6 UL. 6.131111-1119.113"U h r r nd. i in.f- seor-s EnE t . ad-848 from 10 - m M55 s. p4v. AL4 t331f11 in51. 524. 4.3341 6JM-04 5I4. M"1-8N SJOt-0 W1. LaSS-U11 T."111-U111 11 431. 64L, 4.11111114111 4.3 -Nt 6S. S.71-011N .031-6 6. L=-3 Luff-U

• 4. M1. 4.121-N01 S."19f-44 W. 4.9X1K-N1 4.613110 wt. 5.111311111 S.M-U11 M on. 06. 4.11111-Nt SAM-is as. 4A471-1-N4. - US. 4.374-U 4.UZu.U UmARasun iUNmmIAu W IM - IN The restricted area boundary (RAB) was redefined in sectors E and ESE to 833 and 848 from 1055 and 1055 meters, respectively. As a result of this change of range, the dose factors were re-evaluated using the following equation. Here, Fn is the resulting dose factor at the new range (i.e. 833).

FR. is the value provided in the above ODCM tables (i.e. S, SBAR, V, VBAR, G, GBAR). Ro is the former RAB distance (i.e. 1055), and R is the RAB distance (i.e. 833) 1"R = F&{ exp1. 5 This analysis indicates that the change in range would increase the dose factor error by approximately 40%. Since this difference is well within the expected error of the current factors, no further adjustment in the above factors is considered necessary. 11.4-67 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-8 Parameters for Calculations of N-16 Skyshine Radiation From LaSalle Location Occupancy Occupancy Shielding Distance Number Activity Hours Factorc Factor Rk K OHka OFk SFk (m) Living at home 1 (nearest 8360 0.95 0.7 resident) 2 Fishing 400 0.05 1.0 2100 Living at 3 National Guard 2500 0.7 2400 Facility I I I I _I Mh = 5 K = 2.28 E-5 mrem / (MWe-hr) These parameters are used to obtain an initial estimate of skyshine dose to the maximally exposed member of the public using ODCM Part II, Section 5, Equation 5-1. If desired, more realistic parameters could be used in place of these to refine the estimate. For example, one could determine whether the nearest resident really fishes the specified number of hours at the specified location. Notes: a The amount of time in a year that a maximally exposed fisherman would spend fishing near the site is estimates as 12 hours per week for 8 months per year. This yields an estimate of: hours

                                                                            =416-year b

Distance to nearest residence. (See Table 4-1) The OFk is the quotient of the number of hours a location is occupied and the number of hours in a year. Thus, OHk

      /8760 hours = OFk rounded to the nearest 0.01 digit.

In determining the maximally exposed individual, the following possibilities were considered: the nearest resident, fisherman, and persons at the National Guard facility north of the site. The annual exposre time and location of a maximally exposed fisherman were estimated on the basis of discussion with a member of the station staff. The nearest resident was found to have the greatest exposure to skyshine. For details, see Based on Sargent & Lundy, Nuclear Safeguards and Licensing Division, LaSalle calculation no. ATD-01 39, "N-16 Skyshine Ground Level Doses from LaSalle Turbine Systems & Piping, Revision 0. 11.4-68 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-9 (page 1 of 2) Elevated Level Joint Frequency Distribution Table Summary no1 Few Iwi P84111 aft" u m M1 a to I* m an ua 0 Wiwi w o Tesu a .01 oM AN M .114 AM AM AM . .0N I .= I I 41106 1.414 Ni A .01 04i9 IT6 .- " .1:0 .m .41 M Age .=1 . 46 M .# .:= "1 I.=-... t noI .,onB N .4141 ..IN* InI 'I M* M.I 101 I.0" :4" -we I31W .111114

                 ,         0.268 4i8      .1113    .JIN   21           .0I     .I11?      .3M  8.110 .3I1            .011      .446        .840        .41      .11U        .813     4.I01 1i.014 .31o             1.3 142 1.4I0     1.111      #.d      4,II        .11112.1111 I.u         *.I   104 10,11.0        .010                         f.nIn        I.0m a        .oe         .on       .an o        .m       .4e       .o         In        w    .,,       .o=       .M        .ow           M         .ma      .ew         .m        .=

TOW$s 4.901 C.WT R.M *.M6 6.64 CM 4.0111 S.36 6.414 11.411 TAUe O.in COm 0e.0 1.34 4.0"8 165.66

       *N          Ian       ,611      .O*       .301.1111          JOIN     .90       .M     ,        1.0=        ,I      0.011       $.*t      1.0         .9t            M.I     *111111
        *~      .666           eI      .s"      .eo        .od0g    .ogs" .uis          .uT   .0e        .m0       .363      .,6N        .U4        .041     .:1I        .160     Ocm 01pow               111     me          w        IE         I      In         66      on6       I                   a       111111        V        No0        w         no10"06
     .4         o.0 0                    o      .ml        .la 6    .010     .0        .m     .018      .00       .o          0I        .1M        .8w      .00,        .no         -.IS 1.6         .41          .010      .T1      .661       .117     .600     .4112     .411 .11I1 .631            .001      .411141 ONO            .406I4 0             ."o        .4I3 1.68        .1           .M        .O6      .16        .141     .04      .160      .911   .1M       . W       .1N       .16         .141       .16      .36         .3NO      1.116 3.4:        .Ul         .41        .6,      ."        .6        .2"     .,3        .81, ,.,,        .,11         -1                 .. 1       ..-         on       .- 13     8.66:
     .96       .06          .34o       .M       .. 41     .M       .4a      .41        .6114 .411 .011            .416      .46         .041       .442     .48n         .416     1.13 6.N        .I3          .33        .MM      .30        .451     .4ft    .4            W .4             M.4    .46       .4n         .4         .30 .641             .m        6.1
     .N         .6"                    .m61 .111161.1U              .413    .4111      .411      Wm sI                M     .In         .10        .50      .161         .116N    9.11 6.06 1.11W               .1114    3.860 1.3ft 0;1.1             .0910   .36        .6111 1.403 I.=*         4.111      1.04 1.007            1.4*1 1.11101 1.1101            nM1.C6
        .0         0a       .483       .481     .64       .M3      .713     .116       .941 3.110 1.9113        1.=8       1.111146.3*           1.6013     .w3 l.11
     .0        .9           .3116      .161Sm      111111           .4141   .148     9S1     1 103.440          I.M 1 .11W 0.482                 1.908 4.416            .11111    N .on 16."6         .316            M6     .41111 ."16         .M      .240     .8601      .4613.4'      t1.41            143.  .631 411.01           .146     1.310      .404        .33       96.160 6        .6               .m        I.m       .066      .033     .3       .00        A.6. .0          .09           Mo4O 11111 .1111            .141      .810        .05            on W~lk        oUdo                 1nWIN 00 p0=1m1md InNM ftW @W W itW .U.

11.4-69 LASALLE ODCM PART 11SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-9 (page 2 of 2) Elevated Level Joint Frequency Distribution Table Summary 3175 Foflt lvAll00 OMI a..r Tabulew of* #m byp uN ohw Igoe" class a C S

• IF 41 in4 .000 .OOs .mO .eua .Oi .Oi2 .0104 1.01 .006 .004 .004 .11! . 353 .0A0 .603 8.06 .01l .041 .10, 1.640 .56 .301 .010 8.06 .046 .163I .250 3.25I 1.1t ."41 .035 4.06 .102 .243 .4on 4.254 1.I2t .711 .111 1.06 .302N .33 .417 4.1tl 1.141 .ttl .210 6.01 . M .41 .158 4.883 I.312 .1110 .218 6.01 .223 .700 1.11.6t 6061 6.1 to 1.410 .1131 00.09 .141 .430 sles 1.441. 4.9124 1.5I1 .#I 33.05 .134 .404  ;:19 6.9112 6:067 *.M0 p.3

                    .01011             .,M          .166 N           .424

• :3 .:116 .616

• 0.00 .001 .001 .An .M :090 .0 .01 11.4-70 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-10 (Page 1 of 2) Mid Elevation Joint Frequency Distribution Table Summaries aft np N mi I an N - I a4 1 Will V wk,. 1410 114111Taus

        *     .al         a14m .8i0         .i7     .=I         .aam      .w         .11       .863        .81     .441        .n10       .46     '.7                   .60      1.6411W p     .a        .         .2I       .aa S     .          .1         .
                                                                          .iu        .O J"        .0          .w
                                                                                                           .11     .m11        .0e        .11      .eIN      .111       .619      1.4
                        .         .11.n8 .484       .141       .0"        .03e       .ma       .*a         .411    .46        .40 .111             .111      .11T      .111      1.141

• 3.11 e.31 6.81? e.146 41.41O .1To 0.41r 1 0*. .0"6 1."11 o.6 .0

                                                                                                                                         . ,D 8.0" .6-041           1. W       1.4e
              .111      .134 16.6 1.10            1.411      I.3" 1.4                :                  1.6 1.616        In.       1.17        1. a.s I.II0I                 l           8.$
                        .I6       .1?       .       .4S        .e         .10 o.8      .01I.36            I.8 1.6               .6         .80 4 0.03          .4         .4"     11.43
                        .0N n.    ."1 .0im          .O          .2        .- n       .ln    1.644 I.1i             .111       .41        .14       .7        .- n      .1"       1.401 V0401     4.611    4.1IN     6.34T.&.S6           .0      4.840     4.01111
                                                                      ,              .40U 0.111          .1831.9110        6      s08 4.00 1.81r          1.4111    4.14 1          .8 spa"            a        11       a         11        1        EM          s        on               I Not          11 11       1                    -1        11       1      11*4*1
     .,      .0,a     .1ON      .000      .4110         ,     .-Oe      .0e        .oN        .me        .O      e      .4e1em0 .ON       O       .-       .00 o .OWo              .018 6.86     .46      .411      .W11      .043     .638       .011      .040       .034       .41        .41o     .411       .-an       .611      .411      .0"4      .o          .411 1.86      .411     .331      .60       .80      .1         .331      .16o .101            .In         . "1     .301       .149       . us      .11I      .18        .63      11.101 1.08      .4413   312
                      .        1.140      .411     ."1       .410       .101       .1        .2In        .444     .386       .821       .411      .814     .341       .074      T.64 4.86      .141     .06      1.1171     .183     .31        .628      .946       .683       .61M .314           .N01       .466       .481      .-11     .611       .*            .16
                                                                                                                                                                                  .61 6.86      ."1      .144     1.041       .m0     .04        .66       .6 1        .. 1      .631       .86      .81I       .666       .110      .US       .T73, .70          10.01 6.86      .111     .N1      " .410      .me     .1?        .7"6      .106        ."13      .141       .86T     .411       .6.        .41       .1      ":90        .:10     11.6N 6.86     1.416     .=11      .611     6.064          1.661         1.N
                                                                        .113 8      1.4"     1.11m 1.4 113.613              3.484       11.14     1.11011   3.36      0.311     18.1I 3.86       .4T8     .16       .114      .41,     .86n       ."13      .6        0.011    S. u1, - 1.41111               1.101 ".1.3             .11     6.I6        .330     14.411 3.08      .me      .0o6      .0        ..14     .11111m110 .,,,      .                   ,.:8 1.13 1.0o1                 .,,6        .11,0 1.414 ,011              .31401   1.18 11.0       .1o1     .06       .66          am4   .1"        .61       .011                             .163     .. 61     .1"         .860 .M            .9#3       .10       1.01 861.4      .g1      .00       .me01 .04          .g81       .=11.mo              .M         .o6        ,       .04 .66                 0.       .0.4 .031           .-a4        .11 1ot.a     4.979    4.I        .       16.101   1.111      4.840 4.6            9.      I. .18w *.no 1.313               6.m          .1M &.an 1.43               6.o84       8O6.68N 10ME.                %VWolusin Inldf No                            In*W W dsm3         kmo       aMno      iVW diulls.

11.4-71 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-10 (Page 2 of 2) Mid Elevation Joint Frequency Distribution Table Summaries u FoI E11lWON DION 0va.e Tal a I h by IF"0 Ieve

                        .40       .003,     .606      .064         .046    .061      .4il     .65 t.00        .013      .04       .011         .101    .#Is      .030      .0a 2.05        .312      .130      .31t       t.940     .J=2      .An       .20T 11.0        .M        .453      .06        I.3     1.11        .2I       .310 4.06        .7110     .ot       .370      4.11114  1.0         ."a      .I0t 3.00        .112      .333      .90        0.010   2.45I      1.1I0     .M00 0.05        .336      .GW3      .I11      4.13o    I.143     1.46I    11.16 6.0560 41.=4 0.U43.1, 0.010                        0.?       2.

3." 1 .336A 0.05 l.4n .T10 .I70 o.311 4.164 2.81 I.100 2.06 .914 .AN .764 4. IN S.54 .=0 .W

                     !4.06        .N!       .80       ttlI       1.4      .          .04f     .0o0
                        .00       .I        .01M      1i1 W          .6     .m         .I00     .o0 11.4-72 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-11 (Page 1 of 2) Ground Level Joint Frequency Distribution Table Summary Vlaw of kemOd by 0 N 6" N o53inllh m -M a Ise e 9 1w ow SW w V 0 11 w 01 Voge

                                            .0       .904       .300      .118 .S            .1So       .40     .4"       .4:,

S:.,4m°" ::.,. o

                                  .2        .8.11    .211

w

                                                                 .1.671,
                                                                     . 101,.,1       ,.             .=    ,: .1100       2        .293

of 1 4 .004

                                                                                                                                             , .401111  :.U116U 1.36 I       n.o6 .14n1 I                 2 211.11            .. M I9.01119."s .                                        14.11        Mue . ..          4131      .         5.41 9 114        1.4I
                         ,      m.IT           M 0.041. 7     .121 6,1111.9 . 640 .1We               .6M       IT.S  1.025 S.943 I.1* 0.140                       1.500   31.416 a      .3      ."I1 #.,us       1.4011 11.180 1.424 6.16                  1.9161 1.53       1.101111.*"6     6.416 1.161 1.145 1.402                      .9111     414.341
                         . eel    .1        .3       .844       .6        .110         .601 6.33      5.1        .9"   #6.6* 6.*.0             .047     .000        .81      11.41 S,.3         .0N      .610      .01      .AIS       .60 .978 1.082 0..66                   .01      .900     .00         .An       .410     .814        .048      3,.

U1.6. 5.310 2.901'636: 6.290 G.34 6.819, C.OSS 0.10 1.462 0.829 7.400 6.4U 4.07 m.8a .771 2.00 110.9w 3.eT Tom* of ftroeu,6P byr%*Su a"oe peed Now o in 315 am a in 16 a 04 am IV I W 61w 61 16

       .O.... 4       0            o           n     .m          m       .an...me n                 .  .,m
                                                                                                        .on       M.                 .,       .on       .          .mo          .o
     ,.0,       .101    .0,       .010     .04       .404     .,01       .633         .4"      ."1     .01     .0"      .011        .,        .03      .011        .001       1.0 1.,6       .918    .600      .,1, .,11          .44       .1.     .on,           .94S     .021   .44,     .4,1     .4,,        .61,      .616      ,4,, .466            ,.10#

1.5 6.,-4 1. U, 6.5, 6.16 t.1 6.1,o 1.M ,.1 1.14, 1." ,.is ..031 ,.0, 1.6m .. 31 1.01 ,.,, 4.05 11426 .615 1.1121 .133 1.426 1.656 6.466 0.016 1.186 0.113 1.640 3.5 6.214 11.4801.0116.5 .090 .918 3.16 I.6in .141 .01 .11.00 6.*.1 .64 .8" .113 6.111.91 11.006116.613.90 1. O0 0.04 .711 ".903 6.16 I. We .661 . 420 .I06 . 106 .610

                        . 102 .161         . &IS .I8 . 011 .011
                                                              . " ? . 40.80             US   6.041 .44       1.1*      .400 .36              .t14
                                                                                     . 448 0.S es l . a s 0. ftn o .a n I.l a 1.410 1.944 1. 014       .946         AN1    61.100 I N.

0.0 .154 .41 .60 .04, o6 .0it .66 .204 ."1 1 .on .810 .M .64a . " .1 3. a."etI4 .000 .05. .01111

                                           .4        .53
                                                     .40      .140      .401
                                                                        .4           .011
                                                                                     .0       .i.2016 .6 A        .111
                                                                                                               .0       .0t13       .40
                                                                                                                                   .0  6430 41  .11 a.06l4  *11m
                                                                                                                                                       .914 I."             n             .o                           .                                                                                                     .

1.6"1 $.on6.009 4.0416 I 6.4 5.1 4.1 01.21101.TAM6.5 1.0510 0.531111 o .10 1.111 1.801 011101.0011 NO~k W~i OMaim In Ws mn pinold In%W NWy mulE Sell -W W6 11.4-73 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-11 (Page 2 of 2) Ground Level Joint Frequency Distribution Table Summary w Foel lsvsmu D0a0 3m-mw 1 e etremt by %w a 6 slow 03.6w 6 I! a IS

• F

                    .46      .00      .000         .004          .a0m     .00     .030         .00 1.06        .0=I     .00N         .012          .        4
                                                                          .3.     .219         .3In 3.05        .326     .            .1*13 3.13ea 3.34 3.164 1.5"1
                                                   .0 3.06        .915     .57e         .7T e.133 1 211.01 3.36T 3.66 4.05      11.*T4     .111.08        oN 6.436 4.T10 V.0641".2M5 5.66      1.32w      .64          .3003 6.16 14.11011 1.73 1.               103?

6.06 1.201 .570 .004 5.4T2 .049 .81? .351 5.06 1.*" .910 1.O0 6.406, 2.3314 .463 .609 30.05 .110 .422 .518 3.356 1.834 .031 .003 18.65 .410 .$1$ e948 1.4 AN

                                                                          .46      OH           .160 6.100       .11,     .00I,*         0           .i3s     .001    .641          .41 3.060       .002     .012         .000          .0       .004    .00           .0W0 11.4-74 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-12 Station Characteristics STATION: LaSalle LOCATION: Six miles South of Marseilles, Illinois - LaSalle County CHARATERISTICS OF ELEVATED RELEASE POINT

1) Release Height = 112.8 ma 2) Diameter = 5.64 m

3) Exit Speed = 14.7 m/sa 4) Heat Content = 0 Kcal/sa CHARATERISTICS OF VENT STACK RELEASE POINT: NOT APPLICABLE

1) Release Height = ma 2) Diameter = m

3) Exit Speed = m/sa CHARATERISTICS OF GROUND LEVEL RELEASE

1) Release Height = 0 m

2) Building Factor (D) = 56.4 ma METEOROLOGICAL DATA A 400 foot tower is located 725 meters Southeast of elevated release point.

Release Point Wind Speed & Direction Differential Temperature Elevated 375 ft 375 - 33 ft Vent (N/A) (N/A) Ground 33 ft 200 - 33 ft a Used in calculating the meteorological and dose factors in Tables 4-3, and 4-5 through 4-7. 11.4-75 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4 - 13 Dose Factors for Noble Gases Beta Air Beta Skin Gamma Air Gamma Total Dose Factor Dose Factor Dose Factor Body Dose Factor Ni Li Mi Ki Nuclide (mrad/rer (mrem/yr per (mrad/yr er (mrem/yr per uCi/m ) uCi/m) uCi/m uCi/m) Kr-83m 2.88E+02 1.93E+01 7.56E-02 Kr-85m 1.97E+03 1.46E+03 1.23E+03 1 .17E+03 Kr-85 1.95E+03 1.34E+03 1.72E+01 1.61E+01 Kr-87 1.03E+04 9.73E+03 6.17E+03 5.92E+03 Kr-88 2.93E+03 2.37E+03 1.52E+04 1.47E+04 Kr-89 1.06E+04 1.01E+04 1.73E+04 1.66E+04 Kr-90 7.83E+03 7.29E+03 1.63E+04 1.56E+04 Xe- 1.11E+03 4.76E+02 1.56E+02 9.15E+01 131m Xe- 1.48E+03 9.94E+02 3.27E+02 2.51 E+02 133m Xe-1 33 1.05E+03 3.06E+02 3.53E+02 2.94E+02 Xe- 7.39E+02 7.11E+02 3.36E+03 3.12E+03 135m Xe-1 35 2.46E+03 1.86E+03 1.92E+03 1.81 E+03 Xe-1 37 1.27E+04 1.22E+04 1.51E+03 1.42E+03 Xe-1 38 4.75E+03 4.13E+03 9.21 E+03 8.83E+03 Ar-41 3.28E+03 2.69E+03 9.30E+03 8.84E+03 Source: Table B-1 of Reference 6. 11.4-76 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4 - 14 (Page 1 of 3) External Dose Factors for Standing on Contaminated Ground DFG1j (mrem/hr per pCi/ M2 ) Whole Body Element Dose Factor Reference Element Dose Factor Reference H-3 0.OOE+00 6 Be-7 5.95E-10 99 C-14 0.OOE+00 6 F-18 1.19E-08 99 Na-22 2.42E-08 99 Na-24 2.50E-08 6 Mg-27 1.14E-08 99 Mg-28 1.48E-08 99 AI-26 2.95E-08 99 AI-28 2.OOE-08 99 P-32 0.00E+00 6 Cl-38 1.70E-08 99 Ar-41 1.39E-08 99 K-40 2.22E-09 99 K-42 4.64E-09 99 K-43 1.19E-08 99 Ca-47 1.14E-08 99 Sc-44 2.50E-08 99 Sc-46m 1.21 E-09 99 Sc-46 2.24E-08 99 Sc-47 1.46E-09 99 Ti-44 1.95E-09 99 V-48 3.21 E-08 99 Cr-51 2.20E-10 6 Mn-52m 2.79E-08 99 Mn-52 3.80E-08 99 Mn-54 5.80E-09 6 Mn-56 1.10E-08 6 Fe-52 9.12E-09 99 Fe-55 0.OOE+00 6 Fe-59 8.00E-09 6 Co-57 1.65E-09 99 Co-58 7.OOE-09 6 Co-60 1.70E-08 6 Ni-63 0.00E+00 6 Ni-65 3.70E-09 6 Cu-64 1.50E-09 6 Cu-67 1.52E-09 99 Cu-68 8.60E-091 -- Zn-65 4.00E-09 6 Zn-69m 5.06E-09 99 Zn-69 0.OOE+00 6 Ga-66 2.70E-08 99 Ga-67 1.89E-09 99 Ga-68 1.24E-08 99 Ga-72 3.OOE-08 99 Ge-77 1.34E-08 99 As-72 2.23E-08 99 As-73 1.16E-10 99 As-74 9.41 E-09 99 As-76 6.46E-09 99 As-77 1.79E-10 99 Se-73 1.38E-08 99 Se-75 4.98E-09 99 Br-77 3.84E-09 99 Br-80 2.01 E-09 99 Br-82 3.OOE-08 99 Br-83 6.40E-1 1 6 Br-84 1.20E-08 6 Br-85 0.OOE+00 6 Kr-79 3.07E-09 99 Kr-81 1.59E-10 99 Kr-83m 1.42E-1 1 99 Kr-85m 2-24E-09 99 Kr-85 1.35E-10 99 Kr-87 1.03E-08 99 Kr-88 2.07E-08 99 Kr-90 1.56E-08 99 Rb-84 1.07E-08 99 Rb-86 6.30E-10 6 Rb-87 0.OOE+O0 99 Rb-88 3.50E-09 6 Rb-89 1.50E-08 6 Sr-85 6.16E-09 99 Sr-87m 3.92E-09 99 Sr-89 5.60E-13 6 Sr-90 1.84E-11 99 Sr-91 7.10E-09 6 Sr-92 9.OOE-09 6 Y-86 4.OOE-08 99 Y-87 5.53E-09 99 Y-88 2.88E-08 99 Y-90 2.20E-12 6 Y-91 m 3.80E-09 6 Y-91 2.40E-1 1 6 Y-92 1.60E-09 6 Y-93 5.70E-10 6 Zr-95 5.OOE-09 6 Zr-97 5.50E-09 6 Nb-94 1.84E-08 99 Nb-95 5.10E-09 6 Nb-97m 8.57E-09 99 Nb-97 8.48E-09 99 Mo-99 1.90E-09 6 Tc-99m 9.60E-10 6 Tc-101 2.70E-09 6 Tc-104 1.83E-08 1 - Ru-97 2.99E-09 99 Ru-103 3.60E-09 6 Ru-105 4.50E-09 6 Ru/Rh-106 5.76E-09 3 6, 99 Pc-109 3.80E-10 99 Cc-109 1.12E-10 99 In-111 5.11E-09 2 99 In-115m 2.01E-09 99 In-116 0.OOE+00 -- Sn-113 1.15E-09 99 Sn-117m 1.96E-08 99 2 Sn-119m 7.05E-11 99 Sb-117 0.OOE+00 -- 1 1 Sb-122 2.71E-09 -- Sb-124 1.16E-08 -- Sb-125 4.56E-09 99 Sb-126 7.13E-10 99 Ag-108m 1.92E-08 99 Ag-108 1.14E-09 99 Ag-110m 1.80E-08 6 Ag-111 6.75E-10 99 Te-121 m 2.65E-09 99 Te-121 6.75E-09 99 11.4-77 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4 - 14 (Page 2 of 3) External Dose Factors for Standing on Contaminated Ground DFGij (mrem/hr per pCi/m 2 ) Whole Body Element Dose Factor Reference Element Dose Factor Reference Te-123m 1.88E-09 99 Te-125m 3.50E- 11 6 Te-125 0.OOE+00 2 - Te-127m 1.10E-12 6 Te-127 1.OOE-11 6 Te-129m 7.70E-10 6 Te-129 7.10E-10 6 Te-131m 8.40E-09 5 6 Te-131 2.20E-09 6 Te-1-132 3.40E-09 6 Te-134 1.05E-08 99 1-123 2.12E-09 99 1-124 1.23E-08 99 1-125 2.89E-10 99 1-130 1.40E-08 6 1-131 2.80E-09 6 1-133 3-70E-09 6 1-134 1.60E-08 6 1-135 1.20E-08 6 Xe-127 3.44E-09 99 Xe-129m 5.57E-10 99 Xe-131m 2.13E-10 99 Xe-133m 4-81E-10 99 Xe-133 5.91E-10 99 Xe-135m 5.23E-09 99 Xe-135 3.36E-09 99 Xe-137 4.26E-09 99 Xe-1 38 1.30E-08 99 Cs-129 3.39E-09 99 Cs-132 8.40E-09 99 Cs-134 1.20E-08 4 6 Cs-136 1.50E-08 6 Cs-137/Ba-137m 1.14E-08 6,99 Cs-138 2.1OE-08 6 Cs-139 5.15E-09 99 Ba-131 5.74E-09 99 Ba-133m 8.10E-10 99 Ba-133 4.85E-09 99 Ba-135m 7.26E-10 99 Ba-137m 7.17E-09 99 Ba-137 O.OOE+00 2 -- Ba-139 2.40E-09 6 Ba-La-140 1.71E-08 6 6 Ba-141 4.30E-09 6 Ba-142 7.90E-09 6 La-142 1.50E-08 6 Ce-139 2.04E-09 99 Ce-141 5.50E-10 7 6 Ce-143 2.20E-09 6 Ce-Pr-144 5.20E-10 6 Pr-142 1.84E-09 99 Pr-143 0.00E+00 6 Nc-147 1.OOE-09 6 Nc-149 5.32E-09 99 Pm-145 3.38E-10 99 Pm-148m 2.35E-08 99 Pm-148 7.22E-09 99 Pm-149 5.32E-10 99 Sm-153 8.95E-10 99 Eu-152 1.30E-08 99 Eu-154 1.41E-08 99 Eu-155 8.27E-10 99 Gc-153 1.46E-09 99 Dy-157 4.39E-09 99 Er-169 6.12E-14 99 Er-171 5.11E-09 99 Tm-170 3.41 E-10 99 Yb-169 4.12E-09 99 Yb-175 4.94E-10 99 Lu-177 4.60E-10 99 Hf-181 6.67E-09 99 Ta-182 1.42E-08 99 Ta-183 2.93E-091 - W-187 3.10E-09 6 Re-188 1.89E-09 99 Os-191 9.83E-10 99 Ir-194 2.31 E-09 99 Pt-195m 9.79E-10 99 Pt-197 3.57E-10 99 Au-195m 2.54E-09 99 Au-195 1.14E-09 99 Au-198 5.19E-09 99 Au-199 1.18E-09 99 Hg-197 9.33E-10 99 Hg-203 2.89E-09 99 TI-201 1.24E-09 99 TI-206 0.00E+00 2 - TI-208 3.58E-08 99 Pb-203 3.88E-09 99 Pb-210 3.57E-1 1 99 Pb-212 1.91 E-09 99 Pb-214 3.18E-09 99 Bi-206 3.74E-08 99 Bi-207 1.77E-08 99 Bi-214 1.71 E-08 99 Ra-226 8.78E-11 99 Th-232 8.14E-12 99 U-238 7.98E-12 99 Np-239 9.50E-10 6 Am-241 3.48E-10 99 Valued derived by comparing the percentage and MeV of the nuclide's gammas and then comparing to Cesium-1 37, as a value was not available in the literature. 2 0.0 due to low yield and short half-life. A value was not available in the literature. 11.4-78 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4 - 14 (Page 3 of 3) External Dose Factors for Standing on Contaminated Ground DFGij (mrem/hr per pCi/m 2) 3 Value is the sum of Ru-106 (1.50E-9) and Rh-106 (4.26E-9). The Rh-106 value is from Reference 99 and the Ru-106 value is from Reference 6. 4 Value is the sum of Cs-137 (4.20E-9) and Ba-137m (7.17E-9). The values are from references 6 and 99, respectively. 5 Value is the sum of Te-1 32 (1.70E-9) and 1-132 (1.70E-9). 6 Value is the sum of Ba-140 (2.10E-9) and La-140 (1.50E-8) from reference 6. In Reference 6, see Table E-6. 7 Value is the sum of Ce-144 (3.20E-10) and Pr-144 (2.OOE-10) from reference 6. Note: Dose assessments for 10CFR20 and 40CFR190 compliance are made for an adult only. Dose assessments for 10CFR50 Appendix are made using dose factors of Regulatory Guide 1.109 (Reference 6) for all age groups. 11.4-79 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 1 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Kr-83m Total Body Gamma Air Annual Annual 500 hour Direction Distance V1 Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 1.93E-10 1.43E-08 1.43E-08 NNE 1378 2.73E-1 0 4.24E-08 4.24E-08 NE 2408 3.21 E-10 9.37E-08 9.37E-08 ENE 4450 2.73E-1 0 1.25E-07 1.25E-07 E 1996 2.54E-10 5.39E-08 5.39E-08 ESE 1465 2.64E-10 2.83E-08 2.83E-08 SE 969 2.32E-10 8.97E-09 8.97E-09 SSE 838 1.62E-10 6.53E-09 6.53E-09 S 829 1.70E-1 0 1.37E-08 1.37E-08 SSW 835 1.51 E-10 8.61 E-09 8.61 E-09 SW 628 2.16E-10 4.62E-09 4.62E-09 WSW 533 2.05E-1 0 5.53E-1 0 5.53E-1 0 W 524 1.70E-1 0 4.24E-10 4.24E-1 0 WNW 643 1.23E-10 1.11E-09 1.11 E-09 NW 762 1.06E-10 1.41 E-09 1.41E-09 NNW 890 1.27E-10 2.89E-09 2.89E-09 11.4-80 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 2 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Kr-85m Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 2.60E-05 3.86E-05 3.86E-05 NNE 1378 2.51 E-05 3.72E-05 3.72E-05 NE 2408 1.69E-05 2.51 E-05 2.51 E-05 ENE 4450 8.36E-06 1.24E-05 1.24E-05 E 1996 1.69E-05 2.50E-05 2.50E-05 ESE 1465 2.40E-05 3.56E-05 3.56E-05 SE 969 3.18E-05 4.72E-05 4.72E-05 SSE 838 2.60E-05 3.86E-05 3.86E-05 S 829 2.66E-05 3.96E-05 3.96E-05 SSW 835 2.54E-05 3.78E-05 3.78E-05 SW 628 3.90E-05 5.79E-05 5.79E-05 WSW 533 4.13E-05 6.13E-05 6.13E-05 W 524 3.52E-05 5.23E-05 5.23E-05 WNW 643 2.37E-05 3.52E-05 3.52E-05 NW 762 1.96E-05 2.91 E-05 2.91 E-05 NNW 890 2.12E-05 3.15E-05 3.15E-05 11.4-81 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 3 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Kr-85 Total Body Gamma Air Annual Annual 500 hour Direction Distance bi V1 B1 (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 4.71 E-07 7.14E-07 7.14E-07 NNE 1378 4.35E-07 6.59E-07 6.59E-07 NE 2408 2.79E-07 4.23E-07 4.23E-07 ENE 4450 1.30E-07 1.97E-07 1.97E-07 E 1996 2.87E-07 4.35E-07 4.35E-07 ESE 1465 4.16E-07 6.31 E-07 6.31 E-07 SE 969 5.76E-07 8.72E-07 8.72E-07 SSE 838 4.85E-07 7.35E-07 7.35E-07 S 829 5.04E-07 7.64E-07 7.64E-07 SSW 835 4.83E-07 7.32E-07 7.32E-07 SW 628 7.33E-07 1.11E-06 1.11E-06 WSW 533 7.82E-07 1.19E-06 1.19E-06 W 524 6.68E-07 1.01 E-06 1.01E-06 WNW 643 4.47E-07 6.77E-07 6.77E-07 NW 762 3.68E-07 5.58E-07 5.58E-07 NNW 890 3.94E-07 5.96E-07 5.96E-07 11.4-82 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 4 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Kr-87 Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 1.56E-04 2.35E-04 2.35E-04 NNE 1378 1.42E-04 2.13E-04 2.13E-04 NE 2408 8.74E-05 1.31 E-04 1.31E-04 ENE 4450 3.76E-05 5.66E-05 5.66E-05 E 1996 9.12E-05 1.37E-04 1.37E-04 ESE 1465 1.35E-04 2.04E-04 2.04E-04 SE 969 1.92E-04 2.88E-04 2.88E-04 SSE 838 1.63E-04 2.45E-04 2.45E-04 S 829 1.70E-04 2.55E-04 2.55E-04 SSW 835 1.62E-04 2.44E-04 2.44E-04 SW 628 2.48E-04 3.73E-04 3.73E-04 WSW 533 2.66E-04 4.01 E-04 4.01 E-04 W 524 2.27E-04 3.41 E-04 3.41 E-04 WNW 643 1.51 E-04 2.27E-04 2.27E-04 NW 762 1.24E-04 1.86E-04 1.86E-04 NNW 890 1.32E-04 1.98E-04 1.98E-04 11.4-83 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 5 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Kr-88 Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 4.07E-04 6.11 E-04 6.11 E-04 NNE 1378 3.70E-04 5.56E-04 5.56E-04 NE 2408 2.38E-04 3.57E-04 3.57E-04 ENE 4450 1.11E-04 1.67E-04 1.67E-04 E 1996 2.47E-04 3.71 E-04 3.71 E-04 ESE 1465 3.56E-04 5.35E-04 5.35E-04 SE 969 4.95E-04 7.44E-04 7.44E-04 SSE 838 4.23E-04 6.35E-04 6.35E-04 S 829 4.44E-04 6.67E-04 6.67E-04 SSW 835 4.26E-04 6.40E-04 6.40E-04 SW 628 6.36E-04 9.54E-04 9.54E-04 WSW 533 6.80E-04 1.02E-03 1.02E-03 W 524 5.81 E-04 8.72E-04 8.72E-04 WNW 643 3.89E-04 5.84E-04 5.84E-04 NW 762 3.21 E-04 4.82E-04 4.82E-04 NNW 890 3.42E-04 5.14E-04 5.14E-04 11.4-84 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 6 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Kr-89 Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 2.85E-04 4.28E-04 4.28E-04 NNE 1378 2.47E-04 3.71 E-04 3.71 E-04 NE 2408 1.13E-04 1.70E-04 1.70E-04 ENE 4450 2.89E-05 4.35E-05 4.35E-05 E 1996 1.23E-04 1.85E-04 1.85E-04 ESE 1465 2.23E-04 3.34E-04 3.34E-04 SE 969 3.62E-04 5.45E-04 5.45E-04 SSE 838 3.08E-04 4.63E-04 4.63E-04 S 829 3.11E-04 4.67E-04 4.67E-04 SSW 835 2.92E-04 4.39E-04 4.39E-04 SW 628 5.16E-04 7.75E-04 7.75E-04 WSW 533 5.77E-04 8.68E-04 8.68E-04 W 524 4.85E-04 7.29E-04 7.29E-04 WNW 643 3.04E-04 4.57E-04 4.57E-04 NW 762 2.37E-04 3.55E-04 3.55E-04 NNW 890 2.46E-04 3.70E-04 3.70E-04 11.4-85 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 7 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 31 m Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 5.60E-06 8.50E-06 8.50E-06 NNE 1378 5.55E-06 8.53E-06 8.53E-06 NE 2408 3.99E-06 6.29E-06 6.29E-06 ENE 4450 2.18E-06 3.58E-06 3.58E-06 E 1996 3.86E-06 6.02E-06 6.02E-06 ESE 1465 5.32E-06 8.18E-06 8.18E-06 SE 969 6.83E-06 1.04E-05 1.04E-05 SSE 838 5.53E-06 8.36E-06 8.36E-06 S 829 5.67E-06 8.57E-06 8.57E-06 SSW 835 5.39E-06 8.15E-06 8.15E-06 SW 628 8.24E-06 1.24E-05 1.24E-05 WSW 533 8.66E-06 1.30E-05 1.30E-05 W 524 7.39E-06 1.11E-05 1.11E-05 WNW 643 5.OOE-06 7.53E-06 7.53E-06 NW 762 4.14E-06 6.25E-06 6.25E-06 NNW 890 4.51 E-06 6.82E-06 6.82E-06 11.4-86 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 8 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 33m Total Body Gamma Air Annual Annual 500 hour Vi Bi bi Direction Distance (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 4.54E-06 7.05E-06 7.05E-06 NNE 1378 4.43E-06 6.98E-06 6.98E-06 NE 2408 3.13E-06 5.11E-06 5.11 E-06 ENE 4450 1.70E-06 2.91 E-06 2.91 E-06 E 1996 3.06E-06 4.91 E-06 4.91 E-06 ESE 1465 4.24E-06 6.69E-06 6.69E-06 SE 969 5.54E-06 8.60E-06 8.60E-06 SSE 838 4.54E-06 7.01 E-06 7.01 E-06 S 829 4.68E-06 7.23E-06 7.23E-06 SSW 835 4.46E-06 6.88E-06 6.88E-06 SW 628 6.79E-06 1.05E-05 1.05E-05 WSW 533 7.17E-06 1.10E-05 1.10E-05 W 524 6.12E-06 9.39E-06 9.39E-06 WNW 643 4.12E-06 6.34E-06 6.34E-06 NW 762 3.41 E-06 5.25E-06 5.25E-06 NNW 890 3.69E-06 5.70E-06 5.70E-06 11.4-87 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 9 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 33 Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 3.86E-06 5.83E-06 5.83E-06 NNE 1378 3.98E-06 6.08E-06 6.08E-06 NE 2408 3.02E-06 4.74E-06 4.74E-06 ENE 4450 1.76E-06 2.86E-06 2.86E-06 E 1996 2.85E-06 4.42E-06 4.42E-06 ESE 1465 3.82E-06 5.85E-06 5.85E-06 SE 969 4.71 E-06 7.11 E-06 7.11E-06 SSE 838 3.73E-06 5.61 E-06 5.61 E-06 S 829 3.79E-06 5.71 E-06 5.71 E-06 SSW 835 3.59E-06 5.40E-06 5.40E-06 SW 628 5.50E-06 8.25E-06 8.25E-06 WSW 533 5.72E-06 8.56E-06 8.56E-06 W 524 4.88E-06 7.30E-06 7.30E-06 WNW 643 3.32E-06 4.97E-06 4.97E-06 NW 762 2.77E-06 4.15E-06 4.15E-06 NNW 890 3.04E-06 4.58E-06 4.58E-06 11.4-88 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 10 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 35m Total Body Gamma Air Annual Annual 500 hour Direction bi Distance V1 Bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 7.99E-05 1.21 E-04 1.21 E-04 NNE 1378 7.23E-05 1.10E-04 1.10E-04 NE 2408 4.11 E-05 6.23E-05 6.23E-05 ENE 4450 1.46E-05 2.21 E-05 2.21E-05 E 1996 4.32E-05 6.55E-05 6.55E-05 ESE 1465 6.81 E-05 1.03E-04 1.03E-04 SE 969 9.95E-05 1.51 E-04 1.51 E-04 SSE 838 8.38E-05 1.27E-04 1.27E-04 S 829 8.60E-05 1.30E-04 1.30E-04 SSW 835 8.18E-05 1.24E-04 1.24E-04 SW 628 1.31 E-04 1.98E-04 1.98E-04 WSW 533 1.42E-04 2.15E-04 2.15E-04 W 524 1.20E-04 1.82E-04 1.82E-04 WNW 643 7.87E-05 1.19E-04 1.19E-04 NW 762 6.36E-05 9.64E-05 9.64E-05 NNW 890 6.76E-05 1.02E-04 1.02E-04 11.4-89 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 11 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 35 Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 4.50E-05 6.76E-05 6.76E-05 NNE 1378 4.26E-05 6.40E-05 6.40E-05 NE 2408 2.82E-05 4.24E-05 4.24E-05 ENE 4450 1.36E-05 2.05E-05 2.05E-05 E 1996 2.84E-05 4.27E-05 4.27E-05 ESE 1465 4.08E-05 6.12E-05 6.12E-05 SE 969 5.50E-05 8.26E-05 8.26E-05 SSE 838 4.55E-05 6.84E-05 6.84E-05 S 829 4.69E-05 7.05E-05 7.05E-05 SSW 835 4,48E-05 6.74E-05 6.74E-05 SW 628 6.85E-05 1.03E-04 1.03E-04 WSW 533 7.27E-05 1.09E-04 1.09E-04 W 524 6.22E-05 9.34E-05 9.34E-05 WNW 643 4.17E-05 6.26E-05 6.26E-05 NW 762 3.44E-05 5.17E-05 5.17E-05 NNW 890 3.71 E-05 5.57E-05 5.57E-05 11.4-90 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 12 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 37 Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 2.34E-05 3.53E-05 3.53E-05 NNE 1378 2.04E-05 3.08E-05 3.08E-05 NE 2408 8.68E-06 1.31 E-05 1.31 E-05 ENE 4450 1.69E-06 2.55E-06 2.55E-06 E 1996 9.48E-06 1.43E-05 1.43E-05 ESE 1465 1.80E-05 2.73E-05 2.73E-05 SE 969 2.99E-05 4.53E-05 4.53E-05 SSE 838 2.51 E-05 3.80E-05 3.80E-05 S 829 2.51 E-05 3.79E-05 3.79E-05 SSW 835 2.34E-05 3.53E-05 3.53E-05 SW 628 4.28E-05 6.47E-05 6.47E-05 WSW 533 4.81 E-05 7.27E-05 7.27E-05 W 524 4.03E-05 6.09E-05 6.09E-05 WNW 643 2.51 E-05 3.79E-05 3.79E-05 NW 762 1.93E-05 2.92E-05 2.92E-05 NNW 890 2.01 E-05 3.04E-05 3.04E-05 11.4-91 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 13 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 38 Total Body Gamma Air Annual Annual 500 hour Direction Distance V1 Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 2.47E-04 3.71 E-04 3.71 E-04 NNE 1378 2.24E-04 3.37E-04 3.37E-04 NE 2408 1.38E-04 2.07E-04 2.07E-04 ENE 4450 5.80E-05 8.72E-05 8.72E-05 E 1996 1.44E-04 2.17E-04 2.17E-04 ESE 1465 2.15E-04 3.22E-04 3.22E-04 SE 969 3.04E-04 4.56E-04 4.56E-04 SSE 838 2.58E-04 3.87E-04 3.87E-04 S 829 2.69E-04 4.03E-04 4.03E-04 SSW 835 2.57E-04 3.86E-04 3.86E-04 SW 628 3.92E-04 5.89E-04 5.89E-04 WSW 533 4.21 E-04 6.32E-04 6.32E-04 W 524 3.59E-04 5.39E-04 5.39E-04 WNW 643 2.39E-04 3.58E-04 3.58E-04 NW 762 1.96E-04 2.94E-04 2.94E-04 NNW 890 2.09E-04 3.13E-04 3.13E-04 11.4-92 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 14 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Xe-1 39 Total Body Gamma Air Annual Annual 500 hour Direction Distance V1 Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 1.23E-05 1.84E-05 1.84E-05 NNE 1378 8.83E-06 1.33E-05 1.33E-05 NE 2408 2.03E-06 3.04E-06 3.04E-06 ENE 4450 3.82E-07 5.73E-07 5.73E-07 E 1996 2.51 E-06 3.77E-06 3.77E-06 ESE 1465 6.50E-06 9.77E-06 9.77E-06 SE 969 1.51 E-05 2.27E-05 2.27E-05 SSE 838 1.30E-05 1.95E-05 1.95E-05 S 829 1.20E-05 1.80E-05 1.80E-05 SSW 835 1.00E-05 1.50E-05 1.50E-05 SW 628 2.90E-05 4.36E-05 4.36E-05 WSW 533 3.67E-05 5.51 E-05 5.51 E-05 W 524 3.07E-05 4.61 E-05 4.61 E-05 WNW 643 1.67E-05 2.51 E-05 2.51 E-05 NW 762 1.12E-05 1.69E-05 1.69E-05 NNW 890 1.06E-05 1.59E-05 1.59E-05 11.4-93 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-15 (page 15 of 15) Maximum Bi and Vi at or Beyond the Unrestricted Area Boundary for Ar-41 Total Body Gamma Air Annual Annual 500 hour Direction Distance Vi Bi bi (meters) (mrem*sec) (mrad*sec) (mrad*sec) (yr*pCi) (yr*pCi) (yr*pCi) N 1036 3.05E-04 4.57E-04 4.57E-04 NNE 1378 2.75E-04 4.13E-04 4.13E-04 NE 2408 1.70E-04 2.55E-04 2.55E-04 ENE 4450 7.37E-05 1.11E-04 1.11 E-04 E 1996 1.78E-04 2.67E-04 2.67E-04 ESE 1465 2.63E-04 3.95E-04 3.95E-04 SE 969 3.74E-04 5.61 E-04 5.61 E-04 SSE 838 3.19E-04 4.79E-04 4.79E-04 S 829 3.34E-04 5.01 E-04 5.01 E-04 SSW 835 3.20E-04 4.80E-04 4.80E-04 SW 628 4.85E-04 7.28E-04 7.28E-04 WSW 533 5.22E-04 7.83E-04 7.83E-04 W 524 4.44E-04 6.67E-04 6.67E-04 WNW 643 2.96E-04 4.44E-04 4.44E-04 NW 762 2.43E-04 3.64E-04 3.64E-04 NNW 890 2.58E-04 3.87E-04 3.87E-04 11.4-94 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-16 (Page 1 of 4) Infant Drinking Water A, mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 6.63E+00 6.63E+00 6.63E+00 6.63E+00 6.63E+00 6.63E+00 0.00E+00 C-14 8.93E+02 1.91E+02 1.91E+02 1.91E+02 1.91EE+02 1.91E+02 1.91E+02 0.OOE+00 NA-22 3.70E+03 3.70E+03 3.70E+03 3.70E+03 3.70E+03 3.70E+03 3.70E+03 0.OOE+00 NA-24 2.19E+02 2.19E+02 2.19E+02 2.19E+02 2.19E+02 2.19E+02 2.19E+02 O.OOE+00 P-32 6.25E+04 3.68E+03 2.42E+03 0.00E+00 0.00E+00 0.00E+00 8.46E+02 0.OOE+00 CA-41 1.41 E+04 0.OOE+00 1.54E+03 0.OOE+00 0.OOE+00 0.OOE+00 7.20E+00 0.OOE+00 SC-46 1.41 E+00 2.03E+00 6.34E-01 0.OOE+00 1.34E+00 0.00E+00 1.32E+03 0.O0E+00 CR-51 0.00E+00 0.OOE+00 5.25E-01 3.42E-01 7.48E-02 6.66E-01 1.53E+01 O.OOE+00 MN-54 0.OOE+00 7.49E+02 1.70E+02 0.OOE+00 1.66E+02 0.OOE+00 2.75E+02 O.OOE+00 FE-55 5.23E+02 3.38E+02 9.04E+01 0.OOE+00 O.OOE+00 1.65E+02 4.29E+01 0.OOE+00 MN-56 0.OOE+00 1.22E+00 2.11 E-01 0.00E+00 1.05E+00 0.OOE+00 1.11 E+02 0.OOE+00 CO-57 O.OOE+00 4.33E+01 7.04E+01 0.0OE+00 0.OOE+00 0.OOE+00 1.47E+02 0.O0E+00 CO-58 0.O0E+00 1.35E+02 3.37E+02 0.OOE+00 0.OOE+00 0.OOE+00 3.36E+02 0.O0E+00 FE-59 1.15E+03 2.01E+03 7.92E+02 0.OOE+00 0.OOE+00 5.94E+02 9.61E+02 0.OOE+00 CO-60 0.00E+00 4.07E+02 9.60E+02 0.00E+00 0.00E+00 0.OOE+00 9.68E+02 0.OOE+00 NI-59 1.78E+03 5.46E+02 3.08E+02 O.OOE+00 0.00E+00 O.OOE+00 2.70E+01 0.OOE+00 NI-63 2.39E+04 1.48E+03 8.29E+02 0.OOE+00 0.OOE+00 O.OOE+00 7.35E+01 0.OOE+00 CU-64 0.OOE+00 1.19E+01 5.52E+00 0.00E+00 2.02E+01 0.OOE+00 2.45E+02 0.00E+00 NI-65 6.53E+00 7.39E-01 3.36E-01 O.OOE+00 0.OOE+00 0.00E+00 5.62E+01 0.OOE+00 ZN-65 6.92E+02 2.37E+03 1.09E+03 0.OOE+00 1.15E+03 0.00E+00 2.01E+03 0.00E+00 ZN-69m 3.09E+01 6.30E+01 5.74E+00 0.00E+00 2.55E+01 0.OOE+00 8.73E+02 0.O0E+00 ZN-69 4.44E-04 8.OOE-04 5.95E-05 0.OOE+00 3.32E-04 0.OOE+00 6.52E-02 0.OOE+00 SE-79 0.OOE+00 7.91E+02 1.47E+02 0.00E+00 9.15E+02 0.OOE+00 2.1OE+01 0.OOE+00 BR-82 0.00E+00 0.OOE+00 3.78E+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-83 0.00E+00 0.OOE+00 4.21 E-01 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 2.20E-06 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 1.80E-76 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 6.29E+03 3.11E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.61E+02 0.OOE+00 RB-87 0.OOE+00 3.35E+03 1.33E+03 0.OOE+00 0.00E+00 0.OOE+00 2.25E+01 0.OOE+00 RB-88 0.OOE+00 1.25E-11 6.85E-12 0.OOE+00 0.OOE+00 0.OOE+00 1.22E-11 0.00E+00 RB-89 °0.OOE+00 9.88E-14 6.80E-14 0.OOE+00 0.OOE+00 0.OOE+00 3.36E-14 0.OOE+00 SR-89 9.39E+04 O.OOE+00 2.69E+03 O.00E+00 0.00E+00 0.OOE+00 1.93E+03 O.OOE+00 SR-90 1.07E+06 0.OOE+00 2.16E+04 0.OOE+00 0.OOE+00 0.OOE+00 8.70E+03 0.OOE+00 Y-90 2.88E+00 0.OOE+00 7.71E-02 0.OOE+00 0.OOE+00 0.OOE+00 3.97E+03 0.OOE+00 SR-91 7.85E+02 0.00E+00 2.84E+01 0.00E+00 0.OOE+00 0.OOE+00 9.29E+02 0.OOE+00 Y-91m 1.33E-06 0.OOE+00 4.54E-08 0.OOE+00 0.OOE+00 0.OOE+00 4.44E-03 0.OOE+00 Y-91 4.23E+01 0.OOE+00 1.13E+00 0.OOE+00 0.OOE+00 0.OOE+00 3.03E+03 0.OOE+00 11.4-95 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-16 (Page 2 of 4) Infant Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 3.36E+01 0.OOE+00 1.25E+00 0.OOE+00 0.OOE+00 0.OOE+00 3.62E+02 0.00E+00 Y-92 2.75E-02 0.OOE+00 7.73E-04 0.O0E+00 0.OOE+00 0.OOE+00 5.25E+02 0.00E+00 Y-93 4.02E-01 0.00E+00 1.09E-02 0.OOE+00 0.00E+00 0.OOE+00 3.17E+03 0.OOE+00 NB-93m 4.63E+00 1.25E+00 3.92E-01 0.00E+00 1.22E+00 0.00E+00 1.50E+02 O.OOE+00 NB-95 1.57E+00 6.45E-01 3.73E-01 0.OOE+00 4.63E-01 O.00E+00 5.45E+02 O.00E+00 NB-97 1.70E-05 3.64E-06 1.31E-06 0.OOE+00 2.84E-06 0.00E+00 1.15E+00 0.00E+00 ZR-93 7.27E+00 3.46E+00 2.09E+00 0.OOE+00 1.02E+01 0.00E+00 9.OOE+02 0.00E+00 ZR-95 7.72E+00 1.88E+00 1.33E+00 0.OOE+00 2.03E+00 0.00E+00 9.37E+02 0.00E+00 ZR-97 3.41E-01 5.85E-02 2.67E-02 0.OOE+00 5.90E-02 0.00E+00 3.73E+03 0.00E+00 MO-93 0.00E+00 2.13E+03 6.86E+01 0.OOE+00 4.26E+02 0.00E+00 4.56E+01 0.00E+00 MO-99 0.OOE+00 1.13E+03 2.20E+02 0.OOE+00 1.69E+03 0.00E+00 3.72E+02 0.00E+00 TC-99 4.07E+01 5.50E+01 1.71E+01 O.OOE+00 4.63E+02 5.35E+00 2.38E+02 0.OOE+00 TC-99m 1.82E-02 3.75E-02 4.83E-01 0.00E+00 4.03E-01 1.96E-02 1.09E+01 0.00E+00 TC-101 4.66E-17 5.87E-17 5.81E-16 0.00E+00 6.98E-16 3.20E-17 9.98E-15 0.00E+00 RU-103 5.53E+01 0.00E+00 1.85E+01 0.OOE+00 1.15E+02 0.OOE+00 6.72E+02 0.00E+00 RU-105 7.87E-01 0.OOE+00 2.65E-01 0.OOE+00 5.79E+00 0.OOE+00 3.13E+02 0.OOE+00 RU-106 9.07E+02 0.OOE+00 1.13E+02 0.OOE+00 1.07E+03 0.OOE+00 6.89E+03 0.OOE+00 RH-105 3.25E+01 2.12E+01 1.43E+01 0.OOE+00 5.90E+01 0.OOE+00 5.27E+02 0.OOE+00 PD-107 0.OOE+00 4.48E+01 3.18E+00 0.OOE+00 2.56E+02 0.OOE+00 3.56E+01 0.OOE+00 PD-1 09 0.OOE+00 3.04E+01 7.35E+00 0.OOE+00 1.12E+02 0.OOE+00 7.47E+02 0.OOE+00 AG-11Orn 3.75E+01 2.73E+01 1.81E+01 0.OOE+00 3.91E+01 0.OOE+00 1.42E+03 0.OOE+00 AG-1 11 1.87E+01 7.26E+00 3.85E+00 0.OOE+00 1.52E+01 0.OOE+00 1.73E+03 0.OOE+00 CD-i 13m 0.OOE+00 6.67E+02 2.46E+01 0.OOE+00 5.05E+02 0.OOE+00 1.OOE+03 0.OOE+00 CD-1 15m 0.00E+00 5.31 E+02 1.84E+01 0.00E+00 2.77E+02 0.OOE+00 3.02E+03 0.OOE+00 SN-123 9.36E+03 1.46E+02 2.44E+02 1.47E+02 0.OOE+00 0.OOE+00 2.47E+03 0.OOE+00 SN-125 2.69E+03 5.02E+01 1.20E+02 4.94E+01 0.OOE+00 0.OOE+00 4.03E+03 0.OOE+00 SN-126 2.08E+04 2.73E+02 6.78E+02 7.20E+01 0.OOE+00 0.OOE+00 9.49E+02 0.OOE+00 SB-124 8.02E+02 1.18E+01 2.48E+02 2.13E+00 0.OOE+00 5.02E+02 2.47E+03 0.OOE+00 SB-1 25 4.63E+02 4.48E+00 9.53E+01 5.80E-01 0.OOE+00 2.68E+02 6.18E+02 0.OOE+00 SB-126 2.95E+02 5.79E+00 1.07E+02 2.27E+00 0.OOE+00 1.86E+02 3.06E+03 0.OOE+00 SB-127 7.68E+01 1.37E+00 2.38E+01 9.78E-01 0.OOE+00 3.96E+01 2.03E+03 0.OOE+00 TE-125m 8.73E+02 2.92E+02 1.18E+02 2.94E+02 0.OOE+00 0.OOE+00 4.16E+02 0.OOE+00 TE-127m 2.20E+03 7.29E+02 2.66E+02 6.35E+02 5.41E+03 0.OOE+00 8.86E+02 0.OOE+00 TE-127 1.55E+01 5.18E+00 3.33E+00 1.26E+01 3.78E+01 0.OOE+00 3.25E+02 0.00E+00 TE-129m 3.73E+03 1.28E+03 5.74E+02 1.43E+03 9.32E+03 0.OOE+00 2.23E+03 0.OOE+00 TE-129 8.23E-03 2.84E-03 1.92E-03 6.89E-03 2.05E-02 0.OOE+00 6.58E-01 0.OOE+00 TE-133m 1.80E-03 8.25E-04 7.88E-04 1.59E-03 5.62E-03 0.OOE+00 8.90E-02 0.OOE+00 11.4-96 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-16 (Page 3 of 4) Infant Drinking Water Ai mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 6.57E-05 3.30E-05 3.39E-05 5.88E-05 2.22E-04 0.00E+00 7.53E-04 0.OOE+00 1-129 1.08E+03 7.99E+02 5.84E+02 5.12E+05 9.46E+02 0.OOE+00 1.60E+01 0.OOE+00 1-130 1.15E+02 2.54E+02 1;02E+02 2.84E+04 2.79E+02 0.OOE+00 5.44E+01 0.OOE+00 1-131 1.30E+03 1.53E+03 6.71E+02 5.02E+05 1.78E+03 0.OOE+00 5.45E+01 0.OOE+00 TE-131m 4.34E+02 1.75E+02 1.44E+02 3.54E+02 1.20E+03 0.OOE+00 2.94E+03 0.OOE+00 TE-131 1.42E-08 5.24E-09 3.98E-09 1.27E-08 3.63E-08 0.OOE+00 5.73E-07 0.OOE+00 1-132 1.68E+00 3.41 E+00 1.22E+00 1.60E+02 3.81 E+00 0.OOE+00 2.76E+00 0.OOE+00 TE-132 7.04E+02 3.49E+02 3.25E+02 5.15E+02 2.18E+03 0.OOE+00 1.29E+03 0.00E+00 1-133 3.16E+02 4.60E+02 1.35E+02 8.36E+04 5.40E+02 O.OOE+00 7.78E+01 0.00E+00 CS-134m 3.77E-01 6.27E-01 3.17E-01 O.OOE+00 2.42E-01 5.56E-02 4.96E-01 0.OOE+00 CS-1 34 1.42E+04 2.65E+04 2.67E+03 0.OOE+00 6.82E+03 2.79E+03 7.19E+01 0.00E+00 1-134 2.48E-03 5.08E-03 1.81E-03 1.18E-01 5.68E-03 0.OOE+00 5.25E-03 0.00E+00 1-135 3.90E+01 7.75E+01 2.83E+01 6.95E+03 8.64E+01 0.OOE+00 2.80E+01 0.00E+00 CS-135 5.01E+03 4.56E+03 2.37E+02 0.OOE+00 1.30E+03 4.93E+02 1.65E+01 0.00E+00 CS-136 1.68E+03 4.95E+03 1.85E+03 0.OOE+00 1.97E+03 4.04E+02 7.52E+01 0.OOE+00 CS-137 1.97E+04 2.30E+04 1.63E+03 0.OOE+00 6.18E+03 2.50E+03 7.19E+01 0.OOE+00 CS-1 38 3.37E-06 5.47E-06 2.65E-06 0.00E+00 2.73E-06 4.26E-07 8.75E-06 0.OOE+00 CS-139 1.02E-22 1.40E-22 5.34E-23 0.OOE+00 7.22E-23 1.09E-23 8.78E-24 0.OOE+00 BA-1 39 8.18E-02 5.42E-05 2.37E-03 0.OOE+00 3.26E-05 3.29E-05 5.18E+00 0.00E+00 BA-140 6.27E+03 6.27E+00 3.23E+02 0.OOE+00 1.49E+00 3.85E+00 1.54E+03 0.OOE+00 LA-140 6.46E-01 2.55E-01 6.56E-02 0.OOE+00 0.OOE+00 0.OOE+00 2.99E+03 0.OOE+00 BA-141 2.19E-11 1.50E-14 6.92E-13 0.OOE+00 9.03E-15 9.14E-15 2.68E-10 0.OOE+00 LA-141 1.32E-02 3.82E-03 6.66E-04 0.OOE+00 0.OOE+00 0.OOE+00 4.38E+02 0.OOE+00 CE-141 2.93E+00 1.79E+00 2.11E-01 0.OOE+00 5.52E-01 0.00E+00 9.24E+02 0.OOE+00 BA-142 3.84E-20 3.20E-23 1.89E-21 0.OOE+00 1.84E-23 1.93E-23 1.58E-19 0.OOE+00 LA-142 2.22E-04 8.14E-05 1.95E-05 0.OOE+00 0.OOE+00 0.OOE+00 1.38E+01 0.OOE+00 CE-143 4.33E-01 2.88E+02 3.28E-02 0.OOE+00 8.37E-02 0.OOE+00 1.68E+03 0.OOE+00 PR-143 2.99E+00 1.12E+00 1.48E-01 0.OOE+00 4.15E-01 0.OOE+00 1.58E+03 0.OOE+00 CE-144 1.12E+02 4.59E+01 6.28E+00 0.OOE+00 1.85E+01 0.OOE+00 6.43E+03 0.OOE+00 PR-144 2.96E-15 1.14E-15 1.49E-16 0.00E+00 4.14E-16 0.OOE+00 5.32E-11 0.OOE+00 ND-147 2.02E+00 2.07E+00 1.27E-01 0.OOE+00 7.99E-01 O.OOE+00 1.31E+03 0.OOE+00 PM-147 1.46E+01 1.23E+00 5.99E-01 0.OOE+00 1.84E+00 0.00E+00 3.49E+02 0.OOE+00 PM-148m 6.16E+00 1.56E+00 1.23E+00 0.00E+00 1.79E+00 0.OOE+00 2.03E+03 0.OOE+00 PM-148 2.23E+00 3.22E-01 1.62E-01 0.OOE+00 3.85E-01 0.OOE+00 3.44E+03 0.OOE+00 PM-149 4.44E-01 5.83E-02 2.54E-02 0.OOE+00 7.09E-02 0.OOE+00 1.57E+03 0.OOE+00 PM-151 1.74E-01 2.53E-02 1.28E-02 0.OOE+00 3.01E-02 0.OOE+00 1.17E+03 0.OOE+00 SM-151 1.09E+01 2.51E+00 5.42E-01 0.00E+00 1.71E+00 0.00E+00 2.1OE+02 0.OOE+00 11.4-97 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-16 (Page 4 of 4) Infant Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lungi GI-LLI Skin SM-153 2.43E-01 1.88E-01 1.44E-02 0.OOE+00 3.94E-02 0.00E+00 9.84E+02 0.OOE+00 EU-152 2.54E+01 6.74E+00 5.69E+00 0.OOE+00 1.89E+01 0.OOE+00 5.99E+02 0.OOE+00 EU-154 9.94E+01 1.38E+01 8.29E+00 0.00E+00 3.75E+01 0.OOE+00 1.73E+03 0.OOE+00 EU-155 2.04E+01 2.35E+00 1.22E+00 O.OOE+00 5.27E+00 0.OOE+00 3.15E+03 0.OOE+00 EU-156 4.20E+00 2.60E+00 4.12E-01 0.OOE+00 1.20E+00 0.OOE+00 2.46E+03 O.OOE+00 TB-160 9.71E+00 0.OOE+00 1.21E+00 0.OOE+00 2.76E+00 0.OOE+00 1.29E+03 0.OOE+00 HO-166m 4.71E+01 1.01E+01 8.02E+00 0.OOE+00 1.34E+01 0.OOE+00 3.77E-17 O.OOE+00 W-181 3.32E+00 1.02E+00 1.14E-01 0.OOE+00 0.OOE+00 0.OOE+00 1.43E+01 0.OOE+00 W-185 1.36E+02 4.24E+01 4.84E+00 O.OOE+00 0.OOE+00 0.OOE+00 6.07E+02 0.OOE+00 W-187 2.40E+01 1.67E+01 5.77E+00 0.OOE+00 0.OOE+00 0.OOE+00 9.81E+02 0.OOE+00 NP-239 3.61 E-01 3.23E-02 1.82E-02 0.OOE+00 6.44E-02 0.00E+00 9.33E+02 0.OOE+00 U-232 9.12E+05 0.OOE+00 8.14E+04 0.OOE+00 8.93E+04 0.OOE+00 2.65E+03 0.OOE+00 U-233 1.91 E+05 0.OOE+00 1.46E+04 0.OOE+00 4.07E+04 0.OOE+00 2.45E+03 0.OOE+00 U-234 1.84E+05 0.OOE+00 1.43E+04 0.OOE+00 3.99E+04 0.OOE+00 2.40E+03 0.OOE+00 U-235 1.76E+05 0.OOE+00 1.34E+04 0.OOE+00 3.74E+04 0.OOE+00 3.05E+03 O.OOE+00 U-236 1.76E+05 0.OOE+00 1.37E+04 0.OOE+00 3.80E+04 0.OOE+00 2.25E+03 0.00E+00 U-237 1.77E+01 0.OOE+00 4.72E+00 0.OOE+00 4.40E+01 0.OOE+00 7.55E+02 O.OOE+00 U-238 1.68E+05 O.OOE+00 1.25E+04 0.OOE+00 3.50E+04 O.OOE+00 2.15E+03 0.OOE+00 NP-237 9.04E+04 5.99E+03 3.96E+03 0.OOE+00 2.39E+04 0.OOE+00 3.1OE+03 0.OOE+00 NP-238 3.97E+00 9.98E-02 6.14E-02 O.OOE+00 2.18E-01 0.OOE+00 1.33E+03 0.OOE+00 PU-238 4.82E+04 5.65E+03 1.28E+03 0.OOE+00 4.56E+03 0.OOE+00 2.85E+03 0.OOE+00 PU-239 5.20E+04 5.84E+03 1.33E+03 0.OOE+00 4.82E+03 0.OOE+00 2.60E+03 0.OOE+00 PU-240 5.20E+04 5.84E+03 1.33E+03 0.00E+00 4.82E+03 0.OOE+00 2.65E+03 0.OOE+00 PU-241 1.60E+03 6.63E+01 3.32E+01 0.OOE+00 1.19E+02 0.OOE+00 5.46E+01 0.OOE+00 PU-242 4.82E+04 5.61 E+03 1.28E+03 0.OOE+00 4.63E+03 0.OOE+00 2.55E+03 0.OOE+00 PU-244 5.61 E+04 6.44E+03 1.47E+03 0.OOE+00 5.31 E+03 0.OOE+00 3.80E+03 0.OOE+00 AM-241 5.50E+04 4.78E+04 4.11E+03 O.OOE+00 2.47E+04 0.OOE+00 2.90E+03 0.OOE+00 AM-242m 5.69E+04 4.60E+04 4.26E+03 0.OOE+00 2.50E+04 0.OOE+00 3.65E+03 0.OOE+00 AM-243 5.42E+04 4.63E+04 3.99E+03 0.OOE+00 2.40E+04 0.OOE+00 3.40E+03 0.OOE+00 CM-242 5.15E+03 4.77E+03 3.42E+02 0.OOE+00 9.85E+02 0.OOE+00 3.09E+03 0.OOE+00 CM-243 5.27E+04 4.33E+04 3.38E+03 0.OOE+00 1.23E+04 0.OOE+00 3.05E+03 0.OOE+00 CM-244 4.44E+04 3.65E+04 2.86E+03 0.OOE+00 1.02E+04 0.OOE+00 2.95E+03 0.OOE+00 CM-245 6.74E+04 5.46E+04 4.26E+03 0.OOE+00 1.63E+04 0.OOE+00 2.75E+03 0.OOE+00 CM-246 6.67E+04 5.46E+04 4.26E+03 O.OOE+00 1.62E+04 0.OOE+00 2.70E+03 0.OOE+00 CM-247 6.52E+04 5.39E+04 4.18E+03 0.OOE+00 1.60E+04 0.OOE+00 3.55E+03 0.OOE+00 CM-248 5.39E+05 4.45E+05 3.45E+04 O.OOE+00 1.32E+05 0.OOE+00 5.73E+04 0.OOE+00 CF-252 4.59E+04 0.OOE+00 1.11E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.13E+04 0.OOE+00 11.4-98 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-17 (Page 1 of 4) Child Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 6.75E+00 6.75E+00 6.75E+00 6.75E+00 6.75E+00 6.75E+00 0.OOE+00 C-14 7.04E+02 1.41EE+02 1.41E+02 1.41E+02 1.41E+02 1.41E+02 1.41E+02 0.OOE+00 NA-22 3.42E+03 3.42E+03 3.42E+03 3.42E+03 3.42E+03 3.42E+03 3.42E+03 0.OOE+00 NA-24 1.94E+02 1.94E+02 1.94E+02 1.94E+02 1.94E+02 1.94E+02 1.94E+02 0.OOE+00 P-32 4.69E+04 2.19E+03 1.81E+03 O.OOE+00 0.OOE+00 0.OOE+00 1.30E+03 0.OOE+00 CA-41 2.02E+04 0.O0E+00 2.21E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.11E+01 0.OOE+00 SC-46 1.14E+00 1.57E+00 6.03E-01 O.OOE+00 1.39E+00 0.OOE+00 2.29E+03 0.OOE+00 CR-51 0.00E+00 0.OOE+00 5.12E-01 2.84E-01 7.76E-02 5.19E-01 2.71E+01 0.OOE+00 MN-54 0.OOE+00 6.22E+02 1.66E+02 0.OOE+00 1.74E+02 0.OOE+00 5.22E+02 O.OOE+00 FE-55 6.69E+02 3.55E+02 1.1OE+02 O.OOE+00 0.O0E+00 2.01E+02 6.58E+01 O.00E+00 MN-56 0.OOE+00 7.72E-01 1.74E-01 0.OOE+00 9.34E-01 0.OOE+00 1.12E+02 O.OOE+00 CO-57 0.OOE+00 2.87E+01 5.80E+01 0.OOE+00 0.OOE+00 0.OOE+00 2.35E+02 0.O0E+00 CO-58 0.OOE+00 1.04E+02 3.19E+02 0.OOE+00 0.OOE+00 0.OOE+00 6.08E+02 0.OOE+00 FE-59 9.53E+02 1.54E+03 7.68E+02 0.00E+00 O.OOE+00 4.47E+02 1.61E+03 0.OOE+00 CO-60 0.OOE+00 3.08E+02 9.08E+02 0.OOE+00 0.00E+00 0.OOE+00 1.71E+03 0.OOE+00 NI-59 2.34E+03 6.23E+02 3.97E+02 0.OOE+00 0.OOE+00 0.00E+00 4.13E+01 0.OOE+00 NI-63 3.13E+04 1.68E+03 1.07E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.13E+02 0.OOE+00 CU-64 0.OOE+00 7.41 E+00 4.48E+00 0.OOE+00 1.79E+01 0.OOE+00 3.48E+02 0.OOE+00 NI-65 4.76E+00 4.48E-01 2.62E-01 0.OOE+00 O.OOE+00 0.OOE+00 5.49E+01 0.OOE+00 ZN-65 7.96E+02 2.12E+03 1.32E+03 0.OOE+00 1.34E+03 0.OOE+00 3.73E+02 0.OOE+00 ZN-69m 2.26E+01 3.85E+01 4.55E+00 0.OOE+00 2.24E+01 0.OOE+00 1.25E+03 0.OOE+00 ZN-69 3.22E-04 4.66E-04 4.31E-05 0.OOE+00 2.83E-04 0.OOE+00 2.94E-02 0.OOE+00 SE-79 0.OOE+00 4.91 E+02 1.09E+02 0.OOE+00 7.98E+02 0.OOE+00 3.22E+01 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 3.47E+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 3.07E-01 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 1.76E-06 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 O.OOE+00 0.O0E+00 1.31E-76 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 3.83E+03 2.35E+03 0.OOE+00 0.OOE+00 0.OOE+00 2.46E+02 0.OOE+00 RB-87 0.OOE+00 2.30E+03 1.07E+03 0.OOE+00 0.OOE+00 0.00E+00 3.45E+01 O.OOE+00 RB-88 O.OOE+00 7.37E-12 5.12E-12 0.00E+00 0.OOE+00 0.OOE+00 3.61E-13 0.OOE+00 RB-89 0.OOE+00 6.25E-14 5.55E-14 0.OOE+00 0.OOE+00 0.OOE+00 5.45E-16 0.00E+00 SR-89 7.63E+04 0.OOE+00 2.18E+03 0.OOE+00 0.OOE+00 0.OOE+00 2.95E+03 O.OOE+00 SR-90 1.49E+06 0.OOE+00 3.OOE+04 0.OOE+00 0.00E+00 0.OOE+00 1.33E+04 0.OOE+00 Y-90 2.1OE+00 0.OOE+00 5.62E-02 0.OOE+00 0.00E+00 0.OOE+00 5.98E+03 0.00E+00 SR-91 5.82E+02 0.OOE+00 2.20E+01 0.OOE+00 0.OOE+00 0.OOE+00 1.29E+03 0.00E+00 Y-91m 9.71 E-07 0.OOE+00 3.53E-08 0.OOE+00 0.OOE+00 0.OOE+00 1.90E-03 0.OOE+00 Y-91 3.48E+01 0.OOE+00 9.32E-01 0.OOE+00 0.OOE+00 0.OOE+00 4.64E+03 0.OOE+00 11.4-99 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-17 (Page 2 of 4) Child Drinking Water Air mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 2.44E+01 0.00E+00 9.79E-01 0.0OE+00 0.OOE+00 0.OOE+00 4.62E+02 0.00E+00 Y-92 2.00E-02 0.00E+00 5.72E-04 O.OOE+00 0.00E+00 0.00E+00 5.78E+02 O.00E+00 Y-93 2.91E-01 0.00E+00 8.00E-03 0.00E+00 0.00E+00 0.00E+00 4.34E+03 0.OOE+00 NB-93m 6.11E+00 1.53E+00 5.01E-01 0.00E+00 1.65E+00 0.OOE+00 2.30E+02 0.OOE+00 NB-95 1.30E+00 5.05E-01 3.61E-01 0.OOE+00 4.74E-01 0.OOE+00 9.34E+02 0.OOE+00 NB-97 1.25E-05 2.25E-06 1.05E-06 0.OOE+00 2.50E-06 0.00E+00 6.95E-01 0.OOE+00 ZR-93 9.72E+00 3.64E+00 2.59E+00 0.00E+00 1.41E+01 0.OOE+00 1.38E+03 0.OOE+00 ZR-95 6.72E+00 1.48E+00 1.31E+00 0.00E+00 2.11E+00 0.00E+00 1.54E+03 0.00E+00 ZR-97 2.49E-01 3.59E-02 2.12E-02 0.OOE+00 5.16E-02 0.OOE+00 5.45E+03 0.00E+00 MO-93 O.00E+00 1.40E+03 5.04E+01 0.OOE+00 3.70E+02 0.00E+00 7.1OE+01 0.OOE+00 MO-99 0.OOE+00 6.83E+02 1.69E+02 0.00E+00 1.46E+03 0.OOE+00 5.65E+02 0.00E+00 TC-99 3.11E+01 3.47E+01 1.25E+01 0.O0E+00 4.09E+02 3.07E+00 3.64E+02 0.00E+00 TC-99m 1.35E-02 2.65E-02 4.39E-01 0.00E+00 3.85E-01 1.34E-02 1.51 E+01 0.OOE+00 TC-101 3.40E-17 3.55E-17 4.51E-16 0.00E+00 6.06E-16 1.88E-17 1.13E-16 O.OOE+00 RU-103 4.22E+01 O.00E+00 1.62E+01 0.00E+00 1.06E+02 0.OOE+00 1.09E+03 0.00E+00 RU-1 05 5.77E-01 O.00E+00 2.09E-01 0.00E+00 5.07E+00 0.00E+00 3.76E+02 0.00E+00 RU-1 06 6.81E+02 O.00E+00 8.49E+01 0.OOE+00 9.19E+02 0.OOE+00 1.06E+04 0.00E+00 RH-1 05 2.37E+01 1.27E+01 1.09E+01 0.OOE+00 5.06E+01 0.OOE+00 7.87E+02 0.OOE+00 PD-107 0.OOE+00 2.75E+01 2.33E+00 0.OOE+00 2.30E+02 0.OOE+00 5.46E+01 0.OOE+00 PD-109 0.OOE+00 1.78E+01 5.33E+00 0.OOE+00 9.54E+01 0.OOE+00 1.05E+03 0.OOE+00 AG-110m 3.13E+01 2.12E+01 1.69E+01 0.00E+00 3.94E+01 0.OOE+00 2.52E+03 0.OOE+00 AG-1 11 1.38E+01 4.31 E+00 2.85E+00 0.OOE+00 1.30E+01 0.OOE+00 2.64E+03 0.OOE+00 CD-113m 0.OOE+00 5.94E+02 2.53E+01 0.OOE+00 6.11E+02 0.OOE+00 1.53E+03 0.OOE+00 CD-1 15m 0.OOE+00 3.40E+02 1.45E+01 0.OOE+00 2.53E+02 0.OOE+00 4.63E+03 0.OOE+00 SN-1 23 7.72E+03 9.58E+01 1.88E+02 1.02E+02 0.00E+00 0.OOE+00 3.79E+03 0.OOE+00 SN-125 1.99E+03 3.OOE+01 8.93E+01 3.12E+01 0.OOE+00 0.OOE+00 6.18E+03 0.OOE+00 SN-126 1.94E+04 2.42E+02 5.51E+02 6.64E+01 0.OOE+00 0.00E+00 1.46E+03 0.OOE+00 SB-124 6.43E+02 8.34E+00 2.25E+02 1.42E+00 0.OOE+00 3157E+02 4.02E+03 0.OOE+00 SB-125 4.17E+02 3.21E+00 8.73E+01 3.86E-01 0.OOE+00 2.32E+02 9.95E+02 0.OOE+00 SB-126 2.49E+02 3.81E+00 8.95E+01 1.46E+00 0.OOE+00 1.19E+02 5.02E+03 0.OOE+00 SB-127 5.64E+01 8.73E-01 1.96E+01 6.28E-01 0.OOE+00 2.45E+01 3.18E+03 0.OOE+00 TE-125m 6.60E+02 1.79E+02 8.80E+01 1.85E+02 0.OOE+00 0.OOE+00 6.37E+02 0.OOE+00 TE-127m 1.68E+03 4.52E+02 1.99E+02 4.01E+02 4.78E+03 0.OOE+00 1.36E+03 0.OOE+00 TE-127 1.13E+01 3.04E+00 2.42E+00 7.80E+00 3.20E+01 0.00E+00 4.40E+02 0.OOE+00 TE-129m 2.81E+03 7.84E+02 4.36E+02 9.05E+02 8.24E+03 0.OOE+00 3.42E+03 0.OOE+00 TE-1 29 6.00E-03 1.67E-03 1.42E-03 4.28E-03 1.75E-02 0.00E+00 3.73E-01 0.OOE+00 TE-133m 1.33E-03 5.39E-04 6.68E-04 1.03E-03 5.12E-03 0.OOE+00 4.11E-02 0.OOE+00 11.4-100 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-17 (Page 3 of 4) Child Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 4.90E-05 2.20E-05 2.94E-05 3.88E-05 2.04E-04 0.00E+00 2.24E-04 0.00E+00 1-129 8.09E+02 4.97E+02 4.44E+02 3.25E+05 8.38E+02 0.OOE+00 2.50E+01 0.00E+00 1-130 8.67E+01 1.75E+02 9.03E+01 1.93E+04 2.62E+02 O.OOE+00 8.20E+01 0.00E+00 1-131 9.59E+02 9.65E+02 5.48E+02 3.19E+05 1.58E+03 0.00E+00 8.59E+01 0.00E+00 TE-131m 3.18E+02 1.10E+02 1.17E+02 2.26E+02 1.06E+03 O.OOE+00 4.46E+03 0.00E+00 TE-131 1.03E-08 3.15E-09 3.08E-09 7.91E-09 3.13E-08 0.00E+00 5.43E-08 0.OOE+00 1-132 1.25E+00 2.30E+00 1.06E+00 1.07E+02 3.52E+00 0.00E+00 2.71 E+00 0.00E+00 TE-132 5.29E+02 2.34E+02 2.83E+02 3.41E+02 2.17E+03 0.00E+00 2.36E+03 0.00E+00 1-133 2.31E+02 2.86E+02 1.08E+02 5.31E+04 4.76E+02 0.00E+00 1.15E+02 0.00E+00 CS-134m 2.79E-01 4.13E-01 2.70E-01 0.O0E+00 2.18E-01 3.60E-02 5.22E-01 0.OOE+00 CS-134 1.36E+04 2.23E+04 4.71E+03 0.OOE+00 6.92E+03 2.48E+03 1.20E+02 0.OOE+00 1-134 1.85E-03 3.43E-03 1.58E-03 7.90E-02 5.25E-03 0.00E+00 2.28E-03 O.00E+00 1-135 2.89E+01 5.21E+01 2.46E+01 4.61E+03 7.99E+01 0.00E+00 3.97E+01 0.OOE+00 CS-135 4.83E+03 3.37E+03 3.45E+02 0.OOE+00 1.19E+03 3.96E+02 2.52E+01 0.00E+00 CS-136 1.33E+03 3.66E+03 2.37E+03 0.00E+00 1.95E+03 2.91 E+02 1.29E+02 0.00E+00 CS-137 1.90E+04 1.82E+04 2.69E+03 0.OOE+00 5.94E+03 2.14E+03 1.14E+02 0.OOE+00 CS-138 2.47E-06 3.43E-06 2.17E-06 0.00E+00 2.41E-06 2.60E-07 1.58E-06 0.OOE+00 CS-139 7.39E-23 8.21E-23 3.95E-23 0.OOE+00 6.17E-23 6.22E-24 7.39E-27 0.OOE+00 BA-139 5.94E-02 3.17E-05 1.72E-03 0.00E+00 2.77E-05 1.87E-05 3.43E+00 0.OOE+00 BA-140 4.71E+03 4.13E+00 2.75E+02 0.00E+00 1.34E+00 2.46E+00 2.39E+03 0.00E+00 LA-140 4.78E-01 1.67E-01 5.63E-02 0.00E+00 0.00E+00 0.OOE+00 4.66E+03 0.OOE+00 BA-141 1.60E-11 8.93E-15 5.19E-13 0.00E+00 7.73E-15 5.25E-14 9.09E-12 0.OOE+00 LA-141 9.59E-03 2.24E-03 4.85E-04 0.00E+00 0.00E+00 0.OOE+00 4.97E+02 0.OOE+00 CE-141 2.29E+00 1.14E+00 1.69E-01 0.OOE+00 5.00E-01 0.OOE+00 1.42E+03 0.OOE+00 BA-142 2.82E-20 2.03E-23 1.57E-21 0.OOE+00 1.64E-23 1.19E-23 3.68E-22 0.00E+00 LA-142 1.63E-04 5.20E-05 1.63E-05 0.OOE+00 0.00E+00 0.OOE+00 1.03E+01 0.OOE+00 CE-143 3.16E-01 1.71E+02 2.48E-02 0.OOE+00 7.19E-02 0.OOE+00 2.51E+03 0.OOE+00 PR-143 2.23E+00 6.70E-01 1.11E-01 0.00E+00 3.63E-01 0.00E+00 2.41E+03 0.00E+00 CE-144 1.21E+02 3.79E+01 6.45E+00 0.OOE+00 2.1OE+01 0.OOE+00 9.89E+03 0.00E+00 PR-144 2.15E-15 6.65E-16 1.08E-16 O.OOE+00 3.52E-16 0.00E+00 1.43E-12 0.OOE+00 ND-147 1.57E+00 1.27E+00 9.87E-02 0.OOE+00 6.99E-01 0.00E+00 2.02E+03 0.00E+00 PM-147 1.85E+01 1.32E+00 7.1OE-01 0.OOE+00 2.33E+00 0.OOE+00 5.35E+02 0.00E+00 PM-148m 5.95E+00 1.18E+00 1.18E+00 0.00E+00 1.76E+00 0.OOE+00 3.34E+03 0.OOE+00 PM-148 1.65E+00 1.98E-01 1.28E-01 0.00E+00 3.37E-01 0.OOE+00 5.29E+03 0.OOE+00 PM-149 3.23E-01 3.43E-02 1.86E-02 0.00E+00 6.07E-02 0.OOE+00 2.34E+03 0.OOE+00 PM-151 1.27E-01 1.54E-02 1.OOE-02 0.OOE+00 2.61E-02 0.00E+00 1.75E+03 0.00E+00 SM-151 1.49E+01 2.22E+00 6.99E-01 0.OOE+00 2.29E+00 0.00E+00 3.22E+02 0.OOE+00 11.4-101 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-17 (Page 4 of 4) Child Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.78E-01 1.11E-01 1.07E-02 0.OOE+00 3.37E-02 0.00E+00 1.47E+03 0.OOE+00 EU-152 3.58E+01 6.52E+00 7.74E+00 0.00E+00 2.75E+01 0.00E+00 1.07E+03 0.00E+00 EU-154 1.34E+02 1.21E+01 1.10E+01 0.OOE+00 5.29E+01 0.OOE+00 2.80E+03 0.OOE+00 EU-155 2.81E+01 2.02E+00 1.58E+00 0.OOE+00 7.57E+00 0.00E+00 5.06E+03 0.00E+00 EU-156 3.20E+00 1.71E+00 3.55E-01 O.OOE+00 1.10E-+00 O.OOE+00 3.89E+03 0.00E+00 TB-160 9.62E+00 0.OOE+00 1.19E+00 0.OOE+00 2.86E+00 O.OOE+00 2.13E+03 0.00E+00 HO-166m 6.29E+01 1.32E+01 1.11E+01 0.00E+00 1.87E+01 O.00E+00 5.82E-17 0.OOE+00 W-181 2.46E+00 6.04E-01 8.30E-02 0.00E+00 0.00E+00 0.OOE+00 2.20E+01 0.00E+00 W-185 1.OOE+02 2.50E+01 3.51E+00 0.OOE+00 0.OOE+00 0.OOE+00 9.33E+02 0.OOE+00 W-187 1.76E+01 1.04E+01 4.68E+00 0.OOE+00 0.OOE+00 0.OOE+00 1.47E+03 0.00E+00 NP-239 2.64E-01 1.89E-02 1.33E-02 0.OOE+00 5.48E-02 0.OOE+00 1.40E+03 0.00E+00 U-232 1.02E+06 0.OOE+00 7.34E+04 0.OOE+00 7.80E+04 0.OOE+00 4.06E+03 0.OOE+00 U-233 2.17E+05 0.OOE+00 1.31E+04 0.OOE+00 3.55E+04 0.OOE+00 3.76E+03 0.00E+00 U-234 2.08E+05 0.OOE+00 1.29E+04 0.00E+00 3.48E+04 O.00E+00 3.68E+03 0.00E+00 U-235 1.99E+05 0.00E+00 1.21 E+04 0.OOE+00 3.27E+04 0.OOE+00 4.68E+03 0.OOE+00 U-236 1.99E+05 0.OOE+00 1.23E+04 0.00E+00 3.34E+04 0.00E+00 3.45E+03 0.OOE+00 U-237 1.31E+01 0.OOE+00 3.47E+00 0.OOE+00 3.77E+01 0.00E+00 1.15E+03 0.00E+00 U-238 1.90E+05 0.00E+00 1.13E+04 0.OOE+00 3.05E+04 0.OOE+00 3.30E+03 0.OOE+00 NP-237 1.30E+05 8.56E+03 5.70E+03 0.OOE+00 3.52E+04 0.00E+00 4.75E+03 0.00E+00 NP-238 2.88E+00 5.83E-02 4.49E-02 0.OOE+00 1.86E-01 0.00E+00 2.OOE+03 0.00E+00 PU-238 6.93E+04 8.03E+03 1.84E+03 0.OOE+00 6.70E+03 0.00E+00 4.37E+03 0.OOE+00 PU-239 7.51E+04 8.03E+03 1.93E+03 0.OOE+00 7.1OE+03 0.OOE+00 3.99E+03 0.OOE+00 PU-240 7.45E+04 8.33E+03 1.93E+03 0.OOE+00 7.1OE+03 0.OOE+00 4.06E+03 0.OOE+00 PU-241 2.25E+03 9.20E+01 4.68E+01 O.OOE+00 1.72E+02 0.00E+00 8.38E+01 0.OOE+00 PU-242 6.93E+04 8.03E+03 1.86E+03 0.OOE+00 6.81E+03 0.OOE+00 3.91E+03 0.00E+00 PU-244 8.09E+04 9.20E+04 2.13E+03 0.OOE+00 7.86E+03 0.OOE+00 5.82E+03 0.OOE+00 AM-241 7.92E+04 6.81 E+04 5.94E+03 O.OOE+00 3.63E+04 0.00E+00 4.45E+03 0.00E+00 AM-242m 8.15E+04 6.52E+04 6.05E+03 0.00E+00 3.67E+04 O.OOE+00 5.59E+03 0.OOE+00 AM-243 7.80E+04 6.58E+04 5.72E+03 0.OOE+00 3.53E+04 0.00E+00 5.21E+03 0.00E+00 CM-242 5.1OE+03 4.07E+03 3.39E+02 0.OOE+00 1.09E+03 0.00E+00 4.74E+03 O.OOE+00 CM-243 7.45E+04 6.05E+04 4.80E+03 0.OOE+00 1.79E+04 0.00E+00 4.67E+03 0.00E+00 CM-244 6.29E+04 5.09E+04 4.03E+03 0.OOE+00 1.48E+04 0.OOE+00 4.52E+03 0.OOE+00 CM-245 9.72E+04 7.80E+04 6.11E+03 0.00E+00 2.39E+04 0.OOE+00 4.22E+03 0.OOE+00 CM-246 9.61E+04 7.80E+04 6.11E+03 O.00E+00 2.39E+04 0.OOE+00 4.14E+03 O.OOE+00 CM-247 9.37E+04 7.68E+04 6.OOE+03 0.00E+00 2.35E+04 0.00E+00 5.44E+03 0.00E+00 CM-248 7.80E+05 6.35E+05 4.96E+04 0.00E+00 1.94E+05 0.OOE+00 8.79E+04 0.OOE+00 CF-252 6.11 E+04 0.OOE+00 1.48E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.72E+04 0.OOE+00 11.4-102 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-18 (Page I of 4) Teen Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunga GI-LLI Skin H-3 0.00E+00 3.52E+00 3.52E+00 3.52E+00 3.52E+00 3.52E+00 3.52E+00 0.OOE+00 C-14 2.36E+02 4.73E+01 4.73E+01 4.73E+01 4.73E+01 4.73E+01 4.73E+01 0.OOE+00 NA-22 1.36E+03 1.36E+03 1.36E+03 1.36E+03 1.36E+03 1.36E+03 1.36E+03 0.OOE+00 NA-24 7.69E+01 7.69E+01 7.69E+01 7.69E+01 7.69E+01 7.69E+01 7.69E+01 0.OOE+00 P-32 1.57E+04 9.72E+02 6.08E+02 0.OOE+00 0.OOE+00 0.OOE+00 1.32E+03 0.OOE+00 CA-41 1.15E+04 0.OOE+00 1.24E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.14E+01 0.OOE+00 SC-46 4.20E-01 8.18E-01 2.42E-01 0.00E+00 7.83E-01 0.00E+00 2.78E+03 O.OOE+00 CR-51 0.OOE+00 0.OOE+00 2.07E-01 1.15E-01 4.54E-02 2.96E-01 3.48E+01 0.OOE+00 MN-54 0.OOE+00 3.43E+02 6.80E+01 0.OOE+00 1.02E+02 O.OOE+00 7.04E+02 0.OOE+00 FE-55 2.20E+02 1.56E+02 3.64E+01 0.00E+00 0.OOE+00 9.89E+01 6.75E+01 O.OOE+00 MN-56 O.OOE+00 3.65E-01 6.50E-02 0.OOE+00 4.63E-01 O.OOE+00 2.41 E+01 0.OOE+00 CO-57 0.00E+00 1.38E+01 2.32E+01 0.OOE+00 0.OOE+00 0.OOE+00 2.58E+02 0.OOE+00 CO-58 0.OOE+00 5.63E+01 1.30E+02 0.OOE+00 0.OOE+00 0.00E+00 7.76E+02 0.OOE+00 FE-59 3.39E+02 7.91 E+02 3.06E+02 0.OOE+00 0.OOE+00 2.50E+02 1.87E+03 0.OOE+00 CO-6O 0.OOE+00 1.64E+02 3.68E+02 0.OOE+00 0.OOE+00 0.00E+00 2.13E+03 0.OOE+00 NI-59 7.68E+02 2.71 E+02 1.30E+02 0.OOE+00 0.OOE+00 0.00E+00 4.26E+01 0.00E+00 NI-63 1.03E+04 7.28E+02 3.49E+02 0.00E+00 0.OOE+00 0.00E+00 1.16E+02 0.OOE+00 CU-64 O.OOE+00 3.48E+00 1.64E+00 0.OOE+00 8.80E+00 0.0OE+00 2.70E+02 0.OOE+00 NI-65 1.61E+00 2.05E-01 9.36E-02 0.OOE+00 0.OOE+00 0.OOE+00 1.11E+01 0.OOE+00 ZN-65 3.35E+02 1.16E+03 5.42E+02 0.OOE+00 7.44E+02 0.OOE+00 4.92E+02 0.OOE+00 ZN-69m 7.63E+00 1.80E+01 1.65E+00 O.OOE+00 1.09E+01 0.OOE+00 9.89E+02 0.OOE+00 ZN-69 1.08E-04 2.06E-04 1.44E-05 O.OOE+00 1.35E-04 O.OOE+00 3.80E-04 O.OOE+00 SE-79 O.OOE+00 2.17E+02 3.65E+01 O.OOE+00 3.78E+02 O.OOE+00 3.32E+01 O.OOE+00 BR-82 O.OOE+00 O.OOE+00 1.40E+02 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-83 O.OOE+00 O.OOE+00 1.03E-01 O.OOE+00 O.OOE+00 O.OQE+00 O.OOE+00 O.OOE+00 BR-84 O.OOE+00 O.OOE+00 6.42E-07 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-85 O.OOE+00 O.OOE+00 4.38E-77 O.OOE+00 O.OOE+00 O.OOE+00 O.OQE+00 O.OOE+00 RB-86 O.OOE+00 1.70E+03 8.OOE+02 O.OOE+00 O.OOE+00 O.OOE+00 2.52E+02 O.OOE+00 RB-87 O.OOE+00 1.02E+03 3.56E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.56E+01 O.OOE+00 RB-88 O.OOE+00 3.30E-12 1.76E-12 O.OOE+00 O.OOE+00 O.OOE+00 2.83E-19 O.OOE+00 RB-89 O.OOE+00 2.94E-14 2.08E-14 O.OOE+00 O.OOE+00 O.OOE+00 4.50E-23 O.OOE+00 SR-89 2.54E+04 O.OOE+00 7.29E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.03E+03 O.OOE+00 SR-90 5.94E+05 O.OOE+00 1.19E+04 O.OOE+00 O.OOE+00 O.OOE+00 1.36E+04 O.OOE+00 Y-90 7.01E-01 O.OOE+00 1.89E-02 O.OOE+00 O.OOE+00 O.OOE+00 5.78E+03 O.00E+00 SR-91 1.96E+02 O.00E+00 7.79E+00 O.OOE+00 O.OOE+00 O.OOE+00 8.88E+02 O.OOE+00 Y-91m 3.28E-07 O.OOE+00 1.25E-08 O.OOE+00 O.OOE+00 O.OOE+00 1.55E-05 O.OOE+00 Y-91 1.16E+01 O.OOE+00 3.12E-01 O.OOE+00 O.OOE+00 O.OOE+00 4.77E+03 O.OOE+00 11.4-103 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-18 (Page 2 of 4) Teen Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney LunQ GI-LLI Skin SR-92 8.25E+00 0.00E+00 3.52E-01 0.00E+00 0.00E+00 0.OOE+00 2.1OE+02 0.00E+00 Y-92 6.72E-03 0.00E+00 1.94E-04 0.OOE+00 0.00E+00 0.00E+00 1.84E+02 0.00E+00 Y-93 9.79E-02 0.OOE+00 2.68E-03 O.OOE+00 0.OOE+00 0.00E+00 2.99E+03 0.OOE+00 NB-93m 2.OOE+00 6.58E-01 1.65E-01 0.00E+00 7.68E-01 0.OOE+00 2.37E+02 O.OOE+00 NB-95 4.74E-01 2.63E-01 1.45E-01 0.00E+00 2.55E-01 0.00E+00 1.12E+03 0.00E+00 NB-97 4.23E-06 1.05E-06 3.83E-07 0.OOE+00 1.23E-06 0.OOE+00 2.51E-02 0.00E+00 ZR-93 3.22E+00 1.59E+00 8.67E-01 0.00E+00 5.62E+00 0.00E+00 1.50E+03 0.00E+00 ZR-95 2.39E+00 7.53E-01 5.18E-01 0.00E+00 1.11E+00 0.OOE+00 1.74E+03 0.OOE+00 ZR-97 8.43E-02 1.67E-02 7.69E-03 0.OOE+00 2.53E-02 0.OOE+00 4.52E+03 0.00E+00 MO-93 0.OOE+00 6.17E+02 1.69E+01 0.00E+00 1.77E+02 0.OOE+00 7.51E+01 0.OOE+00 MO-99 0.00E+00 3.10E+02 5.90E+01 0.00E+00 7.08E+02 0.00E+00 5.54E+02 0.00E+00 TC-99 1.04E+01 1.53E+01 4.17E+00 0.OOE+00 1.94E+02 1.58E+00 3.75E+02 0.00E+00 TC-99m 4.85E-03 1.35E-02 1.75E-01 0.00E+00 2.02E-01 7.52E-03 8.89E+00 0.00E+00 TC-101 1.14E-17 1.62E-17 1.60E-16 0.00E+00 2.94E-16 9.90E-18 2.78E-24 0.00E+00 RU-103 1.47E+01 0.00E+00 6.29E+00 0.00E+00 5.19E+01 O.OOE+00 1.23E+03 0.OOE+00 RU-105 1.95E-01 0.OOE+00 7.57E-02 0.00E+00 2.46E+00 0.00E+00 1.57E+02 0.00E+00 RU-106 2.28E+02 0.00E+00 2.87E+01 0.00E+00 4.40E+02 0.00E+00 1.09E+04 0.00E+00 RH-105 7.96E+00 5.75E+00 3.77E+00 0.00E+00 2.44E+01 0.00E+00 7.32E+02 0.OOE+00 PD-107 O.00E+00 1.21E+01 7.80E-01 0.00E+00 1.09E+02 0.OOE+00 5.62E+01 0.OOE+00 PD-1 09 0.00E+00 7.87E+00 1.79E+00 0.00E+00 4.55E+01 0.OOE+00 7.94E+02 0.00E+00 AG-11Orn 1.19E+01 1.13E+01 6.86E+00 0.00E+00 2.15E+01 0.OOE+00 3.17E+03 0.OOE+00 AG-111 4.61E+00 1.91E+00 9.61E-01 0.OOE+00 6.22E+00 0.OOE+00 2.67E+03 0.OOE+00 CD-i 13m 0.OOE+00 2.63E+02 8.44E+00 0.OOE+00 2.90E+02 0.OOE+00 1.58E+03 0.OOE+00 CD-i 15m 0.OOE+00 1.50E+02 4.85E+00 0.OOE+00 1.20E+02 0.00E+00 4.75E+03 0.OOE+00 SN-123 2.58E+03 4.23E+01 6.27E+01 3.39E+01 0.OOE+00 0.OOE+00 3.90E+03 0.OOE+00 SN-125 6.68E+02 1.33E+01 3.02E+01 1.04E+01 0.OOE+00 0.OOE+00 6.29E+03 0.OOE+00 SN-126 6.75E+03 1.26E+02 1.92E+02 3.31E+01 0.OOE+00 0.OOE+00 1.50E+03 0.OOE+00 SB-124 2.24E+02 4.13E+00 8.74E+01 5.08E-01 0.OOE+00 1.96E+02 4.52E+03 0.OOE+00 SB-125 1.44E+02 1.58E+00 3.38E+01 1.38E-01 0.OOE+00 1.27E+02 1.12E+03 0.OOE+00 SB-1 26 9.00E+01 1.84E+00 3.23E+01 5.09E-01 0.OOE+00 6.45E+01 5.33E+03 0.OOE+00 SB-127 1.93E+01 4.13E-01 7.29E+00 2.17E-01 0.OOE+00 1.31E+01 3.28E+03 0.OOE+00 TE-125m 2.22E+02 7.99E+01 2.96E+01 6.19E+01 0.OOE+00 0.OOE+00 6.54E+02 0.OOE+00 TE-127m 5.61E+02 1.99E+02 6.67E+01 1.33E+02 2.27E+03 0.00E+00 1.40E+03 0.OOE+00 TE-127 3.78E+00 1.34E+00 8.13E-01 2.61E+00 1.53E+01 0.OOE+00 2.92E+02 0.00E+00 TE-129m 9.39E+02 3.49E+02 1.49E+02 3.03E+02 3.93E+03 0.00E+00 3.53E+03 0.OOE+00 TE-129 2.01E-03 7.48E-04 4.88E-04 1.43E-03 8.42E-03 0.OOE+00 1.10E-02 0.OOE+00 TE-133m 4.59E-04 2.61E-04 2.54E-04 3.64E-04 2.58E-03 0.OOE+00 1.05E-03 0.OOE+00 11.4-104 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-18 (Page 3 of 4) Teen Drinking Water At mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 1.70E-05 1.09E-05 1.14E-05 1.39E-05 1.04E-04 0.00E+00 6.31E-07 0.OOE+00 1-129 2.71E+02 2.28E+02 3.81EE+02 2.78E+05 4.08E+02 0.OOE+00 2.66E+01 0.00E+00 1-130 3.06E+01 8.85E+01 3.53E+01 7.22E+03 1.36E+02 0.00E+00 6.80E+01 0.00E+00 1-131 3.26E+02 4.57E+02 2.45E+02 1.33E+05 7.86E+02 0.OOE+00 9.03E+01 O.0OE+00 TE-131m 1.08E+02 5.16E+01 4.31E+01 7.77E+01 5.38E+02 0.OOE+00 4.14E+03 O.O0E+00 TE-131 3.48E-09 1.43E-09 1.09E-09 2.68E-09 1.52E-08 0.OOE+00 2.85E-10 0.OOE+00 1-132 4.37E-01 1.14E+00 4.10E-01 3.85E+01 1.80E+00 0.OOE+00 4.98E-01 0.00E+00 TE-132 1.83E+02 1.16E+02 1.09E+02 1.22E+02 1.11E+03 0.OOE+00 3.66E+03 0.OOE+00 1-133 7.84E+01 1.33E+02 4.06E+01 1.86E+04 2.33E+02 O.OOE+00 1.01E+02 0.OOE+00 CS-134m 9.72E-02 2.01E-01 1.04E-01 0.OOE+00 1.12E-01 1.97E-02 1.34E-01 0.00E+00 CS-134 4.87E+03 1.15E+04 5.32E+03 0.OOE+00 3.64E+03 1.39E+03 1.43E+02 0.OOE+00 1-134 6.44E-04 1.71E-03 6.13E-04 2.84E-02 2.69E-03 0.OOE+00 2.25E-05 0.OOE+00 1-135 1.01E+01 2.60E+01 9.63E+00 1.67E+03 4.1OE+01 0.00E+00 2.88E+01 0.OOE+00 CS-135 1.62E+03 1.48E+03 3.47E+02 0.OOE+00 5.66E+02 2.05E+02 2.60E+01 0.OOE+00 CS-136 4.87E+02 1.92E+03 1.29E+03 0.OOE+00 1.04E+03 1.64E+02 1.54E+02 0.O0E+00 CS-137 6.52E+03 8.67E+03 3.02E+03 0.OOE+00 2.95E+03 1.15E+03 1.23E+02 0.OOE+00 CS-138 8.39E-07 1.61E-06 8.06E-07 0.OOE+00 1.19E-06 1.38E-07 7.31E-10 0.00E+00 CS-1 39 2.48E-23 3.66E-23 1.34E-23 0.00E+00 2.95E-23 3.23E-24 1.70E-38 0.OOE+00 BA-139 1.99E-02 1.40E-05 5.81E-04 0.OOE+00 1.32E-05 9.67E-06 1.78E-01 0.OOE+00 BA-140 1.61E+03 1.97E+00 1.04E+02 0.OOE+00 6.69E-01 1.33E+00 2.48E+03 0.00E+00 LA-140 1.65E-01 8.1OE-02 2.15E-02 0.OOE+00 0.00E+00 0.OOE+00 4.65E+03 0.OOE+00 BA-141 5.35E-12 4.OOE-15 1.79E-13 0.OOE+00 3.71E-15 2.74E-15 1.14E-17 0.OOE+00 LA-141 3.21E-03 9.87E-04 1.63E-04 0.OOE+00 0.OOE+00 0.OOE+00 1.75E+02 0.OOE+00 CE-141 7.66E-01 5.12E-01 5.88E-02 0.OOE+00 2.41E-01 0.OOE+00 1.46E+03 0.OOE+00 BA-142 9.65E-21 9.65E-24 5.94E-22 0.OOE+00 8.17E-24 6.42E-24 2.96E-32 0.00E+00 LA-142 5.57E-05 2.47E-05 6.16E-06 0.OOE+00 0.OOE+00 0.OOE+00 7.53E-01 0.00E+00 CE-143 1.06E-01 7.74E+01 8.64E-03 0.OOE+00 3.47E-02 0.OOE+00 2.33E+03 0.OOE+00 PRL143 7.43E-01 2.97E-01 3.70E-02 0.OOE+00 1.73E-01 O.OOE+00 2.45E+03 0.OOE+00 CE-144 4.05E+01 1.67E+01 2.17E+00 0.OOE+00 1.OOE+01 0.OOE+00 1.02E+04 0.OOE+00 PR-144 7.17E-16 2.94E-16 3.64E-17 0.OOE+00 1.68E-16 0.OOE+00 7.91E-19 0.OOE+00 ND-147 5.29E-01 5.75E-01 3.45E-02 0.OOE+00 3.38E-01 0.OOE+00 2.08E+03 0.OOE+00 PM-147 6.11iE+00 5.80E-01 2.36E-01 0.OOE+00 1.11E+00 0.00E+00 5.51E+02 0.OOE+00 PM-148m 2.39E+00 6.06E-01 4.74E-01 0.00E+00 9.18E-01 0.OOE+00 3.82E+03 0.OOE+00 PM-148 5.57E-01 9.06E-02 4.56E-02 0.00E+00 1.64E-01 0.OOE+00 5.40E+03 0.OOE+00 PM-149 1.08E-01 1.52E-02 6.22E-03 0.00E+00 2.89E-02 0.00E+00 2.23E+03 0.00E+00 PM-151 4.29E-02 7.08E-03 3.58E-03 0.OOE+00 1.27E-02 0.OOE+00 1.59E+03 0.OOE+00 SM-151 5.08E+00 9.78E-01 2.29E-01 0.OOE+00 1.07E+00 0.OOE+00 3.32E+02 0.00E+00 11.4-105 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II,Offsite Dose Calculation Manual Table 4-18 (Page 4 of 4) Teen Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 5.94E-02 4.92E-02 3.62E-03 0.OOE+00 1.61 E-02 0.OOE+00 1.39E+03 O.OOE+00 EU-152 1.43E+01 3.43E+00 3.03E+00 0.00E+00 1.60E+01 0.00E+00 1.26E+03 0.OOE+00 EU-154 4.60E+01 5.94E+00 4.19E+00 0.OOE+00 2.65E+01 0.0OE+00 3.14E+03 0.00E+00 EU-155 1.01E+01 9.78E-01 6.05E-01 0.00E+00 3.82E+00 O.00E+00 5.61E+03 0.OOE+00 EU-156 1.09E+00 8.19E-01 1.34E-01 0.00E+00 5.51E-01 O.OOE+00 4.19E+03 0.OOE+00 TB-160 3.75E+00 O.00E+00 4.68E-01 0.00E+00 1.48E+00 0.OOE+00 2.43E+03 0.OOE+00 HO-166m 2.08E+01 6.40E+00 4.63E+00 0.00E+00 9.37E+00 0.00E+00 5.82E-17 0.00E+00 W-181 8.24E-01 2.66E-01 2.78E-02 0.00E+00 0.OOE+00 O.00E+00 2.26E+01 0.OOE+00 W-185 3.36E+01 1.11E+01 1.17E+00 0.OOE+00 0.OOE+00 0.00E+00 9.56E+02 0.00E+00 W-187 6.OOE+00 4.89E+00 1.71E+00 0.O0E+00 0.00E+00 0.00E+00 1.32E+03 O.OOE+00 NP-239 8.84E-02 8.34E-03 4.63E-03 O.OOE+00 2.62E-02 0.00E+00 1.34E+03 O.OOE+00 U-232 3.43E+05 0.00E+00 2.45E+04 O.OOE+00 3.71E+04 0.OOE+00 4.19E+03 0.OOE+00 U-233 7.22E+04 O.OOE+00 4.39E+03 0.00E+00 1.69E+04 0.OOE+00 3.87E+03 0.OOE+00 U-234 6.93E+04 0.OOE+00 4.30E+03 0.00E+00 1.66E+04 0.OOE+00 3.79E+03 0.00E+00 U-235 6.64E+04 0.00E+00 4.04E+03 0.00E+00 1.55E+04 0.OOE+00 4.82E+03 O.00E+00 U-236 6.64E+04 0.OOE+00 4.13E+03 0.00E+00 1.59E+04 0.00E+00 3.56E+03 0.OOE+00 U-237 4.36E+00 0.00E+00 1.16E+00 O.OOE+00 1.79E+01 0.00E+00 1.16E+03 0.OOE+00 U-238 6.35E+04 0.OOE+00 3.78E+03 0.OOE+00 1.46E+04 0.OOE+00 3.39E+03 0.OOE+00 NP-237 7.74E+04 5.56E+03 3.41 E+03 0.OOE+00 2.52E+04 0.00E+00 4.90E+03 0.OOE+00 NP-238 9.64E-01 2.58E-02 1.50E-02 0.00E+00 8.85E-02 0.00E+00 1.89E+03 0.OOE+00 PU-238 3.90E+04 5.OOE+03 1.06E+03 0.OOE+00 4.54E+03 0.OOE+00 4.50E+03 0.00E+00 PU-239 4.45E+04 5.41E+03 1.17E+03 O.OOE+00 4.99E+03 0.OOE+00 4.11E+03 0.00E+00 PU-240 4.45E+04 5.40E+03 1.17E+03 0.00E+00 4.98E+03 0.00E+00 4.19E+03 0.00E+00 PU-241 1.02E+03 4.89E+01 2.15E+01 0.00E+00 9.95E+01 0.00E+00 8.62E+01 0.OOE+00 PU-242 4.13E+04 5.20E+03 1.13E+03 0.00E+00 4.80E+03 0.00E+00 4.03E+03 0.00E+00 PU-244 4.82E+04 5.94E+03 1.29E+03 0.OOE+00 5.50E+03 0.OOE+00 6.00E+03 0.00E+00 AM-241 4.65E+04 4.38E+04 3.35E+03 0.00E+00 2.51E+04 0.OOE+00 4.58E+03 0.OOE+00 AM-242m 4.70E+04 4.14E+04 3.38E+03 0.00E+00 2.50E+04 0.00E+00 5.76E+03 0.OOE+00 AM-243 4.63E+04 4.28E+04 3.27E+03 0.00E+00 2.46E+04 0.00E+00 5.37E+03 0.OOE+00 CM-242 1.71E+03 1.80E+03 1.13E+02 0.OOE+00 5.16E+02 0.OOE+00 4.88E+03 0.OOE+00 CM-243 3.78E+04 3.51E+04 2.38E+03 0.OOE+00 1.11E+04 0.OOE+00 4.82E+03 0.OOE+00 CM-244 2.93E+04 2.78E+04 1.86E+03 0.OOE+00 8.67E+03 0.OOE+00 4.66E+03 0.OOE+00 CM-245 5.76E+04 5.07E+04 3.55E+03 0.OOE+00 1.66E+04 0.OOE+00 4.34E+03 0.OOE+00 CM-246 5.72E+04 5.07E+04 3.55E+03 O.OOE+00 1.65E+04 0.OOE+00 4.27E+03 O.OOE+00 CM-247 5.57E+04 4.99E+04 3.49E+03 0.OOE+00 1.63E+04 0.00E+00 5.61 E+03 0.00E+00 CM-248 4.63E+05 4.11 E+05 2.88E+04 0.OOE+00 1.34E+05 0.00E+00 9.02E+04 0.OOE+00 CF-252 2.02E+04 0.OOE+00 4.87E+02 0.OOE+00 0.OOE+00 0.OOE+00 1.78E+04 0.OOE+00 11.4-106 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-19 (Page 1 of 4) Adult Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lungj GI-LLI Skin H-3 0.OOE+00 4.99E+00 4.99E+00 4.99E+00 4.99E+00 4.99E+00 4.99E+00 0.00E+00 C-14 2.37E+02 4.73E+01 4.73E+01 4.73E+01 4.73E+01 4.73E+01 4.73E+01 0.OOE+00 NA-22 1.45E+03 1.45E+03 1.45E+03 1.45E+03 1.45E+03 1.45E+03 1.45E+03 0.00E+00 NA-24 8.14E+01 8.14E+01 8.14E+01 8.14E+01 8.14E+01 8.14E+01 8.14E+01 0.OOE+00 P-32 1.57E+04 9.76E+02 6.07E+02 0.00E+00 0.OOE+00 0.OOE+00 1.77E+03 0.OOE+00 CA-41 1.54E+04 0.OOE+00 1.67E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.53E+01 0.OOE+00 SC-46 4.57E-01 8.88E-01 2.58E-01 0.00E+00 8.29E-01 0.OOE+00 4.32E+03 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 2.19E-01 1.31E-01 4.82E-02 2.91E-01 5.51E+01 O.OOE+00 MN-54 0.OOE+00 3.80E+02 7.26E+01 O.OOE+00 1.13E+02 0.00E+00 1.17E+03 O.OOE+00 FE-55 2.29E+02 1.58E+02 3.69E+01 O.OOE+00 0.OOE+00 8.83E+01 9.08E+01 0.00E+00 MN-56 0.OOE+00 3.81E-01 6.75E-02 O.OOE+00 4.83E-01 0.00E+00 1.21E+01 O.OOE+00 CO-57 O.OOE+00 1.46E+01 2.42E+01 0.OOE+00 O.OOE+00 0.00E+00 3.70E+02 0.00E+00 CO-58 0.00E+00 6.18E+01 1.38E+02 0.OOE+00 0.OOE+00 0.00E+00 1.25E+03 0.00E+00 FE-59 3.59E+02 8.43E+02 3.23E+02 0.OOE+00 0.00E+00 2.36E+02 2.81E+03 O.00E+00 CO-60 0.00E+00 1.78E+02 3.93E+02 0.OOE+00 0.00E+00 0.OOE+00 3.35E+03 0.OOE+00 NI-59 8.13E+02 2.79E+02 1.36E+02 0.OOE+00 0.OOE+00 0.OOE+00 5.75E+01 0.00E+00 NI-63 1.08E+04 7.51 E+02 3.63E+02 0.00E+00 0.00E+00 0.OOE+00 1.57E+02 0.OOE+00 CU-64 0.OOE+00 3.61 E+00 1.69E+00 0.00E+00 9.09E+00 0.OOE+00 3.07E+02 0.00E+00 NI-65 1.62E+00 2.11E-01 9.61E-02 0.00E+00 O.00E+00 0.OOE+00 5.34E+00 0.00E+00 ZN-65 4.03E+02 1.28E+03 5.79E+02 0.00E+00 8.57E+02 0.OOE+00 8.07E+02 O.00E+00 ZN-69m 7.74E+00 1.86E+01 1.70E+00 0.00E+00 1.12E+01 0.00E+00 1.13E+03 0.00E+00 ZN-69 1.08E-04 2.08E-04 1.44E-05 0.00E+00 1.35E-04 0.OOE+00 3.12E-05 0.00E+00 SE-79 0.OOE+00 2.19E+02 3.66E+01 0.00E+00 3.79E+02 0.OOE+00 4.48E+01 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.49E+02 0.00E+00 0.00E+00 0.OOE+00 1.71 E+02 0.00E+00 BR-83 0.OOE+00 0.00E+00 1.03E-01 0.00E+00 0.00E+00 0.OOE+00 1.49E-01 0.00E+00 BR-84 0.00E+00 0.00E+00 6.64E-07 0.00E+00 0.00E+00 0.OOE+00 5.21E-12 0.00E+00 BR-85 0.00E+00 0.00E+00 4.40E-77 O.00E+00 O.00E+00 0.00E+00 0.00E+00 0.00E+00 RB-86 0.00E+00 1.73E+03 8.04E+02 0.00E+00 0.00E+00 0.00E+00 3.40E+02 0.OOE+00 RB-87 0.00E+00 1.03E+03 3.57E+02 0.00E+00 0.OOE+00 0.00E+00 4.80E+01 0.OOE+00 RB-88 0.00E+00 3.36E-12 1.78E-12 0.00E+00 0.OOE+00 0.00E+00 4.64E-23 0.00E+00 RB-89 0.OOE+00 3.06E-14 2.15E-14 0.00E+00 0.OOE+00 0.00E+00 1.78E-27 0.00E+00 SR-89 2.55E+04 0.OOE+00 7.32E+02 0.OOE+00 0.OOE+00 0.OOE+00 4.09E+03 0.OOE+00 SR-90 7.26E+05 0.OOE+00 1.46E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.82E+04 0.OOE+00 Y-90 7.04E-01 0.00E+00 1.89E-02 0.OOE+00 0.OOE+00 0.00E+00 7.47E+03 O.00E+00 SR-91 1.97E+02 0.00E+00 7.95E+00 0.OOE+00 0.OOE+00 0.OOE+00 9.37E+02 0.00E+00 Y-91 m 3.31 E-07 0.OOE+00 1.28E-08 0.00E+00 0.00E+00 0.OOE+00 9.71 E-07 0.OOE+00 Y-91 1.17E+01 0.OOE+00 3.12E-01 0.00E+00 0.00E+00 0.OOE+00 6.43E+03 0.00E+00 11.4-107 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-19 (Page 2 of 4) Adult Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 8.32E+00 0.OOE+00 3.60E-01 0.OOE+00 0.OOE+00 0.OOE+00 1.65E+02 0.OOE+00 Y-92 6.72E-03 0.OOE+00 1.96E-04 0.00E+00 0.00E+00 0.OOE+00 1.18E+02 0.OOE+00 Y-93 9.80E-02 0.OOE+00 2.71E-03 0.00E+00 0.OOE+00 0.OOE+00 3.11E+03 0.00E+00 NB-93m 2.12E+00 6.93E-01 1.71E-01 0.00E+00 7.97E-01 O.OOE+00 3.20E+02 0.OOE+00 NB-95 5.13E-01 2.85E-01 1.53E-01 0.OOE+00 2.82E-01 O.00E+00 1.73E+03 O.00E+00 NB-97 4.29E-06 1.08E-06 3.96E-07 O.OOE+00 1.27E-06 0.OOE+00 4.OOE-03 0.00E+00 ZR-93 3.48E+00 1.95E-01 9.08E-02 0.OOE+00 7.39E-01 0.00E+00 2.03E+02 0.OOE+00 ZR-95 2.52E+00 8.08E-01 5.47E-01 0.OOE+00 1.27E+00 0.OOE+00 2.56E+03 O.OOE+00 ZR-97 8.56E-02 1.73E-02 7.90E-03 0.OOE+00 2.61 E-02 0.OOE+00 5.35E+03 0.00E+00 MO-93 0.OOE+00 6.26E+02 1.69E+01 0.00E+00 1.78E+02 0.OOE+00 1.02E+02 0.00E+00 MO-99 0.OOE+00 3.17E+02 6.02E+01 0.00E+00 7.17E+02 0.OOE+00 7.34E+02 0.OOE+00 TC-99 1.04E+01 1.55E+01 4.18E+00 0.OOE+00 1.95E+02 1.32E+00 5.07E+02 0.OOE+00 TC-99m 5.17E-03 1.46E-02 1.86E-01 0.OOE+00 2.22E-01 7.16E-03 8.64E+00 0.OOE+00 TC-101 1.15E-17 1.66E-17 1.63E-16 0.OOE+00 2.99E-16 8.50E-18 5.00E-29 0.OOE+00 RU-1 03 1.53E+01 0.OOE+00 6.58E+00 0.OOE+00 5.83E+01 0.OOE+00 1.78E+03 0.00E+00 RU-105 1.97E-01 0.OOE+00 7.78E-02 0.OOE+00 2.55E+00 0.00E+00 1.21E+02 0.OOE+00 RU-106 2.29E+02 0.OOE+00 2.90E+01 0.OOE+00 4.42E+02 0.00E+00 1.48E+04 0.OOE+00 RH-1 05 7.97E+00 5.83E+00 3.84E+00 0.OOE+00 2.48E+01 0.OOE+00 9.29E+02 0.OOE+00 PD-107 0.OOE+00 1.23E+01 7.83E-01 0.OOE+00 1.10E+02 0.OOE+00 7.59E+01 0.OOE+00 PD-109 0.OOE+00 7.95E+00 1.79E+00 0.00E+00 4.54E+01 0.OOE+00 8.80E+02 0.OOE+00 AG- 1O1m 1.33E+01 1.23E+01 7.31 E+00 0.OOE+00 2.42E+01 0.OOE+00 5.03E+03 0.OOE+00 AG-1 11 4.62E+00 1.93E+00 9.63E-01 0.OOE+00 6.24E+00 0.OOE+00 3.55E+03 0.OOE+00 CD-113m 0.OOE+00 2.65E+02 8.50E+00 0.OOE+00 2.92E+02 0.OOE+00 2.13E+03 0.OOE+00 CD-1 15m 0.OOE+00 1.52E+02 4.85E+00 0.OOE+00 1.21 E+02 0.OOE+00 6.40E+03 0.OOE+00 SN-123 2.58E+03 4.28E+01 6.31E+01 3.64E+01 0.OOE+00 0.OOE+00 5.26E+03 0.OOE+00 SN-125 6.70E+02 1.35E+01 3.04E+01 1.12E+01 0.OOE+00 0.OOE+00 8.36E+03 0.OOE+00 SN-126 7.04E+03 1.39E+02 2.OOE+02 4.10E+01 0.OOE+00 0.OOE+00 2.03E+03 0.00E+00 SB-124 2.32E+02 4.38E+00 9.20E+01 5.63E-01 0.OOE+00 1.81iE+02 6.59E+03 0.OOE+00 SB-125 1.49E+02 1.67E+00 3.55E+01 1.52E-01 0.OOE+00 1.15E+02 1.64E+03 0.OOE+00 SB-126 9.32E+01 1.90E+00 3.36E+01 5.70E-01 0.OOE+00 5.71E+01 7.62E+03 0.OOE+00 SB-127 1.96E+01 4.30E-01 7.54E+00 2.36E-01 0.OOE+00 1.17E+01 4.49E+03 0.OOE+00 TE-125m 2.22E+02 8.04E+01 2.97E+01 6.68E+01 9.03E+02 0.OOE+00 8.86E+02 0.OOE+00 TE-127m 5.62E+02 2.01E+02 6.85E+01 1.44E+02 2.28E+03 0.OOE+00 1.89E+03 0.OOE+00 TE-127 3.77E+00 1.35E+00 8.15E-01 2.79E+00 1.53E+01 0.OOE+00 2.97E+02 0,00E+00 TE-129m 9.48E+02 3.54E+02 1.50E+02 3.26E+02 3.96E+03 0.00E+00 4.78E+03 0.OOE+00 TE-129 2.01E-03 7.56E-04 4.90E-04 1.54E-03 8.46E-03 0.OOE+00 1.52E-03 0.OOE+00 TE-133m 4.71E-04 2.75E-04 2.65E-04 3.99E-04 2.72E-03 0.OOE+00 9.44E-05 0.OOE+00 11.4-108 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-19 (Page 3 of 4) Adult Drinking Water Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LL1 Skin TE-134 1.76E-05 1.15E-05 7.07E-06 1.54E-05 1.12E-04 0.OOE+00 1.95E-08 0.OOE+00 1-129 2.73E+02 2.34E+02 7.68E+02 6.03E+05 5.03E+02 0.OOE+00 3.70E+01 0.OOE+00 1-130 3.21E+01 9.48E+01 3.74E+01 8.04E+03 1.48E+02 0.OOE+00 8.16E+01 0.OOE+00 1-131 3.32E+02 4.75E+02 2.72E+02 1.56E+05 8.14E+02 0.OOE+00 1.25E+02 0.OOE+00 TE-131m 1.09E+02 5.34E+01 4.45E+01 8.46E+01 5.41 E+02 0.OOE+00 5.31 E+03 0.OOE+00 TE-131 3.51 E-09 1.47E-09 1.11E-09 2.89E-09 1.54E-08 0.OOE+00 4.97E-1 0 0.OOE+00 1-132 4.55E-01 1.22E+00 4.26E-01 4.26E+01 1.94E+00 0.OOE+00 2.28E-01 0.OOE+00 TE-132 1.89E+02 1.22E+02 1.15E+02 1.35E+02 1.18E+03 0.OOE+00 5.78E+03 0.OOE+00 1-133 7.93E+01 1.38E+02 4.21 E+01 2.03E+04 2.41 E+02 0.OOE+00 1.24E+02 0.OOE+00 CS-1 34m 1.01E-01 2.12E-01 1.08E-01 0.OOE+00 1.15E-01 1.81 E-02 7.48E-02 0.OOE+00 CS-134 5.18E+03 1.23E+04 1.01E+04 0.OOE+00 3.99E+03 1.32E+03 2.16E+02 0.OOE+00 1-134 6.69E-04 1.82E-03 6.50E-04 3.15E-02 2.89E-03 0.OOE+00 1.58E-06 0.OOE+00 1-135 1.05E+01 2.75E+01 1.01E+01 1.81 E+03 4.40E+01 0.OOE+00 3.10E+01 0.OOE+00 CS-135 1.63E+03 1.50E+03 6.66E+02 0.OOE+00 5.68E+02 1.70E+02 3.51 E+01 0.OOE+00 CS-136 5.28E+02 2.09E+03 1.50E+03 0.OOE+00 1.16E+03 1.59E+02 2.37E+02 0.OOE+00 CS-137 6.64E+03 9.08E+03 5.95E+03 0.OOE+00 3.08E+03 1.02E+03 1.76E+02 0.OOE+00 CS-138 8.54E-07 1.69E-06 8.36E-07 0.OOE+00 1.24E-06 1.22E-07 7.20E-1 2 0.OOE+00 CS-139 2.49E-23 3.71 E-23 1.35E-23 0.OOE+00 2.97E-23 2.70E-24 8.03E-46 0.OOE+00 BA-1 39 1.99E-02 1.42E-05 5.83E-04 0.OOE+00 1.33E-05 8.05E-06 3.53E-02 0.OOE+00 BA-140 1.65E+03 2.07E+00 1.08E+02 0.OOE+00 7.03E-01 1.18E+00 3.39E+03 0.OOE+00 LA-140 1.69E-01 8.54E-02 2.26E-02 0.OOE+00 0.OOE+00 0.OOE+00 6.27E+03 0.OOE+00 BA-141 5.38E-12 4.06E-15 1.82E-13 0.OOE+00 3.78E-15 2.31E-15 2.53E-21 0.OOE+00 LA-141 3.22E-03 9.99E-04 1.63E-04 0.OOE+00 0.OOE+00 0.OOE+00 1.19E+02 0.OOE+00 CE-141 7.72E-01 5.22E-01 5.92E-02 0.OOE+00 2.42E-01 0.OOE+00 2.OOE+03 0.OOE+00 BA-142 9.84E-21 1.01 E-23 6.19E-22 0.OOE+00 8.55E-24 5.73E-24 1.39E-38 0.OOE+00 LA-142 5.70E-05 2.59E-05 6.46E-06 0.OOE+00 0.OOE+00 0.OOE+00 1.89E-01 0.OOE+00 CE-143 1.07E-01 7.90E+01 8.74E-03 0.OOE+00 3.48E-02 0.OOE+00 2.95E+03 0.OOE+00 PR-143 7.47E-01 3.OOE-01 3.70E-02 0.OOE+00 1.73E-01 0.OOE+00 3.27E+03 0.OOE+00 CE-144 4.06E+01 1.70E+01 2.18E+00 0.OOE+00 1.01E+01 0.OOE+00 1.37E+04 0.OOE+00 PR-1 44 7.19E-16 2.98E-16 3.65E-1 7 0.OOE+00 1.68E-16 0.OOE+00 1.03E-22 0.OOE+00 ND-147 5.08E-01 5.87E-01 3.51 E-02 0.OOE+00 3.43E-01 0.OOE+00 2.82E+03 0.OOE+00 PM-147 6.28E+00 5.91 E-01 2.39E-01 0.OOE+00 1.12E+00 0.OOE+00 7.44E+02 0.OOE+00 PM-148m 2.54E+00 6.57E-01 5.02E-01 0.OOE+00 9.92E-01 0.OOE+00 5.57E+03 0.OOE+00 PM-148 5.60E-01 9.30E-02 4.68E-02 0.OOE+00 1.76E-01 0.OOE+00 7.30E+03 0.OOE+00 PM-149 1.08E-01 1.53E-02 6.26E-03 0.OOE+00 2.89E-02 0.OOE+00 2.87E+03 0.OOE+00 PM-151 4.33E-02 7.27E-03 3.67E-03 0.OOE+00 1.30E-02 0.OOE+00 2.OOE+03 0.OOE+00 SM-151 5.75E+00 9.92E-01 2.37E-01 0.OOE+00 1.11E+00 0.OOE+00 4.37E+02 0.OOE+00 11.4-109 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-19 (Page 4 of 4) Adult Drinking Water Af mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 5.98E-02 4.99E-02 3.64E-03 0.OOE+00 1.61E-02 0.OOE+00 1.78E+03 0.OOE+00 EU-152 1.62E+01 3.70E+00 3.25E+00 0.00E+00 2.29E+01 0.OOE+00 2.13E+03 0.OOE+00 EU-154 5.12E+01 6.30E+00 4.48E+00 0.OOE+00 3.02E+01 0.OOE+00 4.57E+03 0.OOE+00 EU-1 55 7.17E+00 1.02E+00 6.56E-01 0.OOE+00 4.69E+00 0.00E+00 8.OOE+02 O.OE+00 EU-156 1.12E+00 8.63E-01 1.39E-01 0.OOE+00 5.77E-01 0.OOE+00 5.91E+03 O.OOE+00 TB-160 3.90E+00 0.0OE+00 4.86E-01 0.OOE+00 1.61E+00 0.OOE+00 2.12E+03 0.OOE+00 HO-166m 2.25E+01 7.02E+00 5.33E+00 0.OOE+00 1.05E+01 0.OOE+00 8.33E-17 0.OOE+00 W-181 8.23E-01 2.68E-01 2.88E-02 O.OOE+00 0.OOE+00 0.OOE+00 3.06E+01 0.OOE+00 W-185 3.36E+01 1.12E+01 1.18E+00 O.OOE+00 0.OOE+00 0.OOE+00 1.29E+03 0.OOE+00 W-187 6.05E+00 5.06E+00 1.77E+00 0.OOE+00 0.OOE+00 0.OOE+00 1.66E+03 0.OOE+00 NP-239 8.56E-02 8.42E-03 4.64E-03 0.OOE+00 2.63E-02 O.OOE+00 1.73E+03 O.OOE+00 U-232 3.44E+05 0.OOE+00 2.46E+04 0.OOE+00 3.72E+04 0.OOE+00 5.65E+03 0.OOE+00 U-233 7.26E+04 O.OOE+00 4.40E+03 0.OOE+00 1.69E+04 0.OOE+00 5.23E+03 0.OOE+00 U-234 6.97E+04 0.OOE+00 4.31E+03 0.O0E+00 1.66E+04 0.OOE+00 5.12E+03 0.OOE+00 U-235 6.68E+04 0.OOE+00 4.05E+03 0.O0E+00 1.56E+04 0.OOE+00 6.51 E+03 0.OOE+00 U-236 6.68E+04 0.OOE+00 4.13E+03 0.OOE+00 1.59E+04 O.OOE+00 4.80E+03 0.OOE+00 U-237 4.37E+00 0.OOE+00 1.16E+00 0.OOE+00 1.80E+01 0.OOE+00 1.54E+03 0.OOE+00 U-238 6.39E+04 0.OOE+00 3.78E+03 O.OOE+00 1.46E+04 O.OOE+00 4.58E+03 0.OOE+00 NP-237 1.05E+05 7.47E+03 4.62E+03 0.OOE+00 3.43E+04 0.OOE+00 6.62E+03 0.OOE+00 NP-238 9.69E-01 2.61E-02 1.51E-02 O.OOE+00 8.84E-02 O.OOE+00 2.43E+03 0.OOE+00 PU-238 5.25E+04 6.65E+03 1.42E+03 0.OOE+00 6.1OE+03 0.OOE+00 6.08E+03 0.OOE+00 PU-239 6.04E+04 7.26E+03 1.59E+03 0.OOE+00 6.76E+03 0.OOE+00 5.55E+03 0.00E+00 PU-240 6.03E+04 7.25E+03 1.59E+03 0.OOE+00 6.75E+03 0.OOE+00 5.65E+03 0.OOE+00 PU-241 1.31E+03 6.21E+01 2.77E+01 0.OOE+00 1.27E+02 0.OOE+00 1.17E+02 0.OOE+00 PU-242 5.60E+04 6.99E+03 1.53E+03 0.OOE+00 6.51 E+03 0.OOE+00 5.44E+03 0.00E+00 PU-244 6.53E+04 8.01E+03 1.76E+03 0.OOE+00 7.46E+03 0.OOE+00 8.11E+03 0.OOE+00 AM-241 6.29E+04 5.87E+04 4.51E+03 O.OOE+00 3.39E+04 0.OOE+00 6.18E+03 0.OOE+00 AM-242m 6.34E+04 5.52E+04 4.52E+03 0.OOE+00 3.37E+04 0.OOE+00 7.78E+03 0.OOE+00 AM-243 6.28E+04 5.75E+04 4.42E+03 0.00E+00 3.33E+04 0.00E+00 7.25E+03 0.OOE+00 CM-242 1.71E+03 1.82E+03 1.14E+02 0.OOE+00 5.17E+02 0.OOE+00 6.59E+03 0.OOE+00 CM-243 4.99E+04 4.57E+04 3.12E+03 0.OOE+00 1.46E+04 0.OOE+00 6.51E+03 0.00E+00 CM-244 3.80E+04 3.56E+04 2.39E+03 0.OOE+00 1.12E+04 0.OOE+00 6.29E+03 0.OOE+00 CM-245 7.82E+04 6.81 E+04 4.80E+03 0.OOE+00 2.24E+04 0.OOE+00 5.87E+03 0.OOE+00 CM-246 7.75E+04 6.80E+04 4.79E+03 0.OOE+00 2.23E+04 0.OOE+00 5.76E+03 O.OOE+00 CM-247 7.56E+04 6.70E+04 4.73E+03 0.OOE+00 2.20E+04 0.OOE+00 7.58E+03 0.OOE+00 CM-248 6.28E+05 5.53E+05 3.89E+04 0.OOE+00 1.82E+05 0.OOE+00 1.23E+05 0.OOE+00 CF-252 2.17E+04 0.OOE+00 5.24E+02 0.OOE+00 O.OOE+00 0.00E+00 2.40E+04 0.OOE+00 11.4-110 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-20 (Page 1 of 4) Infant Fish Air mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LLI Skin H-3 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 C-14 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NA-22 O.OOE+00 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 NA-24 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 P-32 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 CA-41 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 SC-46 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 MN-54 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 FE-55 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 MN-56 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CO-57 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OE+00 CO-58 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 FE-59 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 CO-60 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NI-59 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NI-63 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CU-64 0.OOE+00 O.OOE+0 +00 0.00E+00 0.00E+00 0.00E+00 0.O0E+00 0.00E+00 NI-65 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 ZN-65 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 ZN-69m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 ZN-69 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 SE-79 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-82 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 BR-84 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 RB-86 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-87 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 RB-88 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-89 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 SR-89 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-90 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Y-90 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-91 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Y-91m 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Y-91 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 11.4-111 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-20 (Page 2 of 4) Infant Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Y-92 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 Y-93 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NB-93m 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 NB-95 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 NB-97 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 ZR-93 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 ZR-95 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 ZR-97 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 MO-93 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 MO-99 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TC-99 0.OOE+00 0.OOE+00 0.00E+00 O.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 TC-99m 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 TC-101 0.OOE+00 0.OOE+00 0.OOE+00 0.O0E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 RU-1 03 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 RU-1 05 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 RU-1 06 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RH-1 05 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PD-107 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PD-1 09 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AG-1 1 Om 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AG-1 11 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 CD-113m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CD-115m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-123 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 SN-125 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-126 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-124 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-1 25 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-1 26 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 SB-127 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-125m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-127m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-127 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-129m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-129 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-133m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 11.4-112 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-20 (Page 3 of 4) Infant Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung. GI-LLI Skin TE-134 0.00E+00 0.OOE+00 0.OOE+00 O.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 1-129 0.00E+00 0.OOE+00 O.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 1-130 0.OOE+00 0.00E+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.00E+00 1-131 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-131m 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 TE-131 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 1-132 0,00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 TE-132 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 1-133 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 CS-1 34m 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CS-134 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1-134 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 1-135 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 CS-135 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 CS-136 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CS-137 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 CS-138 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 CS-139 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-1 39 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-140 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 LA-140 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-141 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 LA-141 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 CE-141 O.OOE+00 0.OOE+00 0.OE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-142 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 LA-142 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0o00E+00 0.OOE+00 0.OOE+00 CE-143 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PR-143 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 CE-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PR-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 ND-147 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-147 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-148m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-148 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-149 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-1 51 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SM-151 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 11.4-113 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-20 (Page 4 of 4) Infant Fish Ait mrem*mLlhr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 EU-1 52 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 EU-154 0.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.O0E+00 0.OOE+00 0.O0E+00 EU-155 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 EU-1 56 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 TB-160 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 HO-166m 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 W-181 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 W-185 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 W-187 0.00E+00 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-239 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 U-232 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-233 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 U-234 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-235 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 U-236 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 U-237 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-238 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-237 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-238 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 PU-238 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-239 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-240 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 PU-241 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 PU-242 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-244 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-241 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-242m 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-243 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-242 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 CM-243 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-244 0.OOE+00 0.00E+00 O.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-245 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 CM-246 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-247 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 CM-248 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CF-252 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 11.4-114 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-21 (Page 1 of 4) Child Fish Air mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 8.22E-02 8.22E-02 8.22E-02 8.22E-02 8.22E-02 8.22E-02 0.OOE+00 C-14 4.38E+04 8.77E+03 8.77E+03 8.77E+03 8.77E+03 8.77E+03 8.77E+03 0.OOE+00 NA-22 4.63E+03 4.63E+03 4.63E+03 4.63E+03 4.63E+03 4.63E+03 4.63E+03 O.OOE+00 NA-24 1.51E+02 1.51EE+02 1.51E+02 1.51EE+02 1.51E+02 1.51E+02 1.51E+02 0.OOE+00 P-32 1.86E+06 8.69E+04 7.16E+04 0.OOE+00 0.OOE+00 O.OOE+00 5.13E+04 O.OOE+00 CA-41 1.09E+04 0.OOE+00 1.19E+03 0.OOE+00 0.OOE+00 O.OOE+00 5.99E+00 0.OOE+00 SC-46 3.08E-02 4.22E-02 1.62E-02 0.OOE+00 3.73E-02 0.OOE+00 6.17E+01 0.00E+00 CR-51 0.00E+00 O.OOE+00 1.37E+00 7.59E-01 2.07E-01 1.39E+00 7.25E+01 0.OOE+00 MN-54 0.OOE+00 3.36E+03 8.96E+02 0.OOE+00 9.43E+02 0.OOE+00 2.82E+03 0.OOE+00 FE-55 9.05E+02 4.80E+02 1.49E+02 0.OOE+00 0.OOE+00 2.72E+02 8.89E+01 0.OOE+00 MN-56 0.OOE+00 1.66E-01 3.75E-02 0.OOE+00 2.01 E-01 O.OOE+00 2.41 E+01 0.OOE+00 CO-57 O.OOE+00 1.94E+01 3.92E+01 0.OOE+00 0.OOE+00 0.OOE+00 1.59E+02 0.OOE+00 CO-58 O.OOE+00 7.02E+01 2.15E+02 0.OOE+00 0.OOE+00 0.OOE+00 4.09E+02 0.OOE+00 FE-59 1.28E+03 2.07E+03 1.03E+03 0.OOE+00 0.OOE+00 6.OOE+02 2.16E+03 0.OOE+00 CO-60 O.OOE+00 2.08E+02 6.14E+02 0.OOE+00 0.OOE+00 O.OE+00 1.15E+03 O.OOE+00 NI-59 3.17E+03 8.43E+02 5.37E+02 0.OOE+00 0.OOE+00 0.OOE+00 5.59E+01 0.O0E+00 NI-63 4.24E+04 2.27E+03 1.44E+03 0.00E+00 0.OOE+00 O.OOE+00 1.53E+02 0.OOE+00 CU-64 0.OOE+00 2.60E+00 1.57E+00 0.OOE+00 6.29E+00 0.OOE+00 1.22E+02 0.OOE+00 NI-65 2.38E-01 2.24E-02 1.31 E-02 0.OOE+00 0.OOE+00 O.OOE+00 2.74E+00 0.OOE+00 ZN-65 2.15E+04 5.73E+04 3.57E+04 0.OOE+00 3.61E+04 0.OOE+00 1.01E+04 0.OOE+00 ZN-69m 3.34E+02 5.69E+02 6.72E+01 0.OOE+00 3.30E+02 0.OOE+00 1.85E+04 0.OOE+00 ZN-69 1.1OE-06 1.59E-06 1.47E-07 O.OOE+00 9.67E-07 O.OOE+00 1.OOE-04 O.OOE+00 SE-79 O.OOE+00 1.13E+03 2.50E+02 O.OOE+00 1.83E+03 O.OOE+00 7.40E+01 O.OOE+00 BR-82 O.OOE+00 O.OOE+00 1.56E+03 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OE+00 BR-83 O.OOE+00 O.OOE+00 5.37E-02 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-84 O.OOE+00 O.OOE+00 1.53E-12 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 BR-85 O.OOE+00 O.OOE+00 1.84E-1 51 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 RB-86 O.OOE+00 1.02E+05 6.25E+04 O.OOE+00 O.OOE+00 O.OOE+00 6.54E+03 O.OOE+00 RB-87 O.OOE+00 6.22E+04 2.88E+04 O.OOE+00 O.OOE+00 O.OOE+00 9.33E+02 O.OOE+00 RB-88 O.OOE+00 1.33E-22 9.22E-23 O.OOE+00 O.OOE+00 O.OOE+00 6.51E-24 O.OOE+00 RB-89 O.OOE+00 1.55E-26 1.38E-26 O.OOE+00 O.OOE+00 O.OOE+00 1.35E-28 O.OOE+00 SR-89 3.08E+04 O.00E+00 8.79E+02 O.OOE+00 O.OOE+00 O.OOE+00 1.19E+03 O.OOE+00 SR-90 6.05E+05 O.OOE+00 1.22E+04 O.OOE+00 O.OOE+00 O.OOE+00 5.41 E+03 O.OOE+00 Y-90 6.24E-01 O.OOE+00 1.67E-02 O.OOE+00 O.OOE+00 O.OOE+00 1.78E+03 O.OOE+00 SR-91 9.84E+01 O.00E+00 3.72E+00 O.OOE+00 O.OOE+00 O.OOE+00 2.17E+02 O.OOE+00 Y-91m 1.43E-11 O.OOE+00 5.21E-13 O.OOE+00 O.OOE+00 O.OOE+00 2.81E-08 O.OOE+00 Y-91 1.17E+01 O.OOE+00 3.13E-01 O.OOE+00 O.OOE+00 O.OOE+00 1.56E+03 O.OOE+00 11.4-115 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-21 (Page 2 of 4) Child Fish Air mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 4.60E-01 0.00E+00 1.85E-02 0.00E+00 0.00E+00 0.00E+00 8.72E+00 0.00E+00 Y-92 6.45E-04 0.00E+00 1.85E-05 0.00E+00 O.OOE+00 0.00E+00 1.86E+01 0.00E+00 Y-93 4.32E-02 0.00E+00 1.19E-03 0.OOE+00 O.OOE+00 0.OOE+00 6.45E+02 0.OOE+00 NB-93m 2.48E+03 6.19E+02 2.03E+02 0.00E+00 6.69E+02 0.00E+00 9.33E+04 0.00E+00 NB-95 5.21 E+02 2.03E+02 1.45E+02 0.00E+00 1.91 E+02 0.OOE+00 3.75E+05 0.OOE+00 NB-97 4.99E-06 9.01E-07 4.20E-07 O.00E+00 9.99E-07 0.00E+00 2.78E-01 0.00E+00 ZR-93 4.34E-01 1.62E-01 1.16E-01 0.00E+00 6.29E-01 0.OOE+00 6.16E+01 0.00E+00 ZR-95 2.98E-01 6.56E-02 5.84E-02 0.00E+00 9.39E-02 0.OOE+00 6.84E+01 0.00E+00 ZR-97 6.79E-03 9.81 E-04 5.79E-04 0.00E+00 1.41 E-03 0.00E+00 1.49E+02 0.00E+00 MO-93 0.OOE+00 1.90E+02 6.81 E+00 0.00E+00 5.OOE+01 0.00E+00 9.61 E+00 0.00E+00 MO-99 0.OOE+00 8.14E+01 2.01E+01 0.00E+00 1.74E+02 0.00E+00 6.73E+01 0.00E+00 TC-99 6.32E+00 7.04E+00 2.53E+00 0.OOE+00 8.29E+01 6.23E-01 7.38E+01 0.OOE+00 TC-99m 6.88E-04 1.35E-03 2.24E-02 0.OOE+00 1.96E-02 6.85E-04 7.68E-01 0.00E+00 TC-101 3.76E-33 3.93E-33 4.99E-32 0.00E+00 6.71E-32 2.08E-33 1.25E-32 0.00E+00 RU-103 5.66E+00 O.OOE+00 2.17E+00 0.00E+00 1.42E+01 0.00E+00 1.46E+02 0.00E+00 RU-1 05 1.20E-02 0.00E+00 4.35E-03 0.00E+00 1.05E-01 0.00E+00 7.82E+00 0.OOE+00 RU-1 06 9.20E+01 0.00E+00 1.15E+01 0.00E+00 1.24E+02 0.00E+00 1.43E+03 0.00E+00 RH-105 2.53E+00 1.36E+00 1.16E+00 0.OOE+00 5.41EE+00 0.00E+00 8.41E+01 0.00E+00 PD-107 0.00E+00 3.72E+00 3.16E-01 0.OOE+00 3.11E+01 O.OOE+00 7.38E+00 0.OOE+00 PD-1 09 0.00E+00 1.30E+00 3.89E-01 0.OOE+00 6.95E+00 0.OOE+00 7.66E+01 0.00E+00 AG-11Orn 9.74E-01 6.58E-01 5.26E-01 0.OOE+00 1.22E+00 0.OOE+00 7.82E+01 0.OOE+00 AG-111 4.09E-01 1.28E-01 8.45E-02 O.OOE+00 3.86E-01 0.OOE+00 7.84E+01 0.OOE+00 CD-113m 0.OOE+00 1.61E+03 6.84E+01 0.OOE+00 1.65E+03 0.OOE+00 4.14E+03 O.OOE+00 CD-115m 0.OOE+00 9.14E+02 3.89E+01 0.OOE+00 6.79E+02 0.00E+00 1.24E+04 0.OOE+00 SN-123 3.13E+05 3.88E+03 7.62E+03 4.11E+03 0.OOE+00 0.OOE+00 1.53E+05 0.OOE+00 SN-125 7.81E+04 1.18E+03 3.50E+03 1.22E+03 0.OOE+00 0.OOE+00 2.42E+05 0.OOE+00 SN-126 7.87E+05 9.81E+03 2.24E+04 2.69E+03 0.OOE+00 0.OOE+00 5.91E+04 0.00E+00 SB-124 8.64E+00 1.12E-01 3.03E+00 1.91E-02 0.OOE+00 4.80E+00 5.40E+01 0.OOE+00 SB-125 5.64E+00 4.34E-02 1.18E+00 5.22E-03 0.OOE+00 3.14E+00 1.35E+01 0.OOE+00 SB-126 3.28E+00 5.01E-02 1.18E+00 1.92E-02 0.OOE+00 1.56E+00 6.61E+01 0.OOE+00 SB-127 6.97E-01 1.08E-02 2.42E-01 7.76E-03 0.OOE+00 3.03E-01 3.93E+01 0.OOE+00 TE-125m 3.55E+03 9.62E+02 4.73E+02 9.96E+02 0.OOE+00 0.OOE+00 3.42E+03 0.OOE+00 TE-127m 9.05E+03 2.44E+03 1.07E+03 2.16E+03 2.58E+04 O.OOE+00 7.33E+03 0.OOE+00 TE-127 2.50E+01 6.75E+00 5.37E+00 1.73E+01 7.13E+01 O.OOE+00 9.78E+02 O.OOE+00 TE-1 29m 1.50E+04 4.20E+03 2.33E+03 4.85E+03 4.41 E+04 O.OOE+00 1.83E+04 0.00E+00 TE-129 2.50E-05 6.97E-06 5.92E-06 1.78E-05 7.30E-05 O.OOE+00 1.55E-03 0.OOE+00 TE-133m 8.82E-07 3.57E-07 4.42E-07 6.84E-07 3.39E-06 0.OOE+00 2.72E-05 0.00E+00 11.4-116 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-21 (Page 3 of 4) Child Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 1.73E-09 7.79E-10 1.04E-09 1.37E-09 7.21E-09 0.OOE+00 7.91E-09 0.OOE+00 1-129 1.64E+02 1.01E+02 9.00E+01 6.59E+04 1.70E+02 0.OOE+00 5.07E+00 0.OOE+00 1-130 8.98E+00 1.81E+01 9.35E+00 2.OOE+03 2.71EE+01 0.00E+00 8.49E+00 0.OOE+00 1-131 1.86E+02 1.88E+02 1.07E+02 6.20E+04 3.08E+02 0.O0E+00 1.67E+01 0.OOE+00 TE-131m 1.30E+03 4.51EE+02 4.80E+02 9.27E+02 4.36E+03 0.00E+00 1.83E+04 0.OOE+00 TE-131 1.20E-16 3,65E-17 3.56E-17 9.16E-17 3.62E-16 0.OOE+00 6.29E-16 0.OOE+00 1-132 6.83E-03 1.25E-02 5.77E-03 5.82E-01 1.92E-02 0.OOE+00 1.48E-02 0.OOE+00 TE-132 2.57E+03 1.14E+03 1.38E+03 1.66E+03 1.06E+04 0.00E+00 1.15E+04 0.OOE+00 1-133 3.14E+01 3.89E+01 1.47E+01 7.22E+03 6.48E+01 0.OOE+00 1.57E+01 O.OOE+00 CS-134m 4.29E-01 6.35E-01 4.15E-01 0.OOE+00 3.35E-01 5.54E-02 8.03E-01 0.OOE+00 CS-134 3.68E+05 6.04E+05 1.27E+05 0.OOE+00 1.87E+05 6.72E+04 3.26E+03 0.OOE+00 1-134 2.84E-08 5.28E-08 2.43E-08 1.21E-06 8.07E-08 0.OOE+00 3.50E-08 0.OOE+00 1-135 1.67E+00 3.00E+00 1.42E+00 2.66E+02 4.61E+00 0.OOE+00 2.29E+00 0.OOE+00 CS-135 1.31E+05 9.11E+04 9.34E+03 0.O0E+00 3.21E+04 1.07E+04 6.82E+02 0.OOE+00 CS-136 3.51E+04 9.65E+04 6.25E+04 0.OOE+00 5.14E+04 7.67E+03 3.39E+03 0.OOE+00 CS-137 5.15E+05 4.93E+05 7.28E+04 0.OOE+00 1.61E+05 5.78E+04 3.09E+03 0.OOE+00 CS-138 1.24E-11 1.72E-11 1.09E-11 0.OOE+00 1.21E-11 1.30E-12 7.93E-12 0.OOE+00 CS-1 39 1.75E-44 1.95E-44 9.35E-45 0.OOE+00 1.46E-44 1.47E-45 1.75E-48 0.OOE+00 BA-1 39 7.93E-06 4.23E-09 2.30E-07 0.OOE+00 3.69E-09 2.49E-09 4.58E-04 0.OOE+00 BA-140 2.48E+02 2.17E-01 1.45E+01 0.OOE+00 7.07E-02 1.30E-01 1.26E+02 0.OOE+00 LA-140 1.32E-01 4.60E-02 1.55E-02 0.OOE+00 0.OOE+00 0.OOE+00 1.28E+03 0.OOE+00 BA-141 1.18E-24 6.62E-28 3.85E-26 0.OOE+00 5.73E-28 3.89E-27 6.74E-25 0.OOE+00 LA-141 3.93E-04 9.16E-05 1.99E-05 0.OOE+00 0.OOE+00 0.OOE+00 2.04E+01 0.OOE+00 CE-141 3.06E-02 1.53E-02 2.27E-03 0.OOE+00 6.69E-03 O.OOE+00 1.90E+01 0.OOE+00 BA-142 8.46E-42 6.09E-45 4.72E-43 0.OOE+00 4.93E-45 3.58E-45 1.1OE-43 0.OOE+00 LA-142 2.95E-07 9.40E-08 2.94E-08 0.OOE+00 0.OOE+00 0.OOE+00 1.86E-02 0.OOE+00 CE-143 3.33E-03 1.80E+00 2.61 E-04 0.OOE+00 7.57E-04 0.OOE+00 2.64E+01 0.OOE+00 PR-143 7.35E-01 2.21E-01 3.65E-02 0.OOE+00 1.20E-01 0.00E+00 7.93E+02 0.OOE+00 CE-144 1.63E+00 5.12E-01 8.72E-02 0.OOE+00 2.84E-01 0.00E+00 1.34E+02 0.OOE+00 PR-144 2.08E-28 6.45E-29 1.05E-29 0.OOE+00 3.41E-29 0.OOE+00 1.39E-25 0.OOE+00 ND-147 5.16E-01 4.18E-01 3.24E-02 0.OOE+00 2.29E-01 0.OOE+00 6.62E+02 0.OOE+00 PM-147 6.26E+00 4.47E-01 2.40E-01 0.OOE+00 7.89E-01 0.OOE+00 1.81E+02 0.OOE+00 PM-148m 1.99E+00 3.97E-01 3.97E-01 0.OOE+00 5.89E-01 0.OOE+00 1.12E+03 0.OOE+00 PM-148 5.23E-01 6.28E-02 4.07E-02 0.OOE+00 1.07E-01 0.OOE+00 1.68E+03 0.00E+00 PM-149 9.34E-02 9.93E-03 5.38E-03 0.00E+00 1.76E-02 0.OOE+00 6.78E+02 0.OOE+00 PM-151 3.20E-02 3.89E-03 2.53E-03 0.OOE+00 6.60E-03 0.OOE+00 4.42E+02 0.OOE+00 SM-151 5.04E+00 7.50E-01 2.36E-01 0.OOE+00 7.76E-01 0.OOE+00 1.09E+02 0.OOE+00 11.4-117 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-21 (Page 4 of 4) Child Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LLI Skin SM-153 5.03E-02 3.13E-02 3.02E-03 0.OOE+00 9.53E-03 0.00E+00 4.16E+02 0.OOE+00 EU-152 1.21E+01 2.21E+00 2.62E+00 0.OOE+00 9.31E+00 0.OOE+00 3.62E+02 0.OOE+00 EU-154 4.53E+01 4.08E+00 3.72E+00 0.OOE+00 1.79E+01 0.OOE+00 9.47E+02 0.00E+00 EU-155 9.49E+00 6.83E-01 5.35E-01 O.OOE+00 2.56E+00 0.OOE+00 1.71E+03 0.00E+00 EU-156 1.06E+00 5.66E-01 1.17E-01 0.OOE+00 3.65E-01 O.00E+00 1.28E+03 0.OOE+00 TB-160 3.24E+00 0.OOE+00 4.02E-01 0.OOE+00 9.63E-01 0.OOE+00 7.18E+02 O.OOE+00 HO-166m 2.13E+01 4.45E+00 3.76E+00 0.OOE+00 6.34E+00 0.OOE+00 1.97E-17 0.OOE+00 W-181 3.98E+01 9.77E+00 1.34E+00 0.00E+00 0.OOE+00 0.OOE+00 3.56E+02 0.OOE+00 W-185 1.62E+03 4.05E+02 5.67E+01 0.00E+00 0.OOE+00 0.00E+00 1.51E+04 O.OOE+00 W-187 2.02E+02 1.19E+02 5.36E+01 0.00E+00 0.OOE+00 0.00E+00 1.68E+04 0.OOE+00 NP-239 3.08E-02 2.21 E-03 1.56E-03 0.OOE+00 6.40E-03 0.00E+00 1.64E+02 O.OOE+00 U-232 2.77E+04 0.OOE+00 1.98E+03 0.OOE+00 2.11E+03 0.00E+00 1.1OE+02 0.OOE+00 U-233 5.86E+03 0.OOE+00 3.54E+02 0.OOE+00 9.61 E+02 0.00E+00 1.02E+02 0.00E+00 U-234 5.62E+03 0.OOE+00 3.48E+02 0.OOE+00 9.42E+02 0.OOE+00 9.96E+01 0.OOE+00 U-235 5.39E+03 0.OOE+00 3.26E+02 0.OOE+00 8.84E+02 O.OE+00 1.27E+02 0.00E+00 U-236 5.39E+03 0.00E+00 3.34E+02 0.OOE+00 9.03E+02 0.OOE+00 9.33E+01 0.OOE+00 U-237 3.35E-01 0.OOE+00 8.91E-02 0.OOE+00 9.68E-01 0.OOE+00 2.96E+01 O.00E+00 U-238 5.15E+03 0.OOE+00 3.06E+02 0.OOE+00 8.25E+02 0.OOE+00 8.92E+01 0.OOE+00 NP-237 1.76E+04 1.16E+03 7.71E+02 0.OOE+00 4.77E+03 0.00E+00 6.43E+02 0.OOE+00 NP-238 3.31E-01 6.70E-03 5.16E-03 0.OOE+00 2.13E-02 0.00E+00 2.29E+02 0.OOE+00 PU-238 3.28E+03 3.80E+02 8.71E+01 0.OOE+00 3.17E+02 0.OOE+00 2.07E+02 O.OOE+00 PU-239 3.56E+03 3.80E+02 9.13E+01 0.00E+00 3.36E+02 0.OOE+00 1.89E+02 0.00E+00 PU-240 3.53E+03 3.94E+02 9.13E+01 0.00E+00 3.36E+02 O.OOE+00 1.92E+02 0.OOE+00 PU-241 1.07E+02 4.36E+00 2.22E+00 0.00E+00 8.16E+00 0.OOE+00 3.97E+00 0.OOE+00 PU-242 3.28E+03 3.80E+02 8.79E+01 0.00E+00 3.23E+02 0.OOE+00 1.85E+02 0.OOE+00 PU-244 3.83E+03 4.36E+03 1.01 E+02 0.OOE+00 3.72E+02 0.OOE+00 2.76E+02 0.OOE+00 AM-241 2.68E+04 2.30E+04 2.01 E+03 0.OOE+00 1.23E+04 0.OOE+00 1.50E+03 0.OOE+00 AM-242m 2.76E+04 2.21 E+04 2.05E+03 0.OOE+00 1.24E+04 0.00E+00 1.89E+03 0.OOE+00 AM-243 2.64E+04 2.23E+04 1.94E+03 0.OOE+00 1.19E+04 0.00E+00 1.76E+03 0.OOE+00 CM-242 1.72E+03 1.37E+03 1.15E+02 0.00E+00 3.67E+02 0.OOE+00 1.60E+03 0.OOE+00 CM-243 2.52E+04 2.05E+04 1.62E+03 0.OOE+00 6.06E+03 0.OOE+00 1.58E+03 0.00E+00 CM-244 2.13E+04 1.72E+04 1.36E+03 0.00E+00 5.OOE+03 0.OOE+00 1.53E+03 0.OOE+00 CM-245 3.29E+04 2.64E+04 2.07E+03 0.OOE+00 8.09E+03 0.OOE+00 1.43E+03 0.OOE+00 CM-246 3.25E+04 2.64E+04 2.07E+03 0.OOE+00 8.07E+03 0.00E+00 1.40E+03 0.OOE+00 CM-247 3.17E+04 2.60E+04 2.03E+03 0.00E+00 7.96E+03 0.OOE+00 1.84E+03 0.OOE+00 CM-248 2.64E+05 2.15E+05 1.68E+04 0.O0E+00 6.56E+04 0.OOE+00 2.97E+04 0.OOE+00 CF-252 2.07E+04 0.OOE+00 5.OOE+02 0.OOE+00 0.OOE+00 0.OOE+00 5.82E+03 0.OOE+00 11.4-118 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-22 (Page 1 of 4) Teen Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 O.OOE+00 9.93E-02 9.93E-02 9.93E-02 9.93E-02 9.93E-02 9.93E-02 0.00E+00 C-14 3.41E+04 6.82E+03 6.82E+03 6.82E+03 6.82E+03 6.82E+03 6.82E+03 0.OOE+00 NA-22 4.27E+03 4.27E+03 4.27E+03 4.27E+03 4.27E+03 4.27E+03 4.27E+03 0.OOE+00 NA-24 1.39E+02 1.39E+02 1.39E+02 1.39E+02 1.39E+02 1.39E+02 1.39E+02 0.00E+00 P-32 1.44E+06 8.93E+04 5.59E+04 0.OOE+00 O.OOE+00 0.OOE+00 1.21 E+05 0.OOE+00 CA-41 1.44E+04 0.00E+00 1.56E+03 0.00E+00 0.00E+00 0.OOE+00 1.42E+01 0.OOE+00 SC-46 2.62E-02 5.11E-02 1.51E-02 0.OOE+00 4.89E-02 0.OOE+00 1.74E+02 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 1.28E+00 7.13E-01 2.81E-01 1.83E+00 2.16E+02 0.00E+00 MN-54 0.OOE+00 4.30E+03 8.53E+02 0.OOE+00 1.28E+03 0.OOE+00 8.82E+03 0.00E+00 FE-55 6.90E+02 4.89E+02 1.14E+02 0.OOE+00 0.00E+00 3.10OE+02 2.12E+02 0.00E+00 MN-56 O.OOE+00 1.82E-01 3.24E-02 0.OOE+00 2.31E-01 O.OOE+00 1.20E+01 0.OOE+00 CO-57 0.OOE+00 2.17E+01 3.63E+01 0.00E+00 0.OOE+00 0.O0E+00 4.04E+02 0.OOE+00 CO-58 0.OOE+00 8.79E+01 2.03E+02 0.OOE+00 0.OOE+00 0.00E+00 1.21E+03 0.OOE+00 FE-59 1.06E+03 2.46E+03 9.51 E+02 0.OOE+00 0.OOE+00 7.77E+02 5.83E+03 0.OOE+00 CO-60 0.00E+00 2.57E+02 5.78E+02 0.OOE+00 0.O0E+00 0.OOE+00 3.34E+03 0.00E+00 NI-59 2.41E+03 8.51EE+02 4.09E+02 0.OOE+00 0.OOE+00 0.00E+00 1.34E+02 0.00E+00 NI-63 3.23E+04 2.28E+03 1.10E+03 0.OOE+00 0.OOE+00 0.OOE+00 3.63E+02 0.OOE+00 CU-64 0.OOE+00 2.83E+00 1.33E+00 0.OOE+00 7.17E+00 0.OOE+00 2.20E+02 O.OOE+00 NI-65 1.86E-01 2.37E-02 1.08E-02 0.OOE+00 0.00E+00 0.OOE+00 1.29E+00 0.OOE+00 ZN-65 2.1OE+04 7.29E+04 3.40E+04 0.OOE+00 4.66E+04 0.00E+00 3.09E+04 0.OOE+00 ZN-69m 2.62E+02 6.17E+02 5.66E+01 0.O0E+00 3.75E+02 0.OOE+00 3.39E+04 0.OOE+00 ZN-69 8.58E-07 1.63E-06 1.14E-07 0.OOE+00 1.07E-06 0.OOE+00 3.01E-06 0.OOE+00 SE-79 0.OOE+00 1.16E+03 1.95E+02 0.OOE+00 2.02E+03 0.OOE+00 1.77E+02 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.46E+03 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 BR-83 0.00E+00 0.O0E+00 4.18E-02 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 1.29E-12 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 BR-85 0.OOE+00 0.OOE+00 1.43E-1 51 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 1.05E+05 4.93E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.55E+04 0.OOE+00 RB-87 0.OOE+00 6.39E+04 2.23E+04 0.OOE+00 0.OOE+00 0.OOE+00 2.23E+03 0.OOE+00 RB-88 0.OOE+00 1.38E-22 7.36E-23 0.OOE+00 0.OOE+00 0.OOE+00 1.18E-29 0.OOE+00 RB-89 0.OOE+00 1.69E-26 1.19E-26 0.OOE+00 0.OOE+00 0.OOE+00 2.59E-35 0.OOE+00 SR-89 2.38E+04 0.OOE+00 6.81 E+02 0.00E+00 0.OOE+00 0.OOE+00 2.83E+03 0.OOE+00 SR-90 5.59E+05 0.OOE+00 1.12E+04 0.00E+00 0.OOE+00 0.OOE+00 1.28E+04 0.OOE+00 Y-90 4.83E-01 0.OOE+00 1.30E-02 0.OOE+00 0.OOE+00 0.OOE+00 3.98E+03 0.OOE+00 SR-91 7.68E+01 0.OOE+00 3.05E+00 0.OOE+00 0.OOE+00 0.OOE+00 3.48E+02 0.OOE+00 Y-91m 1.12E-11 0.00E+00 4.29E-13 0.OOE+00 0.OOE+00 0.00E+00 5.30E-10 0.OOE+00 Y-91 9.07E+00 0.OOE+00 2.43E-01 0.OOE+00 0.OOE+00 0.OOE+00 3.72E+03 0.OOE+00 11.4-119 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-22 (Page 2 of 4) Teen Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 3.61E-01 0.OOE+00 1.54E-02 O.OOE+00 0.OOE+00 0.OOE+00 9.19E+00 0.OOE+00 Y-92 5.03E-04 0.OOE+00 1.45E-05 0.OOE+00 0.OOE+00 0.OOE+00 1.38E+01 0.OOE+00 Y-93 3.37E-02 0.00E+00 9.23E-04 0.00E+00 0.OOE+00 0.O0E+00 1.03E+03 0.OOE+00 NB-93m 1.88E+03 6.19E+02 1.55E+02 0.OOE+00 7.23E+02 0.OOE+00 2.23E+05 0.OOE+00 NB-95 4.42E+02 2.45E+02 1.35E+02 0.OOE+00 2.37E+02 0.OOE+00 1.05E+06 0.00E+00 NB-97 3.93E-06 9.75E-07 3.56E-07 O.OOE+00 1.14E-06 0.00E+00 2.33E-02 0.OOE+00 ZR-93 3.33E-01 1.65E-01 8.98E-02 O.OOE+00 5.82E-01 0.OOE+00 1.56E+02 0.OOE+00 ZR-95 2.46E-01 7.75E-02 5.33E-02 0.OOE+00 1.14E-01 0.OOE+00 1.79E+02 0.OOE+00 ZR-97 5.34E-03 1.06E-03 4.87E-04 0.OOE+00 1.60E-03 0.OOE+00 2.86E+02 0.OOE+00 MO-93 0.0OE+00 1.94E+02 5.30E+00 O.OOE+00 5.55E+01 0.OOE+00 2.36E+01 0.OOE+00 MO-99 0.OOE+00 8.56E+01 1.63E+01 0.OOE+00 1.96E+02 0.OOE+00 1.53E+02 0.OOE+00 TC-99 4.90E+00 7.21E+00 1.96E+00 0.OOE+00 9.15E+01 7.45E-01 1.76E+02 0.OOE+00 TC-99m 5.74E-04 1.60E-03 2.07E-02 0.OOE+00 2.38E-02 8.88E-04 1.05E+00 0.OOE+00 TC-101 2.93E-33 4.17E-33 4.1OE-32 0.OOE+00 7.54E-32 2.54E-33 7.12E-40 0.OOE+00 RU-103 4.58E+00 0.OOE+00 1.96E+00 0.OOE+00 1.61E+01 0.OOE+00 3.82E+02 0.OOE+00 RU-105 9.39E-03 0.OOE+00 3.65E-03 0.00E+00 1.19E-01 0.00E+00 7.58E+00 0.OOE+00 RU-106 7.15E+01 0.OOE+00 9.01E+00 0.OOE+00 1.38E+02 O.OOE+00 3.43E+03 0.00E+00 RH-105 1.97E+00 1.43E+00 9.36E-01 0.OOE+00 6.06E+00 0.OOE+00 1.81E+02 0.OOE+00 PD-107 0.OOE+00 3.80E+00 2.45E-01 O.OOE+00 3.43E+01 0.OOE+00 1.76E+01 0.OOE+00 PD-109 0.OOE+00 1.33E+00 3.02E-01 0.OOE+00 7.69E+00 0.OOE+00 1.34E+02 0.OOE+00 AG-11Orn 8.59E-01 8.13E-01 4.94E-01 0.OOE+00 1.55E+00 0.OOE+00 2.28E+02 0.OOE+00 AG-111 3.17E-01 1.32E-01 6.62E-02 0.OOE+00 4.29E-01 O.OOE+00 1.84E+02 0.OOE+00 CD-1i13m O.OOE+00 1.65E+03 5.30E+01 0.OOE+00 1.82E+03 0.OOE+00 9.90E+03 0.OOE+00 CD-1l15m 0.00E+00 9.35E+02 3.02E+01 0.OOE+00 7.48E+02 O.OOE+00 2.96E+04 0.OOE+00 SN-123 2.42E+05 3.97E+03 5.89E+03 3.18E+03 0.OOE+00 O.OOE+00 3.66E+05 0.OOE+00 SN-125 6.07E+04 1.21E+03 2.74E+03 9.48E+02 0.00E+00 0.OOE+00 5.71E+05 0.OOE+00 SN-126 6.36E+05 1.18E+04 1.81E+04 3.12E+03 0.00E+00 0.OOE+00 1.41E+05 O.OOE+00 SB-1 24 6.99E+00 1.29E-01 2.73E+00 1.59E-02 O.OOE+00 6.1OE+00 1.41E+02 O.OOE+00 SB-125 4.53E+00 4.95E-02 1.06E+00 4.33E-03 0.OOE+00 3.98E+00 3.52E+01 O.OOE+00 SB-126 2.75E+00 5.61E-02 9.86E-01 1.55E-02 0.OOE+00 1.97E+00 1.63E+02 0.OOE+00 SB-1 27 5.54E-01 1.18E-02 2.09E-01 6.22E-03 0.OOE+00 3.77E-01 9.40E+01 O.OOE+00 TE-125m 2.76E+03 9.96E+02 3.70E+02 7.72E+02 0.OOE+00 0.OOE+00 8.16E+03 0.OOE+00 TE-127m 7.02E+03 2.49E+03 8.35E+02 1.67E+03 2.85E+04 O.OOE+00 1.75E+04 O.OOE+00 TE-127 1.95E+01 6.91E+00 4.19E+00 1.34E+01 7.89E+01 O.OOE+00 1.50E+03 0.OOE+00 TE-129m 1.17E+04 4.33E+03 1.85E+03 3.76E+03 4.88E+04 O.OOE+00 4.38E+04 O.OOE+00 TE-129 1.94E-05 7.21E-06 4.71E-06 1.38E-05 8.12E-05 O.OOE+00 1.06E-04 0.OOE+00 TE-133m 7.05E-07 4.OOE-07 3.90E-07 5.59E-07 3.96E-06 O.OOE+00 1.62E-06 O.OOE+00 11.4-120 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-22 (Page 3 of 4) Teen Fish Ai mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 1.39E-09 8.94E-10 9.34E-10 1.14E-09 8.53E-09 0.OOE+00 5.17E-11 O.OOE+00 1-129 1.28E+02 1.07E+02 1.79E+02 1.31E+05 1.92E+02 0.OOE+00 1.25E+01 0.00E+00 1-130 7.35E+00 2.13E+01 8.49E+00 1.73E+03 3.27E+01 0.OOE+00 1.63E+01 0.00E+00 1-131 1.47E+02 2.06E+02 1.11E+02 6.01E+04 3.54E+02 0.00E+00 4.07E+01 0.OOE+00 TE-131m 1.02E+03 4.91E+02 4.10E+02 7.39E+02 5,12E+03 0.00E+00 3.94E+04 0.00E+00 TE-131 9.33E-17 3.85E-17 2.92E-17 7.19E-17 4.08E-16 0.OOE+00 7.66E-18 0.00E+00 1-132 5.52E-03 1.44E-02 5.19E-03 4.87E-01 2.28E-02 0.OOE+00 6.29E-03 0.00E+00 TE-132 2.06E+03 1.31E+03 1.23E+03 1.38E+03 1.25E+04 O.OOE+00 4.13E+04 0.OOE+00 1-133 2.47E+01 4.20E+01 1.28E+01 5.86E+03 7.36E+01 0.OOE+00 3.18E+01 0.OOE+00 CS-134m 3.47E-01 7.18E-01 3.69E-01 0.OOE+00 4.OOE-01 7.01E-02 4.77E-01 0.OOE+00 CS-134 3.05E+05 7.19E+05 3.34E+05 0.00E+00 2.28E+05 8.72E+04 8.94E+03 0.00E+00 1-134 2.30E-08 6.09E-08 2.19E-08 1.01E-06 9.59E-08 0.OOE+00 8.02E-10 0.00E+00 1-135 1.35E+00 3.47E+00 1.29E+00 2.23E+02 5.48E+00 0.OOE+00 3.85E+00 0.OOE+00 CS-135 1.02E+05 9.32E+04 2.18E+04 0.00E+00 3.55E+04 1.29E+04 1.63E+03 0.OOE+00 CS-136 2.98E+04 1.17E+05 7.87E+04 0.OOE+00 6.38E+04 1.01E+04 9.43E+03 0.OOE+00 CS-137 4.09E+05 5.44E+05 1.90E+05 0.OOE+00 1.85E+05 7.20E+04 7.74E+03 0.OOE+00 CS-138 9.78E-12 1.88E-11 9.39E-12 0.OOE+00 1.39E-11 1.61E-12 8.52E-15 0.OOE+00 CS-139 1.36E-44 2.01E-44 7.37E-45 0.OOE+00 1.62E-44 1.78E-45 9.33E-60 0.00E+00 BA-139 6.17E-06 4.34E-09 1.80E-07 0.00E+00 4.09E-09 2.99E-09 5.50E-05 0.OOE+00 BA-140 1.97E+02 2.41E-01 1.27E+01 0.OOE+00 8.17E-02 1.62E-01 3.03E+02 0.OOE+00 LA-140 1.05E-01 5.16E-02 1.37E-02 0.OOE+00 0.OOE+00 0.00E+00 2.97E+03 0.OOE+00 BA-141 9.20E-25 6.87E-28 3.07E-26 0.OOE+00 6.38E-28 4.70E-28 1.96E-30 0.00E+00 LA-141 3.05E-04 9.38E-05 1.55E-05 0.OOE+00 0.00E+00 0.OOE+00 1.66E+01 0.OOE+00 CE-141 2.38E-02 1.59E-02 1.82E-03 0.OOE+00 7.47E-03 0.OOE+00 4.54E+01 0.00E+00 BA-142 6.71E-42 6.71E-45 4.13E-43 0.OOE+00 5.68E-45 4.47E-45 2.06E-53 0.00E+00 LA-142 2.34E-07 1.04E-07 2.58E-08 0.00E+00 0.OOE+00 0.00E+00 3.16E-03 0.00E+00 CE-143 2.59E-03 1.89E+00 2.11E-04 0.OOE+00 8.46E-04 0.OOE+00 5.67E+01 0.OOE+00 PR-143 5.68E-01 2.27E-01 2.83E-02 0.OOE+00 1.32E-01 0.OOE+00 1.87E+03 0.OOE+00 CE-144 1.27E+00 5.25E-01 6.81E-02 0.00E+00 3.13E-01 0.OOE+00 3.19E+02 0.OOE+00 PR-144 1.61E-28 6.60E-29 8.17E-30 0.OOE+00 3.78E-29 0.OOE+00 1.78E-31 0.00E+00 ND-147 4.02E-01 4.37E-01 2.62E-02 0.00E+00 2.57E-01 0.00E+00 1.58E+03 0.00E+00 PM-147 4.79E+00 4.54E-01 1.85E-01 0.00E+00 8.67E-01 0.00E+00 4.32E+02 0.00E+00 PM-148m 1.86E+00 4.71E-01 3.69E-01 0.OOE+00 7.14E-01 0.00E+00 2.97E+03 0.00E+00 PM-148 4.09E-01 6.66E-02 3.36E-02 0.OOE+00 1.20E-01 0.OOE+00 3.97E+03 0.00E+00 PM-149 7.24E-02 1.02E-02 4.17E-03 0.00E+00 1.94E-02 0.OOE+00 1.50E+03 0.00E+00 PM-151 2.51E-02 4.14E-03 2.1OE-03 0.OOE+00 7.45E-03 0.00E+00 9.30E+02 0.00E+00 SM-151 3.99E+00 7.67E-01 1.80E-01 0.00E+00 8.40E-01 0.00E+00 2.60E+02 0.00E+00 11.4-121 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-22 (Page 4 of 4) Teen Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 3.90E-02 3.23E-02 2.38E-03 0.OOE+00 1.06E-02 0.OOE+00 9.11E+02 0.OOE+00 EU-152 1.12E+01 2.69E+00 2.37E+00 0.OOE+00 1.25E+01 0.OOE+00 9.91E+02 0.OOE+00 EU-154 3.61E+01 4.66E+00 3.28E+00 0.OOE+00 2.08E+01 0.OOE+00 2.46E+03 0.OOE+00 EU-1 55 7.94E+00 7.67E-01 4.75E-01 0.OOE+00 3.00E+00 0.OOE+00 4.40E+03 0.OOE+00 EU-156 8.38E-01 6.28E-01 1.03E-01 0.OOE+00 4.23E-01 0.OOE+00 3.21E+03 0.OOE+00 TB-160 2.93E+00 O.OOE+00 3.65E-01 0.OOE+00 1.16E+00 0.OOE+00 1.89E+03 0.OOE+00 HO-166m 1.63E+01 5.02E+00 3.63E+00 0.OOE+00 7.35E+00 0.OOE+00 4.57E-17 0.OOE+00 W-1 81 3.09E+01 9.98E+00 1.04E+00 0.OOE+00 0.OOE+00 0.OOE+00 8.50E+02 0.OOE+00 W-185 1.26E+03 4.15E+02 4.39E+01 0.OOE+00 0.OOE+00 O.OOE+00 3.58E+04 0.OOE+00 W-187 1.59E+02 1.30E+02 4.55E+01 0.OOE+00 0.OOE+00 0.OOE+00 3.51 E+04 0.OOE+00 NP-239 2.39E-02 2.26E-03 1.25E-03 0.OOE+00 7.09E-03 0.OOE+00 3.63E+02 0.OOE+00 U-232 2.15E+04 0.OOE+00 1.54E+03 O.OOE+00 2.33E+03 0.OOE+00 2.63E+02 0.O0E+00 U-233 4.53E+03 0.OOE+00 2.75E+02 0.OOE+00 1.06E+03 0.OOE+00 2.43E+02 0.OOE+00 U-234 4.35E+03 0.OOE+00 2.70E+02 0.OOE+00 1.04E+03 0.OOE+00 2.38E+02 0.OOE+00 U-235 4.16E+03 0.00E+00 2.54E+02 0.OOE+00 9.75E+02 0.OOE+00 3.02E+02 0.OOE+00 U-236 4.16E+03 0.OOE+00 2.59E+02 0.OOE+00 9.97E+02 0.OOE+00 2.23E+02 0.OOE+00 U-237 2.60E-01 0.OOE+00 6.92E-02 0.OOE+00 1.07E+00 0.OOE+00 6.89E+01 0.OOE+00 U-238 3.98E+03 0.OOE+00 2.37E+02 0.OOE+00 9.13E+02 0.OOE+00 2.13E+02 0.OOE+00 NP-237 2.43E+04 1.74E+03 1.07E+03 0.OOE+00 7.91 E+03 0.OOE+00 1.54E+03 0.OOE+00 NP-238 2.57E-01 6.87E-03 4.OOE-03 O.OOE+00 2.36E-02 0.OOE+00 5.04E+02 0.OOE+00 PU-238 4.28E+03 5.48E+02 1.16E+02 0.OOE+00 4.99E+02 0.OOE+00 4.94E+02 0.OOE+00 PU-239 4.89E+03 5.94E+02 1.28E+02 0.OOE+00 5.48E+02 0.OOE+00 4.51 E+02 0.00E+00 PU-240 4.88E+03 5.93E+02 1.28E+02 0.OOE+00 5.47E+02 0.OOE+00 4.60E+02 0.OOE+00 PU-241 1.12E+02 5.37E+00 2.36E+00 0.OOE+00 1.09E+01 0.OOE+00 9.46E+00 0.OOE+00 PU-242 4.53E+03 5.72E+02 1.24E+02 0.OOE+00 5.27E+02 0.OOE+00 4.42E+02 0.00E+00 PU-244 5.29E+03 6.52E+02 1.42E+02 0.OOE+00 6.04E+02 0.OOE+00 6.58E+02 0.OOE+00 AM-241 3.64E+04 3.44E+04 2.63E+03 0.OOE+00 1.97E+04 0.OOE+00 3.59E+03 0.OOE+00 AM-242m 3.68E+04 3.25E+04 2.65E+03 0.OOE+00 1.96E+04 0.OOE+00 4.52E+03 0.OOE+00 AM-243 3.63E+04 3.36E+04 2.57E+03 0.OOE+00 1.93E+04 0.OOE+00 4.21E+03 0.OOE+00 CM-242 1.34E+03 1.41 E+03 8.87E+01 0.OOE+00 4.04E+02 0.OOE+00 3.82E+03 0.OOE+00 CM-243 2.97E+04 2.75E+04 1.87E+03 0.OOE+00 8.72E+03 0.OOE+00 3.78E+03 0.OOE+00 CM-244 2.30E+04 2.18E+04 1.46E+03 0.OOE+00 6.80E+03 0.OOE+00 3.65E+03 0.OOE+00 CM-245 4.52E+04 3.98E+04 2.79E+03 0.OOE+00 1.30E+04 0.OOE+00 3.41EE+03 0.OOE+00 CM-246 4.48E+04 3.97E+04 2.78E+03 0.OOE+00 1.30E+04 0.OOE+00 3.35E+03 O.OOE+00 CM-247 4.37E+04 3.91 E+04 2.74E+03 0.OOE+00 1.28E+04 0.OOE+00 4.40E+03 0.OOE+00 CM-248 3.63E+05 3.22E+05 2.26E+04 0.OOE+00 1.05E+05 0.OOE+00 7.08E+04 0.OOE+00 CF-252 1.58E+04 0.OOE+00 3.82E+02 O.OOE+00 0.00E+00 0.00E+00 1.39E+04 0.OOE+00 11.4-122 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-23 (Page 1 of 4) Adult Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 O.OOE+00 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.29E-01 0.OOE+00 C-14 3.13E+04 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 0.OOE+00 NA-22 4.17E+03 4.17E+03 4.17E+03 4.17E+03 4.17E+03 4.17E+03 4.17E+03 0.O0E+00 NA-24 1.34E+02 1.34E+02 1.34E+02 1.34E+02 1.34E+02 1.34E+02 1.34E+02 0.00E+00 P-32 1,32E+06 8.22E+04 5.11E+04 O.OOE+00 0.OOE+00 O.00E+00 1.49E+05 O.OOE+00 CA-41 1.77E+04 0.OOE+00 1.92E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.76E+01 0.00E+00 SC-46 2.62E-02 5.09E-02 1.48E-02 0.OOE+00 4.75E-02 0.OOE+00 2.48E+02 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 1.24E+00 7.43E-01 2.74E-01 1.65E+00 3.13E+02 0.OOE+00 MN-54 0.OOE+00 4.37E+03 8.34E+02 0.OOE+00 1.30E+03 0.00E+00 1.34E+04 O.OOE+00 FE-55 6.59E+02 4.55E+02 1.06E+02 0.OOE+00 0.O0E+00 2.54E+02 2.61E+02 0.OOE+00 MN-56 0.OOE+00 1.74E-01 3.09E-02 0.OOE+00 2.21 E-01 O.OOE+00 5.55E+00 0.OOE+00 CO-57 0.OOE+00 2.09E+01 3.48E+01 0.OOE+00 0.OOE+00 0.OOE+00 5.31E+02 0.OOE+00 CO-58 0.OOE+00 8.84E+01 1.98E+02 0.OOE+00 O.OOE+00 0.OOE+00 1.79E+03 0.O0E+00 FE-59 1.02E+03 2.41E+03 9.23E+02 0.OE+00 0.OOE+00 6.73E+02 8,03E+03 0.OOE+00 CO-6O 0.00E+00 2.56E+02 5.66E+02 0.OOE+00 0.00E+00 0.OOE+00 4.82E+03 0.OOE+00 NI-59 2.34E+03 8.03E+02 3.91E+02 0.OOE+00 0.OOE+00 0.00E+00 1.65E+02 0.OOE+00 NI-63 3.12E+04 2.16E+03 1.05E+03 0.OOE+00 0.OOE+00 0.OOE+00 4.51E+02 0.OOE+00 CU-64 0.OOE+00 2.69E+00 1.26E+00 0.OOE+00 6.79E+00 0.OOE+00 2.30E+02 0.OOE+00 NI-65 1.72E-01 2.23E-02 1.02E-02 0.OOE+00 0.OOE+00 0.OOE+00 5.67E-01 O.00E+00 ZN-65 2.31 E+04 7.36E+04 3.33E+04 0.00E+00 4.92E+04 0.OOE+00 4.64E+04 0.OOE+00 ZN-69m 2.43E+02 5.84E+02 5.34E+01 0.OOE+00 3.53E+02 O.OOE+00 3.56E+04 0.OOE+00 ZN-69 7.89E-07 1.51 E-06 1.05E-07 0.OOE+00 9.81 E-07 0.OOE+00 2.27E-07 0.OOE+00 SE-79 0.OOE+00 1.07E+03 1.79E+02 0.OOE+00 1.85E+03 0.OOE+00 2.19E+02 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.42E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.63E+03 0.OOE+00 BR-83 0.00E+00 0.O0E+00 3.84E-02 0.OOE+00 O.OE+00 0.OOE+00 5.53E-02 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 1.23E-12 0.OOE+00 0.OOE+00 0.OOE+00 9.62E-18 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 1.31E-151 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 9.75E+04 4.54E+04 0.0OE+00 0.00E+00 0.OOE+00 1.92E+04 O.OE+00 RB-87 0.OOE+00 5.90E+04 2.05E+04 0.00E+00 0.OOE+00 0.OOE+00 2.76E+03 0.OOE+00 RB-88 0.OOE+00 1.29E-22 6.83E-23 0.00E+00 0.OOE+00 0.OOE+00 1.78E-33 0.OOE+00 RB-89 0.OOE+00 1.62E-26 1 .14E-26 0.OOE+00 0.OOE+00 0.OOE+00 9.39E-40 0.OOE+00 SR-89 2.18E+04 0.00E+00 6.27E+02 0.00E+00 O.OOE+00 0.OOE+00 3.50E+03 0.OOE+00 SR-90 6.26E+05 0.OOE+00 1.26E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.57E+04 0.00E+00 Y-90 4.45E-01 0.OOE+00 1.19E-02 0.OOE+00 0.OOE+00 0.OOE+00 4.72E+03 0.OOE+00 SR-91 7.08E+01 0.OOE+00 2.86E+00 0.OOE+00 0.OOE+00 0.OOE+00 3.37E+02 0.OOE+00 Y-91m 1.04E-11 0.OOE+00 4.02E-13 0.OOE+00 0.OOE+00 O.OOE+00 3.05E-11 0.OOE+00 Y-91 8.35E+00 0.00E+00 2.23E-01 0.OOE+00 0.OOE+00 0.00E+00 4.60E+03 O.OOE+00 11.4-123 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-23 (Page 2 of 4) Adult Fish Ait mrem*mUhr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 3.34E-01 0.00E+00 1.44E-02 0.OOE+00 0.00E+00 O.OOE+00 6.61 E+00 0.00E+00 Y-92 4.61 E-04 0.OOE+00 1.35E-05 0.OOE÷00 0.OOE+00 0.OOE+00 8.07E+00 0.OOE+00 Y-93 3.09E-02 0.00E+00 8.54E-04 0.00E+00 0.00E+00 0.0OE+00 9.81 E+02 0.OOE+00 NB-93m 1.83E+03 5.98E+02 1.47E+02 0.00E+00 6.88E+02 0.OOE+00 2.76E+05 0.OOE+00 NB-95 4.39E+02 2.44E+02 1.31 E+02 0.00E+00 2.41 E+02 0.00E+00 1.48E+06 0.OOE+00 NB-97 3.65E-06 9.23E-07 3.37E-07 0.OOE+00 1.08E-06 0.OOE+00 3.40E-03 0.00E+00 ZR-93 3.31E-01 1.85E-02 8.62E-03 0.00E+00 7.02E-02 0.00E+00 1.92E+01 0.00E+00 ZR-95 2.38E-01 7.63E-02 5.17E-02 0.OOE+00 1.20E-01 0.OOE+00 2.42E+02 0.00E+00 ZR-97 4.97E-03 1.00E-03 4.58E-04 0.00E+00 1.51E-03 0.00E+00 3.1OE+02 0.OOE+00 MO-93 0.00E+00 1.80E+02 4.87E+00 0.O0E+00 5.11E+01 0.00E+00 2.92E+01 0.OOE+00 MO-99 0.00E+00 8.03E+01 1.53E+01 0.00E+00 1.82E+02 0.00E+00 1.86E+02 O.OOE+00 TC-99 4.49E+00 6.69E+00 1.81E+00 0.00E+00 8.41E+01 5.68E-01 2.19E+02 0.00E+00 TC-99m 5.60E-04 1.58E-03 2.02E-02 0.00E+00 2.40E-02 7.76E-04 9.37E-01 0.00E+00 TC-101 2.71E-33 3.91E-33 3.84E-32 0.OOE+00 7.04E-32 2.00E-33 1.18E-44 0.OOE+00 RU-1 03 4.36E+00 0.OOE+00 1.88E+00 0.OOE+00 1.66E+01 0.OOE+00 5.09E+02 O.00E+00 RU-105 8.71E-03 0.OOE+00 3.44E-03 0.OOE+00 1.13E-01 0.00E+00 5.33E+00 0.OOE+00 RU-1 06 6.58E+01 0.OOE+00 8.33E+00 0.OOE+00 1.27E+02 0.OOE+00 4.26E+03 0.OOE+00 RH-105 1.81E+00 1.33E+00 8.73E-01 0.OOE+00 5.63E+00 0.OOE+00 2.11E+02 0.OOE+00 PD-107 0.OOE+00 3.52E+00 2.25E-01 0.00E+00 3.16E+01 0.OOE+00 2.18E+01 0.OOE+00 PD-1 09 0.OOE+00 1.23E+00 2.78E-01 0.00E+00 7.03E+00 0.OOE+00 1.36E+02 0.OOE+00 AG-11Orn 8.80E-01 8.14E-01 4.83E-01 0.OOE+00 1.60E+00 0.OOE+00 3.32E+02 0.OOE+00 AG-1 11 2.92E-01 1.22E-01 6.08E-02 0.OOE+00 3.94E-01 0.OOE+00 2.24E+02 0.OOE+00 CD-i 13m 0.OOE+00 1.52E+03 4.89E+01 0.OOE+00 1.68E+03 0.OOE+00 1.23E+04 0.OOE+00 CD-115m 0.OOE+00 8.69E+02 2.77E+01 0.OOE+00 6.89E+02 0.OOE+00 3.65E+04 0.OOE+00 SN-123 2.22E+05 3.68E+03 5.43E+03 3.13E+03 0.OOE+00 0.OOE+00 4.53E+05 0.OOE+00 SN-125 5.58E+04 1.12E+03 2.53E+03 9.30E+02 0.OOE+00 0.OOE+00 6.96E+05 0.OOE+00 SN-126 6.08E+05 1.20E+04 1.73E+04 3.54E+03 0.OOE+00 0.OOE+00 1.75E+05 0.OOE+00 SB-124 6.64E+00 1.25E-01 2.63E+00 1.61E-02 0.OOE+00 5.17E+00 1.88E+02 0.OOE+00 SB-125 4.29E+00 4.79E-02 1.02E+00 4.36E-03 0.OOE+00 3.31E+00 4.72E+01 0.00E+00 SB-126 2.61E+00 5.30E-02 9.41E-01 1.60E-02 0.OOE+00 1.60E+00 2.13E+02 0.OOE+00 SB-127 5.17E-01 1.13E-02 1.98E-01 6.21E-03 0.OOE+00 3.06E-01 1.18E+02 0.OOE+00 TE-125m 2.54E+03 9.20E+02 3.40E+02 7.64E+02 1.03E+04 0.OOE+00 1.01E+04 0.OOE+00 TE-127m 6.45E+03 2.31E+03 7.86E+02 1.65E+03 2.62E+04 0.OOE+00 2.16E+04 0.OOE+00 TE-127 1.78E+01 6.39E+00 3.85E+00 1.32E+01 7.25E+01 0.OOE+00 1.40E+03 0.OOE+00 TE-129m 1.08E+04 4.03E+03 1.71E+03 3.71E+03 4.51E+04 0.OOE+00 5.44E+04 0.00E+00 TE-129 1.78E-05 6.69E-06 4.34E-06 1.37E-05 7.48E-05 0.OOE+00 1.34E-05 0.OOE+00 TE-133m 6.63E-07 3.88E-07 3.73E-07 5.61E-07 3.83E-06 0.OOE+00 1.33E-07 0.OOE+00 11.4-124 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-23 (Page 3 of 4) Adult Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 1.32E-09 8.66E-10 5.31E-10 1.16E-09 8.38E-09 0.OOE+00 1.47E-12 0.OOE+00 1-129 1.18E+02 1.01E+02 3.31E+02 2.60E+05 2.17E+02 0.00E+00 1.60E+01 0.00E+00 1-130 7.08E+00 2.09E+01 8.24E+00 1.77E+03 3.26E+01 0.00E+00 1.80E+01 0.00E+00 1-131 1.37E+02 1.96E+02 1.12E+02 6.43E+04 3.36E+02 0.OOE+00 5.18E+01 0.OOE+00 TE-131m 9.53E+02 4.66E+02 3.88E+02 7.38E+02 4.72E+03 0.OOE+00 4.63E+04 0.OOE+00 TE-131 8.65E-17 3.61E-17 2.73E-17 7.11E-17 3.79E-16 0.00E+00 1.22E-17 0.OOE+00 1-132 5.27E-03 1.41 E-02 4.94E-03 4.94E-01 2.25E-02 0.00E+00 2.65E-03 0.00E+00 TE-132 1.95E+03 1.26E+03 1.19E+03 1.40E+03 1.22E+04 0.OOE+00 5.98E+04 0.OOE+00 1-133 2.29E+01 3.99E+01 1.22E+01 5.87E+03 6.97E+01 O.00E+00 3.59E+01 O.00E+00 CS-134m 3.29E-01 6.93E-01 3.54E-01 O.OOE+00 3.76E-01 5.92E-02 2.44E-01 O.00E+00 CS-1 34 2.98E+05 7.09E+05 5.80E+05 0.00E+00 2.29E+05 7.62E+04 1.24E+04 O.OOE+00 1-134 2.19E-08 5.94E-08 2.13E-08 1.03E-06 9.45E-08 0.00E+00 5.18E-11 0.OOE+00 1-135 1.29E+00 3.37E+00 1.24E+00 2.22E+02 5.40E+00 0.00E+00 3.80E+00 0.00E+00 CS-135 9.35E+04 8.63E+04 3.83E+04 O.OOE+00 3.27E+04 9.78E+03 2.02E+03 0.00E+00 CS-136 2.96E+04 1.17E+05 8.41E+04 0.OOE+00 6.50E+04 8.92E+03 1.33E+04 0.OOE+00 CS-1 37 3.82E+05 5.23E+05 3.42E+05 0.00E+00 1.77E+05 5.90E+04 1.01 E+04 0.00E+00 CS-138 9.13E-12 1.80E-11 8.93E-12 0.OOE+00 1.32E-11 1.31E-12 7.69E-17 0.00E+00 CS-139 1.25E-44 1.87E-44 6.80E-45 0.OOE+00 1.50E-44 1.36E-45 4.04E-67 0.OOE+00 BA-1 39 5.65E-06 4.03E-09 1.65E-07 0.OOE+00 3.76E-09 2.28E-09 1.O0E-05 0.OOE+00 BA-140 1.84E+02 2.32E-01 1.21E+01 0.OOE+00 7.88E-02 1.33E-01 3.80E+02 0.OOE+00 LA-140 9.91E-02 4.99E-02 1.32E-02 0.00E+00 0.OOE+00 0.OOE+00 3.67E+03 0.OOE+00 BA-141 8.48E-25 6.41E-28 2.86E-26 0.OOE+00 5.96E-28 3.64E-28 4.OOE-34 0.00E+00 LA-141 2.80E-04 8.70E-05 1.42E-05 0.OOE+00 0.00E+00 0.OOE+00 1.04E+01 0.OOE+00 CE-141 2.20E-02 1.49E-02 1.68E-03 0.OOE+00 6.90E-03 0.00E+00 5.68E+01 0.00E+00 BA-142 6.28E-42 6.45E-45 3.95E-43 0.00E+00 5.45E-45 3.65E-45 8.84E-60 0.OOE+00 LA-142 2.19E-07 9.97E-08 2.48E-08 0.OOE+00 0.OOE+00 0.00E+00 7.28E-04 0.OOE+00 CE-143 2.39E-03 1.77E+00 1.95E-04 0.OOE+00 7.78E-04 0.OOE+00 6.60E+01 0.OOE+00 PR-143 5.24E-01 2.10E-01 2.60E-02 0.00E+00 1.21E-01 0.OOE+00 2.29E+03 0.00E+00 CE-144 1.17E+00 4.88E-01 6.27E-02 0.00E+00 2.89E-01 0.OOE+00 3.95E+02 0.OOE+00 PR-144 1.48E-28 6.15E-29 7.53E-30 0.OOE+00 3.47E-29 0.OOE+00 2.13E-35 0.OOE+00 ND-147 3.54E-01 4.09E-01 2.45E-02 0.00E+00 2.39E-01 0.OOE+00 1.96E+03 0.OOE+00 PM-147 4.52E+00 4.25E-01 1.72E-01 0.OOE+00 8.03E-01 0.OOE+00 5.35E+02 0.OOE+00 PM-148m 1.81E+00 4.69E-01 3.58E-01 0.00E+00 7.07E-01 0.OOE+00 3.97E+03 0.OOE+00 PM-148 3.78E-01 6.27E-02 3.16E-02 0.00E+00 1.19E-01 0.OOE+00 4.93E+03 0.00E+00 PM-149 6.66E-02 9.42E-03 3.85E-03 0.00E+00 1.78E-02 0.00E+00 1.77E+03 0.OOE+00 PM-151 2.33E-02 3.90E-03 1.97E-03 0.00E+00 6.97E-03 0.00E+00 1.07E+03 0.OOE+00 SM-151 4.14E+00 7.13E-01 1.71E-01 0.00E+00 7.97E-01 0.00E+00 3.15E+02 0.OOE+00 11.4-125 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-23 (Page 4 of 4) Adult Fish Ait mrem*mL/hr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 3.60E-02 3.OOE-02 2.19E-03 0.OOE+00 9.70E-03 0.00E+00 1.07E+03 0.OOE+00 EU-152 1.17E+01 2.66E+00 2.34E+00 0.OOE+00 1.65E+01 O.OOE+00 1.53E+03 0.OOE+00 EU-154 3.68E+01 4.53E+00 3.22E+00 0.OOE+00 2.17E+01 0.00E+00 3.28E+03 0.OOE+00 EU-155 5.15E+00 7.31E-01 4.71E-01 0.OOE+00 3.37E+00 0.OOE+00 5.75E+02 0.0OE+00 EU-1 56 7.84E-01 6.07E-01 9.79E-02 0.OOE+00 4.05E-01 0.OOE+00 4.16E+03 0.OOE+00 TB-160 2.79E+00 0.OOE+00 3.48E-01 0.OOE+00 1.15E+00 0.00E+00 1.52E+03 0.OOE+00 HO-166m 1.62E+01 5.05E+00 3.84E+00 0.OOE+00 7.55E+00 0.OOE+00 5.99E-17 0.OOE+00 W-181 2.83E+01 9.24E+00 9.90E-01 0.OOE+00 0.OOE+00 O.OOE+00 1.05E+03 0.00E+00 W-185 1.15E+03 3.85E+02 4.05E+01 0.OOE+00 0.OOE+00 0.OOE+00 4.45E+04 0.OOE+00 W-1 87 1.47E+02 1.23E+02 4.31 E+01 0.OOE+00 0.OOE+00 0.OOE+00 4.04E+04 0.00E+00 NP-239 2.13E-02 2.09E-03 1.15E-03 O.OOE+00 6.52E-03 0.OOE+00 4.29E+02 O.OOE+00 U-232 1.98E+04 0.OOE+00 1.41 E+03 O.OOE+00 2.14E+03 0.OOE+00 3.25E+02 0.0OE+00 U-233 4.18E+03 0.OOE+00 2.53E+02 0.OOE+00 9.73E+02 0.OOE+00 3.01E+02 0.OOE+00 U-234 4.01E+03 0.OOE+00 2.48E+02 0.OOE+00 9.54E+02 0.OOE+00 2.94E+02 0.OOE+00 U-235 3.84E+03 0.OOE+00 2.33E+02 0.OOE+00 8.97E+02 0.OOE+00 3.74E+02 0.OOE+00 U-236 3.84E+03 0.OOE+00 2.38E+02 0.0OE+00 9.16E+02 0.OOE+00 2.76E+02 0.OOE+00 U-237 2.39E-01 0.OOE+00 6.36E-02 0.OOE+00 9.82E-01 0.OOE+00 8.39E+01 0.OOE+00 U-238 3.68E+03 0.OOE+00 2.18E+02 0.OOE+00 8.39E+02 0.OOE+00 2.64E+02 0.OOE+00 NP-237 3.02E+04 2.15E+03 1.33E+03 0.OOE+00 9.88E+03 0.OOE+00 1.90E+03 0.OOE+00 NP-238 2.37E-01 6.38E-03 3.68E-03 0.00E+00 2.16E-02 0.00E+00 5.93E+02 0.OOE+00 PU-238 5.29E+03 6.70E+02 1.43E+02 0.OOE+00 6.14E+02 0.OOE+00 6.12E+02 0.OOE+00 PU-239 6.08E+03 7.31 E+02 1.60E+02 0.OOE+00 6.80E+02 0.OOE+00 5.59E+02 0.OOE+00 PU-240 6.07E+03 7.30E+02 1.60E+02 0.OOE+00 6.80E+02 0.OOE+00 5.69E+02 0.OOE+00 PU-241 1.32E+02 6.25E+00 2.79E+00 0.OOE+00 1.28E+01 0.OOE+00 1.17E+01 0.OOE+00 PU-242 5.64E+03 7.04E+02 1.54E+02 0.OOE+00 6.55E+02 0.OOE+00 5.48E+02 0.OOE+00 PU-244 6.58E+03 8.06E+02 1.77E+02 O.OOE+00 7.51E+02 0.OOE+00 8.16E+02 0.OOE+00 AM-241 4.52E+04 4.23E+04 3.24E+03 0.OOE+00 2.44E+04 O.OOE+00 4.45E+03 0.OOE+00 AM-242m 4.56E+04 3.97E+04 3.25E+03 0.OOE+00 2.43E+04 0.OOE+00 5.60E+03 0.OOE+00 AM-243 4.52E+04 4.14E+04 3.18E+03 0.OOE+00 2.39E+04 0.OOE+00 5.21EE+03 0.OOE+00 CM-242 1.23E+03 1.31E+03 8.18E+01 0.OOE+00 3.71E+02 0.OOE+00 4.73E+03 0.OOE+00 CM-243 3.59E+04 3.29E+04 2.25E+03 0.OOE+00 1.05E+04 0.OOE+00 4.68E+03 0.OOE+00 CM-244 2.73E+04 2.56E+04 1.72E+03 0.00E+00 8.03E+03 0.OOE+00 4.52E+03 0.OOE+00 CM-245 5.62E+04 4.90E+04 3.45E+03 0.OOE+00 1.61 E+04 0.00E+00 4.22E+03 0.OOE+00 CM-246 5.57E+04 4.89E+04 3.45E+03 0.00E+00 1.61E+04 O.OOE+00 4.14E+03 0.OOE+00 CM-247 5.44E+04 4.82E+04 3.40E+03 0.00E+00 1.58E+04 0.00E+00 5.45E+03 0.OOE+00 CM-248 4.52E+05 3.97E+05 2.80E+04 0.00E+00 1.31E+05 O.OOE+00 8.81E+04 0.00E+00 CF-252 1.56E+04 0.OOE+00 3.77E+02 0.00E+00 0.00E+00 O.00E+00 1.72E+04 0.OOE+00 11.4-126 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-24 (Page 1 of 4) Infant Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 0.OOE+00 C-14 2.65E+04 5.31EE+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 0.OOE+00 NA-22 1.03E+05 1.03E+05 1.03E+05 1.03E+05 1.03E+05 1.03E+05 1.03E+05 0.00E+00 NA-24 1.06E+04 1.06E1+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 0.00E+00 P-32 2.03E+06 1.12E+05 7.74E+04 0.OOE+00 0.OOE+00 O.OOE+00 1.61E+04 0.OOE+00 CA-41 1.05E+05 0.OOE+00 1.14E+04 0.OOE+00 0.OOE+00 9.72E+07 4.14E+02 0.OOE+00 SC-46 5.25E+05 7.57E+05 2.37E+05 0.00E+00 4.98E+05 0.OOE+00 3.07E+04 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 8.95E+01 5.75E+01 1.32E+01 1.28E+04 3.57E+02 O.OOE+00 MN-54 0.OOE+00 2.53E+04 4.98E+03 0.OOE+00 4.98E+03 1.OOE+06 7.06E+03 0.OOE+00 FE-55 1.97E+04 1.18E+04 3.33E+03 O.O0E+00 0.OOE+00 8.69E+04 1.10E+03 0.OOE+00 MN-56 0.OOE+00 1.54E+00 2.21E-01 0.OOE+00 1.10E+00 1.25E+04 7.17E+04 0.OOE+00 CO-57 0.OOE+00 6.51 E+02 6.41 E+02 0.OOE+00 0.OOE+00 3.79E+05 4.86E+03 0.O0E+00 CO-58 O.OOE+00 1.22E+03 1.82E+03 0.OOE+00 0.OOE+00 7.77E+05 1.11E+04 0.OOE+00 FE-59 1.36E+04 2.35E+04 9.48E+03 0.OOE+00 0.OOE+00 1.02E+06 2.48E+04 0.OOE+00 CO-60 0.OOE+00 8.02E+03 1.18E+04 0.OOE+00 0.OOE+00 4.51E+06 3.19E+04 0.OOE+00 NI-59 2.53E+04 7.62E+03 4.34E+03 0.OOE+00 0.OOE+00 7.67E+04 8.88E+02 0.OOE+00 NI-63 3.39E+05 2.04E+04 1.16E+04 0.00E+00 0.00E+00 2.09E+05 2.42E+03 0.OOE+00 CU-64 O.OOE+00 1.88E+00 7.74E-01 0.OOE+00 3.98E+00 9.30E+03 1.50E+04 0.OOE+00 NI-65 2.39E+00 2.84E-01 1.23E-01 0.OOE+00 O.00E+00 8.12E+03 5.01E+04 0.OOE+00 ZN-65 1.93E+04 6.26E+04 3.11E+04 0.OOE+00 3.25E+04 6.47E+05 5.14E+04 0.OOE+00 ZN-69m 1.26E+01 2.58E+01 2.34E+00 0.OOE+00 1.04E+01 2.67E+04 4.09E+04 0.OOE+00 ZN-69 5.39E-02 9.67E-02 7.18E-03 0.OOE+00 4.02E-02 1.47E+03 1.32E+04 0.OOE+00 SE-79 0.OOE+00 3.15E+03 5.88E+02 0.OOE+00 3.46E+03 4.19E+05 4.84E+04 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.33E+04 0.OOE+00 0.OOE+00 O.OOE+00 1.40E-15 0.OOE+00 BR-83 0.OOE+00 O.OOE+00 3.81E+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 BR-84 0.OOE+00 0.OOE+00 4.OOE+02 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 2.04E+01 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 RB-86 0.OOE+00 1.90E+05 8.82E+04 0.OOE+00 0.OOE+00 0.00E+00 3.04E+03 0.OOE+00 RB-87 0.00E+00 1.24E+05 4.93E+04 0.OOE+00 0.OOE+00 0.OOE+00 8.37E+02 0.00E+00 RB-88 0.00E+00 5.57E+02 2.87E+02 0.OOE+00 0.OOE+00 0.OOE+00 3.39E+02 0.OOE+00 RB-89 0.OOE+00 3.21E+02 2.06E+02 0.OOE+00 0.OOE+00 0.OOE+00 6.82E+01 O.OOE+00 SR-89 3.98E+05 0.OOE+00 1.14E+04 0.OOE+00 0.OOE+00 2.03E+06 6.40E+04 0.OOE+00 SR-90 4.09E+07 0.OOE+00 2.59E+06 0.OOE+00 O.OOE+00 1.12E+07 1.31E+05 0.OOE+00 Y-90 3.29E+03 0.OOE+00 8.82E+01 0.OOE+00 0.00E+00 2.69E+05 1.04E+05 0.OOE+00 SR-91 9.56E+01 0.OOE+00 3.46E+00 0.OOE+00 0.00E+00 5.26E+04 7.34E+04 0.OOE+00 Y-91m 4.07E-01 0.OOE+00 1.39E-02 0.OOE+00 0.00E+00 2.79E+03 2.35E+03 O.OOE+00 Y-91 5.88E+05 0.OOE+00 1.57E+04 0.OOE+00 0.OOE+00 2.45E+06 7.03E+04 0.00E+00 11.4-127 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-24 (Page 2 of 4) Infant Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 1.05E+01 0.OOE+00 3.91E-01 0.OOE+00 0.00E+00 2.38E+04 1.40E+05 0.OOE+00 Y-92 1.64E+01 0.OOE+00 4.61 E-01 0.OOE+00 0.OOE+00 2.45E+04 1.27E+05 O.OOE+00 Y-93 1.50E+02 0.OOE+00 4.07E+00 0.00E+00 0.OOE+00 7.64E+04 1.67E+05 0.OOE+00 NB-93m 1.93E+05 5.03E+04 1.61E+04 0.00E+00 5.15E+04 2.93E+05 3.46E+03 0.OOE+00 NB-95 1.57E+04 6.43E+03 3.78E+03 0.OOE+00 4.72E+03 4.79E+05 1.27E+04 0.OOE+00 NB-97 3.42E-01 7.29E-02 2.63E-02 0.OOE+00 5.70E-02 3.32E+03 2.69E+04 0.00E+00 ZR-93 3.14E+05 1.33E+05 8.65E+04 0.OOE+00 4.47E+05 1.92E+06 2.07E+04 0.OOE+00 ZR-95 1.15E+05 2.79E+04 2.03E+04 O.OOE+00 3.11E+04 1.75E+06 2.17E+04 0.00E+00 ZR-97 1.50E+02 2.56E+01 1.17E+01 O.OOE+00 2.59E+01 1.1OE+05 1.40E+05 0.00E+00 MO-93 0.00E+00 9.04E+03 3.11E+02 O.OOE+00 2.16E+03 4.76E+05 5.26E+03 0.00E+00 MO-99 0.00E+00 1.65E+02 3.23E+01 O.00E+00 2.65E+02 1.35E+05 4.87E+04 0.00E+00 TC-99 2.93E+02 3.75E+02 1.24E+02 0.00E+00 3.49E+03 9.48E+05 1.09E+04 0.OOE+00 TC-99m 1.40E-03 2.88E-03 3.72E-02 0.00E+00 3.11E-02 8.11E+02 2.03E+03 0.00E+00 TC-101 6.51E-05 8.23E-05 8.12E-04 0.OOE+00 9.79E-04 5.84E+02 8.44E+02 0.00E+00 RU-103 2.02E+03 0.OOE+00 6.79E+02 0.00E+00 4.24E+03 5.52E+05 1.61E+04 0.OOE+00 RU-105 1.22E+00 0.OOE+00 4.10E-01 O.OOE+00 8.99E-01 1.57E+04 4.84E+04 0.OOE+00 RU-1 06 8.68E+04 0.OOE+00 1.09E+04 0.OOE+00 1.07E+05 1.16E+07 1.64E+05 0.00E+00 RH-105 1.16E+01 7.57E+00 5.08E+00 0.OOE+00 2.1OE+01 2.91EE+04 1.92E+04 0.OOE+00 PD-1 07 0.00E+00 6.89E+01 5.75E+01 0.OOE+00 3.85E+03 8.88E+04 1.03E+03 0.00E+00 PD-1 09 0.00E+00 5.49E+00 1.47E+00 0.OOE+00 1.79E+01 2.35E+04 3.99E+04 0.00E+00 AG- 1O1m 9.98E+03 7.22E+03 5.OOE+03 0.00E+00 1.09E+04 3.67E+06 3.30E+04 0.00E+00 AG-1 11 5.25E+02 2.03E+02 1.09E+02 0.OOE+00 4.27E+02 2.88E+05 4.23E+04 0.00E+00 CD-113m 0.OOE+00 9.34E+05 3.70E+04 0.OOE+00 8.12E+05 1.96E+06 2.31E+04 0.OOE+00 CD-115m 0.OOE+00 2.42E+05 8.67E+03 0.00E+00 1.32E+05 2.06E+06 7.03E+04 0.OOE+00 SN-123 2.93E+05 5.89E+03 1.02E+04 5.98E+03 0.00E+00 3.11E+06 5.71E+04 0.OOE+00 SN-1 25 1.41 E+04 3.51 E+02 8.40E+02 3.46E+02 0.OOE+00 9.OOE+05 1.02E+05 0.OOE+00 SN-126 1.16E+06 2.02E+04 4.93E+04 5.38E+03 0.OOE+00 6.90E+06 2.31E+04 0.OOE+00 SB-124 3.79E+04 5.56E+02 1.20E+04 1.01E+02 0.OOE+00 2.65E+06 5.91E+04 0.OOE+00 SB-125 5.45E+04 4.77E+02 1.09E+04 6.23E+01 0.OOE+00 1.64E+06 1.47E+04 0.OOE+00 SB-126 4.31E+03 8.41E+01 1.55E+02 3.29E+01 0.OOE+00 9.63E+05 7.46E+04 0.OOE+00 SB-127 3.95E+02 7.06E+00 1.23E+02 5.04E+00 0.OOE+00 2.16E+05 5.29E+04 0.OOE+00 TE-125m 4.76E+03 1.99E+03 6.58E+02 1.62E+03 0.OOE+00 4.47E+05 1.29E+04 0.OOE+00 TE-127m 1.67E+04 6.90E+03 2.07E+03 4.87E+03 3.75E+04 1.31E+06 2.73E+04 0.OOE+00 TE-127 2.23E+00 9.53E-01 4.89E-01 1.85E+00 4.86E+00 1.04E+04 2.44E+04 0.OOE+00 TE-129m 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 0.OOE+00 TE-129 7.88E-02 3.47E-02 1.88E-02 6.75E-02 1.75E-01 3.OOE+03 2.63E+04 0.OOE+00 TE-133m 8.58E-02 5.03E-02 3.84E-02 7.73E-02 2.41E-01 5.49E+03 2.23E+04 0.OOE+00 11.4-128 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-24 (Page 3 of 4) Infant Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 4.45E-02 2.86E-02 2.35E-02 4.07E-02 1.34E-01 4.1OE+03 3.54E+03 0.OOE+00 1-129 3.02E+04 2.23E+04 1.62E+04 1.46E+07 2.63E+04 0.OOE+00 2.97E+02 0.OOE+00 1-130 6.36E+03 1.39E+04 5.57E+03 1.60E+06 1.53E+04 0.OOE+00 1.99E+03 0.OOE+00 1-131 3.79E+04 4.44E+04 1.96E+04 1.48E+07 5.18E+04 O.00E+00 1.06E+03 0.OOE+00 TE-131m 1.07E+02 5.50E+01 3.63E+01 8.93E+01 2.65E+02 1.99E+05 1.19E+05 0.OOE+00 TE-131 1.74E-02 8.22E-03 5.OOE-03 1.58E-02 3.99E-02 2.06E+03 8.22E+03 0.OOE+00 1-132 1.69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 0.OOE+00 1.90E+03 0.OOE+00 TE-132 3.72E+02 2.37E+02 1.76E+02 2.79E+02 1.04E+03 3.40E+05 4.41E+04 0.OOE+00 1-133 1.32E+04 1.92E+04 5.60E+03 3.56E+06 2.24E+04 0.OOE+00 2.16E+03 0.OOE+00 CS-134m 1.85E+02 2.94E+02 1.55E+02 0.OOE+00 1.19E+02 2.80E+01 1.62E+02 0.OOE+00 CS-134 3.96E+05 7.03E+05 7.45E+04 0.OOE+00 1.90E+05 7.97E+04 1.33E+03 0.OOE+00 1-134 9.21E+02 1.88E+03 6.65E+02 4.45E+04 2.09E+03 0.OOE+00 1.29E+03 0.OOE+00 1-135 3.86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 0.OOE+00 1.83E+03 0.OOE+00 CS-135 1.40E+05 1.21E+05 6.62E+03 0.OOE+00 3.61E+04 1.41E+04 3.05E+02 0.OOE+00 CS-136 4.83E+04 1.35E+05 5.29E+04 0.OOE+00 5.64E+04 1.18E+04 1.43E+03 0.OOE+00 CS-137 5.49E+05 6.12E+05 4.55E+04 0.OOE+00 1.72E+05 7.13E+04 1.33E+03 0.OOE+00 CS-138 5.05E+02 7.81E+02 3.98E+02 0.OOE+00 4.1OE+02 6.54E+01 8.76E+02 0.OOE+00 CS-139 3.25E+02 4.24E+02 1.71E+02 0.OOE+00 2.31E+02 3.54E+01 1.86E+01 0.OOE+00 BA-1 39 1.48E+00 9.84E-04 4.30E-02 0.OOE+00 5.92E-04 5.95E+03 5.1OE+04 0.OOE+00 BA-140 5.60E+04 5.60E+01 2.90E+03 0.OOE+00 1.34E+01 1.60E+06 3.84E+04 0.OOE+00 LA-140 5.05E+02 2.OOE+02 5.15E+01 0.OOE+00 0.OOE+00 1.68E+05 8.48E+04 0.OOE+00 BA-141 1.57E-01 1.08E-04 4.97E-03 0.OOE+00 6.50E-05 2.97E+03 4.75E+03 0.OOE+00 LA-141 6.79E+00 1.96E+00 3.43E-01 0.OOE+00 0.OOE+00 1.71E+04 8.34E+04 0.OOE+00 CE-141 2.77E+04 1.67E+04 1.99E+03 0.OOE+00 5.25E+03 5.17E+05 2.16E+04 0.OOE+00 BA-142 3.98E-02 3.30E-05 1.96E-03 0.OOE+00 1.90E-05 1.55E+03 6.93E+02 0.00E+00 LA-142 1.03E+00 3.77E-01 9.04E-02 0.OOE+00 0.OOE+00 8.22E+03 5.95E+04 0.OOE+00 CE-143 2.93E+02 1.93E+02 2.21E+01 0.OOE+00 5.64E+01 1.16E+05 4.97E+04 0.OOE+00 PR-143 1.40E+04 5.24E+03 6.99E+02 0.OOE+00 1.97E+03 4.33E+05 3.72E+04 0.OOE+00 CE-144 3.19E+06 1.21E+06 1.76E+05 0.OOE+00 5.38E+05 9.84E+06 1.48E+05 0.OOE+00 PR-144 4.79E-02 1.85E-02 2.41E-03 0.OOE+00 6.72E-03 1.61E+03 4.28E+03 0.OOE+00 ND-147 7.94E+03 8.13E+03 5.OOE+02 0.OOE+00 3.15E+03 3.22E+05 3.12E+04 0.OOE+00 PM-147 5.47E+05 4.30E+04 2.18E+04 0.OOE+00 6.90E+04 6.37E+05 8.05E+03 0.OOE+00 PM-148m 7.OOE+04 1.74E+04 1.39E+04 0.00E+00 2.03E+04 1.71EE+06 4.72E+04 0.00E+00 PM-148 4.68E+03 6.75E+01 3.42E+02 0.OOE+00 8.06E+02 4.48E+05 8.46E+04 0.OOE+00 PM-149 4.34E+02 5.71E+01 2.49E+01 0.OOE+00 6.94E+01 9.1OE+04 4.21EE+04 0.OOE+00 PM-151 1.05E+02 1.54E+01 7.77E+00 0.OOE+00 1.82E+01 4.55E+04 3.61EE+04 0.OOE+00 SM-151 4.73E+05 9.03E+04 2.28E+04 0.OOE+00 7.34E+04 4.17E+05 4.84E+03 0.OOE+00 11.4-129 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-24 (Page 4 of 4) Infant Inhalation Pi mrem*m3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 2.14E+02 1.65E+02 1.27E+01 0.00E+00 3.46E+01 5.18E+04 2.70E+04 0.00E+00 EU-152 1.1OE+06 2.48E+05 2.41E+05 0.00E+00 8.32E+05 2.07E+06 1.38E+04 0.OOE+00 EU-154 4.14E+06 4.84E+05 3.43E+05 0.OOE+00 1.60E+06 4.27E+06 3.98E+04 0.OOE+00 EU-155 8.36E+05 8.01E+04 4.84E+04 0.OOE+00 2.21E+05 7.28E+05 7.27E+04 0.O0E+00 EU-156 2.18E+04 1.34E+04 2.16E+03 0.OOE+00 6.27E+03 8.57E+05 5.80E+04 O.00E+00 TB-160 1.57E+05 0.00E+00 1.96E+04 0.OOE+00 4.48E+04 1.55E+06 3.OOE+04 0.00E+00 HO-166m 2.03E+05 4.30E+05 3.51E+05 O.OOE+00 5.91E+05 2.87E+06 2.31E+04 0.00E+00 W-181 6.80E+01 2.04E+01 2.34E+00 0.OOE+00 O.OOE+00 1.86E+04 3.68E+02 0.OOE+00 W-185 2.20E+03 6.76E+02 7.81E+01 0.00E+00 0.00E+00 6.27E+05 1.57E+04 0.00E+00 W-187 1.30E+01 9.02E+00 3.12E+00 0.00E+00 0.00E+00 3.96E+04 3.56E+04 0.00E+00 NP-239 3.71 E+02 3.32E+01 1.88E+01 0.00E+00 6.62E+01 5.95E+04 2.49E+04 O.OOE+00 U-232 3.60E+08 0.00E+00 2.98E+07 0.OOE+00 3.36E+07 2.09E+09 6.10E+04 0.OOE+00 U-233 7.62E+07 0.OOE+00 5.36E+06 0.OOE+00 1.53E+07 4.98E+08 5.64E+04 0.OOE+00 U-234 7.31 E+07 0.OOE+00 5.25E+06 0.OOE+00 1.50E+07 4.89E+08 5.53E+04 0.OOE+00 U-235 7.01 E+07 0.OOE+00 4.93E+06 0.00E+00 1.41 E+07 4.59E+08 7.03E+04 0.OOE+00 U-236 7.01E+07 0.00E+00 5.04E+06 O.OOE+00 1.44E+07 4.69E+08 5.19E+04 0.OOE+00 U-237 4.55E+02 0.OOE+00 1.21E+02 0.00E+00 1.13E+03 1.28E+05 1.83E+04 0.00E+00 U-238 6.71 E+07 0.OOE+00 4.61 E+06 0.00E+00 1.32E+07 4.28E+08 4.96E+04 0.00E+00 NP-237 4.03E+09 2.39E+09 1.76E+08 0.00E+00 1.08E+09 4.89E+08 7.14E+04 0.00E+00 NP-238 3.74E+03 8.47E+02 5.82E+01 0.OOE+00 2.06E+02 1.29E+05 3.61E+04 0.00E+00 PU-238 3.77E+09 2.35E+09 1.78E+08 0.OOE+00 6.50E+08 1.26E+09 6.57E+04 0.00E+00 PU-239 4.10E+09 2.46E+09 1.88E+08 0.00E+00 6.93E+08 1.19E+09 5.99E+04 0.OOE+00 PU-240 4.1OE+09 2.45E+09 1.88E+08 0.OOE+00 6.92E+08 1.19E+09 6.1OE+04 0.OOE+00 PU-241 1.18E+08 2.59E+07 4.35E+06 0.00E+00 1.61E+07 1.07E+06 1.26E+03 O.OOE+00 PU-242 3.81E+09 2.37E+09 1.81E+08 0.00E+00 6.68E+08 1.14E+09 5.88E+04 0.00E+00 PU-244 4.44E+09 2.72E+09 2.07E+08 0.00E+00 7.64E+08 1.31E+09 8.76E+04 0.OOE+00 AM-241 4.41E+09 2.73E+09 1.83E+08 0.OOE+00 1.11E+09 5.68E+08 6.69E+04 0.OOE+00 AM-242m 4.55E+09 2.60E+09 1.89E+08 0.OOE+00 1.12E+09 2.30E+08 8.41E+04 0.OOE+00 AM-243 4.34E+09 2.63E+09 1.78E+08 0.00E+00 1.08E+09 5.39E+08 7.84E+04 0.OOE+00 CM-242 1.79E+08 1.21E+08 7.98E+06 0.OOE+00 2.37E+07 4.16E+08 7.14E+04 0.00E+00 CM-243 3.46E+09 2.13E+09 1.48E+08 0.OOE+00 5.47E+08 5.94E+08 7.03E+04 0.OOE+00 CM-244 2.90E+09 1.78E+09 1.24E+08 0.OOE+00 4.49E+08 5.71E+08 6.80E+04 O.OOE+00 CM-245 4.51 E+09 2.74E+09 1.90E+08 0.OOE+00 7.32E+08 5.49E+08 6.34E+04 0.OOE+00 CM-246 4.48E+09 2.74E+09 1.90E+08 O.OOE+00 7.32E+08 5.59E+08 6.23E+04 0.OOE+00 CM-247 4.35E+09 2.70E+09 1.86E+08 0.OOE+00 7.21E+08 5.49E+08 8.19E+04 0.OOE+00 CM-248 3.61E+10 2.23E+10 1.54E+09 0.OOE+00 5.94E+09 4.52E+09 1.32E+06 0.OOE+00 CF-252 3.32E+09 0.00E+00 1.41E+08 0.OOE+00 0.00E+00 1.92E+09 2.59E+05 0.OOE+00 11.4-130 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-25 (Page 1 of 4) Child Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung_ GI-LLI Skin H-3 O.OOE+00 1.13E+03 1.13E+03 1.13E+03 1.13E+03 1.13E+03 1.13E+03 0.OOE+00 C-14 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 0.00E+00 NA-22 1.63E+05 1.63E+05 1.63E+05 1.63E+05 1.63E+05 1.63E+05 1.63E+05 0.OOE+00 NA-24 1.61EE+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 0.OOE+00 P-32 2.61E+06 1.14E+05 9.88E+04 0.OOE+00 0.OOE+00 0.OOE+00 4.22E+04 O.OOE+00 CA-41 2.61E+05 0.OOE+00 2.85E+04 0.OOE+00 0.OOE+00 2.67E+08 1.09E+03 0.OOE+00 SC-46 7.29E+05 9.99E+05 3.85E+05 0.OOE+00 8.84E+05 0.OOE+00 9.07E+04 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 1.54E+02 8.55E+01 2.43E+01 1.70E+04 1.08E+03 0.OOE+00 MN-54 0.00E+00 4.29E+04 9.51 E+03 0.OOE+00 1.OOE+04 1.58E+06 2.29E+04 0.OOE+00 FE-55 4.74E+04 2.52E+04 7.77E+03 0.OOE+00 0.OOE+00 1.11E+05 2.87E+03 0.OOE+00 MN-56 0.OOE+00 1.66E+00 3.12E-01 O.OOE+00 1.67E+00 1.31E+04 1.23E+05 0.OOE+00 CO-57 0.OOE+00 9.03E+02 1.07E+03 0.OOE+00 0.OOE+00 5.07E+05 1.32E+04 0.OOE+00 CO-58 0.OOE+00 1.77E+03 3.16E+03 0.OOE+00 0.OOE+00 1.11E+06 3.44E+04 0.OOE+00 FE-59 2.07E+04 3.35E+04 1.67E+04 0.OOE+00 0.OOE+00 1.27E+06 7.07E+04 0.OOE+00 CO-60 0.OOE+00 1.31 E+04 2.26E+04 0.OOE+00 0.OOE+00 7.07E+06 9.62E+04 0.OOE+00 NI-59 6.14E+04 1.73E+04 1.05E+04 0.OOE+00 0.OOE+00 1.01E+05 2.33E+03 0.OOE+00 NI-63 8.21E+05 4.63E+04 2.80E+04 0.OOE+00 0.OOE+00 2.75E+05 6.33E+03 0.OOE+00 CU-64 0.OOE+00 1.99E+00 1.07E+00 0.00E+00 6.03E+00 9.58E+03 3.67E+04 0.OOE+00 NI-65 2.99E+00 2.96E-01 1.64E-01 0.OOE+00 0.OOE+00 8.18E+03 8.40E+04 O.OOE+00 ZN-65 4.26E+04 1.13E+05 7.03E+04 0.OOE+00 7.14E+04 9.95E+05 1.63E+04 0.OOE+00 ZN-69m 1.58E+01 2.69E+01 3.18E+00 0.OOE+00 1.56E+01 2.72E+04 1.OOE+05 O.OOE+00 ZN-69 6.70E-02 9.66E-02 8.92E-03 0.OOE+00 5.85E-02 1.42E+03 1.02E+04 0.OOE+00 SE-79 0.OOE+00 4.55E+03 9.62E+02 0.OOE+00 6.33E+03 5.51E+05 1.27E+04 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 2.09E+04 0.OOE+00 0.OOE+00 0.OOE+00 3.70E-15 0.OOE+00 BR-83 0.OOE+00 O.00E+00 4.74E+02 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 5.48E+02 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 2.53E+01 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 1.98E+05 1.14E+05 O.00E+00 0.OOE+00 0.OOE+00 7.99E+03 0.OOE+00 RB-87 0.OOE+00 1.17E+05 5.07E+04 0.OOE+00 0.OOE+00 0.00E+00 1.10E+03 0.OOE+00 RB-88 0.OOE+00 5.62E+02 3.66E+02 0.OOE+00 0.OOE+00 0.00E+00 1.72E+01 O.OOE+00 RB-89 0.OOE+00 3.45E+02 2.90E+02 0.00E+00 0.OOE+00 0.OOE+00 1.89E+00 0.OOE+00 SR-89 5.99E+05 0.OOE+00 1.72E+04 0.OOE+00 0.OOE+00 2.16E+06 1.67E+05 O.OOE+00 SR-90 1.01 E+08 0.OOE+00 6.44E+06 0.OOE+00 0.00E+00 1.48E+07 3.43E+05 0.OOE+00 Y-90 4.11E+03 0.OOE+00 1.11E+02 0.OOE+00 0.00E+00 2.62E+05 2.68E+05 0.OOE+00 SR-91 1.21E+02 0.OOE+00 4.59E+00 0.OOE+00 0.OOE+00 5.33E+04 1.74E+05 0.OOE+00 Y-91 m 5.07E-01 0.OOE+00 1.84E-02 0.OOE+00 O.OOE+00 2.81 E+03 1.72E+03 0.OOE+00 Y-91 9.14E+05 0.OOE+00 2.44E+04 0,00E+00 0.OOE+00 2.63E+06 1.84E+05 0.OOE+00 11.4-131 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-25 (Page 2 of 4) Child Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 1.31E+01 0.OOE+00 5.25E-01 0.OOE+00 O.OOE+00 2.40E+04 2.42E+05 0.OOE+00 Y-92 2.04E+01 0.00E+00 5.81E-01 0.00E+00 O.OOE+00 2.39E+04 2.39E+05 0.OOE+00 Y-93 1.87E+02 0.00E+00 5.11 E+00 0.OOE+00 0.OOE+00 7.44E+04 3.89E+05 0.OOE+00 NB-93m 4.70E+05 1.17E+05 3.85E+04 0.OOE+00 1.26E+05 3.85E+05 9.07E+03 0.00E+00 NB-95 2.35E+04 9.18E+03 6.55E+03 0.00E+00 8.62E+03 6.14E+05 3.70E+04 0.00E+00 NB-97 4.29E-01 7.70E-02 3.60E-02 0.00E+00 8.55E-02 3.42E+03 2.78E+04 0.00E+00 ZR-93 7.66E+05 2.89E+05 2.05E+05 0.OOE+00 1.11E+06 2.63E+06 5.44E+04 0.OOE+00 ZR-95 1.90E+05 4.18E+04 3.70E+04 0.OOE+00 5.96E+04 2.23E+06 6.11E+04 0.OOE+00 ZR-97 1.88E+02 2.72E+01 1.60E+01 0.OOE+00 3.89E+01 1.13E+05 3.51E+05 0.00E+00 MO-93 0.OOE+00 1.39E+04 5.00E+02 0.OOE+00 3.92E+03 6.29E+05 1.40E+04 0.00E+00 MO-99 0.00E+00 1.72E+02 4.26E+01 0.OOE+00 3.92E+02 1.35E+05 1.27E+05 0.00E+00 TC-99 4.96E+02 5.51 E+02 1.98E+02 0.00E+00 6.48E+03 1.25E+06 2.87E+04 0.OOE+00 TC-99m 1.78E-03 3.48E-03 5.77E-02 0.00E+00 5.07E-02 9.51 E+02 4.81 E+03 0.OOE+00 TC-101 8.1OE-05 8.51E-05 1.08E-03 0.00E+00 1.45E-03 5.85E+02 1.63E+01 0.OOE+00 RU-1 03 2.79E+03 O.00E+00 1.07E+03 0.OOE+00 7.03E+03 6.62E+05 4.48E+04 O.OOE+00 RU-105 1.53E+00 0.OOE+00 5.55E-01 0.OOE+00 1.34E+00 1.59E+04 9.95E+04 0.OOE+00 RU-106 1.36E+05 0.OOE+00 1.69E+04 0.OOE+00 1.84E+05 1.43E+07 4.29E+05 0.OOE+00 RH-105 1.45E+01 7.77E+00 6.62E+00 O.OOE+00 3.1OE+01 2.89E+04 4.92E+04 0.OOE+00 PD-107 0.OOE+00 9.81E+02 9.29E+01 0.OOE+00 7.29E+03 1.17E+05 2.69E+03 0.OOE+00 PD-109 O.00E+00 5.48E+00 1.83E+00 O.OOE+00 2.61E+01 2.28E+04 9.58E+04 O.OOE+00 AG-11Orn 1.69E+04 1.14E+04 9.14E+03 O.OOE+00 2.12E+04 5.48E+06 1.OOE+05 0.OOE+00 AG-111 6.70E+02 2.1OE+02 1.39E+02 0.OOE+00 6.33E+02 2.86E+05 1.1OE+05 0.OOE+00 CD-113m 0.OOE+00 1.82E+06 7.84E+04 O.OOE+00 1.90E+06 2.57E+06 6.03E+04 0.OOE+00 CD-115m 0.OOE+00 2.92E+05 1.25E+04 O.OOE+00 2.19E+05 2.17E+06 1.84E+05 0.OOE+00 SN- 23 4.77E+05 7.92E+03 1.55E+04 8.40E+03 0.OOE+00 3.55E+06 1.50E+05 0.OOE+00 SN-125 1.83E+04 3.68E+02 1.09E+03 3.81E+02 O.OOE+00 8.99E+05 2.65E+05 0.OOE+00 SN-126 2.31E+06 3.85E+04 8.73E+04 1.05E+04 O.OOE+00 1.12E+07 6.03E+04 0.OOE+00 SB-124 5.66E+06 7.40E+02 2.OOE+04 1.26E+02 0.OOE+00 3.24E+06 1.64E+05 O.OOE+00 SB-125 9.84E+04 7.59E+02 1.99E+04 9.1OE+01 0.OOE+00 2.32E+06 4.03E+04 0.00E+00 SB-126 6.36E+03 9.69E+01 2.28E+03 3.70E+01 0.OOE+00 1.06E+06 2.1OE+05 0.OOE+00 SB- 27 5.03E+02 7.73E+00 1.74E+02 5.59E+00 0.OOE+00 2.28E+05 1.41E+05 0.OOE+00 TE-125m 6.73E+03 2.33E+03 9.14E+02 1.92E+03 0.OOE+00 4.77E+05 3.38E+04 0.OOE+00 TE-127m 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 O.OOE+00 TE-127 2.77E+00 9.51E-01 6.11E-01 1.96E+00 7.07E+00 1.OOE+04 5.62E+04 O.OOE+00 TE-129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 O.OOE+00 TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 O.OOE+00 TE-133m 1.08E-01 5.59E-02 5.55E-02 8.58E-02 3.74E-01 5.92E+03 1.76E+04 O.OOE+00 11.4-132 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-25 (Page 3 of 4) Child Inhalation Pi mrem*m3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 5.66E-02 3.26E-02 3.48E-02 4.59E-02 2.11E-01 4.55E+03 1.80E+03 0.OOE+00 1-129 3.89E+04 2.37E+04 2.11E+04 1.58E+07 4.OOE+04 0.OOE+00 7.96E+02 0.OOE+00 1-130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 0.OOE+00 5.11E+03 0.OOE+00 1-131 4.81EE+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 O.OOE+00 2.84E+03 O.OOE+00 TE-131m 1.34E+02 5.92E+01 5.07E+01 9.77E+01 4.OOE+02 2.06E+05 3.08E+05 0.OOE+00 TE-131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 2.05E+03 1.33E+03 0.OOE+00 1-132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 O.OOE+00 3.20E+03 0.OOE+00 TE-132 4.81E+02 2.72E+02 2.63E+02 3.18E+02 1.77E+03 3.77E+05 1.38E+05 0.OOE+00 1-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 0.00E+00 5.48E+03 0.OOE+00 CS-134m 2.34E+02 3.30E+02 2.26E+02 0.OOE+00 1.83E+02 3.09E+01 2.93E+02 0.00E+00 CS-134 6.51E+05 1.01E+06 2.25E+05 0.OOE+00 3.30E+05 1.21E+05 3.85E+03 0.00E+00 1-134 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 0.OOE+00 9.55E+02 0.OOE+00 1-135 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 0.OOE+00 4.44E+03 0.OOE+00 CS-135 2.31E+05 1.53E+05 1.65E+04 0,00E+00 5.66E+04 1,93E+04 8.03E+02 0,OOE+00 CS-136 6.51E+04 1.71E+05 1.16E+05 0.OOE+00 9.55E+04 1.45E+04 4.18E+03 0.OOE+00 CS-137 9.07E+05 8.25E+05 1.28E+05 O.OOE+00 2.82E+05 1.04E+05 3.62E+03 0.00E+00 CS-138 6.33E+02 8.40E+02 5.55E+02 0.OOE+00 6.22E+02 6.81EE+01 2.70E+02 0.OOE+00 CS-139 4.03E+02 4.26E+02 2.15E+02 0.00E+00 3.36E+02 3.46E+01 2.68E-02 O.OOE+00 BA-1 39 1.84E+00 9.84E-04 5.37E-02 0.00E+00 8.62E-04 5.77E+03 5.77E+04 0.OOE+00 BA-140 7.40E+04 6.48E+01 4.33E+03 0.00E+00 2.11EE+01 1.74E+06 1.02E+05 0.OOE+00 LA-140 6.44E+02 2.25E+02 7.55E+01 0.OOE+00 0.OOE+00 1.83E+05 2.26E+05 0.OOE+00 BA-141 1.96E-01 1.09E-04 6.36E-03 0.OOE+00 9.47E-05 2.92E+03 2.75E+02 0.OOE+00 LA-141 8.47E+00 1.96E+00 4.26E-01 0.OOE+00 0.OOE+00 1.66E+04 1.62E+05 O.OOE+00 CE-141 3.92E+04 1.95E+04 2.90E+03 0.OOE+00 8.55E+03 5.44E+05 5.66E+04 0.OOE+00 BA-142 5.OOE-02 3.60E-05 2.79E-03 0.OOE+00 2.91E-05 1.64E+03 2.74E+00 0.OOE+00 LA-142 1.30E+00 4.11E-01 1.29E-01 0.00E+00 0.00E+00 8.70E+03 7.59E+04 0.00E+00 CE-143 3.66E+02 1.99E+02 2.88E+01 0.OOE+00 8.36E+01 1.15E+05 1.27E+05 0.OOE+00 PR-143 1.85E+04 5.55E+03 9.14E+02 0.OOE+00 3.OOE+03 4.33E+05 9.73E+04 0.OOE+00 CE-144 6.77E+06 2.12E+06 3.62E+05 0.OOE+00 1.17E+06 1.20E+07 3.89E+05 0.OOE+00 PR-144 5.96E-02 1.85E-02 3.OOE-03 0.OOE+00 9.77E-03 1.57E+03 1.97E+02 0.OOE+00 ND-147 1.08E+04 8.73E+03 6.81E+02 0.OOE+00 4.81E+03 3.28E+05 8.21E+04 0.OOE+00 PM-147 1.30E+06 9.32E+04 5.03E+04 O.OOE+00 1.65E+05 8.14E+05 2.11E+04 0.OOE+00 PM-148m 1.22E+05 2.42E+04 2.42E+04 0.00E+00 3.60E+04 2.12E+06 1.32E+05 0.OOE+00 PM-148 5.96E+03 7.18E+02 4.63E+02 0.OOE+00 1.22E+03 4.59E+05 2.22E+05 0.OOE+00 PM-149 5.44E+02 5.77E+01 3.13E+01 0.OOE+00 1.02E+02 8.88E+04 1.08E+05 0.OOE+00 PM-151 1.32E+02 1.60E+01 1.04E+01 0.00E+00 2.72E+01 4.59E+04 9.55E+04 0.OOE+00 SM-151 1.16E+06 1.76E+05 5.51E+04 0.00E+00 1.81E+05 5.48E+05 1.27E+04 0.00E+00 11.4-133 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-25 (Page 4 of 4) Child Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 2.68E+02 1.67E+02 1.61EE+01 0.OOE+00 5.07E+01 5.07E+04 6.92E+04 0.OOE+00 EU-152 2.75E+06 5.07E+05 5.96E+05 0.OOE+00 2.12E+06 3.33E+06 4.22E+04 0.00E+00 EU-154 1.01E+07 9.21E+05 8.40E+05 0.OOE+00 4.03E+06 6.14E+06 1.10E+05 0.OOE+00 EU-155 2.07E+06 1.50E+05 1.18E+05 O.OOE+00 5.59E+05 1.03E+06 1.99E+05 0.OOE+00 EU-156 2.92E+04 1.57E+04 3.24E+03 0.OOE+00 1.01E+04 9.40E+05 1.57E+05 0.OOE+00 TB-160 2.88E+05 O.OOE+00 3.58E+04 0.OOE+00 8.58E+04 1.98E+06 8.44E+04 0.OOE+00 HO-166m 4.96E+06 1.04E+06 8.77E+05 0.OOE+00 1.48E+06 4.18E+06 6.03E+04 0.OOE+00 W-181 9.84E+01 2.41E+01 3.33E+00 0.OOE+00 0.OOE+00 2.11E+04 9.66E+02 0.OOE+00 W-185 3.07E+03 7.70E+02 1.08E+02 0.OOE+00 O.OOE+00 6.88E+05 4.11E+04 0.OOE+00 W-187 1.63E+01 9.66E+00 4.33E+00 0.OOE+00 0.OOE+00 4.11E+04 9.1OE+04 0.OOE+00 NP-239 4.66E+02 3.35E+01 2.35E+01 O.OOE+00 9.73E+01 5.81E+04 6.40E+04 0.00E+00 U-232 8.1OE+08 0.OOE+00 5.77E+07 0.OOE+00 6.18E+07 2.75E+09 1.60E+05 0.OOE+00 U-233 1.72E+08 0.OOE+00 1.04E+07 0.00E+00 2.82E+07 6.55E+08 1.48E+05 0.OOE+00 U-234 1.65E+08 0.O0E+00 1.02E+07 0.OOE+00 2.76E+07 6.44E+08 1.45E+05 0.OOE+00 U-235 1.58E+08 O.OOE+00 9.58E+06 0.OOE+00 2.59E+07 6.03E+08 1.84E+05 0.OOE+00 U-236 1.58E+08 0.OOE+00 9.81E+06 0.OOE+00 2.65E+07 6.18E+08 1.36E+05 0.OOE+00 U-237 5.81 E+02 0.OOE+00 1.54E+02 0.OOE+00 1.68E+03 1.26E+05 4.77E+04 0.OOE+00 U-238 1.51 E+08 0.OOE+00 8.95E+06 0.OOE+00 2.42E+07 5.66E+08 1.30E+05 0.OOE+00 NP-237 1.01E+10 5.99E+09 4.40E+08 0.OOE+00 2.74E+09 6.44E+08 1.87E+05 O.OOE+00 NP-238 4.66E+03 8.51 E+02 7.29E+01 O.OOE+00 3.02E+02 1.25E+05 9.25E+04 O.OOE+00 PU-238 9.44E+09 5.92E+09 4.48E+08 0.OOE+00 1.65E+09 2.25E+09 1.72E+05 0.OOE+00 PU-239 1.03E+10 6.22E+09 4.74E+08 0.00E+00 1.77E+09 2.12E+09 1.57E+05 0.OOE+00 PU-240 1.03E+10 6.22E+09 4.70E+08 0.OOE+00 1.76E+09 2.11E+09 1.60E+05 0.OOE+00 PU-241 2.94E+08 6.48E+07 1.08E+07 0.OOE+00 4.07E+07 1.87E+06 3.29E+03 0.OOE+00 PU-242 9.58E+09 5.99E+09 4.55E+08 0.OOE+00 1.70E+09 2.04E+09 1.54E+05 0.00E+00 PU-244 1.12E+10 6.85E+09 5.22E+08 0.OOE+00 1.95E+09 2.33E+09 2.29E+05 0.OOE+00 AM-241 1.10E+10 6.81E+09 4.59E+08 0.OOE+00 2.82E+09 7.47E+08 1.75E+05 0.OOE+00 AM-242m 1.14E+10 6.51E+09 4.70E+08 0.OOE+00 2.85E+09 3.01E+08 2.21E+05 0.00E+00 AM-243 1.09E+10 6.59E+09 4.44E+08 0.OOE+00 2.75E+09 7.1OE+08 2.05E+05 0.OOE+00 CM-242 3.51E+08 2.10E+08 1.55E+07 0.OOE+00 4.96E+07 4.85E+08 1.87E+05 0.OOE+00 CM-243 8.58E+09 5.25E+09 3.68E+08 0.OOE+00 1.38E+09 7.77E+08 1.84E+05 0.OOE+00 CM-244 7.18E+09 4.37E+09 3.07E+08 0.OOE+00 1.13E+09 7.47E+08 1.78E+05 0.OOE+00 CM-245 1.13E+10 6.81E+09 4.74E+08 0.OOE+00 1.86E+09 7.22E+08 1.66E+05 0.OOE+00 CM-246 1.12E+10 6.81EE+09 4.74E+08 0.OOE+00 1.86E+09 7.36E+08 1.63E+05 0.OOE+00 CM-247 1.09E+10 6.73E+09 4.66E+08 0.OOE+00 1.83E+09 7.22E+08 2.15E+05 0.OOE+00 CM-248 9.07E+10 5.55E+10 3.85E+09 0.OOE+00 1.51E+10 5.96E+09 3.46E+06 0.OOE+00 CF-252 8.07E+09 0.OOE+00 3.45E+08 0.OOE+00 O.OE+00 2.45E+09 6.81 E+05 0.OOE+00 11.4-134 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-26 (Page 1 of 4) Teen Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Luncg GI-LLI Skin H-3 0.00E+00 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 0.OOE+00 C-14 2.60E+04 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 0.OOE+00 NA-22 1.41E+05 1.41E+05 1.41E+05 1.41E+05 1.41E+05 1.41E+05 1.41E+05 0.OOE+00 NA-24 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 0.OOE+00 P-32 1.89E+06 1.10E+05 7.16E+04 0.OOE+00 O.OOE+00 0.OOE+00 9.28E+04 0.OOE+00 CA-41 3.24E+05 O.OOE+00 3.50E+04 0.OOE+00 1.08E+06 8.08E+08 2.38E+05 0.OOE+00 SC-46 5.79E+05 1.13E+06 3.34E+05 7.50E+01 3.07E+01 2.1OE+04 3.OOE+03 0.00E+00 CR-51 0.OOE+00 O.OOE+00 1.35E+02 7.50E+01 3.07E+01 2.1OE+04 3.OOE+03 0.OOE+00 MN-54 0.OOE+00 5.11 E+04 8.40E+03 0.OOE+00 1.27E+04 1.98E+06 6.68E+04 0.OOE+00 FE-55 3.34E+04 2.38E+04 5.54E+03 0.00E+00 0.OOE+00 1.24E+05 6.39E+03 0.OOE+00 MN-56 0.OOE+00 1.70E+00 2.52E-01 0.OOE+00 1.79E+00 1.52E+04 5.74E+04 0.OOE+00 CO-57 0.OOE+00 9.44E+02 9.20E+02 0.OOE+00 0.OOE+00 5.86E+05 3.14E+04 0.OOE+00 CO-58 O.OOE+00 2.07E+03 2.78E+03 0.OOE+00 0.OOE+00 1.34E+06 9.52E+04 O.OOE+00 FE-59 1.59E+04 3.70E+04 1.43E+04 0.OOE+00 O.OOE+00 1.53E+06 1.78E+05 O.OOE+00 CO-60 0.OOE+00 1.51 E+04 1.98E+04 0.OOE+00 0.OOE+00 8.72E+06 2.59E+05 O.OOE+00 NI-59 4.35E+04 1.62E+04 7.39E+03 0.OOE+00 0.OOE+00 1.13E+05 5.18E+03 O.OOE+00 NI-63 5.80E+05 4.34E+04 1.98E+04 0.OOE+00 0.00E+00 3.07E+05 1.42E+04 0.OOE+00 CU-64 0.OOE+00 2.03E+00 8.48E-01 0.OOE+00 6.41E+00 1.11E+04 6.14E+04 O.OOE+00 NI-65 2.18E+00 2.93E-01 1.27E-01 0.OOE+00 0.OOE+00 9.36E+03 3.67E+04 O.OOE+00 ZN-65 3.86E+04 1.34E+05 6.24E+04 0.00E+00 8.64E+04 1.24E+06 4.66E+04 0.OOE+00 ZN-69m 1.15E+01 2.47E+01 2.49E+00 0.OOE+00 1.65E+01 3.14E+04 1.71E+05 0.OOE+00 ZN-69 4.83E-02 9.20E-02 6.46E-03 0.00E+00 6.02E-02 1.58E+03 2.85E+02 0.OOE+00 SE-79 0.OOE+00 4.34E+03 6.97E+02 0.OOE+00 6.50E+03 6.17E+05 2.82E+04 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.82E+04 0.00E+00 0.OOE+00 O.OOE+00 8.OOE-15 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 3.44E+02 0.00E+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 4.33E+02 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.00E+00 1.83E+01 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 RB-86 0.OOE+00 1.90E+05 8.40E+04 0.OOE+00 0.00E+00 0.OOE+00 1.77E+04 0.O0E+0O RB-87 0.OOE+00 1.12E+05 3.66E+04 0.OOE+00 0.OOE+00 0.00E+00 2.44E+03 0.00E+00 RB-88 0.OOE+00 5.46E+02 2.72E+02 0.OOE+00 0.00E+00 0.OOE+00 2.92E-05 0.OOE+00 RB-89 0.OOE+00 3.52E+02 2.33E+02 0.OOE+00 0.OOE+00 0.00E+00 3.38E-07 0.OOE+00 SR-89 4.34E+05 0.OOE+00 1.25E+04 0.OOE+00 0.OOE+00 2.42E+06 3.71E+05 0.OOE+00 SR-90 1.08E+08 0.OOE+00 6.68E+06 0.OOE+00 0.OOE+00 1.65E+07 7.65E+05 0.00E+00 Y-90 2.98E+03 0.OOE+00 8.OOE+01 0.OOE+00 0.OOE+00 2.93E+05 5.59E+05 0.OOE+00 SR-91 8.80E+01 0.OOE+00 3.51E+00 0.OOE+00 0.OOE+00 6.07E+04 2.59E+05 0.OOE+00 Y-91 m 3.70E-01 0.OOE+00 1.42E-02 0.OOE+00 O.OOE+00 3.20E+03 3.02E+01 0.OOE+00 Y-91 6.61E+05 0.OOE+00 1.77E+04 0.OOE+00 0.OOE+00 2.94E+06 4.09E+05 0.OOE+00 11.4-135 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-26 (Page 2 of 4) Teen Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 9.52E+00 0.OOE+00 4.06E-01 0.OOE+00 0.00E+00 2.74E+04 1.19E+05 0.00E+00 Y-92 1.47E+01 0.00E+00 4.29E-01 0.OOE+00 0.OOE+00 2.68E+04 1.65E+05 0.00E+00 Y-93 1.35E+02 0.OOE+00 3.72E+00 0.OOE+00 0.OOE+00 8.32E+04 5.79E+05 0.00E+00 NB-93m 3.31 E+05 1.09E+05 2.73E+04 0.OOE+00 1.27E+05 4.29E+05 2.02E+04 O.OOE+00 NB-95 1.86E+04 1.03E+04 5.66E+03 0.00E+00 1.00E+04 7.51 E+05 9.68E+04 0.OOE+00 NB-97 3.14E-01 7.78E-02 2.84E-02 0.00E+00 9.12E-02 3.93E+03 2.17E+03 0.OOE+00 ZR-93 5.46E+05 2.70E+05 1.47E+05 0.00E+00 9.28E+05 2.94E+06 1.28E+05 O.00E+00 ZR-95 1.46E+05 4.58E+04 3.15E+04 0.OOE+00 6.74E+04 2.69E+06 1.49E+05 0.00E+00 ZR-97 1.38E+02 2.72E+01 1.26E+01 0.OOE+00 4.12E+01 1.30E+05 6.30E+05 0.00E+00 MO-93 0.00E+00 1.33E+04 3.62E+02 0.00E+00 4.05E+03 7.05E+05 3.19E+04 0.00E+00 MO-99 0.00E+00 1.69E+02 3.22E+01 0.OOE+00 4.11EE+02 1.54E+05 2.69E+05 0.00E+00 TC-99 3.58E+02 5.26E+02 1.43E+02 0.OOE+00 6.68E+03 1.39E+06 6.39E+04 0.OOE+00 TC-99m 1.38E-03 3.86E-03 4.99E-02 0.00E+00 5.76E-02 1.15E+03 6.13E+03 0.OOE+00 TC-101 5.92E-05 8.40E-05 8.24E-04 0.00E+00 1.52E-03 6.67E+02 8.72E-07 0.OOE+00 RU-1 03 2.10E+03 0.OOE+00 8.96E+02 0.00E+00 7.43E+03 7.83E+05 1.09E+05 0.00E+00 RU-105 1.12E+00 0.OOE+00 4.34E-01 0.OOE+00 1.41E+00 1.82E+04 9.04E+04 0.00E+00 RU-1 06 9.84E+04 0.OOE+00 1.24E+04 0.OOE+00 1.90E+05 1.61 E+07 9.60E+05 0.OOE+00 RH-1 05 1.06E+01 7.58E+00 4.99E+00 0.00E+00 3.23E+01 3.27E+04 9.84E+04 0.00E+00 PD-107 0.00E+00 9.36E+02 6.71E+01 0.OOE+00 7.51EE+03 1.30E+05 5.99E+03 0.00E+00 PD-1 09 0.00E+00 5.25E+00 1.33E+00 0.00E+00 2.69E+01 2.55E+04 1.57E+05 0.00E+00 AG- 1O1m 1.38E+04 1.31 E+04 7.99E+03 0.00E+00 2.50E+04 6.75E+06 2.73E+05 0.00E+00 AG-1 11 4.86E+02 2.02E+02 1.02E+02 0.OOE+00 6.54E+02 3.20E+05 2.40E+05 0.OOE+00 CD-113m 0.OOE+00 1.74E+06 5.68E+04 0.OOE+00 1.94E+06 2.87E+06 1.34E+05 0.OOE+00 CD-115m 0.OOE+00 2.78E+05 9.12E+03 0.00E+00 2.26E+05 2.42E+06 4.08E+05 0.OOE+00 SN-123 3.45E+05 7.55E+03 1.12E+04 6.04E+03 0.00E+00 3.97E+05 3.33E+05 0.OOE+00 SN-125 1.33E+04 3.54E+02 7.99E+02 2.76E+02 0.OOE+00 1.01E+06 5.83E+05 0.OOE+00 SN-i26 1.74E+06 4.31E+04 6.59E+04 1.14E+04 0.OOE+00 1.38E+07 1.34E+05 0.OOE+00 SB-124 4.30E+04 7.94E+02 1.68E+04 9.76E+01 0.OOE+00 3.85E+06 3.98E+05 0.OOE+00 SB- 25 7.38E+04 8.08E+02 1.72E+04 7.04E+01 0.OOE+00 2.74E+06 9.92E+04 0.OOE+00 SB-i26 4.95E+03 1.02E+02 1.78E+03 2.80E+01 0.OOE+00 1.24E+06 4.81E+05 0.OOE+00 SB-127 3.71iE+02 7.94E+00 1.40E+02 4.17E+00 0.OOE+00 2.65E+05 3.15E+05 0.OOE+00 TE-125m 4.88E+03 2.24E+03 6.67E+02 1.40E+03 0.OOE+00 5.36E+05 7.50E+04 0.OOE+00 TE-127m 1.80E+04 8.16E+03 2.18E+03 4.38E+03 6.54E+04 1.66E+06 1.59E+05 0.OOE+00 TE-127 2.01E+00 9.12E-01 4.42E-01 1.42E+00 7.28E+00 1.12E+04 8.08E+04 0.OOE+00 TE-129m 1.39E+04 6.58E+03 2.25E+03 4.58E+03 5.19E+04 1.98E+06 4.05E+05 0.OOE+00 TE-129 7.1OE-02 3.38E-02 1.76E-02 5.18E-02 2.66E-01 3.30E+03 1.62E+03 0.OOE+00 TE-133m 8.08E-02 5.86E-02 4.57E-02 6.54E-02 2.46E-01 6.97E+03 9.84E+02 0.OOE+00 11.4-136 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-26 (Page 3 of 4) Teen Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 4.25E-02 3.48E-02 2.91E-02 3.57E-02 2.33E-01 5.38E+03 1.10E+01 O.OOE+00 1-129 2.82E+04 2.35E+04 7.12E+04 2.93E+07 4.21E+04 0.OOE+00 1.83E+03 0.OOE+00 1-130 6.24E+03 1.79E+04 7.17E+03 1.49E+06 2.75E+04 0.OOE+00 9.12E+03 0.OOE+00 1-131 3.54E+04 4.91 E+04 2.64E+04 1.46E+07 8.40E+04 O.OOE+00 6.49E+03 0.OOE+00 TE-131m 9.84E+01 6.01E+01 4.02E+01 7.25E+01 4.39E+02 2.38E+05 6.21EE+05 0.OOE+00 TE-131 1.58E-02 8.32E-03 5.04E-03 1.24E-02 6.18E-02 2.34E+03 1.51E+01 0.OOE+00 1-132 1.59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 0.OOE+00 1.27E+03 0.OOE+00 TE-132 3.60E+02 2.90E+02 2.19E+02 2.46E+02 1.95E+03 4.49E+05 4.63E+05 0.OOE+00 1-133 1.22E+04 2.05E+04 6.22E+03 2.92E+06 3.59E+04 0.OOE+00 1.03E+04 0.OOE+00 CS-134m 1.76E+02 3.48E+02 1.88E+02 0.00E+00 2.03E+02 3.65E+01 1.62E+02 0.OOE+00 CS-134 5.02E+05 1.13E+06 5.49E+05 0.OOE+00 3.75E+05 1.46E+05 9.76E+03 0.OOE+00 1-134 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 0.OOE+00 2.04E+01 0.OOE+00 1-135 3.70E+03 9.44E+03 3.49E+03 6.21E+05 1.49E+04 0.OOE+00 6.95E+03 0.OOE+00 CS-135 1.66E+05 1.46E+05 3.58E+04 0.OOE+00 5.84E+04 2.16E+04 1.78E+03 0.OOE+00 CS-136 5.15E+04 1.94E+05 1.37E+05 0.OOE+00 1.10E+05 1.78E+04 1.09E+04 0.O0E+00 CS-137 6.70E+05 8.48E+05 3.11E+05 0.OOE+00 3.04E+05 1.21E+05 8.48E+03 0.OOE+00 CS-138 4.66E+02 8.56E+02 4.46E+02 0.OOE+00 6.62E+02 7.87E+01 2.70E-01 0.OOE+00 CS-139 2.92E+02 4.10E+02 1.58E+02 0.OOE+00 3.47E+02 3.89E+01 1.33E-13 0.O0E+00 BA-1 39 1.34E+00 9.44E-04 3.90E-02 0.OOE+00 8.88E-04 6.46E+03 6.45E+03 0.OOE+00 BA-140 5.47E+04 6.70E+01 3.52E+03 0.OOE+00 2.28E+01 2.03E+06 2.29E+05 0.OOE+00 LA-140 4.79E+02 2.36E+02 6.26E+01 0.OOE+00 0.OOE+00 2.14E+05 4.87E+05 0.OOE+00 BA-141 1.42E-01 1.06E-04 4.74E-03 0.OOE+00 9.84E-05 3.29E+03 7.46E-04 0.OOE+00 LA-141 6.1OE+00 1.88E+00 3.10E-01 0.OOE+00 0.OOE+00 1.85E+04 1.23E+05 0.OOE+00 CE-141 2.84E+04 1.90E+04 2.17E+03 0.OOE+00 8.88E+03 6.14E+05 1.26E+05 0.OOE+00 BA-142 3.70E-02 3.70E-05 2.27E-03 0.OOE+00 3.14E-05 1.91EE+03 4.79E-10 0.OOE+00 LA-142 9.60E-01 4.25E-01 1.06E-01 0.OOE+00 OOOE+00 1.02E+04 1.20E+04 0.00E+00 CE-143 2.66E+02 1.94E+02 2.16E+01 0.OOE+00 8.64E+01 1.30E+05 2.55E+05 0.OOE+00 PR-143 1.34E+04 5.31E+03 6.62E+02 0.OOE+00 3.09E+03 4.83E+05 2.14E+05 0.OOE+00 CE-144 4.89E+06 2.02E+06 2.62E+05 0.OOE+00 1.21E+06 1.34E+07 8.64E+05 0.OOE+00 PR-144 4.30E-02 1.76E-02 2.18E-03 O.OOE+00 1.01E-02 1.75E+03 2.35E-04 0.OOE+00 ND-147 7.86E+03 8.56E+03 5.13E+02 0.OOE+00 5.02E+03 3.72E+05 1.82E+05 0.OOE+00 PM-147 9.20E+05 8.80E+04 3.60E+04 O.OOE+00 1.68E+05 9.12E+05 4.70E+04 O.00E+00 PM-148m 1.06E+05 2.68E+04 2.1OE+04 O.OOE+00 4.06E+04 2.56E+06 3.28E+05 O.OOE+00 PM-148 4.35E+03 7.1OE+02 3.58E+02 O.00E+00 1.28E+03 5.22E+05 4.91EE+05 O.OOE+00 PM-149 3.93E+02 5.51E+01 2.27E+01 O.OOE+00 1.05E+02 9.92E+04 2.23E+05 O.OOE+00 PM-151 9.60E+01 1.59E+01 8.08E+00 O.OOE+00 2.86E+01 4.52E+04 1.82E+05 O.OOE+00 SM-151 8.56E+05 1.68E+05 3.89E+04 O.OOE+00 1.82E+05 6.14E+05 2.82E+04 O.OOE+00 11.4-137 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-26 (Page 4 of 4) Teen Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.94E+02 1.61E+02 1.18E+01 0.OOE+00 5.25E+01 5.69E+04 1.42E+05 0.OOE+00 EU-152 2.37E+06 5.75E+05 5.04E+05 0.00E+00 2.67E+06 4.01 E+06 1.08E+05 0.00E+00 EU-154 7.54E+06 9.84E+05 6.88E+05 0.OOE+00 4.35E+06 7.30E+06 2.67E+05 0.OOE+00 EU-155 1.60E+06 1.57E+05 9.68E+04 0.OOE+00 6.12E+05 1.21E+07 4.78E+05 0.OOE+00 EU-156 2.16E+04 1.62E+04 2.64E+03 0.00E+00 1.09E+04 1.10E+06 3.65E+05 0.OOE+00 TB-160 2.43E+05 0.OOE+00 3.03E+04 0.OOE+00 9.60E+04 3.18E+06 2.08E+05 0.OOE+00 HO-166m 3.52E+06 1.25E+06 7.90E+05 O.00E+00 1.60E+06 4.99E+06 1.34E+05 0.00E+00 W-181 7.12E+01 2.30E+01 2.41E+00 0.OOE+00 0.00E+00 2.36E+04 2.15E+03 0.OOE+00 W-185 2.22E+03 7.34E+02 7.78E+01 0.OOE+00 O.OOE+00 7.68E+05 9.12E+04 0.OOE+00 W-187 1.20E+01 9.76E+00 3.43E+00 0.OOE+00 0.OOE+00 4.74E+04 1.77E+05 0.OOE+00 NP-239 3.38E+02 3.19E+01 1.77E+01 O.OOE+00 1.00E+02 6.49E+04 1.32E+05 O.OOE+00 U-232 5.85E+08 O.OOE+00 4.18E+07 0.00E+00 6.35E+07 3.07E+09 3.57E+05 0.OOE+00 U-233 1.24E+08 0.00E+00 7.54E+06 0.OOE+00 2.90E+07 7.34E+08 3.30E+05 0.OOE+00 U-234 1.18E+08 0.00E+00 7.38E+06 0.OOE+00 2.84E+07 7.19E+08 3.23E+05 0.OOE+00 U-235 1.14E+08 0.OOE+00 6.94E+06 0.OOE+00 2.67E+07 6.75E+08 4.1OE+05 0.OOE+00 U-236 1.14E+08 0.00E+00 7.09E+06 0.00E+00 2.73E+07 6.90E+08 3.03E+05 0.OOE+00 U-237 4.20E+02 0.00E+00 1.12E+02 O.00E+00 1.73E+03 1.41E+05 1.03E+05 0.OOE+00 U-238 1.09E+08 0.OOE+00 6.48E+06 0.OOE+00 2.50E+07 6.31E+08 2.90E+05 0.00E+00 NP-237 1.31E+10 8.48E+09 5.77E+08 0.OOE+00 4.28E+09 7.19E+08 4.18E+05 0.00E+00 NP-238 3.38E+03 8.16E+02 5.27E+01 0.OOE+00 3.1OE+02 1.40E+05 1.90E+05 0.OOE+00 PU-238 1.20E+10 8.24E+09 5.78E+08 0.00E+00 2.48E+09 2.50E+09 3.83E+05 0.OOE+00 PU-239 1.38E+10 8.96E+09 6.44E+08 O.OOE+00 2.75E+09 2.34E+09 3.50E+05 0.OOE+00 PU-240 1.38E+10 8.96E+09 6.43E+08 0.OOE+00 2.74E+09 2.34E+09 3.57E+05 0.00E+00 PU-241 2.99E+08 7.65E+07 1.12E+07 O.OOE+00 5.18E+07 2.08E+06 7.34E+03 0.00E+00 PU-242 1.28E+10 8.64E+09 6.20E+08 O.OOE+00 2.65E+09 2.26E+09 3.43E+05 O.OOE+00 PU-244 1.50E+10 9.92E+09 7.1OE+08 0.OOE+00 3.03E+09 2.58E+09 5.11E+05 0.OOE+00 AM-241 1.42E+10 9.60E+09 5.68E+08 O.00E+00 4.26E+09 8.40E+08 3.90E+05 0.OOE+00 AM-242m 1.43E+10 9.04E+09 5.72E+08 0.OOE+00 4.24E+09 3.37E+08 4.91 E+05 0.OOE+00 AM-243 1.42E+10 9.36E+09 5.56E+08 0.OOE+00 4.17E+09 7.93E+08 4.58E+05 0.OOE+00 CM-242 2.54E+08 2.01E+08 1.13E+07 0.OOE+00 5.12E+07 5.41E+08 4.17E+05 0.OOE+00 CM-243 9.52E+09 6.64E+09 4.OOE+08 0.00E+00 1.87E+09 8.72E+08 4.10E+05 0.OOE+00 CM-244 7.35E+09 5.22E+09 3.10E+08 0.OOE+00 1.45E+09 8.40E+08 3.97E+05 0.OOE+00 CM-245 1.46E+10 9.76E+09 6.02E+08 0.OOE+00 2.82E+09 8.08E+08 3.70E+05 0.OOE+00 CM-246 1.45E+10 9.76E+09 6.02E+08 0.00E+00 2.81E+09 8.24E+08 3.63E+05 O.00E+00 CM-247 1.42E+10 9.52E+09 5.93E+08 O.OOE+00 2.77E+09 8.08E+08 4.78E+05 0.OOE+00 CM-248 1.18E+11 7.86E+10 4.89E+09 0.OOE+00 2.28E+10 6.66E+09 7.70E+06 0.00E+00 CF-252 5.73E+09 0.OOE+00 2.46E+08 O.OOE+00 0.00E+00 2.74E+09 1.51E+06 0.OOE+00 11.4-138 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-27 (Page 1 of 4) Adult Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 O.OOE+00 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 O.OOE+00 C-14 1.82E+04 3.41E+03 3.41E+03 3.41E+03 3.41E+03 3.41EE+03 3.41E+03 0.OOE+00 NA-22 1.04E+05 1.04E+05 1.04E+05 1.04E+05 1.04E+05 1.04E+05 1.04E+05 0.OOE+00 NA-24 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 0.OOE+00 P-32 1.32E+06 7.71E+04 5.01EE+04 0.OOE+00 0.OOE+00 0.OOE+00 8.64E+04 0.OOE+00 CA-41 3.06E+05 0.OOE+00 3.30E+04 O.OOE+00 0.OOE+00 3.06E+04 2.29E+03 0.OOE+00 SC-46 4.41E+05 8.56E+05 2.49E+05 0.OOE+00 7.99E+05 0.OOE+00 2.58E+05 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 1.OOE+02 5.95E+01 2.28E+01 1.44E+04 3.32E+03 0.OOE+00 MN-54 0.OOE+00 3.96E+04 6.30E+03 O.OOE+00 9.84E+03 1.40E+06 7.74E+04 0.OOE+00 FE-55 2.46E+04 1.70E+04 3.94E+03 0.OOE+00 0.OOE+00 7.21E+04 6.03E+03 0.OOE+00 MN-56 0.OOE+00 1.24E+00 1.83E-01 0.OOE+00 1.30E+00 9.44E+03 2.02E+04 0.OOE+00 CO-57 0.OOE+00 6.92E+02 6.71E+02 0.OOE+00 0.OOE+00 3.70E+05 3.14E+04 0.OOE+00 CO-58 0.OOE+00 1.58E+03 2.07E+03 0.OOE+00 0.OOE+00 9.28E+05 1.06E+05 0.OOE+00 FE-59 1.18E+04 2.78E+04 1.06E+04 0.OOE+00 0.OOE+00 1.02E+06 1.88E+05 0.OOE+00 CO-60 0.OOE+00 1.15E+04 1.48E+04 0.OOE+00 0.OOE+00 5.97E+06 2.85E+05 0.OOE+00 NI-59 3.25E+04 1.17E+04 5.42E+03 0.OOE+00 0.OOE+00 6.56E+04 4.89E+03 0.OOE+00 NI-63 4.32E+05 3.14E+04 1.45E+04 0.OOE+00 0.OOE+00 1.78E+05 1.34E+04 0.OOE+00 CU-64 0.OOE+00 1.46E+00 6.15E-01 O.OOE+00 4.62E+00 6.78E+03 4.90E+04 O.OOE+00 NI-65 1.54E+00 2.1OE-01 9.12E-02 0.OOE+00 0.OOE+00 5.60E+03 1.23E+04 0.OOE+00 ZN-65 3.24E+04 1.03E+05 4.66E+04 0.OOE+00 6.90E+04 8.64E+05 5.34E+04 0.OOE+00 ZN-69m 8.16E+00 1.96E+01 1.79E+00 0.OOE+00 1.18E+01 1.90E+04 1.37E+05 0.OOE+00 ZN-69 3.38E-02 6.51 E-02 4.52E-03 0.OOE+00 4.22E-02 9.20E+02 1.63E+01 0.OOE+00 SE-79 0.OOE+00 3.06E+03 4.87E+02 0.OOE+00 4.55E+03 3.58E+05 2.66E+04 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.35E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.04E+04 0.OOE+00 BR-83 0.OOE+00 0.O0E+00 2.41 E+02 O.OOE+00 0.OOE+00 0.OOE+00 2.32E+02 O.OOE+00 BR-84 0.OOE+00 0.OOE+00 3.13E+02 0.00E+00 0.OOE+00 0.OOE+00 1.64E-03 0.OOE+00 BR-85 0.OOE+00 O.OOE+00 1.28E+01 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 RB-86 0.00E+00 1.35E+05 5.90E+04 0.OOE+00 O.OOE+00 0.OOE+00 1.66E+04 0.OOE+00 RB-87 0.OOE+00 3.87E+02 2.57E+04 0.OOE+00 0.OOE+00 0.OOE+00 2.30E+03 0.OOE+00 RB-88 O.OOE+00 3.87E+02 1.93E+02 0.OOE+00 0.OOE+00 O.OOE+00 3.34E-09 0.OOE+00 RB-89 0.OOE+00 2.56E+02 1.70E+02 0.OOE+00 0.OOE+00 0.OOE+00 9.28E-12 0.OOE+00 SR-89 3.04E+05 0.OOE+00 8.72E+03 0.OOE+00 0.00E+00 1.40E+06 3.50E+05 O.OOE+00 SR-90 9.92E+07 0.OOE+00 6.1OE+06 0.OOE+00 0.OOE+00 9.60E+06 7.22E+05 0.OOE+00 Y-90 2.09E+03 O.OOE+00 5.61 E+01 0.OOE+00 0.00E+00 1.70E+05 5.06E+05 O.OOE+00 SR-91 6.19E+01 0.OOE+00 2.50E+00 0.OOE+00 0.OOE+00 3.65E+04 1.91E+05 0.OOE+00 Y-91m 2.61E-01 0.OOE+00 1.02E-02 O.OOE+00 0.OOE+00 1.92E+03 1.33E+00 O.OOE+00 Y-91 4.62E+05 0.OOE+00 1.24E+04 0.OOE+00 0.OOE+00 1.70E+06 3.85E+05 0.OOE+00 11.4-139 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-27 (Page 2 of 4) Adult Inhalation Pi mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 6.74E+00 0.00E+00 2.91E-01 0.OOE+00 0.OOE+00 1.65E+04 4.30E+04 0.OOE+00 Y-92 1.03E+01 0.00E+00 3.02E-01 0.00E+00 0.00E+00 1.57E+04 7.35E+04 0.00E+00 Y-93 9.44E+01 0.00E+00 2.61 E+00 0.OOE+00 0.00E+00 4.85E+04 4.22E+05 0.00E+00 NB-93m 2.48E+05 8.08E+04 1.99E+04 0.OOE+00 9.28E+04 2.49E+05 1.90E+04 0.00E+00 NB-95 1.41E+04 7.82E+03 4.21E+03 0.OOE+00 7.74E+03 5.05E+05 1.04E+05 O.00E+00 NB-97 2.22E-01 5.62E-02 2.05E-02 0.00E+00 6.54E-02 2.40E+03 2.42E+02 0.00E+00 ZR-93 4.18E+05 2.34E+04 1.10E+04 0.00E+00 8.88E+04 1.70E+05 1.21E+04 0.00E+00 ZR-95 1.07E+05 3.44E+04 2.33E+04 0.OOE+00 5.42E+04 1.77E+06 1.50E+05 0.00E+00 ZR-97 9.68E+01 1.96E+01 9.04E+00 0.OOE+00 2.97E+01 7.87E+04 5.23E+05 0.00E+00 MO-93 0.00E+00 9.36E+03 2.54E+02 0.OOE+00 2.84E+03 4.09E+05 3.03E+04 0.00E+00 MO-99 0.00E+00 1.21E+02 2.30E+01 0.OOE+00 2.91E+02 9.12E+04 2.48E+05 0.00E+00 TC-99 2.50E+02 3.71 E+02 11.00E+02 0.00E+00 4.68E+03 8.08E+05 6.03E+04 0.00E+00 TC-99m 1.03E-03 2.91E-03 3.70E-02 O.00E+00 4.42E-02 7.64E+02 4.16E+03 0.OOE+00 TC-101 4.18E-05 6.02E-05 5.90E-04 0.00E+00 1.08E-03 3.99E+02 1.09E-11 0.OOE+00 RU-1 03 1.53E+03 0.OOE+00 6.58E+02 0.00E+00 5.83E+03 5.05E+05 1.10E+05 0.OOE+00 RU-105 7.90E-01 0.OOE+00 3.11E-01 0.OOE+00 1.02E+00 1.10E+04 4.82E+04 0.00E+00 RU-106 6.91E+04 0.00E+00 8.72E+03 0.OOE+00 1.34E+05 9.36E+06 9.12E+05 0.00E+00 RH-1 05 7.39E+00 5.38E+00 3.54E+00 0.OOE+00 2.29E+01 1.93E+04 8.72E+04 0.OOE+00 PD-107 0.OOE+00 6.62E+02 4.70E+01 0.OOE+00 5.26E+03 7.58E+04 5.65E+03 0.OOE+00 PD-1 09 0.OOE+00 3.70E+00 9.28E-01 0.OOE+00 1.88E+01 1.48E+04 1.22E+05 0.OOE+00 AG-11im 1.08E+04 1.OOE+04 5.94E+03 0.OOE+00 1.97E+04 4.63E+06 3.02E+05 0.00E+00 AG-111 3.40E+02 1.42E+02 7.10E+01 0.OOE+00 4.59E+02 1.86E+05 2.23E+05 0.OOE+00 CD-i 13m 0.OOE+00 1.23E+06 3.98E+04 0.OOE+00 1.37E+06 1.66E+06 1.27E+05 0.OOE+00 CD-115m 0.OOE+00 1.97E+05 6.36E+03 0.OOE+00 1.58E+05 1.41E+06 3.84E+05 0.00E+00 SN-123 2.42E+05 5.34E+03 7.86E+03 4.54E+03 0.OOE+00 2.30E+06 3.14E+05 0.OOE+00 SN-125 9.28E+03 2.50E+02 5.62E+02 2.07E+02 0.OOE+00 5.90E+05 5.45E+05 0.OOE+00 SN-126 1.26E+06 3.34E+04 4.80E+04 9.84E+03 0.OOE+00 9.36E+06 1.27E+05 0.OOE+00 SB-124 3.12E+04 5.89E+02 1.22E+04 7.55E+01 0.OOE+00 2.48E+06 4.06E+05 0.00E+00 SB-125 5.34E+04 5.95E+02 1.26E+04 5.40E+01 0.OOE+00 1.74E+06 1.01E+05 0.OOE+00 SB-126 3.60E+03 7.30E+01 1.30E+03 2.20E+01 0.OOE+00 7.66E+05 4.81E+05 0.OOE+00 SB-127 2.64E+02 5.78E+00 1.02E+02 3.18E+00 0.OOE+00 1.64E+05 3.02E+05 0.00E+00 TE-125m 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+04 3.14E+05 7.06E+04 0.OOE+00 TE-127m 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E+04 9.60E+05 1.50E+05 0.OOE+00 TE-127 1.40E+00 6.42E-01 3.1OE-01 1.06E+00 5.1OE+00 6.51E+03 5.74E+04 0.OOE+00 TE-129m 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83E+05 0.00E+00 TE-129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E+03 1.57E+02 0.OOE+00 TE-133m 5.79E-02 4.32E-02 3.34E-02 5.02E-02 2.99E-01 4.41E+03 4.39E+02 0.OOE+00 11.4-140 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-27 (Page 3 of 4) Adult Inhalation Pi mrem*m3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 3.07E-02 2.58E-02 1.26E-02 2.75E-02 1.74E-01 3.47E+03 2.38E-01 0.OOE+00 1-129 1.98E+04 1.69E+04 5.53E+04 4.43E+07 3.62E+04 0.00E+00 1.78E+03 0.OOE+00 1-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 0.00E+00 7.69E+03 0.00E+00 1-131 2.52E+04 3.58E+04 2.05E+04 1.19E+07 6.13E+04 0.00E+00 6.28E+03 0.00E+00 TE-131m 6.99E1+01 4.36E+01 2.90E+01 5.50E+01 3.09E+02 1.46E+05 5.56E+05 0.OOE+00 TE-131 1.11E-02 5.95E-03 3.59E-03 9.36E-03 4.37E-02 1.39E+03 1.84E+01 0.OOE+00 1-132 1.16E+03 3.26E+03 1.16E+03 1.14E+05 5.18E+03 0.OOE+00 4.06E+02 O.00E+00 TE-132 2.60E+02 2.15E+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 5.10E+05 0.00E+00 1-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 O.OOE+00 8.88E+03 0.00E+00 CS-134m 1.27E+02 2.56E+02 1.38E+02 0.OOE+00 1.46E+02 2.34E+01 6.34E+01 0.OOE+00 CS-134 3.73E+05 8.48E+05 7.28E+05 0.OOE+00 2.87E+05 9.76E+04 1.04E+04 O.OOE+00 1-134 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 0.OOE+00 1.01E+00 0.OOE+00 1-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.11E+04 0.OOE+00 5.25E+03 0.OOE+00 CS-135 1.17E+05 1.03E+05 4.79E+04 0.OOE+00 4.09E+04 1.26E+04 1.69E+03 0.OOE+00 CS-136 3.90E+04 1.46E+05 1.10E+05 0.OOE+00 8.56E+04 1.20E+04 1.17E+04 0.OOE+00 CS-137 4.78E+05 6.21 E+05 4.28E+05 0.OOE+00 2.22E+05 7.52E+04 8.40E+03 0.OOE+00 CS-138 3.31E+02 6.21E+02 3.24E+02 0.00E+00 4.80E+02 4.86E+01 1.86E-03 O.OOE+00 CS-139 2.05E+02 2.90E+02 1.11E+02 0.OOE+00 2.44E+02 2.27E+01 4.39E-21 0.OOE+00 BA-1 39 9.36E-01 6.66E-04 2.74E-02 0.OOE+00 6.22E-04 3.76E+03 8.96E+02 0.OOE+00 BA-140 3.90E+04 4.90E+01 2.57E+03 0.00E+00 1.67E+01 1.27E+06 2.18E+05 0.OOE+00 LA-140 3.44E+02 1.74E+02 4.58E+01 0.OOE+00 0.OOE+00 1.36E+05 4.58E+05 0.00E+00 BA-141 1.O0E-01 7.53E-05 3.36E-03 0.OOE+00 7.OOE-05 1.94E+03 1.16E-07 0.OOE+00 LA-141 4.27E+00 1.33E+00 2.17E-01 0.OOE+00 0.OOE+00 1.08E+04 5.85E+04 0.OOE+00 CE-141 1.99E+04 1.35E+04 1.53E+03 0.OOE+00 6.26E+03 3.62E+05 1.20E+05 0.OOE+00 BA-142 2.63E-02 2.70E-05 1.66E-03 O.OOE+00 2.29E-05 1.19E+03 1.57E-16 0.OOE+00 LA-142 6.83E-01 3.10E-01 7.72E-02 0.OOE+00 0.OOE+00 6.33E+03 2.11E+03 0.OOE+00 CE-143 1.86E+02 1.38E+02 1.53E+01 0.OOE+00 6.08E+01 7.98E+04 2.26E+05 0.OOE+00 PR-143 9.36E+03 3.75E+03 4.64E+02 0.OOE+00 2.16E+03 2.81E+05 2.00E+05 0.OOE+00 CE-144 3.43E+06 1.43E+06 1.84E+05 0.OOE+00 8.48E+05 7.78E+06 8.16E+05 0.00E+00 PR-144 3.01E-02 1.25E-02 1.53E-03 0.OOE+00 7.05E-03 1.02E+03 2.15E-08 0.OOE+00 ND-147 5.27E+03 6.10E+03 3.65E+02 0.OOE+00 3.56E+03 2.21E+05 1.73E+05 0.OOE+00 PM-147 6.70E+05 6.30E+04 2.55E+04 0.OOE+00 1.19E+05 5.28E+05 4.43E+04 0.OOE+00 PM-148m 7.86E+04 2.03E+04 1.55E+04 0.OOE+00 3.08E+04 1.71E+06 3.34E+05 0.OOE+00 PM-148 3.07E+03 5.1OE+02 2.56E+02 0.OOE+00 9.60E+02 3.13E+05 4.64E+05 0.OOE+00 PM-149 2.75E+02 3.90E+01 1.59E+01 0.OOE+00 7.35E+01 5.77E+04 2.00E+05 0.OOE+00 PM-151 6.80E+01 1.14E+01 5.77E+00 0.OOE+00 2.04E+01 3.15E+04 1.60E+05 0.OOE+00 SM-151 6.87E+05 1.18E+05 2.84E+04 0.00E+00 1.33E+05 3.56E+05 2.60E+04 0.OOE+00 11.4-141 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-27 (Page 4 of 4) Adult Inhalation Pi mrem*m3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.36E+02 1.14E+02 8.32E+00 0.OOE+00 3.67E+01 3.31E+04 1.26E+05 0.OOE+00 EU-152 1.90E+06 4.33E+05 3.81 E+05 0.OOE+00 2.68E+06 2.74E+06 1.27E+05 0.00E+00 EU-154 5.92E+06 7.28E+05 5.18E+05 0.00E+00 3.49E+06 4.67E+06 2.72E+05 0.OOE+00 EU-155 8.08E+05 1.14E+05 7.37E+04 0.OOE+00 5.27E+05 7.57E+05 4.76E+04 0.OOE+00 EU-156 1.54E+04 1.18E+04 1.92E+03 0.00E+00 7.96E+03 6.85E+05 3.60E+05 0.OOE+00 TB-160 1.77E+05 0.OOE+00 2.20E+04 0.OOE+00 7.28E+04 1.54E+06 2.14E+05 O.OOE+00 HO-166m 2.70E+06 8.40E+05 6.40E+05 0.00E+00 1.26E+06 3.15E+06 1.27E+05 0.OOE+00 W-181 4.98E+01 1.62E+01 1.74E+00 0.OOE+00 0.OOE+00 1.37E+04 2.02E+03 O.OOE+00 W-185 1.56E+03 5.18E+02 5.45E+01 0.OOE+00 0.OOE+00 4.46E+05 8.56E+04 0.00E+00 W-187 8.48E+00 7.08E+00 2.48E+00 0.OOE+00 0.OOE+00 2.90E+04 1.55E+05 O.OOE+00 NP-239 2.30E+02 2.26E+01 1.24E+01 O.OOE+00 7.OOE+01 3.76E+04 1.19E+05 O.00E+00 U-232 4.11E+08 0.OOE+00 2.93E+07 0.OOE+00 4.45E+07 1.78E+09 3.37E+05 0.OOE+00 U-233 8.72E+07 0.OOE+00 5.28E+06 0.OOE+00 2.03E+07 4.26E+08 3.11E+05 O.OOE+00 U-234 8.32E+07 0.OOE+00 5.17E+06 0.OOE+00 1.99E+07 4.18E+08 3.05E+05 0.OOE+00 U-235 8.OOE+07 0.00E+00 4.86E+06 0.OOE+00 1.87E+07 3.92E+08 3.87E+05 0.OOE+00 U-236 8.OOE+07 O.OOE+00 4.96E+06 0.OOE+00 1.91 E+07 4.00E+08 2.86E+05 0.OOE+00 U-237 2.94E+02 0.OOE+00 7.82E+01 0.OOE+00 1.21E+03 8.16E+04 9.60E+04 0.OOE+00 U-238 7.66E+07 O.OOE+00 4.54E+06 0.OOE+00 1.74E+07 3.66E+08 2.73E+05 0.OOE+00 NP-237 1.25E+10 8.OOE+09 5.50E+08 0.00E+00 4.08E+09 4.18E+08 3.94E+05 0.OOE+00 NP-238 2.37E+03 5.76E+02 3.69E+01 0.00E+00 2.18E+02 8.16E+04 1.70E+05 0.OOE+00 PU-238 1.14E+10 7.77E+09 5.52E+08 0.OOE+00 2.37E+09 1.46E+09 3.62E+05 0.OOE+00 PU-239 1.33E+10 8.56E+09 6.20E+08 0.00E+00 2.64E+09 1.38E+09 3.30E+05 0.OOE+00 PU-240 1.32E+10 8.56E+09 6.18E+08 0.OOE+00 2.63E+09 1.38E+09 3.37E+05 0.OOE+00 PU-241 2.74E+08 6.95E+07 1.03E+07 0.OOE+00 4.74E+07 1.22E+06 6.92E+03 0.OOE+00 PU-242 1.22E+10 8.24E+09 5.97E+08 0.OOE+00 2.54E+09 1.32E+09 3.24E+05 0.OOE+00 PU-244 1.43E+10 9.44E+09 6.83E+08 0.OOE+00 2.91E+09 1.51E+09 4.82E+05 0.OOE+00 AM-241 1.34E+10 9.04E+09 5.37E+08 0.00E+00 4.03E+09 4.85E+08 3.68E+05 0.OOE+00 AM-242m 1.36E+10 8.48E+09 5.38E+08 0.OOE+00 4.01E+09 1.95E+08 4.63E+05 0.OOE+00 AM-243 1.34E+10 8.80E+09 5.26E+08 0.OOE+00 3.96E+09 4.60E+08 4.32E+05 0.OOE+00 CM-242 1.78E+08 1.42E+08 7.87E+06 0.OOE+00 3.58E+07 3.14E+08 3.93E+05 O.OOE+00 CM-243 8.80E+09 6.09E+09 3.69E+08 0.00E+00 1.72E+09 5.05E+08 3.87E+05 0.OOE+00 CM-244 6.70E+09 4.70E+09 2.81E+08 0.OOE+00 1.31E+09 4.85E+08 3.74E+05 0.OOE+00 CM-245 1.39E+10 9.12E+09 5.71E+08 0.OOE+00 2.66E+09 4.68E+08 3.49E+05 0.OOE+00 CM-246 1.38E+10 9.12E+09 5.70E+08 0.OOE+00 2.66E+09 4.77E+08 3.43E+05 0.00E+00 CM-247 1.34E+10 8.96E+09 5.62E+08 0.OOE+00 2.62E+09 4.68E+08 4.50E+05 0.OOE+00 CM-248 1.12E+11 7.41E+10 4.63E+09 0.OOE+00 2.16E+10 3.86E+09 7.27E+06 0.OOE+00 CF-252 4,34E+09 0.OOE+00 1.86E+08 0.OOE+00 0.OOE+00 1.59E+09 1.42E+06 0.OOE+00 11.4-142 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-28 (Page 1 of 4) All Age Groups Ground Plane Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 C-14 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NA-22 1.16E+10 1.16E+10 1.16E+10 1.16E+10 1.16E+10 1.16E+10 1.16E+10 1.31E+10 NA-24 1.19E+07 1.19E+07 1.19E+07 1.19E+07 1.19E+07 1.19E+07 1.19E+07 1.39E+07 P-32 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CA-41 1.98E+10 1.98E+10 1.98E+10 1.98E+10 1.98E+10 1.98E+10 1.98E+10 2.33E+10 SC-46 8.33E+08 8.33E+08 8.33E+08 8.33E+08 8.33E+08 8.33E+08 8.33E+08 9.61EE+08 CR-51 4.66E+06 4.66E+06 4.66E+06 4.66E+06 4.66E+06 4.66E+06 4.66E+06 5.51E+06 MN-54 1.39E+09 1.39E+09 1.39E+09 1.39E+09 1.39E+09 1.39E+09 1.39E+09 1.63E+09 FE-55 0.OOE+00 0.00E+00 O.OE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.00E+00 MN-56 9.03E+05 9.03E+05 9.03E+05 9.03E+05 9.03E+05 9.03E+05 9.03E+05 1.07E+06 CO-57 1.88E+08 1.88E+08 1.88E+08 1.88E+08 1.88E+08 1.88E+08 1.88E+08 2.07E+08 CO-58 3.79E+08 3.79E+08 3.79E+08 3.79E+08 3.79E+08 3.79E+08 3.79E+08 4.44E+08 FE-59 2.73E+08 2.73E+08 2.73E+08 2.73E+08 2.73E+08 2.73E+08 2.73E+08 3.21E+08 CO-60 2.45E+10 2.45E+10 2.45E+10 2.45E+10 2.45E+10 2.45E+10 2.45E+10 2.89E+10 NI-59 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 NI-63 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CU-64 6.07E+05 6.07E+05 6.07E+05 6.07E+05 6.07E+05 6.07E+05 6.07E+05 6.88E+05 NI-65 2.97E+05 2.97E+05 2.97E+05 2.97E+05 2.97E+05 2.97E+05 2.97E+05 3.45E+05 ZN-65 7.47E+08 7.47E+08 7.47E+08 7.47E+08 7.47E+08 7.47E+08 7.47E+08 8.59E+08 ZN-69m 1.27E+06 1.27E+06 1.27E+06 1.27E+06 1.27E+06 1.27E+06 1.27E+06 1.49E+06 ZN-69 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 SE-79 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-82 2.14E+07 2.14E+07 2.14E+07 2.14E+07 2.14E+07 2.14E+07 2.14E+07 2.47E+07 BR-83 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 7.08E+03 BR-84 2.03E+05 2.03E+05 2.03E+05 2.03E+05 2.03E+05 2.03E+05 2.03E+05 2.36E+05 BR-85 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 RB-86 8.99E+06 8.99E+06 8.99E+06 8.99E+06 8.99E+06 8.99E+06 8.99E+06 1.03E+07 RB-87 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 RB-88 3.31E+04 3.31E+04 3.31E+04 3.31E+04 3.31E+04 3.31E+04 3.31E+04 3.78E+04 RB-89 1.23E+05 1.23E+05 1.23E+05 1.23E+05 1.23E+05 1.23E+05 1.23E+05 1.48E+05 SR-89 2.16E+04 2.16E+04 2.16E+04 2.16E+04 2.16E+04 2.16E+04 2.16E+04 2.51E+04 SR-90 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Y-90 4.49E+03 4.49E+03 4.49E+03 4.49E+03 4.49E+03 4.49E+03 4.49E+03 5.31E+03 SR-91 2.15E+06 2.15E+06 2.15E+06 2.15E+06 2.15E+06 2.15E+06 2.15E+06 2.51E+06 Y-91m 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 1.16E+05 Y-91 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.21E+06 11.4-143 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-28 (Page 2 of 4) All Age Groups Ground Plane Ri m 2 *mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 7.77E+05 7.77E+05 7.77E+05 7.77E+05 7.77E+05 7.77E+05 7.77E+05 8.63E+05 Y-92 1.80E+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 2.14E+05 Y-93 1.83E+05 1.83E+05 1.83E+05 1.83E+05 1.83E+05 1.83E+05 1.83E+05 2.51 E+05 NB-93m 2.54E+06 2.54E+06 2.54E+06 2.54E+06 2.54E+06 2.54E+06 2.54E+06 3.09E+08 NB-95 1.37E+08 1.37E+08 1.37E+08 1.37E+08 1.37E+08 1.37E+08 1.37E+08 1.61 E+08 NB-97 1.76E+05 1.76E+05 1.76E+05 1.76E+05 1.76E+05 1.76E+05 1.76E+05 2.07E+05 ZR-93 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ZR-95 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.84E+08 ZR-97 2.96E+06 2.96E+06 2.96E+06 2.96E+06 2.96E+06 2.96E+06 2.96E+06 3.44E+06 MO-93 1.32E+08 1.32E+08 1.32E+08 1.32E+08 1.32E+08 1.32E+08 1.32E+08 5.39E+09 MO-99 3.99E+06 3.99E+06 3.99E+06 3.99E+06 3.99E+06 3.99E+06 3.99E+06 4.63E+06 TC-99 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.O0E+00 TC-99m 1.84E+05 1.84E+05 1.84E+05 1.84E+05 1.84E+05 1.84E+05 1.84E+05 2.11 E+05 TC-101 2.04E+04 2.04E+04 2.04E+04 2.04E+04 2.04E+04 2.04E+04 2.04E+04 2.26E+04 RU-1 03 1.08E+08 1.08E+08 1.08E+08 1.08E+08 1.08E+08 1.08E+08 1.08E+08 1.26E+08 RU-105 6.36E+05 6.36E+05 6.36E+05 6.36E+05 6.36E+05 6.36E+05 6.36E+05 7.21E+05 RU-1 06 4.22E+08 4.22E+08 4.22E+08 4.22E+08 4.22E+08 4.22E+08 4.22E+08 5.07E+08 RH-1 05 7.43E+05 7.43E+05 7.43E+05 7.43E+05 7.43E+05 7.43E+05 7.43E+05 8.67E+05 PD-107 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PD-109 1.50E+04 1.50E+04 1.50E+04 1.50E+04 1.50E+04 1.50E+04 1.50E+04 1.71E+04 AG-i 10m 3.44E+09 3.44E+09 3.44E+09 3.44E+09 3.44E+09 3.44E+09 3.44E+09 4.01E+09 AG-1 11 1.03E+06 1.03E+06 1.03E+06 1.03E+06 1.03E+06 1.03E+06 1.03E+06 1.20E+06 CD-i 13m 6.87E+06 6.87E+06 6.87E+06 6.87E+06 6.87E+06 6.87E+06 6.87E+06 7.76E+06 CD-115m 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 SN-123 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 6.38E+09 SN-125 4.20E+06 4.20E+06 4.20E+06 4.20E+06 4.20E+06 4.20E+06 4.20E+06 4.86E+06 SN-126 5.22E+10 5.22E+10 5.22E+10 5.22E+10 5.22E+10 5.22E+10 5.22E+10 5.80E+10 SB-1 24 5.98E+08 5.98E+08 5.98E+08 5.98E+08 5.98E+08 5.98E+08 5.98E+08 6.90E+08 SB-125 2.40E+09 2.40E+09 2.40E+09 2.40E+09 2.40E+09 2.40E+09 2.40E+09 2.71E+09 SB-1 26 8.44E+07 8.44E+07 8.44E+07 8.44E+07 8.44E+07 8.44E+07 8.44E+07 9.48E+07 SB-127 1.68E+07 1.68E+07 1.68E+07 1.68E+07 1.68E+07 1.68E+07 1.68E+07 1.94E+07 TE-125m 1.55E+06 1.55E+06 1.55E+06 1.55E+06 1.55E+06 1.55E+06 1.55E+06 2.13E+06 TE-127m 9.16E+04 9.16E+04 9.16E+04 9.16E+04 9.16E+04 9.16E+04 9.16E+04 1.08E+05 TE-127 2.98E+03 2.98E+03 2.98E+03 2.98E+03 2.98E+03 2.98E+03 2.98E+03 3.28E+03 TE-129m 1.98E+07 1.98E+07 1.98E+07 1.98E+07 1.98E+07 1.98E+07 1.98E+07 2.31E+07 TE-129 2.62E+04 2.62E+04 2.62E+04 2.62E+04 2.62E+04 2.62E+04 2.62E+04 3.1OE+04 TE-133m 4.41E+05 4.41E+05 4.41E+05 4.41EE+05 4.41E+05 4.41E+05 4.41E+05 5.OOE+05 11.4-144 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-28 (Page 3 of 4) All Age Groups Ground Plane Ri m 2 *mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 2.22E+04 2.22E+04 2.22E+04 2.22E+04 2.22E+04 2.22E+04 2.22E+04 2.66E+04 1-129 2.61E+09 2.61E+09 2.61E+09 2.61E+09 2.61E+09 2.61EE+09 2.61EE+09 4.35E+09 1-130 5.51E+06 5.51E+06 5.51E+06 5.51E+06 5.51E+06 5.51EE+06 5.51E+06 6.69E+06 1-131 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 2.09E+07 TE-131m 8.03E+06 8.03E+06 8.03E+06 8.03E+06 8.03E+06 8.03E+06 8.03E+06 9.46E+06 TE-131 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 3.45E+07 1-132 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.46E+06 TE-132 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.23E+06 4.98E+06 1-133 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.98E+06 CS-134m 5.73E+04 5.73E+04 5.73E+04 5.73E+04 5.73E+04 5.73E+04 5.73E+04 6.74E+04 CS-134 6.91E+09 6.91E+09 6.91EE+09 6.91E+09 6.91E+09 6.91E+09 6.91E+09 8.06E+09 1-134 4.47E+05 4.47E+05 4.47E+05 4.47E+05 4.47E+05 4.47E+05 4.47E+05 5.30E+05 1-135 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.95E+06 CS-135 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CS-136 1.51E+08 1.51E+08 1.51E+08 1.51E+08 1.51E+08 1.51E+08 1.51E+08 1.71E+08 CS-137 1.76E+10 1.76E+10 1.76E+10 1.76E+10 1.76E+10 1.76E+10 1.76E+10 2.05E+10 CS-1 38 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 4.1OE+05 CS-139 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.59E+04 BA-139 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.19E+05 BA-140 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.35E+07 LA-140 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 2.18E+07 BA-141 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.75E+04 LA-141 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.14E+04 3.51E+04 CE-141 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.54E+07 BA-142 4.49E+04 4.49E+04 4.49E+04 4.49E+04 4.49E+04 4.49E+04 4.49E+04 5.11E+04 LA-142 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 9.11E+05 CE-143 2.31E+06 2.31E+06 2.31E+06 2.31E+06 2.31E+06 2.31EE+06 2.31E+06 2.63E+06 PR-143 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 CE-144 6.95E+07 6.95E+07 6.95E+07 6.95E+07 6.95E+07 6.95E+07 6.95E+07 8.04E+07 PR-144 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 2.11E+03 ND-147 8.39E+06 8.39E+06 8.39E+06 8.39E+06 8.39E+06 8.39E+06 8.39E+06 1.01E+07 PM-147 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 PM-148m 4.45E+08 4.45E+08 4.45E+08 4.45E+08 4.45E+08 4.45E+08 4.45E+08 2.58E+09 PM-148 1.89E+07 1.89E+07 1.89E+07 1.89E+07 1.89E+07 1.89E+07 1.89E+07 2.18E+07 PM-149 4.23E+04 4.23E+04 4.23E+04 4.23E+04 4.23E+04 4.23E+04 4.23E+04 4.90E+04 PM-151 1.99E+06 1.99E+06 1.99E+06 1.99E+06 1.99E+06 1.99E+06 1.99E+06 2.08E+06 SM-151 2.49E+08 2.49E+08 2.49E+08 2.49E+08 2.49E+08 2.49E+08 2.49E+08 1.09E+09 11.4-145 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-28 (Page 4 of 4) All Age Groups Ground Plane Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 4.02E+05 4.02E+05 4.02E+05 4.02E+05 4.02E+05 4.02E+05 4.02E+05 4.46E+05 EU-152 2.19E+10 2.19E+10 2.19E+10 2.19E+10 2.19E+10 2.19E+10 2.19E+10 2.54E+10 EU-154 1.74E+10 1.74E+10 1.74E+10 1.74E+10 1.74E+10 1.74E+10 1.74E+10 2.OOE+10 EU-155 5.20E+08 5.20E+08 5.20E+08 5.20E+08 5.20E+08 5.20E+08 5.20E+08 5.90E+08 EU-156 8.82E+07 8.82E+07 8.82E+07 8.82E+07 8.82E+07 8.82E+07 8.82E+07 1.01 E+08 TB-160 4.75E+08 4.75E+08 4.75E+08 4.75E+08 4.75E+08 4.75E+08 4.75E+08 5.53E+08 HO-166m 5.12E+10 5.12E+10 5.12E+10 5.12E+10 5.12E+10 5.12E+10 5.12E+10 5.75E+10 W-181 1.94E+05 1.94E+05 1.94E+05 1.94E+05 1.94E+05 1.94E+05 1.94E+05 2.59E+05 W-185 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 W-187 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.73E+06 NP-239 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.98E+06 U-232 1.31E+07 1.31EE+07 1.31E+07 1.31EE+07 1.31E+07 1.31E+07 1.31E+07 1.36E+08 U-233 1.33E+10 1.33E+10 1.33E+10 1.33E+10 1.33E+10 1.33E+10 1.33E+10 1.62E+10 U-234 3.67E+06 3.67E+06 3.67E+06 3.67E+06 3.67E+06 3.67E+06 3.67E+06 9.22E+08 U-235 1.86E+10 1.86E+10 1.86E+10 1.86E+10 1.86E+10 1.86E+10 1.86E+10 2.32E+10 U-236 1.22E+05 1.22E+05 1.22E+05 1.22E+05 1.22E+05 1.22E+05 1.22E+05 1.04E+08 U-237 5.16E+06 5.16E+06 5.16E+06 5.16E+06 5.16E+06 5.16E+06 5.16E+06 6.71E+06 U-238 6.38E+08 6.38E+08 6.38E+08 6.38E+08 6.38E+08 6.38E+08 6.38E+08 8.70E+08 NP-237 8.12E+09 8.12E+09 8.12E+09 8.12E+09 8.12E+09 8.12E+09 8.12E+09 9.28E+09 NP-238 4.53E+06 4.53E+06 4.53E+06 4.53E+06 4.53E+06 4.53E+06 4.53E+06 5.18E+06 PU-238 6.71E+06 6.71E+06 6.71E+06 6.71E+06 6.71E+06 6.71E+06 6.71E+06 9.30E+07 PU-239 4.58E+06 4.58E+06 4.58E+06 4.58E+06 4.58E+06 4.58E+06 4.58E+06 4.46E+07 PU-240 7.53E+06 7.53E+06 7.53E+06 7.53E+06 7.53E+06 7.53E+06 7.53E+06 1.04E+08 PU-241 1.41E+07 1.41E+07 1.41E+07 1.41E+07 1.41E+07 1.41E+07 1.41E+07 2.09E+07 PU-242 6.38E+06 6.38E+06 6.38E+06 6.38E+06 6.38E+06 6.38E+06 6.38E+06 9.28E+07 PU-244 5.19E+09 5.19E+09 5.19E+09 5.19E+09 5.19E+09 5.19E+09 5.19E+09 5.58E+09 AM-241 1.02E+09 1.02E+09 1.02E+09 1.02E+09 1.02E+09 1.02E+09 1.02E+09 1.47E+09 AM-242m 1.41 E+08 1.41 E+08 1.41 E+08 1.41 E+08 1.41 E+08 1.41 E+08 1.41 E+08 9.76E+08 AM-243 7.53E+09 7.53E+09 7.53E+09 7.53E+09 7.53E+09 7.53E+09 7.53E+09 8.69E+09 CM-242 6.86E+05 6.86E+05 6.86E+05 6.86E+05 6.86E+05 6.86E+05 6.86E+05 2.87E+06 CM-243 9.47E+09 9.47E+09 9.47E+09 9.47E+09 9.47E+09 9.47E+09 9.47E+09 1.19E+10 CM-244 1.OOE+07 1.OOE+07 1.OOE+07 1.OOE+07 1.00E+07 1.OOE+07 1.OOE+07 6.21E+07 CM-245 5.50E+09 5.50E+09 5.50E+09 5.50E+09 5.50E+09 5.50E+09 5.50E+09 6.95E+09 CM-246 5.79E+06 5.79E+06 5.79E+06 5.79E+06 5.79E+06 5.79E+06 5.79E+06 8.68E+07 CM-247 1.28E+10 1.28E+10 1.28E+10 1.28E+10 1.28E+10 1.28E+10 1.28E+10 1.51E+10 CM-248 3.03E+10 3.03E+10 3.03E+10 3.03E+10 3.03E+10 3.03E+10 3.03E+10 3.95E+10 CF-252 4.86E+10 4.86E+10 4.86E+10 4.86E+10 4.86E+10 4.86E+10 4.86E+10 5.30E+10 11.4-146 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-29 (Page 1 of 4) Infant Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 0.OOE+00 C-14 2.65E+04 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.31EE+03 5.31E+03 0.OOE+00 NA-22 1.03E+05 1.03E+05 1.03E+05 1.03E+05 1.03E+05 1.03E+05 1.03E+05 0.OOE+00 NA-24 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 0.OOE+00 P-32 2.03E+06 1.12E+05 7.74E+04 0.OOE+00 O.OOE+00 0.OOE+00 1.61E+04 0.OOE+00 CA-41 1.05E+05 0.OOE+00 1.14E+04 0.OOE+00 0.OOE+00 9.72E+07 4.14E+02 0.OOE+00 SC-46 5.25E+05 7.57E+05 2.37E+05 0.OOE+00 4.98E+05 0.OOE+00 3.07E+04 0.00E+00 CR-51 0.OOE+00 O.OOE+00 8.95E+01 5.75E+01 1.32E+01 1.28E+04 3.57E+02 0.OOE+00 MN-54 O.OOE+00 2.53E+04 4.98E+03 0.OOE+00 4.98E+03 1.OOE+06 7.06E+03 0.OOE+00 FE-55 1.97E+04 1.18E+04 3.33E+03 0.O0E+00 0.00E+00 8.69E+04 1.1OE+03 0.OOE+00 MN-56 0.OOE+00 1.54E+00 2.21E-01 0.OOE+00 1.10E+00 1.25E+04 7.17E+04 0.OOE+00 CO-57 O.OE+00 6.51 E+02 6.41 E+02 0.OOE+00 0.OOE+00 3.79E+05 4.86E+03 0.OOE+00 CO-58 0.OOE+00 1.22E+03 1.82E+03 0.OOE+00 0.OOE+00 7.77E+05 1.11E+04 0.OOE+00 FE-59 1,36E+04 2-35E+04 9.48E+03 0,OOE+00 0.OOE+00 1,02E+06 2.48E+04 O.00E+00 CO-60 0.OOE+00 8.02E+03 1.18E+04 0.OOE+00 0.OOE+00 4.51E+06 3.19E+04 0.00E+00 NI-59 2.53E+04 7.62E+03 4.34E+03 0.OOE+00 0.OOE+00 7.67E+04 8.88E+02 0.OOE+00 NI-63 3.39E+05 2.04E+04 1 .16E+04 0.OOE+00 0.OOE+00 2.09E+05 2.42E+03 0.00E+00 CU-64 0.OOE+00 1.88E+00 7.74E-01 O.OOE+00 3.98E+00 9.30E+03 1.50E+04 0.OOE+00 NI-65 2.39E+00 2.84E-01 1.23E-01 O.OOE+00 O.OOE+00 8.12E+03 5.01E+04 0.OOE+00 ZN-65 1.93E+04 6.26E+04 3.11E+04 O.OOE+00 3.25E+04 6.47E+05 5.14E+04 0.OOE+00 ZN-69m 1.26E+01 2.58E+01 2.34E+00 0.00E+00 1.04E+01 2.67E+04 4.09E+04 0.OOE+00 ZN-69 5.39E-02 9.67E-02 7.18E-03 0.OOE+00 4.02E-02 1.47E+03 1.32E+04 0.OOE+00 SE-79 0.OOE+00 3.15E+03 5.88E+02 0.OOE+00 3.46E+03 4.19E+05 4.84E+04 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.33E+04 O.OOE+00 0.OOE+00 0.OOE+00 1.40E-15 0.OOE+00 BR-83 O.OOE+00 0.00E+00 3.81E+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 O.OOE+00 4.OOE+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.00E+00 2.04E+01 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 RB-86 0.OOE+00 1.90E+05 8.82E+04 0.OOE+00 0.OOE+00 0.OOE+00 3.04E+03 0.OOE+00 RB-87 0.OOE+00 1.24E+05 4.93E+04 0.OOE+00 0.OOE+00 0.00E+00 8.37E+02 0.OOE+00 RB-88 0.OOE+00 5.57E+02 2.87E+02 0.OOE+00 0.OOE+00 0.OOE+00 3.39E+02 0.OOE+00 RB-89 0.OOE+00 3.21EE+02 2.06E+02 0.OOE+00 0.OOE+00 0.OOE+00 6.82E+01 0.OOE+00 SR-89 3.98E+05 0.OOE+00 1.14E+04 0.OOE+00 0.00E+00 2.03E+06 6.40E+04 0.OOE+00 SR-90 4.09E+07 0.OOE+00 2.59E+06 0.OOE+00 0.OOE+00 1.12E+07 1.31E+05 0.OOE+00 Y-90 3.29E+03 O.OOE+00 8.82E+01 0.OOE+00 0.OOE+00 2.69E+05 1.04E+05 O.OOE+00 SR-91 9.56E+01 0.OOE+00 3.46E+00 0.OOE+00 0.OOE+00 5.26E+04 7.34E+04 0.OOE+00 Y-91rm 4.07E-01 O.OOE+00 1.39E-02 0.OOE+00 0,OOE+00 2.79E+03 2.35E+03 0.OOE+00 Y-91 5.88E+05 0.OOE+00 1.57E+04 0.OOE+00 0.OOE+00 2.45E+06 7.03E+04 0.00E+00 11.4-147 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-29 (Page 2 of 4) Infant Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 1.05E+01 0.OOE+00 3.91 E-01 0.00E+00 0.OOE+00 2.38E+04 1.40E+05 0.OOE+00 Y-92 1.64E+01 0.OOE+00 4.61 E-01 O.00E+00 0.OOE+00 2.45E+04 1.27E+05 0.OOE+00 Y-93 1.50E+02 0.OOE+00 4.07E+00 0.OOE+00 0.OOE+00 7.64E+04 1.67E+05 0.OOE+00 NB-93m 1.93E+05 5.03E+04 1.61EE+04 O.OOE+00 5.15E+04 2.93E+05 3.46E+03 0.OOE+00 NB-95 1.57E+04 6.43E+03 3.78E+03 0.OOE+00 4.72E+03 4.79E+05 1.27E+04 0.OOE+00 NB-97 3.42E-01 7.29E-02 2.63E-02 O.OOE+00 5.70E-02 3.32E+03 2.69E+04 0.OOE+00 ZR-93 3.14E+05 1.33E+05 8.65E+04 0.OOE+00 4.47E+05 1.92E+06 2.07E+04 0.OOE+00 ZR-95 1.15E+05 2.79E+04 2.03E+04 0.OOE+00 3.11E+04 1.75E+06 2.17E+04 0.OOE+00 ZR-97 1.50E+02 2.56E+01 1.17E+01 0.OOE+00 2.59E+01 1.1OE+05 1.40E+05 0.OOE+00 MO-93 0.OOE+00 9.04E+03 3.11E+02 0.OOE+00 2.16E+03 4.76E+05 5.26E+03 0.OOE+00 MO-99 O.OOE+00 1.65E+02 3.23E+01 0.OOE+00 2.65E+02 1.35E+05 4.87E+04 0.OOE+00 TC-99 2.93E+02 3.75E+02 1.24E+02 0.OOE+00 3.49E+03 9.48E+05 1.09E+04 0.OOE+00 TC-99m 1.40E-03 2.88E-03 3.72E-02 0.OOE+00 3.11E-02 8.11E+02 2.03E+03 0.OOE+00 TC-101 6.51E-05 8.23E-05 8.12E-04 0.OOE+00 9.79E-04 5.84E+02 8.44E+02 0.OOE+00 RU-103 2.02E+03 O.OOE+00 6.79E+02 0.00E+00 4.24E+03 5.52E+05 1.61E+04 0.OOE+00 RU-105 1.22E+00 0.OOE+00 4.1OE-01 O.OOE+00 8.99E-01 1.57E+04 4.84E+04 O.00E+00 RU-106 8.68E+04 0.OOE+00 1.09E+04 0.OOE+00 1.07E+05 1.16E+07 1.64E+05 0.OOE+00 RH-105 1.16E+01 7.57E+00 5.08E+00 0.OOE+00 2.10E+01 2.91E+04 1.92E+04 0.OOE+00 PD-107 O.OOE+00 6.89E+01 5.75E+01 0.OOE+00 3.85E+03 8.88E+04 1.03E+03 0.OOE+00 PD-109 0.OOE+00 5.49E+00 1.47E+00 0.OOE+00 1.79E+01 2.35E+04 3.99E+04 0.OOE+00 AG-110m 9.98E+03 7.22E+03 5.OOE+03 O.OOE+00 1.09E+04 3.67E+06 3.30E+04 O.OOE+00 AG-111 5.25E+02 2.03E+02 1.09E+02 O.OOE+00 4.27E+02 2.88E+05 4.23E+04 O.OOE+00 CD-113m 0.OOE+00 9.34E+05 3.70E+04 O.OOE+00 8.12E+05 1.96E+06 2.31E+04 O.OOE+00 CD-1 15m O.OOE+00 2.42E+05 8.67E+03 O.OOE+00 1.32E+05 2.06E+06 7.03E+04 O.OOE+00 SN-123 2.93E+05 5.89E+03 1.02E+04 5.98E+03 O.OOE+00 3.11E+06 5.71E+04 O.OOE+00 SN-125 1.41E+04 3.51E+02 8.40E+02 3.46E+02 O.OOE+00 9.OOE+05 1.02E+05 0.OOE+00 SN-126 1.16E+06 2.02E+04 4.93E+04 5.38E+03 O.OOE+00 6.90E+06 2.31E+04 O.OOE+00 SB-124 3.79E+04 5.56E+02 1.20E+04 1.01E+02 0.OOE+00 2.65E+06 5.91E+04 O.OOE+00 SB-1 25 5.45E+04 4.77E+02 1.09E+04 6.23E+01 0.OOE+00 1.64E+06 1.47E+04 O.OOE+00 SB-126 4.31E+03 8.41E+01 1.55E+02 3.29E+01 0.OOE+00 9.63E+05 7.46E+04 O.OOE+00 SB-1 27 3.95E+02 7.06E+00 1.23E+02 5.04E+00 O.OOE+00 2.16E+05 5.29E+04 O.OOE+00 TE-125m 4.76E+03 1.99E+03 6.58E+02 1.62E+03 0.OOE+00 4.47E+05 1.29E+04 0.OOE+00 TE-127m 1.67E+04 6.90E+03 2.07E+03 4.87E+03 3.75E+04 1.31EE+06 2.73E+04 O.OOE+00 TE-127 2.23E+00 9.53E-01 4.89E-01 1.85E+00 4.86E+00 1.04E+04 2.44E+04 O.OOE+00 TE-129m 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 O.OOE+00 TE-129 7.88E-02 3.47E-02 1.88E-02 6.75E-02 1.75E-01 3.OOE+03 2.63E+04 O.OOE+00 TE-133m 8.58E-02 5.03E-02 3.84E-02 7.73E-02 2.41E-01 5.49E+03 2.23E+04 O.OOE+00 11.4-148 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-29 (Page 3 of 4) Infant Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 4.45E-02 2.86E-02 2.35E-02 4.07E-02 1.34E-01 4.1OE+03 3.54E+03 0.00E+00 1-129 3.02E+04 2.23E+04 1.62E+04 1.46E+07 2.63E+04 0.OOE+00 2.97E+02 0.OOE+00 1-130 6.36E+03 1.39E+04 5.57E+03 1.60E+06 1.53E+04 O.OOE+00 1.99E+03 0.OOE+00 1-131 3.79E+04 4.44E+04 1.96E+04 1.48E+07 5.18E+04 0.OOE+00 1.06E+03 0.00E+00 TE-131m 1.07E+02 5.50E+01 3.63E+01 8.93E+01 2.65E+02 1.99E+05 1.19E+05 0.OOE+00 TE-131 1.74E-02 8.22E-03 5.OOE-03 1.58E-02 3.99E-02 2.06E+03 8.22E+03 0.OOE+00 1-132 1.69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 O.OOE+00 1.90E+03 O.OOE+00 TE-132 3.72E+02 2.37E+02 1.76E+02 2.79E+02 1.04E+03 3.40E+05 4.41EE+04 0.00E+00 1-133 1.32E+04 1.92E+04 5.60E+03 3.56E+06 2.24E+04 0.OOE+00 2.16E+03 0.OOE+00 CS-134m 1.85E+02 2.94E+02 1.55E+02 0.OOE+00 1.19E+02 2.80E+01 1.62E+02 0.00E+00 CS-1 34 3.96E+05 7.03E+05 7.45E+04 0.OOE+00 1.90E+05 7.97E+04 1.33E+03 0.00E+00 1-134 9.21 E+02 1.88E+03 6.65E+02 4.45E+04 2.09E+03 0.OOE+00 1.29E+03 0.OOE+00 1-135 3.86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 0.OOE+00 1.83E+03 0.OOE+00 CS-135 1.40E+05 1.21E+05 6.62E+03 0.00E+00 3.61E+04 1.41E+04 3.05E+02 0.OOE+00 CS-136 4.83E+04 1.35E+05 5.29E+04 0.OOE+00 5.64E+04 1.18E+04 1.43E+03 0.00E+00 CS-137 5.49E+05 6.12E+05 4.55E+04 0.OOE+00 1.72E+05 7.13E+04 1.33E+03 0.OOE+00 CS-138 5.05E+02 7.81E+02 3.98E+02 0.OOE+00 4.1OE+02 6.54E+01 8.76E+02 0.OOE+00 CS-139 3.25E+02 4.24E+02 1.71E+02 0.OOE+00 2.31E+02 3.54E+01 1.86E+01 0.OOE+00 BA-1 39 1.48E+00 9.84E-04 4.30E-02 0.OOE+00 5.92E-04 5.95E+03 5.10E+04 0.OOE+00 BA-140 5.60E+04 5.60E+01 2.90E+03 0.OOE+00 1.34E+01 1.60E+06 3.84E+04 0.00E+00 LA-140 5.05E+02 2.OOE+02 5.15E+01 0.OOE+00 0.OOE+00 1.68E+05 8.48E+04 0.00E+00 BA-141 1.57E-01 1.08E-04 4.97E-03 0.OOE+00 6.50E-05 2.97E+03 4.75E+03 0.00E+00 LA-141 6.79E+00 1.96E+00 3.43E-01 0.OOE+00 0.OOE+00 1.71EE+04 8.34E+04 0.OOE+00 CE-141 2.77E+04 1.67E+04 1.99E+03 0.OOE+00 5.25E+03 5.17E+05 2.16E+04 0.OOE+00 BA-142 3.98E-02 3.30E-05 1.96E-03 0.OOE+00 1.90E-05 1.55E+03 6.93E+02 0.OOE+00 LA-142 1.03E+00 3.77E-01 9.04E-02 0.OOE+00 0.OOE+00 8.22E+03 5.95E+04 0.OOE+00 CE-143 2.93E+02 1.93E+02 2.21E+01 0.OOE+00 5.64E+01 1.16E+05 4.97E+04 0.OOE+00 PR-143 1.40E+04 5.24E+03 6.99E+02 0.OOE+00 1.97E+03 4.33E+05 3.72E+04 0.OOE+00 CE-144 3.19E+06 1.21E+06 1.76E+05 0.OOE+00 5.38E+05 9.84E+06 1.48E+05 0.OOE+00 PR-144 4.79E-02 1.85E-02 2.41E-03 0.OOE+00 6.72E-03 1.61E+03 4.28E+03 0.OOE+00 ND-147 7.94E+03 8.13E+03 5.OOE+02 0.OOE+00 3.15E+03 3.22E+05 3.12E+04 0.OOE+00 PM-147 5.47E+05 4.30E+04 2.18E+04 0.OOE+00 6.90E+04 6.37E+05 8.05E+03 0.00E+00 PM-148m 7.OOE+04 1.74E+04 1.39E+04 0.OOE+00 2.03E+04 1.71E+06 4.72E+04 0.OOE+00 PM-148 4.68E+03 6.75E+01 3.42E+02 O.OOE+00 8.06E+02 4.48E+05 8.46E+04 0.OOE+00 PM-149 4.34E+02 5.71E+01 2.49E+01 0.OOE+00 6.94E+01 9.1OE+04 4.21EE+04 0.OOE+00 PM-151 1.05E+02 1.54E+01 7.77E+00 0.OOE+00 1.82E+01 4.55E+04 3.61EE+04 0.OOE+00 SM-151 4.73E+05 9.03E+04 2.28E+04 0.OOE+00 7.34E+04 4.17E+05 4.84E+03 0.OOE+00 11.4-149 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-29 (Page 4 of 4) Infant Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 2.14E+02 1.65E+02 1.27E+01 0.00E+00 3.46E+01 5.18E+04 2.70E+04 0.OOE+00 EU-152 1.1OE+06 2.48E+05 2.41E+05 0.OOE+00 8.32E+05 2.07E+06 1.38E+04 0.OOE+00 EU-154 4.14E+06 4.84E+05 3.43E+05 0.OOE+00 1.60E+06 4.27E+06 3.98E+04 0.O0E+00 EU-155 8.36E+05 8.01E+04 4.84E+04 0.OOE+00 2.21E+05 7.28E+05 7.27E+04 0.OOE+00 EU-156 2.18E+04 1.34E+04 2.16E+03 0.OOE+00 6.27E+03 8.57E+05 5.80E+04 0.00E+00 TB-160 1.57E+05 0.00E+00 1.96E+04 0.OOE+00 4.48E+04 1.55E+06 3.OOE+04 0.00E+00 HO-166m 2.03E+05 4.30E+05 3.51E+05 0.00E+00 5.91E+05 2.87E+06 2.31E+04 0.00E+00 W-181 6.80E+01 2.04E+01 2.34E+00 O.00E+00 O.OOE+00 1.86E+04 3.68E+02 0.OOE+00 W-185 2.20E+03 6.76E+02 7.81E+01 O.00E+00 0.OOE+00 6.27E+05 1.57E+04 0.00E+00 W-187 1.30E+01 9.02E+00 3.12E+00 0.00E+00 O.00E+00 3.96E+04 3.56E+04 0.00E+00 NP-239 3.71E+02 3.32E+01 1.88E+01 O.OOE+00 6.62E+01 5.95E+04 2.49E+04 0.00E+00 U-232 3.60E+08 0.OOE+00 2.98E+07 0.00E+00 3.36E+07 2.09E+09 6.10E+04 0.00E+00 U-233 7.62E+07 O.00E+00 5.36E+06 0.00E+00 1.53E+07 4.98E+08 5.64E+04 0.OOE+00 U-234 7.31E+07 0.00E+00 5.25E+06 0.OOE+00 1.50E+07 4.89E+08 5.53E+04 0.OOE+00 U-235 7.01 E+07 0.OOE+00 4.93E+06 0.OOE+00 1.41 E+07 4.59E+08 7.03E+04 0.OOE+00 U-236 7.01E+07 0.OOE+00 5.04E+06 0.00E+00 1.44E+07 4.69E+08 5.19E+04 0.OOE+00 U-237 4.55E+02 0.00E+00 1.21E+02 O.00E+00 1.13E+03 1.28E+05 1.83E+04 0.00E+00 U-238 6.71 E+07 0.00E+00 4.61 E+06 0.00E+00 1.32E+07 4.28E+08 4.96E+04 0.00E+00 NP-237 4.03E+09 2.39E+09 1.76E+08 0.OOE+00 1.08E+09 4.89E+08 7.14E+04 0.00E+00 NP-238 3.74E+03 8.47E+02 5.82E+01 0.OOE+00 2.06E+02 1.29E+05 3.61E+04 0.00E+00 PU-238 3.77E+09 2.35E+09 1.78E+08 O.OOE+00 6.50E+08 1.26E+09 6.57E+04 0.00E+00 PU-239 4.1OE+09 2.46E+09 1.88E+08 O.OOE+00 6.93E+08 1.19E+09 5.99E+04 0.OOE+00 PU-240 4.1OE+09 2.45E+09 1.88E+08 0.OOE+00 6.92E+08 1.19E+09 6.10E+04 0.00E+00 PU-241 1.18E+08 2.59E+07 4.35E+06 0.OOE+00 1.61E+07 1.07E+06 1.26E+03 0.00E+00 PU-242 3.81EE+09 2.37E+09 1.81E+08 0.OOE+00 6.68E+08 1.14E+09 5.88E+04 0.00E+00 PU-244 4.44E+09 2.72E+09 2.07E+08 0.OOE+00 7.64E+08 1.31E+09 8.76E+04 0.00E+00 AM-241 4.41E+09 2.73E+09 1.83E+08 0.00E+00 1.11E+09 5.68E+08 6.69E+04 0.00E+00 AM-242m 4.55E+09 2.60E+09 1.89E+08 0.OOE+00 1.12E+09 2.30E+08 8.41E+04 0.00E+00 AM-243 4.34E+09 2.63E+09 1.78E+08 0.OOE+00 1.08E+09 5.39E+08 7.84E+04 0.OOE+00 CM-242 1.79E+08 1.21E+08 7.98E+06 0.OOE+00 2.37E+07 4.16E+08 7.14E+04 0.00E+00 CM-243 3.46E+09 2.13E+09 1.48E+08 0.00E+00 5.47E+08 5.94E+08 7.03E+04 0.OOE+00 CM-244 2.90E+09 1.78E+09 1.24E+08 0.OOE+00 4.49E+08 5.71EE+08 6.80E+04 0.00E+00 CM-245 4.51E+09 2.74E+09 1.90E+08 0.OOE+00 7.32E+08 5.49E+08 6.34E+04 0.OOE+00 CM-246 4.48E+09 2.74E+09 1.90E+08 0.OOE+00 7.32E+08 5.59E+08 6.23E+04 0.OOE+00 CM-247 4.35E+09 2.70E+09 1.86E+08 0.OOE+00 7.21EE+08 5.49E+08 8.19E+04 0.00E+00 CM-248 3.61E+10 2.23E+10 1.54E+09 0.OOE+00 5.94E+09 4.52E+09 1.32E+06 0.OOE+00 CF-252 3.32E+09 0.00E+00 1.41EE+08 0.OOE+00 0.OOE+00 1.92E+09 2.59E+05 0.00E+00 11.4-150 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-30 (Page 1 of 4) Child Inhalation R, mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LLI Skin H-3 0.00E+00 1.13E+03 1.13E+03 1.13E+03 1.13E+03 1.13E+03 1.13E+03 0.OOE+00 C-14 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 0.00E+00 NA-22 1.63E+05 1.63E+05 1.63E+05 1.63E+05 1.63E+05 1.63E+05 1.63E+05 0.00E+00 NA-24 1.61EE+04 1.61EE+04 1.61E+04 1.61E+04 1.61E+04 1.61EE+04 1.61EE+04 0.OOE+00 P-32 2.61 E+06 1.14E+05 9.88E+04 0.00E+00 0.00E+00 0.OOE+00 4.22E+04 0.OOE+00 CA-41 2.61 E+05 0.OOE+00 2.85E+04 0.OOE+00 0.OOE+00 2.67E+08 1.09E+03 0.OOE+00 SC-46 7.29E+05 9.99E+05 3.85E+05 0.00E+00 8.84E+05 0.OOE+00 9.07E+04 0.OOE+00 CR-51 0.OOE+00 0.00E+00 1.54E+02 8.55E+01 2.43E+01 1.70E+04 1.08E+03 0.OOE+00 MN-54 0.00E+00 4.29E+04 9.51 E+03 0.OOE+00 1.00E+04 1.58E+06 2.29E+04 0.OOE+00 FE-55 4.74E+04 2.52E+04 7.77E+03 0.00E+00 0.OOE+00 1.11 E+05 2.87E+03 0.OOE+00 MN-56 0.00E+00 1.66E+00 3.12E-01 0.OOE+00 1.67E+00 1.31E+04 1.23E+05 0.OOE+00 CO-57 0.00E+00 9.03E+02 1.07E+03 0.OOE+00 0.OOE+00 5.07E+05 1.32E+04 0.OOE+00 CO-58 0.00E+00 1.77E+03 3.16E+03 0.OOE+00 0.OOE+00 1.11 E+06 3.44E+04 0.OOE+00 FE-59 2.07E+04 3.35E+04 1.67E+04 0.OOE+00 0.OOE+00 1.27E+06 7.07E+04 0.OOE+00 CO-60 0.OOE+00 1.31 E+04 2.26E+04 0.OOE+00 0.00E+00 7.07E+06 9.62E+04 0.OOE+00 NI-59 6.14E+04 1.73E+04 1.05E+04 0.OOE+00 0.OOE+00 1.01E+05 2.33E+03 0.OOE+00 NI-63 8.21E+05 4.63E+04 2.80E+04 0.00E+00 0.00E+00 2.75E+05 6.33E+03 0.OOE+00 CU-64 0.OOE+00 1.99E+00 1.07E+00 0.00E+00 6.03E+00 9.58E+03 3.67E+04 0.OOE+00 NI-65 2.99E+00 2.96E-01 1.64E-01 0.00E+00 0.OOE+00 8.18E+03 8.40E+04 0.OOE+00 ZN-65 4.26E+04 1.13E+05 7.03E+04 0.00E+00 7.14E+04 9.95E+05 1.63E+04 0.00E+00 ZN-69m 1.58E+01 2.69E+01 3.18E+00 0.00E+00 1.56E+01 2.72E+04 1.00E+05 0.OOE+00 ZN-69 6.70E-02 9.66E-02 8.92E-03 0.OOE+00 5.85E-02 1.42E+03 1.02E+04 0.00E+00 SE-79 0.OOE+00 4.55E+03 9.62E+02 0.OOE+00 6.33E+03 5.51 E+05 1.27E+04 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 2.09E+04 0.00E+00 0.OOE+00 0.OOE+00 3.70E-15 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 4.74E+02 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 BR-84 0.00E+00 0.OOE+00 5.48E+02 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.00E+00 0.OOE+00 2.53E+01 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.00E+00 1.98E+05 1.14E+05 0.OOE+00 0.00E+00 0.OOE+00 7.99E+03 0.OOE+00 RB-87 0.OOE+00 1.17E+05 5.07E+04 0.OOE+00 0.00E+00 0.OOE+00 1.1OE+03 0.00E+00 RB-88 0.OOE+00 5.62E+02 3.66E+02 0.OOE+00 0.OOE+00 0.00E+00 1.72E+01 0.00E+00 RB-89 0.OOE+00 3.45E+02 2.90E+02 0.OOE+00 0.OOE+00 0.OOE+00 1.89E+00 O.OOE+00 SR-89 5.99E+05 0.OOE+00 1.72E+04 0.00E+00 0.OOE+00 2.16E+06 1.67E+05 0.OOE+00 SR-90 1.01 E+08 0.OOE+00 6.44E+06 0.OOE+00 0.OOE+00 1.48E+07 3.43E+05 0.00E+00 Y-90 4.11E+03 0.OOE+00 1.11E+02 0.OOE+00 0.00E+00 2.62E+05 2.68E+05 0.OOE+00 SR-91 1.21E+02 0.00E+00 4.59E+00 0.OOE+00 0.00E+00 5.33E+04 1.74E+05 0.OOE+00 Y-91 m 5.07E-01 0.00E+00 1.84E-02 0.OOE+00 0,00E+00 2.81 E+03 1,72E+03 0.00E+00 Y-91 9.14E+05 0.OOE+00 2.44E+04 0.OOE+00 0.00E+00 2.63E+06 1.84E+05 0.OOE+00 11.4-151 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-30 (Page 2 of 4) Child Inhalation R, mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 1.31 E+01 0.00E+00 5.25E-01 O.00E+00 0.00E+00 2.40E+04 2.42E+05 0.00E+00 Y-92 2.04E+01 0.OOE+00 5.81E-01 0.OOE+00 0.00E+00 2.39E+04 2.39E÷05 0.OOE+00 Y-93 1.87E+02 0.OOE+00 5.11E+00 0.00E+00 0.00E+00 7.44E+04 3.89E+05 0.OOE+00 NB-93m 4.70E+05 1.17E+05 3.85E+04 0.O0E+00 1.26E+05 3.85E+05 9.07E+03 0.OOE+00 NB-95 2.35E+04 9.18E+03 6.55E+03 0.OOE+00 8.62E+03 6.14E+05 3.70E+04 0.00E+00 NB-97 4.29E-01 7.70E-02 3.60E-02 0.00E+00 8.55E-02 3.42E+03 2.78E+04 0.00E+00 ZR-93 7.66E+05 2.89E+05 2.05E+05 0.OOE+00 1.11E+06 2.63E+06 5.44E+04 0.00E+00 ZR-95 1.90E+05 4.18E+04 3.70E+04 0.00E+00 5.96E+04 2.23E+06 6.11E+04 0.OOE+00 ZR-97 1.88E+02 2.72E+01 1.60E+01 0.00E+00 3.89E+01 1.13E+05 3.51E+05 0.OOE+00 MO-93 0.00E+00 1.39E+04 5.00E+02 0.00E+00 3.92E+03 6.29E+05 1.40E+04 0.OOE+00 MO-99 0.00E+00 1.72E+02 4.26E+01 0.00E+00 3.92E+02 1.35E+05 1.27E+05 0.OOE+00 TC-99 4.96E+02 5.51 E+02 1.98E+02 0.00E+00 6.48E+03 1.25E+06 2.87E+04 0.00E+00 TC-99m 1.78E-03 3.48E-03 5.77E-02 0.00E+00 5.07E-02 9.51 E+02 4.81 E+03 0.00E+00 TC-101 8.10E-05 8.51E-05 1.08E-03 0.00E+00 1.45E-03 5.85E+02 1.63E+01 0.00E+00 RU-103 2.79E+03 0.00E+00 1.07E+03 0.00E+00 7.03E+03 6.62E+05 4.48E+04 0.00E+00 RU-105 1.53E+00 0.OOE+00 5.55E-01 0.OOE+00 1.34E+00 1.59E+04 9.95E+04 0.OOE+00 RU-1 06 1.36E+05 0.OOE+00 1.69E+04 0.OOE+00 1.84E+05 1.43E+07 4.29E+05 0.OOE+00 RH-105 1.45E+01 7.77E+00 6.62E+00 0.00E+00 3.10E+01 2.89E+04 4.92E+04 0.OOE+00 PD-107 0.OOE+00 9.81E+02 9.29E+01 O.OOE+00 7.29E+03 1.17E+05 2.69E+03 0.OOE+00 PD-109 0.00E+00 5.48E+00 1.83E+00 0.OOE+00 2.61E+01 2.28E+04 9.58E+04 0.OOE+00 AG-11Orn 1.69E+04 1.14E+04 9.14E+03 0.OOE+00 2.12E+04 5.48E+06 1.OOE+05 0.OOE+00 AG-111 6.70E+02 2.1OE+02 1.39E+02 0.OOE+00 6.33E+02 2.86E+05 1.1OE+05 0.OOE+00 CD-i 13m 0.OOE+00 1.82E+06 7.84E+04 0.OOE+00 1.90E+06 2.57E+06 6.03E+04 0.OOE+00 CD-115m 0.OOE+00 2.92E+05 1.25E+04 0.OOE+00 2.19E+05 2.17E+06 1.84E+05 0.OOE+00 SN-123 4.77E+05 7.92E+03 1.55E+04 8.40E+03 0.OOE+00 3.55E+06 1.50E+05 0.OOE+00 SN-125 1.83E+04 3.68E+02 1.09E+03 3.81iE+02 0.OOE+00 8.99E+05 2.65E+05 0.OOE+00 SN-126 2.31E+06 3.85E+04 8.73E+04 1.05E+04 0.OOE+00 1.12E+07 6.03E+04 0.OOE+00 SB-1 24 5.66E+06 7.40E+02 2.OOE+04 1.26E+02 0.OOE+00 3.24E+06 1.64E+05 0.OOE+00 SB-125 9.84E+04 7.59E+02 1.99E+04 9.10E+01 0.OOE+00 2.32E+06 4.03E+04 0.OOE+00 SB-126 6.36E+03 9.69E+01 2.28E+03 3.70E+01 0.OOE+00 1.06E+06 2.1OE+05 0.OOE+00 SB-127 5.03E+02 7.73E+00 1.74E+02 5.59E+00 0.OOE+00 2.28E+05 1.41E+05 0.OOE+00 TE-125m 6.73E+03 2.33E+03 9.14E+02 1.92E+03 0.OOE+00 4.77E+05 3.38E+04 0.OOE+00 TE-127m 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 0.OOE+00 TE-127 2.77E+00 9.51E-01 6.11E-01 1.96E+00 7.07E+00 1.OOE+04 5.62E+04 0.OOE+00 TE-129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 0.OOE+00 TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 0.OOE+00 TE-133m 1.08E-01 5.59E-02 5.55E-02 8.58E-02 3.74E-01 5.92E+03 1.76E+04 0.OOE+00 11.4-152 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-30 (Page 2 of 4) Child Inhalation R, mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 1.31 E+01 0.00E+00 5.25E-01 0.OOE+00 0.00E+00 2.40E+04 2.42E+05 0.OOE+00 Y-92 2.04E+01 0.OOE+00 5.81 E-01 0.OOE+00 0.OOE+00 2.39E+04 2.39E+05 0.00E+00 Y-93 1.87E+02 0.OOE+00 5.11 E+00 0.OOE+00 0.OOE+00 7.44E+04 3.89E+05 0.OOE+00 NB-93m 4.70E+05 1.17E+05 3.85E+04 0.OOE+00 1.26E+05 3.85E+05 9.07E+03 0.OOE+00 NB-95 2.35E+04 9.18E+03 6.55E+03 0.00E+00 8.62E+03 6.14E+05 3.70E+04 0.OOE+00 NB-97 4.29E-01 7.70E-02 3.60E-02 0.OOE+00 8.55E-02 3.42E+03 2.78E+04 0.OOE+00 ZR-93 7.66E+05 2.89E+05 2.05E+05 0.OOE+00 1.11E+06 2;63E+06 5.44E+04 0.OOE+00 ZR-95 1.90E+05 4.18E+04 3.70E+04 0.00E+00 5.96E+04 2.23E+06 6.11E+04 0.OOE+00 ZR-97 1.88E+02 2.72E+01 1.60E+01 0.OOE+00 3.89E+01 1.13E+05 3.51E+05 0.OOE+00 MO-93 0.OOE+00 1.39E+04 5.OOE+02 0.OOE+00 3.92E+03 6.29E+05 1.40E+04 0.OOE+00 MO-99 0.OOE+00 1.72E+02 4.26E+01 0.OOE+00 3.92E+02 1.35E+05 1.27E+05 0.00E+00 TC-99 4.96E+02 5.51 E+02 1.98E+02 0.00E+00 6.48E+03 1.25E+06 2.87E+04 0.OOE+00 TC-99m 1.78E-03 3.48E-03 5.77E-02 0.OOE+00 5.07E-02 9.51 E+02 4.81 E+03 0.OOE+00 TC-101 8.1OE-05 8.51E-05 1.08E-03 0.OOE+00 1.45E-03 5.85E+02 1.63E+01 0.00E+00 RU-103 2.79E+03 0.00E+00 1.07E+03 0.OOE+00 7.03E+03 6.62E+05 4.48E+04 0.OOE+00 RU-105 1.53E+00 0.OOE+00 5.55E-01 0.OOE+00 1.34E+00 1;59E+04 9.95E+04 0.OOE+00 RU-106 1.36E+05 0.00E+00 1.69E+04 0.00E+00 1.84E+05 1.43E+07 4.29E+05 0.00E+00 RH-1 05 1.45E+01 7.77E+00 6.62E+00 0.OOE+00 3.10E+01 2;89E+04 4.92E+04 0.OOE+00 PD-1 07 0.OOE+00 9.81E+02 9.29E+01 0.OOE+00 7.29E+03 1.17E+05 2.69E+03 0.OOE+00 PD-109 0.OOE+00 5.48E+00 1.83E+00 0.OOE+00 2.61E+01 2.28E+04 9.58E+04 0.OOE+00 AG-110m 1.69E+04 1.14E+04 9.14E+03 0.OOE+00 2.12E+04 5.48E+06 1.OOE+05 0.OOE+00 AG-111 6.70E+02 2.1OE+02 1.39E+02 0.OOE+00 6.33E+02 2.86E+05 1.1OE+05 0.OOE+00 CD-1 13m 0.OOE+00 1.82E+06 7.84E+04 0.OOE+00 1.90E+06 2.57E+06 6.03E+04 0.OOE+00 CD-115m 0.OOE+00 2.92E+05 1.25E+04 0.OOE+00 2.19E+05 2.17E+06 1.84E+05 0.OOE+00 SN-123 4.77E+05 7.92E+03 1.55E+04 8.40E+03 0.OOE+00 3.55E+06 1.50E+05 0.OOE+00 SN-125 1.83E+04 3.68E+02 1.09E+03 3181E+02 0.OOE+00 8.99E+05 2.65E+05 0.OOE+00 SN-126 2.31E+06 3.85E+04 8.73E+04 1.05E+04 O.OOE+00 1.12E+07 6.03E+04 0.OOE+00 SB-1 24 5.66E+06 7.40E+02 2.OOE+04 1.26E+02 0.OOE+00 3124E+06 1.64E+05 0.OOE+00 SB-1 25 9.84E+04 7.59E+02 1.99E+04 9.1OE+01 0.OOE+00 2.32E+06 4.03E+04 0.OOE+00 SB-126 6.36E+03 9.69E+01 2.28E+03 3.70E+01 0.OOE+00 1.06E+06 2.1OE+05 0.OOE+00 SB-127 5.03E+02 7.73E+00 1.74E+02 5.59E+00 0.OOE+00 2.28E+05 1.41E+05 0.OOE+00 TE-125m 6.73E+03 2.33E+03 9.14E+02 1.92E+03 0.OOE+00 4.77E+05 3.38E+04 0.OOE+00 TE-127m 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 0.OOE+00 TE-127 2.77E+00 9.51E-01 6.11E-01 1.96E+00 7.07E+00 1.00E+04 5.62E+04 0.OOE+00 TE-129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 0.00E+00 TE-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 0.OOE+00 TE-133m 1.08E-01 5.59E-02 5.55E-02 8.58E-02 3.74E-01 5.92E+03 1.76E+04 0.OOE+00 11.4-152 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-30 (Page 3 of 4) Child Inhalation Ri mrem*m 3/yr*lpCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 5.66E-02 3.26E-02 3.48E-02 4.59E-02 2.11E-01 4.55E+03 1.80E+03 0.OOE+00 1-129 3.89E+04 2.37E+04 2.11E+04 1.58E+07 4.OOE+04 0.00E+00 7.96E+02 0.OOE+00 1-130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 0.OOE+00 5.11EE+03 0.00E+00 1-131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 0.OOE+00 2.84E+03 0.O0E+00 TE-131m 1.34E+02 5.92E+01 5.07E+01 9.77E+01 4.00E+02 2.06E+05 3.08E+05 0.00E+00 TE-131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 2.05E+03 1.33E+03 0.OOE+00 1-132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 0.00E+00 3.20E+03 0.OOE+00 TE-132 4.81E+02 2.72E+02 2.63E+02 3.18E+02 1.77E+03 3.77E+05 1.38E+05 0.OOE+00 1-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 0.00E+00 5.48E+03 O.00E+00 CS-134m 2.34E+02 3.30E+02 2.26E+02 0.OOE+00 1.83E+02 3.09E+01 2.93E+02 0.OOE+00 CS-134 6.51E+05 1.01E+06 2.25E+05 0.OOE+00 3.30E+05 1.21E+05 3.85E+03 0.OOE+00 1-134 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 0.OOE+00 9.55E+02 0.OOE+00 1-135 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 0.OOE+00 4.44E+03 0.OOE+00 CS-135 2.31E+05 1.53E+05 1.65E+04 0.OOE+00 5.66E+04 1.93E+04 8.03E+02 0.OOE+00 CS-136 6.51E+04 1.71E+05 1.16E+05 0.OOE+00 9.55E+04 1.45E+04 4.18E+03 0.OOE+00 CS-1 37 9.07E+05 8.25E+05 1.28E+05 0.OOE+00 2.82E+05 1.04E+05 3.62E+03 0.00E+00 CS-138 6.33E+02 8.40E+02 5.55E+02 0.OOE+00 6.22E+02 6.81E+01 2.70E+02 0.OOE+00 CS-139 4.03E+02 4.26E+02 2.15E+02 0.OOE+00 3.36E+02 3.46E+01 2.68E-02 0.OOE+00 BA-1 39 1.84E+00 9.84E-04 5.37E-02 0.OOE+00 8.62E-04 5.77E+03 5.77E+04 0.00E+00 BA-140 7.40E+04 6.48E+01 4.33E+03 0.00E+00 2.11E+01 1.74E+06 1.02E+05 0.OOE+00 LA-140 6.44E+02 2.25E+02 7.55E+01 0.OOE+00 0.OOE+00 1.83E+05 2.26E+05 0.OOE+00 BA-141 1.96E-01 1.09E-04 6.36E-03 0.OOE+00 9.47E-05 2.92E+03 2.75E+02 0.OOE+00 LA-141 8.47E+00 1.96E+00 4.26E-01 0.OOE+00 0.OOE+00 1.66E+04 1.62E+05 0.OOE+00 CE-141 3.92E+04 1.95E+04 2.90E+03 0.OOE+00 8.55E+03 5.44E+05 5.66E+04 0.OOE+00 BA-142 5.OOE-02 3.60E-05 2.79E-03 0.OOE+00 2.91E-05 1.64E+03 2.74E+00 0.OOE+00 LA-142 1.30E+00 4.11E-01 1.29E-01 0.OOE+00 0.OOE+00 8.70E+03 7.59E+04 0.OOE+00 CE-143 3.66E+02 1.99E+02 2.88E+01 0.OOE+00 8.36E+01 1.15E+05 1.27E+05 0.OOE+00 PR-143 1.85E+04 5.55E+03 9.14E+02 0.OOE+00 3.OOE+03 4.33E+05 9.73E+04 0.OOE+00 CE-144 6.77E+06 2.12E+06 3.62E+05 0.OOE+00 1.17E+06 1.20E+07 3.89E+05 0.OOE+00 PR-144 5.96E-02 1.85E-02 3.OOE-03 0.OOE+00 9.77E-03 1.57E+03 1.97E+02 0.OOE+00 ND-147 1.08E+04 8.73E+03 6.81E+02 0.OOE+00 4.81E+03 3.28E+05 8.21E+04 0.OOE+00 PM-147 1.30E+06 9.32E+04 5.03E+04 0.00E+00 1.65E+05 8.14E+05 2.11E+04 0.OOE+00 PM-148m 1.22E+05 2.42E+04 2.42E+04 0.OOE+00 3.60E+04 2.12E+06 1.32E+05 0.OOE+00 PM-148 5.96E+03 7.18E+02 4.63E+02 0.OOE+00 1.22E+03 4.59E+05 2.22E+05 0.OOE+00 PM-149 5.44E+02 5.77E+01 3.13E+01 0.OOE+00 1.02E+02 8.88E+04 1.08E+05 0.OOE+00 PM-151 1.32E+02 1.60E+01 1.04E+01 0.OOE+00 2.72E+01 4.59E+04 9.55E+04 0.OOE+00 SM-151 1.16E+06 1.76E+05 5.51E+04 0.00E+00 1.81E+05 5.48E+05 1.27E+04 0.OOE+00 11.4-153 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-30 (Page 4 of 4) Child Inhalation Ri mrem*m 3 /yr*lpCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 2.68E+02 1.67E+02 1.61 E+01 0.OOE+00 5.07E+01 5.07E+04 6.92E+04 0.OOE+00 EU-152 2.75E+06 5.07E+05 5.96E+05 0.OOE+00 2.12E+06 3.33E+06 4.22E+04 0.OOE+00 EU-154 1.01E+07 9.21E+05 8.40E+05 0.OOE+00 4.03E+06 6.14E+06 1.1OE+05 0.OOE+00 EU-155 2.07E+06 1.50E+05 1.18E+05 0.00E+00 5.59E+05 1.03E+06 1.99E+05 0.OOE+00 EU-156 2.92E+04 1.57E+04 3.24E+03 0.OOE+00 1.01E+04 9.40E+05 1.57E+05 0.00E+00 TB-160 2.88E+05 0.OOE+00 3.58E+04 0.00E+00 8.58E+04 1.98E+06 8.44E+04 0.OOE+00 HO-166m 4.96E+06 1.04E+06 8.77E+05 0,00E+00 1.48E+06 4.18E+06 6.03E+04 0.OOE+00 W-181 9.84E+01 2.41E+01 3.33E+00 0.00E+00 0.OOE+00 2.11E+04 9.66E+02 0.OOE+00 W-185 3.07E+03 7.70E+02 1.08E+02 0.OOE+00 0.OOE+00 6.88E+05 4.11E+04 0.OOE+00 W-187 1.63E+01 9.66E+00 4.33E+00 0.OOE+00 0.OOE+00 4.11E+04 9.1OE+04 0.OOE+00 NP-239 4.66E+02 3.35E+01 2.35E+01 0.OOE+00 9.73E+01 5.81E+04 6.40E+04 0.OOE+00 U-232 8.1iOE+08 0.OOE+00 5.77E+07 0.OOE+00 6.18E+07 2.75E+09 1.60E+05 0.OOE+00 U-233 1.72E+08 0.OOE+00 1.04E+07 0.OOE+00 2.82E+07 6.55E+08 1.48E+05 0.OOE+00 U-234 1.65E+08 0.OOE+00 1.02E+07 0.OOE+00 2.76E+07 6.44E+08 1.45E+05 0.OOE+00 U-235 1.58E+08 0.OOE+00 9.58E+06 0.00E+00 2.59E+07 6.03E+08 1.84E+05 0.OOE+00 U-236 1.58E+08 0.OOE+00 9.81E+06 0.OOE+00 2.65E+07 6.18E+08 1.36E+05 0.OOE+00 U-237 5.81 E+02 0.OOE+00 1.54E+02 0.OOE+00 1.68E+03 1.26E+05 4.77E+04 0.OOE+00 U-238 1.51E+08 0.OOE+00 8.95E+06 0.OOE+00 2.42E+07 5.66E+08 1.30E+05 0.OOE+00 NP-237 1.01E+10 5.99E+09 4.40E+08 0.OOE+00 2.74E+09 6.44E+08 1.87E+05 0.OOE+00 NP-238 4.66E+03 8.51 E+02 7.29E+01 0.00E+00 3.02E+02 1.25E+05 9.25E+04 0.OOE+00 PU-238 9.44E+09 5.92E+09 4.48E+08 0.OOE+00 1.65E+09 2.25E+09 1.72E+05 0.OOE+00 PU-239 1.03E+10 6.22E+09 4.74E+08 0.OOE+00 1.77E+09 2.12E+09 1.57E+05 0.OOE+00 PU-240 1.03E+10 6.22E+09 4.70E+08 0.OOE+00 1.76E+09 2.11E+09 1.60E+05 0.OOE+00 PU-241 2.94E+08 6.48E+07 1.08E+07 0.OOE+00 4.07E+07 1.87E+06 3.29E+03 0.OOE+00 PU-242 9.58E+09 5.99E+09 4.55E+08 0.OOE+00 1.70E+09 2.04E+09 1.54E+05 0.OOE+00 PU-244 1.12E+10 6.85E+09 5.22E+08 0.OOE+00 1.95E+09 2.33E+09 2.29E+05 0.OOE+00 AM-241 1.10E+10 6.81E+09 4.59E+08 0.OOE+00 2.82E+09 7.47E+08 1.75E+05 0.OOE+00 AM-242m 1.14E+10 6.51E+09 4.70E+08 0.OOE+00 2.85E+09 3.01E+08 2.21E+05 0.OOE+00 AM-243 1.09E+10 6.59E+09 4.44E+08 0.OOE+00 2.75E+09 7.1OE+08 2.05E+05 0.OOE+00 CM-242 3.51E+08 2.10E+08 1.55E+07 0.OOE+00 4.96E+07 4.85E+08 1.87E+05 0.OOE+00 CM-243 8.58E+09 5.25E+09 3.68E+08 0.OOE+00 1.38E+09 7.77E+08 1.84E+05 0.00E+00 CM-244 7.18E+09 4.37E+09 3.07E+08 0.OOE+00 1.13E+09 7.47E+08 1.78E+05 0.OOE+00 CM-245 1.13E+10 6.81E+09 4.74E+08 0.OOE+00 1.86E+09 7.22E+08 1.66E+05 0.OOE+00 CM-246 1.12E+10 6.81EE+09 4.74E+08 0.OOE+00 1.86E+09 7.36E+08 1.63E+05 0.OOE+00 CM-247 1.09E+10 6.73E+09 4.66E+08 0.OOE+00 1.83E+09 7.22E+08 2.15E+05 0.OOE+00 CM-248 9.07E+10 5.55E+10 3.85E+09 0.OOE+00 1.51E+10 5.96E+09 3.46E+06 0.OOE+00 CF-252 8.07E+09 0.OOE+00 3.45E+08 0.OOE+00 0.OOE+00 2.45E+09 6.81E+05 0.OOE+00 11.4-154 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-31 (Page 1 of 4) Teen Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 0.00E+00 C-14 2.60E+04 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 0.OOE+00 NA-22 1.41E+05 1.41E+05 1.41E+05 1.41E+05 1.41E+05 1.41E+05 1.41E+05 0.OOE+00 NA-24 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 0.OOE+00 P-32 1.89E+06 1.10E+05 7.16E+04 0.OOE+00 0.00E+00 0.OOE+00 9.28E+04 O.OOE+00 CA-41 3.24E+05 0.O0E+00 3.50E+04 O.00E+00 1.08E+06 8.08E+08 2.38E+05 0.OOE+00 SC-46 5.79E+05 1.13E+06 3.34E+05 7.50E+01 3.07E+01 2.1OE+04 3.OOE+03 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 1.35E+02 7.50E+01 3.07E+01 2.1OE+04 3.OOE+03 0.OOE+00 MN-54 0.00E+00 5.11 E+04 8.40E+03 O.00E+00 1.27E+04 1.98E+06 6.68E+04 0.OOE+00 FE-55 3.34E+04 2.38E+04 5.54E+03 0.OOE+00 0.OOE+00 1.24E+05 6.39E+03 0.OOE+00 MN-56 0.OOE+00 1.70E+00 2.52E-01 O.OOE+00 1.79E+00 1.52E+04 5.74E+04 0.OOE+00 CO-57 O.OOE+00 9.44E+02 9.20E+02 O.OOE+00 0.0OE+00 5.86E+05 3.14E+04 0.OOE+00 CO-58 0.OOE+00 2.07E+03 2.78E+03 0.00E+00 0.OOE+00 1.34E+06 9.52E+04 0.OOE+00 FE-59 1.59E+04 3.70E+04 1.43E+04 0.OOE+00 0.00E+00 1.53E+06 1.78E+05 0.OOE+00 CO-60 0.OOE+00 1.51 E+04 1.98E+04 0.OOE+00 0.OOE+00 8.72E+06 2.59E+05 0.OOE+00 NI-59 4.35E+04 1.62E+04 7.39E+03 0.OOE+00 0.00E+00 1.13E+05 5.18E+03 0.OOE+00 NI-63 5.80E+05 4.34E+04 1.98E+04 0.OOE+00 0.OOE+00 3.07E+05 1.42E+04 0.OOE+00 CU-64 0.OOE+00 2.03E+00 8.48E-01 0.OOE+00 6.41E+00 1.11E+04 6.14E+04 0.OOE+00 NI-65 2.18E+00 2.93E-01 1.27E-01 O.0OE+00 0.OOE+00 9.36E+03 3.67E+04 0.OOE+00 ZN-65 3.86E+04 1.34E+05 6.24E+04 0.OOE+00 8.64E+04 1.24E+06 4.66E+04 0.OOE+00 ZN-69m 1.15E+01 2.47E+01 2.49E+00 0.OOE+00 1.65E+01 3.14E+04 1.71E+05 0.00E+00 ZN-69 4.83E-02 9.20E-02 6.46E-03 0.OOE+00 6.02E-02 1.58E+03 2.85E+02 0.OOE+00 SE-79 0.OOE+00 4.34E+03 6.97E+02 0.OOE+00 6.50E+03 6.17E+05 2.82E+04 0.OOE+00 BR-82 0.OOE+00 0.00E+00 1.82E+04 0.OOE+00 0.OOE+00 0.OOE+00 8.OOE-15 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 3.44E+02 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.00E+00 4.33E+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.O0E+00 0.OOE+00 1.83E+01 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 RB-86 O.OOE+00 1.90E+05 8.40E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.77E+04 0.00E+00 RB-87 0.OOE+00 1.12E+05 3.66E+04 0.OOE+00 0.OOE+00 0.OOE+00 2.44E+03 0.OOE+00 RB-88 0.OOE+00 5.46E+02 2.72E+02 0.OOE+00 0.OOE+00 0.OOE+00 2.92E-05 0.OOE+00 RB-89 0.00E+00 3.52E+02 2.33E+02 0.OOE+00 0.OOE+00 0.OOE+00 3.38E-07 0.OOE+00 SR-89 4.34E+05 0.OOE+00 1.25E+04 0.OOE+00 0.OOE+00 2.42E+06 3.71E+05 0.OOE+00 SR-90 1.08E+08 0.OOE+00 6.68E+06 0.OOE+00 0.OOE+00 1.65E+07 7.65E+05 0.OOE+00 Y-90 2.98E+03 0.00E+00 8.OOE+01 0.OOE+00 0.00E+00 2.93E+05 5.59E+05 0.OOE+00 SR-91 8.80E+01 0.00E+00 3.51E+00 0.OOE+00 0.00E+00 6.07E+04 2.59E+05 0.00E+00 Y-91m 3.70E-01 0.00E+00 1.42E-02 0.OOE+00 0.OOE+00 3.20E+03 3.02E+01 0.OOE+00 Y-91 6.61E+05 0.OOE+00 1.77E+04 0.OOE+00 0.OOE+00 2.94E+06 4.09E+05 0.OOE+00 11.4-155 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-31 (Page 2 of 4) Teen Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 9.52E+00 0.OOE+00 4.06E-01 0.OOE+00 0.00E+00 2.74E+04 1.19E+05 0.OOE+00 Y-92 1.47E+01 0.00E+00 4.29E-01 0.OOE+00 0.OOE+00 2.68E+04 1.65E+05 0.00E+00 Y-93 1.35E+02 0.00E+00 3.72E+00 0.OOE+00 0.OOE+00 8.32E+04 5.79E+05 0.OOE+00 NB-93m 3.31 E+05 1.09E+05 2.73E+04 0.OOE+00 1.27E+05 4.29E+05 2.02E+04 0.00E+00 NB-95 1.86E+04 1.03E+04 5.66E+03 0.00E+00 1.00E+04 7.51 E+05 9.68E+04 0.00E+00 NB-97 3.14E-01 7.78E-02 2.84E-02 0.00E+00 9.12E-02 3.93E+03 2.17E+03 0.00E+00 ZR-93 5.46E+05 2.70E+05 1.47E+05 0.00E+00 9.28E+05 2.94E+06 1.28E+05 0.00E+00 ZR-95 1.46E+05 4.58E+04 3.15E+04 0.00E+00 6.74E+04 2.69E+06 1.49E+05 0.00E+00 ZR-97 1.38E+02 2.72E+01 1.26E+01 0.00E+00 4.12E+01 1.30E+05 6.30E+05 0.00E+00 MO-93 0.OOE+00 1.33E+04 3.62E+02 0.00E+00 4.05E+03 7.05E+05 3.19E+04 0.00E+00 MO-99 0.00E+00 1.69E+02 3.22E+01 0.00E+00 4.11E+02 1.54E+05 2.69E+05 O.00E+00 TC-99 3.58E+02 5.26E+02 1.43E+02 0.00E+00 6.68E+03 1.39E+06 6.39E+04 0.OOE+00 TC-99m 1.38E-03 3.86E-03 4.99E-02 0.OOE+00 5.76E-02 1.15E+03 6.13E+03 0.00E+00 TC-1 01 5.92E-05 8.40E-05 8.24E-04 0.OOE+00 1.52E-03 6.67E+02 8.72E-07 0.00E+00 RU-1 03 2.10E+03 0.OOE+00 8.96E+02 0.OOE+00 7.43E+03 7.83E+05 1.09E+05 0.OOE+00 RU-105 1.12E+00 0.00E+00 4.34E-01 0.OOE+00 1.41E+00 1.82E+04 9.04E+04 0.00E+00 RU-106 9.84E+04 0.OOE+00 1.24E+04 0.OOE+00 1.90E+05 1.61E+07 9.60E+05 0.00E+00 RH-1 05 1.06E+01 7.58E+00 4.99E+00 0.OOE+00 3.23E+01 3.27E+04 9.84E+04 0.OOE+00 PD-107 0.OOE+00 9.36E+02 6.71E+01 0.OOE+00 7.51E+03 1.30E+05 5.99E+03 0.OOE+00 PD-109 0.00E+00 5.25E+00 1.33E+00 0.OOE+00 2.69E+01 2.55E+04 1.57E+05 0.00E+00 AG-110m 1.38E+04 1.31E+04 7.99E+03 0.00E+00 2.50E+04 6.75E+06 2.73E+05 0.OOE+00 AG-1 11 4.86E+02 2.02E+02 1.02E+02 0.OOE+00 6.54E+02 3.20E+05 2.40E+05 0.OOE+00 CD-i 13m 0.OOE+00 1.74E+06 5.68E+04 0.OOE+00 1.94E+06 2.87E+06 1.34E+05 0.00E+00 CD-115m 0.OOE+00 2.78E+05 9.12E+03 0.OOE+00 2.26E+05 2.42E+06 4.08E+05 0.00E+00 SN-1 23 3.45E+05 7.55E+03 1.12E+04 6.04E+03 0.OOE+00 3.97E+05 3.33E+05 0.OOE+00 SN-125 1.33E+04 3.54E+02 7.99E+02 2.76E+02 0.OOE+00 1.01E+06 5.83E+05 0.OOE+00 SN-126 1.74E+06 4.31iE+04 6.59E+04 1.14E+04 0.OOE+00 1.38E+07 1.34E+05 0.OOE+00 SB-124 4.30E+04 7.94E+02 1.68E+04 9.76E+01 0.OOE+00 3.85E+06 3.98E+05 0.OOE+00 SB-1 25 7.38E+04 8.08E+02 1.72E+04 7.04E+01 0.OOE+00 2.74E+06 9.92E+04 0.OOE+00 SB-126 4.95E+03 1.02E+02 1.78E+03 2.80E+01 0.OOE+00 1.24E+06 4.81E+05 0.OOE+00 SB-127 3.71E+02 7.94E+00 1.40E+02 4.17E+00 0.OOE+00 2.65E+05 3.15E+05 0.OOE+00 TE-125m 4.88E+03 2.24E+03 6.67E+02 1.40E+03 0.OOE+00 5.36E+05 7.50E+04 0.OOE+00 TE-127m 1.80E+04 8.16E+03 2.18E+03 4.38E+03 6.54E+04 1.66E+06 1.59E+05 0.OOE+00 TE-127 2.01E+00 9.12E-01 4.42E-01 1.42E+00 7.28E+00 1.12E+04 8.08E+04 0.OOE+00 TE-129m 1.39E+04 6.58E+03 2.25E+03 4.58E+03 5.19E+04 1.98E+06 4.05E+05 0.OOE+00 TE-129 7.1OE-02 3.38E-02 1.76E-02 5.18E-02 2.66E-01 3.30E+03 1.62E+03 0.OOE+00 TE-133m 8.08E-02 5.86E-02 4.57E-02 6.54E-02 2.46E-01 6.97E+03 9.84E+02 0.OOE+00 11.4-156 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-31 (Page 3 of 4) Teen Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 4.25E-02 3.48E-02 2.91E-02 3.57E-02 2.33E-01 5.38E+03 1.10E+01 0.OOE+00 1-129 2.82E+04 2.35E+04 7.12E+04 2.93E+07 4.21EE+04 0.OOE+00 1.83E+03 0.OOE+00 1-130 6.24E+03 1.79E+04 7.17E+03 1.49E+06 2.75E+04 0.00E+00 9.12E+03 0.00E+00 1-131 3.54E+04 4.91 E+04 2.64E+04 1.46E+07 8.40E+04 0.OOE+00 6.49E+03 0.OOE+00 TE-131m 9.84E+01 6.01E+01 4.02E+01 7.25E+01 4.39E+02 2.38E+05 6.21E+05 0.00E+00 TE-131 1.58E-02 8.32E-03 5.04E-03 1,24E-02 6.18E-02 2.34E+03 1.51E+01 0.OOE+00 1-132 1.59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 0.OOE+00 1.27E+03 0.OOE+00 TE-132 3.60E+02 2.90E+02 2.19E+02 2.46E+02 1.95E+03 4.49E+05 4.63E+05 0.OOE+00 1-133 1.22E+04 2.05E+04 6.22E+03 2.92E+06 3.59E+04 0.OOE+00 1.03E+04 0.00E+00 CS-134m 1.76E+02 3.48E+02 1.88E+02 0.OOE+00 2.03E+02 3.65E+01 1.62E+02 0.OOE+00 CS-134 5.02E+05 1.13E+06 5.49E+05 0.OOE+00 3.75E+05 1.46E+05 9.76E+03 O.OOE+00 1-134 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 0.OOE+00 2.04E+01 0.00E+00 1-135 3.70E+03 9.44E+03 3.49E+03 6.21 E+05 1.49E+04 0.OOE+00 6.95E+03 0.00E+00 CS-135 1.66E+05 1.46E+05 3.58E+04 0.OOE+00 5.84E+04 2.16E+04 1.78E+03 0.OOE+00 CS-136 5.15E+04 1.94E+05 1.37E+05 0.OOE+00 1.10E+05 1.78E+04 1.09E+04 0.OOE+00 CS-137 6.70E+05 8.48E+05 3.11E+05 0.OOE+00 3.04E+05 1.21E+05 8.48E+03 0.OOE+00 CS-138 4.66E+02 8.56E+02 4.46E+02 0.OOE+00 6.62E+02 7.87E+01 2.70E-01 0.00E+00 CS-139 2.92E+02 4.10E+02 1.58E+02 0.OOE+00 3.47E+02 3.89E+01 1.33E-13 0.OOE+00 BA-139 1.34E+00 9.44E-04 3.90E-02 0.OOE+00 8.88E-04 6.46E+03 6.45E+03 0.OOE+00 BA-140 5.47E+04 6.70E+01 3.52E+03 0.00E+00 2.28E+01 2.03E+06 2.29E+05 0.OOE+00 LA-140 4.79E+02 2.36E+02 6.26E+01 0.OOE+00 0.00E+00 2.14E+05 4.87E+05 0.OOE+00 BA-141 1.42E-01 1.06E-04 4.74E-03 0.OOE+00 9.84E-05 3.29E+03 7.46E-04 0.OOE+00 LA-141 6.1OE+00 1.88E+00 3.10E-01 0.OOE+00 0.OOE+00 1.85E+04 1.23E+05 0.OOE+00 CE-141 2.84E+04 1.90E+04 2.17E+03 0.OOE+00 8.88E+03 6.14E+05 1.26E+05 0.OOE+00 BA-142 3.70E-02 3.70E-05 2.27E-03 0.OOE+00 3.14E-05 1.91E+03 4.79E-10 0.OOE+00 LA-142 9.60E-01 4.25E-01 1.06E-01 0.OOE+00 0.OOE+00 1.02E+04 1.20E+04 0.OOE+00 CE-143 2.66E+02 1.94E+02 2.16E+01 0.OOE+00 8.64E+01 1.30E+05 2.55E+05 0.OOE+00 PR-143 1.34E+04 5.31E+03 6.62E+02 0.OOE+00 3.09E+03 4.83E+05 2.14E+05 0.OOE+00 CE-144 4.89E+06 2.02E+06 2.62E+05 0.OOE+00 1.21E+06 1.34E+07 8.64E+05 0.00E+00 PR-144 4.30E-02 1.76E-02 2.18E-03 0.OOE+00 1.01E-02 1.75E+03 2.35E-04 0.OOE+00 ND-147 7.86E+03 8.56E+03 5.13E+02 0.OOE+00 5.02E+03 3.72E+05 1.82E+05 0.OOE+00 PM-147 9.20E+05 8.80E+04 3.60E+04 0.OOE+00 1.68E+05 9.12E+05 4.70E+04 0.OOE+00 PM-148m 1.06E+05 2.68E+04 2.1OE+04 0.OOE+00 4.06E+04 2.56E+06 3.28E+05 0.OOE+00 PM-148 4.35E+03 7.1OE+02 3.58E+02 0.OOE+00 1.28E+03 5.22E+05 4.91E+05 0.OOE+00 PM-149 3.93E+02 5.51E+01 2.27E+01 0.OOE+00 1.05E+02 9.92E+04 2.23E+05 0.OOE+00 PM-151 9.60E+01 1.59E+01 8.08E+00 0.OOE+00 2.86E+01 4.52E+04 1.82E+05 0.OOE+00 SM-151 8.56E+05 1.68E+05 3.89E+04 0.OOE+00 1.82E+05 6.14E+05 2.82E+04 0.OOE+00 11.4-157 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-31 (Page 4 of 4) Teen Inhalation Ri mrem*m3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.94E+02 1.61E+02 1.18E+01 0.OOE+00 5.25E+01 5.69E+04 1.42E+05 0.OOE+00 EU-152 2.37E+06 5.75E+05 5.04E+05 0.OOE+00 2.67E+06 4.01EE+06 1.08E+05 0.OOE+00 EU-154 7.54E+06 9.84E+05 6.88E+05 0.OOE+00 4.35E+06 7.30E+06 2.67E+05 0.00E+00 EU-155 1.60E+06 1.57E+05 9.68E+04 0.OOE+00 6.12E+05 1.21E+07 4.78E+05 0.0OE+00 EU-156 2.16E+04 1.62E+04 2.64E+03 0.OOE+00 1.09E+04 1.1OE+06 3.65E+05 0.OOE+00 TB-160 2.43E+05 0.OOE+00 3.03E+04 0.OOE+00 9.60E+04 3.18E+06 2.08E+05 0.OOE+00 HO-166m 3.52E+06 1.25E+06 7.90E+05 0.00E+00 1.60E+06 4.99E+06 1.34E+05 0.OOE+00 W-181 7.12E+01 2.30E+01 2.41E+00 0.OOE+00 0.OOE+00 2.36E+04 2.15E+03 0.OOE+00 W-185 2.22E+03 7.34E+02 7.78E+01 O.OOE+00 O.OOE+00 7.68E+05 9.12E+04 0.OOE+00 W-187 1.20E+01 9.76E+00 3.43E+00 0.O0E+00 0.OOE+00 4.74E+04 1.77E+05 0.OOE+00 NP-239 3.38E+02 3.19E+01 1.77E+01 O.OOE+00 1.OOE+02 6.49E+04 1.32E+05 0.OOE+00 U-232 5.85E+08 0.OOE+00 4.18E+07 0.OOE+00 6.35E+07 3.07E+09 3.57E+05 0.OOE+00 U-233 1.24E+08 0.OOE+00 7.54E+06 0.OOE+00 2.90E+07 7.34E+08 3.30E+05 0.O0E+00 U-234 1 .18E+08 O.OOE+00 7.38E+06 0.OOE+00 2.84E+07 7.19E+08 3.23E+05 0.OOE+00 U-235 1.14E+08 0.00E+00 6.94E+06 0.OOE+00 2.67E+07 6.75E+08 4.10E+05 0.OOE+00 U-236 1.14E+08 0.OOE+00 7.09E+06 0.OOE+00 2.73E+07 6.90E+08 3.03E+05 O.OOE+00 U-237 4.20E+02 O.OOE+00 1.12E+02 0.OOE+00 1.73E+03 1.41E+05 1.03E+05 O.OOE+00 U-238 1.09E+08 0.OOE+00 6.48E+06 0.OOE+00 2.50E+07 6.31 E+08 2.90E+05 0.OOE+00 NP-237 1.31E+10 8.48E+09 5.77E+08 0.OOE+00 4.28E+09 7.19E+08 4.18E+05 0.OOE+00 NP-238 3.38E+03 8.16E+02 5.27E+01 0.OOE+00 3.1OE+02 1.40E+05 1.90E+05 0.OOE+00 PU-238 1.20E+10 8.24E+09 5.78E+08 0.OOE+00 2.48E+09 2.50E+09 3.83E+05 0.OOE+00 PU-239 1.38E+10 8.96E+09 6.44E+08 0.OOE+00 2.75E+09 2.34E+09 3.50E+05 0.OOE+00 PU-240 1.38E+10 8.96E+09 6.43E+08 0.OOE+00 2.74E+09 2.34E+09 3.57E+05 0.OOE+00 PU-241 2.99E+08 7.65E+07 1.12E+07 0.OOE+00 5.18E+07 2.08E+06 7.34E+03 0.OOE+00 PU-242 1.28E+10 8.64E+09 6.20E+08 0.OOE+00 2.65E+09 2.26E+09 3.43E+05 0.00E+00 PU-244 1.50E+10 9.92E+09 7.1OE+08 0.00E+00 3.03E+09 2.58E+09 5.11E+05 0.OOE+00 AM-241 1.42E+10 9.60E+09 5.68E+08 0.00E+00 4.26E+09 8.40E+08 3.90E+05 0.OOE+00 AM-242m 1.43E+10 9.04E+09 5.72E+08 0oOOE+00 4.24E+09 3.37E+08 4.91E+05 0.OOE+00 AM-243 1.42E+10 9.36E+09 5.56E+08 0.OOE+00 4.17E+09 7.93E+08 4.58E+05 0.OOE+00 CM-242 2.54E+08 2.01E+08 1.13E+07 0.OOE+00 5.12E+07 5.41E+08 4.17E+05 0.OOE+00 CM-243 9.52E+09 6.64E+09 4.OOE+08 0.OOE+00 1.87E+09 8.72E+08 4.1OE+05 0.OOE+00 CM-244 7.35E+09 5.22E+09 3.1OE+08 0.00E+00 1.45E+09 8.40E+08 3.97E+05 0.OOE+00 CM-245 1.46E+10 9.76E+09 6.02E+08 0.OOE+00 2.82E+09 8.08E+08 3.70E+05 O.OOE+00 CM-246 1.45E+10 9.76E+09 6.02E+08 0.00E+00 2.81E+09 8.24E+08 3.63E+05 0.OOE+00 CM-247 1.42E+10 9.52E+09 5.93E+08 0.OOE+00 2.77E+09 8.08E+08 4.78E+05 0.OOE+00 CM-248 1.18E+11 7.86E+10 4.89E+09 O.OOE+00 2.28E+10 6.66E+09 7.70E+06 0.OOE+00 CF-252 5.73E+09 0.OOE+00 2.46E+08 O.OOE+00 0.OOE+00 2.74E+09 1.51E+06 0.OOE+00 11.4-158 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-32 (Page 1 of 4) Adult Inhalation Ri mrem*m 3/yr*JCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 0.OOE+00 C-14 1.82E+04 3.41E+03 3.41E+03 3.41E+03 3.41E+03 3.41E+03 3.41E+03 0.OOE+00 NA-22 1.04E+05 1.04E+05 1.04E+05 1.04E+05 1.04E+05 1.04E+05 1.04E+05 0.00E+00 NA-24 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 0.00E+00 P-32 1.32E+06 7.71 E+04 5.01 E+04 0.00E+00 0.00E+00 0.OOE+00 8.64E+04 0.OOE+00 CA-41 3.06E+05 0.00E+00 3.30E+04 0.00E+00 0.OOE+00 3.06E+04 2.29E+03 0.OOE+00 SC-46 4.41EE+05 8.56E+05 2.49E+05 0.OOE+00 7.99E+05 O.OOE+00 2.58E+05 0.OOE+00 CR-51 0.00E+00 O.OOE+00 1.OOE+02 5.95E+01 2.28E+01 1.44E+04 3.32E+03 0.00E+00 MN-54 0.00E+00 3.96E+04 6.30E+03 0.OOE+00 9,84E+03 1.40E+06 7,74E+04 O.OOE+00 FE-55 2.46E+04 1.70E+04 3.94E+03 0.OOE+00 0.OOE+00 7.21 E+04 6.03E+03 0.OOE+00 MN-56 0.OOE+00 1.24E+00 1.83E-01 O.OOE+00 1.30E+00 9.44E+03 2.02E+04 0.OOE+00 CO-57 0.OOE+00 6.92E+02 6.71E+02 O.OOE+00 0.OOE+00 3.70E+05 3.14E+04 0.OOE+00 CO-58 0.OOE+00 1.58E+03 2.07E+03 0.OOE+00 0.OOE+00 9.28E+05 1.06E+05 0.OOE+00 FE-59 1.18E+04 2.78E+04 1.06E+04 0.OOE+00 0.OOE+00 1.02E+06 1.88E+05 0.OOE+00 CO-60 0.OOE+00 1.15E+04 1.48E+04 0.OOE+00 0.OOE+00 5.97E+06 2.85E+05 0.OOE+00 NI-59 3.25E+04 1.17E+04 5.42E+03 0.OOE+00 0.OOE+00 6.56E+04 4.89E+03 0.OOE+00 NI-63 4.32E+05 3.14E+04 1.45E+04 0.OOE+00 0.OOE+00 1.78E+05 1.34E+04 0.OOE+00 CU-64 0.00E+00 1.46E+00 6.15E-01 0.OOE+00 4.62E+00 6.78E+03 4.90E+04 0.00E+00 NI-65 1.54E+00 2.10E-01 9.12E-02 0.OOE+00 0.OOE+00 5.60E+03 1.23E+04 0.OOE+00 ZN-65 3.24E+04 1.03E+05 4.66E+04 0.OOE+00 6.90E+04 8.64E+05 5.34E+04 0.00E+00 ZN-69m 8.16E+00 1.96E+01 1.79E+00 0.OOE+00 1.18E+01 1.90E+04 1.37E+05 0.OOE+00 ZN-69 3.38E-02 6.51 E-02 4.52E-03 0.00E+00 4.22E-02 9.20E+02 1.63E+01 0.OOE+00 SE-79 0.OOE+00 3.06E+03 4.87E+02 0.OOE+00 4.55E+03 3.58E+05 2.66E+04 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.35E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.04E+04 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 2.41E+02 0.OOE+00 0.OOE+00 0.00E+00 2.32E+02 0.OOE+00 BR-84 0.OOE+00 0.00E+00 3.13E+02 0.OOE+00 0.OOE+00 0.OOE+00 1.64E-03 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 1.28E+01 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 1.35E+05 5.90E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.66E+04 0.OOE+00 RB-87 0.OOE+00 3.87E+02 2.57E+04 0.OOE+00 0.OOE+00 0.OOE+00 2.30E+03 0.OOE+00 RB-88 0.OOE+00 3.87E+02 1.93E+02 0.OOE+00 0.OOE+00 0.OOE+00 3.34E-09 0.00E+00 RB-89 0.00E+00 2.56E+02 1.70E+02 0.00E+00 0.00E+00 0.00E+00 9.28E-12 0.00E+00 SR-89 3.04E+05 0.OOE+00 8.72E+03 0.OOE+00 0.OOE+00 1.40E+06 3.50E+05 0.OOE+00 SR-90 9.92E+07 0.OOE+00 6.1OE+06 0.OOE+00 0.OOE+00 9.60E+06 7.22E+05 0.OOE+00 Y-90 2.09E+03 0.OOE+00 5.61E+01 0.OOE+00 0.OOE+00 1.70E+05 5.06E+05 0.OOE+00 SR-91 6.19E+01 O.OOE+00 2.50E+00 0.OOE+00 0.OOE+00 3.65E+04 1.91E+05 0.OOE+00 Y-91m 2.61E-01 O.OOE+00 1.02E-02 0.OOE+00 0.OOE+00 1.92E+03 1.33E+00 0.OOE+00 Y-91 4.62E+05 0.OOE+00 1.24E+04 0.OOE+00 0.00E+00 1.70E+06 3.85E+05 0.OOE+00 11.4-159 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-32 (Page 2 of 4) Adult Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 6.74E+00 0.OOE+00 2.91 E-01 0.OOE+00 0.00E+00 1.65E+04 4.30E+04 0.00E+00 Y-92 1.03E+01 0.00E+00 3.02E-01 0.00E+00 0.OOE+00 1.57E+04 7.35E+04 0.OOE+00 Y-93 9.44E+01 0.OOE+00 2.61E+00 0.OOE+00 0.00E+00 4.85E+04 4.22E+05 0.00E+00 NB-93m 2.48E+05 8.08E+04 1.99E+04 0.OOE+00 9.28E+04 2.49E+05 1.90E+04 0.OOE+00 NB-95 1.41 E+04 7.82E+03 4.21 E+03 0.00E+00 7.74E+03 5.05E+05 1.04E+05 0.00E+00 NB-97 2.22E-01 5.62E-02 2.05E-02 0.OOE+00 6.54E-02 2.40E+03 2.42E+02 0.00E+00 ZR-93 4.18E+05 2.34E+04 1.10E+04 0.OOE+00 8.88E+04 1.70E+05 1.21E+04 0.OOE+00 ZR-95 1.07E+05 3.44E+04 2.33E+04 0.OOE+00 5.42E+04 1.77E+06 1.50E+05 0.00E+00 ZR-97 9.68E+01 1.96E+01 9.04E+00 0.00E+00 2.97E+01 7.87E+04 5.23E+05 0.00E+00 MO-93 0.OOE+00 9.36E+03 2.54E+02 0.OOE+00 2.84E+03 4.09E+05 3.03E+04 0.00E+00 MO-99 0.OOE+00 1.21E+02 2.30E+01 0.OOE+00 2.91E+02 9.12E+04 2.48E+05 0.00E+00 TC-99 2.50E+02 3.71E+02 1.00E+02 0.OOE+00 4.68E+03 8.08E+05 6.03E+04 0.00E+00 TC-99m 1.03E-03 2.91E-03 3.70E-02 0.OOE+00 4.42E-02 7.64E+02 4.16E+03 0.OOE+00 TC-101 4.18E-05 6.02E-05 5.90E-04 0.00E+00 1.08E-03 3.99E+02 1.09E-11 0.00E+00 RU-103 1.53E+03 0.OOE+00 6.58E+02 0.00E+00 5.83E+03 5.05E+05 1.10E+05 0.OOE+00 RU-105 7.90E-01 0.OOE+00 3.11E-01 0.OOE+00 1.02E+00 1.10E+04 4.82E+04 0.00E+00 RU-106 6.91E+04 0.00E+00 8.72E+03 0.OOE+00 1.34E+05 9.36E+06 9.12E+05 0.OOE+00 RH-105 7.39E+00 5.38E+00 3.54E+00 0.OOE+00 2.29E+01 1.93E+04 8.72E+04 0.OOE+00 PD-107 0.00E+00 6.62E+02 4.70E+01 0.00E+00 5.26E+03 7.58E+04 5.65E+03 0.00E+00 PD-1 09 0.00E+00 3.70E+00 9.28E-01 0.00E+00 1.88E+01 1.48E+04 1.22E+05 0.00E+00 AG-11im 1.08E+04 1.00E+04 5.94E+03 0.00E+00 1.97E+04 4.63E+06 3.02E+05 0.00E+00 AG-111 3.40E+02 1.42E+02 7.10E+01 0.00E+00 4.59E+02 1.86E+05 2.23E+05 0.00E+00 CD-113m 0.00E+00 1.23E+06 3.98E+04 0.00E+00 1.37E+06 1.66E+06 1.27E+05 0.00E+00 CD-i 15m 0.00E+00 1.97E+05 6.36E+03 0.00E+00 1.58E+05 1.41E+06 3.84E+05 0.00E+00 SN-123 2.42E+05 5.34E+03 7.86E+03 4.54E+03 0.00E+00 2.30E+06 3.14E+05 0.00E+00 SN-1 25 9.28E+03 2.50E+02 5.62E+02 2.07E+02 0.00E+00 5.90E+05 5.45E+05 0.00E+00 SN-126 1.26E+06 3.34E+04 4.80E+04 9.84E+03 0.00E+00 9.36E+06 1.27E+05 0.00E+00 SB-124 3.12E+04 5.89E+02 1.22E+04 7.55E+01 0.00E+00 2.48E+06 4.06E+05 0.00E+00 SB-125 5.34E+04 5.95E+02 1.26E+04 5.40E+01 0.00E+00 1.74E+06 1.01E+05 0.00E+00 SB-126 3.60E+03 7.30E+01 1.30E+03 2.20E+01 0.00E+00 7.66E+05 4.81E+05 0.00E+00 SB-127 2.64E+02 5.78E+00 1.02E+02 3.18E+00 0.00E+00 1.64E+05 3.02E+05 0.00E+00 TE-125m 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+04 3.14E+05 7.06E+04 0.00E+00 TE-127m 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E+04 9.60E+05 1.50E+05 0.00E+00 TE-127 1.40E+00 6.42E-01 3.10E-01 1.06E+00 5.10E+00 6.51E+03 5.74E+04 0.00E+00 TE-129m 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83E+05 0.00E+00 TE-129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E+03 1.57E+02 0.00E+00 TE-133m 5.79E-02 4.32E-02 3.34E-02 5.02E-02 2.99E-01 4.41E+03 4.39E+02 0.00E+00 11.4-160 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-32 (Page 3 of 4) Adult Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 3.07E-02 2.58E-02 1.26E-02 2.75E-02 1.74E-01 3.47E+03 2.38E-01 0.OOE+00 1-129 1.98E+04 1.69E+04 5.53E+04 4.43E+07 3.62E+04 0.OOE+00 1.78E+03 0.OOE+00 1-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 0.00E+00 7.69E+03 0.OOE+00 1-131 2.52E+04 3.58E+04 2.05E+04 1.19E+07 6.13E+04 0.OOE+00 6.28E+03 0.00E+00 TE-131m 6.99E+01 4.36E+01 2.90E+01 5.50E+01 3.09E+02 1.46E+05 5.56E+05 0.00E+00 TE-131 1.11E-02 5.95E-03 3.59E-03 9.36E-03 4.37E-02 1.39E+03 1.84E+01 0.OOE+00 1-132 1.16E+03 3.26E+03 1.16E+03 1.14E+05 5.18E+03 O.0OE+00 4.06E+02 0.00E+00 TE-132 2.60E+02 2.15E+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 5.1OE+05 0.OOE+00 1-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 0.OOE+00 8.88E+03 0.00E+00 CS-134m 1.27E+02 2.56E+02 1.38E+02 O.00E+00 1.46E+02 2.34E+01 6.34E+01 0.00E+00 CS-134 3.73E+05 8.48E+05 7.28E+05 0.OOE+00 2.87E+05 9.76E+04 1.04E+04 0.OOE+00 1-134 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 0.00E+00 1.01E+00 0.00E+00 1-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.11E+04 0.OOE+00 5.25E+03 0.OOE+00 CS-135 1.17E+05 1.03E+05 4.79E+04 0.O0E+00 4.09E+04 1.26E+04 1.69E+03 0.OOE+00 CS-136 3.90E+04 1.46E+05 1.10E-+05 0.OOE+00 8.56E+04 1.20E+04 1.17E+04 0.OOE+00 CS-1 37 4.78E+05 6.21 E+05 4.28E+05 0.00E+00 2.22E+05 7.52E+04 8.40E+03 0.OOE+00 CS-138 3.31E+02 6.21E+02 3.24E+02 0.OOE+00 4.80E+02 4.86E+01 1.86E-03 0.OOE+00 CS-139 2.05E+02 2.90E+02 1.11E+02 0.OOE+00 2.44E+02 2.27E+01 4.39E-21 0.OOE+00 BA-1 39 9.36E-01 6.66E-04 2.74E-02 0.OOE+00 6.22E-04 3.76E+03 8.96E+02 0.OOE+00 BA-140 3.90E+04 4.90E+01 2.57E+03 0.OOE+00 1.67E+01 1.27E+06 2.18E+05 0.00E+00 LA-140 3.44E+02 1.74E+02 4.58E+01 0.OOE+00 0.00E+00 1.36E+05 4.58E+05 0.OOE+00 BA-141 1.O0E-01 7.53E-05 3.36E-03 0.OOE+00 7.OOE-05 1.94E+03 1.16E-07 0.OOE+00 LA-141 4.27E+00 1.33E+00 2.17E-01 0.OOE+00 0.OOE+00 1.08E+04 5.85E+04 0.OOE+00 CE-141 1.99E+04 1.35E+04 1.53E+03 0.OOE+00 6.26E+03 3.62E+05 1.20E+05 0.00E+00 BA-142 2.63E-02 2.70E-05 1.66E-03 0.OOE+00 2.29E-05 1.19E+03 1.57E-16 0.OOE+00 LA-142 6.83E-01 3.10E-01 7.72E-02 0.OOE+00 0.OOE+00 6.33E+03 2.11E+03 0.OOE+00 CE-143 1.86E+02 1.38E+02 1.53E+01 0.OOE+00 6.08E+01 7.98E+04 2.26E+05 0.OOE+00 PR-143 9.36E+03 3.75E+03 4.64E+02 0.OOE+00 2.16E+03 2.81E+05 2.OOE+05 0.OOE+00 CE-144 3.43E+06 1.43E+06 1.84E+05 0.OOE+00 8.48E+05 7.78E+06 8.16E+05 0.OOE+00 PR-144 3.01E-02 1.25E-02 1.53E-03 0.00E+00 7.05E-03 1.02E+03 2.15E-08 0.0OE+00 ND-147 5.27E+03 6.1OE+03 3.65E+02 0.OOE+00 3.56E+03 2.21E+05 1.73E+05 0.OOE+00 PM-147 6.70E+05 6.30E+04 2.55E+04 0.OOE+00 1.19E+05 5.28E+05 4.43E+04 0.OOE+00 PM-148m 7,86E+04 2.03E+04 1,55E+04 0.OOE+00 3.08E+04 1.71E+06 3.34E+05 0.OOE+00 PM-148 3.07E+03 5.10E+02 2.56E+02 0.OOE+00 9.60E+02 3.13E+05 4.64E+05 0.OOE+00 PM-149 2.75E+02 3.90E+01 1.59E+01 0.OOE+00 7.35E+01 5.77E+04 2.OOE+05 0.OOE+00 PM-151 6.80E+01 1.14E+01 5.77E+00 0.OOE+00 2.04E+01 3.15E+04 1.60E+05 0.OOE+00 SM-151 6.87E+05 1.18E+05 2.84E+04 0.OOE+00 1.33E+05 3.56E+05 2.60E+04 0.OOE+00 11.4-161 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-32 (Page 4 of 4) Adult Inhalation Ri mrem*m 3/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.36E+02 1.14E+02 8.32E+00 0.OOE+00 3.67E+01 3.31E+04 1.26E+05 0.00E+00 EU-152 1.90E+06 4.33E+05 3.81 E+05 0.OOE+00 2.68E+06 2.74E÷06 1.27E+05 0.OOE+00 EU-154 5.92E+06 7.28E+05 5.18E+05 0.OOE+00 3.49E+06 4.67E+06 2.72E+05 0.OOE+00 EU-155 8.08E+05 1.14E+05 7.37E+04 0.OOE+00 5.27E+05 7.57E+05 4.76E+04 O.OOE+00 EU-156 1.54E+04 1.18E+04 1.92E+03 0.OOE+00 7.96E+03 6.85E+05 3.60E+05 O.OOE+00 TB-160 1.77E+05 0.OOE+00 2.20E+04 0.OOE+00 7.28E+04 1.54E+06 2.14E+05 0.OOE+00 HO-166m 2.70E+06 8.40E+05 6.40E+05 0.OOE+00 1.26E+06 3.15E+06 1.27E+05 0.OOE+00 W-181 4.98E+01 1.62E+01 1.74E+00 0.OOE+00 0.OOE+00 1.37E+04 2.02E+03 0.OOE+00 W-185 1.56E+03 5.18E+02 5.45E+01 0.OOE+00 0.OOE+00 4.46E+05 8.56E+04 O.OOE+00 W-187 8.48E+00 7.08E+00 2.48E+00 0.O0E+00 0.OOE+00 2.90E+04 1.55E+05 0.OOE+00 NP-239 2.30E+02 2.26E+01 1.24E+01 0.OOE+00 7.OOE+01 3.76E+04 1.19E+05 0.OOE+00 U-232 4.11E+08 0.OOE+00 2.93E+07 0.OOE+00 4.45E+07 1.78E+09 3.37E+05 0.OOE+00 U-233 8.72E+07 0.OOE+00 5.28E+06 0.OOE+00 2.03E+07 4.26E+08 3.11E+05 0.OOE+00 U-234 8.32E+07 0.O0E+00 5.17E+06 0.00E+00 1.99E+07 4.18E+08 3.05E+05 0.OOE+00 U-235 8.OOE+07 O.OOE+00 4.86E+06 0.OOE+00 1.87E+07 3.92E+08 3.87E+05 0.OOE+00 U-236 8.OOE+07 O.OE+00 4.96E+06 0.OOE+00 1.91 E+07 4.OOE+08 2.86E+05 0.OOE+00 U-237 2.94E+02 0.OOE+00 7.82E+01 0.OOE+00 1.21E+03 8.16E+04 9.60E+04 0.OOE+00 U-238 7.66E+07 O.00E+00 4.54E+06 0.OOE+00 1.74E+07 3.66E+08 2.73E+05 0.OOE+00 NP-237 1.25E+10 8.OOE+09 5.50E+08 0.OOE+00 4.08E+09 4.18E+08 3.94E+05 0.OOE+00 NP-238 2.37E+03 5.76E+02 3.69E+01 0,o00E+00 2.18E+02 8.16E+04 1.70E+05 0.OOE+00 PU-238 1.14E+10 7.77E+09 5.52E+08 0.OOE+00 2.37E+09 1.46E+09 3.62E+05 0.OOE+00 PU-239 1.33E+10 8.56E+09 6.20E+08 0.OOE+00 2.64E+09 1.38E+09 3.30E+05 0.OOE+00 PU-240 1.32E+10 8.56E+09 6.18E+08 0.OOE+00 2.63E+09 1.38E+09 3.37E+05 0.OOE+00 PU-241 2.74E+08 6.95E+07 1.03E+07 0.OOE+00 4.74E+07 1.22E+06 6.92E+03 0.OOE+00 PU-242 1.22E+10 8.24E+09 5.97E+08 0.OOE+00 2.54E+09 1.32E+09 3.24E+05 0.OOE+00 PU-244 1.43E+10 9.44E+09 6.83E+08 0.OOE+00 2.91E+09 1.51E+09 4.82E+05 0.OOE+00 AM-241 1.34E+10 9.04E+09 5.37E+08 0.OOE+00 4.03E+09 4.85E+08 3.68E+05 0.OOE+00 AM-242m 1.36E+10 8.48E+09 5.38E+08 0.OOE+00 4.01E+09 1.95E+08 4.63E+05 0.OOE+00 AM-243 1.34E+10 8.80E+09 5.26E+08 0.OOE+00 3.96E+09 4.60E+08 4.32E+05 0.OOE+00 CM-242 1.78E+08 1.42E+08 7.87E+06 0.OOE+00 3.58E+07 3.14E+08 3.93E+05 0.OOE+00 CM-243 8.80E+09 6.09E+09 3.69E+08 0.OOE+00 1.72E+09 5.05E+08 3.87E+05 0.OOE+00 CM-244 6.70E+09 4.70E+09 2.81E+08 0.OOE+00 1.31E+09 4.85E+08 3.74E+05 0.OOE+00 CM-245 1.39E+10 9.12E+09 5.71EE+08 0.OOE+00 2.66E+09 4.68E+08 3.49E+05 0.OOE+00 CM-246 1.38E+10 9.12E+09 5.70E+08 0.OOE+00 2.66E+09 4.77E+08 3.43E+05 O.OOE+00 CM-247 1.34E+10 8.96E+09 5.62E+08 0.OOE+00 2.62E+09 4.68E+08 4.50E+05 0.OOE+00 CM-248 1.12E+11 7.41E+10 4.63E+09 0.OOE+00 2.16E+10 3.86E+09 7.27E+06 0.OOE+00 CF-252 4.34E+09 0.OOE+00 1.86E+08 0.OOE+00 0.OOE+00 1.59E+09 1.42E+06 0.OOE+00 11.4-162 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-33 (Page 1 of 4) Infant Vegetation Ri m 2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 C-14 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 NA-22 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NA-24 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 P-32 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 O.00E+00 0.OOE+00 0.00E+00 0.OOE+00 CA-41 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 SC-46 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 CR-51 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 MN-54 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 FE-55 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.0OE+00 0.00E+00 MN-56 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 O.00E+00 0.00E+00 0.OOE+00 0.OOE+00 CO-57 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CO-58 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 FE-59 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 CO-60 0.O0E+00 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 NI-59 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 NI-63 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CU-64 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 NI-65 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 ZN-65 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 ZN-69m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.0OE+00 0.00E+00 ZN-69 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 SE-79 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-82 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-87 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-88 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-89 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-89 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-90 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 Y-90 0.OOE+00 0.OOE+00 0.OOE+00 0,00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 SR-91 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 Y-91m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 Y-91 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 11.4-163 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-33 (Page 2 of 4) Infant Vegetation R, m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 Y-92 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 Y-93 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NB-93m 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 NB-95 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 NB-97 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 ZR-93 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 ZR-95 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 ZR-97 O.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 MO-93 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 O.OOE+00 MO-99 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 TC-99 0.00E+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TC-99m 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 TC-101 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.O0E+00 RU-1 03 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 RU-105 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 RU-1 06 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 RH-1 05 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 PD- 07 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PD-109 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AG- 1 Om 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AG- 11 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CD-i 13m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CD-1 15m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-1 23 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-125 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-1 26 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-124 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-125 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-126 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-1 27 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-125m 0.00E+0O 0.00E+00 0.00E+00 O.O0E+00 0.OOE+0O 0.OOE+00 0.00E+00 0.OOE+00 TE-127m 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-127 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-129m 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 TE-129 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 TE-133m 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 11.4-164 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-33 (Page 3 of 4) Infant Vegetation Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lungq GI-LLI Skin TE-134 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1-129 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1-130 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 1-131 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 TE-131m 0.OOE+00 0.OOE+00 0.OOE+00 O.00E+00 O.OOE+00 0.OOE+00 O.OOE+00 0.O0E+00 TE-131 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 1-132 0.0OE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 TE-132 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1-133 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 CS-134m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.0OE+00 0.OOE+00 0.OOE+00 0.OOE+00 CS-134 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 1-134 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1-135 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CS-1 35 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 CS-136 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.O0E+00 CS-1 37 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CS-1 36 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CS-1 39 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 BA-1 39 0.00E+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-140 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 LA-140 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-141 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 LA-141 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CE-141 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-142 0.OOE+00 0.OOE+00 0.0OE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 LA-142 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CE-143 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 PR-143 O.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 CE-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 PR-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 ND-147 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-147 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 PM-148m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-148 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 PM-149 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-1 51 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 SM-151 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 11.4-165 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-33 (Page 4 of 4) Infant Vegetation R, m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.001E+00 0.OOE+00 0.00E+00 EU-152 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 EU-154 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 EU-1 55 O.OE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.0OE+00 O.OOE+00 0.OOE+00 EU-1 56 O.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 TB-160 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 HO-166m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 W-181 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 W-185 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 O.00E+00 0.OOE+00 W-187 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 NP-239 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 U-232 0.00E+00 O.00E+00 0.00E+00 0.00E+00 O.00E+00 0.00E+00 0.00E+00 0.OOE+00 U-233 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 U-234 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-235 0.OOE+00 0.O0E+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-236 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-237 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 U-238 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-237 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-238 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-238 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-239 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-240 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 PU-241 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 PU-242 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-244 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-241 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-242m O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-243 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-242 0.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-243 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 CM-244 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-245 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-246 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 CM-247 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-248 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CF-252 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 11.4-166 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-34 (Page 1 of 4) Child Vegetation Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 2.29E+03 2.29E+03 2.29E+03 2.29E+03 2.29E+03 2.29E+03 O.00E+00 C-14 3.50E+06 7.01E+05 7.01E+05 7.01E+05 7.01E+05 7.01E+05 7.01E+05 0.OOE+00 NA-22 4.09E+09 4.09E+09 4.09E+09 4.09E+09 4.09E+09 4.09E+09 4.09E+09 0.00E+00 NA-24 3.71E+05 3.71E+05 3.71E+05 3.71E+05 3.71E+05 3.71E+05 3.71E+05 0.00E+00 P-32 3.37E+09 1.58E+08 1.30E+08 O.00E+00 0.00E+00 0.00E+00 9.31 E+07 0.00E+00 CA-41 2.55E+10 0.00E+00 2.79E+09 O.00E+00 0.00E+00 0.00E+00 1.40E+07 0.00E+00 SC-46 7.85E+05 1.08E+06 4.14E+05 0.00E+00 9.53E+05 0.OOE+00 1.57E+09 0.00E+00 CR-51 0.00E+00 0.00E+00 1.17E+05 6.50E+04 1.78E+04 1.19E+05 6.21E+06 0.OOE+00 MN-54 0.00E+00 6.65E+08 1.77E+08 0.00E+00 1.86E+08 0.00E+00 5.58E+08 0.00E+00 FE-55 8.01 E+08 4.25E+08 1.32E+08 0.OOE+00 O.OOE+00 2.40E+08 7.87E+07 0.00E+00 MN-56 0.00E+00 1.82E+01 4.11E+00 0.0OE+00 2.20E+01 0.00E+00 2.64E+03 0.00E+00 CO-57 0.O0E+00 2.99E+07 6.04E+07 0.00E+00 0.00E+00 0.00E+00 2.45E+08 0.OOE+00 CO-58 0.00E+00 6.44E+07 1.97E+08 0.00E+00 0.00E+00 0.00E+00 3.76E+08 0.00E+00 FE-59 3.98E+08 6.43E+08 3.20E+08 0.00E+00 0.00E+00 1.86E+08 6.70E+08 0.00E+00 CO-60 O.00E+00 3.78E+08 1.12E+09 0.OOE+00 0.00E+00 0.O0E+00 2.1OE+09 0.OOE+00 NI-59 2.96E+09 7.87E+08 5.01E+08 0.00E+00 0.00E+00 0.00E+00 5.22E+07 0.00E+00 NI-63 3.95E+10 2.11E+09 1.34E+09 0.OOE+00 0.00E+00 0.00E+00 1.42E+08 0.OOE+00 CU-64 0.00E+00 1.09E+04 6.60E+03 O.OOE+00 2.64E+04 O.00E+00 5.13E+05 0.00E+00 NI-65 1.02E+02 9.59E+00 5.60E+00 0.OOE+00 0.00E+00 0.OOE+00 1.17E+03 0.00E+00 ZN-65 8.13E+08 2.16E+09 1.35E+09 0.OOE+00 1.36E+09 0.OOE+00 3.80E+08 0.00E+00 ZN-69m 3.78E+04 6.44E+04 7.61E+03 0.OOE+00 3.74E+04 0.00E+00 2.1OE+06 0.OOE+00 ZN-69 8.73E-06 1.26E-05 1.17E-06 0.OOE+00 7.66E-06 0.OOE+00 7.96E-04 0.OOE+00 SE-79 0.00E+00 6.20E+08 1.37E+08 0.OOE+00 1.01 E+09 0.00E+00 4.06E+07 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 2.03E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 BR-83 0.OOE+00 0.OOE+00 5.20E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.00E+00 3.30E-1 1 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 3.59E-151 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 4.52E+08 2.78E+08 0.00E+00 0.OOE+00 0.OOE+00 2.91E+07 0.00E+00 RB-87 0.00E+00 2.90E+09 1.35E+09 0.00E+00 0.OOE+00 0.OOE+00 4.35E+07 0.OOE+00 RB-88 0.OOE+00 3.37E-22 2.34E-22 0.00E+00 0.OOE+00 0.00E+00 1.65E-23 0.OOE+00 RB-89 0.OOE+00 3.42E-26 3.04E-26 0.00E+00 0.00E+00 0.00E+00 2.98E-28 0.00E+00 SR-89 3.60E+10 0.OOE+00 1.03E+09 0.00E+00 0.OOE+00 0.OOE+00 1.39E+09 0.00E+00 SR-90 1.87E+12 0.OOE+00 3.77E+10 0.00E+00 0.00E+00 0.OOE+00 1.67E+10 0.OOE+00 Y-90 2.30E+04 0.00E+00 6.17E+02 0,00E+00 0.00E+00 0.OOE+00 6.56E+07 0.00E+00 SR-91 5.20E+05 0.00E+00 1.96E+04 0.00E+00 0.00E+00 0.00E+00 1.15E+06 0.00E+00 Y-91m 8.12E-09 0.OOE+00 2.95E-10 0.OOE+00 0.00E+00 0.OOE+00 1.59E-05 0.OOE+00 Y-91 1.86E+07 0.OOE+00 4.99E+05 0.00E+00 0.00E+00 0.OOE+00 2.48E+09 0.00E+00 11.4-167 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-34 (Page 2 of 4) Child Vegetation R, m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 7.07E+02 0.OOE+00 2.84E+01 O.OOE+00 0.OOE+00 0.00E+00 1.34E+04 0.OOE+00 Y-92 1.55E+00 0.00E+00 4.43E-02 O.00E+00 O.OOE+00 0.00E+00 4.48E+04 0.00E+00 Y-93 2.91E+02 0.00E+00 7.98E+00 0.OOE+00 0.OOE+00 0.OOE+00 4.34E+06 0.OOE+00 NB-93m 7.64E+06 1.91 E+06 6.27E+05 0.00E+00 2.06E+06 0.OOE+00 2.87E+08 0.OOE+00 NB-95 4.1OE+05 1.60E+05 1.14E+05 0.00E+00 1.50E+05 0.OOE+00 2.96E+08 0.OOE+00 NB-97 3.41E-06 6.16E-07 2.88E-07 0.OOE+00 6.84E-07 0.OOE+00 1.90E-01 0.OOE+00 ZR-93 1.23E+07 4.59E+06 3.27E+06 0.00E+00 1.78E+07 0.OOE+00 1.74E+09 0.OOE+00 ZR-95 3.86E+06 8.48E+05 7.55E+05 0.OOE+00 1.21 E+06 0.OOE+00 8.85E+08 0.OOE+00 ZR-97 5.68E+02 8.20E+01 4.84E+01 0.00E+00 1.18E+02 0.OOE+00 1.24E+07 0.00E+00 MO-93 O.OOE+00 1.77E+09 6.36E+07 0.OOE+00 4.67E+08 0.OOE+00 8.97E+07 0.OOE+00 MO-99 O.OOE+00 7.70E+06 1.91E+06 0.OOE+00 1.64E+07 0.OOE+00 6.37E+06 0.OOE+00 TC-99 3.93E+07 4.38E+07 1.57E+07 0.OOE+00 5.16E+08 3.87E+06 4.59E+08 0.OOE+00 TC-99m 4.65E+00 9.12E+00 1.51E+02 0.OOE+00 1.32E+02 4.63E+00 5.19E+03 0.OOE+00 TC-101 1.02E-30 1.06E-30 1.35E-29 0.OOE+00 1.81E-29 5.62E-31 3.38E-30 0.OOE+00 RU-103 1.53E+07 0.00E+00 5.90E+06 0.OOE+00 3.86E+07 O.00E+00 3.97E+08 0.OOE+00 RU-105 9.01E+01 0.OOE+00 3.27E+01 0.00E+00 7.92E+02 0.OOE+00 5.88E+04 0.OOE+00 RU-106 7.45E+08 O.OE+00 9.30E+07 0.OOE+00 1.01E+09 0.00E+00 1.16E+10 0.00E+00 RH-1 05 1.39E+05 7.45E+04 6.37E+04 0.OOE+00 2.97E+05 O.OOE+00 4.62E+06 0.00E+00 PD-107 0.OOE+00 3.47E+07 2.95E+06 0.00E+00 2.90E+08 0.OOE+00 6.89E+07 0.00E+00 PD-1 09 0.OOE+00 2.88E+04 8.62E+03 0.OOE+00 1.54E+05 0.OOE+00 1.70E+06 0.00E+00 AG-110m 3.21E+07 2.17E+07 1.73E+07 O.OOE+00 4.04E+07 O.OOE+00 2.58E+09 0.OOE+00 AG-111 3.79E+05 1 .19E+05 7.83E+04 O.OOE+00 3.58E+05 O.OOE+00 7.26E+07 0.OOE+00 CD-113m O.OOE+00 7.42E+08 3.16E+07 O.00E+00 7.64E+08 O.OOE+00 1.91E+09 0.OOE+00 CD-1 15m 0.OOE+00 1.42E+08 6.04E+06 0.OOE+00 1.05E+08 O.OOE+00 1.93E+09 O.OOE+00 SN-123 6.54E+09 8.12E+07 1.59E+08 8.61E+07 0.OOE+00 0.OOE+00 3.21E+09 0.OOE+00 SN-125 7.45E+07 1.12E+06 3.34E+06 1.17E+06 0.OOE+00 0.OOE+00 2.31iE+08 0.OOE+00 SN-126 2.45E+10 3.05E+08 6.95E+08 8.38E+07 0.OOE+00 0.OOE+00 1.84E+09 0.OOE+00 SB-124 3.52E+08 4.56E+06 1.23E+08 7.77E+05 0.OOE+00 1.95E+08 2.20E+09 0.OOE+00 SB-125 5.OOE+08 3.85E+06 1.05E+08 4.63E+05 0.OOE+00 2.78E+08 1.19E+09 0.OOE+00 SB-126 1.39E+07 2.12E+05 4.98E+06 8.13E+04 0.OOE+00 6.62E+06 2.79E+08 0.OOE+00 SB-127 8.67E+05 1.34E+04 3.01E+05 9.65E+03 0.OOE+00 3.76E+05 4.88E+07 0.OOE+00 TE-125m 3.51E+08 9.50E+07 4.67E+07 9.84E+07 0.OOE+00 0.OOE+00 3.38E+08 0.OOE+00 TE-127m 1.32E+09 3.56E+08 1.57E+08 3.16E+08 3.77E+09 O.OOE+00 1.07E+09 O.OOE+00 TE-127 9.76E+03 2.63E+03 2.09E+03 6.76E+03 2.78E+04 0.OOE+00 3.81E+05 O.OOE+00 TE-129m 8.41E+08 2.35E+08 1.31E+08 2.71E+08 2.47E+09 O.OOE+00 1.03E+09 O.OOE+00 TE-129 1.24E-03 3.45E-04 2.94E-04 8.82E-04 3.62E-03 O.OOE+00 7.70E-02 O.OOE+00 TE-133m 3.48E-05 1.41E-05 1.74E-05 2.70E-05 1.34E-04 O.OOE+00 1.07E-03 O.OOE+00 11.4-168 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-34 (Page 3 of 4) Child Vegetation Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 5.16E-08 2.32E-08 3.1OE-08 4.08E-08 2.15E-07 0.00E+00 2.36E-07 0.00E+00 1-129 5.11E+09 3.14E+09 2.80E+09 2.05E+12 5.29E+09 0.OOE+00 1.58E+08 0.OOE+00 1-130 6.12E+05 1.24E+06 6.37E+05 1.36E+08 1.85E+06 0.OOE+00 5.78E+05 0.OOE+00 1-131 1.43E+08 1.44E+08 8.17E+07 4.75E+10 2.36E+08 0.OOE+00 1.28E+07 0.OOE+00 TE-131m 1.54E+06 5.32E+05 5.66E+05 1.09E+06 5.15E+06 0.OOE+00 2.16E+07 0.OOE+00 TE-131 2.14E-15 6.51E-16 6.35E-16 1.63E-15 6.46E-15 0.OOE+00 1.12E-14 0.OOE+00 1-132 8.91E+01 1.64E+02 7.53E+01 7.60E+03 2.51E+02 0.00E+00 1.93E+02 O.OOE+00 TE-132 6.99E+06 3.10E+06 3.74E+06 4.51E+06 2.87E+07 O.OOE+00 3.12E+07 0.OOE+00 1-133 3.52E+06 4.35E+06 1.65E+06 8.08E+08 7.25E+06 0.OOE+00 1.75E+06 0.00E+00 CS-134m 1.06E+01 1.57E+01 1.02E+01 0.OOE+00 8.26E+00 1.37E+00 1.98E+01 0.OOE+00 CS-1 34 1.60E+10 2.63E+10 5.55E+09 0.OOE+00 8.15E+09 2.93E+09 1.42E+08 0.OOE+00 1-134 1.42E-04 2.64E-04 1.21E-04 6.07E-03 4.03E-04 0.OOE+00 1.75E-04 0.OOE+00 1-135 6.18E+04 1.11E+05 5.26E+04 9.86E+06 1.71E+05 0.OOE+00 8.48E+04 0.OOE+00 CS-135 6.1OE+09 4.25E+09 4.36E+08 0.OOE+00 1.50E+09 5.01E+08 3.18E+07 0.OOE+00 CS-136 8.24E+07 2.27E+08 1.47E+08 0.OOE+00 1.21E+08 1.80E+07 7.96E+06 0.OOE+00 CS-137 2.39E+10 2.29E+10 3.38E+09 0.OOE+00 7.46E+09 2.68E+09 1.43E+08 0.OOE+00 CS-138 5.69E-11 7.91E-11 5.02E-11 0.OOE+00 5.57E-11 5.99E-12 3.64E-11 0.00E+00 CS-139 2.35E-44 2.61E-44 1.26E-44 0.00E+00 1.96E-44 1.98E-45 2.35E-48 0.OOE+00 BA-1 39 4.69E-02 2.50E-05 1.36E-03 0.00E+00 2.18E-05 1.47E-05 2.70E+00 0.OOE+00 BA-140 2.77E+08 2.42E+05 1.61E+07 0.OOE+00 7.89E+04 1.44E+05 1.40E+08 O.OOE+00 LA-140 3.24E+03 1.13E+03 3.82E+02 0.OOE+00 0.OOE+00 0.OOE+00 3.16E+07 0.00E+00 BA-141 1.54E-21 8.64E-25 5.02E-23 0.OOE+00 7.47E-25 5.07E-24 8.79E-22 0.OOE+00 LA-141 1.05E+00 2.44E-01 5.31E-02 0.OOE+00 0.00E+00 0.OOE+00 5.44E+04 0.OOE+00 CE-141 6.56E+05 3.27E+05 4.86E+04 0.00E+00 1.43E+05 0.00E+00 4.08E+08 0.OOE+00 BA-142 6.46E-39 4.65E-42 3.61E-40 0.00E+00 3.76E-42 2.74E-42 8.43E-41 O.OOE+00 LA-142 3.20E-04 1.02E-04 3.19E-05 0.OOE+00 0.OOE+00 0.OOE+00 2.02E+01 0.OOE+00 CE-143 1.71E+03 9.29E+05 1.35E+02 0.OOE+00 3.90E+02 O.OOE+00 1.36E+07 0.OOE+00 PR-143 1.46E+05 4.37E+04 7.22E+03 0.OOE+00 2.37E+04 0.OOE+00 1.57E+08 0.OOE+00 CE-144 1.27E+08 3.98E+07 6.78E+06 0.OOE+00 2.21E+07 0.00E+00 1.04E+10 0.OOE+00 PR-144 4.11E-26 1.27E-26 2.07E-27 0.OOE+00 6.73E-27 O.OOE+00 2.74E-23 0.OOE+00 ND-147 7.15E+04 5.79E+04 4.48E+03 O.OOE+00 3.18E+04 0.OOE+00 9.17E+07 0.OOE+00 PM-147 2.21E+07 1.58E+06 8.49E+05 0.00E+00 2.79E+06 0OOE+00 6.39E+08 0.OOE+00 PM-148m 2.28E+06 4.54E+05 4.54E+05 0.OOE+00 6.74E+05 0.00E+00 1.28E+09 0.OOE+00 PM-148 3.36E+04 4.04E+03 2.62E+03 0.OOE+00 6.87E+03 0,OOE+00 1.08E+08 0.OOE+00 PM-149 2.94E+03 3.12E+02 1.69E+02 0.OOE+00 5.52E+02 0OOE+00 2.13E+07 0OOE+00 PM-151 5.75E+02 6.99E+01 4.55E+01 0.OOE+00 1.19E+02 0.OOE+00 7.93E+06 0OOE+00 SM-151 1.88E+07 2.80E+06 8.81E+05 0.OOE+00 2.89E+06 0.OOE+00 4.06E+08 0001E+00 11.4-169 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-34 (Page 4 of 4) Child Vegetation R1 m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LLI Skin SM-153 1.42E+03 8.80E+02 8.49E+01 0.O0E+00 2.68E+02 0.00E+00 1.17E+07 0.OOE+00 EU-152 4.47E+07 8.15E+06 9.67E+06 0.00E+00 3.44E+07 0.OOE+00 1.34E+09 0.OOE+00 EU-154 1.66E+08 1.50E+07 1.37E+07 0.00E+00 6.57E+07 0.OOE+00 3.48E+09 0.00E+00 EU-155 3.44E+07 2.48E+06 1.94E+06 0.00E+00 9.28E+06 0.00E+00 6.20E+09 0.OOE+00 EU-156 2.58E+05 1.38E+05 2.86E+04 0.OOE+00 8.89E+04 0.OOE+00 3.13E+08 0.OOE+00 TB-160 6.02E+06 0.OOE+00 7.47E+05 0.OOE+00 1.79E+06 0.OOE+00 1.34E+09 O.OOE+00 HO-166m 7.94E+07 1.66E+07 1.40E+07 0.00E+00 2.37E+07 0.00E+00 7.35E-11 0.OOE+00 W-181 2.03E+06 4.98E+05 6.85E+04 0.OOE+00 0.00E+00 0.00E+00 1.81E+07 0.OOE+00 W-185 6.44E+07 1.61E+07 2.25E+06 0.00E+00 0.OOE+00 0.00E+00 5.99E+08 0.00E+00 W-187 6.41E+04 3.80E+04 1.70E+04 0.00E+00 0.OOE+00 0.00E+00 5.34E+06 0.00E+00 NP-239 2.56E+03 1.84E+02 1.29E+02 0.00E+00 5.31 E+02 0.00E+00 1.36E+07 0.00E+00 U-232 1.29E+12 0.00E+00 9.24E+10 0.OOE+00 9.83E+10 0.OOE+00 5.12E+09 0.OOE+00 U-233 2.73E+11 0.00E+00 1.65E+10 0.00E+00 4.48E+10 0.00E+00 4.74E+09 0.00E+00 U-234 2.62E+11 0.OOE+00 1.62E+10 0.OOE+00 4.40E+10 0.00E+00 4.65E+09 0.00E+00 U-235 2.51E+11 0.OOE+00 1.52E+10 0.OOE+00 4.12E+10 0.00E+00 5.90E+09 0.00E+00 U-236 2.51E+11 0.OOE+00 1.56E+10 0.OOE+00 4.21E+10 0.OOE+00 4.35E+09 0.OOE+00 U-237 3.26E+05 O.00E+00 8.65E+04 0.00E+00 9.39E+05 0.00E+00 2.87E+07 0.00E+00 U-238 2.40E+11 0.00E+00 1.43E+10 0.00E+00 3.85E+10 0.00E+00 4.16E+09 0.00E+00 NP-237 1.64E+11 1.08E+10 7.20E+09 0.00E+00 4.45E+10 0.OOE+00 6.00E+09 0.00E+00 NP-238 2.50E+04 5.07E+02 3.90E+02 0.00E+00 1.62E+03 0.00E+00 1.74E+07 0.00E+00 PU-238 8.73E+10 1.01E+10 2.32E+09 0.00E+00 8.44E+09 0.00E+00 5.50E+09 0.00E+00 PU-239 9.48E+10 1.01E+10 2.43E+09 0.00E+00 8.97E+09 0.00E+00 5.04E+09 0.00E+00 PU-240 9.41E+10 1.05E+10 2.43E+09 0.00E+00 8.97E+09 0.00E+00 5.13E+09 0.00E+00 PU-241 2.82E+09 1.15E+08 5.85E+07 0.OOE+00 2.15E+08 0.OOE+00 1.05E+08 0.00E+00 PU-242 8.75E+10 1.01E+10 2.34E+09 0.OOE+00 8.60E+09 0.OOE+00 4.93E+09 0.00E+00 PU-244 1.02E+11 1.16E+11 2.68E+09 0.OOE+00 9.92E+09 0.OOE+00 7.35E+09 0.OOE+00 AM-241 9.99E+10 8.60E+10 7.50E+09 0.OOE+00 4.58E+10 0.00E+00 5.61E+09 0.OOE+00 AM-242m 1.03E+11 8.23E+10 7.64E+09 O.00E+00 4.63E+10 0.OOE+00 7.06E+09 0.OOE+00 AM-243 9.85E+10 8.31E+10 7.23E+09 0.00E+00 4.45E+10 0.OOE+00 6.58E+09 0.00E+00 CM-242 4.69E+09 3.74E+09 3.12E+08 0.00E+00 9.99E+08 O0OOE+00 4.36E+09 0.00E+00 CM-243 9.36E+10 7.61E+10 6.03E+09 0.OOE+00 2.25E+10 0.00E+00 5.87E+09 O.OOE+00 CM-244 7.88E+10 6.37E+10 5.05E+09 0.OOE+00 1.85E+10 0.OOE+00 5.67E+09 0.OOE+00 CM-245 1.23E+11 9.85E+10 7.72E+09 0.OOE+00 3.02E+10 0.00E+00 5.32E+09 0.OOE+00 CM-246 1.21E+11 9.85E+10 7.72E+09 0.OOE+00 3.01E+10 0.00E+00 5.23E+09 0.OOE+00 CM-247 1.18E+11 9.70E+10 7.57E+09 0.OOE+00 2.97E+10 0.00E+00 6.87E+09 0.00E+00 CM-248 9,85E+11 8.01E+11 6.26E+10 0.OOE+00 2.45E+11 0.OOE+00 1.11E+11 0.00E+00 CF-252 7.31E+10 0.00E+00 1.77E+09 0.OOE+00 0.OOE+00 0.OOE+00 2.06E+10 0.00E+00 11.4-170 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-35 (Page 1 of 4) Teen Vegetation Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 1.47E+03 1.47E+03 1.47E+03 1.47E+03 1.47E+03 1.47E+03 0.OOE+00 C-14 1.45E+06 2.91E+05 2.91E+05 2.91E+05 2.91E+05 2.91E+05 2.91E+05 0.OOE+00 NA-22 2.01E+09 2.01E+09 2.01E+09 2.01E+09 2.01E+09 2.01E+09 2.01E+09 0.OOE+00 NA-24 2.38E+05 2.38E+05 2.38E+05 2.38E+05 2.38E+05 2.38E+05 2.38E+05 0.OOE+00 P-32 1.61 E+09 9.97E+07 6.24E+07 0.OOE+00 0.OOE+00 0.00E+00 1.35E+08 0.OOE+00 CA-41 1.79E+10 0.OOE+00 1.94E+09 0.OOE+00 0.OOE+00 0.OOE+00 1.77E+07 0.OOE+00 SC-46 3.61E+05 7.03E+05 2.08E+05 0.00E+00 6.73E+05 0.00E+00 2.39E+09 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 6.17E+04 3.43E+04 1.35E+04 8.81E+04 1.04E+07 0.OOE+00 MN-54 0.OOE+00 4.54E+08 9.01E+07 0.OOE+00 1.36E+08 0.00E+00 9.32E+08 0.00E+00 FE-55 3.26E+08 2.31E+08 5.39E+07 0.OOE+00 0.OOE+00 1.47E+08 1.OOE+08 0.OOE+00 MN-56 O.OOE+00 1.39E+01 2.47E+00 0.OOE+00 1.76E+01 0.OOE+00 9.16E+02 0.OOE+00 CO-57 O.OE+00 1.79E+07 3.OOE+07 O.OOE+00 0.OOE+00 0.OOE+00 3.33E+08 0.OOE+00 CO-58 O.OOE+00 4.36E+07 1.OOE+08 0.OOE+00 0.OOE+00 0.OOE+00 6.01 E+08 0.OOE+00 FE-59 1.79E+08 4.19E+08 1.62E+08 0.OOE+00 0.OOE+00 1.32E+08 9.90E+08 0.O0E+00 CO-60 0.OOE+00 2.49E+08 5.60E+08 0.00E+00 0.00E+00 O.OOE+00 3.24E+09 0.OOE+00 NI-59 1.20E+09 4.24E+08 2.04E+08 0.OOE+00 0.00E+00 0.OOE+00 6.64E+07 0.OOE+00 NI-63 1.61E+10 1.13E+09 5.45E+08 0.OOE+00 0.00E+00 0.OOE+00 1.81E+08 0.OOE+00 CU-64 0.OOE+00 8.29E+03 3.90E+03 0.OOE+00 2.1OE+04 0.OOE+00 6.43E+05 0.OOE+00 NI-65 5.55E+01 7.09E+00 3.23E+00 0.OOE+00 0.OOE+00 0.OOE+00 3.85E+02 0.OOE+00 ZN-65 4.24E+08 1.47E+09 6.87E+08 0.OOE+00 9.42E+08 0.OOE+00 6.23E+08 0.OOE+00 ZN-69m 2.06E+04 4.87E+04 4.46E+03 0.00E+00 2.96E+04 0.OOE+00 2.68E+06 0.OOE+00 ZN-69 4.73E-06 9.02E-06 6.31 E-07 0.OOE+00 5.89E-06 0.OOE+00 1.66E-05 0.OOE+00 SE-79 0.OOE+00 3.39E+08 5.70E+07 0.OOE+00 5.91E+08 0.OOE+00 5.18E+07 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.32E+06 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-83 0.OOE+00 0.00E+00 2.82E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 1.95E-1 1 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 1.94E-151 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 2.74E+08 1.29E+08 0.OOE+00 0.OOE+00 0.OOE+00 4.05E+07 0.OOE+00 RB-87 0.OOE+00 1.59E+09 5.55E+08 0.OOE+00 0.OOE+00 0.00E+00 5.55E+07 0.OOE+00 RB-88 0.OOE+00 2.44E-22 1.30E-22 0.OOE+00 0.OOE+00 0.OOE+00 2.09E-29 0.OOE+00 RB-89 0.OOE+00 2.59E-26 1.83E-26 0.OOE+00 0.00E+00 0.OOE+00 3.98E-35 0.OOE+00 SR-89 1.51E+10 0.00E+00 4.34E+08 0.OOE+00 0.OOE+00 0.OOE+00 1.80E+09 0.OOE+00 SR-90 9.22E+11 0.OOE+00 1.84E+10 0.00E+00 0.OOE+00 0.OOE+00 2.11E+10 0.OOE+00 Y-90 1.24E+04 0.OOE+00 3.34E+02 0.00E+00 0.OOE+00 0.00E+00 1.02E+08 0.00E+00 SR-91 2.82E+05 0.00E+00 1.12E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.28E+06 0.OOE+00 Y-91m 4.43E-09 0.OOE+00 1.69E-10 0.OOE+00 0.OOE+00 0.00E+00 2.09E-07 0.OOE+00 Y-91 7.84E+06 0.OOE+00 2.1OE+05 0.OOE+00 0.OOE+00 0.00E+00 3.21EE+09 0.OOE+00 11.4-171 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-35 (Page 2 of 4) Teen Vegetation Ri m 2 *mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 3.86E+02 0.00E+00 1.65E+01 0.00E+00 0.OOE+00 0.00E+00 9.83E+03 0.OOE+00 Y-92 8.42E-01 0.00E+00 2.43E-02 0.00E+00 0.00E+00 0.00E+00 2.31 E+04 0.00E+00 Y-93 1.58E+02 O.00E+00 4.33E+00 0.00E+00 0.00E+00 0.00E+00 4.82E+06 0.00E+00 NB-93m 3.10E+06 1.02E+06 2.55E+05 O.00E+00 1.19E+06 0.OOE+00 3.66E+08 O.OOE+00 NB-95 1.92E+05 1.07E+05 5.87E+04 0.00E+00 1.03E+05 0.00E+00 4.56E+08 0.00E+00 NB-97 1.87E-06 4.65E-07 1.70E-07 0.00E+00 5.43E-07 0.00E+00 1.11E-02 0.OOE+00 ZR-93 5.03E+06 2.48E+06 1.35E+06 0.00E+00 8.77E+06 0.OOE+00 2.34E+09 0.OOE+00 ZR-95 1.72E+06 5.43E+05 3.73E+05 0.OOE+00 7.98E+05 0.OOE+00 1.25E+09 0.OOE+00 ZR-97 3.11E+02 6.15E+01 2.83E+01 0.OOE+00 9.33E+01 0.OOE+00 1.67E+07 0.OOE+00 MO-93 O.OOE+00 9.63E+08 2.64E+07 0.OOE+00 2.76E+08 0.OOE+00 1.17E+08 0.OOE+00 MO-99 0.OOE+00 5.64E+06 1.08E+06 0.00E+00 1.29E+07 0.00E+00 1.01E+07 0.OOE+00 TC-99 1.63E+07 2.39E+07 6.52E+06 0.OOE+00 3.04E+08 2.47E+06 5.85E+08 0.OOE+00 TC-99m 2.70E+00 7.54E+00 9.77E+01 0.OOE+00 1.12E+02 4.18E+00 4.95E+03 0.OOE+00 TC-101 5.52E-31 7.85E-31 7.71E-30 0.OOE+00 1.42E-29 4.78E-31 1.34E-37 0.OOE+00 RU-1 03 6.82E+06 0.OOE+00 2.92E+06 0.OOE+00 2.40E+07 0.OOE+00 5.70E+08 0.OOE+00 RU-105 4.92E+01 0.OOE+00 1.91E+01 0.OOE+00 6.20E+02 0.OOE+00 3.97E+04 0.OOE+00 RU-106 3.1OE+08 0.OOE+00 3.90E+07 0.OOE+00 5.97E+08 0.OOE+00 1.48E+10 0.OOE+00 RH-1 05 7.54E+04 5.45E+04 3.58E+04 0.OOE+00 2.32E+05 0.OOE+00 6.93E+06 0.OOE+00 PD-107 0.OOE+00 1.89E+07 1.22E+06 0.OOE+00 1.71E+08 0.OOE+00 8.78E+07 0.OOE+00 PD-1 09 0.OOE+00 2.06E+04 4.67E+03 0.OOE+00 1.19E+05 0.OOE+00 2.07E+06 0.OOE+00 AG-110m 1.52E+07 1.43E+07 8.72E+06 0.OOE+00 2.74E+07 0.OOE+00 4.03E+09 0.OOE+00 AG-111 2.02E+05 8.37E+04 4.21E+04 0.OOE+00 2.72E+05 0.OOE+00 1.17E+08 0.OOE+00 CD-113m 0.OOE+00 4.06E+08 1.30E+07 0.OOE+00 4.49E+08 0.OOE+00 2.44E+09 0.OOE+00 CD-1 15m 0.OOE+00 7.94E+07 2.56E+06 0.OOE+00 6.35E+07 0.OOE+00 2.51 E+09 0.OOE+00 SN-123 2.72E+09 4.46E+07 6.61E+07 3.58E+07 0.OOE+00 0.OOE+00 4.11E+09 0.OOE+00 SN-125 3.85E+07 7.68E+05 1.74E+06 6.02E+05 0.OOE+00 0.OOE+00 3.63E+08 0.OOE+00 SN-126 1.05E+10 1.96E+08 3.OOE+08 5.17E+07 0.OOE+00 0.OOE+00 2.34E+09 0.OOE+00 SB-124 1.54E+08 2.84E+06 6.02E+07 3.50E+05 0.OOE+00 1.35E+08 3.11E+09 0.OOE+00 SB-125 2.14E+08 2.34E+06 5.01E+07 2.05E+05 0.OOE+00 1.88E+08 1.67E+09 0.OOE+00 SB-1 26 7.36E+06 1.50E+05 2.64E+06 4.16E+04 0.OOE+00 5.28E+06 4.36E+08 0.OOE+00 SB-127 4.79E+05 1.02E+04 1.81E+05 5.39E+03 0.OOE+00 3.26E+05 8.14E+07 0.OOE+00 TE-125m 1.48E+08 5.34E+07 1.98E+07 4.14E+07 0.OOE+00 0.OOE+00 4.37E+08 0.OOE+00 TE-127m 5.51EE+08 1.96E+08 6.56E+07 1.31E+08 2.24E+09 0.OOE+00 1.37E+09 0.OOE+00 TE-127 5.29E+03 1.88E+03 1.14E+03 3.65E+03 2.14E+04 0.OOE+00 4.09E+05 0.OOE+00 TE-129m 3.62E+08 1.34E+08 5.73E+07 1.17E+08 1.51EE+09 0.OOE+00 1.36E+09 0.OOE+00 TE-1 29 6.68E-04 2.49E-04 1.63E-04 4.77E-04 2.80E-03 0.OOE+00 3.65E-03 0.00E+00 TE-133m 1.94E-05 1.1OE-05 1.07E-05 1.54E-05 1.09E-04 0.OOE+00 4.45E-05 0.OOE+00 11.4-172 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-35 (Page 3 of 4) Teen Vegetation Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 2.89E-08 1.85E-08 1.94E-08 2.37E-08 1.77E-07 0.OOE+00 1.07E-09 0.00E+00 1-129 2.12E+09 1.78E+09 2.97E+09 2.17E+12 3.19E+09 O.00E+00 2.08E+08 0.OOE+00 1-130 3.49E+05 1.01E+06 4.03E+05 8.22E+07 1.55E+06 0.OOE+00 7.75E+05 0.OOE+00 1-131 7.68E+07 1.08E+08 5.78E+07 3.14E+10 1.85E+08 0.00E+00 2.13E+07 O.00E+00 TE-131m 8.42E+05 4.04E+05 3.37E+05 6.07E+05 4.21E+06 0.00E+00 3.24E+07 O.00E+00 TE-131 1.16E-15 4.78E-16 3.62E-16 8.93E-16 5.07E-15 0.OOE+00 9.52E-17 0.00E+00 1-132 5.02E+01 1.31E+02 4.72E+01 4.43E+03 2.07E+02 0.OOE+00 5.72E+01 O.00E+00 TE-132 3.90E+06 2.47E+06 2.33E+06 2.61E+06 2.37E+07 O.OOE+00 7.83E+07 0.00E+00 1-133 1.93E+06 3.27E+06 9.99E+05 4.57E+08 5.74E+06 0.OOE+00 2.48E+06 0.OOE+00 CS-134m 5.95E+00 1.23E+01 6.33E+00 0.OOE+00 6.86E+00 1.20E+00 8.20E+00 0.OOE+00 CS-134 7.10E+09 1.67E+10 7.75E+09 0.OOE+00 5.31E+09 2.03E+09 2.08E+08 0.OOE+00 1-134 7.99E-05 2.12E-04 7.61E-05 3.53E-03 3.34E-04 O.OOE+00 2.79E-06 0.00E+00 1-135 3.48E+04 8.96E+04 3.32E+04 5.76E+06 1.42E+05 0.00E+00 9.93E+04 0.00E+00 CS-135 2.53E+09 2.32E+09 5.42E+08 0.00E+00 8.84E+08 3.20E+08 4.05E+07 0.00E+00 CS-136 4.37E+07 1.72E+08 1.16E+08 0.OOE+00 9.37E+07 1.48E+07 1.38E+07 0.OOE+00 CS-137 1.01E+10 1.35E+10 4.69E+09 0.00E+00 4.59E+09 1.78E+09 1.92E+08 0.00E+00 CS-138 3.13E-11 6.01E-11 3.OOE-11 0.OOE+00 4.44E-11 5.16E-12 2.73E-14 0.OOE+00 CS-139 1.28E-44 1.88E-44 6.89E-45 0.OOE+00 1.52E-44 1.66E-45 8.72E-60 0.OOE+00 BA-1 39 2.54E-02 1.79E-05 7.40E-04 0.00E+00 1.69E-05 1.23E-05 2.27E-01 0.OOE+00 BA-140 1.38E+08 1.69E+05 8.90E+06 0.OOE+00 5.74E+04 1.14E+05 2.13E+08 0.00E+00 LA-140 1.80E+03 8.86E+02 2.36E+02 0.OOE+00 0.OOE+00 0.00E+00 5.09E+07 0.OOE+00 BA-141 8.36E-22 6.24E-25 2.79E-23 0.OOE+00 5.79E-25 4.27E-25 1.78E-27 0.OOE+00 LA-141 5.67E-01 1.74E-01 2.88E-02 0.OOE+00 0.OOE+00 0.OOE+00 3.09E+04 0.OOE+00 CE-141 2.83E+05 1.89E+05 2.17E+04 0.OOE+00 8.89E+04 0.OOE+00 5.40E+08 0.00E+00 BA-142 3.57E-39 3.57E-42 2.20E-40 0.00E+00 3.02E-42 2.38E-42 1.10E-50 0.OOE+00 LA-142 1.77E-04 7.84E-05 1.95E-05 0.00E+00 0.OOE+00 0.OOE+00 2.39E+00 0.OOE+00 CE-143 9.30E+02 6.77E+05 7.56E+01 0.OOE+00 3.04E+02 0.OOE+00 2.04E+07 0.OOE+00 PR-143 7.OOE+04 2.80E+04 3.49E+03 0.00E+00 1.62E+04 0.OOE+00 2.30E+08 0.OOE+00 CE-144 5.27E+07 2.18E+07 2.83E+06 0.OOE+00 1.30E+07 0.OOE+00 1.33E+10 0.OOE+00 PR-144 2.22E-26 9.07E-27 1.12E-27 0.OOE+00 5.20E-27 0.00E+00 2.44E-29 0.OOE+00 ND-147 3.62E+04 3.94E+04 2.36E+03 0.OOE+00 2.31EE+04 0.OOE+00 1.42E+08 0.OOE+00 PM-147 9.04E+06 8.57E+05 3.49E+05 0.OOE+00 1.64E+06 0.OOE+00 8.15E+08 0.OOE+00 PM-148m 1.17E+06 2.96E+05 2.32E+05 0.OOE+00 4.48E+05 0.OOE+00 1.86E+09 0.OOE+00 PM-148 1.83E+04 2.98E+03 1.50E+03 0.00E+00 5.39E+03 0.OOE+00 1.78E+08 0.00E+00 PM-149 1.59E+03 2.23E+02 9.14E+01 0.OOE+00 4.25E+02 0.00E+00 3.28E+07 0.OOE+00 PM-151 3.14E+02 5.18E+01 2.62E+01 0.OOE+00 9.32E+01 0.OOE+00 1.16E+07 0.OOE+00 SM-151 7.92E+06 1.52E+06 3.58E+05 0.OOE+00 1.67E+06 0.00E+00 5.17E+08 0.OOE+00 11.4-173 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-35 (Page 4 of 4) Teen Vegetation Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LLI Skin SM-153 7.64E+02 6.33E+02 4.65E+01 0.OOE+00 2.07E+02 O.OOE+00 1.79E+07 0.OOE+00 EU-152 2.20E+07 5.31 E+06 4.68E+06 0.00E+00 2.46E+07 0.00E+00 1.95E+09 0.00E+00 EU-154 7.07E+07 9.12E+06 6.43E+06 0.OOE+00 4.08E+07 0.OOE+00 4.82E+09 0.OOE+00 EU-155 1.54E+07 1.48E+06 9.18E+05 0.OOE+00 5.80E+06 0.OOE+00 8.50E+09 0.OOE+00 EU-156 1.24E+05 9.31E+04 1.52E+04 0.OOE+00 6.26E+04 0.OOE+00 4.76E+08 O.00E+00 TB-160 2.94E+06 0.00E+00 3.67E+05 0.OOE+00 1.16E+06 O.OOE+00 1.91EE+09 O.00E+00 HO-166m 3.24E+07 1.OOE+07 7.23E+06 O.OOE+00 1.46E+07 0.00E+00 9.09E-11 0.OOE+00 W-181 8.47E+05 2.73E+05 2.86E+04 0.OOE+00 0.00E+00 0.OOE+00 2.33E+07 O.OOE+00 W-185 2.70E+07 8.90E+06 9.42E+05 0.OOE+00 0.00E+00 0.OOE+00 7.69E+08 0.OOE+00 W-187 3.53E+04 2.87E+04 1.01E+04 0.00E+00 0.00E+00 0.00E+00 7.78E+06 0.OOE+00 NP-239 1.38E+03 1.31E+02 7.25E+01 0.OOE+00 4.1OE+02 0.OOE+00 2.1OE+07 0.OOE+00 U-232 5.34E+11 O.OOE+00 3.82E+10 O.00E+00 5.79E+10 0.00E+00 6.52E+09 0.OOE+00 U-233 1.13E+11 0.OOE+00 6.85E+09 0.OOE+00 2.64E+10 0.00E+00 6.04E+09 0.OOE+00 U-234 1.08E+1 1 0.OOE+00 6.72E+09 0.OOE+00 2.59E+10 0.OOE+00 5.92E+09 0.O0E+00 U-235 1.04E+11 0.00E+00 6.31E+09 0.OOE+00 2.43E+10 0.OOE+00 7.53E+09 0.OOE+00 U-236 1.04E+1 1 0.00E+00 6.44E+09 0.OOE+00 2.48E+10 0.00E+00 5.55E+09 0.00E+00 U-237 1.74E+05 0.OOE+00 4.64E+04 0.OOE+00 7.16E+05 0.OOE+00 4.62E+07 0.OOE+00 U-238 9.91E+10 0.OOE+00 5.90E+09 O.OOE+00 2.27E+10 O.OOE+00 5.30E+09 O.OOE+00 NP-237 1.21E+11 8.68E+09 5.32E+09 O.OOE+00 3.94E+10 O.OE+00 7.64E+09 0.OOE+00 NP-238 1.35E+04 3.62E+02 2.11E+02 0.00E+00 1.24E+03 0.OOE+00 2.66E+07 O.00E+00 PU-238 6.08E+10 7.79E+09 1.65E+09 O.OOE+00 7.08E+09 O.OOE+00 7.01E+09 O.OOE+00 PU-239 6.95E+10 8.44E+09 1.83E+09 0.00E+00 7.79E+09 0.OOE+00 6.42E+09 0.OOE+00 PU-240 6.94E+10 8.43E+09 1.83E+09 0.OOE+00 7.78E+09 0.OOE+00 6.53E+09 0.OOE+00 PU-241 1.57E+09 7.56E+07 3.32E+07 0.OOE+00 1.54E+08 O.OOE+00 1.33E+08 0.OOE+00 PU-242 6.44E+10 8.13E+09 1.76E+09 0.00E+00 7.50E+09 0.00E+00 6.29E+09 0.00E+00 PU-244 7.53E+10 9.27E+09 2.02E+09 0.00E+00 8.59E+09 0.00E+00 9.36E+09 0.00E+00 AM-241 7.25E+10 6.84E+10 5.22E+09 0.00E+00 3.92E+10 0.OOE+00 7.15E+09 0.00E+00 AM-242m 7.33E+10 6.46E+10 5.27E+09 0oOOE+00 3.90E+10 0.00E+00 8.99E+09 0.OOE+00 AM-243 7.23E+10 6.68E+10 5.11E+09 0.OOE+00 3.84E+10 O.OOE+00 8.39E+09 O.OOE+00 CM-242 1.95E+09 2.06E+09 1.29E+08 O.OOE+00 5.90E+08 O.OOE+00 5.58E+09 0.OOE+00 CM-243 5.88E+10 5.45E+10 3.70E+09 0.OOE+00 1.73E+10 0.00E+00 7.49E+09 0.00E+00 CM-244 4.54E+10 4.30E+10 2.88E+09 0.OOE+00 1.34E+10 0.OOE+00 7.21E+09 0.OOE+00 CM-245 9.OOE+10 7.92E+10 5.54E+09 0.OOE+00 2.59E+10 0.OOE+00 6.78E+09 0.OOE+00 CM-246 8.93E+10 7.91E+10 5.54E+09 0.00E+00 2.58E+10 0.00E+00 6.66E+09 0.OOE+00 CM-247 8.70E+10 7.79E+10 5.45E+09 0.00E+00 2.54E+10 0.00E+00 8.75E+09 0.00E+00 CM-248 7.23E+11 6.42E+11 4.50E+10 0.OOE+00 2.10E+11 0.00E+00 1.41E+11 0.OOE+00 CF-252 2.99E+10 0.OOE+00 7.21E+08 0.OOE+00 0.OOE+00 0.OOE+00 2.63E+10 0.OOE+00 11.4-174 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-36 (Page 1 of 4) Adult Vegetation Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 1.29E+03 1.29E+03 1.29E+03 1.29E+03 1.29E+03 1.29E+03 0.OOE+00 C-14 8.97E+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 0.OOE+00 NA-22 1.32E+09 1.32E+09 1.32E+09 1.32E+09 1.32E+09 1.32E+09 1.32E+09 0.OOE+00 NA-24 2.68E+05 2.68E+05 2.68E+05 2.68E+05 2.68E+05 2.68E+05 2.68E+05 0.O0E+00 P-32 1.40E+09 8.73E+07 5.43E+07 0.OOE+00 O.OOE+00 0.00E+00 1.58E+08 O.OOE+00 CA-41 1.48E+10 0.OOE+00 1.60E+09 0.OOE+00 0.OOE+00 0.OOE+00 1.47E+07 0.OOE+00 SC-46 2.51E+05 4.87E+05 1.41E+05 0.OOE+00 4.54E+05 0.OOE+00 2.37E+09 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 4.64E+04 2.78E+04 1.02E+04 6.16E+04 1.17E+07 0.OOE+00 MN-54 0.OOE+00 3.13E+08 5.97E+07 0.OOE+00 9.31E+07 0.OOE+00 9.59E+08 0.OOE+00 FE-55 2.1OE+08 1.45E+08 3.38E+07 0.OOE+00 0.OOE+00 8.08E+07 8.31E+07 0.00E+00 MN-56 0.OOE+00 1.54E+01 2.74E+00 O.OOE+00 1.96E+01 0.OOE+00 4.93E+02 O.OOE+00 CO-57 O.OOE+00 1.17E+07 1.95E+07 0.OOE+00 0.OOE+00 0.OOE+00 2.97E+08 0.OOE+00 CO-58 0.00E+00 3.07E+07 6.89E+07 0.OOE+00 0.00E+00 0.OOE+00 6.23E+08 0.OOE+00 FE-59 1.26E+08 2.96E+08 1.14E+08 0.OOE+00 0.OOE+00 8.28E+07 9.88E+08 0.OOE+00 CO-60 0.00E+00 1.67E+08 3.69E+08 0.00E+00 0.OOE+00 0.OOE+00 3.14E+09 0.OOE+00 NI-59 7.82E+08 2.68E+08 1.31 E+08 0.OOE+00 0.OOE+00 0.OOE+00 5.53E+07 0.OOE+00 NI-63 1.04E+10 7.21EE+08 3.49E+08 0.OOE+00 0.OOE+00 0.OOE+00 1.50E+08 0.00E+00 CU-64 0.OOE+00 9.15E+03 4.29E+03 0.OOE+00 2.31E+04 0.00E+00 7.79E+05 0.OOE+00 NI-65 5.96E+01 7.75E+00 3.54E+00 0.OOE+00 0.OOE+00 0.OOE+00 1.97E+02 0.00E+00 ZN-65 3.17E+08 1.01E+09 4.56E+08 0.OOE+00 6.75E+08 0.OOE+00 6.36E+08 0.OOE+00 ZN-69m 2.23E+04 5.35E+04 4.89E+03 0.OOE+00 3.24E+04 0.OOE+00 3.26E+06 0.OOE+00 ZN-69 5.06E-06 9.67E-06 6.72E-07 0.00E+00 6.28E-06 0.OOE+00 1.45E-06 O.OOE+00 SE-79 0.OOE+00 2.11E+08 3.52E+07 0.OOE+00 3.65E+08 0.00E+00 4.31E+07 O.OOE+00 BR-82 0.OOE+00 O.OOE+00 1.50E+06 O.OOE+00 0.OOE+00 0.OOE+00 1.72E+06 0.OOE+00 BR-83 O.OOE+00 0.OOE+00 3.01E+00 O.OOE+00 0.0OE+00 0.00E+00 4.33E+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 2.14E-11 O.OOE+00 0.OOE+00 0.OOE+00 1.68E-16 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 2.07E-151 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 2.19E+08 1.02E+08 O.OOE+00 0.OOE+00 O.OOE+00 4.33E+07 O.0OE+00 RB-87 0.00E+00 9.86E+08 3.43E+08 0.OOE+00 0.OOE+00 0.OOE+00 4.62E+07 0.OOE+00 RB-88 0.OOE+00 2.64E-22 1.40E-22 0.00E+00 0.00E+00 0.OOE+00 3.65E-33 0.OOE+00 RB-89 0.OOE+00 2.88E-26 2.03E-26 0.OOE+00 0.00E+00 0.OOE+00 1.67E-39 0.OOE+00 SR-89 9.97E+09 0.OOE+00 2.86E+08 0.OOE+00 0.OOE+00 0.OOE+00 1.60E+09 0.OOE+00 SR-90 6.95E+11 0.OOE+00 1.40E+10 0.OOE+00 0.OOE+00 0.OOE+00 1.75E+10 0.00E+00 Y-90 1.33E+04 0.OOE+00 3.56E+02 0.00E+00 0.OOE+00 0.00E+00 1.41 E+08 0.00E+00 SR-91 3.02E+05 0.OOE+00 1.22E+04 0.00E+00 0.OOE+00 0.OOE+00 1.44E+06 O.OOE+00 Y-91m 4.76E-09 0.OOE+00 1.84E-10 0.OOE+00 O.OOE+00 0.OOE+00 1.40E-08 0.00E+00 Y-91 5.11E+06 0.OOE+00 1.37E+05 0.OOE+00 0.OOE+00 0.OOE+00 2.81E+09 0.OOE+00 11.4-175 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-36 (Page 2 of 4) Adult Vegetation Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung. GI-LLI Skin SR-92 4.15E+02 0.OOE+00 1.79E+01 0.OOE+00 0.00E+00 0.OOE+00 8.21iE+03 0.OOE+00 Y-92 8.96E-01 0.00E+00 2.62E-02 0.OOE+00 0.00E+00 0.OOE+00 1.57E+04 0.OOE+00 Y-93 1.68E+02 0.OOE+00 4.65E+00 0.OOE+00 0.OOE+00 0.OOE+00 5.34E+06 0.OOE+00 NB-93m 2.02E+06 6.61 E+05 1.63E+05 0.OOE+00 7.60E+05 0.OOE+00 3.05E+08 0.OOE+00 NB-95 1,42E+05 7.92E+04 4.26E+04 0.OOE+00 7.83E+04 0.OOE+00 4.81E+08 0.OOE+00 NB-97 2.02E-06 5.11E-07 1.87E-07 0.OOE+00 5.96E-07 0.OOE+00 1.88E-03 0.OOE+00 ZR-93 3.35E+06 1.88E+05 8.74E+04 0.OOE+00 7.11E+05 0.OOE+00 1.95E+08 0.OOE+00 ZR-95 1.17E+06 3.77E+05 2.55E+05 0.OOE+00 5.91E+05 O.OOE+00 1.19E+09 0.OOE+00 ZR-97 3.36E+02 6.78E+01 3.10E+01 0.OOE+00 1.02E+02 0.OOE+00 2.10E+07 0.OOE+00 MO-93 0.OOE+00 6.02E+08 1.63E+07 0.OOE+00 1.71 E+08 O.OOE+00 9.78E+07 O.OE+00 MO-99 0.00E+00 6.14E+06 1.17E+06 0.OOE+00 1.39E+07 O.OOE+00 1.42E+07 O.OOE+00 TC-99 1.00E+07 1.49E+07 4.02E+06 0.OOE+00 1.88E+08 1.27E+06 4.87E+08 0.OOE+00 TC-99m 3.06E+00 8.66E+00 1.1OE+02 O.OOE+00 1.31E+02 4.24E+00 5.12E+03 O.OOE+00 TC-101 5.93E-31 8.55E-31 8,39E-30 0.OOE+00 1.54E-29 4.37E-31 2.57E-42 0,OOE+00 RU-1 03 4.77E+06 0.OOE+00 2.06E+06 0.00E+00 1.82E+07 0.OOE+00 5.57E+08 0.OOE+00 RU-1 05 5.29E+01 0.OOE+00 2.09E+01 0.OOE+00 6.84E+02 0.OOE+00 3.24E+04 0.OOE+00 RU-106 1.93E+08 0.OOE+00 2.44E+07 0.OOE+00 3.72E+08 0.OOE+00 1.25E+10 0.OOE+00 RH-1 05 8.04E+04 5.88E+04 3.87E+04 0.OOE+00 2.50E+05 0.OOE+00 9.37E+06 0.OOE+00 PD-107 0.OOE+00 1.18E+07 7.53E+05 0.00E+00 1.06E+08 0.OOE+00 7.30E+07 0.OOE+00 PD-109 0.OOE+00 2.21E+04 4.98E+03 0.OOE+00 1.26E+05 0.OOE+00 2.45E+06 0.OOE+00 AG-110m 1.05E+07 9.75E+06 5.79E+06 0.OOE+00 1.92E+07 O.OOE+00 3.98E+09 0.OOE+00 AG-1 11 2.11 E+05 8.82E+04 4.39E+04 0.OOE+00 2.85E+05 0.OOE+00 1.62E+08 0.OOE+00 CD-1 13m 0.OOE+00 2.52E+08 8.09E+06 0.OOE+00 2.78E+08 0.OOE+00 2.03E+09 0.OOE+00 CD-1 15m 0.00E+00 5.34E+07 1.70E+06 0.OOE+00 4.24E+07 0.OOE+00 2.25E+09 0.OOE+00 SN-123 1.71E+09 2.84E+07 4.18E+07 2.41E+07 0.OOE+00 0.OOE+00 3.49E+09 0.OOE+00 SN-125 3.85E+07 7.75E+05 1.74E+06 6.42E+05 0.OOE+00 0.OOE+00 4.80E+08 0.OOE+00 SN-126 6.77E+09 1.34E+08 1.92E+08 3.94E+07 0.OOE+00 0.OOE+00 1.95E+09 0.OOE+00 SB-124 1.04E+08 1.96E+06 4.11E+07 2.51E+05 0.OOE+00 8.07E+07 2.94E+09 0.OOE+00 SB-125 1.37E+08 1.53E+06 3.25E+07 1.39E+05 0.OOE+00 1.05E+08 1.50E+09 0.OOE+00 SB-126 7.01E+06 1.43E+05 2.53E+06 4.29E+04 0.OOE+00 4.30E+06 5.73E+08 0.OOE+00 SB-127 5.19E+05 1.14E+04 1.99E+05 6.24E+03 0.OOE+00 3.08E+05 1.19E+08 0.OOE+00 TE-125m 9.66E+07 3.50E+07 1.29E+07 2.90E+07 3.93E+08 0.OOE+00 3.86E+08 0.OOE+00 TE-127m 3.49E+08 1.25E+08 4.26E+07 8.92E+07 1.42E+09 0.OOE+00 1.17E+09 0.OOE+00 TE-127 5.61E+03 2.02E+03 1.21E+03 4.16E+03 2.29E+04 0.OOE+00 4.43E+05 0.OOE+00 TE-129m 2.51E+08 9.38E+07 3.98E+07 8.63E+07 1.05E+09 0.OOE+00 1.27E+09 0.OOE+00 TE-129 7.13E-04 2.68E-04 1.74E-04 5.48E-04 3.OOE-03 0.OOE+00 5.38E-04 0.OOE+00 TE-133m 2.12E-05 1.24E-05 1.19E-05 1.79E-05 1.22E-04 0.OOE+00 4.24E-06 0.OOE+00 11.4-176 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-36 (Page 3 of 4) Adult Vegetation Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 3.19E-08 2.09E-08 1.28E-08 2.79E-08 2.02E-07 0.OOE+00 3.54E-11 0.00E+00 1-129 1.31E+09 1.13E+09 3.69E+09 2.90E+12 2.42E+09 0.OOE+00 1.78E+08 0.OOE+00 1-130 3.90E+05 1.15E+06 4.54E+05 9.75E+07 1.79E+06 0.OOE+00 9.90E+05 0.OOE+00 1-131 8.07E+07 1.15E+08 6.62E+07 3.78E+10 1.98E+08 0.OOE+00 3.05E+07 0.OOE+00 TE-131m 9.1OE+05 4.45E+05 3.71E+05 7.05E+05 4.51E+06 0.OOE+00 4.42E+07 O.OOE+00 TE-131 1.25E-15 5.21E-16 3.94E-16 1.03E-15 5.47E-15 0.OOE+00 1.77E-16 O.OOE+00 1-132 5.57E+01 1.49E+02 5.21E+01 5.21E+03 2.37E+02 0.OOE+00 2.80E+01 0.OOE+00 TE-132 4.30E+06 2.78E+06 2.61E+06 3.07E+06 2.68E+07 0.00E+00 1.31E+08 0.OOE+00 1-133 2.08E+06 3.61E+06 1.1OE+06 5.31E+08 6.31E+06 O.OOE+00 3.25E+06 0.OOE+00 CS-134m 6.57E+00 1.38E+01 7.06E+00 0.OOE+00 7.49E+00 1.18E+00 4.87E+00 0.OOE+00 CS-134 4.67E+09 1.11E+10 9.08E+09 0.OOE+00 3.59E+09 1.19E+09 1.94E+08 0.OOE+00 1-134 8.84E-05 2.40E-04 8.59E-05 4.16E-03 3.82E-04 0.OOE+00 2.09E-07 O.OOE+00 1-135 3.85E+04 1.01E+05 3.72E+04 6.65E+06 1.62E+05 0.OOE+00 1.14E+05 0.OOE+00 CS-135 1.56E+09 1.44E+09 6.40E+08 0.OOE+00 5.46E+08 1.63E+08 3.37E+07 0.00E+00 CS-136 4.27E+07 1.68E+08 1.21E+08 0.00E+00 9.37E+07 1.28E+07 1.91E+07 0.OOE+00 CS-137 6.36E+09 8.70E+09 5.70E+09 0.OOE+00 2.95E+09 9.81E+08 1.68E+08 0.OOE+00 CS-138 3.39E-11 6.70E-11 3.32E-11 0.00E+00 4.92E-11 4.86E-12 2.86E-16 0.OOE+00 CS-1 39 1.36E-44 2.03E-44 7.39E-45 0.OOE+00 1.62E-44 1.48E-45 4.39E-67 0.O0E+00 BA-139 2.70E-02 1.92E-05 7.91E-04 0.OOE+00 1.80E-05 1.09E-05 4.79E-02 0.OOE+00 BA-140 1.28E+08 1.61E+05 8.42E+06 0.OOE+00 5.49E+04 9.24E+04 2.65E+08 0.OOE+00 LA-140 1.97E+03 9.95E+02 2.63E+02 0.OOE+00 0.OOE+00 0.OOE+00 7.30E+07 0.OOE+00 BA-141 8.94E-22 6.76E-25 3.02E-23 0.OOE+00 6.28E-25 3.83E-25 4.21E-31 0.OOE+00 LA-141 6.06E-01 1.88E-01 3.08E-02 0.OOE+00 0.OOE+00 0.OOE+00 2.24E+04 0.OOE+00 CE-141 1.97E+05 1.33E+05 1.51E+04 0.OOE+00 6.19E+04 0.00E+00 5.1OE+08 0.OOE+00 BA-142 3.88E-39 3.99E-42 2.44E-40 O.OOE+00 3.37E-42 2.26E-42 5.46E-57 0.OOE+00 LA-142 1.92E-04 8.75E-05 2.18E-05 0.OOE+00 0.OOE+00 0.00E+00 6.39E-01 0.00E+00 CE-143 9.95E+02 7.36E+05 8.14E+01 0.OOE+00 3.24E+02 0.OOE+00 2.75E+07 0.00E+00 PR-143 6.26E+04 2.51E+04 3.1OE+03 0.OOE+00 1.45E+04 0.OOE+00 2.74E+08 0.OOE+00 CE-144 3.29E+07 1.38E+07 1.77E+06 0.OOE+00 8.16E+06 0.OOE+00 1.11E+10 0.OOE+00 PR-144 2.36E-26 9.81E-27 1.20E-27 0.00E+00 5.53E-27 0.OOE+00 3.40E-33 0.OOE+00 ND-147 3.33E+04 3.85E+04 2.30E+03 0.OOE+00 2.25E+04 0.OOE+00 1.85E+08 0.OOE+00 PM-147 5.74E+06 5.39E+05 2.18E+05 0.OOE+00 1.02E+06 0.O0E+00 6.80E+08 0.OOE+00 PM-148m 8.30E+05 2.15E+05 1.64E+05 0.OOE+00 3.24E+05 0.OOE+00 1.82E+09 0.OOE+00 PM-148 1.96E+04 3.25E+03 1.64E+03 0.OOE+00 6.14E+03 0.OOE+00 2.55E+08 0.OOE+00 PM-149 1.69E+03 2.39E+02 9.78E+01 0.OOE+00 4.52E+02 0.OOE+00 4.49E+07 0.OOE+00 PM-151 3.38E+02 5.67E+01 2.86E+01 0.OOE+00 1.01EE+02 0.OOE+00 1.56E+07 0.OOE+00 SM-151 5.52E+06 9.52E+05 2.28E+05 0.OOE+00 1.06E+06 0.OOE+00 4.20E+08 0.OOE+00 11.4-177 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-36 (Page 4 of 4) Adult Vegetation Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 8.18E+02 6.82E+02 4.98E+01 0.O0E+00 2.20E+02 0.00E+00 2.43E+07 0.OOE+00 EU-152 1.55E+07 3.52E+06 3.09E+06 0.OOE+00 2.18E+07 O.OOE+00 2.03E+09 0.OOE+00 EU-154 4.85E+07 5.97E+06 4.25E+06 O.OOE+00 2.86E+07 0.OOE+00 4.32E+09 0.OOE+00 EU-155 6.71E+06 9.51E+05 6.14E+05 O.OOE+00 4.39E+06 0.OOE+00 7.48E+08 0.OOE+00 EU-156 1.08E+05 8.35E+04 1.35E+04 O.OOE+00 5.58E+04 0.OOE+00 5.72E+08 0.OOE+00 TB-160 1.96E+06 0.OOE+00 2.45E+05 0.OOE+00 8.11E+05 0.OOE+00 1.07E+09 0.OOE+00 HO-166m 2.16E+07 6.76E+06 5.13E+06 0.OOE+00 1.01E+07 0.OOE+00 8.01E-11 0.OOE+00 W-181 5.33E+05 1.74E+05 1.86E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.98E+07 0.OOE+00 W-185 1.73E+07 5.77E+06 6.07E+05 0.OOE+00 0.OOE+00 0.OOE+00 6.67E+08 0.OOE+00 W-187 3.79E+04 3.17E+04 1.11E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.04E+07 0.OOE+00 NP-239 1.43E+03 1.40E+02 7.73E+01 0.OOE+00 4.37E+02 0.OOE+00 2.88E+07 0.OOE+00 U-232 3.30E+11 0.OOE+00 2.36E+10 O.OOE+00 3.58E+10 0.OOE+00 5.42E+09 0.OOE+00 U-233 6.98E+10 0.OOE+00 4.23E+09 O.OOE+00 1.63E+10 0.OOE+00 5.02E+09 0.OOE+00 U-234 6.70E+10 0.OOE+00 4.14E+09 0.OOE+00 1.59E+10 0.OOE+00 4.92E+09 0.OOE+00 U-235 6.42E+10 0.OOE+00 3.89E+09 0.OOE+00 1.50E+10 0.OOE+00 6.26E+09 0.OOE+00 U-236 6.42E+10 0.OOE+00 3.97E+09 0.OOE+00 1.53E+10 0.OOE+00 4.62E+09 0.OOE+00 U-237 1.84E+05 0.OOE+00 4.89E+04 0.OOE+00 7.55E+05 0.OOE+00 6.45E+07 O.OOE+00 U-238 6.15E+10 0.OOE+00 3.64E+09 0.OOE+00 1.40E+10 0.OOE+00 4.41E+09 0.OOE+00 NP-237 1.01E+11 7.18E+09 4.44E+09 0.OOE+00 3.30E+10 0.OOE+00 6.36E+09 O.OOE+00 NP-238 1.45E+04 3.90E+02 2.25E+02 0.OOE+00 1.32E+03 0.OOE+00 3.63E+07 0.OOE+00 PU-238 5.04E+10 6.39E+09 1.37E+09 0.OOE+00 5.86E+09 0.OOE+00 5.84E+09 0.OOE+00 PU-239 5.81E+10 6.98E+09 1.53E+09 0.OOE+00 6.50E+09 0.OOE+00 5.34E+09 0.OOE+00 PU-240 5.80E+10 6.97E+09 1.53E+09 0.OOE+00 6.49E+09 0.OOE+00 5.43E+09 0.OOE+00 PU-241 1.25E+09 5.91E+07 2.64E+07 0.OOE+00 1.21EE+08 0.OOE+00 1.11E+08 0.OOE+00 PU-242 5.39E+10 6.72E+09 1.47E+09 0.OOE+00 6.26E+09 O.OOE+00 5.23E+09 0.OOE+00 PU-244 6.28E+10 7.70E+09 1.69E+09 0.OOE+00 7.17E+09 0.OOE+00 7.80E+09 0.OOE+00 AM-241 6.05E+10 5.65E+10 4.33E+09 0.OOE+00 3.26E+10 0.OOE+00 5.94E+09 0.OOE+00 AM-242m 6.09E+10 5.31E+10 4.35E+09 O.OOE+00 3.24E+10 O.OOE+00 7.48E+09 0.OOE+00 AM-243 6.04E+10 5.53E+10 4.25E+09 0.OOE+00 3.20E+10 0.OOE+00 6.97E+09 0.OOE+00 CM-242 1.23E+09 1.30E+09 8.15E+07 0.OOE+00 3.70E+08 O.OOE+00 4.71E+09 0.OOE+00 CM-243 4.78E+10 4.38E+10 2.99E+09 0.OOE+00 1.40E+10 0.OOE+00 6.23E+09 0.OOE+00 CM-244 3.63E+10 3.40E+10 2.28E+09 0.OOE+00 1.07E+10 0.OOE+00 6.01E+09 0.OOE+00 CM-245 7.52E+10 6.55E+10 4.62E+09 0.OOE+00 2.16E+10 O.OOE+00 5.64E+09 0.OOE+00 CM-246 7.45E+10 6.54E+10 4.61E+09 0.00E+00 2.15E+10 0.OOE+00 5.54E+09 0.OOE+00 CM-247 7.27E+10 6.44E+10 4.54E+09 0.00E+00 2.12E+10 0.OOE+00 7.28E+09 0.OOE+00 CM-248 6.04E+11 5.31E+11 3.74E+10 O.OOE+00 1.75E+11 0.OOE+00 1.18E+11 0.OOE+00 CF-252 1.99E+10 0.OOE+00 4.79E+08 0.OOE+00 0.OOE+00 0.OOE+00 2.19E+10 0.OOE+00 11.4-178 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-37 (Page 1 of 4) Infant Milk Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LLI Skin H-3 0.OOE+00 1.36E+03 1.36E+03 1.36E+03 1.36E+03 1.36E+03 1.36E+03 0.OOE+00 C-14 3.23E+06 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 0.OOE+00 NA-22 3.18E+10 3.18E+10 3.18E+10 3.18E+10 3.18E+10 3.18E+10 3.18E+10 0.00E+00 NA-24 1.54E+07 1.54E+07 1.54E+07 1.54E+07 1.54E+07 1.54E+07 1.54E+07 0.OOE+00 P-32 1.60E+11 9.43E+09 6.21E+09 0.OOE+00 0.OOE+00 0.00E+00 2.17E+09 0.00E+00 CA-41 2.46E+10 0.OOE+00 2.69E+09 O.00E+00 0.OOE+00 0.00E+00 1.26E+07 0.OOE+00 SC-46 1.30E+03 1.88E+03 5.86E+02 0.OOE+00 1.23E+03 0.00E+00 1.22E+06 0.00E+00 CR-51 0.OOE+00 0.00E+00 1.61 E+05 1.05E+05 2.30E+04 2.05E+05 4.70E+06 0.OOE+00 MN-54 0.00E+00 3.90E+07 8.84E+06 0.OOE+00 8.64E+06 O.OOE+00 1.43E+07 0.OOE+00 FE-55 1.35E+08 8.73E+07 2.33E+07 0.OOE+00 0.00E+00 4.27E+07 1.11E+07 0.OOE+00 MN-56 0.OOE+00 3.14E-02 5.42E-03 0.OOE+00 2.70E-02 O.OOE+00 2.85E+00 0.00E+00 CO-57 0.00E+00 8.95E+06 1.46E+07 0.00E+00 0.OOE+00 0.00E+00 3.05E+07 0.OOE+00 CO-58 0.OOE+00 2.42E+07 6.05E+07 0.00E+00 0.OOE+00 0.00E+00 6.04E+07 0.OOE+00 FE-59 2.24E+08 3.92E+08 1.54E+08 0.00E+00 0.OOE+00 1.16E+08 1.87E+08 0.OOE+00 CO-60 0.OOE+00 8.82E+07 2.08E+08 0.OOE+00 0.OOE+00 0.OOE+00 2.1OE+08 0.OOE+00 NI-59 2.61E+09 7.99E+08 4.50E+08 0.00E+00 0.OOE+00 0.00E+00 3.95E+07 0.OOE+00 NI-63 3.49E+10 2.16E+09 1.21E+09 0.OOE+00 0.OOE+00 0.00E+00 1.07E+08 0.00E+00 CU-64 0.00E+00 1.86E+05 8.59E+04 0.OOE+00 3.14E+05 0.00E+00 3.81E+06 O.OOE+00 NI-65 3.50E+00 3.97E-01 1.80E-01 0.OOE+00 0.OOE+00 0.00E+00 3.02E+01 0.OOE+00 ZN-65 5.55E+09 1.90E+10 8.78E+09 O.OOE+00 9.23E+09 0.OOE+00 1.61E+10 0.OOE+00 ZN-69m 1.68E+06 3.43E+06 3.13E+05 O.OOE+00 1.39E+06 0.OOE+00 4.75E+07 0.00E+00 ZN-69 2.02E-11 3.63E-11 2.70E-12 0.OOE+00 1.51E-11 0.OOE+00 2.96E-09 0.OOE+00 SE-79 0.00E+00 7.77E+09 1.44E+09 0.OOE+00 9.OOE+09 O.OOE+00 2.07E+08 0.OOE+00 BR-82 0.00E+00 0.00E+00 1.93E+08 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 9.34E-01 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.00E+00 1.26E-22 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 BR-85 0.OOE+00 0.00E+00 1.88E-300 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 RB-86 0.OOE+00 2.23E+10 1.10E+10 0.00E+00 0.OOE+00 0.00E+00 5.69E+08 0.OOE+00 RB-87 0.00E+00 2.19E+10 8.69E+09 0.00E+00 0.OOE+00 0.OOE+00 1.48E+08 0.OOE+00 RB-88 0.OOE+00 1.87E-44 1.03E-44 O.OOE+00 0.OOE+00 0.OOE+00 1.83E-44 0.OOE+00 RB-89 0.OOE+00 3.29E-52 2.26E-52 0.OOE+00 O.OOE+00 0.OOE+00 1.12E-52 0.OOE+00 SR-89 1.26E+10 0.OOE+00 3.61E+08 0.OOE+00 0.OOE+00 0.OOE+00 2.59E+08 0.OOE+00 SR-90 1.86E+11 0.OOE+00 3.77E+09 0.OOE+00 0.OOE+00 0.OOE+00 1.52E+09 0.OOE+00 Y-90 6.81E+02 0.OOE+00 1.83E+01 0.OOE+00 0.OOE+00 0.OOE+00 9.41E+05 0.OOE+00 SR-91 2.72E+05 0.OOE+00 9.83E+03 0.OOE+00 0.OOE+00 0.OOE+00 3.21E+05 0.OOE+00 Y-91m 5.67E-19 0.OOE+00 1.93E-20 0.OOE+00 0.OOE+00 0.OOE+00 1.89E-15 0.OOE+00 Y-91 7.33E+04 0.OOE+00 1.95E+03 0.OOE+00 0.00E+00 0.OOE+00 5.25E+06 0.OOE+00 11.4-179 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-37 (Page 2 of 4) Infant Milk Ri m 2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 4.64E+00 0.00E+00 1.72E-01 0.OOE+00 0.OOE+00 0.OOE+00 5.OOE+01 0.OOE+00 Y-92 5.38E-04 0.OOE+00 1.51E-05 0.OOE+00 0.OOE+00 0.OOE+00 1.03E+01 O.OOE+00 Y-93 2.16E+00 0.OOE+00 5.87E-02 0.OOE+00 0.OOE+00 0.OOE+00 1.70E+04 0.OOE+00 NB-93m 2.52E+06 6.83E+05 2.13E+05 O.OOE+00 6.67E+05 0.OOE+00 8.16E+07 O.OOE+00 NB-95 5.93E+05 2.44E+05 1.41 E+05 0.OOE+00 1.75E+05 0.OOE+00 2.06E+08 0.OOE+00 NB-97 3.08E-11 6.57E-12 2.37E-12 0.OOE+00 5.13E-12 0.OOE+00 2.07E-06 0.OOE+00 ZR-93 7.94E+03 3.78E+03 2.28E+03 0.OOE+00 1.11E+04 0.OOE+00 9.83E+05 0.OOE+00 ZR-95 6.80E+03 1.66E+03 1.18E+03 0.OOE+00 1.79E+03 0.OOE+00 8.26E+05 0.OOE+00 ZR-97 4.06E+00 6.97E-01 3.18E-01 0.OOE+00 7.03E-01 0.OOE+00 4.45E+04 0.OOE+00 MO-93 0.OOE+00 3.49E+09 1.12E+08 O.OOE+00 6.97E+08 0.OOE+00 7.47E+07 0.OOE+00 MO-99 0.OOE+00 2.08E+08 4.06E+07 0.OOE+00 3.11 E+08 0.OOE+00 6.85E+07 0.OOE+00 TC-99 2.22E+08 3.OOE+08 9.36E+07 0.OOE+00 2.53E+09 2.92E+07 1.30E+09 0.OOE+00 TC-99m 2.75E+01 5.67E+01 7.30E+02 0.OOE+00 6.1OE+02 2.96E+01 1.65E+04 0.OOE+00 TC-101 2.47E-59 3.11E-59 3.07E-58 0.OOE+00 3.69E-58 1.69E-59 5.28E-57 0.OOE+00 RU-103 8.67E+03 0.OOE+00 2.90E+03 0.OOE+00 1.80E+04 0.OOE+00 1.05E+05 0.OOE+00 RU-105 8.05E-03 0.OOE+00 2.71E-03 0.OOE+00 5.92E-02 0.OOE+00 3.20E+00 0.OOE+00 RU-106 1.90E+05 0.OOE+00 2.38E+04 0.OOE+00 2.25E+05 0.OOE+00 1.44E+06 0.OOE+00 RH-105 3.33E+06 2.18E+06 1.46E+06 O.OOE+00 6.05E+06 0.OOE+00 5.41E+07 O.OOE+00 PD-107 O.OOE+00 9.79E+07 6.95E+06 O.OOE+00 5.59E+08 O.OOE+00 7.78E+07 O.OOE+00 PD-109 O.OOE+00 3.99E+05 9.64E+04 O.OOE+00 1.47E+06 O.OOE+00 9.80E+06 O.OOE+00 AG-11Orn 3.86E+08 2.82E+08 1.86E+08 O.OOE+00 4.03E+08 O.OOE+00 1.46E+10 O.OOE+00 AG-111 6.17E+07 2.40E+07 1.27E+07 O.OOE+00 5.01E+07 O.OOE+00 5.72E+09 O.OOE+00 CD-i 13m O.OOE+00 1.74E+07 6.42E+05 O.OOE+00 1.32E+07 O.OOE+00 2.62E+07 O.OOE+00 CD-1 15m O.OOE+00 1.03E+07 3.59E+05 O.OOE+00 5.40E+06 O.OOE+00 5.89E+07 O.OOE+00 SN-123 4.57E+09 7.14E+07 1.19E+08 7.18E+07 O.OOE+00 O.OOE+00 1.21E+09 O.OOE+00 SN-125 5.38E+08 1.00E+07 2.39E+07 9.88E+06 O.OOE+00 O.OOE+00 8.06E+08 O.OOE+00 SN-126 1.14E+10 1.49E+08 3.70E+08 3.93E+07 O.OOE+00 O.OOE+00 5.18E+08 O.OOE+00 SB-1 24 2.09E+08 3.08E+06 6.49E+07 5.56E+05 O.OOE+00 1.31 E+08 6.46E+08 O.OOE+00 SB-1 25 1.50E+08 1.45E+06 3.08E+07 1.87E+05 O.OOE+00 8.66E+07 1.99E+08 O.OOE+00 SB-126 4.18E+07 8.19E+05 1.51E+07 3.21E+05 O.OOE+00 2.63E+07 4.33E+08 O.OOE+00 SB-127 4.14E+06 7.39E+04 1.28E+06 5.27E+04 0.OOE+00 2.13E+06 1.1OE+08 O.OOE+00 TE-125m 1.51E+08 5.04E+07 2.04E+07 5.07E+07 O.OOE+00 0.OOE+00 7.18E+07 0.OOE+00 TE-127m 4.21E+08 1.40E+08 5.1OE+07 1.22E+08 1.04E+09 O.OOE+00 1.70E+08 O.OOE+00 TE-127 6.32E+03 2.12E+03 1.36E+03 5.14E+03 1.54E+04 O.OOE+00 1.33E+05 O.OOE+00 TE-129m 5.57E+08 1.91E+08 8.58E+07 2.14E+08 1.39E+09 O.OOE+00 3.33E+08 O.OOE+00 TE-129 2.72E-09 9.37E-10 6.35E-10 2.28E-09 6.77E-09 O.OOE+00 2.17E-07 O.OOE+00 TE-133m 1.90E-12 8.68E-13 8.29E-13 1.67E-12 5.92E-12 O.OOE+00 9.36E-11 O.OOE+00 11.4-180 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-37 (Page 3 of 4) Infant Milk Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI Skin TE-134 7.81E-18 3.92E-18 4.04E-18 6.99E-18 2.64E-17 0.OOE+00 8.95E-17 0.00E+00 1-129 7.06E+09 5.23E+09 3.83E+09 3.36E+12 6.20E+09 0.OOE+00 1.05E+08 0.OOE+00 1-130 3.55E+06 7.81E+06 3.13E+06 8.75E+08 8.58E+06 0.OOE+00 1.67E+06 0.OOE+00 1-131 2.72E+09 3.20E+09 1.41E+09 1.05E+12 3.74E+09 0.OOE+00 1.14E+08 0.OOE+00 TE-131m 3.38E+06 1.36E+06 1.12E+06 2.75E+06 9.35E+06 0.OOE+00 2.29E+07 0.OOE+00 TE-131 3.43E-32 1.27E-32 9.62E-33 3.06E-32 8.76E-32 0.OOE+00 1.38E-30 0.OOE+00 1-132 1.43E+00 2.90E+00 1.03E+00 1.36E+02 3.24E+00 0.OOE+00 2.35E+00 0.OOE+00 TE-132 2.11E+07 1.04E+07 9.75E+06 1.54E+07 6.53E+07 O.OOE+00 3.87E+07 0.OOE+00 1-133 3.63E+07 5.28E+07 1.55E+07 9.60E+09 6.21E+07 0.OOE+00 8.93E+06 O.OOE+00 CS-134m 1.53E+00 2.54E+00 1.28E+00 0.OOE+00 9.81E-01 2.26E-01 2.01E+00 0.OOE+00 CS-134 3.65E+10 6.80E+10 6.87E+09 0.OOE+00 1.75E+10 7.18E+09 1.85E+08 0.OOE+00 1-134 1.76E-11 3.60E-11 1.28E-11 8.40E-10 4.03E-11 O.OOE+00 3.73E-11 0.OOE+00 1-135 1.12E+05 2.23E+05 8.14E+04 2.OOE+07 2.49E+05 0.OOE+00 8.08E+04 0.OOE+00 CS-135 1.31E+10 1.19E+10 6.22E+08 0.OOE+00 3.40E+09 1.29E+09 4.31E+07 O.OOE+00 CS-136 1.98E+09 5.81E+09 2.17E+09 0.OOE+00 2.32E+09 4.74E+08 8.82E+07 0.OOE+00 CS-137 5.15E+10 6.02E+10 4.27E+09 0.OOE+00 1.62E+10 6.55E+09 1.88E+08 0.OOE+00 CS-138 8.39E-23 1.36E-22 6.61E-23 0.00E+00 6.80E-23 1.06E-23 2.18E-22 0.OOE+00 CS-139 6.56E-89 8.97E-89 3.43E-89 0.OOE+00 4.64E-89 6.98E-90 5.63E-90 0.OOE+00 BA-139 4.27E-07 2.83E-10 1.24E-08 0.OOE+00 1.70E-10 1.72E-10 2.71E-05 0.OOE+00 BA-140 2.41E+08 2.41E+05 1.24E+07 0.OOE+00 5.72E+04 1.48E+05 5.92E+07 0.OOE+00 LA-140 4.05E+01 1.60E+01 4.11E+00 0.OOE+00 0.OOE+00 0.OOE+00 1.88E+05 0.OOE+00 BA-141 3.93E-45 2.69E-48 1.24E-46 0.00E+00 1.62E-48 1.64E-48 4.80E-44 0.OOE+00 LA-141 2.93E-04 8.51E-05 1.48E-05 0.OOE+00 0.OOE+00 0.OOE+00 9.76E+00 0.OOE+00 CE-141 4.34E+04 2.64E+04 3.11E+03 0.OOE+00 8.15E+03 0.OOE+00 1.37E+07 0.OOE+00 BA-142 2.44E-79 2.03E-82 1.20E-80 0.OOE+00 1.17E-82 1.23E-82 1.01E-78 0.OOE+00 LA-142 1.70E-10 6.24E-11 1.49E-11 0.OOE+00 0.OOE+00 0.OOE+00 1.06E-05 0.OOE+00 CE-143 3.97E+02 2.63E+05 3.OOE+01 0.OOE+00 7.67E+01 0.OOE+00 1.54E+06 0.OOE+00 PR-143 1.49E+03 5.55E+02 7.36E+01 0.OOE+00 2.06E+02 0.OOE+00 7.84E+05 0.OOE+00 CE-144 2.33E+06 9.52E+05 1.30E+05 0.00E+00 3.85E+05 0.OOE+00 1.33E+08 0.OOE+00 PR-144 5.69E-53 2.20E-53 2.86E-54 0.OOE+00 7.97E-54 0.OOE+00 1.02E-48 0.OOE+00 ND-147 8.81E+02 9.05E+02 5.55E+01 0.OOE+00 3.49E+02 0.OOE+00 5.74E+05 0.OOE+00 PM-147 1.57E+04 1.32E+03 6.44E+02 0.00E+00 1.98E+03 0.OOE+00 3.75E+05 0.OOE+00 PM-148m 4.90E+03 1.24E+03 9.74E+02 0.OOE+00 1.43E+03 0.OOE+00 1.62E+06 0.OOE+00 PM-1 48 5.57E+02 8.04E+01 4.05E+01 O.OOE+00 9.60E+01 0.OOE+00 8.58E+05 0.OOE+00 PM-149 4.13E+01 5.42E+00 2.37E+00 0.OOE+00 6.59E+00 0.OOE+00 1.46E+05 0.OOE+00 PM-151 6.13E+00 8.94E-01 4.52E-01 0.OOE+00 1.06E+00 0.OOE+00 4.14E+04 0.OOE+00 SM-151 1.19E+04 2.74E+03 5.92E+02 0.OOE+00 1.86E+03 0.OOE+00 2.29E+05 0.OOE+00 11.4-181 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-37 (Page 4 of 4) Infant Milk Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lungi GI-LLI Skin SM-153 1.90E+01 1.47E+01 1.13E+00 0.OOE+00 3.07E+00 0.OOE+00 7.67E+04 0.OOE+00 EU-152 2.76E+04 7.34E+03 6.19E+03 0.OOE+00 2.06E+04 0.OOE+00 6.52E+05 0.OOE+00 EU-154 1.08E+05 1.50E+04 9.01EE+03 O.OOE+00 4.07E+04 0.OOE+00 1.88E+06 0.OOE+00 EU-155 2.21E+04 2.55E+03 1.32E+03 0.OOE+00 5.71E+03 O.OOE+00 3.41E+06 0.OOE+00 EU-156 2.23E+03 1.38E+03 2.19E+02 0.OOE+00 6.37E+02 0.OOE+00 1.30E+06 0.OOE+00 TB-160 8.76E+03 0.O0E+00 1.10E+03 0.OOE+00 2.49E+03 O.OOE+00 1.17E+06 0.OOE+00 HO-166m 5.14E+04 1.11E+04 8.76E+03 0.OOE+00 1.47E+04 0.OOE+00 4.11E-14 0.00E+00 W-181 3.23E+05 9.91E+04 1.11E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.39E+06 0.OOE+00 W-185 1.23E+07 3.85E+06 4.39E+05 O.OOE+00 0.OOE+00 0.OOE+00 5.51 E+07 0.OOE+00 W-187 6.08E+04 4.23E+04 1.46E+04 0.OOE+00 0.OOE+00 0.OOE+00 2.48E+06 0.OOE+00 NP-239 3.65E+01 3.26E+00 1.84E+00 0.OOE+00 6.51 E+00 0.OOE+00 9.43E+04 0.OOE+00 U-232 9.95E+10 0.OOE+00 8.88E+09 0.OOE+00 9.74E+09 O.OOE+00 2.89E+08 0.O0E+00 U-233 2.09E+10 0.O0E+00 1.59E+09 0.OOE+00 4.44E+09 O.OOE+00 2.68E+08 0.OOE+00 U-234 2.01E+10 0.O0E+00 1.56E+09 0.OOE+00 4.36E+09 0.OOE+00 2.62E+08 0.OOE+00 U-235 1.92E+10 0.OOE+00 1.46E+09 0.OOE+00 4.08E+09 0.OOE+00 3.33E+08 0.OOE+00 U-236 1.92E+10 0.OOE+00 1.50E+09 0.OOE+00 4.15E+09 0.OOE+00 2.46E+08 0.OOE+00 U-237 5.39E+05 0.O0E+00 1.44E+05 0.OOE+00 1.34E+06 0.OOE+00 2.30E+07 0.OOE+00 U-238 1.84E+10 0.OOE+00 1.37E+09 O.OOE+00 3.82E+09 0.OOE+00 2.35E+08 0.OOE+00 NP-237 9.87E+07 6.54E+06 4.32E+06 0.OOE+00 2.61E+07 0.OOE+00 3.39E+06 0.OOE+00 NP-238 3.48E+02 8.75E+00 5.39E+00 0.OOE+00 1.91E+01 0.OOE+00 1.17E+05 0.OOE+00 PU-238 2.11E+07 2.47E+06 5.59E+05 O.OOE+00 1.99E+06 0.OOE+00 1.25E+06 0.O0E+00 PU-239 2.27E+07 2.55E+06 5.82E+05 0.OOE+00 2.11E+06 0.OOE+00 1.14E+06 0.OOE+00 PU-240 2.27E+07 2.55E+06 5.82E+05 0.OOE+00 2.11E+06 0.OOE+00 1.16E+06 0.OOE+00 PU-241 6.97E+05 2.89E+04 1.45E+04 0.OOE+00 5.20E+04 0.OOE+00 2.38E+04 0.OOE+00 PU-242 2.11E+07 2.45E+06 5.61E+05 0.OOE+00 2.02E+06 0.OOE+00 1.11E+06 0.OOE+00 PU-244 2.45E+07 2.81 E+06 6.43E+05 0.OOE+00 2.32E+06 0.OOE+00 1.66E+06 0.OOE+00 AM-241 6.01E+07 5.22E+07 4.48E+06 0.OOE+00 2.69E+07 0.OOE+00 3.17E+06 0.OOE+00 AM-242m 6.21EE+07 5.02E+07 4.65E+06 0.OOE+00 2.73E+07 0.OOE+00 3.99E+06 0.00E+00 AM-243 5.92E+07 5.06E+07 4.36E+06 0.OOE+00 2.62E+07 0.OOE+00 3.71 E+06 0.OOE+00 CM-242 5.15E+06 4.77E+06 3.42E+05 0.OOE+00 9.84E+05 0.OOE+00 3.09E+06 O.OOE+00 CM-243 5.75E+07 4.72E+07 3.69E+06 0.OOE+00 1.34E+07 0.OOE+00 3.33E+06 0.OOE+00 CM-244 4.84E+07 3.98E+07 3.12E+06 0.OOE+00 1.11E+07 0.OOE+00 3.22E+06 0.OOE+00 CM-245 7.36E+07 5.96E+07 4.65E+06 0.OOE+00 1.78E+07 0.OOE+00 3.OOE+06 0.OOE+00 CM-246 7.28E+07 5.96E+07 4.65E+06 0.OOE+00 1.77E+07 0.OOE+00 2.95E+06 0.OOE+00 CM-247 7.12E+07 5.88E+07 4.57E+06 0.OOE+00 1.74E+07 0.OOE+00 3.88E+06 0.OOE+00 CM-248 5.88E+08 4.85E+08 3.77E+07 0.OOE+00 1.44E+08 0.OOE+00 6.25E+07 0.OOE+00 CF-252 4.94E+07 0.OOE+00 1.19E+06 0.OOE+00 0.OOE+00 0.OOE+00 1.21E+07 0.OOE+00 11.4-182 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-38 (Page 1 of 4) Child Milk Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI Skin H-3 0.00E+00 8.97E+02 8.97E+02 8.97E+02 8.97E+02 8.97E+02 8.97E+02 0.00E+00 C-14 1.65E+06 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 0.00E+00 NA-22 1.90E+10 1.90E+10 1.90E+10 1.90E+10 1.90E+10 1.90E+10 1.90E+10 O.00E+00 NA-24 8.85E+06 8.85E+06 8.85E+06 8.85E+06 8.85E+06 8.85E+06 8.85E+06 0.00E+00 P-32 7.78E+10 3.64E+09 3.00E+09 0.OOE+00 O.00E+00 0.OOE+00 2.15E+09 0.OOE+00 CA-41 2.28E+10 O.OOE+00 2.49E+09 0.OOE+00 0.OOE+00 0.00E+00 1.25E+07 O.00E+00 SC-46 6.83E+02 9.36E+02 3.61 E+02 0.OOE+00 8.29E+02 0.OOE+00 1.37E+06 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 1.02E+05 5.65E+04 1.54E+04 1.03E+05 5.40E+06 0.OOE+00 MN-54 O.OOE+00 2.1OE+07 5.59E+06 0.00E+00 5.88E+06 0.OOE+00 1.76E+07 0.00E+00 FE-55 1.12E+08 5.93E+07 1.84E+07 0.OOE+00 O.OOE+00 3.35E+07 1.1OE+07 0.00E+00 MN-56 O.OOE+00 1.28E-02 2.90E-03 0.OOE+00 1.55E-02 0.OOE+00 1.86E+00 0.OOE+00 CO-57 0.OOE+00 3.84E+06 7.77E+06 O.OE+00 0.O0E+00 0.OOE+00 3.14E+07 O.OOE+00 CO-58 0.OOE+00 1.21 E+07 3.71 E+07 0.00E+00 0.OOE+00 0.OOE+00 7.07E+07 0.00E+00 FE-59 1.20E+08 1.95E+08 9.69E+07 0.OOE+00 0.OOE+00 5.64E+07 2.03E+08 0.OOE+00 CO-60 0.00E+00 4.32E+07 1.27E+08 0.OOE+00 0.00E+00 0.OOE+00 2.39E+08 0.OOE+00 NI-59 2.22E+09 5.90E+08 3.76E+08 0.OOE+00 0.00E+00 0.OOE+00 3.91E+07 0.OOE+00 NI-63 2.96E+10 1.59E+09 1.01E+09 0.00E+00 0.00E+00 0.OOE+00 1.07E+08 0.00E+00 CU-64 0.00E+00 7.46E+04 4.51E+04 0.OOE+00 1.80E+05 0.00E+00 3.50E+06 0.00E+00 NI-65 1.66E+00 1.56E-01 9.1OE-02 0.OOE+00 O.OOE+00 0.OOE+00 1.91E+01 0.OOE+00 ZN-65 4.13E+09 1.10E+10 6.85E+09 0.OOE+00 6.94E+09 0.OOE+00 1.93E+09 0.OOE+00 ZN-69m 7.96E+05 1.36E+06 1.60E+05 0.OOE+00 7.88E+05 0.OOE+00 4.41 E+07 0.OOE+00 ZN-69 9.47E-12 1.37E-11 1.26E-12 0.OOE+00 8.30E-12 0.OOE+00 8.62E-10 0.OOE+00 SE-79 0.OOE+00 3.12E+09 6.92E+08 0.OOE+00 5.07E+09 0.OOE+00 2.05E+08 0.OOE+00 BR-82 0.OOE+00 0.00E+00 1.15E+08 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 4.40E-01 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 6.51E-23 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 8.85E-301 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 8.77E+09 5.39E+09 0.OOE+00 0.00E+00 0.OOE+00 5.64E+08 0.OOE+00 RB-87 0.00E+00 9.75E+09 4.52E+09 0.OOE+00 0.00E+00 0.00E+00 1.46E+08 0.OOE+00 RB-88 0.OOE+00 7.15E-45 4.97E-45 0.OOE+00 0.OOE+00 0.OOE+00 3.51E-46 0.OOE+00 RB-89 0.00E+00 1.34E-52 1.20E-52 0.OOE+00 0.OOE+00 0.OOE+00 1.17E-54 0.OOE+00 SR-89 6.62E+09 0.00E+00 1.89E+08 0.OOE+00 0.00E+00 0.00E+00 2.56E+08 0.00E+00 SR-90 1.68E+11 0.00E+00 3.38E+09 0.OOE+00 0.OOE+00 0.00E+00 1.51E+09 0.OOE+00 Y-90 3.22E+02 0.OOE+00 8.62E+00 0.00E+00 0.00E+00 0.OOE+00 9.17E+05 0.00E+00 SR-91 1.30E+05 0.00E+00 4.92E+03 0.OOE+00 0.00E+00 0.00E+00 2.88E+05 0.OOE+00 Y-91m 2.68E-19 0.00E+00 9.74E-21 0.00E+00 0.00E+00 0.OOE+00 5.24E-16 0.00E+00 Y-91 3.90E+04 0.OOE+00 1.04E+03 0.OOE+00 0.00E+00 0.OOE+00 5.20E+06 0.OOE+00 11.4-183 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-38 (Page 2 of 4) Child Milk Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 2.18E+00 0.00E+00 8.75E-02 0.00E+00 0.00E+00 0.00E+00 4.13E+01 0.00E+00 Y-92 2.53E-04 0.OOE+00 7.24E-06 0.00E+00 0.00E+00 O.OOE+00 7.31 E+00 0.00E+00 Y-93 1.01E+00 0.00E+00 2.78E-02 0.00E+00 0.0OE+00 0.OOE+00 1.51E+04 0.00E+00 NB-93m 2.15E+06 5.37E+05 1.77E+05 0.001E+00 5.80E+05 0.00E+00 8.10E+07 O.OOE+00 NB-95 3.18E+05 1.24E+05 8.84E+04 0.OOE+00 1.16E+05 0.00E+00 2.29E+08 0.OOE+00 NB-97 1.46E-11 2.63E-12 1.23E-12 0.OOE+00 2.92E-12 0.00E+00 8.12E-07 O.00E+00 ZR-93 6.87E+03 2.57E+03 1.83E+03 0.OOE+00 9.96E+03 0.00E+00 9.75E+05 O.00E+00 ZR-95 3.83E+03 8.42E+02 7.50E+02 0.OOE+00 1.21 E+03 0.00E+00 8.79E+05 0.00E+00 ZR-97 1.92E+00 2.77E-01 1.64E-01 O.OOE+00 3.98E-01 0.00E+00 4.20E+04 0.00E+00 MO-93 0.00E+00 1.49E+09 5.34E+07 0.OOE+00 3.92E+08 0.00E+00 7.53E+07 0.00E+00 MO-99 0.OOE+00 8.14E+07 2.01E+07 O.00E+00 1.74E+08 0.OOE+00 6.73E+07 0.00E+00 TC-99 1.1OE+08 1.23E+08 4.40E+07 0.00E+00 1.44E+09 1.08E+07 1.29E+09 0.00E+00 TC-99m 1.32E+01 2.59E+01 4.29E+02 0.00E+00 3.76E+02 1.32E+01 1.47E+04 0.00E+00 TC-101 1.16E-59 1,22E-59 1.54E-58 0.00E+00 2.08E-58 6,43E-60 3.87E-59 0.OOE+00 RU-103 4.28E+03 0.OOE+00 1.65E+03 0.OOE+00 1.08E+04 0.00E+00 1.i11iE+05 0.OOE+00 RU-1 05 3.82E-03 0.00E+00 1.39E-03 0.00E+00 3.36E-02 O.OOE+00 2.49E+00 0.OOE+00 RU-1 06 9.24E+04 0.OOE+00 1.15E+04 0.OOE+00 1.25E+05 0.00E+00 1.44E+06 0.00E+00 RH-105 1.57E+06 8.43E+05 7.21E+05 0.OOE+00 3.36E+06 0.OOE+00 5.22E+07 0.OOE+00 PD-107 0.OOE+00 3.88E+07 3.30E+06 0.OOE+00 3.25E+08 0.OOE+00 7.71E+07 0.OOE+00 PD-109 0.OOE+00 1.51E+05 4.53E+04 0.00E+00 8.1OE+05 0.OOE+00 8.92E+06 0.OOE+00 AG-11Orn 2.09E+08 1.41E+08 1.13E+08 0.OOE+00 2.63E+08 0.OOE+00 1.68E+10 0.OOE+00 AG-1 11 2.94E+07 9.21 E+06 6.08E+06 0.OOE+00 2.78E+07 0.OOE+00 5.64E+09 0.OOE+00 CD-113m 0.OOE+00 1.OOE+07 4.27E+05 0.OOE+00 1.03E+07 0.OOE+00 2.59E+07 0.OOE+00 CD-115m 0.OOE+00 4.29E+06 1.83E+05 0.OOE+00 3.19E+06 0.OOE+00 5.83E+07 0.OOE+00 SN-123 2.44E+09 3.03E+07 5.95E+07 3.21E+07 0.OOE+00 0.OOE+00 1.20E+09 0.OOE+00 SN-125 2.58E+08 3.89E+06 1.15E+07 4.03E+06 0.OOE+00 0.OOE+00 7.99E+08 0.OOE+00 SN-126 6.85E+09 8.54E+07 1.95E+08 2.34E+07 0.OOE+00 0.OOE+00 5.14E+08 O.OOE+00 SB-124 1.09E+08 1.41E+06 3.81E+07 2.40E+05 0.OOE+00 6.03E+07 6.79E+08 0.OOE+00 SB-125 8.70E+07 6.71E+05 1.82E+07 8.06E+04 0.OOE+00 4.85E+07 2.08E+08 0.OOE+00 SB-126 2.28E+07 3.49E+05 8.19E+06 1.34E+05 0.OOE+00 1.09E+07 4.60E+08 0.OOE+00 SB-127 1.97E+06 3.04E+04 6.83E+05 2.19E+04 0.OOE+00 8.54E+05 1.11E+08 0.OOE+00 TE-125m 7.38E+07 2.OOE+07 9.84E+06 2.07E+07 O.00E+00 0.00E+00 7.12E+07 0.OOE+00 TE-127m 2.08E+08 5.60E+07 2.47E+07 4.97E+07 5.93E+08 0.OOE+00 1.68E+08 0.OOE+00 TE-127 2.98E+03 8.02E+02 6.38E+02 2.06E+03 8.47E+03 O.OOE+00 1.16E+05 0.OOE+00 TE-129m 2.71E+08 7.58E+07 4.21E+07 8.75E+07 7.97E+08 O.OOE+00 3.31iE+08 O.OOE+00 TE-129 1.28E-09 3.58E-10 3.04E-10 9.15E-10 3.75E-09 0.OOE+00 7.98E-08 0.OOE+00 TE-133m 9.07E-13 3.67E-13 4.54E-13 7.03E-13 3.48E-12 O.OOE+00 2.80E-11 0.OOE+00 11.4-184 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-38 (Page 3 of 4) Child Milk Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 3.77E-18 1.70E-18 2.26E-18 2.98E-18 1.57E-17 0.OE+00 1.72E-17 0.00E+00 1-129 3.43E+09 2.11E+09 1.88E+09 1.38E+12 3.55E+09 0.OOE+00 1.06E+08 0.OOE+00 1-130 1.73E+06 3.49E+06 1.80E+06 3.84E+08 5.22E+06 0.OOE+00 1.63E+06 0.OOE+00 1-131 1.30E+09 1.31E+09 7.45E+08 4.33E+11 2.15E+09 0.OOE+00 1.17E+08 O.OOE+00 TE-131m 1.60E+06 5.53E+05 5.89E+05 1.14E+06 5.35E+06 0.00E+00 2.24E+07 0.OOE+00 TE-131 1.62E-32 4.93E-33 4.81E-33 1.24E-32 4.89E-32 0.OOE+00 8.49E-32 0.OOE+00 1-132 6.89E-01 1.27E+00 5.82E-01 5.87E+01 1.94E+00 0.OOE+00 1.49E+00 0.OOE+00 TE-132 1.02E+07 4.53E+06 5.48E+06 6.60E+06 4.21E+07 0.OOE+00 4.57E+07 0.OOE+00 1-133 1.72E+07 2.12E+07 8.03E+06 3.94E+09 3.54E+07 0.OOE+00 8.56E+06 O.OOE+00 CS-134m 7.32E-01 1.08E+00 7.08E-01 0.OOE+00 5.72E-01 9.46E-02 1.37E+00 O.OOE+00 CS-134 2.26E+10 3.72E+10 7.84E+09 0.OOE+00 1.15E+10 4.13E+09 2.OOE+08 O.OOE+00 1-134 8.48E-12 1.58E-11 7.25E-12 3.62E-10 2.41E-11 0.OOE+00 1.04E-11 0.OOE+00 1-135 5.40E+04 9.72E+04 4.60E+04 8.61E+06 1.49E+05 0.OOE+00 7.40E+04 O.OOE+00 CS-135 8.19E+09 5.71E+09 5.85E+08 0.OOE+00 2.01E+09 6.72E+08 4.27E+07 0.OOE+00 CS-136 1.01E+09 2.78E+09 1.80E+09 0.OOE+00 1.48E+09 2.21E+08 9.77E+07 0.OOE+00 CS-137 3.22E+10 3.09E+10 4.55E+09 O.OOE+00 1.01E+10 3.62E+09 1.93E+08 0.OOE+00 CS-138 3.98E-23 5.53E-23 3.51E-23 0.OOE+00 3.89E-23 4.19E-24 2.55E-23 O.OOE+00 CS-139 3.07E-89 3.41E-89 1.64E-89 0.OOE+00 2.56E-89 2.58E-90 3.07E-93 0.OOE+00 BA-139 2.01E-07 1.07E-10 5.82E-09 0.OOE+00 9.36E-11 6.30E-11 1.16E-05 0.OOE+00 BA-140 1.17E+08 1.03E+05 6.84E+06 0.OOE+00 3.34E+04 6.12E+04 5.93E+07 0.OOE+00 LA-140 1.94E+01 6.78E+00 2.29E+00 0.OOE+00 0.OOE+00 0.OOE+00 1.89E+05 0.OOE+00 BA-141 1.85E-45 1.04E-48 6.02E-47 0.OOE+00 8.96E-49 6.09E-48 1.05E-45 0.OOE+00 LA-141 1.38E-04 3.22E-05 6.99E-06 0.OOE+00 0.OOE+00 0.OOE+00 7.16E+00 0.OOE+00 CE-141 2.19E+04 1.09E+04 1.62E+03 0.OOE+00 4.78E+03 0.OOE+00 1.36E+07 O.OOE+00 BA-142 1.16E-79 8.35E-83 6.48E-81 O.OOE+00 6.76E-83 4.91E-83 1.51E-81 0.OOE+00 LA-142 8.1OE-11 2.58E-11 8.08E-12 0.OOE+00 0.OOE+00 0.OOE+00 5.11E-06 O.OOE+00 CE-143 1.87E+02 1.02E+05 1.47E+01 0.00E+00 4.26E+01 0.OOE+00 1.49E+06 0.OOE+00 PR-143 7.18E+02 2.16E+02 3.56E+01 0.OOE+00 1.17E+02 0.OOE+00 7.75E+05 0.OOE+00 CE-144 1.62E+06 5.09E+05 8.66E+04 0.OOE+00 2.82E+05 0.OOE+00 1.33E+08 0.OOE+00 PR-144 2.68E-53 8.28E-54 1.35E-54 O.OOE+00 4.38E-54 0.OOE+00 1.78E-50 O.OOE+00 ND-147 4.45E+02 3.60E+02 2.79E+01 0.OOE+00 1.98E+02 0.OOE+00 5.70E+05 0.OOE+00 PM-147 1.29E+04 9.19E+02 4.94E+02 0.00E+00 1.62E+03 0.OOE+00 3.72E+05 0.OOE+00 PM-148m 3.06E+03 6.09E+02 6.09E+02 0.OOE+00 9.03E+02 0.OOE+00 1.72E+06 O.OOE+00 PM-148 2.66E+02 3.20E+01 2.07E+01 O.OOE+00 5.43E+01 0.OOE+00 8.54E+05 0.OOE+00 PM-149 1.94E+01 2.07E+00 1.12E+00 O.OOE+00 3.66E+00 O.OOE+00 1.41E+05 O.OOE+00 PM-151 2.90E+00 3.52E-01 2.29E-01 0.OOE+00 5.97E-01 0.OOE+00 4.OOE+04 O.OOE+00 SM-151 1.05E+04 1.57E+03 4.93E+02 0.OOE+00 1.62E+03 0.OOE+00 2.27E+05 0.OOE+00 11.4-185 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-38 (Page 4 of 4) Child Milk Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung. GI-LLI Skin SM-153 8.98E+00 5.58E+00 5.39E-01 0.OOE+00 1.70E+00 0.00E+00 7.43E+04 0.OOE+00 EU-152 2.52E+04 4.59E+03 5.45E+03 0.OOE+00 1.94E+04 0.OOE+00 7.55E+05 0.00E+00 EU-154 9.42E+04 8.47E+03 7.74E+03 0.OOE+00 3.72E+04 0.OOE+00 1.97E+06 0.OOE+00 EU-155 1.97E+04 1.42E+03 1.11 E+03 0.OOE+00 5.30E+03 0.OOE+00 3.54E+06 O.00E+00 EU-156 1.1OE+03 5.88E+02 1.22E+02 0.00E+00 3.79E+02 0.OOE+00 1.33E+06 O.OOE+00 TB-160 5.61E+03 0.OOE+00 6.96E+02 0.OOE+00 1.67E+03 0.OOE+00 1.24E+06 0.OOE+00 HO-166m 4.44E+04 9.30E+03 7.86E+03 0.OOE+00 1.32E+04 0.OOE+00 4.11E-14 0.OOE+00 W-1 81 1.54E+05 3.79E+04 5.21 E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.38E+06 0.OOE+00 W-185 5.89E+06 1.47E+06 2.06E+05 0.OOE+00 0.OOE+00 O.OOE+00 5.48E+07 0.OOE+00 W-187 2.89E+04 1.71E+04 7.68E+03 0.OOE+00 0.OOE+00 0.OOE+00 2.40E+06 0.OOE+00 NP-239 1.72E+01 1.24E+00 8.71E-01 0.OOE+00 3.58E+00 O.OOE+00 9.17E+04 0.OOE+00 U-232 7.24E+10 0.00E+00 5.18E+09 O.OOE+00 5.51E+09 0.OOE+00 2.87E+08 0.OOE+00 U-233 1.53E+10 0.00E+00 9.26E+08 0.OOE+00 2.51E+09 0.OOE+00 2.65E+08 0.OOE+00 U-234 1.47E+10 0.O0E+00 9.09E+08 0.OOE+00 2.46E+09 0.OOE+00 2.60E+08 0.OOE+00 U-235 1.41E+10 0.OOE+00 8.52E+08 O.00E+00 2.31E+09 0.OOE+00 3.30E+08 O.OOE+00 U-236 1.41 E+1 0 0.OOE+00 8.72E+08 0.OOE+00 2.36E+09 0.OOE+00 2.44E+08 0.OOE+00 U-237 2.57E+05 0.00E+00 6.83E+04 0.OOE+00 7.42E+05 0.O0E+00 2.27E+07 0.OOE+00 U-238 1.35E+10 0.OOE+00 7.98E+08 O.OOE+00 2.16E+09 0.OOE+00 2.33E+08 O.OOE+00 NP-237 9.17E+07 6.05E+06 4.03E+06 0.OOE+00 2.49E+07 O.00E+00 3.36E+06 0.00E+00 NP-238 1.64E+02 3.31E+00 2.55E+00 O.OOE+00 1.05E+01 O.OOE+00 1.13E+05 0.OOE+00 PU-238 1.96E+07 2.27E+06 5.20E+05 0.OOE+00 1.89E+06 O.OOE+00 1.23E+06 O.OOE+00 PU-239 2.12E+07 2.27E+06 5.45E+05 0.OOE+00 2.01E+06 0.OOE+00 1.13E+06 0.OOE+00 PU-240 2.11E+07 2.35E+06 5.45E+05 0.OOE+00 2.01E+06 0.OOE+00 1.15E+06 0.00E+00 PU-241 6.35E+05 2.59E+04 1.32E+04 0.OOE+00 4.86E+04 0.OOE+00 2.36E+04 0.OOE+00 PU-242 1.96E+07 2.27E+06 5.25E+05 0.OOE+00 1.93E+06 0.OOE+00 1.1OE+06 0.OOE+00 PU-244 2.29E+07 2.60E+07 6.01 E+05 0.OOE+00 2.22E+06 0.OOE+00 1.65E+06 0.OOE+00 AM-241 5.59E+07 4.81E+07 4.20E+06 0.OOE+00 2.56E+07 0.OOE+00 3.14E+06 0.OOE+00 AM-242m 5.76E+07 4.61E+07 4.28E+06 0.OOE+00 2.59E+07 0.OOE+00 3.95E+06 0.OOE+00 AM-243 5.51 E+07 4.65E+07 4.04E+06 0.OOE+00 2.49E+07 0.OOE+00 3.68E+06 0.OOE+00 CM-242 3.30E+06 2.63E+06 2.19E+05 0.OOE+00 7.02E+05 0.OOE+00 3.07E+06 0.OOE+00 CM-243 5.26E+07 4.27E+07 3.38E+06 0.OOE+00 1.27E+07 0.OOE+00 3.30E+06 0.OOE+00 CM-244 4.43E+07 3.59E+07 2.84E+06 0.OOE+00 1.04E+07 0.00E+00 3.19E+06 0.OOE+00 CM-245 6.87E+07 5.51E+07 4.32E+06 0.OOE+00 1.69E+07 0.OOE+00 2.98E+06 0.OOE+00 CM-246 6.79E+07 5.51E+07 4.32E+06 0.00E+00 1.69E+07 0.OOE+00 2.92E+06 0.OOE+00 CM-247 ,6.62E+07 5.43E+07 4.24E+06 0.OOE+00 1.66E+07 0.OOE+00 3.85E+06 0.OOE+00 CM-248 5.51 E+08 4.48E+08 3.50E+07 0.OOE+00 1.37E+08 0.OOE+00 6.21 E+07 0.OOE+00 CF-252 4.25E+07 0.OOE+00 1.03E+06 0.OOE+00 0.OOE+00 0.OOE+00 1.20E+07 0.OOE+00 11.4-186 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-39 (Page 1 of 4) Teen Milk Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 5.66E+02 5.66E+02 5.66E+02 5.66E+02 5.66E+02 5.66E+02 0.OOE+00 C-14 6.70E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 0.OOE+00 NA-22 9.19E+09 9.19E+09 9.19E+09 9.19E+09 9.19E+09 9.19E+09 9.19E+09 O.OOE+00 NA-24 4.26E+06 4.26E+06 4.26E+06 4.26E+06 4.26E+06 4.26E+06 4.26E+06 0.OOE+00 P-32 3.15E+10 1°95E+09 1.22E+09 0.OOE+00 0.OOE+00 0.OOE+00 2.65E+09 0.OOE+00 CA-41 1.57E+10 0.OOE+00 1.70E+09 0.OOE+00 0.OOE+00 O.OOE+00 1.56E+07 O.OOE+00 SC-46 3.04E+02 5.93E+02 1.76E+02 0.0OE+00 5.67E+02 0.OOE+00 2,02E+06 O.OOE+00 CR-51 0.00E+00 0.OOE+00 4.99E+04 2.77E+04 1.09E+04 7.13E+04 8.39E+06 0.OOE+00 MN-54 0.OOE+00 1.40E+07 2.78E+06 0.OOE+00 4.18E+06 0.OOE+00 2.87E+07 O.OOE+00 FE-55 4.45E+07 3.16E+07 7.36E+06 0.OOE+00 0.OOE+00 2.OOE+07 1.37E+07 0.OOE+00 MN-56 O.OOE+00 7.36E-03 1.31E-03 0.OOE+00 9.31E-03 O.OOE+00 4.84E-01 0.OOE+00 CO-57 0.OOE+00 2.25E+06 3.76E+06 0.OOE+00 0.OOE+00 0.OOE+00 4.19E+07 0.00E+00 CO-58 0.OOE+00 7.94E+06 1.83E+07 O.OOE+00 O.OOE+00 0.OOE+00 1.09E+08 0.OOE+00 FE-59 5.18E+07 1.21E+08 4.67E+07 0.OOE+00 0,00E+00 3.81E+07 2.86E+08 0.OOE+00 CO-60 O.OOE+00 2.78E+07 6.26E+07 0.OOE+00 0.OOE+00 0.00E+00 3.62E+08 0.00E+00 NI-59 8.82E+08 3.11 E+08 1.50E+08 0.OOE+00 0.OOE+00 0.OOE+00 4.88E+07 0.OOE+00 NI-63 1.18E+10 8.35E+08 4.01EE+08 0.OOE+00 O.OOE+00 0.00E+00 1.33E+08 0.OOE+00 CU-64 0.OOE+00 4.25E+04 2.OOE+04 0.OOE+00 1.07E+05 0.OOE+00 3.29E+06 0.OOE+00 NI-65 6.77E-01 8.65E-02 3.94E-02 0.OOE+00 0.OOE+00 0.O0E+00 4.69E+00 0.OOE+00 ZN-65 2.11E+09 7.32E+09 3.41E+09 0.OOE+00 4.68E+09 0.OOE+00 3.1OE+09 0.OOE+00 ZN-69m 3.26E+05 7.69E+05 7.05E+04 0.OOE+00 4.67E+05 0.OOE+00 4.22E+07 0.00E+00 ZN-69 3.85E-12 7.34E-12 5.13E-13 0.OOE+00 4.79E-12 0.OOE+00 1.35E-11 O.OE+00 SE-79 0.OOE+00 1.67E+09 2.81E+08 0.OOE+00 2.92E+09 0.OOE+00 2.56E+08 0.OOE+00 BR-82 0.OOE+00 O.OOE+00 5.61 E+07 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.O0E+00 BR-83 O.OE+00 0.OOE+00 1.79E-01 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 O.OOE+00 2.88E-23 0.OOE+00 0.OOE+00 0.0OE+00 O.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.00E+00 3.59E-301 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 4.73E+09 2.22E+09 0.OOE+00 0.OOE+00 0.OOE+00 7.OOE+08 0.OOE+00 RB-87 0.OOE+00 5.24E+09 1.83E+09 0.OOE+00 0.OOE+00 0.00E+00 1.83E+08 0.OOE+00 RB-88 0.00E+00 3.89E-45 2.07E-45 O.OOE+00 0.OOE+00 O.OOE+00 3.33E-52 0.OOE+00 RB-89 0.OOE+00 7.66E-53 5.42E-53 0.OOE+00 0.OOE+00 0.OOE+00 1.17E-61 0.OOE+00 SR-89 2.67E+09 0.O0E+00 7.66E+07 0.OOE+00 0.00E+00 0.OOE+00 3.19E+08 O.OOE+00 SR-90 8.13E+10 0.OOE+00 1.63E+09 0.OOE+00 0.OOE+00 0.OOE+00 1.86E+09 0.OOE+00 Y-90 1.30E+02 0,00E+00 3.51 E+00 0.OOE+00 0.OOE+00 0.OOE+00 1.07E+06 O.OOE+00 SR-91 5.31E+04 0.OOE+00 2.11EE+03 0.OOE+00 O.OOE+00 0.OOE+00 2.41E+05 0.OOE+00 Y-91m 1.10E-19 0.OOE+00 4.19E-21 O.OOE+00 0.OOE+00 0.OOE+00 5.17E-18 0.OOE+00 Y-91 1.58E+04 0.OOE+00 4.24E+02 0.OOE+00 0.OOE+00 0.00E+00 6.48E+06 0.OOE+00 11.4-187 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-39 (Page 2 of 4) Teen Milk Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 8.94E-01 0.OOE+00 3.81E-02 0.00E+00 0.00E+00 0.00E+00 2.28E+01 0.00E+00 Y-92 1.03E-04 0.00E+00 2.98E-06 0.OOE+00 0.OOE+00 0.00E+00 2.83E+00 0.00E+00 Y-93 4.12E-01 0.OOE+00 1.13E-02 0.OOE+00 0.00E+00 0.00E+00 1.26E+04 0.00E+00 NB-93m 8.55E+05 2.81E+05 7.04E+04 O.OOE+00 3.28E+05 0.00E+00 1.01E+08 0.00E+00 NB-95 1.41 E+05 7.81 E+04 4.30E+04 O.00E+00 7.57E+04 0.00E+00 3.34E+08 0.00E+00 NB-97 5.99E-12 1.49E-12 5.43E-13 O.00E+00 1.74E-12 O.00E+00 3.55E-08 0.00E+00 ZR-93 2.76E+03 1.36E+03 7.43E+02 0.OOE+00 4.81 E+03 0.00E+00 1.29E+06 0.00E+00 ZR-95 1.65E+03 5.20E+02 3.58E+02 0.00E+00 7.65E+02 0.OOE+00 1.20E+06 0.OOE+00 ZR-97 7.88E-01 1.56E-01 7.19E-02 O.00E+00 2.37E-01 0.00E+00 4.22E+04 O.00E+00 MO-93 0.OOE+00 7.93E+08 2.17E+07 0.00E+00 2.27E+08 0.00E+00 9.65E+07 0.OOE+00 MO-99 0.OOE+00 4.47E+07 8.53E+06 O.00E+00 1.02E+08 0.00E+00 8.01 E+07 0.00E+00 TC-99 4.46E+07 6.56E+07 1.79E+07 0.00E+00 8.33E+08 6.78E+06 1.61E+09 0.00E+00 TC-99m 5.76E+00 1.61 E+01 2.08E+02 0.00E+00 2.39E+02 8.92E+00 1.05E+04 0.OOE+00 TC-101 4.74E-60 6.74E-60 6.62E-59 0.00E+00 1.22E-58 4.11E-60 1.15E-66 0.00E+00 RU-1 03 1.81E+03 0.OOE+00 7.74E+02 0.O0E+00 6.38E+03 0.OOE+00 1.51E+05 0.OOE+00 RU-1 05 1.56E-03 0.00E+00 6.07E-04 0.00E+00 1.97E-02 0.OOE+00 1.26E+00 0.00E+00 RU-106 3.75E+04 0.OOE+00 4.73E+03 0.00E+00 7.24E+04 0.OOE+00 1.80E+06 0.OOE+00 RH-105 6.40E+05 4.63E+05 3.04E+05 0.OOE+00 1.97E+06 0.OOE+00 5.89E+07 0.OOE+00 PD-107 0.OOE+00 2.07E+07 1.34E+06 0.OOE+00 1.87E+08 0.OOE+00 9.63E+07 0.OOE+00 PD-109 0.OOE+00 8.1OE+04 1.84E+04 0.OOE+00 4.68E+05 0.OOE+00 8.17E+06 0.OOE+00 AG-11im 9.63E+07 9.11E+07 5.54E+07 0.OOE+00 1.74E+08 0.OOE+00 2.56E+10 0.OOE+00 AG-111 1.19E+07 4.95E+06 2.49E+06 0.00E+00 1.61E+07 0.OOE+00 6.91E+09 0.OOE+00 CD-i 13m 0.OOE+00 5.38E+06 1.73E+05 0.OOE+00 5.95E+06 0.OOE+00 3.23E+07 0.OOE+00 CD-115m 0.OOE+00 2.30E+06 7.41E+04 0.OOE+00 1.84E+06 0.OOE+00 7.27E+07 0.OOE+00 SN-123 9.88E+08 1.62E+07 2.40E+07 1.30E+07 0.OOE+00 0.OOE+00 1.49E+09 0.OOE+00 SN-125 1.05E+08 2.09E+06 4.73E+06 1.64E+06 0.OOE+00 0.OOE+00 9.86E+08 0.OOE+00 SN-1 26 2.89E+09 5.39E+07 8.23E+07 1.42E+07 0.OOE+00 0.OOE+00 6.43E+08 0.OOE+00 SB-124 4.59E+07 8.46E+05 1.79E+07 1.04E+05 0.OOE+00 4.01E+07 9.25E+08 0.OOE+00 SB-125 3.65E+07 3.99E+05 8.55E+06 3.49E+04 0.OOE+00 3.21E+07 2.84E+08 0.OOE+00 SB-126 9.99E+06 2.04E+05 3.59E+06 5.65E+04 0.OOE+00 7.16E+06 5.91E+08 0.OOE+00 SB-127 8.17E+05 1.75E+04 3.08E+05 9.18E+03 0.OOE+00 5.56E+05 1.39E+08 0.OOE+00 TE-125m 3.OOE+07 1.08E+07 4.02E+06 8.39E+06 0.OOE+00 0.OOE+00 8.86E+07 0.OOE+00 TE-127m 8.44E+07 2.99E+07 1.OOE+07 2.01E+07 3.42E+08 0.OOE+00 2.1OE+08 0.OOE+00 TE-127 1.21E+03 4.29E+02 2.60E+02 8.35E+02 4.90E+03 0.OOE+00 9.34E+04 0.OOE+00 TE-129m 1.1OE+08 4.09E+07 1.74E+07 3.55E+07 4.61EE+08 0.OOE+00 4.13E+08 0.OOE+00 TE-129 5.20E-10 1.94E-10 1.26E-10 3.71E-10 2.18E-09 0.OOE+00 2.84E-09 0.OOE+00 TE-133m 3.79E-13 2.15E-13 2.09E-13 3.OOE-13 2.13E-12 0.OOE+00 8.70E-13 0.OOE+00 11.4-188 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-39 (Page 3 of 4) Teen Milk R, m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 1.59E-18 1.02E-18 1.06E-18 1.30E-18 9.72E-18 0.OOE+00 5.89E-20 0.00E+00 1-129 1.39E+09 1.17E+09 1.96E+09 1.43E+12 2.1OE+09 0.OOE+00 1.37E+08 0.OOE+00 1-130 7.38E+05 2.14E+06 8.53E+05 1.74E+08 3.29E+06 0.00E+00 1.64E+06 0.OOE+00 1-131 5.37E+08 7.52E+08 4.04E+08 2.19E+11 1.29E+09 0.00E+00 1.49E+08 0.00E+00 TE-131m 6.57E+05 3.15E+05 2.63E+05 4.74E+05 3.29E+06 0.OOE+00 2.53E+07 0.OOE+00 TE-131 6.58E-33 2.71E-33 2.06E-33 5.07E-33 2.88E-32 0.OOE+00 5.40E-34 0.00E+00 1-132 2.91E-01 7.62E-01 2.74E-01 2.57E+01 1.20E+00 0.OOE+00 3.32E-01 0.00E+00 TE-132 4.29E+06 2.72E+06 2.56E+06 2.87E+06 2.61E+07 0.OOE+00 8.61E+07 0.00E+00 1-133 7.07E+06 1.20E+07 3.66E+06 1.67E+09 2.1OE+07 0.OOE+00 9.07E+06 0.OOE+00 CS-134m 3.09E-01 6.41E-01 3.29E-01 0.OOE+00 3.57E-01 6.26E-02 4.26E-01 0.OOE+00 CS-134 9.82E+09 2.31E+10 1.07E+10 0.OOE+00 7.34E+09 2.80E+09 2.87E+08 0.OOE+00 1-134 3.58E-12 9.50E-12 3.41E-12 1.58E-10 1.50E-11 0.OOE+00 1.25E-13 0.OOE+00 1-135 2.28E+04 5.87E+04 2.18E+04 3.78E+06 9.27E+04 0.OOE+00 6.51E+04 0.OOE+00 CS-135 3.33E+09 3.05E+09 7.13E+08 0.OOE+00 1.16E+09 4.21E+08 5.34E+07 0.OOE+00 CS-136 4.48E+08 1.76E+09 1.18E+09 0.OOE+00 9.60E+08 1.51E+08 1.42E+08 0.OOE+00 CS-137 1.34E+10 1.78E+10 6.20E+09 0.OOE+00 6.06E+09 2.35E+09 2.53E+08 0.OOE+00 CS-138 1.64E-23 3.15E-23 1.57E-23 0.00E+00 2.33E-23 2.71E-24 1.43E-26 0.00E+00 CS-139 1.25E-89 1.84E-89 6.75E-90 0.00E+00 1.49E-89 1.63E-90 8.54E-105 0.OOE+00 BA-139 8.17E-08 5.75E-11 2.38E-09 0.OOE+00 5.42E-11 3.96E-11 7.29E-07 0.OOE+00 BA-140 4.85E+07 5.95E+04 3.13E+06 0.OOE+00 2.02E+04 4.OOE+04 7.48E+07 0.OOE+00 LA-140 8.1OE+00 3.98E+00 1.06E+00 0.OOE+00 0.OOE+00 0.OOE+00 2.29E+05 0.OOE+00 BA-141 7.52E-46 5.62E-49 2.51E-47 O.OOE+00 5.21E-49 3.85E-49 1.60E-51 0.OOE+00 LA-141 5.60E-05 1.72E-05 2.84E-06 0.OOE+00 0.OOE+00 0.OOE+00 3.05E+00 0.OOE+00 CE-141 8.88E+03 5.93E+03 6.81E+02 0.OOE+00 2.79E+03 0.OOE+00 1.70E+07 0.00E+00 BA-142 4.81E-80 4.81E-83 2.96E-81 0.00E+00 4.07E-83 3.20E-83 1.48E-91 0.OOE+00 LA-142 3.35E-11 1.49E-11 3.71E-12 0.OOE+00 0.OOE+00 0.OOE+00 4.53E-07 0.OOE+00 CE-143 7.64E+01 5.56E+04 6.21E+00 0.OOE+00 2.49E+01 0.OOE+00 1.67E+06 0.OOE+00 PR-143 2.90E+02 1.16E+02 1.44E+01 0.OOE+00 6.73E+01 0.OOE+00 9.54E+05 0.OOE+00 CE-144 6.58E+05 2.72E+05 3.54E+04 0.OOE+00 1.63E+05 0.OOE+00 1.66E+08 0.OOE+00 PR-144 1.08E-53 4.43E-54 5.48E-55 0.OOE+00 2.54E-54 0.OOE+00 1.19E-56 0.OOE+00 ND-147 1.81E+02 1.97E+02 1.18E+01 0.OOE+00 1.16E+02 0.OOE+00 7.11EE+05 0.OOE+00 PM-147 5.15E+03 4.89E+02 1.99E+02 0.OOE+00 9.32E+02 0.OOE+00 4.65E+05 0.OOE+00 PM-148m 1.49E+03 3.78E+02 2.96E+02 0.OOE+00 5.73E+02 0.OOE+00 2.38E+06 0.OOE+00 PM-148 1.09E+02 1.77E+01 8.92E+00 0.OOE+00 3.20E+01 0.OOE+00 1.06E+06 0.OOE+00 PM-149 7.88E+00 1.11EE+00 4.54E-01 0.OOE+00 2.11EE+00 0.OOE+00 1.63E+05 0.OOE+00 PM-151 1.19E+00 1.96E-01 9.92E-02 0.OOE+00 3.52E-01 0.OOE+00 4.40E+04 0.OOE+00 SM-151 4.35E+03 8.37E+02 1.96E+02 0.OOE+00 9.17E+02 0.OOE+00 2.84E+05 0.OOE+00 11.4-189 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-39 (Page 4 of 4) Teen Milk R, m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 3.64E+00 3.01E+00 2.22E-01 0.OOE+00 9.84E-01 0.OOE+00 8.50E+04 0.OOE+00 EU-152 1.22E+04 2.93E+03 2.58E+03 0.OOE+00 1.36E+04 0.OOE+00 1.08E+06 0.OOE+00 EU-1 54 3.93E+04 5.06E+03 3.57E+03 0.OOE+00 2.26E+04 0.OOE+00 2.67E+06 O.OOE+00 EU-155 8.60E+03 8.31E+02 5.14E+02 0.00E+00 3.25E+03 0.OOE+00 4.76E+06 O.00E+00 EU-156 4.55E+02 3.41E+02 5.57E+01 0.OOE+00 2.29E+02 0.00E+00 1.74E+06 0.OOE+00 TB-160 2.65E+03 0.OOE+00 3.31E+02 O.OOE+00 1.05E+03 0.OOE+00 1.72E+06 0.OOE+00 HO-166m 1.78E+04 5.48E+03 3.97E+03 O.OOE+00 8.03E+03 0.OOE+00 4.99E-14 0.OOE+00 W-181 6.27E+04 2.02E+04 2.12E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.72E+06 0.OOE+00 W-185 2.39E+06 7.88E+05 8.33E+04 O.OOE+00 0.OOE+00 O.OOE+00 6.81E+07 0.OOE+00 W-187 1.19E+04 9.71E+03 3.40E+03 O.OOE+00 0.00E+00 0.OOE+00 2.63E+06 0.OOE+00 NP-239 7.01E+00 6.61E-01 3.67E-01 0.OOE+00 2.07E+00 0.OOE+00 1.06E+05 0.OOE+00 U-232 2.94E+10 0.OOE+00 2.10E+09 0.OOE+00 3.18E+09 0.OOE+00 3.58E+08 0.OOE+00 U-233 6.18E+09 0.OOE+00 3.76E+08 0.OOE+00 1.45E+09 0.OOE+00 3.32E+08 0.OOE+00 U-234 5.93E+09 0.OOE+00 3.68E+08 0.OOE+00 1.42E+09 0.OOE+00 3.25E+08 0.O0E+00 U-235 5.68E+09 0.OOE+00 3.46E+08 0.OOE+00 1.33E+09 0.OOE+00 4.13E+08 O.OOE+00 U-236 5.68E+09 0.OOE+00 3.54E+08 O.OOE+00 1.36E+09 O.OOE+00 3.05E+08 0.OOE+00 U-237 1.04E+05 0.OOE+00 2.77E+04 0.OOE+00 4.28E+05 0.OOE+00 2.76E+07 0.OOE+00 U-238 5.44E+09 0.00E+00 3.24E+08 0.OOE+00 1.25E+09 0.OOE+00 2.91 E+08 0.OOE+00 NP-237 6.63E+07 4.76E+06 2.92E+06 0.OOE+00 2.16E+07 0.OOE+00 4.19E+06 0.OOE+00 NP-238 6.63E+01 1.77E+00 1.03E+00 0.OOE+00 6.09E+00 0.OOE+00 1.30E+05 0.OOE+00 PU-238 1.34E+07 1.71E+06 3.63E+05 0.OOE+00 1.55E+06 O.OOE+00 1.54E+06 0.OOE+00 PU-239 1.53E+07 1.85E+06 4.01E+05 0.OOE+00 1.71E+06 0.OOE+00 1.41E+06 0.OOE+00 PU-240 1.52E+07 1.85E+06 4.01E+05 0.OOE+00 1.71E+06 0.OOE+00 1.43E+06 0.OOE+00 PU-241 3.48E+05 1.67E+04 7.34E+03 0.OOE+00 3.40E+04 0.OOE+00 2.94E+04 0.OOE+00 PU-242 1.41 E+07 1.78E+06 3.87E+05 0.OOE+00 1.65E+06 0.OOE+00 1.38E+06 O.OOE+00 PU-244 1.65E+07 2.03E+06 4.43E+05 0.OOE+00 1.88E+06 0.OOE+00 2.05E+06 0.OOE+00 AM-241 3.98E+07 3.75E+07 2.87E+06 0.OOE+00 2.15E+07 0.OOE+00 3.92E+06 O.OOE+00 AM-242m 4.02E+07 3.54E+07 2.89E+06 0.OOE+00 2.14E+07 0.OOE+00 4.94E+06 0.OOE+00 AM-243 3.97E+07 3.66E+07 2.80E+06 0.OOE+00 2.1OE+07 0.OOE+00 4.60E+06 0.OOE+00 CM-242 1.34E+06 1.41 E+06 8.88E+04 0.OOE+00 4.05E+05 0.OOE+00 3.82E+06 0.OOE+00 CM-243 3.24E+07 3.OOE+07 2.04E+06 0.OOE+00 9.51E+06 0.OOE+00 4.12E+06 0.OOE+00 CM-244 2.51E+07 2.37E+07 1.59E+06 0.00E+00 7.41E+06 0.OOE+00 3.98E+06 0.OOE+00 CM-245 4.94E+07 4.34E+07 3.04E+06 0.OOE+00 1.42E+07 0.OOE+00 3.72E+06 0.OOE+00 CM-246 4.90E+07 4.34E+07 3.04E+06 O.OOE+00 1.42E+07 0.00E+00 3.65E+06 0.OOE+00 CM-247 4.77E+07 4.27E+07 2.99E+06 0.OOE+00 1.40E+07 0.OOE+00 4.80E+06 0.OOE+00 CM-248 3.96E+08 3.52E+08 2.47E+07 O.OOE+00 1.15E+08 0.OOE+00 7.73E+07 O.OOE+00 CF-252 1.70E+07 0.OOE+00 4.11EE+05 0.OOE+00 0.OOE+00 0.OOE+00 1.50E+07 0.OOE+00 11.4-190 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-40 (Page 1 of 4) Adult Milk Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.00E+00 4.35E+02 4.35E+02 4.35E+02 4.35E+02 4.35E+02 4.35E+02 0.OOE+00 C-14 3.63E+05 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 0.00E+00 NA-22 5.29E+09 5.29E+09 5.29E+09 5.29E+09 5.29E+09 5.29E+09 5.29E+09 0.00E+00 NA-24 2.44E+06 2.44E+06 2.44E+06 2.44E+06 2.44E+06 2.44E+06 2.44E+06 0.00E+00 P-32 1.71E+10 1.06E+09 6.61E+08 0.00E+00 0.00E+00 0.OOE+00 1.92E+09 0.OOE+00 CA-41 1.14E+10 0.00E+00 1.24E+09 O.OOE+00 0.OOE+00 0.OOE+00 1.14E+07 0.00E+00 SC-46 1.79E+02 3.48E+02 1.01 E+02 0.OOE+00 3.25E+02 0.00E+00 1.70E+06 0.00E+00 CR-51 0.00E+00 0.OOE+00 2.86E+04 1.71E+04 6.30E+03 3.79E+04 7.19E+06 0.OOE+00 MN-54 0.OOE+00 8.41E+06 1.61EE+06 0.00E+00 2.50E+06 0.00E+00 2.58E+07 0.OOE+00 FE-55 2.51 E+07 1.74E+07 4.05E+06 0.OOE+00 0.OOE+00 9.68E+06 9.95E+06 0.00E+00 MN-56 0.00E+00 4.15E-03 7.36E-04 0.00E+00 5.27E-03 0.00E+00 1.32E-01 0.OOE+00 CO-57 O.00E+00 1.28E+06 2.13E+06 0.00E+00 0.00E+00 0.00E+00 3.25E+07 0.00E+00 CO-58 0.00E+00 4.71 E+06 1.06E+07 0.00E+00 0.00E+00 0.00E+00 9.55E+07 0.00E+00 FE-59 2.97E+07 6.98E+07 2.68E+07 0.00E+00 0.00E+00 1.95E+07 2.33E+08 0o.00E+00 CO-60 0.OOE+00 1.64E+07 3.62E+07 0.OOE+00 0.OOE+00 0.OOE+00 3.08E+08 0.OOE+00 NI-59 5.05E+08 1.73E+08 8.44E+07 0.OOE+00 0.OOE+00 0.OOE+00 3.57E+07 0.00E+00 NI-63 6.73E+09 4.66E+08 2.26E+08 0.00E+00 0.00E+00 0.OOE+00 9.73E+07 0.00E+00 CU-64 0.00E+00 2.38E+04 1.12E+04 0.OOE+00 6.01E+04 0.00E+00 2.03E+06 0.00E+00 NI-65 3.70E-01 4.81E-02 2.19E-02 0.OOE+00 0.00E+00 0.OOE+00 1.22E+00 0.00E+00 ZN-65 1.37E+09 4.37E+09 1.97E+09 0.OOE+00 2.92E+09 0.00E+00 2.75E+09 0.OOE+00 ZN-69m 1.79E+05 4.29E+05 3.93E+04 0.OOE+00 2.60E+05 0.00E+00 2.62E+07 0.00E+00 ZN-69 2.09E-12 4.00E-12 2.78E-13 0.OOE+00 2.60E-12 0.OOE+00 6.01E-13 0.OOE+00 SE-79 0.00E+00 9.15E+08 1.53E+08 0.OOE+00 1.58E+09 0.00E+00 1.87E+08 0.OOE+00 BR-82 0.00E+00 0.00E+00 3.23E+07 0.OOE+00 0.OOE+00 0.00E+00 3.70E+07 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 9.72E-02 0.OOE+00 0.00E+00 0.00E+00 1.40E-01 0.OOE+00 BR-84 0.00E+00 0.00E+00 1.61E-23 0.00E+00 0.OOE+00 0.OOE+00 1.26E-28 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 1.95E-301 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 2.59E+09 1.21E+09 0.00E+00 0.00E+00 0.OOE+00 5.12E+08 0.00E+00 RB-87 0.OOE+00 2.85E+09 9.92E+08 0.00E+00 0.00E+00 0.00E+00 1.34E+08 0.00E+00 RB-88 0.OOE+00 2.14E-45 1.13E-45 0.OOE+00 0.00E+00 0.OOE+00 2.96E-56 0.00E+00 RB-89 0.00E+00 4.33E-53 3.05E-53 0.00E+00 0.00E+00 0.00E+00 2.52E-66 0.OOE+00 SR-89 1.45E+09 0.OOE+00 4.16E+07 0.OOE+00 0.OOE+00 0.OOE+00 2.33E+08 0.OOE+00 SR-90 5.38E+10 0.OOE+00 1.08E+09 0.OOE+00 0.OOE+00 0.OOE+00 1.35E+09 0.OOE+00 Y-90 7.08E+01 0.OOE+00 1.90E+00 0.OOE+00 0.OOE+00 0.00E+00 7.51 E+05 0.OOE+00 SR-91 2.89E+04 0.00E+00 1.17E+03 0.OOE+00 0.00E+00 0.OOE+00 1.38E+05 0.OOE+00 Y-91m 5.98E-20 0.OOE+00 2.32E-21 0.OOE+00 0.OOE+00 0.OOE+00 1.76E-19 0.OOE+00 Y-91 8.59E+03 0.00E+00 2.30E+02 0.00E+00 0.00E+00 0.00E+00 4.73E+06 0.OOE+00 11.4-191 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-40 (Page 2 of 4) Adult Milk Ri m 2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 4.88E-01 0.00E+00 2.11E-02 0.00E+00 0.00E+00 0.00E+00 9.68E+00 0.00E+00 Y-92 5.58E-05 0.00E+00 1.63E-06 0.OOE+00 0.00E+00 O.OOE+00 9.77E-01 0.00E+00 Y-93 2.23E-01 0.00E+00 6.17E-03 0.OOE+00 0.00E+00 0.OOE+00 7.08E+03 0.OOE+00 NB-93m 4.91 E+05 1.60E+05 3.95E+04 O.OOE+00 1.84E+05 O.OE+00 7.40E+07 0.OOE+00 NB-95 8.26E+04 4.59E+04 2.47E+04 0.OOE+00 4.54E+04 0.00E+00 2.79E+08 0.00E+00 NB-97 3.29E-12 8.32E-13 3.04E-13 0.OOE+00 9.71E-13 0.00E+00 3.07E-09 0.00E+00 ZR-93 1.62E+03 9.04E+01 4.21E+01 0.00E+00 3.43E+02 0.OOE+00 9.39E+04 0.OOE+00 ZR-95 9.43E+02 3.03E+02 2.05E+02 0.OOE+00 4.75E+02 0.OOE+00 9.59E+05 0.00E+00 ZR-97 4.33E-01 8.74E-02 4.00E-02 O.00E+00 1.32E-01 0.00E+00 2.71 E+04 0.00E+00 MO-93 0.00E+00 4.35E+08 1.18E+07 0.00E+00 1.23E+08 0.00E+00 7.07E+07 0.00E+00 MO-99 0.OOE+00 2.48E+07 4.71 E+06 0.00E+00 5.61 E+07 0.00E+00 5.74E+07 0.00E+00 TC-99 2.42E+07 3.59E+07 9.70E+06 0.OOE+00 4.52E+08 3.05E+06 1.17E+09 0.00E+00 TC-99m 3.32E+00 9.38E+00 1.20E+02 0.OOE+00 1.43E+02 4.60E+00 5.55E+03 0.00E+00 TC-101 2.59E-60 3.74E-60 3.66E-59 0.00E+00 6.73E-59 1.91E-60 1.12E-71 0.00E+00 RU-103 1.02E+03 0.OOE+00 4.39E+02 0.OOE+00 3.89E+03 0.OOE+00 1.19E+05 0.OOE+00 RU-105 8.57E-04 0.OOE+00 3.38E-04 0.00E+00 1.11E-02 0.OOE+00 5.24E-01 0.OOE+00 RU-1 06 2.04E+04 0.00E+00 2.58E+03 0.00E+00 3.94E+04 0.OOE+00 1.32E+06 0.00E+00 RH-105 3.47E+05 2.54E+05 1.67E+05 0.OOE+00 1.08E+06 0.00E+00 4.04E+07 0.00E+00 PD-107 0.00E+00 1.14E+07 7.27E+05 0.OOE+00 1.02E+08 0.00E+00 7.04E+07 0.OOE+00 PD-109 0.00E+00 4.43E+04 9.98E+03 0.OOE+00 2.53E+05 0.OOE+00 4.90E+06 0.OOE+00 AG- 1O1m 5.82E+07 5.39E+07 3.20E+07 0.OOE+00 1.06E+08 0.OOE+00 2.20E+1 0 0.00E+00 AG-1 11 6.48E+06 2.71 E+06 1.35E+06 0.OOE+00 8.74E+06 0.OOE+00 4.97E+09 0.OOE+00 CD-1 13m 0.OOE+00 2.94E+06 9.43E+04 0.OOE+00 3.24E+06 0.OOE+00 2.37E+07 0.OOE+00 CD-1 15m 0.OOE+00 1.26E+06 4.02E+04 0.OOE+00 9.99E+05 0.OOE+00 5.30E+07 0.OOE+00 SN-123 5.36E+08 8.88E+06 1.31E+07 7.55E+06 0.OOE+00 0.OOE+00 1.09E+09 0.00E+00 SN-125 5.68E+07 1.15E+06 2.58E+06 9.48E+05 0.OOE+00 0.OOE+00 7.1OE+08 0.OOE+00 SN-126 1.63E+09 3.23E+07 4.64E+07 9.51E+06 0.OOE+00 0.00E+00 4.70E+08 0.OOE+00 SB-124 2.57E+07 4.86E+05 1.02E+07 6.24E+04 0.OOE+00 2.OOE+07 7.31E+08 0.OOE+00 SB-125 2.04E+07 2.28E+05 4.86E+06 2.08E+04 0.OOE+00 1.58E+07 2.25E+08 0.OOE+00 SB-1 26 5.60E+06 1.14E+05 2.02E+06 3.43E+04 0.OOE+00 3.43E+06 4.58E+08 0.OOE+00 SB-127 4.50E+05 9.85E+03 1.73E+05 5.41E+03 0.OOE+00 2.67E+05 1.03E+08 0.OOE+00 TE-125m 1.63E+07 5.90E+06 2.18E+06 4.90E+06 6.63E+07 0.00E+00 6.50E+07 0.00E+00 TE-127m 4.58E+07 1.64E+07 5.58E+06 1.17E+07 1.86E+08 0.OOE+00 1.54E+08 0.OOE+00 TE-127 6.53E+02 2.34E+02 1.41E+02 4.84E+02 2.66E+03 0.OOE+00 5.15E+04 0.OOE+00 TE-129m 6.02E+07 2.25E+07 9.53E+06 2.07E+07 2.51E+08 0.00E+00 3.03E+08 0.00E+00 TE-129 2.82E-10 1.06E-10 6.88E-11 2.17E-10 1.19E-09 O.OOE+00 2.13E-10 0.OOE+00 TE-133m 2.10E-13 1.23E-13 1.18E-13 1.78E-13 1.22E-12 0.OOE+00 4.22E-14 0.OOE+00 11.4-192 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-40 (Page 3 of 4) Adult Milk Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI Skin TE-134 8.90E-19 5.83E-19 3.57E-19 7.78E-19 5.63E-18 0.00E+00 9.87E-22 0.00E+00 1-129 7.58E+08 6.52E+08 2.14E+09 1.68E+12 1.40E+09 0.00E+00 1.03E+08 0.00E+00 1-130 4.20E+05 1.24E+06 4.89E+05 1.05E+08 1.93E+06 0.OOE+00 1.07E+06 0.OOE+00 1-131 2.96E+-08 4.23E+08 2.43E+08 1.39E+11 7.26E+08 O.OOE+00 1.12E+08 0.O0E+00 TE-131m 3.61E+05 1.77E+05 1.47E+05 2.80E+05 1.79E+06 0.OOE+00 1.75E+07 0.OOE+00 TE-131 3.60E-33 1.51E-33 1.14E-33 2.96E-33 1.58E-32 0.OOE+00 5.1OE-34 0.OOE+00 1-132 1.64E-01 4.39E-01 1.54E-01 1.54E+01 7.OOE-01 0.OOE+00 8.25E-02 0.OOE+00 TE-132 2.40E+06 1.55E+06 1.46E+06 1.72E+06 1.50E+07 0.OOE+00 7.35E+07 0.OOE+00 1-133 3.87E+06 6.73E+06 2.05E+06 9.89E+08 1.17E+07 0.00E+00 6.05E+06 0.OOE+00 CS-134m 1.74E-01 3.65E-01 1.87E-01 0.OOE+00 1.98E-01 3.12E-02 1.29E-01 0.OOE+00 CS-134 5.65E+09 1.35E+10 1.10E+10 0.OOE+00 4.35E+09 1.45E+09 2.35E+08 0.OOE+00 1-134 2.02E-12 5.48E-12 1.96E-12 9.49E-11 8.71E-12 0.00E+00 4.77E-15 0.OOE+00 1-135 1.28E+04 3.36E+04 1.24E+04 2.22E+06 5.39E+04 0.00E+00 3.80E+04 0.00E+00 CS-135 1.81E+09 1.67E+09 7.41E+08 0.OOE+00 6.32E+08 1.89E+08 3.90E+07 0.OOE+00 CS-136 2.63E+08 1.04E+09 7.48E+08 0.OOE+00 5.78E+08 7.93E+07 1.18E+08 0.OOE+00 CS-137 7.38E+09 1.01E+10 6.61E+09 0.OOE+00 3.43E+09 1.14E+09 1.95E+08 0.OOE+00 CS-138 9.04E-24 1.79E-23 8.85E-24 0.00E+00 1.31 E-23 1.30E-24 7.62E-29 0.OOE+00 CS-139 6.78E-90 1.01E-89 3.68E-90 0.OOE+00 8.09E-90 7.36E-91 2.19E-112 0.OOE+00 BA-139 4.42E-08 3.15E-11 1.29E-09 0.00E+00 2.94E-11 1.79E-11 7.84E-08 0.OOE+00 BA-140 2.69E+07 3.38E+04 1.76E+06 0.OOE+00 1.15E+04 1.93E+04 5.53E+07 0.OOE+00 LA-140 4.51E+00 2.27E+00 6.01E-01 0.OOE+00 0.OOE+00 0.00E+00 1.67E+05 0.OOE+00 BA-141 4.09E-46 3.09E-49 1.38E-47 0.OOE+00 2.88E-49 1.76E-49 1.93E-55 0.OOE+00 LA-141 3.04E-05 9.44E-06 1.55E-06 0.OOE+00 0.OOE+00 0.OOE+00 1.13E+00 0.00E+00 CE-141 4.84E+03 3.28E+03 3.72E+02 0.OOE+00 1.52E+03 0.OOE+00 1.25E+07 0.OOE+00 BA-142 2.66E-80 2.73E-83 1.67E-81 0.00E+00 2.31E-83 1.55E-83 3.74E-98 0.00E+00 LA-142 1.86E-11 8.45E-12 2.10E-12 0.OOE+00 0.OOE+00 0.00E+00 6.17E-08 0.OOE+00 CE-143 4.16E+01 3.07E+04 3.40E+00 0.OOE+00 1.35E+01 0.OOE+00 1.15E+06 0.OOE+00 PR-143 1.58E+02 6.33E+01 7.83E+00 O.OOE+00 3.66E+01 0.OOE+00 6.92E+05 0.OOE+00 CE-144 3.58E+05 1.50E+05 1.92E+04 0.OOE+00 8.87E+04 0.OOE+00 1.21EE+08 0.OOE+00 PR-144 5.87E-54 2.44E-54 2.98E-55 0.OOE+00 1.37E-54 0.OOE+00 8.44E-61 0.OOE+00 ND-147 9.42E+01 1.09E+02 6.51E+00 0.OOE+00 6.36E+01 0.OOE+00 5.22E+05 0.OOE+00 PM-147 2.87E+03 2.70E+02 1.09E+02 0.00E+00 5.1OE+02 0.OOE+00 3.40E+05 0.OOE+00 PM-148m 8.57E+02 2.22E+02 1.70E+02 0.OOE+00 3.35E+02 0.OOE+00 1.88E+06 0.OOE+00 PM-148 5.93E+01 9.84E+00 4.96E+00 0.OOE+00 1.86E+01 0.00E+00 7.74E+05 0.00E+00 PM-149 4.28E+00 6.05E-01 2.47E-01 0.00E+00 1.14E+00 0.00E+00 1.13E+05 0.OOE+00 PM-151 6.50E-01 1.09E-01 5.51E-02 0.OOE+00 1.95E-01 0.OOE+00 3.OOE+04 0.00E+00 SM-151 2.67E+03 4.60E+02 1.1OE+02 0.OOE+00 5.14E+02 0.OOE+00 2.03E+05 0.OOE+00 11.4-193 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-40 (Page 4 of 4) Adult Milk Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.98E+00 1.65E+00 1.21E-01 0.OOE+00 5.34E-01 0.00E+00 5.89E+04 0.00E+00 EU-1 52 7.51 E+03 1.71 E+03 1.50E+03 0.OOE+00 1.06E+04 0.OOE+00 9.86E+05 0.OOE+00 EU-154 2.37E+04 2.91E+03 2.07E+03 0.00E+00 1.39E+04 0.OOE+00 2.11E+06 0.00E+00 EU-1 55 3.30E+03 4.67E+02 3.02E+02 0.OOE+00 2.16E+03 0.OOE+00 3.68E+05 0.OOE+00 EU-156 2.51E+02 1.95E+02 3.14E+01 0.00E+00 1.30E+02 0.00E+00 1.33E+06 0.00E+00 TB-160 1.49E+03 0.00E+00 1.86E+02 0.OOE+00 6.16E+02 0.OOE+00 8.13E+05 0.OOE+00 HO-166m 1.04E+04 3.26E+03 2.47E+03 0.OOE+00 4.87E+03 0.OOE+00 3.86E-14 0.00E+00 W-181 3.39E+04 1.11E+04 1.18E+03 0.OOE+00 0.00E+00 0.OOE+00 1.26E+06 0.OOE+00 W-185 1.29E+06 4.32E+05 4.54E+04 0.OOE+00 0.OOE+00 0.OOE+00 4.99E+07 0.OOE+00 W-187 6.51E+03 5.45E+03 1.90E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.78E+06 0.OOE+00 NP-239 3.67E+00 3.61E-01 1.99E-01 0.OOE+00 1.13E+00 0.OOE+00 7.41E+04 0.00E+00 U-232 1.60E+10 0.OOE+00 1.14E+09 0.00E+00 1.73E+09 0.00E+00 2.62E+08 0.OOE+00 U-233 3.37E+09 0.OOE+00 2.04E+08 0.OOE+00 7.84E+08 0.00E+00 2.42E+08 0.00E+00 U-234 3.23E+09 0.OOE+00 2.OOE+08 0.OOE+00 7.69E+08 0.OOE+00 2.37E+08 0.00E+00 U-235 3.1OE+09 0.OOE+00 1.88E+08 0.00E+00 7.23E+08 0.OOE+00 3.02E+08 0.OOE+00 U-236 3.1OE+09 0.00E+00 1.92E+08 0.00E+00 7.38E+08 0.OOE+00 2.23E+08 0.OOE+00 U-237 5.65E+04 0.O0E+0Q 1.50E+04 0.OOE+00 2.32E+05 O.OOE+00 1.99E+07 0.00E+00 U-238 2.96E+09 0.OOE+00 1.75E+08 0.OOE+00 6.76E+08 0.OOE+00 2.13E+08 0.OOE+00 NP-237 4.87E+07 3.46E+06 2.14E+06 0.00E+00 1.59E+07 0.OOE+00 3.07E+06 0.OOE+00 NP-238 3.61E+01 9.72E-01 5.61E-01 0.OOE+00 3.29E+00 0.OOE+00 9.04E+04 0.00E+00 PU-238 9.73E+06 1.23E+06 2.64E+05 0.OOE+00 1.13E+06 0.OOE+00 1.13E+06 0.OOE+00 PU-239 1.12E+07 1.35E+06 2.95E+05 0.OOE+00 1.25E+06 0.OOE+00 1.03E+06 0.OOE+00 PU-240 1.12E+07 1.34E+06 2.95E+05 0.OOE+00 1.25E+06 0.OOE+00 1.05E+06 0.OOE+00 PU-241 2.42E+05 1.15E+04 5.12E+03 0.OOE+00 2.36E+04 O.OOE+00 2.16E+04 0.OOE+00 PU-242 1.04E+07 1.30E+06 2.84E+05 0.OOE+00 1.21 E+06 0.OOE+00 1.01 E+06 0.OOE+00 PU-244 1.21 E+07 1.49E+06 3.26E+05 0.OOE+00 1.38E+06 0.OOE+00 1.50E+06 0.OOE+00 AM-241 2.92E+07 2.72E+07 2.09E+06 0.OOE+00 1.57E+07 0.OOE+00 2.87E+06 0.OOE+00 AM-242m 2.94E+07 2.56E+07 2.1OE+06 0.OOE+00 1.56E+07 0.OOE+00 3.61E+06 0.OOE+00 AM-243 2.91 E+07 2.67E+07 2.05E+06 0.OOE+00 1.54E+07 0.OOE+00 3.36E+06 0.OOE+00 CM-242 7.27E+05 7.73E+05 4.83E+04 O.OOE+00 2.19E+05 0.OOE+00 2.79E+06 0.OOE+00 CM-243 2.31EE+07 2.12E+07 1.45E+06 0.OOE+00 6.75E+06 0.00E+00 3.01E+06 0.OOE+00 CM-244 1.76E+07 1.65E+07 1.11EE+06 0.OOE+00 5.17E+06 0.OOE+00 2.91E+06 0.OOE+00 CM-245 3.62E+07 3.16E+07 2.23E+06 0.OOE+00 1.04E+07 0.OOE+00 2.72E+06 0.OOE+00 CM-246 3.59E+07 3.15E+07 2.22E+06 0.00E+00 1.04E+07 0.00E+00 2.67E+06 0.OOE+00 CM-247 3.50E+07 3.11E+07 2.19E+06 0.OOE+00 1.02E+07 0.00E+00 3.51E+06 0.OOE+00 CM-248 2.91 E+08 2.56E+08 1.80E+07 0.OOE+00 8.42E+07 0.00E+00 5.68E+07 0.OOE+00 CF-252 9.93E+06 0.OOE+00 2.39E+05 0.OOE+00 0.00E+00 0.OOE+00 1.1OE+07 0.OOE+00 11.4-194 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-41 (Page 1 of 4) Infant Meat R1 m2*mrem*seclyr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 0,00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 C-14 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 NA-22 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 NA-24 O.0OE+00 O.OE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 P-32 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CA-41 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 SC-46 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 MN-54 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 FE-55 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 MN-56 O.OOE+00 0.00E+00 O.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 CO-57 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CO-58 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 FE-59 0.OOE+00 0.OOE+00 0.0OE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 CO-60 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 NI-59 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 NI-63 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 CU-64 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 NI-65 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 ZN-65 O.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 ZN-69m O.0OE+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 ZN-69 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SE-79 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 BR-83 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 BR-84 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 BR-85 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 RB-86 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OE+00 RB-87 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 RB-88 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 RB-89 0.00E+00 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 SR-89 0.OOE+00 0.00E+00 0,00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-90 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Y-90 0.OOE+00 O.OOE+00 0.00E+00 0,00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-91 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 Y-91m 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 0OOE+00 Y-91 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 11.4-195 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-41 (Page 2 of 4) Infant Meat Ri m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lungq GI-LLI Skin SR-92 O.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 O.00E+00 0.00E+00 0.OOE+00 0.00E+00 Y-92 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 Y-93 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 NB-93m 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.00E+00 O.OOE+00 NB-95 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 NB-97 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 O.OOE+00 O.00E+00 0.OOE+00 0.00E+00 ZR-93 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 O.00E+00 0.OOE+00 0.00E+00 0.OOE+00 ZR-95 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 ZR-97 O.00E+00 0.OOE+00 0.00E+00 0.OOE+00 O.00E+00 0.00E+00 0.00E+00 0.00E+00 MO-93 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 MO-99 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 TC-99 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 TC-99m O.OOE+00 O.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 O.00E+00 TC-101 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 RU-1 03 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 O.00E+00 0.OOE+00 0.00E+00 0.00E+00 RU-1 05 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 RU-1 06 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 RH-1 05 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PD-1 07 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PD-109 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AG-110m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 AG-1 11 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CD-1 13m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CD-115m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-123 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-125 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SN-126 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-1 24 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-1 25 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-1 26 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 SB-127 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-125m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-127m 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 TE-127 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 TE-129m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-129 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 TE-133m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 11.4-196 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-41 (Page 3 of 4) Infant Meat Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 1-129 0.00E+00 0.00E÷00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 1-130 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 1-131 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 TE-1 31 m 0.00E+00 0.O0E+00 0.00E+00 O.00E+00 O.OOE+00 0.00E+OO 0.00E+000.00E+00 TE-131 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 1-132 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 TE-132 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 1-133 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 CS-1 34m 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 CS-1 34 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 O.00E+00 1-134 0.00E+00 0.00E+00 0.00E+00 O.OE+00 0.00E+00 0.00E+00 0.00E+00 0.O0E+00 1-135 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 CS-1 35 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 CS-136 O.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 CS-1 37 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 CS-138 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 CS-139 0.00E+0O 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 BA-1 39 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 BA-140 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 LA-1 40 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 BA-141 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 LA-141 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CE-141 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 BA-1 42 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 LA-142 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CE-143 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 PR-143 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 CE-144 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 PR-144 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 ND-147 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-147 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 PM-148m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 PM-148 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 PM-149 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 PM-151 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SM-151 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 11.4-197 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-41 (Page 4 of 4) Infant Meat Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI Skin SM-153 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 EU-152 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 EU-154 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 EU-155 0.00E+00 0.OOE+00 0.OOE+00 0.001E+00 0.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 EU-156 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 TB-160 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 HO-166m 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 W-181 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 W-185 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 W-187 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-239 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 U-232 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 U-233 0.OOE+00 0.OOE+00 0.0OE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-234 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 U-235 0.OOE+00 0.OOE+00 0.OQE+00 0.OOE+00 0.OOE+00 O.OE+00 0.00E+00 O.OE+00 U-236 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 U-237 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 U-238 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-237 0.OOE+00 0.OOE+00 O.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 NP-238 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 PU-238 0.OOE+00 0.OOE+00 0.OOE+00 O.OE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 PU-239 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 PU-240 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 PU-241 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 PU-242 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OE+00 PU-244 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-241 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 AM-242m 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 AM-243 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 CM-242 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-243 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 CM-244 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-245 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 CM-246 0.OOE+00 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.0OE+00 CM-247 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CM-248 0.OOE+00 0.00E+0 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 CF-252 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 11.4-198 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-42 (Page 1 of 4) Child Meat Ri m 2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI Skin H-3 0.OOE+00 1.34E+02 1.34E+02 1.34E+02 1.34E+02 1.34E+02 1.34E+02 0.00E+00 C-14 5.29E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 0.OOE+00 NA-22 1.75E+09 1.75E+09 1.75E+09 1.75E+09 1.75E+09 1.75E+09 1.75E+09 0.OOE+00 NA-24 1.72E-03 1.72E-03 1.72E-03 1.72E-03 1.72E-03 1.72E-03 1.72E-03 0.00E+00 P-32 7.42E+09 3.47E+08 2.86E+08 0.00E+00 O.00E+00 0.OOE+00 2.05E+08 0.OOE+00 CA-41 1,42E+09 0.OOE+00 1.55E+08 0.00E+00 0.00E+00 0.00E+00 7.77E+05 0.00E+00 SC-46 2.34E+05 3.21 E+05 1.24E+05 0.OOE+00 2.84E+05 0.OOE+00 4.69E+08 0.OOE+00 CR-51 0.OOE+00 O.OOE+00 8.79E+03 4.88E+03 1.33E+03 8.91E+03 4.66E+05 O.OOE+00 MN-54 0.00E+00 8.01E+06 2.13E+06 O.OOE+00 2.25E+06 O.OOE+00 6.72E+06 0.00E+00 FE-55 4.57E+08 2.42E+08 7.51 E+07 0.OOE+00 0.00E+00 1.37E+08 4.49E+07 0.00E+00 MN-56 O.OOE+00 1.64E-53 3.70E-54 O.OOE+00 1.98E-53 0.OOE+00 2.38E-51 0.00E+00 CO-57 0.OOE+00 5.92E+06 1.20E+07 O.00E+00 0.00E+00 0.00E+00 4.85E+07 O.00E+00 CO-58 O.OOE+00 1.64E+07 5.02E+07 O.OOE+00 0.OOE+00 0.OOE+00 9.58E+07 0.OOE+00 FE-59 3.76E+08 6.09E+08 3.03E+08 0.OOE+00 0.OOE+00 1.77E+08 6.34E+08 0.00E+00 CO-60 0.OOE+00 6.93E+07 2.04E+08 0.OOE+00 0.00E+00 0.OOE+00 3.84E+08 0.00E+00 NI-59 2.18E+08 5.80E+07 3.69E+07 0.OOE+00 0.OOE+00 0.OOE+00 3.85E+06 0.OOE+00 NI-63 2.91 E+09 1.56E+08 9.91 E+07 0.OOE+00 0.OOE+00 0.OOE+00 1.05E+07 0.OOE+00 CU-64 0.00E+00 2.97E-07 1.80E-07 O.OOE+00 7.19E-07 0.00E+00 1.40E-05 0.OOE+00 NI-65 3.52E-53 3.31 E-54 1.93E-54 0.OOE+00 O.OOE+00 0.OOE+00 4.06E-52 0.OOE+00 ZN-65 3.75E+08 1.00E+09 6.22E+08 0.OOE+00 6.30E+08 0.OOE+00 1.76E+08 0.OOE+00 ZN-69m 2.61 E-05 4.45E-05 5.25E-06 0.OOE+00 2.58E-05 0.OOE+00 1.45E-03 0.OOE+00 ZN-69 2.87E-153 4.15E-153 3.83E-154 0.00E+00 2.52E-153 O.OOE+00 2.61E-151 O.OOE+00 SE-79 0.OOE+00 1.29E+08 2.87E+07 0.OOE+00 2.1OE+08 0.OOE+00 8.48E+06 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.52E+03 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 O.00E+00 BR-83 0.O0E+00 0.00E+00 9.52E-57 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 9.37E-270 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 BR-85 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0,00E+00 5.77E+08 3155E+08 0.OOE+00 0.OOE+00 0.OOE+00 3.71E+07 0.00E+00 RB-87 0.00E+00 1.25E+09 5.80E+08 0.OOE+00 0.OOE+00 O.OOE+00 1.88E+07 0.OOE+00 RB-88 0.OOE+00 0.OOE+00 0.00E+00 O.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 RB-89 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-89 4.82E+08 0.OOE+00 1.38E+07 0.OOE+00 0.OOE+00 0.OOE+00 1.87E+07 0.OOE+00 SR-90 1.57E+10 0.OOE+00 3.15E+08 0.OOE+00 0.OOE+00 0.OOE+00 1.40E+08 0.OOE+00 Y-90 1.71E+02 0.OOE+00 4.59E+00 0.00E+00 0.OOE+00 0.00E+00 4.88E+05 0.OOE+00 SR-91 2.40E-10 0.OOE+00 9.05E-12 0.OOE+00 0.OOE+00 0.00E+00 5.29E-10 0.OOE+00 Y-91m 1.09E-174 0.OOE+00 3.98E-176 0.OOE+00 0.OOE+00 0.OOE+00 2.14E-171 0.OOE+00 Y-91 1.80E+06 0.OOE+00 4.82E+04 0.OOE+00 0.00E+00 0.OOE+00 2.40E+08 0.OOE+00 11.4-199 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-42 (Page 2 of 4) Child Meat R, m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SR-92 1.84E-49 0.OOE+00 7.39E-51 0.OOE+00 0.00E+00 0.00E+00 3.49E-48 0.OOE+00 Y-92 2.41E-39 0.OOE+00 6.89E-41 0.00E+00 0.OOE+00 0.00E+00 6.96E-35 0.OOE+00 Y-93 7.44E-12 O.OOE+00 2.04E-13 0.00E+00 0.OOE+00 0.00E+00 1.11E-07 0.00E+00 NB-93m 2.99E+07 7.46E+06 2.45E+06 O.0OE+00 8.06E+06 0.00E+00 1.12E+09 0.OOE+00 NB-95 3.1OE+06 1.21E+06 8.62E+05 0.OOE+00 1.13E+06 0.00E+00 2.23E+09 0.00E+00 NB-97 9.14E-119 1.65E-119 7.71E-120 0.00E+00 1.83E-119 0.00E+00 5.1OE-114 0.00E+00 ZR-93 5.80E+06 2.17E+06 1.55E+06 0.00E+00 8.41E+06 0.00E+00 8.24E+08 0.OOE+00 ZR-95 2.66E+06 5.85E+05 5.21E+05 0.00E+00 8.38E+05 0.00E+00 6.11Ei+08 0.OOE+00 ZR-97 3.21E-05 4.63E-06 2.73E-06 0.00E+00 6.65E-06 0.OOE+00 7.02E-01 0.OOE+00 MO-93 0.00E+00 1.97E+08 7.07E+06 0.00E+00 5.19E+07 0.00E+00 9.98E+06 0.00E+00 MO-99 0.00E+00 1.15E+05 2.84E+04 0.00E+00 2.46E+05 0.00E+00 9.51E+04 0.00E+00 TC-99 2.19E+08 2.44E+08 8.75E+07 0.OOE+00 2.87E+09 2.15E+07 2.56E+09 0.00E+00 TC-99m 6.20E-21 1.22E-20 2.01E-19 0.00E+00 1.77E-19 6.17E-21 6.91E-18 0.00E+00 TC-101 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 RU-103 1.55E+08 0.00E+00 5.96E+07 0.00E+00 3.90E+08 0.OOE+00 4.01E+09 O.OOE+00 RU-1 05 9.02E-28 0.00E+00 3.27E-28 0.00E+00 7.93E-27 0.00E+00 5.88E-25 0.00E+00 RU-106 4.44E+09 0.00E+00 5.54E+08 0.OOE+00 5.99E+09 0.OOE+00 6.90E+10 O.00E+00 RH-105 6.08E+00 3.27E+00 2.79E+00 0.00E+00 1.30E+01 0.OOE+00 2.02E+02 0.OOE+00 PD-107 0.OOE+00 1.93E+06 1.64E+05 0.00E+00 1.62E+07 0.OOE+00 3.83E+06 0.OOE+00 PD-109 0.OOE+00 1.58E-06 4.72E-07 0.00E+00 8.45E-06 0.OOE+00 9.31 E-05 0.00E+00 AG-11Orn 8.39E+06 5.67E+06 4.53E+06 0.OOE+00 1.06E+07 O.OOE+00 6.74E+08 0.00E+00 AG-1 11 2.33E+05 7.29E+04 4.81 E+04 0.OOE+00 2.20E+05 O.OOE+00 4.46E+07 O.OOE+00 CD-i 13m 0.OOE+00 5.50E+06 2.34E+05 O.OOE+00 5.66E+06 0.OOE+00 1.42E+07 O.OOE+00 CD-115m O.00E+00 1.78E+06 7.58E+04 O.00E+00 1.32E+06 O.OOE+00 2.42E+07 0.OOE+00 SN-123 8.81E+09 1.09E+08 2.15E+08 1.16E+08 0.OOE+00 O.OOE+00 4.32E+09 O.OOE+00 SN-125 2.81EE+08 4.23E+06 1.26E+07 4.39E+06 O.OOE+00 O.OOE+00 8.69E+08 O.OOE+00 SN-126 2.72E+10 3.39E+08 7.74E+08 9.32E+07 0.OOE+00 0.OOE+00 2.04E+09 0.OOE+00 SB-1 24 2.92E+07 3.79E+05 1.02E+07 6.45E+04 O.OOE+00 1.62E+07 1.83E+08 0.OOE+00 SB-1 25 2.85E+07 2.20E+05 5.97E+06 2.64E+04 0.OOE+00 1.59E+07 6.80E+07 0.00E+00 SB-126 2.76E+06 4.22E+04 9.91E+05 1.62E+04 0.00E+00 1.32E+06 5.56E+07 0.OOE+00 SB-127 2.54E+04 3.93E+02 8.82E+03 2.83E+02 0.OOE+00 1.10E+04 1.43E+06 0.OOE+00 TE-125m 5.69E+08 1.54E+08 7.59E+07 1.60E+08 0.OOE+00 0.OOE+00 5.49E+08 0.OOE+00 TE-127m 1.77E+09 4.78E+08 2.11E+08 4.24E+08 5.06E+09 O.OOE+00 1.44E+09 0.OOE+00 TE-127 3.39E-10 9.13E-11 7.26E-11 2.34E-10 9.63E-10 0.00E+00 1.32E-08 O.OOE+00 TE-129m 1.79E+09 5.00E+08 2.78E+08 5.77E+08 5.26E+09 O.OOE+00 2.18E+09 O.OOE+00 TE-129 7.1OE-121 1.98E-121 1.69E-121 5.07E-121 2.08E-120 0.OOE+00 4.42E-119 0.00E+00 TE-133m 8.56E-153 3.46E-153 4.29E-153 6,64E-153 3.29E-152 O.OOE+00 2.64E-151 O.OOE+00 11.4-200 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-42 (Page 3 of 4) Child Meat Ri m 2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 4.72E-204 2.12E-204 2.83E-204 3.73E-204 1.97E-203 0.OOE+00 2.16E-203 0.OOE+00 1-129 2.06E+08 1.26E+08 1.13E+08 8.27E+10 2.13E+08 0.OOE+00 6.36E+06 0.OOE+00 1-130 3.04E-06 6.13E-06 3.16E-06 6.76E-04 9.17E-06 0.OOE+00 2.87E-06 0.00E+00 1-131 1.65E+07 1.66E+07 9.46E+06 5.50E+09 2.73E+07 0.OOE+00 1.48E+06 0.OOE+00 TE-131rm 7.OOE+02 2.42E+02 2.58E+02 4.98E+02 2.34E+03 0.OOE+00 9.82E+03 0.OOE+00 TE-131 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1-132 1.02E-58 1.88E-58 8.65E-59 8.72E-57 2.88E-58 0.OOE+00 2.21E-58 0.OOE+00 TE-132 2.12E+06 9.38E+05 1.13E+06 1.37E+06 8.71E+06 0.OOE+00 9.45E+06 0.OOE+00 1-133 5.67E-01 7.02E-01 2.66E-01 1.30E+02 1.17E+00 0.OOE+00 2.83E-01 O.OE+00 CS-134m 3.86E-47 5.72E-47 3.73E-47 0.OOE+00 3.02E-47 4.99E-48 7.23E-47 0.O0E+00 CS-134 9.22E+08 1.51E+09 3.19E+08 0.OOE+00 4.69E+08 1.68E+08 8.16E+06 0.OOE+00 1-134 1.57E-161 2.91E-161 1.34E-161 6.70E-160 4.45E-161 O.OOE+00 1.93E-161 0.OOE+00 1-135 6.52E-17 1.17E-16 5.55E-17 1.04E-14 1.80E-16 O.OOE+00 8.94E-17 O.OOE+00 CS-135 3.39E+08 2.36E+08 2.42E+07 0.OOE+00 8.34E+07 2.78E+07 1.77E+06 O0OOE+00 CS-136 1.62E+07 4.46E+07 2.88E+07 0.OOE+00 2.37E+07 3.54E+06 1.57E+06 O.OOE+00 CS-137 1.33E+09 1.28E+09 1.88E+08 0.OOE+00 4.16E+08 1.50E+08 7.99E+06 O.OOE+00 CS-138 4.13E-267 5.75E-267 3.64E-267 0.OOE+00 4.04E-267 4.35E-268 2.65E-267 0.OOE+00 CS-139 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE--00 O.OOE+00 BA-139 1.98E-101 1.06E-104 5.73E-103 O.OOE+00 9.22E-105 6.21E-105 1.14E-99 0.OOE+00 BA-140 4.38E+07 3.84E+04 2.56E+06 O.OOE+00 1.25E+04 2.29E+04 2.22E+07 0.OOE+00 LA-140 5.59E-02 1.95E-02 6.58E-03 0.OOE+00 0.OOE+00 0.OOE+00 5.44E+02 0.OOE+00 BA-141 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 LA-141 6.19E-37 1.44E-37 3.13E-38 0.OOE+00 O.OOE+00 0.OOE+00 3.21E-32 0.OOE+00 CE-141 2.22E+04 1.11E+04 1.64E+03 0.OOE+00 4.86E+03 0.OOE+00 1.38E+07 0.OOE+00 BA-142 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 LA-142 5.26E-92 1.68E-92 5.25E-93 0.OOE+00 O.OOE+00 0.OOE+00 3.32E-87 0.OOE+00 CE-143 3.17E-02 1.72E+01 2.49E-03 0.OOE+00 7.21E-03 0.OOE+00 2.52E+02 0.OOE+00 PR-143 3.34E+04 1.OOE+04 1.66E+03 0.OOE+00 5.43E+03 0.OOE+00 3.60E+07 0.OOE+00 CE-144 2.32E+06 7.26E+05 1.24E+05 0.OOE+00 4.02E+05 0.OOE+00 1.89E+08 0.OOE+00 PR-144 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.O0E+00 ND-147 1.17E+04 9.47E+03 7.33E+02 0.OOE+00 5.19E+03 0.00E+00 1.50E+07 0.OOE+00 PM-147 1.52E+06 1.08E+05 5.81EE+04 0.OOE+00 1.91E+05 D.OOE+00 4.38E+07 0.OOE+00 PM-148m 2.70E+05 5.37E+04 5.37E+04 0.OOE+00 7.96E+04 0.OOE+00 1.51E+08 0.OOE+00 PM-148 3.1OE+03 3.72E+02 2.41E+02 0.OOE+00 6.33E+02 0.OOE+00 9.95E+06 0.OOE+00 PM-149 8.18E+00 8.69E-01 4.71E-01 0.OOE+00 1.54E+00 O.OOE+00 5.93E+04 O.OOE+00 PM-151 9.OOE-03 1.09E-03 7.12E-04 0.OOE+00 1.86E-03 O.OOE+00 1.24E+02 O.OOE+00 SM-151 1.31E+06 1.95E+05 6.13E+04 O.OOE+00 2.01EE+05 0.OOE+00 2.82E+07 0.OOE+00 11.4-201 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-42 (Page 4 of 4) Child Meat Ri m2mrem*sec/yr*lJCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.82E+00 1.13E+00 1.09E-01 0.OOE+00 3.44E-01 0.OOE+00 1.50E+04 0.OOE+00 EU-152 3.00E+06 5.46E+05 6.49E+05 0.OOE+00 2.31E+06 0.00E+00 8.98E+07 0.00E+00 EU-154 1.12E+07 1.01E+06 9.19E+05 0.00E+00 4.42E+06 O.OOE+00 2.34E+08 0.OOE+00 EU-155 2.33E+06 1.68E+05 1.31EE+05 O.OOE+00 6.28E+05 O.OOE+00 4.20E+08 0.OOE+00 EU-156 5.75E+04 3.08E+04 6.38E+03 0.00E+00 1.99E+04 0.00E+00 6.99E+07 0.00E+00 TB-160 5.16E+05 0.OOE+00 6.41E+04 0.00E+00 1.54E+05 0.00E+00 1.14E+08 0.OOE+00 HO-166m 4.86E+06 1.02E+06 8.59E+05 0.00E+00 1.45E+06 0.00E+00 4.50E-12 0.OOE+00 W-181 4.49E+04 1.10E+04 1.52E+03 0.00E+00 0.OOE+00 0.00E+00 4.02E+05 0.OOE+00 W-1 85 1.61 E+06 4.02E+05 5.63E+04 0.OOE+00 0.00E+00 0.OOE+00 1.50E+07 0.00E+00 W-187 3.21E-02 1.90E-02 8.53E-03 0.OOE+00 0.OOE+00 0.OOE+00 2.67E+00 0.0OE+00 NP-239 4.26E-01 3.06E-02 2.15E-02 0.OOE+00 8.85E-02 0.OOE+00 2.26E+03 0.00E+00 U-232 6.11E+09 0.OOE+00 4.37E+08 0.OOE+00 4.65E+08 0.OOE+00 2.42E+07 0.OOE+00 U-233 1.29E+09 0.OOE+00 7.82E+07 0.00E+00 2.12E+08 0.00E+00 2.24E+07 0.00E+00 U-234 1.24E+09 0.OOE+00 7.68E+07 0.OOE+00 2.08E+08 0.OOE+00 2.20E+07 0.00E+00 U-235 1.19E+09 0.OOE+00 7.19E+07 0.OOE+00 1.95E+08 0.00E+00 2.79E+07 0.00E+00 U-236 1.19E+09 0.00E+00 7.37E+07 0.OOE+00 1.99E+08 O.OOE+00 2.06E+07 0.OOE+00 U-237 3.41E+03 0.00E+00 9.07E+02 O.OOE+00 9.85E+03 0.OOE+00 3.01E+05 0.OOE+00 U-238 1.14E+09 0.OOE+00 6.74E+07 0.00E+00 1.82E+08 0.00E+00 1.97E+07 O.00E+00 NP-237 4.56E+08 3.01 E+07 2.OOE+07 O.OOE+00 1.24E+08 0.OOE+00 1.67E+07 0.OOE+00 NP-238 2.23E+00 4.50E-02 3.47E-02 0.OOE+00 1.44E-01 0.OOE+00 1.54E+03 0.OOE+00 PU-238 1.70E+07 1.97E+06 4.52E+05 O.OOE+00 1.64E+06 0.OOE+00 1.07E+06 0.OOE+00 PU-239 1.85E+07 1.97E+06 4.74E+05 O.OOE+00 1.75E+06 0.OOE+00 9.80E+05 0.OOE+00 PU-240 1.83E+07 2.05E+06 4.74E+05 0.OOE+00 1.75E+06 0.OOE+00 9.99E+05 0.00E+00 PU-241 5.51E+05 2.25E+04 1.14E+04 0.OOE+00 4.21E+04 0.00E+00 2.05E+04 O.OOE+00 PU-242 1.70E+07 1.97E+06 4.57E+05 O.OOE+00 1.67E+06 0.OOE+00 9.60E+05 0.OOE+00 PU-244 1.99E+07 2.26E+07 5.22E+05 0.00E+00 1.93E+06 0.OOE+00 1.43E+06 0.OOE+00 AM-241 2.78E+08 2.39E+08 2.08E+07 0.OOE+00 1.27E+08 0.OOE+00 1.56E+07 0.OOE+00 AM-242m 2.86E+08 2.29E+08 2.13E+07 0.OOE+00 1.29E+08 0.00E+00 1.96E+07 0.OOE+00 AM-243 2.74E+08 2.31E+08 2.01E+07 0.OOE+00 1.24E+08 0.OOE+00 1.83E+07 0.OOE+00 CM-242 1.52E+07 1.21 E+07 1.01 E+06 0.OOE+00 3.23E+06 0.OOE+00 1.41 E+07 0.OOE+00 CM-243 2.61E+08 2.12E+08 1.68E+07 0.OOE+00 6.28E+07 0.OOE+00 1.64E+07 0.OOE+00 CM-244 2.20E+08 1.78E+08 1.41E+07 0.OOE+00 5.17E+07 0.OOE+00 1.58E+07 0.OOE+00 CM-245 3.41E+08 2.74E+08 2.15E+07 0.00E+00 8.40E+07 0.00E+00 1.48E+07 0.OOE+00 CM-246 3.37E+08 2.74E+08 2.15E+07 0.00E+00 8.38E+07 0.00E+00 1.45E+07 0.OOE+00 CM-247 3.29E+08 2.70E+08 2.11E+07 0.00E+00 8.26E+07 0.OOE+00 1.91E+07 0.OOE+00 CM-248 2.74E+09 2.23E+09 1.74E+08 0.OOE+00 6.81E+08 0.OOE+00 3.09E+08 0.OOE+00 CF-252 2.09E+08 0.OOE+00 5.05E+06 0.OOE+00 0.OOE+00 0.00E+00 5.88E+07 0.OOE+00 11.4-202 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-43 (Page 1 of 4) Teen Meat Ri m 2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 1.10E+02 1.10E+02 1.10E+02 1.10E+02 1.10E+02 1.1OE+02 0.OOE+00 C-14 2.81EE+05 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 0.OOE+00 NA-22 1.1OE+09 1.10E+09 1.10OE+09 1.1OE+09 1.10E+09 1.10E+09 1.1OE+09 0.OOE+00 NA-24 1.08E-03 1.08E-03 1.08E-03 1.08E-03 1.08E-03 1.08E-03 1.08E-03 0.OOE+00 P-32 3.93E+09 2.44E+08 1.53E+08 O.OOE+00 0.OOE+00 0.OOE+00 3.31E+08 0.OOE+00 CA-41 1.28E+09 0.OOE+00 1.38E+08 0.OOE+00 0.OOE+00 0.OOE+00 1.26E+06 0.OOE+00 SC-46 1.36E+05 2.65E+05 7.87E+04 O.OOE+00 2.54E+05 O.OOE+00 9.04E+08 0.OOE+00 CR-51 0.OOE+00 0.OOE+00 5.64E+03 3.13E+03 1.24E+03 8.05E+03 9.47E+05 0.OOE+00 MN-54 0.OOE+00 7.OOE+06 1.39E+06 0.OOE+00 2.09E+06 0.OOE+00 1.44E+07 0.OOE+00 FE-55 2.38E+08 1.69E+08 3.94E+07 0.OOE+00 0.OOE+00 1.07E+08 7.31 E+07 0.OOE+00 MN-56 0.OOE+00 1.23E-53 2.19E-54 0.OOE+00 1.56E-53 0.OOE+00 8.10E-52 O.OOE+00 CO-57 0.OOE+00 4.53E+06 7.59E+06 0.OOE+00 0.OOE+00 0.OOE+00 8.45E+07 0.OOE+00 CO-58 0.00E+00 1.41 E+07 3.24E+07 0.OOE+00 0.OOE+00 0.OOE+00 1.94E+08 0.OOE+00 FE-59 2.12E+08 4.95E+08 1.91E+08 0.OOE+00 0.OOE+00 1.56E+08 1.17E+09 0.OOE+00 CO-60 0.00E+00 5.83E+07 1.31 E+08 0.OOE+00 0.OOE+00 0.OOE+00 7.60E+08 O.OOE+00 NI-59 1.13E+08 4.OOE+07 1.92E+07 0.OOE+00 0.OOE+00 0.OOE+00 6.28E+06 0.OOE+00 NI-63 1.52E+09 1.07E+08 5.15E+07 0.OOE+00 0.OOE+00 O.OOE+00 1.71E+07 0.OOE+00 CU-64 0.OOE+00 2.21E-07 1.04E-07 0.OOE+00 5.60E-07 0.OOE+00 1.72E-05 O.OOE+00 NI-65 1.88E-53 2.41E-54 1.1OE-54 O.OOE+00 0.OOE+00 0.OOE+00 1.30E-52 O.OOE+00 ZN-65 2.50E+08 8.69E+08 4.05E+08 0.OOE+00 5.56E+08 0.OOE+00 3.68E+08 0.OOE+00 ZN-69m 1.40E-05 3.30E-05 3.02E-06 0.OOE+00 2.OOE-05 0.OOE+00 1.81 E-03 0.OOE+00 ZN-69 1.53E-153 2.91E-153 2.04E-154 0.OOE+00 1.90E-153 0.OOE+00 5.36E-153 0.OOE+00 SE-79 O.OOE+00 9.07E+07 1.52E+07 O.OOE+00 1.58E+08 O.OOE+00 1.39E+07 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 9.72E+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 BR-83 0.OOE+00 0.OOE+00 5.07E-57 0.OOE+00 0.OOE+00 O.OE+00 0.OOE+00 O.OOE+00 BR-84 0.OOE+00 0.OOE+00 5.42E-270 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 BR-85 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 4.07E+08 1.91E+08 0.OOE+00 0.OOE+00 0.OOE+00 6.02E+07 0.OOE+00 RB-87 0.OOE+00 8.79E+08 3.07E+08 0.OOE+00 0.OOE+00 0.OOE+00 3.07E+07 0.OOE+00 RB-88 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 RB-89 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 SR-89 2.55E+08 O.OOE+00 7.29E+06 0.OOE+00 0.OOE+00 0.OOE+00 3.03E+07 O.OOE+00 SR-90 9.89E+09 O.OOE+00 1.98E+08 O.OOE+00 O.OOE+00 0.OOE+00 2.26E+08 0.O0E+00 Y-90 9.06E+01 0.OOE+00 2.44E+00 O.OOE+00 O.OOE+00 0.OOE+00 7.47E+05 0.OOE+00 SR-91 1.28E-10 O.OOE+00 5.08E-12 0.OOE+00 O.OOE+00 0.OOE+00 5.79E-10 0.OOE+00 Y-91m 5.85E-175 O.OOE+00 2.24E-176 O.OOE+00 0.OOE+00 O.00E+00 2.76E-173 O.OOE+00 Y-91 9.54E+05 0.00E+00 2.56E+04 0.OOE+00 O.OOE+00 0.OOE+00 3.91EE+08 0.00E+00 11.4-203 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-43 (Page 2 of 4) Teen Meat Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI Skin SR-92 9.88E-50 0.OOE+00 4.21E-51 0.OOE+00 0.OOE+00 0.OOE+00 2.52E-48 0.OOE+00 Y-92 1.28E-39 0.OOE+00 3.71 E-41 0.OOE+00 0.OOE+00 0.OOE+00 3.52E-35 0.OOE+00 Y-93 3.96E-12 0.OOE+00 1.09E-13 0.OOE+00 0.OOE+00 0.OOE+00 1.21 E-07 0.OOE-'00 NB-93m 1.55E+07 5.1OE+06 1.28E+06 0.OOE+00 5.96E+06 0.OOE+00 1.84E+09 0.OOE+00 NB-95 1.79E+06 9.95E+05 5.48E+05 0.OOE+00 9.65E+05 0.OOE+00 4.26E+09 0.OOE+00 NB-97 4.92E-1 19 1.22E-1 19 4.46E-120 0.OOE+00 1.43E-1 19 0.OOE+00 2.92E-1 15 0.OOE+00 ZR-93 3.05E+06 1.50E+06 8.21 E+05 0.OOE+00 5.32E+06 0.00E+00 1.42E+09 0.OOE-'00 ZR-95 1.50E+06 4.73E+05 3.25E+05 0.OOE+00 6.95E+05 0.OOE+00 1.09E+09 0.OOE+00 ZR-97 1.72E-05 3.41 E-06 1.57E-06 0.OOE+00 5.17E-06 0.OOE+00 9.23E-01 0.OOE+00 MO-93 0.OOE+00 1.37E+08 3.76E+06 0.OOE+00 3.94E+07 0.OOE+00 1.67E+07 0.OOE+00 MO-99 0.OOE+00 8.27E+04 1.58E+04 0.OOE+00 1.89E+05 0.OOE+00 1.48E+05 0.OOE+00 TC-99 1.16E+08 1.70E+08 4.65E+07 0.OOE+00 2.17E+09 1.76E+07 4.17E+09 0.OOE+00 TC-99m 3.53E-21 9.86E-21 1.28E-19 0.OOE+00 1.47E-19 5.47E-21 6.47E-1 8 0.OOE+00 TC-101 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RU-1 03 8.57E+07 0.OOE+00 3.66E+07 0.OOE+00 3.02E+08 0.OOE+00 7.16E+09 0.OOE+00 RU-1 05 4.83E-28 0.OOE+00 1.87E-28 0.OOE+00 6.09E-27 0.OOE+00 3.90E-25 0.OOE+00 RU-106 2.36E+09 0.OOE+00 2.97E+08 0.OOE+00 4.55E+09 0.OOE+00 1.13E+11 0.OOE+00 RH-1 05 3.25E+00 2.35E+00 1.54E+00 0.OOE+00 9.96E+00 0.OOE+00 2.98E+02 0.OOE+00 PD-1 07 0.OOE+00 1.35E+06 8.69E+04 0.OOE+00 1.22E+07 0.OOE+00 6.26E+06 0.OOE+00 PD-1 09 0.OOE+00 1.11E-06 2.51E-07 0.OOE+00 6.39E-06 0.OOE+00 1.11E-04 0.OOE+00 AG-11Orn 5.06E+06 4.79E+06 2.91 E+06 0.OOE+00 9.13E+06 0.OOE+00 1.34E+09 0.OOE+00 AG-111 1.24E+05 5.13E+04 2.58E+04 0.OOE+00 1.67E+05 0.OOE+00 7.15E+07 0.OOE+00 CD-1 13m 0.OOE+00 3.85E+06 1.24E+05 0.OOE+00 4.26E+06 0.OOE+00 2.31 E+07 0.OOE+00 CD-1 15m 0.OOE+00 1.25E+06 4.02E+04 0.OOE+00 9.96E+05 0.OOE+00 3.94E+07 0.OOE+00 SN-123 4.66E+09 7.66E+07 1.13E+08 6.14E+07 0.OOE+00 0.OOE+00 7.05E+09 0.OOE+00 SN-125 1.49E+08 2.97E+06 6.73E+06 2.33E+06 0.OOE+00 0.OOE+00 1.40E+09 0.OOE+00 SN-126 1.50E+10 2.80E+08 4.28E+08 7.38E+07 0.OOE+00 0.OOE+00 3.34E+09 0.OOE+00 SB-124 1.62E+07 2.98E+05 6.31 E+06 3.67E+04 0.OOE+00 1.41 E+07 3.26E+08 0.OOE+00 SB-125 1.56E+07 1.71 E+05 3.66E+06 1.49E+04 0.OOE+00 1.37E+07 1.22E+08 0.OOE+00 SB-126 1.58E+06 3.23E+04 5.68E+05 8.94E+03 0.OOE+00 1.13E+06 9.35E+07 0.OOE+00 SB-127 1.38E+04 2.95E+02 5.21E+03 1.55E+02 0.OOE+00 9.39E+03 2.34E+06 0.OOE+00 TE-125m 3.03E+08 1.09E+08 4.05E+07 8.47E+07 0.OOE+00 0.OOE+00 8.94E+08 0.OOE-'00 TE-127m 9.41 E+08 3.34E+08 1.12E+08 2.24E+08 3.82E+09 0.OOE+00 2.35E+09 0.OOE+00 TE-127 1.80E-10 6.38E-11 3.88E-1i1 1.24E-10 7.29E-10 0.OOE+00 1.39E-08 0.OOE+00 TE-129m 9.50E+08 3.53E+08 1.50E+08 3.07E+08 3.97E+09 0.OOE+00 3.57E+09 0.00E4-00 TE-129 3.76E-1 21 1.40E-1 21 9.16E-122 2.69E-1 21 1.58E-120 0.OOE+00 2.06E-120 0.00E4-00 TE-133m 4.67E-153 2.66E-1 53 2.58E-153 3.71E-153 2.63E-1 52 0.OOE+00 1.07E-1 52 0.OOE+00 11.4-204 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-43 (Page 3 of 4) Teen Meat Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin TE-134 2.59E-204 1.67E-204 1.74E-204 2.13E-204 1.59E-203 0.OOE+00 9.63E-206 0.OOE+00 1-129 1.10E+08 .9.21E+07 1.54E+08 1.12E+11 1.65E+08 0.OOE+00 1.07E+07 0.OOE+00 1-130 1.70E-06 4.91E-06 1.96E-06 4.OOE-04 7.56E-06 0.00E+00 3.77E-06 O.OOE+00 1-131 8.92E+06 1.25E+07 6.71E+06 3.65E+09 2.15E+07 0.00E+00 2.47E+06 O.OOE+00 TE-131m 3.76E+02 1.80E+02 1.50E+02 2.71E+02 1.88E+03 0.OOE+00 1.45E+04 0.OOE+00 TE-131 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1-132 5.66E-59 1.48E-58 5.31 E-59 4.99E-57 2.33E-58 0.00E+00 6.45E-59 0.OOE+00 TE-132 1.16E+06 7.36E+05 6.92E+05 7.76E+05 7.06E+06 0.OOE+00 2.33E+07 O.OOE+00 1-133 3.05E-01 5.18E-01 1.58E-01 7.23E+01 9.09E-01 0.00E+00 3.92E-01 O.OOE+00 CS-134m 2.13E-47 4.42E-47 2.27E-47 0.OOE+00 2.46E-47 4.32E-48 2.94E-47 0.OOE+00 CS-134 5.23E+08 1.23E+09 5.71E+08 O.OOE+00 3.91E+08 1.49E+08 1.53E+07 O.OOE+00 1-134 8.66E-162 2.30E-161 8.24E-162 3.83E-160 3.62E-161 0.OOE+00 3.02E-163 0.OOE+00 1-135 3.60E-17 9.27E-17 3.44E-17 5.96E-15 1.46E-16 0.00E+00 1.03E-16 0.OOE+00 CS-135 1.80E+08 1.65E+08 3.86E+07 0.OOE+00 6.31E+07 2.28E+07 2.89E+06 0.OOE+00 CS-136 9.40E+06 3.70E+07 2.48E+07 0.00E+00 2.01E+07 3.17E+06 2.98E+06 0.OOE+00 CS-1 37 7.24E+08 9.63E+08 3.36E+08 0.OOE+00 3.28E+08 1.27E+08 1.37E+07 0.OOE+00 CS-138 2.23E-267 4.28E-267 2.14E-267 0.OOE+00 3.16E-267 3.68E-268 1.94E-270 0.OOE+00 CS-139 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 BA-139 1.05E-101 7.41E-105 3.07E-103 0.00E+00 6.98E-105 5.1OE-105 9.39E-101 0.OOE+00 BA-140 2.38E+07 2.91E+04 1.53E+06 0.OOE+00 9.87E+03 1.96E+04 3.66E+07 0.OOE+00 LA-140 3.05E-02 1.50E-02 3.99E-03 0.OOE+00 0.OOE+00 0.OOE+00 8.61 E+02 0.OOE+00 BA-141 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 LA-141 3.29E-37 1.01E-37 1.67E-38 0.OOE+00 0.OOE+00 0.OOE+00 1.79E-32 0.OOE+00 CE-141 1.18E+04 7.87E+03 9.04E+02 0.OOE+00 3.71E+03 0.OOE+00 2.25E+07 0.OOE+00 BA-142 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 LA-142 2.85E-92 1.26E-92 3.15E-93 0.OOE+00 0.OOE+00 0.OOE+00 3.85E-88 0.OOE+00 CE-143 1.69E-02 1.23E+01 1.37E-03 0.OOE+00 5.51E-03 0.OOE+00 3.69E+02 0.OOE+00 PR-143 1.76E+04 7.04E+03 8.78E+02 0.OOE+00 4.09E+03 0.OOE+00 5.80E+07 O.OOE+00 CE-144 1.23E+06 5.08E+05 6.60E+04 0.OOE+00 3.04E+05 0.OOE+00 3.09E+08 0.OOE+00 PR-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 ND-147 6.23E+03 6.77E+03 4.06E+02 0.OOE+00 3.98E+03 0.OOE+00 2.44E+07 0.OOE+00 PM-147 7.93E+05 7.53E+04 3.07E+04 0.OOE+00 1.44E+05 0.OOE+00 7.16E+07 0.OOE+00 PM-148m 1.72E+05 4.36E+04 3.41 E+04 0.OOE+00 6.60E+04 0.OOE+00 2.74E+08 O.OOE+00 PM-148 1.66E+03 2.70E+02 1.36E+02 0.OOE+00 4.88E+02 0.OOE+00 1.61E+07 0.OOE+00 PM-149 4.33E+00 6.09E-01 2.50E-01 0.OOE+00 1.16E+00 0.OOE+00 8.97E+04 0.OOE+00 PM-151 4.82E-03 7.96E-04 4.03E-04 0.OOE+00 1.43E-03 0.OOE+00 1.79E+02 0.OOE+00 SM-151 7.07E+05 1.36E+05 3.19E+04 0.OOE+00 1.49E+05 0.OOE+00 4.61EE+07 0.OOE+00 11.4-205 LASALLE ODCM PART II SECTION 4.doc

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-43 (Page 4 of 4) Teen Meat R, m4mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 9.63E-01 7.97E-01 5.87E-02 0.OOE+00 2.61E-01 0.OOE+00 2.25E+04 0.OOE+00 EU-152 1.90E+06 4.56E+05 4.02E+05 0.OOE+00 2.12E+06 0.OOE+00 1.68E+08 0.OOE+00 EU-154 6.1OE+06 7.87E+05 5.54E+05 0.OOE+00 3.52E+06 0.OOE+00 4.16E+08 0.OOE+00 EU-155 1.33E+06 1.29E+05 7.97E+04 0.OOE+00 5.03E+05 0.OOE+00 7.38E+08 0.OOE+00 EU-156 3.12E+04 2.34E+04 3.81E+03 0.OOE+00 1.57E+04 0.OOE+00 1.19E+08 0.OOE+00 TB-160 3.19E+05 0.OOE+00 3.98E+04 0.OOE+00 1.26E+05 0.OOE+00 2.07E+08 0.OOE+00 HO-166m 2.55E+06 7.84E+05 5.68E+05 0.OOE+00 1.15E+06 0.OOE+00 7.13E-12 0.OOE+00 W-181 2.39E+04 7.71E+03 8.06E+02 0.OOE+00 0.OOE+00 0.OOE+00 6.57E+05 0.OOE+00 W-185 8.55E+05 2.82E+05 2.98E+04 0.OOE+00 O.OOE+00 O.OOE+00 2.44E+07 O.OOE+00 W-187 1.73E-02 1.41E-02 4.95E-03 0.OOE+00 0.OOE+00 0.OOE+00 3.82E+00 0.OOE+00 NP-239 2.26E-01 2.14E-02 1.19E-02 0.OOE+00 6.70E-02 O.OOE+00 3.44E+03 0.OOE+00 U-232 3.24E+09 0.OOE+00 2.32E+08 0.O0E+00 3.51E+08 0.OOE+00 3.96E+07 0.OOE+00 U-233 6.83E+08 0.OOE+00 4.15E+07 O.OOE+00 1.60E+08 0.OOE+00 3.66E+07 O.OOE+00 U-234 6.56E+08 0.OOE+00 4.07E+07 0.OOE+00 1.57E+08 0.OOE+00 3.59E+07 0.OOE+00 U-235 6.28E+08 0.OOE+00 3.82E+07 0.OOE+00 1.47E+08 O.OOE+00 4.56E+07 0.OOE+00 U-236 6.28E+08 O.OOE+00 3.91 E+07 O.OOE+00 1.50E+08 0.OOE+00 3.37E+07 0.00E+00 U-237 1.81E+03 O.0OE+00 4.82E+02 O.O0E+00 7.43E+03 O.0OE+00 4.79E+05 0.0OE+00 U-238 6.01E+08 0.OOE+00 3.58E+07 0.OOE+00 1.38E+08 0.OOE+00 3.21E+07 O.OOE+00 NP-237 4.31E+08 3.10E+07 1.90E+07 0.OOE+00 1.40E+08 0.OOE+00 2.73E+07 O.OOE+00 NP-238 1.18E+00 3.16E-02 1.84E-02 0.OOE+00 1.08E-01 0.OOE+00 2.32E+03 0.OOE+00 PU-238 1.52E+07 1.94E+06 4.13E+05 0.OOE+00 1.77E+06 O.OOE+00 1.75E+06 0.OOE+00 PU-239 1.74E+07 2.11E+06 4.56E+05 O.OOE+00 1.94E+06 0.OOE+00 1.60E+06 0.OOE+00 PU-240 1.73E+07 2.1OE+06 4.56E+05 0.OOE+00 1.94E+06 0.OOE+00 1.63E+06 0.OOE+00 PU-241 3.95E+05 1.90E+04 8.33E+03 0.OOE+00 3.86E+04 0.OOE+00 3.34E+04 O.OOE+00 PU-242 1.61 E+07 2.03E+06 4.40E+05 0.OOE+00 1.87E+06 0.OOE+00 1.57E+06 0.OOE+00 PU-244 1.88E+07 2.31E+06 5.04E+05 0.OOE+00 2.14E+06 0.OOE+00 2.34E+06 0.OOE+00 AM-241 2.59E+08 2.44E+08 1.86E+07 0.OOE+00 1.40E+08 0.OOE+00 2.55E+07 O.OOE+00 AM-242m 2.61 E+08 2.30E+08 1.88E+07 0.OOE+00 1.39E+08 0.OOE+00 3.21 E+07 0.OOE+00 AM-243 2.58E+08 2.38E+08 1.82E+07 0.OOE+00 1.37E+08 0.OOE+00 2.99E+07 0.OOE+00 CM-242 8.06E+06 8.50E+06 5.35E+05 0.OOE+00 2.44E+06 0.OOE+00 2.30E+07 0.OOE+00 CM-243 2.1OE+08 1.95E+08 1.32E+07 0.OOE+00 6.17E+07 0.OOE+00 2.68E+07 0.OOE+00 CM-244 1.63E+08 1.54E+08 1.03E+07 0.OOE+00 4.81E+07 0.OOE+00 2.58E+07 0.OOE+00 CM-245 3.21 E+08 2.82E+08 1.98E+07 0.OOE+00 9.24E+07 0.OOE+00 2.42E+07 0.OOE+00 CM-246 3.18E+08 2.82E+08 1.97E+07 0.OOE+00 9.20E+07 0.OOE+00 2.38E+07 0.OOE+00 CM-247 3.1OE+08 2.78E+08 1.94E+07 0.OOE+00 9.08E+07 0.OOE+00 3.12E+07 0.OOE+00 CM-248 2.58E+09 2.29E+09 1.60E+08 0.OOE+00 7.49E+08 0.OOE+00 5.02E+08 0.OOE+00 CF-252 1.09E+08 0.OOE+00 2.64E+06 0.OOE+00 0.OOE+00 0.OOE+00 9.60E+07 0.OOE+00 11.4-206 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-44 (Page 1 of 4) Adult Meat Ri m2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin H-3 0.OOE+00 1.85E+02 1.85E+02 1.85E+02 1.85E+02 1.85E+02 1.85E+02 0.OOE+00 C-14 3.33E+05 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04 0.OOE+00 NA-22 1.39E+09 1.39E+09 1.39E+09 1.39E+09 1.39E+09 1.39E+09 1.39E+09 0.OOE+00 NA-24 1.36E-03 1.36E-03 1.36E-03 1.36E-03 1.36E-03 1.36E-03 1.36E-03 0.OOE+00 P-32 4.66E+09 2.90E+08 1.80E+08 0.00E+00 0.00E+00 0.OOE+00 5.24E+08 0.OOE+00 CA-41 2.03E+09 0.OOE+00 2.19E+08 0.OOE+00 0.OOE+00 0.00E+00 2.02E+06 0.OOE+00 SC-46 1.76E+05 3.41E+05 9.91E+04 0.OOE+00 3,18E+05 0.00E+00 1.66E+09 O.OOE+00 CR-51 O.OOE+00 0.OOE+00 7.05E+03 4.21E+03 1.55E+03 9.35E+03 1.77E+06 0.OOE+00 MN-54 0.OOE+00 9.18E+06 1.75E+06 0.OOE+00 2.73E+06 0.OOE+00 2.81E+07 0.00E+00 FE-55 2.93E+08 2.03E+08 4.72E+07 0.00E+00 0.00E+00 1.13E+08 1.16E+08 0.OOE+00 MN-56 0.OOE+00 1.52E-53 2.69E-54 0.OOE+00 1.92E-53 O.OOE+00 4.84E-52 0.00E+00 CO-57 0.OOE+00 5.64E+06 9.37E+06 O.OOE+00 0.OOE+00 0.OOE+00 1.43E+08 0.00E+00 CO-58 0.OOE+00 1.82E+07 4.09E+07 0.OOE+00 0.OOE+00 0.OOE+00 3.69E+08 0.OOE+00 FE-59 2.66E+08 6.24E+08 2.39E+08 0.OOE+00 0.00E+00 1.74E+08 2.08E+09 O.OOE+00 CO-60 0.OOE+00 7.52E+07 1.66E+08 O.OOE+00 0.OOE+00 0.OOE+00 1.41 E+09 0.00E+00 NI-59 1.42E+08 4.87E+07 2.37E+07 0.OOE+00 0.00E+00 0.OOE+00 1.OOE+07 0.OOE+00 NI-63 1.89E+09 1.31 E+08 6.33E+07 0.OOE+00 0.00E+00 0.OOE+00 2.73E+07 O.OOE+00 CU-64 0.OOE+00 2.71E-07 1.27E-07 O.OOE+00 6.84E-07 0.00E+00 2.31E-05 O.OOE+00 Ni-65 2.25E-53 2.92E-54 1.33E-54 0.OOE+00 0.OOE+00 0.OOE+00 7.40E-53 0.00E+00 ZN-65 3.56E+08 1.13E+09 5.12E+08 O.OOE+00 7.57E+08 0.OOE+00 7.13E+08 0.OOE+00 ZN-69m 1.68E-05 4.02E-05 3.68E-06 0.OOE+00 2.43E-05 0.OOE+00 2.45E-03 0.OOE+00 ZN-69 1.81E-153 3.46E-153 2.41E-154 0.OOE+00 2.25E-153 0.OOE+00 5.20E-154 0.OOE+00 SE-79 0.OOE+00 1.08E+08 1.81E+07 0.OOE+00 1.87E+08 0.OOE+00 2.21E+07 0.OOE+00 BR-82 0.OOE+00 0.OOE+00 1.22E+03 0.OOE+00 0.OOE+00 0.OOE+00 1.40E+03 0.OOE+00 BR-83 0.OOE+00 0.OOE+00 6.00E-57 0.OOE+00 0.00E+00 0.OOE+00 8.65E-57 0.OOE+00 BR-84 0.OOE+00 0.OOE+00 6.62E-270 0.OOE+00 0.OOE+00 0.OOE+00 5.19E-275 0.00E+00 BR-85 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-86 0.OOE+00 4.87E+08 2.27E+08 0.OOE+00 0.OOE+00 0.OOE+00 9.60E+07 0.OOE+00 RB-87 0.OOE+00 1.05E+09 3.64E+08 0.OOE+00 0.OOE+00 0.OOE+00 4.90E+07 0.OOE+00 RB-88 0.OOE+00 O.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 RB-89 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 SR-89 3.02E+08 0.OOE+00 8.66E+06 0.OOE+00 0.OOE+00 0.00E+00 4.84E+07 0.OOE+00 SR-90 1.43E+10 0.OOE+00 2.87E+08 0.00E+00 0.OOE+00 0.OOE+00 3.59E+08 0.00E+00 Y-90 1.08E+02 0.OOE+00 2.89E+00 0.00E+00 0.OOE+00 0.OOE+00 1.14E+06 0.OOE+00 SR-91 1.52E-10 0.00E+00 6.14E-12 0.OOE+00 0.00E+00 0.OOE+00 7.23E-10 0.OOE+00 Y-91m 6.98E-175 0.OOE+00 2.70E-176 0.OOE+00 0.OOE+00 0.OOE+00 2.05E-174 0.OOE+00 Y-91 1.13E+06 0.OOE+00 3.03E+04 0.00E+00 0.OOE+00 0.00E+00 6.23E+08 0.OOE+00 11.4-207 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-44 (Page 2 of 4) Adult Meat Ri m 2mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung_ GI-LLI Skin SR-92 1.18E-49 0.00E+00 5.1OE-51 O.00E+00 0.00E+00 0.00E+00 2.33E-48 0.00E+00 Y-92 1.52E-39 0.OOE+00 4.43E-41 0.00E+00 0.00E+00 0.00E+00 2.66E-35 0.00E+00 Y-93 4.69E-12 0.00E+00 1.30E-13 0.00E+00 0.O0E+00 0.OOE+00 1.49E-07 O.00E+00 NB-93m 1.95E+07 6.36E+06 1.57E+06 0.00E+00 7.31 E+06 0.OOE+00 2.93E+09 0.00E+00 NB-95 2.30E+06 1.28E+06 6.87E+05 0.OOE+00 1.26E+06 0.00E+00 7.76E+09 0.00E+00 NB-97 5.90E-119 1.49E-119 5.45E-120 O.OOE+00 1.74E-119 O.00E+00 5.50E-116 0.00E+00 ZR-93 3.90E+06 2.18E+05 1.02E+05 0.00E+00 8.27E+05 O.OE+00 2.27E+08 0.00E+00 ZR-95 1.87E+06 6.01 E+05 4.07E+05 0.OOE+00 9.42E+05 0.OOE+00 1.90E+09 0.00E+00 ZR-97 2.07E-05 4.17E-06 1.91E-06 0.OOE+00 6.30E-06 0.00E+00 1.29E+00 0.OOE+00 MO-93 0.00E+00 1.65E+08 4.45E+06 0.00E+00 4.67E+07 0.00E+00 2.68E+07 0.OOE+00 MO-99 0.00E+00 11.00E+05 1.90E+04 O.00E+00 2.26E+05 0.00E+00 2.32E+05 0.OOE+00 TC-99 1.37E+08 2.04E+08 5.51E+07 0.00E+00 2.57E+09 1.73E+07 6.67E+09 0.OOE+00 TC-99m 4.45E-21 1.26E-20 1.60E-19 0.00E+00 1.91E-19 6.16E-21 7.44E-18 0.OOE+00 TC-101 0,00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 RU-103 1.05E+08 0.00E+00 4.53E+07 0.00E+00 4.01E+08 0.OOE+00 1.23E+10 0.00E+00 RU-1 05 5.78E-28 O.00E+00 2.28E-28 0.00E+00 7.46E-27 0.00E+00 3.53E-25 0.00E+00 RU-106 2.80E+09 0.OOE+00 3.54E+08 0.OOE+00 5.40E+09 0.OOE+00 1.81E+11 0.OOE+00 RH-105 3.84E+00 2.81E+00 1.85E+00 0.OOE+00 1.19E+01 0.OOE+00 4.48E+02 0.OOE+00 PD-107 0.OOE+00 1.61E+06 1.03E+05 0.00E+00 1.45E+07 0.OOE+00 9.99E+06 0.OOE+00 PD-1 09 0.OOE+00 1.32E-06 2.97E-07 0.OOE+00 7.53E-06 0.OOE+00 1.46E-04 O.OOE+00 AG-11Orn 6.68E+06 6.18E+06 3.67E+06 0.OOE+00 1.22E+07 0.OOE+00 2.52E+09 0.OOE+00 AG-111 1.47E+05 6.13E+04 3.05E+04 0.OOE+00 1.98E+05 0.OOE+00 1.12E+08 0.OOE+00 CD-i 13m 0.00E+00 4.60E+06 1.47E+05 0.OOE+00 5.06E+06 0.OOE+00 3.70E+07 0.OOE+00 CD-115m 0.OOE+00 1.49E+06 4.76E+04 0.OOE+00 1.18E+06 0.OOE+00 6.27E+07 0.OOE+00 SN-123 5.53E+09 9.16E+07 1.35E+08 7.79E+07 0.OOE+00 0.OOE+00 1.13E+10 0.OOE+00 SN-125 1.77E+08 3.56E+06 8.01E+06 2.95E+06 0.OOE+00 0.OOE+00 2.21E+09 0.OOE+00 SN-1 26 1.85E+10 3.66E+08 5.27E+08 1.08E+08 0.OOE+00 0.OOE+00 5.33E+09 0.OOE+00 SB-124 1.98E+07 3.74E+05 7.84E+06 4.80E+04 0.OOE+00 1.54E+07 5.62E+08 0.OOE+00 SB-125 1.91E+07 2.13E+05 4.55E+06 1.94E+04 0.OOE+00 1.47E+07 2.1OE+08 0.OOE+00 SB-126 1.93E+06 3.94E+04 6.98E+05 1.18E+04 0.OOE+00 1.19E+06 1.58E+08 0.OOE+00 SB-1 27 1.66E+04 3.63E+02 6.37E+03 1.99E+02 0.OOE+00 9.84E+03 3.80E+06 0.OOE+00 TE-125m 3.59E+08 1.30E+08 4.81iE+07 1.08E+08 1.46E+09 0.OOE+00 1.43E+09 0.OOE+00 TE-127m 1.12E+09 3.99E+08 1.36E+08 2.85E+08 4.53E+09 0.OOE+00 3.74E+09 0.OOE+00 TE-127 2.12E-10 7.62E-11 4.59E-11 1.57E-10 8.64E-10 0.OOE+00 1.67E-08 0.OOE+00 TE-129m 1.13E+09 4.23E+08 1.79E+08 3.90E+08 4.73E+09 O.OOE+00 5.71E+09 O.OOE+00 TE-129 4.47E-121 1.68E-121 1.09E-121 3.43E-121 1.88E-120 0.OOE+00 3.37E-121 0.OOE+00 TE-133m 5.67E-153 3.32E-153 3.19E-153 4.80E-153 3.28E-152 O.OOE+00 1.14E-153 0.OOE+00 11.4-208 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-44 (Page 3 of 4) Adult Meat Rj m 2 *m rem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lunq GI-LLI Skin TE-134 3.18E-204 2.08E-204 1.28E-204 2.78E-204 2.01E-203 0.OOE+00 3.53E-207 0.00E+00 1-129 1.30E+08 1.12E+08 3.66E+08 2.88E+11 2.40E+08 0.00E+00 1.77E+07 0.00E+00 1-130 2.11E-06 6.22E-06 2.45E-06 5.27E-04 9.71E-06 0.OOE+00 5.35E-06 0.OOE+00 1-131 1.07E+07 1.54E+07 8.80E+06 5.03E+09 2.63E+07 0.OOE+00 4.05E+06 0.00E+00 TE-131m 4.51EE+02 2.21EE+02 1.84E+02 3.49E+02 2.23E+03 O.O0E+00 2.19E+04 0.00E+00 TE-131 0.00E+00 0.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 1-132 6.97E-59 1.86E-58 6.52E-59 6.52E-57 2.97E-58 O.00E+00 3.50E-59 0.00E+00 TE-132 1.42E+06 9.18E+05 8.62E+05 1.01E+06 8.84E+06 0.00E+00 4.34E+07 0.00E+00 1-133 3.65E-01 6.35E-01 1.94E-01 9.34E+01 1.11E+00 0.OOE+00 5.71E-01 0.00E+00 CS-134m 2.62E-47 5.50E-47 2.81E-47 0.OOE+00 2.98E-47 4.70E-48 1.94E-47 0.OOE+00 CS-1 34 6.58E+08 1.56E+09 1.28E+09 0.00E+00 5.06E+08 1.68E+08 2.74E+07 0.00E+00 1-134 1.06E-161 2.89E-161 1.03E-161 5.01E-160 4.60E-161 0.00E+00 2.52E-164 0.00E+00 1-135 4.43E-17 1.16E-16 4.28E-17 7.64E-15 1.86E-16 0.00E+00 1.31E-16 0.00E1+00 CS-135 2.14E+08 1.97E+08 8.76E+07 0.OOE+00 7.47E+07 2.24E+07 4.62E+06 0.OOE+00 CS-136 1.21 E+07 4.76E+07 3.43E+07 0.00E+00 2.65E+07 3.63E+06 5.41 E+06 0.OOE+00 CS-137 8.72E+08 1.19E+09 7.81E+08 0.OOE+00 4.05E+08 1.35E+08 2.31E+07 0.00E+00 CS-1 38 2.68E-267 5.30E-267 2.63E-267 0.00E+00 3.90E-267 3.85E-268 2.26E-272 0.00E+00 CS-1 39 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 BA-139 1.24E-101 8.86E-105 3.64E-103 0.OOE+00 8.28E-105 5.02E-105 2.20E-101 0.00E+00 BA-140 2.87E+07 3.61E+04 1.88E+06 0.OOE+00 1.23E+04 2.07E+04 5.92E+07 0.OOE+00 LA-140 3.71E-02 1.87E-02 4.94E-03 0.OOE+00 0.OOE+00 0.OOE+00 1.37E+03 0.00E+00 BA-141 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 LA-141 3.90E-37 1.21E-37 1.98E-38 0.OOE+00 0.OOE+00 0.00E+00 1.44E-32 0.OOE+00 CE-141 1.40E+04 9.50E+03 1.08E+03 0.OOE+00 4.41E+03 0.00E+00 3.63E+07 0.00E+00 BA-142 0.00E+00 0.00E+0Q 0.00E+00 0.OOE+00 0.OOE+00 0.O0E+00 0.00E+00 0.00E+00 LA-142 3.45E-92 1.57E-92 3.90E-93 0.OOE+00 0.OOE+00 0.OOE+00 1.14E-88 0.00E+00 CE-143 2.01E-02 1.48E+01 1.64E-03 0.OOE+00 6.53E-03 0.00E+00 5.55E+02 0.00E+00 PR-143 2.1OE+04 8.41EE+03 1.04E+03 0.00E+00 4.85E+03 0.OOE+00 9.18E+07 0.00E+00 CE-144 1.46E+06 6.09E+05 7.83E+04 0.OOE+00 3.61E+05 0.00E+00 4.93E+08 0.00E+00 PR-144 0.OOE+00 O.0OE+00 0.00E+00 0.O0E+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 ND-147 7.07E+03 8.17E+03 4.89E+02 0.OOE+00 4.78E+03 0.OOE+00 3.92E+07 0.OOE+00 PM-147 9.64E+05 9.07E+04 3.67E+04 0.OOE+00 1.71E+05 0.00E+00 1.14E+08 0.OOE+00 PM-148m 2,16E+05 5.58E+04 4.27E+04 0,OOE+00 8.43E+04 0.OOE+00 4.73E+08 0.OOE+00 PM-148 1.97E+03 3.28E+02 1.65E+02 0.OOE+00 6.19E+02 0.00E+00 2.57E+07 0.OOE+00 PM-149 5.14E+00 7.27E-01 2.97E-01 0.00E+00 1.37E+00 0.00E+00 1.36E+05 0.00E+00 PM-151 5.76E-03 9.67E-04 4.89E-04 0.00E+00 1.73E-03 0.OOE+00 2.66E+02 0.00E+00 SM-151 9.45E+05 1.63E+05 3.90E+04 0.00E+00 1.82E+05 0.OOE+00 7.19E+07 0.OOE+00 11.4-209 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 4-44 (Page 4 of 4) Adult Meat Rj m2*mrem*sec/yr*pCi Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Skin SM-153 1.15E+00 9.55E-01 6.97E-02 0.OOE+00 3.09E-01 0.00E+00 3.41E+04 0.OOE+00 EU-152 2.55E+06 5.81 E+05 5.11 E+05 0.OOE+00 3.60E+06 0.OOE+00 3.35E+08 0.OOE+00 EU-154 8.03E+06 9.87E+05 7.02E+05 0.OOE+00 4.72E+06 0.OOE+00 7.15E+08 0.OOE+00 EU-155 1.11E+06 1.58E+05 1.02E+05 0.OOE+00 7.30E+05 0.OOE+00 1.24E+08 0.00E+00 EU-1 56 3.76E+04 2.91 E+04 4.70E+03 0.00E+00 1.94E+04 0.OOE+00 1.99E+08 0.00E+00 TB-160 3.92E+05 O.OOE+00 4.89E+04 0.OOE+00 1.62E+05 0.OOE+00 2.14E+08 0.OOE+00 HO-166m 3.26E+06 1.02E+06 7.72E+05 0.00E+00 1.52E+06 0.OOE+00 1.21E-11 0.OOE+00 W-181 2.82E+04 9.20E+03 9.86E+02 0.OOE+00 0.OOE+00 0.OOE+00 1.05E+06 0.OOE+00 W-185 1.01E+06 3.37E+05 3.55E+04 0.OOE+00 0.OOE+00 0.OOE+00 3.90E+07 0.OOE+00 W-187 2.07E-02 1.73E-02 6.04E-03 0.00E+00 O.OOE+00 0.OOE+00 5.66E+00 0.OOE+00 NP-239 2.59E-01 2.55E-02 1.40E-02 0.00E+00 7.95E-02 0.OOE+00 5.23E+03 0.OOE+00 U-232 3.85E+09 0.OOE+00 2.75E+08 0.OOE+00 4.16E+08 0.OOE+00 6.32E+07 O.OOE+00 U-233 8.12E+08 0.00E+00 4.92E+07 0.OOE+00 1.89E+08 O.OOE+00 5.85E+07 0.00E+00 U-234 7.80E+08 0.OOE+00 4.82E+07 0.OOE+00 1.86E+08 0.OOE+00 5.73E+07 0.OOE+00 U-235 7.47E+08 0.OOE+00 4.53E+07 0.OOE+00 1.74E+08 O.00E+00 7.28E+07 0.OOE+00 U-236 7.47E+08 0.OOE+00 4.62E+07 O.OOE+00 1.78E+08 0.OOE+00 5.37E+07 0.OOE+00 U-237 2.14E+03 0.OOE+00 5.70E+02 0.OOE+00 8.81E+03 0.OOE+00 7.53E+05 0.OOE+00 U-238 7.15E+08 0.OOE+00 4.23E+07 O.OOE+00 1.63E+08 0.00E+00 5.13E+07 0.OOE+00 NP-237 6.91E+08 4.91E+07 3.04E+07 0.OOE+00 2.26E+08 O.OOE+00 4.36E+07 0.OOE+00 NP-238 1.40E+00 3.78E-02 2.18E-02 0.00E+00 1.28E-01 0.00E+00 3.51E+03 0.OOE+00 PU-238 2.42E+07 3.06E+06 6.56E+05 0.OOE+00 2.81E+06 0.OOE+00 2.80E+06 O.OOE+00 PU-239 2.78E+07 3.34E+06 7.33E+05 0.OOE+00 3.11 E+06 0.OOE+00 2.56E+06 0.OOE+00 PU-240 2.78E+07 3.34E+06 7.33E+05 0.OOE+00 3.11 E+06 0.OOE+00 2.60E+06 0.OOE+00 PU-241 6.OOE+05 2.85E+04 1.27E+04 0.OOE+00 5.84E+04 0.OOE+00 5.35E+04 0.OOE+00 PU-242 2.58E+07 3.22E+06 7.06E+05 0.OOE+00 3.OOE+06 0.OOE+00 2.51E+06 0.OOE+00 PU-244 3.01E+07 3.69E+06 8.1OE+05 0.OOE+00 3.44E+06 0.OOE+00 3.74E+06 0.OOE+00 AM-241 4.14E+08 3.87E+08 2.97E+07 0.OOE+00 2.23E+08 0.OOE+00 4.07E+07 0.OOE+00 AM-242m 4.17E+08 3.63E+08 2.98E+07 0.OOE+00 2.22E+08 0.OOE+00 5.12E+07 0.OOE+00 AM-243 4.14E+08 3.78E+08 2.91E+07 0.00E+00 2.19E+08 0.OOE+00 4.77E+07 0.OOE+00 CM-242 9.56E+06 1.02E+07 6.36E+05 0.OOE+00 2.89E+06 0.OOE+00 3.67E+07 0.OOE+00 CM-243 3.28E+08 3.OOE+08 2.05E+07 0.OOE+00 9.57E+07 0.OOE+00 4.27E+07 0.OOE+00 CM-244 2.49E+08 2.33E+08 1.57E+07 0.OOE+00 7.32E+07 0.00E+00 4.12E+07 0.OOE+00 CM-245 5.14E+08 4.48E+08 3.16E+07 0.00E+00 1.48E+08 0.OOE+00 3.86E+07 O.OOE+00 CM-246 5.1OE+08 4.48E+08 3.15E+07 0.OOE+00 1.47E+08 0.00E+00 3.79E+07 0.OOE+00 CM-247 4.97E+08 4.41E+08 3.11E+07 0.00E+00 1.45E+08 0.00E+00 4.99E+07 0.OOE+00 CM-248 4.14E+09 3.64E+09 2.56E+08 0.OOE+00 1.20E+09 0.OOE+00 8.06E+08 0.00E+00 CF-252 1.39E+08 0.00E+00 3.35E+06 0.OOE+00 0.OOE+00 0.OOE+00 1.53E+08 0.OOE+00 11.4-210 LASALLE ODCM PART II SECTION 4.doc

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 5.0 TOTAL DOSE Radioactivity contained within tanks, pipes or other systems and contained radioactive material or waste stored on site can produce radiation at offsite locations. Annual offsite radiation doses near the station due to such sources were judged to be negligible in comparison with applicable limits except for doses due to BWR turbine skyshine, Independent Spent Fuel Storage Installations (ISFSI), and potential doses due to radioactive waste storage facilities (excludes radioactive material storage). Changes or modifications to the power station that may impact the offsite dose through increases to the direct radiation levels need to be evaluated on a case-by-case basis and added to the Radiological Effluent Controls (RECS) to the ODCM when applicable. 5.1 Total Dose Calculation Requirements 5.1.1 Total Effective Dose Equivalent Limits; 10CFR20 and 40CFR190 LaSalle Station is required to determine the total dose to a member of the public due to all uranium fuel cycle sources in order to assess compliance with 40CFR190 as part of demonstrating compliance with 10CFR20. The total dose for the uranium fuel cycle is the sum of doses due to radioactivity in airborne and liquid effluents and the doses due to direct radiation from contained sources at the nuclear power station. When evaluation of total dose is required for a station, the following contributions are summed:

• Doses due to airborne and liquid effluents from the station.
• Doses due to liquid effluents from nuclear power stations upstream.
• Doses due to any onsite radioactive waste storage facilities, if applicable.
• Doses due to any onsite Independent Spent Fuel Storage Installations (ISFSI)
• Doses due to nitrogen - 16 (N16 ) skyshine.

10CFR20 requires compliance to dose limits expressed as "Total Effective Dose Equivalent" (TEDE). Although annual dose limits in 10CFR20 are now expressed in terms of TEDEs, 40CFR190 limits remain stated as organ dose. The NRC continues to require 10CFR50 Appendix I and 40CFR190 doses to be reported in terms of organ dose and not TEDE. Due to the fact that organ dose limits set forth in 40CFR190 are substantially lower than those of 10CFR20 (25 mrem/yr vs. 100 mrem/yr), the NRC has stated that demonstration of compliance with the dose limits in 40CFR1 90 will be deemed as demonstration of compliance with the dose limits of Page 11.5-1 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 10CFR20 for most facilities (Reference 104). In addition to compliance with 40CFR1 90, it may be necessary for a nuclear power plant to address dose from on-site activity by members of the public. 5.1.2 Total Dose Calculation Methodology There are presently two types of contained sources of radioactivity that are of concern in LaSalle Station's offsite radiological dose assessments. The first source is that due to gamma rays from nitrogen-16 (16 N) carried over to the turbine in BWR (boiling water reactor) steam. The second source is that due to gamma rays associated with radioactive material resident in onsite Independent Spent Fuel Storage Installations (ISFSI) and radwaste storage facilities. Gamma radiation from these sources contributes to the total body dose (deep dose equivalent). In addition to the total body, skin and single organ dose assessments previously described, an additional assessment is required. The additional assessment addresses radiation dose due to radioactivity contained within the nuclear power station and its structures. 5.1.3 BWR Skyshine The most significant dose component to members of the public produced by "contained sources" is nitrogen-16 (16 N) within the turbine building of BWRs. Although primary side shielding is around the turbine and its piping, 16N gamma rays scattered by air molecules in the overhead air space above the turbine and piping cause a measurable "skyshine" radiation dose in the local power plant environs. Equation 5-1 is used to evaluate skyshine dose. A complicating factor in the calculation is the practice at some stations of adding hydrogen to reactor coolant to improve coolant chemistry. The addition of hydrogen can increase the dose rate due to skyshine up to a factor of 10 times expected levels depending on injection rates and power levels (Reference 39). Increasing the hydrogen injection rate will increase the dose rates even further. (See Reference 102) The skyshine dose determined by Equation 5-1 depends on the following factors:

• The distance of the dose recipient location from the turbine.
• The number of hours per year that the location is occupied by a dose recipient.

Page 11.5-2 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual The total energy [MWe-hr] generated by the nuclear power station with hydrogen addition. The total energy [MWe-hr] generated by the nuclear power station without hydrogen addition. 5.1.4 Independent Spent Fuel Storage Installation (ISFSI) 10CFR72.104 dose limits are the same as those specified by 40CFR190. Even a fully loaded ISFSI is not expected to become the prominent contributor to the limits in this section. ISFSI dose contribution is in the form of direct radiation as no liquid or gas releases are expected to occur. The 10CFR72.212 report prepared in accordance with ISFSI requirements assumes a certain array of casks exists on the pad. The dose contribution from this array of casks, in combination with historical uranium fuel cycle operations (e.g. LSCS 1 & 2) prior to ISFSI operations, was analyzed to be within the 40CFR190 and 10CFR72.104 limits. If the dose limits of 40CFR190 or 10CFR72.104 are exceeded, a special report to the NRC as well as an appropriate request for exemption/variance is required to be submitted to the NRC. The requirement that the dose limits of IOCFR72.104 apply to "any real individual" is controlled for ISFSI activities in the ISFSI 72.212 report. The nearest real individual to the ISFSI was also determined to be the nearest real individual to the plant. Therefore, for the purposes of analyzing dose, the member of the public as defined in 40CFR190 is the same as the real individual identified in the 72.212 report. The dose rate calculated to the nearest real individual from a fully loaded ISFSI (as listed in the 10CFR72.212 report) is 5.87E-02 mRem/year. To ensure compliance in a conservative fashion, one half of the annual ISFSI dose will be added to each Unit's external body dose, assuming a fully loaded ISFSI under the conditions listed in the LaSalle 10CFR72.212 report. 5.2 BWR Skyshine Calculation The contained onsite radioactivity source that results in the most significant offsite radiation levels at LaSalle Station is skyshine resulting from 16 N decay inside turbines and steam piping. Page 11.5-3 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual The 16 N that produces the skyshine effect is formulated through neutron activation of the oxygen atoms (oxygen-16, or 160) in reactor coolant as the coolant passes through the operating reactor core. The 16 N travels with the steam produced in the reactor to the steam driven turbine. While the 16N is in transport, it radioactively decays with a half-life of about 7 seconds and produces 6 to 7 MeV gamma rays. Typically, offsite dose points are shielded from a direct view of components containing 16 N, but there can be skyshine radiation at offsite locations due to scattering of gamma rays off the mass of air above the steamlines and turbine. The offsite dose rate due to skyshine has been found to have the following dependencies:

       " The dose rate decreases as distance from the station increases.

• The dose rate increases non-linearly as the power production level increases.
• The dose rate increases when hydrogen is added to the reactor coolant, an action taken to improve reactor coolant chemistry characteristics (see Reference 39).

To calculate offsite dose due to skyshine in a given time period due to skyshine, LaSalle Station must track the following parameters:

       " The total gross energy Eh produced with hydrogen being added.

• The total gross energy Eo produced without hydrogen being added.

The turbines at the site are sufficiently close to each other that energy generated by the two operating units at may be summed. An initial estimate of skyshine dose is calculated per the following equation: Ds ky = (K)(Eo +MhEh)Z {OFK SFK e-'.°"7RK} (5-1) The summation is over all locations k occupied by a hypothetical maximally exposed member of the public characterized by the parameters specified in ODCM Table 4-8. The parameters in Equation 5-1 are defined as follows: Dssky Dose Due to N-16 Skyshine [mrem] Gamma External direct gamma dose (deep dose equivalent) due to BWR N-16 skyshine for the time period of interest. Page 11.5-4 LaSalle ODCM Part II Section 5

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual K Empirical Constant [mrem/(MWe-hr)] A constant determined by fitting data measured at the each station. E, Electrical Energy Generated Without Hydrogen Addition [MWe-hr] Total gross electrical energy generated without hydrogen addition in the time period of interest. Eh Electrical Energy Generated with Hydrogen Addition [MWe-hr] Total gross electrical energy generated with hydrogen addition in the period of interest. Mh Multiplication Factor for Hydrogen Addition [dimensionless] Factor applied to offsite dose rate when skyshine is present. Hydrogen addition increases main steam line radiation levels typically up to a factor of approximately 5 (see Page 8-1 of Reference 39). Mh is station specific and is given in ODCM Table 4-8. OFk Occupancy Factor [dimensionless] The fraction of time that the dose recipient spends at location k during the period of interest. See ODCM Table 4-8. SFk Shielding Factor (dimensionless] A dimensionless factor that accounts for shielding due to occupancy of structures. SFk = 0.7 if there is a structure at location k; SFk = 1.0 otherwise. See ODCM Table 4-8. 0.007 Empirical Constant [m-1] A constant determined by fitting data measured at the LaSalle station (see Reference 45). Rk Distance [im] Page 11.5-5 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Distance from the turbine to location k. See ODCM Table 4-8. 5.3 Onsite Radwaste and Rad Material Storage Facilities 5.3.1 Process Waste Storage Facilities

• Interim Radwaste Storage Facility (IRSF) structure
• Concrete vaults containing radwaste liners 5.3.2 DAW Storage Facilities
• Dry Active Waste (DAW) facilities (may include Butler buildings/warehouses)
• Seavans or other temporary warehouses 5.3.3 ISFSI Facilities
• Independent spent fuel storage installation facilities.

5.4 Methodology The external total body dose is comprised of the following parts:

1) Total body dose due to noble gas radionuclides in gaseous effluents (Section 4.2.1.1),

2) Dose due to 16 N skyshine (section 5.2) and other contained sources (section 5.3) and

3) Total body dose due to radioactivity deposited on the ground (Section 4.2.3.1).

Page 11.5-6 LaSalle ODCM Part II Section 5

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual The external total body dose due to radioactivity deposited on the ground is accounted for in the determination of the non-noble gas dose and is considered in section 5.5. The total external total body dose, DEx, is given by: DEX = DTB + Dsky + DOSF (5-2) DEx Total External Total Body Dose [mrem] Total external total body dose due to irradiation by external sources at the location of interest. DTB Noble Gas Total Body Dose [mrem] External total body dose due to gamma radiation from noble gas radionuclides released in gaseous effluents at the location of interest. See Section 4.2.2.3. DSky Dose Due to N-16 Skyshine Total Body Dose [mrem] External total body dose due to N-16 skyshine for the period and location of interest. See Equation 5-1. DOSF Dose From On-Site Storage Facilities [mrem] External total body dose due to gamma radiation from on-site storage facilities at the location of interest. See Section 5.3. 5.5 Total Dose The total dose, Dmot, in the unrestricted area to a member of the public due to plant operations is given by: D+ =DLq nTa + DNNG (5-3) where: DTot Total Dose To Member of Public [mrem] Total off-site dose to a member of public due to plant operations. DEX Total External Total Body Dose [mrem] Page 11.5-7 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Total body dose due to external exposure to noble gases, N-16 skyshine and on-site storage facilities. DLaQ Liquid Effluent Dose [mrem] Dose due to liquid effluents to age group a and organ

j. The age group and organ with the highest dose from liquid effluents is used.

D"NG ai Non-Noble Gaseous Effluent Dose [mrem] Dose due to non-noble gaseous effluents to age group a and organ j. The age group and organ with the highest dose from non-noble gas effluents is used. 5.6 COMPLIANCE TO TOTAL DOSE LIMITS 5.6.1 Total Effective Dose Equivalent Limit- 10CFR20 Compliance Each station's RECS limits the Total Effective Dose Equivalent (TEDE) to an annual limit of 100 mrem, as required by 10CFR20.1301 (a)(1). Demonstration of compliance with the limits of 40CFR190 (per Section 4.2.2) will be considered to demonstrate compliance with the 100 mrem/year limit. 5.6.2 Dose to a MEMBER OF THE PUBLIC in the Unrestricted Area The NRC has stated that demonstration of compliance with the limits of 40CFR1 90 or with the design objectives of Appendix I to 10CFR50 will be deemed to demonstrate compliance with the limits of 10CFR20.1301(a)(1). Power reactors that comply with Appendix I may also have to demonstrate that they are within the 25 mrem limit of 40CFR190 (See Reference 104). 5.6.3 Dose to a MEMBER OF THE PUBLIC in the Restricted Area In August of 1995, a revision to 10CFR20 was implemented that changed the definition of a member of the public. As a result, for each nuclear station, estimated doses were calculated for a member of the public who enters the site boundary, but is not authorized for unescorted access to the protected area of the site and does not enter any radiologically posted areas on the site. Page 11.5-8 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Realistic assumptions were made for occupancy times and locations visited while within the site boundary. These evaluations indicate that the doses estimated for these members of the public are well within the 10CFR20 limits. Evaluation of the 40CFR1 90 dose is used to demonstrate compliance to 10CFR20 and satisfy station RECS and Technical Specifications (see ODCM Part I). 5.6.4 Total Dose due to the Uranium Fuel Cycle (40CFR190) RECS and 40CFR190 limit the annual (calendar year) dose or dose commitment to any member of the public due to releases of radioactivity and to radiation from uranium fuel cycle sources to the following:

• Less than or equal to 25 mrem to the total body.
• Less than or equal to 25 mrem to any organ except the thyroid.

Less than or equal to 75 mrem to the thyroid. Total Dose Components This requirement includes the total dose from operations at the nuclear power station. This includes doses due to radioactive effluents (airborne and liquid) and dose due to direct radiation from non-effluent sources (e.g., sources contained in systems on site). It also includes dose due to plants under consideration, neighboring plants and dose due to other facilities in the uranium fuel cycle. The operations comprising the uranium fuel cycle are specified in 40CFR190.02(b). The following are included to the extent that they directly support the production of electrical power for public use utilizing nuclear energy:

• Milling of uranium ore.
• Chemical conversion of uranium.
• Isotopic enrichment of uranium.
• Fabrication of uranium fuel.
• Generation of electricity by a light-watered-cooled nuclear power plant using uranium fuel.

Reprocessing of spent uranium fuel. Page 11.5-9 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Excluded are:

• Mining operations.
• Operations at waste disposal sites.
• Transportation of any radioactive material in support of these operations.

The re-use of recovered non-uranium special nuclear and by-product materials from the cycle. 5.7 When Compliance Assessment is Required Compliance with the 40CFR190 regulations is now required as part of demonstration of compliance to 10CFR20 regulations per 10CFR20.1301(d). The dose due to the uranium fuel cycle is determined by equation 5-3 Page 11.5-10 LaSalle ODCM Part II Section 5

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual 6.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The Radiological Environmental Monitoring Program for the environs around LaSalle Station is given in Table 6-1. Figure 6-1 through Figure 6-3 show sampling and monitoring locations. 11.6-1 LaSalle ODCM Part II Section 6

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 6-1 (Page 1 of 7) Radiological Environmental Monitoring Program Exposure Pathway Sample or Monitoring Location Sampling or Collection Type and Frequency of and/or Sample Frequency Analysis

1. Airborne Continuous sampler Radioiodine Canisters:

operation with particulate Radioiodine and 1). Indicators-Near Field sample collection weekly, 1-131 analysis biweekly Particulates or more frequently if on near field and control L-01, Nearsite No. 1, 1.5 mi (2.4 kin) NNW(N 410 16.016', W88° 40.920') required by dust loading, samples 1 . L-03, Onsite No. 3, 1.0 mi (1.6 km) ENE (N41* 15.145', W 86° 39.174') and radioiodine canister L-05, Onsite No. 5, 0.3 mi (0.5 km) ESE (N 41' 14.520', W 88* 39.355') collection biweekly. Particulate Sampler: L-06, Nearsite No. 6, 0.4 mi (0.6 kin) W(N 41° 14.602', W88' 41.056') Gross beta analysis followinj weekly filter changepand gamma 3 isotopic analysis quarterly on composite filters by location on near field and control samples.'

2. Indicators-Far Field L-04, Rte 170, 3.2 mi (5.1 kin) E (N41* 15.243', W88° 36.451')

L-07, Seneca, 5.2 mi (8.4 km) NNE (N 41° 19.093', W88° 36.473') L-08, Marseilles, 6.0 mi (9.7 km) NNW (N 41

• 19.645', W 88° 42.925')

L-1 1, Ransom, 6.0 mi (9.7 kin) S (N410 09.405', W 880 39.533)

3. Controls L-10, Streator, 13.5 mi (21.7 km) SW (N 410 06.642', W 88°49.481')

11.6-2 LaSalle ODCM Part II Section 6

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 6-1 (Page 2 of 7) Radiological Environmental Monitoring Program Exposure Pathway Sampling or Collection Type and Frequency of and/or Sample Sample or Monitoring Location Frequency Analysis

2. Direct Radiation 1) Indicators-Inner Ring Quarterly Gamma dose on each TLD L-101-1, 0.5 mi (0.8 km) N (N 410 15.084', W88*40.087') quarterly.

a. TLD L-101-2, 0.5 mi (0.8 km) N (N 41° 15.084', W88°40.087')

L-102-1, 0.6 mi (1.0 km) NNE (N 410 15.226', W88°39.915' L-102-2, 0.6 mi (1.0 km) NNE (N 410 15.226', W88*39.915' L-103-1, 0.7 mi (1.1 km) NE (N 410 15.168', W 88°39.492') L-103-2, 0.7 mi (1.1 km) NE (N 410 15.168', W 88°39.492') L-104-1, 0.8 mi (1.3 km) ENE (N 410 15.138', W88039.185') L-104-2, 0.8 mi (1.3 km) ENE (N 410 15.138', W88°39.185') L-105-1, 0.7 mi (1.1 km) E (N 410 14.724', W880 39.425') L-105-2, 0.7 mi (1.1 km) E (N 410 14.724', W88°39.425') L-106-1, 1.4 mi (2.2 km) ESE (N 410 14.328', W88°38.751') L-106-2, 1.4 mi (2.2 km) ESE (N 410 14.328', W 88°38.751') L-107-1, 0.8 mi (1.3 km) SE (N 410 14.308', W88°39.502') L-107-2, 0.8 mi (1.3 km) SE (N 410 14.308', W88°39.502') L-108-1, 0.5 mi (0.8 km) SSE (N 410 14.305', W 88°39.825') L-108-2, 0.5 mi (0.8 km) SSE (N 410 14.305', W88°39.825') L-109-1, 0.6 mi (1.0 km) S (N 410 14.299', W88°40.106') L-109-2, 0.6 mi (1.0 km) S (N 410 14.299', W88°40.106') L-110-1, 0.6 mi (1.0 km) SSW(N 410 14.290', W 88°40.388') L-110-2, 0.6 mi (1.0 km) SSW(N 410 14.290', W 88°40.388') L-1 1lb-1, 0.8 mi (1.3 km) SW (N 410 14.277', W 88040.878') L-1 11 b-2, 0.8 mi (1.3 km) SW (N 41

• 14.277', W 88040.878')

L-1 12-1, 0.9 mi (1.4 km) WSW (N 410 14.403', W 88041.050') L-1 12-2, 0.9 mi (1.4 kin) WSW (N 410 14.403', W 88041.050') L-1 13a-1, 0.8 mi (1.3 km) W (N 41° 14.658', W 88041.055') L-113a-2, 0.8 mi (1.3 km) W (N 41 o 14.658', W 880 41.055') L-1 14-1, 0.9 mi (1-4 km) WNW (N 410 14.991', W 88041.070') L-1 14-2, 0.9 mi (1.4 km) WNW (N 410 14.991', W 88041.070') L-115-1, 0.7 mi (1.1 km) NW(N 410 15.054', W 88°40.529') L-115-2, 0.7 mi (1.1 km) NW(N 410 15.054', W 88°40.529') L-1 16-1, 0.6 mi (1.0 km) NNW (N 410 15.210', W 88040.366') L-1 16-2, 0.6 mi (1.0 km) NNW (N 410 15.210', W 88040.366') 11.6-3 LaSalle ODCM Part II Section 6

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 6-1 (Page 3 of 7) Radiological Environmental Monitoring Program Exposure Pathway Sampling or Collection Type and Frequency of and/or Sample Sample or Monitorng Loction Frequency Analysis

2. Direct Radiation 2) Indicators-Outer Ring Quarterly Gamma dose on each TLD (Cont'd) L-201-3, 4.0 mi (6.4 km) N (N 41° 18.205', W88'40.162') quarterly.

a. TLD L-201-4, 4.0 mi (6.4 km) N (N 410 18.205', W88°40.162')

L-202-3, 3.6 mi (5.8 km) NNE (N 41' 17.793', W88°38.287') L-202-4, 3.6 mi (5.8 km) NNE (N 410 17.793', W88°38.287') L-203-1, 4.0 mi (6.4 km) NE (N 410 17.291', W88°36.311') L-203-2, 4.0 mi (6.4 km) NE (N 41* 17.291', W 88°36.311') L-204-1, 3.2 mi (5.2 kin) ENE (N 410 15.346', W88°36.442') L-204-2, 3.2 mi (5.2 kin) ENE (N 41' 15.346', W88°36.442') L-205-1, 3.2 mi (5.2 km) ESE (N 410 14.144', W88°36.410') L-205-2, 3.2 mi (5.2 km) ESE (N 41° 14.144', W88°36.410') L-205-3, 5.1 mi (8.2 km) E (N 410 14.774', W88°34.209') L-205-4, 5.1 mi (8.2 km) E (N 410 14.774', W88o34.209') L-206-1, 4.3 mi (6.9 km) SE (N 41° 12.825', W88°36.388') L-206-2, 4.3 mi (6.9 km) SE (N 41* 12.825', W88°36.388') L-207-1, 4.5 mi (7.2 km) SSE (N 410 11.476', W 88°37.546') L-207-2, 4.5 mi (7.2 km) SSE (N 410 11.476', W 88°37.546') L-208-1, 4.5 mi (7.2 km) S (N 41 10.818', W 88o39.432') L-208-2, 4.5 mi (7.2 kin) S (N 410 10.818', W 88°39.432') L-209-1, 4.0 mi (6.4 km) SSW(N 41° 11.662', W88°41.173') L-209-2, 4.0 mi (6.4 km) SSW (N 41' 11.662', W 88°41.173') L-210-1, 3.3 mi (5.3 km) SW(N 410 12.519', W88°42.364') L-210-2, 3.3 mi (5.3 kin) SW(N 410 12.519', W88°42.364') L-211-1, 4.5 mi (7.2 km) WSW(N 41' 12.557', W 88°44.489') L-211-2, 4.5 mi (7.2 km) WSW(N 410 12.557', W 88°44.489') L-212-1, 4.0 mi (6.4 km) W(N 410 14.095', W88°44.508') L-212-2, 4.0 mi (6.4 km) W(N 410 14.095', W 88°44.508') L-213-3. 4.9 mi (7.9 km) W(N 410 14.402', W 88°45.674') L-213-4, 4.9 mi (7.9 kin) W(N 410 14.402', W88°45.674') L-214-3, 5.1 mi (8.2 km) WNW(N 410 16.028', W88°45.708') L-214-4, 5.1 mi (8.2 km) WNW(N 41* 16.028', W 88°45.708') L-215-3, 5.0 mi (8.0 km) NW(N 41* 17.760', W88°44.133') L-215-4, 5.0 mi (8.0 km) NW(N 41° 17.760', W88°44.133') L-216-3, 5.0 mi (8.0 km) NNW(N 41° 18.823', W88'42.087') L-216-4, 5.0 mi (8.0 km)NNW(N 410 18.823', W88°42.087') 11.6-4 LaSalle ODCM Part II Section 6

CY-LA-170-301 Revision 3 Part II,Offsite Dose Calculation Manual Table 6-1 (Page 4 of 7) Radiological Environmental Monitoring Program Exposure Pathway Sampling or Collection Type and Frequency of and/or Sample Sample or Monitoring Location Frequency Analysis

2. Direct Radiation 3) Indicators - Other (Cont'd)

a. TLD One at each of the airborne location given in part 1.a.1 and 1.a.2 4). Controls One at each airborne control location given in part 1.a.3 11.6-5 LaSalle ODCM Part II Section 6

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 6-1 (Page 5 of 7) Radiological Environmental Monitoring Program Exposure Pathway and/or S Sampling or Collection Type and Frequency of Sample Sample ~~~~Sample or Monitoring Location FeunyAayi Frequency Analysis

3. Waterborne 3

a. Ground/Well 1) Indicators Quarterly Gamma isotopic and tritium analysis quarterly.

L-27, LSCS Onsite Well at Station (N 41° 14.665', W 88- 40.127') L-28 #6, Marseilles Well, 0 7.0 mi (11.3 km ) N (N 41° 18.215', W 88 39.430')

2) Control Alternate based on availability L-28 #4, Marseilles Well, 6.8 mi (10.9 kin) NNW (N 41° 20.367', W88° 42.054')

L-28 #5, Marseilles Well, 6.6 mi (10.km) NNW (N 41- 20.142', W88° 42.563')

b. Drinking Water There is no drinking water pathway within 6.2 mi (10 kin) downstream of station.

c. Surface Water 1) Indicator Weekly grab sample Gross beta and gamma L-40, Illinois River downstream, isotopic analysis on monthly 5.2 mi (8.4 kin) NNW composite; tritium analysis on (N 41° 19.230', W 88° 42.048') quarterly composite.

2) Control L-21, Illinois River at Seneca, 4.0 mi (6.4 kin) NE (N 41-17.892', W88° 36.308')

d. Sediments 1)Indicators Semiannually Gamma isotopic analysis 3 L-40, Illinois River downstream, 5.2 mi (8.4 kin) NNW semiannually.

(N 41- 19.230', W88° 42.048') L-41, Illinois River downstream 4.6 mi (7.4 kin) N (N 41° 18.678', W88- 40.368')

2) Control L-21, Illinois River at Seneca 4.0 mi (6.4 kin) NE (N 41°17.892', W88' 36.308')

11.6-6 LaSalle ODCM Part II Section 6

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 6-1 (Page 6 of 7) Radiological Environmental Monitoring Program Exposure Pathway Sampling or Collection Type and Frequency of and/or Sample Sample or Monitoring Location Frequency Analysis

4. Ingestion

1) Indicators

a. Milk At the time of this revision, there are no dairies Biweekly: May through Gamma isotopic? and 1-131 4

within 6.2 miles which consistently produce milk. October; monthly: analysis biweekly May November through April through October, monthly

2) Controls November through April.

L-42, Biros Dairy, 14.2 mi (22.9 km)E (N 410 15.379', W88- 23.823') 3

b. Fish 1) Indicator Two times annually Gamma isotopic analysis L-35, Marseilles Pool of Illinois River, on edible portions of each 6.5 mi (10.5 km)NNW (N 41- 19.386', W 88- 42.492')

L-34, LaSalle Lake 2 mi (3.2 km) E

2) Control L-36, Illinois River upstream of discharge, 4.3 mi (6.9 km) NE (N 41- 17.892', W88- 36.308')

a. Indicators Annually Gamma isotopic analysis 3

c. Food Products and 1-131 analysis each Two samples from each of the four major quadrants sample.

within 6.2 miles of the station, ifavailable. Sample locations for food products may vary based on availability and therefore are not required to be identified here but shall be taken.

b. Controls Two samples within 9.3 to 18.6 miles of the station, if available.

11.6-7 LaSalle ODCM Part II Section 6

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Table 6-1 (Page 7 of 7) Radiological Environmental Monitoring Program Far field samples are analyzed when near field results are inconsistent with previous measurements and radioactivity is confirmed as having its origin in airborne effluents released from the station, or at the discretion of the ODCM Specialist. 2 Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours or more after sampling to allow for radon and thorium daughter decay. If gross beta activity in air particulate samples is greater than 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples. Gamma isotopic analysis means the identification and quantification of gamma emitting radionuclides that may be attributable to the effluents from the station. 4 1-131 analysis means the analytical separation and counting procedure are specific for this radionuclide. 11.6-8 LaSalle ODCM Part II Section 6

CY-LA-1 70-301 Revision 3 Part II, Offsite Dose Calculation Manual Figure 6-1 Fixed Air Sampling Sites and Outer Ring TLD Locations 11.6-9 LaSalle ODCM Part II Section 6

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Figure 6-2 Inner Ring TLD Locations 11.6-10 LaSalle ODCM Part II Section 6

CY-LA-170-301 Revision 3 Part II, Offsite Dose Calculation Manual Figure 6-3 Ingestion and Waterborne Exposure Pathway Sample Locations 11.6-11 LaSalle ODCM Part II Section 6}}